PROGRAM - American Urological Association

M E E T I N GPROGRAM

MA

Y 1

3-16

New Orleans

AUA Publications: The Definitive and

Collective Voice of Urology

LAUNCHING JANUARY 2023

Learn more at the Publications Booth in

ENGAGE | EXPLORE RELAX | REFUEL

AUA Café

AUA Central Member Services AUAUniversity Store

Poster Gallery

Video Abstract Theater

AUA Census

AUA Publications

President’s Circle

Registration

Urology Care Foundation

Where will your patients gowith Myrbetriq®?

Find out at Booth #123To learn more, visit MyrbetriqHCP.com

SETTING THE STANDARD FOR UROLOGY WORLDWIDE

join us!Not a member? Visit the AUA Central Booth in

The Square to learn more!

AUAnet.org/join

MORE EDUCATION

MORE RESOURCES

MORE SAVINGS

1

CO

URS

ESSU

ND

AYM

ON

DAY

EXH

IBIT

ORS

THU

RSD

AYFR

IDAY

SATU

RDAY

Table of Contents

Board of Directors ��3

Committees ��4

CME Information ��7

Specialty Programs ��9

Exhibitors ��10

Office of Education Courses ��13

ThursdaySociety of Academic Urologists (SAU) ��19The Economics of Healthcare: Understanding Physician Compensation ��20Your Essential Guide to Congenitalism and Transitional Care Presented by the

AUA in Collaboration with GURS, SPU, and SUFU ��21

FridayPlenary: Prime Time Friday Morning Session ��25Plenary: Prime Time Friday Afternoon Session ��26Poster, Podium and Video Sessions (MP1–3, PD1–4, V1) ��27Indian American Urological Association (IAUA)��36AQUA Forum & Breakfast ��37Confederación Americana de Urología (CAU)��37Sexual Medicine Society of North America (SMSNA) ��38Poster Sessions (MP4–6) ��39AUA Robotics Theater Sponsored by Intuitive: Multiport Robotic Procedures—Prostate

and Kidney Cancers ��44Podium and Video Sessions (MP5–8, V2) ��44Society of Genitourinary Reconstructive Surgeons (GURS) ��49Poster Sessions (MP7–9) ��50Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) ��55Editorial Workshop: Getting Published and Beyond ��55History of Urology Forum ��56Poster, Podium and Video Sessions (MP10–12, PD9–12, V3) ��57Poster and Podium Sessions (MP13–15, PD13–16) ��68Poster Sessions (MP16–18) ��77

SaturdayPlenary: Prime Time Saturday Morning Session ��85Plenary: Prime Time Saturday Afternoon Session ��85Poster, Podium and Video Sessions (MP19–21, PD17–21, V4) ��86Urologic Care for the Advanced Practice Provider ��98Societies for Pediatric Urology (SPU) ��98Society for Basic Urologic Research/Society of Urologic Oncology (SBUR/SUO) ��100American College of Osteopathic Surgeons (ACOS) ��100Poster Sessions (MP22–24) ��100AUA Robotics Theater Sponsored by Intuitive: Multiport Benign Innovation and

Surgical Procedures—Reconstruction and Bladder Cancer ��106Podium Sessions (PD22–25) ��107Young Urologists Forum��111Poster Sessions (MP25–27) ��111Society of Urologic Oncology (SUO) ��117Poster, Podium and Video Sessions (MP28–30, PD26–30, V5) ��118Asociación Española de Urología (AEU) ��129Society for Basic Urologic Research (SBUR) ��129Brazilian/Portuguese Urology Program (BPUP) ��130Korean World Urologic Congress (KWUC) ��130

2

Poster Sessions (MP31, 32) ��131Sociedad Colombiana de Urología ��134Clinical Controversies in Men’s Health ��134Podium and Video Sessions (PD31–34, V6) ��135Medical Student Forum ��140Poster Sessions (MP33–35) ��141

SundayPlenary: Prime Time Sunday Morning Session ��149Plenary: Prime Time Sunday Afternoon Session ��149Residents Forum ��150Poster, Podium and Video Sessions (MP36–38, PD35–39, V7) ��151Society of Women in Urology (SWIU) ��162Challenges for Urologic Research Symposium ��162Engineering and Urology Section of the Endourology Society (EUS) ��163American Society for Men’s Health (ASMH) ��163Urologic Care for the Advanced Practice Provider ��164Poster Sessions (MP39,40) ��164AUA Robotics Theater Sponsored by Intuitive: Single Port Robotic Procedures ��168Podium and Video Sessions (PD40–44, V8) ��168International Prostate Forum ��175Poster Sessions (MP41–43) ��176Urological Society for American Veterans (USAV) ��181Society of Urologic Robotic Surgery (SURS) ��181Poster, Podium and Video Sessions (MP44–46, PD45–48, V9) ��182Late-Breaking Abstract I – Cancer & BPH ��193Early Career Investigators Showcase ��193Geriatric Urological Society (GUS) ��193Engineering and Urology Section of the Endourology Society (EUS) Poster Session ��194Society for Infection and Inflammation (SIIU) ��194R� Frank Jones Urological Society (RFJUS) ��194Society for the Study of Male Reproduction (SSMR) ��195Urologic Society for Transplantation & Renal Surgery (USTRS) ��195Quality Improvement Summit ��196Bladder Cancer Forum ��196British Association of Urological Surgeons/BJU International/Urological Society of Australia

and New Zealand/Scandinavian Association of Urology (BAUS/BJUI/USANZ/SCAUR) ��197Sociedad Argentina de Urología (SAU) ��198Società Italiana di Urologia (SIU) ��198Poster, Podium and Video Sessions (MP47,48, PD49–51, V10) ��199Late-Breaking Abstract II – Benign Disease ��207Poster Sessions (MP49–51) ��208

MondayPlenary: Prime Time Monday Morning Session ��217Plenary: Prime Time Monday Afternoon Session ��217Research on Calculus Kinetics Society (ROCK) Non-CME Industry Sponsored

Breakfast Program ��217Research on Calculus Kinetics Society (ROCK) ��218Research on Calculus Kinetics Society (ROCK) Non-CME Industry Sponsored

Lunch Program ��218Poster, Podium and Video Sessions (MP52,53, PD52–54, V11) ��218Society of Benign Prostate Disease ��226Urological Association of Central America & the Caribbean (AUCA)��227Poster, Podium and Video Sessions (MP54,55, PD55–57, V12) ��227Poster, Podium and Video Sessions (MP56–59, PD58–60, V13) ��234

3

AUA Annual Business MeetingErnest N. Morial Convention Center

Rivergate RoomMonday, May 16, 2022 @ 12:00–12:30 pm

2021–2022 Board of Directors

Officers of the Board of Directors

President ..............................................................................................................Raju Thomas, MD, FACS, FRCS President-Elect ....................................................................................................Edward M. Messing, MD, FACSImmediate Past President ......................................................................................Scott K. Swanson, MD, FACSSecretary .................................................................................................... John D. Denstedt, MD, FACS, FRCSCTreasurer .................................................................................................................Thomas F. Stringer, MD, FACS

Section Representatives to the Board of Directors

Mid-Atlantic .................................................................................................................Kurt A. McCammon, MDNew England ..................................................................................................................... Arthur Tarantino, MDNew York .......................................................................................................................... Reza Ghavamian, MDNorth Central .................................................................................................................James C. Ulchaker, MDNortheastern .............................................................................................................. Hassan Razvi, MD, FRCSCSouth Central .....................................................................................................................Anthony Y. Smith, MDSoutheastern .......................................................................................................... Martin K. Dineen, MD, FACSWestern ................................................................................................................................Eric J. Zeidman, MD

AUA HeadquartersAmerican Urological Association, Inc.

1000 Corporate BoulevardLinthicum, Maryland 21090Telephone: 410-689-3700

FAX: 410-689-3800Email: [email protected]

Website: www.auanet.org

4

2022 Committees

Program Planning CommitteeDean Assimos Paul Austin John Barry Marc BjurlinTimothy Brand Serge Carrier Michael Chancellor Ben Chew Michael Cookson Nick Cowan Lindsey Cox John DenstedtAnanias Diokno Ahmed GhaziDavid Ginsberg Leonard Gomella Tomas Griebling C. D. Anthony HerndonJames Hotaling Haojie Huang David Jarrard Steven Kaplan Anil Kapoor Susan Kasper Mohit KheraZiya Kirkali Tobias Kohler Steven Kraus Dolores Lamb Vincent Laudone Brian Matlaga

Kurt McCammon Linda McIntire Patrick McKennaAkanksha Mehta Jeremy Myers Vernon Pais Margaret Pearle Anne Pelletier-CameronKristina Penniston David Penson Michel Pontari Raj Pruthi Jay Raman Polina ReyblatBenjamin Ristau Neal Rowe Andrew Rule Brad Schwartz Kymora Scotland Alp Sener Ojas Shah David Shin James Smith Li-Ming Su Chandru Sundaram Ash Tewari Simone ThavaseelanJannah ThompsonSandip VasavadaJeffrey Veale James Wysock

Video Abstract Review Committee

Sero AndonianAngela ArlenClinton Bahler Cooper BensonMarc BjurlinRonald BorisDavid CanesDavid Chen Allen ChiuSung Yong Cho Joseph ClarkElizabeth Corrales Akhil DasCarley Davis Daniel Dugi Bradley EricksonGregg Eure Sarah Faris Robert FigenshauAlvin GohHanan Goldberg

Tamsin Greenwell Guillermo GueglioMohan Gundeti Justin HanGerard Henry Lindsey Herrel Sender Herschorn Mathias Hofer Stanton Honig Elias Hyams Brett Johnson Pankaj Joshi Matthew Kaag Taek Won KangEric KimJohn Knoedler Jason Kovac Ryan KrlinAnant KumarCostas Lallas Aaron Lay

Wai Lee Max Levine Amy Luckenbaugh Susan MacDonald Ayman Mahdy Rich Matulewicz Andrew McIntoshFrancesco Montorsi Ryan Mori Rachel Moses Dena Moskowitz Robert Nadler Gladys NgKenneth Ogan Andrew Peterson Ruben PinkhasovSima Porten James PorterErick Ramirez Perez Benjamin RistauChad Ritch

Marcelino RiveraKyle Rove Matthew Rutman Kristen ScarpatoEd SchaefferAriel Schulman Michael Schwartz J. Patrick Selph Michele Jo Semins Ahmed Shoma Ajay SinglaMichael StaehlerRobert SteinNecole Streeper Kristina Suson Chad TracyKrishnan Venkatesan Ramakrishna Venkatesh Boyd Viers Eric Wallen Jennifer Yang

Program Abstract Review Committee

Philip AbboshRobert AbouassalyNitya AbrahamAndre AbreuRosalyn AdamRajesh AhlawatJennifer AhnDivya Ajay

Horacio AlemanHusain AleneziZaki AlmallahSeth AlpertJoseph AlukalChristopher AmlingChristopher AndersonKenneth Angermeier

Jodi AntonelliAndrés Arley VargasMonish AronWilliam AronsonHugo Arriaga MoralesDean AssimosAnthony AtalaMelanie Aube Peterkin

J. Christopher AustinPaul AustinRiccardo AutorinoMárcio AverbeckTimothy AverchKara BabaianKetan BadaniGopal Badlani

5

Michael BaileyLinda BakerK. C. BalajiD. Duane BaldwinChris BangmaMarcelo BaptistussiChristopher BarbieriPaholo Barboglio RomoDaniel BarocasAaron BayneDarren BeikoRyan BerglundJonathan BergmanNorberto BernardoSara BestNaeem BhojaniTrinity BivalacquaJennifer BjazevicDale BjorlingPeter BlackMichael BluteStephen BoorjianJoseph BorerMichael BorofskyLuis BragaTimothy BrandSteven BrandesRobert BranniganBen BreyerAlberto BrigantiGerald BrockGregory BroderickJoshua BroghammerJames BrooksBenjamin BruckerJill BuckleyFiona BurkhardFrank BurksArthur BurnettJeremy BurtonJeffrey CadedduBrian CaldwellJeff CampbellSteven CampbellBenjamin CanalesGlenn CannonStephen CanonNoah CanvasserMaude CarmelSerge CarrierPeter CarrollWilliam CatalonaToby ChaiKarim ChamieMichael ChancellorSam ChangEarl ChengTom ChiJoseph ChinChristina ChingEdmund ChiongKellen ChoiMatthew ChristmanDavid ChuKai-wen ChuangBilal ChughtaiDoreen ChungPeter ClarkQuentin ClemensMichael CoburnSeth Cohen

Craig ComiterPablo ContrerasMichael CooksonChristopher CooperMatthew CooperbergHillary CoppNicholas CostNicholas CowanLindsey CoxJimena CubillosAnthony D’AmicoRajvir DahiyaDaniel DaJustaMargot DamaserSiamak DaneshmandKassa DargeProkar DasguptaTimothy DaskivichCasey DauwBenjamin DaviesKelvin DaviesJohn DavisShubha DeRoger De FilippoDavid DeGraffChristopher DeibertDonna DengIthaar DerweeshJanak DesaiMihir DesaiHeather Di CarloRian DicksteinMartin DineenMichael DiSantoMiroslav DjordjevicRoger DmochowskiSteeve DoiziS. Machele DonatTracy DownsBeth DrzewieckiDavid DucheneJames EasthamMark EdneyScott EggenerKaryn EilberBrian EisnerObi EkwennaChristopher ElliottDaniel ElliottSean ElliottJonathan EllisonDean EltermanCarlos EstradaMasatoshi EtoChristopher EvansCarlos Fajardo RiveraDarren FeldmanAmr FerganyJose Luis FernandezMario FernandezFernando FerrerChristopher FilsonNeil FleshnerBrian FlynnJames FordeStephen FreedlandMichael FreemanDominic FrimbergerGerhard FuchsPat FulghamAllen Gao

Mark GarzottoJohn GattiBoris GershmanKhurshid GhaniReza GhavamianAhmed GhaziGamal GhoniemGianluca GiannariniBradley GillJason GilleranPeter GillingDavid GinsbergSidney GlinaEhud GnessinDavid GoldfarbHoward GoldmanAndrew GoldsteinLeonard GomellaAlexander GomelskyReynaldo GomezMario GonzalezRicardo GonzalezMark Gonzalgo Ronak GorJennifer GordetskyJohn GoreE. GormleyAngelo GousseCandace GranbergMichael GrassoChristian GratzkeKirsten GreeneAndreas GrossAmy GuiseGopal GuptaMantu GuptaPriyanka GuptaKhurshid GuruJorge Gutierrez-AcevesGeorges HaberJudith HagedornAri HakimiJoshua HalpernLindsay HampsonJoanna HannanPhilip HannoKelly HealyJason HedgesMarah HehemannBrian HelfandWayne HellstromSevann HeloAshok HemalC. D. Anthony HerndonTy HiguchiJeffrey HolzbeierleinSung Kyu HongRyan HsiJim HuWilliam C. HuangWilliam J. HuangShu-Pin HuangKatherine Hubert ChanSteven HudakMitchell HumphreysAndrew HungKathleen HwangBrant InmanVesna IvancicMicah JacobsDavid Jarrard

Keith JarviVenkata JayanthiLawrence JenkinsTravis JerdeEmilie JohnsonTed JohnsonJ. Stephen JonesSteven JoniauMark JordanJean JosephKerstin JunkerAshish KamatChristopher KaneJihad KaoukSteven KaplanAnil KapoorR. Jeffrey KarnesAaron KatzLouis KavoussiDeborah KayeMelise KeaysMichael KennellyMohit KheraAdam KibelKathleen KieranFernando KimSimon KimAdam KlausnerThomas KnollBodo KnudsenEdmund KoKathleen KobashiChester KohTobias KohlerPaul KokorowskiPeter KolettisThomas KolonKevin KooRobert KovellAmy KrambeckEvgeniy KreydinAaron KrillBradley KroppTracey KrupskiJanet KukrejaSanjay KulkarniRajeev KumarAli KuralMichael KurtzEric KurzrockAlexander KutikovM. Pilar LagunaHenry LaiDolores LambJaime LandmanDirk LangeAlessandro LarcherJerilyn LatiniJohn LavelleBenjamin LeeByron LeeJason LeeKyu-Sung LeeUna LeeGary LemackSara LenherrHerbert LeporSeth LernerLaurence LevineDaniel LibermanJohn Lieske

6

Daniel LinBrian LinderMichael LipkinLarry LipshultzMichael LissMark LitwinDennis LiuKirk LoStacy LoebBal LokeshwarVinata LokeshwarChristopher LongArmando LorenzoYair LotanKevin LoughlinFranklin LoweAlvaro LucioniPatrick LukeJohn LynchThomas LynchDanil MakarovRena MalikStanley MalkowiczJodi MaranchieVitaly MargulisChristopher MarshPuneet MassonViraj MasterTimothy MastersonRanjiv MathewsSurena MatinBrian MatlagaEduardo MazzucchiTimothy McClureElspeth McDougallPatrick McKennaJames McKiernanErin McNamaraKevin McVaryJoshua MeeksAkanksha MehtaAlex MellerArturo Mendoza-ValdésPaul MerguerianEdward MessingMichael MetroBadar MianNicole MillerJesse MillsSuks MinhasRosalia MisseriNihal MohamedRobert MoldwinFriedrich MollCaroline MooreAllen MoreyTodd Morgan Bradley MorgansternMarco MoschiniPiruz MotamediniaJudd MoulM. Sherif MouradJohn MulhallAlana MurphyKatie MurrayNicolas MuruveJamal NabhaniStephen NakadaNissrine NakibNeema NavaiRoman Nawroth

Caleb NelsonChristian NelsonCasey NgJ. Curtis NickelAlan NiederAmanda NorthUnwanaobong NseyoZeph OkekeBulent OnalMichael OrdonKenneth PacePriya PadmanabhanAllan PantuckAthanasios PapatsorisGyan PareekWilliam ParkerC. Lowell ParsonsSutchin PatelJohn PattarasStephen PautlerMargaret PearleAmy PearlmanAnne Pelletier CameronKristina PennistonDavid PensonIngrid PersckyFiras PetrosDaniel PetrylakCurtis PettawayMichael PhelanJohn PhillipsPhillip PierorazioPeter PintoJoao Pippi SalleCarol PodlasekKamal PoharHans PohlThomas PolascikMichel PontariDix PoppasFrancesco PorpigliaChristopher PorterNicholas PowerKevin PranikoffGlenn PremingerGail PrinsSilvia ProiettiRaj PruthiSarah PsutkaYeong-Shiau PuSanoj PunnenJ. Todd PurvesRonald RabinowitzOmer RaheemGanesh RajDavid RalphRanjith RamasamyDavid RappAndrew RasmussenHassan RazviLeonardo Reis William RickeLeslie RickeyMack RoachWilliam RobertsClaus RoehrbornNirit RosenblumAshley RossKeith RourkeJonathan RouthEric Rovner

Neal RoweRachel RubinMichael RuggieriLeticia RuizDaniel RukstalisPaul RussoFred SaadRavindra SabnisHossein Sadeghi-NejadChristopher SaigalAndrea SaloniaCarolyn SalterMary SamplaskiMartin SandaJaspreet SandhuJay SandlowGrannum SantRichard Santucci Kemal SaricaA. Oliver SartorStephen SavageCharles ScalesAnthony SchaefferDouglas ScherrPeter SchlegelBruce SchlomerFranz SchmidlinAnne SchuckmanBradley SchwartzKymora ScotlandAlp SenerAmlesh SethOjas ShahJoel SheinfeldPatrick ShenotCourtney Shepard StreurAlan ShindelNeal ShoreAseem ShuklaD. Robert SiemensKarl-Dietrich SievertJennifer SingerEila SkinnerAndreas SkolarikosTed SkolarusAngela SmithAriana SmithEdwin SmithJoseph SmithNorm SmithZachary SmithPhilippe SpiessArmando StabileArnulf StenzlHeidi StephanyKevan SternbergChristian StiefDouglas StormLynn StothersDouglas StrandKelly StrattonSeth StropeLi-Ming Su Chandru SundaramDebasish SundiAnne SuskindSuzette SutherlandRobert SweetKonrad SzymanskiRajeev T.P. Thomas Tailly

Elizabeth TakacsHung-Jui (Ray) TanKazunari TanabeStacy TanakaSamir TanejaSimon TanguayGregory TasianJennifer TaylorAlexis TeRyan TerleckiMartha TerrisChristopher TessierSimone ThavaseelanJohn ThomasKay ThomasJannah ThompsonR. Houston ThompsonPraveen ThumbikatMatt TollefsonKarim TouijerEdouard TrabulsiOlivier TraxerLandon TrostThomas TurkBen TurneyJames UlchakerRobert UzzoAndre van der MerweBrian VanderBrinkEvan VapnekSandip VasavadaJeffrey VealeChad VezinaSarah VijCarlos VillanuevaBryan VoelzkeM. Chad WallisJulian WanPeter WangRun WangChristopher WarlickSamuel WashingtonGraham WatsonJohn WeiDana WeissRobert WeissBlayne WelkCharles WelliverHunter WessellsO. Lenaine WestneyMichael WhalenJohn WienerDuncan WilcoxStuart WolfKyle WoodGuan WuHsi-Yang WuFaysal YafiClaire YangElizabeth YerkesEzekiel YoungRichard YuRebecca ZeeLee ZhaoMatthew ZiegelmannArmand ZiniMichael ZitzmannKevin Zorn

7

CME Information

Statement of Need

Urology practitioners need thorough knowledge of the most recent developments and techniques, as well as established guidelines in urology, to ensure the highest standards of patient care and safety.

Learning Objectives

At the conclusion of the 2022 Annual Meeting, partici-pants should be able to:● Describe recent developments in the medical and

surgical management of urology patients.● Identify new technologies for the treatment of uro-

logical conditions.● Integrate the latest guidelines on the management

of urological diseases into their practice.● Incorporate evidence-based research and literature

into the shared decision-making process.

Method of Participation

Learners will participate by attending the in-person session(s), logging into the live virtual session(s), or logging into the on-demand (enduring) activity(ies) beginning May 12, 2022 through August 31, 2022. Af-ter completing selected sessions/activities, learners will complete the credit claim attestation and activ-ity evaluation.

Accreditation Statement

The American Urological Association (AUA) is accredit-ed by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical ed-ucation (CME) for physicians.

Credit Designation*

The AUA designates this other activity (live and endur-ing materials) for a maximum of 457.5 AMA PRA Cate-gory 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (*Note, the maximum credits is subject to change if sessions are added or canceled prior to the activity start date.)

Other Learners

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the ac-tivity was certified for AMA PRA Category 1 Credit™.

Evidence-Based Content

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy

All persons in a position to control the content of an edu-cational activity (i.e., activity planners, presenters, authors, reviewers) are required to disclose to the provider any rel-evant financial relationships with any commercial interest during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educa-tional content and mitigate any conflicts of interest prior to the commencement of the educational activity. The in-tent of this disclosure is not to prevent individuals with rel-evant financial relationships from participating, but rather to provide learners with information so they can make their own judgments.

Disclosures are posted online at www.auanet.org/ annualmeeting/speakers/disclosures.

Mitigation of Identified Conflict of Interest

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Educa-tion staff, will document the mechanism(s) for manage-ment and mitigation of the conflict of interest, and final approval of the activity will be documented prior to im-plementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:● Peer review for valid, evidence-based content by the

AUA COI Review Work Group.● Attestation that clinical recommendations are evi-

dence based and free of commercial bias.● Introduction of a debate format (point-counter-

point).● Inclusion of moderated panel discussion with unbi-

ased moderator.● Publication of a parallel or rebuttal article for an arti-

cle that is felt to be biased.● Divestiture of the relationship by faculty.● Recusal from controlling relevant aspects of planning.● Selection of alternative faculty for specific topic.

Off-Label or Unapproved Use of Drugs or Devices

The audience is advised that this CME activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing infor-mation for full disclosure of approved uses.

http://www.auanet.org/annualmeeting/speakers/disclosures

http://www.auanet.org/annualmeeting/speakers/disclosures

8

Disclaimer

The opinions and recommendations expressed by faculty, authors, and other experts whose input is includ-ed in this program are their own and do not necessarily represent the viewpoint of the AUA.

Claiming Your Certificate of Attendance

You may receive your Certificate of Attendance using one of the following options:● Scan your badge onsite in the Registration Hall on

Sunday, May 15, 2022 or Monday, May 16, 2022.● Log in to www.auanet.org/annualmeeting/attend-

ee-info/cme-credits.

Claiming Your CME Credits

To claim credit/participation hours:1. Scan your badge upon entrance into accredited

sessions (except for in-person Plenary), log in to the live virtual sessions or on-demand sessions.

2. Log in to the CME Credit Claim: www.auanet.org/ annualmeeting/attendee-info/cme-credits.

3. Accredited sessions that you logged into or scanned into will be listed.

4. Add any in-person Plenary sessions you attended to your list of sessions.

5. For each session you attended, select the appropri-ate number of credits/hours that correspond to your participation in the session.

6. After you have completed all sessions, you must complete the activity evaluation and attest to your fi-nal credits/hours to have your credits added to your AUA transcript. Note: No changes may be made af-ter final submission of your credits/hours.

Note: ● You may participate in on-demand activities through

August 31, 2022. After this date, you will no longer have access to view on-demand sessions.

● Credit/participation hours must be claimed by December 31, 2022.

Questions? Email [email protected].

CME Information

http://www.auanet.org/annualmeeting/attendee-info/cme-credits




9

Specialty Programs

Page

American College of Osteopathic Surgeons ..............................................................................................100

American Society for Men’s Health ..............................................................................................................163

Asociación Española de Urología ...............................................................................................................129

AUA/Brazilian Portuguese Urology Program ................................................................................................130

AUA/Confederación Americana de Urología ...............................................................................................37

British Association of Urological Surgeons ...................................................................................................197

Engineering and Urology Section of the Endourological Society ..............................................................163

Geriatric Urological Society ..........................................................................................................................193

Indian American Urological Association .......................................................................................................36

Korean World Urologic Congress ..................................................................................................................130

R. Frank Jones Urological Society .................................................................................................................194

Research on Calculus Kinetics Society ........................................................................................................218

Sexual Medicine Society of North America ...................................................................................................38

Sociedad Argentina de Urología .................................................................................................................197

Sociedad Colombiana de Urología ............................................................................................................134

Società Italiana di Urologia ..........................................................................................................................198

Societies for Pediatric Urology ........................................................................................................................98

Society for Basic Urologic Research .............................................................................................................129

Society for Basic Urologic Research and Society of Urologic Oncology ...................................................100

Society for Benign Prostate Disease .............................................................................................................226

Society for Infection and Inflammation in Urology ......................................................................................194

Society for the Study of Male Reproduction ................................................................................................195

Society of Women in Urology ........................................................................................................................162

Society of Academic Urologists ......................................................................................................................19

Society of Genitourinary Reconstructive Surgeons .......................................................................................49

Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction .....................................55

Society of Urologic Oncology .......................................................................................................................117

Society of Urologic Robotic Surgery .............................................................................................................181

Urologic Society for Transplantation & Renal Surgery .................................................................................195

Urological Association of Central America & the Caribbean ....................................................................227

Urological Society for American Veterans ....................................................................................................181

10

A&E Endoscopy 2008A.M.I. Agency for Medical Innovations

GmbH 1044AAAASF 2225AbbVie 725Accord BioPharma 2343Acerus Pharmacueticals

Corporation 2245, 2639Advance Medical Designs 2007Advanced Accelerator Applications 2630AGILITI 1318Akina Pharmacy 1562AmbiMedInc 1843Ambry Genetics 905Ambu Inc 2001, 2736, 2741America Medic & Science, AMS 2065American Medical Endoscopy/

Strauss Surgical 1928AngioDynamics 1460Antares Pharma, Inc 1455Applaud Medical, Inc. 1862Asclepion Laser Technologies GmbH 2423Asociación Urológica de

Centroamerica y Caribe (AUCA) 2131Aspirus Health 1860ASSI-Accurate Surgical & Scientific

Inst 1805Astellas Pharma US 123AstraZeneca 617, 2661, 2760Auris Health 1207, 2654Avenda Health 854Axonics, Inc. 2145BARD1 Life Sciences Ltd 1841Bayer 1537BD 2627, 2637Best Medical International 1963Biobot Surgical 2327BioProtect Ltd. 1229Biote Medical 1852BK Medical 1317, 2756Blue Earth Diagnostics, Inc. 455Bonraybio CO., LTD. 1658Boston Scientific 137, 2537, 2649Bostwick Laboratories 929Bristol Myers Squibb 2427, 2454Butterfly Medical 857Butterfly Network 2355Calyxo, Inc. 2561Canadian Urological Association 1845Candel Therapeutics 1020CareMed Specialty Pharmacy/

Onco360 Oncology Pharmacy 2425CAREstream America 2326Caris Life Sciences 2328Carle Health 2224Case Recruiters, Inc 963CellOxess Biotechnology 1654Celularity Inc. 1759CG Oncology, Inc. 2526CIVCO MEDICAL SOLUTIONS 2323Clarity Diagnostics 2260Clarus Therapeutics 1507Cleveland Diagnostics, Inc. 2530Colegio Mexicano de Urología

Nacional, A. C. 2117Coloplast Corp. 707, 2667, 2673, 2772Combat Medical Ltd. 959CompHealth 2110Confederación Americana de

Urología 2117Connected Medical Services (CMS) 1760Convergent Laser Technologies 1309Cook Medical 1325Cook MyoSite 1000CoolBeans Men’s Health Underwear 2361Corinth MedTech 955Creative Medical Technology

Holdings Inc 2062CS Surgical, Inc 2231Dartmouth-Hitchcock 2056Deep Bio 2161

Dendreon Pharmaceuticals LLC 1017Department of Veterans Affairs 1856Designs for Vision, Inc. 911DOCTUS EQUIPAMENTOS MEDICOS

LTDA 2417Dornier MedTech 1637Ecleris USA 2058Edge Pharma 2318Eigen Health 2349Electro Medical Systems SA 1036Elsevier 1008EMD Serono/Pfizer Aliance 2229Encore, Inc. 1961Endo Pharmaceuticals 1301, 2737Endoscopy Solutions 1946Endourological Society, Inc. 1861Ethicon 2461European Association of Urology 1908EVEXIAS Health Solutions 1762Exact Sciences/Oncotype 647, 2567Exelixis, Inc. 1945Exosome Diagnostics, a Bio-Techne

brand 461Fellow 2329Firefly Global 1006FirmTech Inc. 2538Flume Catheter Company 2439Focal Healthcare, Inc. 1936Focal One 117Focalyx, LLC 1555Foundation Medicine, Inc. 1709Francis Medical 2666Fujifilm 1701Genentech 2005GEOTEK Medical USA LLC. 2324Gilead Sciences, Inc. 2428Global Fair Play 2100Global Medical Endoscopy 2000GloShield 1959GoPath Diagnostics 2053GOTOP Medical, Inc. 1022Guangzhou Red Pine Medical

Instrument Co., Ltd 2523Guerbet, LLC 2317Health Best International LLC 2006Health First Medical Group 2429HealthTronics, Inc. 845Hispanic Urology Society North

America 1956Huger Medical Instrument Co. Ltd 1056Hunan Vathin Medical Instrument

Co.,Ltd. 2216Imagin Medical 2555ImmunityBio, Inc. 559INB Medical 2109Inform Diagnostics 2421Infuserve America 1942Innovex Medical 759inReach Health 1361Insightec 2465Integra Life Sciences 2422Intermountain Healthcare 2221Intuitive 207, 2759, 2761Irrisept 2111isoray 2516IVUmed 1328Janssen Biotech, Inc. 1023, 2642, 2672, 2742Japanese Urological Association 2127KARL STORZ Endoscopy - America,Inc. 1937Kidney Cancer Association 2108Koelis 1201Laborie Medical Technologies Corp. 517Lantheus 1337Lazarus 3D 1046LiNA Medical 755LithoLyte 701LocumTenens.com 1821LP Surgical Fibers 1916LynxDx 1663Male From Home 1064Marshfield Clinic Health System 2060

McLeod Health 2259Mcube Technology Co., Ltd. 1847MDxHealth 801Med Fibers, Inc. 663MedicaMetrix, Inc. 2258Medifix Inc. 1560Mediflex 954Mediplus 917Medispec Ltd. 1355Medpro 1217Medtronic 1601Melzi 1761Memorial Healthcare System 2220MenHealth 1858Merck & Co., Inc. 1645, 2655MicroGenDX 1753Mid-Atlantic Section of the AUA 1954Millennium Physician Group 1004MIM Software Inc. 1026miR Scientific LLC 945, 2743Mitaka USA 2623Modernizing Medicine 1609Molecular Lab Partners 1559Molecular Testing Labs 1661Moonstone Nutrition 1763Multiphze LLC 859My PCR Lab LLC 2626Myovant Sciences, Inc. and Pfizer,

Inc. 1917, 2543, 2754Myriad Genetics 2460, 2771MysteryVibe 2223NAED, Inc 1955NanoEnTek America, Inc 961Nanospectra Biosciences 958National Ultrasound 2230Neoscope2020 1461NeoTract | Teleflex 323New York Section Of The American

Urological Association Inc 1859NextMed 109NinoMed 1501North Central Section of the AUA,

Inc./South Central Section of the AUA, Inc. 1962

Northwell Health 2438Norton Children’s Urology, affiliated

with the UofL School of Medicine 2104Ochsner Health 2463Officite 1223Ohio Valley Healthcare Solutions 1225Olympus 537OPERATION HAPPENIS 2222OPKO Health, Inc. 747Optical Integrity, Inc. 1060Oruba Technology & Innovation 2358OSF HealthCare 2227OTU Medical Inc 1330Pacey Medtech Ltd 2528Pacific Edge Diagnostics 1829Paige 2360Palette Life Sciences 2264, 2265Panacea Financial 1324Pathnostics 361Pelvic Wave 2527Perineologic 257Pfizer Oncology 337, 2643Philips 717Photocure 2237, 2755Porter Instrument 1659PracticeLink.com 2436Practis 1316Prairie Lakes Healthcare System 2419PROCEPT BioRobotics 147, 2545, 2549ProEndoscopy 2325Profound Medical 1447Prologics Healthcare 1322Promaxo 1009Prometheus Group, The 1837Promis Dx 1757Prostate Conditions Education Council 1024Prostatype Genomics AB 1365

2022 Annual Meeting Exhibits

Booth(s) Booth(s) Booth(s)

11

Pusen Medical 101QDx Pathology Services 1801Quanta System SPA 447Quantib 1944Quibim 2155QuickChange/UI Medical 858Qventus 2106Reditus Laboratories, LLC 2253Revive Rx 2165RG Medical 2052Rhosse Medical 2337Richard Wolf Medical Instruments

Corporation 1926, 1927Rigicon,Inc. 1058ROCAMED 201Rose Micro Solutions LLC 1030, 2217RosmanSearch 2004Sagent Urology 919SCRUBS RRG 1219Seagen, Inc. 1953SEPLOU INC. 1940Sesen Bio 2773SH MEDICAL CORP 901Shanghai SeeGen Photoelectric

Technology Co.,Ltd. 2424Siemens Healthineers 2137Signati Medical, Inc. 1823Skagit Regional Health 2426Sociedad Argentina de Urología 2121Sociedade Brasileira de

Urologia (SBU) 2123Sociedad Colombiana de Urología 2129Société Internationale d’Urologie (SIU) 1958Society of Government Service

Urologists (SGSU) 1855Sonablate Corp 549Soniquence 1922SonoMotion, Inc. 1909

Sontec Instruments 1900Soundable Health 1924Southeastern Section of the AUA,

Inc./Northeastern Section of the AUA, Inc. 1964

Specialty Networks, LLC 1221Spectrum Health Lakeland 2518Spero Therapeutics 1907, 2766Springfield Clinic 2159SRS Medical Corp. 317Stanford Medicine Technology

Enabled Clinical Improvement (TECI) Center 2517

STERIS Corporation 1653Strauss Surgical USA 2261Stream Dx 1564Stryker 2455Sun Pharma 1901Surgical Affiliates Management

Group 1463Surgical Science - Simbionix

Simulators 1016Surgitel 1905Telix Pharmaceuticals (US) Inc. 655Tempus 2163Teradek 2722The Gideons International 2459The Guthrie Clinic 2226The Permanente Medical Group 2622Theator 1054Theralogix 855Tolmar Pharmaceuticals 527TrackableMed 2009Travere Therapeutics - Thiola EC 927Uberlube 2330UC-CARE 921UFM Underwear for Men 2431UHS 2320

United Endoscopy 1807United Medical Systems 1417United States Navy Recruiting 2105University Compounding Pharmacy 1547Urethrotech 907URO-1, Inc 923UroChoice 2219UroGen Pharma Inc 837, 2775Urology Surgical Consulting/

Better Body MD 1758Urology Times 1906UrologyLocums.com 2449UROTRAINER 1904Urotronic 1817Urovant Sciences, Inc. 1001, 2748, 2768UroViu Corporation 355Utiva, by Szio+ 2254Valencia Technologies 2617Vascular Technology 1409Veracyte 1563Verana Health 2529VERU INC 2059, 2765Verve Medical, Inc. 2747Veterans Prostate Cancer

Awareness Inc. 263Viomerse 2101Virtuoso Surgical Inc. 2548Wasatch Medical Specialties 2316Weatherby Healthcare 2339WebMD 925Well Lead Medical Co. Ltd. 1347Western Section American Urological

Association Inc (AUA) 1857Wolters Kluwer 909Xodus Medical 1465Yuma Regional Medical Center 1062Zenflow, Inc. 2573Zimmer MedizinSystems 2322

List as of March 25, 2022.

13

CO

UR

SE

S

OFFICE OF EDUCATION COURSES ALL COURSES ARE APPROVED FOR AMA PRA CATEGORY 1 CREDITTM

Friday, May 13, 2022 7:30 am – 6:00 pm

7:30 am – 9:30 am

001IC PRACTICAL URODYNAMICS Craig Comiter, Course Director

Sandip Vasavada Room: 204 @ Ernest N. Morial Convention Center

002IC SHOULD I ORDER A PET SCAN? INTEGRATING MOLECULAR IMAGING INTO UROLOGIC ONCOLOGY CLINICAL PRACTICE: CURRENT APPROACHES AND FUTURE OPPORTUNITIES

Marc Bjurlin, Course Director Thomas Hope, Michael Gorin, Tracy Rose

Room: 207 @ Ernest N. Morial Convention Center

003IC CASE-BASED DISCUSSION OF NEW LASER TECHNOLOGY IN ENDOUROLOGY - UPPER TRACT STONES/STRICTURES/TUMORS

Brian Eisner, Course Director Ojas Shah, Silvia Proietti, Julie Riley


004IC TELEUROLOGY: PRACTICAL GUIDE TO IMPROV-ING PATIENT ACCESS TO UROLOGIC CARE

Aaron Martin, Emmanuel Abara, Course Directors Room: 210 @ Ernest N. Morial Convention Center

005IC ADVANCING GENDER EQUITY IN UROLOGY: ALLYSHIP FOR MEN AND ADVOCACY FOR WOMEN

Simone Thavaseelan, Akanksha Mehta, Course Directors Mathew Sorensen, Nishant Patel, Maria Uloko, Sam Chang


028IC WELCOME TO THE CLASSROOM: HIGHLY INTERACTIVE CASE-BASED DISCUSSIONS OF ISSUES IN FEMALE PELVIC MEDICINE

Howard Goldman, Course Director Victor Nitti, Elizabeth Takacs


9:00 am – 12:00 pm

103HO PROSTATE MR IMAGING: WHAT A UROLOGIST SHOULD KNOW – LIVE VIRTUAL

Art Rastinehad, Jelle Barentsz, Course Directors Vibeke Logager, Maarten de Rooij, Arvin George, Faculty Timothy McClure, Srinivas Vourganti,

Byron Gaing, Svetlana Yablok, Proctors

10:00 am – 12:00 pm

007IC A GUIDELINES-BASED APPROACH TO RECUR-RENT UTIS IN WOMEN

Jennifer Anger, Course Director Una Lee, Toby Chai, Ann Stapleton


008IC AVOIDING MEDICAL MALPRACTICE Mitchell Benson, Course Director

Ben Rubinowitz Room: 207 @ Ernest N. Morial Convention Center

009IC THE GENERAL UROLOGIST AND KIDNEY TRANSPLANTATION

John Barry, Course Director Brian Duty, Ian Metzler Room: 208 @ Ernest N. Morial Convention Center

010IC DUST OR BUST: A BEGINNERS GUIDE TO MODERN-DAY LASER LITHOTRIPSY STRATEGIES FOR URETEROSCOPY

Khurshid Ghani, Course Director William Roberts, Joel Teichman, Matthew Bultitude Room: 210 @ Ernest N. Morial Convention Center

011IC ADVANCED URODYNAMICS: INTERACTIVE COMPLEX CASES

Stephen Kraus, Course Director Victor Nitti, E. Ann Gormley, Alvaro Lucioni,

Elizabeth Rourke Room: 211 @ Ernest N. Morial Convention Center

012IC MANAGING PATIENTS WITH COMPLEX VOIDING DYSFUNCTION: A “FLIPPED CLASSROOM” HOT AIR BALLOON DEBATE

John Stoffel, Course Director Anne Pelletier Cameron, Rose Khavari, Michael Kennelly,

Humphrey Atiemo Room: 219 @ Ernest N. Morial Convention Center

Thursday, May 12, 2022 7:00 am – 5:00 pm

7:00 am – 5:00 pm

101HO HANDS-ON UROLOGIC ULTRASOUND (HOUU) Pat Fulgham, Course Director Majid Eshghi, Christopher Porter,

Daniel Rukstalis, Stephen Savage, Edouard Trabulsi, Mohammad Bhatti, Lewis Chan, Craig Smith, Faculty

Level 2, R05 @ Ernest N. Morial Convention Center

14


1:30 pm – 3:30 pm

013IC WINNING THE BATTLE AGAINST BURNOUT Paul Maroni, Course Director Amanda North, Ryan Terlecki Room: 204 @ Ernest N. Morial Convention Center

014IC METABOLIC EVALUATION AND MEDICAL MAN-AGEMENT FOR KIDNEY STONE PREVENTION

Michael Lipkin, Course Director Brian Eisner, Jodi Antonelli, Sara Best Room: 207 @ Ernest N. Morial Convention Center

015IC MALE RECONSTRUCTIVE UROLOGY FOR THE GENERAL UROLOGIST

Joel Gelman, Course Director Keith Rourke, Nima Baradaran, Faysal Yafi Room: 208 @ Ernest N. Morial Convention Center

016IC COMMON PROBLEMS IN PEDIATRIC UROLOGY: WHAT EVERY UROLOGIST SHOULD KNOW

Mark Cain, Course Director Benjamin Whittam Room: 210 @ Ernest N. Morial Convention Center

017IC A CASE-BASED APPROACH TO THE EVALUATION AND MANAGEMENT OF URINARY TRACT BLEEDING: NAVIGATING AUA MICROHEMATURIA GUIDELINES TO INTRACTABLE HEMORRHAGIC CYSTITIS

Stephen Boorjian, Course Director Daniel Barocas, Jay Raman Room: 211 @ Ernest N. Morial Convention Center

018IC WORK SMARTER, NOT HARDER - OPTIMIZING EFFICIENCY IN CLINIC

Jyoti Chouhan, Course Director Sarah Hecht, Kyle Rove Room: 219 @ Ernest N. Morial Convention Center

2:00 pm – 5:00 pm

105HO INTRODUCTION TO OFFICE-BASED TRANSPERINEAL PROSTATE INTERVENTIONS: SYSTEMATIC BIOPSY, RECTAL HYDROGEL SPACER AND MR/US FUSION

Arvin George, John Wei, Course Directors Abhinav Sidana, Timothy Byler, Faculty Michael Gorin, Richard Szabo, John Dibianco, Amit Patel,

Amin Herati, Andre Luis Abreu, Kevin Ginsburg, Wayne Brisbane, Proctors


4:00 pm – 6:00 pm

019IC THE CHANGING FACE OF ADVANCED PROSTATE CANCER 2022

Judd Moul, Course Director Lawrence Karsh, Alicia Morgans Room: 204 @ Ernest N. Morial Convention Center

020IC TRIMODALITY THERAPY FOR MANAGEMENT OF MUSCLE INVASIVE BLADDER CANCER

Adam Feldman, Course Director Jason Efstathiou, Matthew Wszolek, Richard Lee Room: 207 @ Ernest N. Morial Convention Center

021IC AMERICAN UROLOGICAL ASSOCIATION SURGICAL AND MEDICAL MANAGEMENT OF STONE DISEASE GUIDELINES: UPDATE AND COMPLEX CASES

Ojas Shah, Course Director Brian Matlaga, Dean Assimos, John Lieske Room: 208 @ Ernest N. Morial Convention Center

022IC OVERCOMING THE LEARNING CURVE FOR RETZIUS-SPARING PROSTATECTOMY

Keith Kowalczyk, Course Director Jim Hu, John Davis, Kirsten Greene Room: 210 @ Ernest N. Morial Convention Center

Saturday, May 14, 2022 7:30 am – 6:00 pm

7:30 am – 9:30 am

006IC THE INDICATIONS FOR VAGINAL THERMOTHER-APY: WHAT IT IS & IS THERE A ROLE FOR LASER & RADIOFREQUENCY TREATMENTS

Roger Dmochowski, Course Director Mickey Karram Room: 211 @ Ernest N. Morial Convention Center

024IC NEW AUA BPH GUIDELINES: HOW TO BEST DIAGNOSE AND HOW TO MOST EFFECTIVELY AND SAFELY TREAT

Steven Kaplan, Course Director Claus Roehrborn, Kevin McVary, Alexis Te, Lori Lerner Room: 204 @ Ernest N. Morial Convention Center

025IC 2022 LOCALIZED PROSTATE CANCER James Eastham, Course Director Stephen Boorjian, Daniel Barocas, Alicia Morgans,

Sean McBride Room: 207 @ Ernest N. Morial Convention Center

026IC CURRENT UROLOGIC MANAGEMENT OF FEMALE SEXUAL DYSFUNCTION

Irwin Goldstein, Course Director Noel Kim, Rachel Rubin, Maria Uloko Room: 219 @ Ernest N. Morial Convention Center

027IC ADAPTIVE PCNL: UTILIZING A CONTEMPORARY TOOLBOX

Nishant Patel, Course Director Ryan Hsi, Karen Stern, David Tzou, Rajat Jain Room: 210 @ Ernest N. Morial Convention Center

053IC DIFFICULT CASES IN HIGH-RISK BLADDER CANCER: AN EVIDENCE-BASED APPROACH

Michael Cookson, Course Director Sanjay Patel, Jeffrey Holzbeierlein, Timothy Masterson Room: 208 @ Ernest N. Morial Convention Center

15

CO

UR

SE

S


8:00 am – 12:00 pm

102HO INTERVENTIONAL ULTRASONOGRAPHY: A NEW UROLOGY PARADIGM FOR USING RENAL ULTRASOUND TO GUIDE RENAL ACCESS AND BIOPSIES

Thomas Chi, Roger Sur, Jaime Landman, Course Directors Gregory Tasian, Joel Abbott, Patrick Mufarrij, Seth Bechis, Amy Krambeck, David Tzou, Ryan Hsi, Thomas Tailly, Kaitlan Cobb, David Bayne, Roshan Patel, Mantu Gupta, Noah Canvasser, Fadl Hamouche, Justin Ahn, Proctors


10:00 am – 12:00 pm

029IC COMPLICATIONS AND RECURRENCE AFTER FOCAL THERAPY FOR PROSTATE CANCER

Andre Luis Abreu, Course Director Inderbir Gill, Rafael Sanchez-Salas Room: 211 @ Ernest N. Morial Convention Center

030IC 3D PRINTING, AUGMENTED REALITY, AND VIRTUAL REALITY: WHY, HOW, WHAT TO INCORPORATE INTO DAILY PRACTICE

Ahmed Ghazi, Course Director Marc Bjurlin, Lauren Shepard Room: 207 @ Ernest N. Morial Convention Center

031IC UROLOGICAL TRAUMA & RECONSTRUCTION Steven Hudak, Course Director Noel Armenakas, Michael Coburn Room: 208 @ Ernest N. Morial Convention Center

032IC CURRENT CONCEPTS AND CONTROVERSIES IN MALE HORMONE REPLACEMENT THERAPY

Wayne Hellstrom, Course Director Martin Miner, John Mulhall, Mohit Khera Room: 210 @ Ernest N. Morial Convention Center

034IC REPRODUCTIVE HEALTH AND FERTILITY PRESERVATION IN UROLOGIC SURGEONS AND TRAINEES

Christine Van Horn, Jennifer Yates Katherine Rotker, Course Directors


045IC CONTEMPORARY PHARMACOTHERAPY FOR OVERACTIVE BLADDER 2022: MONOTHERAPY AND COMBINED PHARMACOTHERAPY TO OPTIMIZE TREATMENT

Eric Rovner, Course Director Alan Wein, Christopher Chapple, Room: 204 @ Ernest N. Morial Convention Center

1:30 pm – 3:30 pm

035IC DIVERSITY EQUITY AND INCLUSION IN UROLOGY, WHAT DO WE NEED TO KNOW

Linda McIntire, Course Director Tracy Downs, Yahir Santiago-Lastra, Gjanje Smith,

Alejandro Sanchez, David Bloom Room: 204 @ Ernest N. Morial Convention Center

036IC EVALUATION AND MANAGEMENT OF PRIAPISM Martin Gross, Course Director Trinity Bivalacqua, Jay Simhan, Faysal Yafi Room: 207 @ Ernest N. Morial Convention Center

037IC PRACTICAL VAGINAL SURGERY FOR THE UROLOGIST 2022: A COURSE TO ENHANCE PRACTICAL SURGICAL THINKING, APPROACHES, AND TECHNIQUES TO COMMON UROLOGICAL CONDITIONS

Victor Nitti, Course Director Nirit Rosenblum, Benjamin Brucker, Ja-Hong Kim Room: 208 @ Ernest N. Morial Convention Center

038IC COMPLEX MALE NON-NEUROGENIC URINARY INCONTINENCE

Francisco Martins, Course Director Sarah Fraumann Faris, Matthias Hofer Room: 210 @ Ernest N. Morial Convention Center

039IC OPTIMIZING SURGICAL OUTCOMES IN OLDER ADULTS

Charles Scales, Course Director Anne Suskind Room: 211 @ Ernest N. Morial Convention Center

040IC AUA 2022 SPANISH COURSE ON GENITOURINARY RECONSTRUCTIVE SURGERY

Ramon Virasoro, Course Director Reynaldo Gomez, Javier Ponce De Leon Room: 219 @ Ernest N. Morial Convention Center

2:00 pm – 5:00 pm

104HO INTRODUCTION TO PROSTATE TISSUE ABLATION: HIGH INTENSITY FOCUSED ULTRASOUND AND CRYOTHERAPY

Samir Taneja, Arvin George, Course Directors Abhinav Sidana, Faculty Amir Lebastchi, Arieh Shalhav, James Wysock, Puneet

Sindhwani, Aaron Katz, Derek Lomas, Art Rastinehad, Fernando Kim, Proctors


4:00 pm – 6:00 pm

033IC REFRACTORY OVERACTIVE BLADDER: HOW TO SELECT 3RD-LINE THERAPIES AND OPTIMIZE OUTCOMES

Kathleen Kobashi, Course Director David Ginsberg, Sandip Vasavada Room: 204 @ Ernest N. Morial Convention Center

041IC WOMEN’S HEALTH UPDATE: GYNECOLOGIC CONSIDERATIONS FOR THE UROLOGIST

Ariana Smith, Course Director Nirit Rosenblum, Una Lee Room: 211 @ Ernest N. Morial Convention Center

042IC UPDATES IN THE MANAGEMENT OF PENILE CANCER: A CASE-BASED APPROACH

Philippe Spiess, Course Director Viraj Master, Timothy Masterson, Andrea Necchi,

Chris Protzel Room: 207 @ Ernest N. Morial Convention Center

043IC GENITOURINARY CANCER SURVIVORSHIP: A PRACTICAL MASTER CLASS

Steven Brandes, Course Director Andrew Peterson, Cooper Benson, Shyam Sukumar,

Joseph Alukal Room: 219 @ Ernest N. Morial Convention Center

16


044IC HOW TO ESTABLISH A SUCCESSFUL MEN’S HEALTH AND ANDROLOGY PRACTICE

Ranjith Ramasamy, Course Director Jason Kovac, Ryan Smith, Libert Ramos Room: 210 @ Ernest N. Morial Convention Center

046IC INTEGRATING CARE FOR ONCOLOGY PATIENTS: ESTABLISHING A MULTIDISCIPLINARY ONCOLO-GY CLINIC WITH ADVANCED THERAPEUTICS

Kelly Stratton, Course Director Alicia Morgans, Kelvin Moses, Brian Shuch Room: 208 @ Ernest N. Morial Convention Center

Sunday, May 15, 2022 7:30 am – 6:00 pm

7:30 am – 9:30 am

047IC COMPLICATIONS OF ROBOTIC UROLOGICAL SURGERY: PREVENTION, RECOGNITION AND MANAGEMENT

Rene Sotelo, Course Director Mihir Desai, Michael Stifelman, Richard Gaston Room: 204 @ Ernest N. Morial Convention Center

048IC GENETIC TESTING IN PROSTATE CANCER: CLINICAL IMPLICATIONS FOR EARLY DETEC-TION AND MANAGEMENT OF LOCALIZED AND ADVANCED DISEASE

Todd Morgan, Course Director Heather Cheng, Leonard Gomella Room: 207 @ Ernest N. Morial Convention Center

049IC SINGLE-PORT AND MULTI-PORT ADVANCED ROBOTIC UROLOGIC ONCOLOGY: EXTREME UNFORGETTABLE CASES AND THEIR MANAGEMENT

Vipul Patel, Course Director Alexandre Mottrie, Rafael Coelho, Bernardo Maria Rocco Room: 208 @ Ernest N. Morial Convention Center

050IC SURGICAL CONSIDERATIONS AND COORDI-NATED MEDICAL MANAGEMENT OF DIFFICULT RETROPERITONEAL TUMORS

Clint Cary, Course Director Timothy Masterson, Lawrence Einhorn Room: 210 @ Ernest N. Morial Convention Center

051IC MANAGEMENT OF LOWER URINARY TRACT DYSFUNCTION AFTER PROSTATE CANCER TREATMENT

Jaspreet Sandhu, Course Director Kurt McCammon, O. Lenaine Westney Room: 211 @ Ernest N. Morial Convention Center

052IC RENAL MASS AND LOCALIZED RENAL CANCER: EVALUATION, MANAGEMENT AND FOLLOW-UP - A CASE-BASED APPROACH

Steven Campbell, Course Director Phillip Pierorazio, Christopher Weight, Robert Uzzo Room: 219 @ Ernest N. Morial Convention Center

9:00 am – 12:00 pm

106HO SURGICAL ABLATIVE TECHNIQUES FOR BPH Amy Krambeck, Course Director Lori Lerner, Dean Elterman, John Knoedler, Faculty Naeem Bhojani, Gregg Eure, Tobias Kohler, Kevin Zorn,

Smita De, Mark Assmus, Matthew Lee, Joel Funk, Proctors


10:00 am – 12:00 pm

054IC PROSTATE CANCER DIAGNOSTICS: BIOMARK-ERS, MRI AND BIOPSY TECHNIQUES

Daniel Barocas, Course Director John Wei, Scott Eggener, Jeffrey Tosoian, Sigrid Carlsson Room: 207 @ Ernest N. Morial Convention Center

055IC BLADDER CANCER TREATMENT DILEMMAS: THE CASES YOU FACE AND WHAT TO DO ABOUT THEM

Sam Chang, James McKiernan, Course Directors Kristen Scarpato, Christopher Anderson, Chad Ritch Room: 208 @ Ernest N. Morial Convention Center

056IC EVALUATION AND MANAGEMENT OF ADRENAL MASSES: A CASE-BASED APPROACH

Neal Rowe, Course Director Thomas McGregor, Craig Rogers Room: 204 @ Ernest N. Morial Convention Center

057IC NOCTURIA: ADVANCES IN DIAGNOSIS AND MANAGEMENT INCLUDING TRANSLATIONAL SCIENCE

Jeffrey Weiss, Course Director Alan Wein, Jerry Blaivas, Lori Birder Room: 211 @ Ernest N. Morial Convention Center

058IC VASECTOMY: A VERY PRACTICAL CASE-BASED COURSE ON PREOPERATIVE, INTRAOPERATIVE AND POSTOPERATIVE MANAGEMENT

Ira Sharlip, Course Director Jay Sandlow, Stanton Honig Room: 219 @ Ernest N. Morial Convention Center

023IC URINARY DIVERSION: CURRENT INDICATIONS, TECHNIQUES AND MANAGEMENT OF COMPLICATIONS

Siamak Daneshmand, Course Director Anne Schuckman, Matthew Dunn Room: 210 @ Ernest N. Morial Convention Center

17

CO

UR

SE

S


1:30 pm – 3:30 pm

059IC CATASTROPHES, COMPLICATIONS AND COR-RECTIONS IN PERCUTANEOUS RENAL SURGERY

Arthur Smith, Course Director Mantu Gupta, Mahesh Desai, Ralph Clayman,

Arun Rai, Zeph Okeke Room: 204 @ Ernest N. Morial Convention Center

060IC MALE INFERTILITY UPDATE 2022 Larry Lipshultz, Course Director Robert Brannigan, Michael Eisenberg, Mary Samplaski Room: 207 @ Ernest N. Morial Convention Center

061IC MANAGEMENT OF COMMON PROSTATE CANCER DILEMMAS

Gerald Andriole, Course Director Adam Kibel,Anthony D’Amico, A. Oliver Sartor Room: 208 @ Ernest N. Morial Convention Center

062IC PROSTATE CANCER UPDATE 2022 William Catalona, Course Director Douglas Dahl, Robert Nadler, Stacy Loeb,

Stanley Liauw, Russell Szmulewitz Room: 210 @ Ernest N. Morial Convention Center

063IC ROBOTIC UPPER URINARY TRACT RECON-STRUCTION: A TOP TO BOTTOM APPROACH

Lee Zhao, Course Director Michael Stifelman, Daniel Eun, Raju Thomas Room: 211 @ Ernest N. Morial Convention Center

064IC GETTING IT RIGHT THE FIRST TIME: AN EVIDENCE-BASED APPROACH TO PRIMARY HYPOSPADIAS REPAIR

Warren Snodgrass, Course Director Nicol Bush Room: 219 @ Ernest N. Morial Convention Center

2:00 pm – 5:00 pm

107HO FUNDAMENTALS OF PCNL ACCESS Robert Sweet, Course Director D.Duane Baldwin, Benjamin Canales,

Bodo Knudsen, Thomas Chi, Zeph Okeke, Faculty David Leavitt, David Hoenig, Jonathan Harper, Ian Met-

zler, Patrick Samson, Roshan Patel, Proctors Level 2, R05 @ Ernest N. Morial Convention Center

4:00 pm – 6:00 pm

065IC AUA GUIDELINES ON ADVANCED PROSTATE CANCER

Michael Cookson, Course Director Adam Kibel, Kristen Scarpato, David Jarrard Room: 204 @ Ernest N. Morial Convention Center

066IC PRACTICAL AND EVIDENCE-BASED MINIMALLY INVASIVE AND ROBOTIC-ASSISTED SURGERY IN PEDIATRIC UROLOGY

Patricio Gargollo, Course Director Aseem Shukla, Michael Ost, Chester Koh Room: 207 @ Ernest N. Morial Convention Center

067IC MALE INFERTILITY GUIDELINES: A PRACTICAL GUIDE FOR THE PRACTICING UROLOGIST TO ENHANCE EVALUATION AND TREATMENT OF THE MAN IN AN INFERTILE RELATIONSHIP BASED ON PUBLISHED EVIDENCE

Peter Schlegel, Course Director Mark Sigman, Cigdem Tanrikut Room: 210 @ Ernest N. Morial Convention Center

068IC SURGICAL & MEDICAL MANAGEMENT OF HIGH-RISK RENAL CELL CARCINOMA: NEW PARADIGMS FOR TREATMENT

Benjamin Lee, Course Director A. Oliver Sartor, Chandru Sundaram Room: 208 @ Ernest N. Morial Convention Center

069IC WHAT THE GENERAL UROLOGIST SHOULD KNOW ABOUT CARE OF TRANSGENDER PATIENTS

Polina Reyblat, Dmitriy Nikolavsky, Course Directors Geolani Dy, Min Suk Jun


070IC UPPER TRACT UROTHELIAL CARCINOMA TUMOR BOARD: A CASE-BASED APPROACH TO MANAGEMENT

Surena Matin, Course Director Jean Hoffman-Censits, Jonathan Coleman Room: 219 @ Ernest N. Morial Convention Center

Monday, May 16, 2022 7:30 am – 3:30 pm

7:30 am – 9:30 am

071IC MODERN CONCEPTS FOR PENILE PROSTHESIS SUCCESS

Tobias Kohler, Course Director Steven Wilson, Paul Perito Room: 204 @ Ernest N. Morial Convention Center

072IC INCORPORATING GENOMIC TESTING FOR PROSTATE CANCER INTO YOUR PRACTICE

Joseph Wagner, Course Director Matthew Cooperberg, Daniel Lin, David Penson Room: 207 @ Ernest N. Morial Convention Center

073IC DON’T CUT ME! A CASE-BASED GUIDE TO SAFE ACTIVE SURVEILLANCE FOR SOLID AND CYSTIC RENAL MASSES

Phillip Pierorazio, Course Director Mark Ball, Antonio Finelli, Sarah Psutka Room: 208 @ Ernest N. Morial Convention Center

074IC PERSONAL FINANCE BOOTCAMP FOR THE EARLY CAREER UROLOGIST

Richard Sarle, Course Director Michael Fumo Room: 210 @ Ernest N. Morial Convention Center

18


075IC GLOBAL PERSPECTIVES IN URETHRAL RECONSTRUCTION: CONTROVERSIES IN BULBAR URETHRAL STRICTURE DISEASE

Sanjay Kulkarni, Course Director Evelyn Moshokoa, Course Director, Alex Vanni,

Pankaj Joshi Room: 211 @ Ernest N. Morial Convention Center

076IC YOUR VIDEO, OUR COURSE: DEEP ANALYSIS OF ATTENDEES SURGICAL VIDEO EXPERIENCES

Marcelo Orvieto, Rafael Coelho, Course Directors Antonio Villamil, Vipul Patel, Bernardo Maria Rocco Room: 219 @ Ernest N. Morial Convention Center

10:00 am – 12:00 pm

077IC OPERATIONALIZING CHECKPOINT INHIBITORS IN UROLOGIC PRACTICE

Gautam Jayram, Course Director Gordon Brown, Neal Shore Room: 204 @ Ernest N. Morial Convention Center

078IC DIAGNOSIS AND MANAGEMENT OF LOCALIZED, LOCALLY ADVANCED AND ADVANCED KIDNEY CANCER

W. Marston Linehan, Course Director Mark Ball, Ramaprasad Srinivasan, David McDermott Room: 207 @ Ernest N. Morial Convention Center

079IC CHEMOTHERAPY AND IMMUNOTHERAPY FOR THE UROLOGIST AND ADVANCED PRACTICE PROVIDER

Costas Lallas, Course Director Edouard Trabulsi, Anne Calvaresi Room: 208 @ Ernest N. Morial Convention Center

080IC A PRACTICAL APPROACH TO THE EVALUATION AND MANAGEMENT OF CHRONIC MALE PELVIC PAIN

Ryan Smith, Course Director Parviz Kavoussi, Luriel Smith-Harrison, Sarah Krzastek,

Reza Salajeghe Room: 210 @ Ernest N. Morial Convention Center

081IC COMPLICATIONS OF VAGINAL MESH Kamran Sajadi, Course Director Farzeen Firoozi, Christopher Tenggardjaja Room: 211 @ Ernest N. Morial Convention Center

082IC GERIATRIC UROLOGY: BEYOND THE BASICS - A MODERATED CASE-BASED DEBATE

Tomas Griebling, Course Director E.Camille Vaughan, Jonathan Bergman Room: 219 @ Ernest N. Morial Convention Center

1:30 pm - 3:30 pm

083IC ACTIVE SURVEILLANCE 2022 Laurence Klotz, Course Director Mark Emberton, Ian Thompson, Derya Tilki Room: 204 @ Ernest N. Morial Convention Center

084IC NLUTD GUIDELINES COURSE David Ginsberg, Course Director Anne Pelletier Cameron, Stephen Kraus Room: 207 @ Ernest N. Morial Convention Center

085IC INTERSTITIAL CYSTITIS AMENDMENT Quentin Clemens, Course Director Henry Lai Room: 208 @ Ernest N. Morial Convention Center

086IC REVISITING ENDOSCOPIC MANAGEMENT OF UROTHELIAL TUMORS

Jonathan Silberstein, Course Director Mark Soloway, Joshua Meeks Room: 210 @ Ernest N. Morial Convention Center

087IC SURGICAL MANAGEMENT OF UROLITHIASIS: CONTROVERSIES AND CASE-BASED DISCUSSION

Stephen Nakada, Course Director Margaret Pearle Room: 211 @ Ernest N. Morial Convention Center

088IC MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER: PRACTICAL SOLUTIONS FOR COMMON PROBLEMS

Kamal Pohar, Course Director Ashish Kamat, J. Witjes, Cheryl Lee Room: 219 @ Ernest N. Morial Convention Center

19

TH

UR

SD

AY

*Presenting author


SOCIETY OF ACADEMIC UROLOGISTS (SAU)Room 225 @ Ernest N. Morial Convention Center

8:00 WELCOME AND INTRODUCTION Chairs: Christopher Gonzalez, Kristen Scarpato

8:07 AUA OFFICE OF EDUCATION UPDATE Jay Raman

8:14 RRC UPDATE Eric Wallen

8:21 ABU UPDATE J. Brantley Thrasher

8:28 AAMC UPDATE Mark Jordan

8:35 AUA OFFICE OF RESEARCH UPDATE Steven Kaplan

8:42 R. FRANK JONES UPDATE Efe Ghanney Simons

8:49 SWIU UPDATE Akanksha Mehta

8:56 SAU UPDATE Society President: James Brown

9:03 DISCUSSION/Q&A

9:10 EDUCATION AND RESEARCH IN THE MODERN TRAINING PROGRAM

INCORPORATING QUALITY INITIATIVES INTO YOUR DEPARTMENT AND RESIDENCY TRAINING

Jennifer Robles

STRATEGIES FOR ENGAGING FACULTY AND RESIDENTS IN HEALTH SERVICES RESEARCH

Martha Terris

STRATEGIES FOR ENGAGING FACULTY AND RESIDENTS IN TRANSLATIONAL RESEARCH

David Jarrard

PANEL: WHAT CAN WE LEARN FROM EXISTING MODELS AND WHICH IS BEST, AND HOW DO WE FUND THEM?

Panelists: David Jarrard, Matthew Nielsen, Andrew Peterson, Martha Terris

DISCUSSION/Q&A

10:35 BREAK

10:50 BUSINESS, WORK-LIFE, AND LEADERSHIP IN TRANSITION TO PRACTICE

MANAGING YOUR MONEY AND EMPLOYER BENEFITS

Eugene Rhee

MANAGING YOUR TIME AND WORK-LIFE BALANCE Sam Chang

HOSPITAL LEADERSHIP: HOW, WHEN AND WHY TO GET INVOLVED

Joel Nelson

DISCUSSION/Q&A

11:45 LUNCH/ANNUAL BUSINESS MEETING

12:45 SAU GRANT UPDATES

UROLOGISTS AS POLICY LEADERS: AN E-CURRICULUM IN THE FUNDAMENTALS OF HEALTH POLICY

Denise Asafu-Adjei

CONFIDENCE AND COMPETENCE ASSESSMENT OF UROLOGICAL SURGERY RESIDENTS

Katie Murray

DEVELOPMENT AND VALIDATION OF A NOVEL UROLOGY RESIDENCY EVALUATION AND FEEDBACK SYSTEM

Elizabeth Takacs

DEVELOPING AN ORGANIZATIONAL LEADER-SHIP CURRICULUM FOR UROLOGY CHIEF RESIDENTS

Kevin Koo

ASSESSING READINESS FOR INDEPENDENT PRACTICE IN UROLOGY RESIDENCY TRAINING

Kate Kraft

INTERACTIVE ONLINE MODULES: ASYNCHRO-NOUS LEARNING TO IMPROVE MEDICAL STUDENT UROLOGIC EDUCATION

Ezra Margolin

THE ROLE OF RACE/ETHNICITY IN PERCEIVED EXPOSURE, ACCESS AND TRAINING IN UROL-OGY: EXPERIENCES AND PERSPECTIVES OF UNDER-REPRESENTED IN MEDICINE (URM) UROLOGISTS

Efe Ghanney Simons, Christopher Saigal

PILOT EVALUATION OF MIXED REALITY (MR) TECHNOLOGIES FOR FEEDBACK AND GUIDANCE DURING TRANSRECTAL ULTRASOUND BIOPSY SIMULATION: A PROSPECTIVE, RANDOMIZED COMPARATIVE TRIAL

Ahmed Ghazi

DISCUSSION/Q&A

1:30 ATTRACTING MODERN FACULTY AND APPLICANTS

FOSTERING AUTONOMY IN SURGICAL TRAINING & FACILITATING ENTRUSTMENT BY FACULTY

Jill Buckley

SUPPORTING PREGNANCY AND PARENTAL LEAVE DURING TRAINING & PRACTICE

Mathew Sorensen

ATTRACTING MEDICAL STUDENTS TO UROLOGY Kevin Rice

SURGICAL SIMULATION IN 2022: WHERE SHOULD WE BE?

Ahmed Ghazi

DISCUSSION/Q&A

2:20 PREPARING FOR THE 10-YEAR SITE VISIT Kristin Baldea

DISCUSSION/Q&A

2:35 STARTING AN INTERNATIONAL TRAINING PROGRAM Kashif Saddiqi

DISCUSSION/Q&A

20

2:50 BENCHMARKING FOR COMPENSATION AND PRODUCTIVITY IN ACADEMIC UROLOGY: SAU SURVEY

Raj Pruthi

DISCUSSION/Q&A

3:05 RESIDENCY BUDGET AND DEPARTMENT EXPAN-SION: WHAT DO YOU NEED AND HOW CAN YOU GET MORE?

Scott Delacroix

DISCUSSION/Q&A

3:20 BREAK

3:30 WHAT HAVE WE LEARNED FROM THE COVID PANDEMIC?

VIRTUAL INTERVIEWS: PROS/CONS AND THE WAY FORWARD

Sarah Faris, Davis Viprakasit

PREFERENCE SIGNALING: OUTCOMES & PERCEPTIONS

Simone Thavaseelan

DIGITAL RESIDENT RECRUITING: HOW TO SUCCESSFULLY HIGHLIGHT YOUR PROGRAM & PROMOTE YOUR FACULTY

Benjamin Breyer

DISCUSSION/Q&A

4:30 SAU TASK FORCE UPDATES

INCORPORATION OF BEST PRACTICES IN AVOID-ANCE OF BIAS & DISCRIMINATION IN RESIDENT RECRUITMENT & TRAINING

Kate Kraft

ASSESSING RESIDENCY APPLICANTS IN THE POST-USMLE STEP 1 SCORE ERA

Patrick Shenot

OPTIMIZING THE APPLICANT EXPERIENCE IN THE VIRTUAL INTERVIEW ERA

Gary Lemack

RESIDENT MENTAL WELLBEING AND SUICIDE PREVENTION

Moben Mirza

DISCUSSION/Q&A

5:25 CLOSING REMARKS Chairs: Christopher Gonzalez, Kristen Scarpato

APPROVED FOR AMA PRA CATEGORY 1 CREDITTM

ForumsTHE ECONOMICS OF HEALTHCARE: UNDERSTANDING PHYSICIAN COMPENSATION

Room 353–355 @ Ernest N. Morial Convention Center

8:30 WELCOME & INTRODUCTION OF THE AUA INSTI-TUTE FOR LEADERSHIP & BUSINESS

Course Co-Director: John McConnell

8:40 GENERAL HEALTHCARE ECONOMICS THAT AF-FECT PHYSICIAN COMPENSATION

Course Co-Director: John McConnell

9:15 COMPLEXITY OF RVU-BASED COMPENSATION: THE GOOD, THE BAD, THE UGLY

Faculty: Mark Painter

10:05 BREAK

10:20 UNDERSTANDING OVERHEAD COSTS AND THE IMPACT OF PRACTICE EFFICIENCY

11:10 ROUND TABLE DISCUSSIONS: ACADEMIC, HEALTH SYSTEM EMPLOYED, INDEPENDENT GROUP PRACTICE

12:00 LUNCH BREAK

1:30 STRATEGIES FOR NEGOTIATING COMPENSA-TION

Faculty: Brad Lerner

2:15 CRITICAL ASPECTS OF EMPLOYMENT AGREE-MENTS BEYOND COMPENSATION

Faculty: Jennifer Miles-Thomas

2:45 BREAK

3:00 LEGAL ASPECTS OF EMPLOYMENT AND CON-TRACTUAL AGREEMENTS

3:30 KNOW YOUR VALUE Course Co-Director: Kenneth Berger

4:15 ROUND TABLE DISCUSSIONS: ACADEMIC, HEALTH SYSTEM EMPLOYED, INDEPENDENT GROUP PRACTICE

5:00 WRAP-UP/COURSE ADJOURNS Course Co-Directors: John McConnell, Kenneth Berger


21

TH

UR

SD

AY

ForumsYOUR ESSENTIAL GUIDE TO CONGENITALISM AND TRANSITIONAL CARE PRESENTED BY THE AUA

IN COLLABORATION WITH GURS, SPU, AND SUFURoom 262 @ Ernest N. Morial Convention Center

1:00 WELCOME Course Co-Directors: Hadley Wood, Melissa Kaufman

1:15 UROLOGIC SURVEILLANCE Faculty: David Joseph

1:25 MEN’S HEALTH Faculty: John Wiener

1:35 NEUROGENIC LOWER URINARY TRACT DYSFUNCTION

Faculty: Tracey Wilson

1:45 PERIOPERATIVE CONSIDERATIONS Faculty: Sean Elliott

2:15 Q&A

2:30 BREAK

2:45 BLADDER AND POUCH STONES Faculty: Nicole Miller

2:55 MANAGEMENT OF UPPER TRACT STONES IN COMPLEX CONGENITAL PATIENTS

Faculty: Dean Assimos

3:05 METABOLIC CONSIDERATIONS AND BONE HEALTH IN NON-WEIGHT BEARING PATIENTS

Faculty: Robert Kovell

3:15 CASE DISCUSSIONS Faculty: Dean Assimos, Nicole Miller, Robert Kovell

3:30 AUGMENT RUPTURE/BLADDER PERFORATION Faculty: Rosalia Misseri

3:50 PREGNANCY AND DELIVERY MANAGEMENT Faculty: Dan Wood

4:10 ACUTE RETENTION RELATED TO INABILITY TO CATHETERIZE

Faculty: Erin McNamara

4:30 PRACTICE HACKS—PRACTICAL IDEAS TO HELP PATIENTS BE SUCCESSFUL NAVIGATING COMPLEX CARE

Faculty: Melissa Kaufman

4:50 Q&A

Thursday, May 12, 2022 12:30 pm – 5:00 pm

*Presenting author

25*Presenting author

FR

IDA

Y

MP = Moderated Poster Session, PD = Podium Session

Friday, May 13, 2022 Plenary: Prime Time Friday Morning Session 7:30 am – 11:30 am

Great Hall A @ Ernest N. Morial Convention Center

7:30 SECOND OPINION CASES: FOCAL THERAPY FOR PROSTATE CANCER: SHOULD IT REPLACE STANDARD OF CARE? Moderator: Michael Koch Panelists: Kelly Stratton, Scott Eggener

7:50 STATE-OF-THE-ART LECTURE: PSMA DIAGNOSTICS AND THERANOSTICS Presenter: William Aronson

8:05 PANEL DISCUSSION: WOMEN IN UROLOGIC ONCOLOGY: PAST, PRESENT AND FUTURE Moderator: Eila Skinner Panelists: Cheryl Lee, Sarah Psutka, Sima Porten, Kristen Scarpato

8:25 PANEL DISCUSSION: WHAT IS THE OPTIMAL MULTIDISCIPLINARY TEAM IN 2022: DRAFTING FOR THE FUTURE Moderator: Leonard Gomella Panelists: Michael Cookson, Neal Shore

8:45 PANEL DISCUSSION: BEST PROSTATE BIOPSY TECHNIQUES IN 2022: MPMRI/US FUSION, TRANSPERINEAL, STANDARD, MICRO-ULTRASOUND, LIQUID BIOPSY

Moderator: Laurence Klotz Panelists: Arvin George, Benjamin Ristau

9:15 PANEL DISCUSSION: MANAGEMENT OF INCIDENTALLY DISCOVERED 3 CM SOLID RENAL MASS CANCER Moderator: Costas Lallas Panelists: Brian Lane, Lee Ponsky, Jaime Landman

9:45 PANEL DISCUSSION: CONFRONTING RESISTANCE TO IMMUNOTHERAPY—WHAT’S NEXT? Panelist: Padmanee Sharma

10:05 SURVIVOR DEBATE: NON-MUSCLE INVASIVE BLADDER CANCER REFRACTORY TO BCG: CYSTECTOMY, SYSTEMIC IMMUNOTHERAPY, INTRAVESICAL CHEMOTHERAPY

Moderator: Tracy Downs Panelists: James McKiernan, Seth Lerner

10:35 BATTLE OF THE ROBOTS: WHICH IS SUPERIOR? SINGLE-PORT VS MULTI-PORT ROBOTIC PROSTATECTOMY Moderator: Li-Ming Su Debater (Multi-port): Jeffrey Cadeddu Debater (Single-Port): Jihad Kaouk

11:05 LATE-BREAKING ABSTRACT: PLLBA-01: FINAL CLINICAL RESULTS OF PIVOTAL TRIAL OF IL-15RaFC SUPERAGONIST N-803 WITH BCG IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CIS AND PAPILLARY COHORTS

Presenter: Karim Chamie

11:13 LATE-BREAKING ABSTRACT: PLLBA-02: IMPACT OF 18F-RHPSMA-7.3 PET ON UPSTAGING OF PATIENTS WITH PROSTATE CANCER RECURRENCE: RESULTS FROM THE PROSPECTIVE, PHASE 3, MULTICENTER, SPOTLIGHT STUDY

Presenter: Mark Fleming

11:21 LATE-BREAKING ABSTRACT: PLLBA-03: EFFICACY AND SAFETY OF A NOVEL GENE THERAPY (URO-902; PVAX/HSLO) IN FEMALE PATIENTS WITH OVERACTIVE BLADDER AND URGE URINARY INCONTINENCE: RESULTS FROM A PHASE 2A TRIAL

Presenter: Kenneth Peters

26

Friday, May 13, 2022 Plenary: Prime Time Friday Afternoon Session 1:00 pm – 4:30 pm


1:00 SEMI-LIVE/SURGICAL TECHNIQUES: ONCOLOGY Surgeon: Kenneth Goldberg

2:00 AUA GUIDELINES: LOCALIZED PROSTATE CANCER Presenter: James Eastham

2:15 CONFEDERACIÓN AMERICANA DE UROLOGÍA (CAU) LECTURE: THE FINE BORDERLINE BETWEEN HIGH-RISK, LOCALLY-ADVANCED AND OLIGOMETASTATIC PROSTATE CANCER

Presenter: Rafael Sanchez-Salas

2:30 UROLOGICAL ASSOCIATION OF ASIA (UAA) LECTURE: NOVEL GERMLINE MUTATION IN PROSTATE CANCER—THE NEXT FRONTIER IN PERSONALIZED THERAPY FOR ASIA AND BEYOND

Presenter: Damien Bolton

2:45 AUA GUIDELINES UPDATE: RENAL MASS Presenter: Steven Campbell

3:00 CONTROVERSIES IN UROLOGY DEBATE: FOCAL ABLATION VERSUS ACTIVE SURVEILLANCE IN A 65M WITH GGG2, MRI CONCORDANT UNILATERAL PROSTATE CANCER

Moderator: Kirsten Greene Debaters: Dipen Parekh, Robert Reiter

3:30 PANEL DISCUSSION: RADICAL PROSTATECTOMY WITH BOTH SEVERE INCONTINENCE AND SEVERE ERECTILE DYSFUNCTION

Panelists: Paul Chung, Arthur Burnett

3:50 SEMI-LIVE/SURGICAL TECHNIQUES: ENDOUROLOGY Surgeons: Sri Sivalingam, Bodo Knudsen


FR

IDA

Y

Friday, May 13, 2022 7:00 am – 8:15 am

Moderated Poster Session 1BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY I

Room 228 @ Ernest N. Morial Convention CenterModerators: Dean Elterman, Bradley Gill & James Forde

ABSTRACTNUMBER TITLE

MP01-01 EXIME® URETHRAL STENT IMPLANTATION (EUSI) AS INITIAL TREATMENT FOR PATIENTS PRESENTING WITH ACUTE URINARY RETENTION (AUR) FOR THE FIRST TIME AS A RESULT OF BPH

Nordine Amara*, Leffrinckoucke, France, Tarek Al Youssef, Jordan Massa, Elias Elkhouri, Dunker-que, France, Belur Patel, Temple, TX

MP01-02 THE “BUTTERFLY” TRANSURETHRAL RETRACTION DEVICE FOR BPH – OVER 1 YEAR FOLLOW UP

Ran Katz*, Muhamad Abu Ahmed, Ali Safadi, Safed, Israel, Shmuel Roizman, Amnon Zisman, Rishon Lezion, Israel, Maharan Kabha, Yoram Dekel, Haifa, Israel, Jack Baniel, Shachar Aharo-ni, Petach Tikva, Israel

MP01-03 TRANSURETHRAL ULTRASOUND ABLATION FOR BENIGN PROSTATIC HYPERPLASIA: THREE-MONTH CLINICAL OUTCOMES OF A PHASE 1-2 STUDY

Mikael Anttinen*, Antti Viitala, Turku, Finland, Pouya Doerwald, Hamburg, Germany, Pietari Mäkelä, Pekka Taimen, Roberto Blanco Sequei-ros, Peter Boström, Turku, Finland

MP01-04 LONG-TERM GROSS HEMATURIA IMPROVEMENTS AFTER PROSTATIC ARTERY EMBOLIZATION: COMPARING RESULTS IN GLAND VOLUMES OF ≤80ML VERSUS >80ML

Saumik Rahman, Taylor Powell, Lawrence Staib, Raj Ayyagari*, New Haven, CT

MP01-05 PROSTATIC ARTERY EMBOLIZATION COMPARED TO TRANS-URETHRAL RESECTION OF THE PROSTATE AND PROSTATIC URETHRAL LIFT: A REAL-WORLD POPULATION-BASED STUDY

Brendan L. Raizenne*, Montréal, Canada, Xinyan Zheng, New York, NY, Kussil Oumedjbeur, Mon-treal, Canada, Jialin Mao, New York, NY, Kevin C. Zorn, Montréal, Canada, Dean Elterman, Toronto, Canada, Naeem Bhojani, Montréal, Canada, Art Sedrakyan, Bilal Chughtai, New York, NY

MP01-06 OFFICE BASED TRANSPERINEAL LASER ABLATION FOR BENIGN PROSTATIC HYPERPLASIA: 3 & 6 MONTHS OUTCOMES.

Luna Eusebio*, Luis Avila, Alberto Lopez-Prieto, Edward Gheiler, Ariel Kaufman, David Cohen, Fernando Bianco, Miami, FL

MP01-07 FACTORS ASSOCIATED WITH USE OF PROSTATIC URETHRAL LIFT (PUL)

Samantha L. Thorogood*, Tenny R. Zhang, Christina Sze, Gina DeMeo, Mary O. Strasser, Richard K. Lee, Bilal Chughtai, Alexis Te, Jim C. Hu, New York, NY


MP01-08 CONVECTIVE WATER VAPOR THERMAL THERAPY (CWVTT) IMPROVES NOCTURIA AND SUBJECTIVE SLEEP QUALITY

Aya Bsatee*, Gaurav Pahouja, Michael Felice, Hiten D. Patel, Kevin T. McVary, Maywood, IL

MP01-09 RISK FACTORS FOR A DELAYED IMPROVEMENT IN LOWER URINARY TRACT SYMPTOMS FOLLOWING CONVECTIVE WATER VAPOR THERMAL THERAPY

Sarang Janakiraman*, Michael Felice, Aya Bsatee, Gaurav Pahouja, Kevin T. McVary, Maywood, IL

MP01-10 EFFICACY OF REZU-M WATER VAPOR THERMAL

THERAPY FOR SURGICAL MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA IN PROSTATES OVER 80 GRAMS

Adam M. Jenks*, Tiffany Damm, Robert Petros-sian, Kristin Delfino, Danuta Dynda, Nicholas Tadros, Springfield, IL

MP01-11 LARGE, MULTI-CENTER, PROSPECTIVE REGISTRY OF REZU

-M WATER VAPOR

THERAPY BENIGN PROSTATIC ENLARGEMENT

Dean Elterman*, Toronto, Canada, Naeem Bho-jani, Montreal, Canada, Bilal Chughtai, New York, NY, Kevin C Zorn, Montreal, Canada

MP01-12 PHARMACOTHERAPY VS MINIMALLY INVASIVE THERAPIES AS INITIAL THERAPY FOR PATIENTS WITH BENIGN PROSTATE HYPERPLASIA: A MICROSIMULATION MODEL

Yeva Sahakyan, Aysegul Erman, Toronto, Canada, Naeem Bhojani, Montreal, Canada, Bilal Chughtai, New York, NY, Kevin C Zorn, Montreal, Canada, Beate Sander, Dean Elterman*, Toronto, Canada

MP01-13 COMPARISON OF TRADITIONAL OUTCOME MEASURES AND SELF-ASSESSED GOAL ACHIEVEMENT IN PATIENTS TREATED SURGICALLY FOR BENIGN PROSTATIC HYPERPLASIA

Manolis Pratsinis*, Gautier Müllhaupt, Sabine Güsewell, Patrick Betschart, Valentin Zumstein, Daniel Engeler, Hans-Peter Schmid, St. Gallen, Switzerland, Dominik Abt, Biel, Switzerland

MP01-14 ASSOCIATION BETWEEN INDUSTRY PAYMENTS AND PUBLISHED POSITION ON USE OF DEVICES FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS

Armaan Singh*, Sarah Faris, Piyush Agarwal, Luke Reynolds, Parth Modi, Chicago, IL

MP01-15 SEDATION AS AN ALTERNATIVE ANESTHETIC TECHNIQUE FOR FRAGILE PATIENTS IN TRANSURETHRAL RESECTION OF THE PROSTATE

Christian Ayoub*, Nassib Abou Heidar, Adnan El-Ach-kar, Hani Tamim, Albert El Hajj, Beirut, Lebanon

28

MP01-16 FUNCTIONAL AND SURGICAL OUTCOMES OF AQUABLATION IN ELDERLY MEN

Brendan L. Raizenne*, Montréal, Canada, David Bouhadana, Montreal, Canada, Kevin C. Zorn, Montréal, Canada, Bilal Chughtai, New York, NY, Dean Elterman, Toronto, Canada, Naeem Bhojani, Montréal, Canada

MP01-17 IMPACT OF ASA ON POST-OPERATIVE HOLEP OUTCOMES AND COMPLICATIONS

Mary Soyster*, Indianapolis, IN, Deepak Agarwal, Minneapolis, MN, Austen Slade, Erica Sahm, Tim Large, Marcelino Rivera, Indianapolis, IN

MP01-18 GREENLIGHT PHOTOVAPORIZATION OF THE PROSTATE IN HIGH-MEDICAL-RISK PATIENTS: AN ANALYSIS OF THE GLOBAL GREENLIGHT GROUP (GGG) DATABASE

David-Dan Nguyen, Claudia Deyirmendjian*, Kyle Law, Naeem Bhojani, Montreal, Canada, Dean Elterman, Toronto, Canada, Bilal Chughtai, New York, NY, Franck Bruyere, Centre Val de Loire, France, Luca Cindolo, Giovanni Ferrari, Modena, Italy, Carlos Vasquez-Lastra, Mexico City, Mexico, Tiago Borelli-Bovo, Sao Paulo, Brazil, Edgardo Becher, Buenos Aires, Argentina, Hannes Cash, Magdeburg, Germany, Maximillian Reimann, Berlin, Germany, Enrique Rijo, Barcelona, Spain, Vincent Misrai, Toulouse, France, Kevin Zorn, Montreal, Canada

MP01-19 MINIMALLY INVASIVE AND ENDOSCOPIC THERAPIES FOR BENIGN PROSTATIC HYPERPLASIA: HEAD-TO-HEAD COMPARISON OF SHORT-TERM OUTCOMES BY NETWORK META-ANALYSIS

Linda Hamed, Jamaal Jackson*, Ephrem Olweny, Chicago, IL

MP01-20 A RANDOMIZED CONTROLLED TRIAL FOR OPIOID-LIMITING PAIN CONTROL AFTER TRANSURETHRAL RESECTION OF THE PROSTATE: MULTIMODAL PAIN REGIMEN WITH EDUCATIONAL INTERVENTION VERSUS STANDARD OF CARE

Adam Daily*, Seattle, WA, Ryan Donahue, San Antonio, TX, Andrew Stamm, Silverdale, WA, Paul Kozlowski, Christopher Porter, Fred Govier, Nicholas Cowan, Alvaro Lucioni, Chris-tian Kuhr, Kathleen Kobashi, Seattle, WA, Neil Hanson, Minneapolis, MN, John Corman, Una Lee, Seattle, WA

APPROVED FOR AMA PRA CATEGORY 1.25 CREDITSTM

Friday, May 13, 2022 7:00 am – 8:15 am

Moderated Poster Session 2INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: KIDNEY & BLADDER I

Room 225 @ Ernest N. Morial Convention CenterModerators: Christina Ching, Joel Teichman & Michael Liss


MP02-01 COMPARATIVE TRANSCRIPTOMICS SUGGESTS CONVERGENT AND DIVERGENT PROPERTIES OF UROPATHOGENIC ESCHERICHIA COLI

Jacob Hogins*, Richardson, TX, Philippe Zim-mern, Dallas, TX, Larry Reitzer, Richardson, TX

MP02-02 COMPARISON OF UROPATHOGENIC AND NON-PATHOGENIC ESCHERICHIA COLI GROWTH CHARACTERISTICS IN THE PRESENCE OF AN ANTIMICROBIAL PEPTIDE AND LIMITING NUTRIENT AVAILABILITY

Samuel Kusin*, Dallas, TX, Jacob Hogins, Richardson, TX, Philippe Zimmern, Dallas, TX, Larry Reitzer, Richardson, TX

MP02-03 GENETIC ADAPTATIONS OF ENTEROCOCCUS FAECALIS TO FITNESS AND PERSISTENCE IN THE URINARY TRACT

Belle Sharon*, Dennise Palacious Araya, Moutusee Islam, Richardson, TX, Philippe Zimmern, Dallas, TX, Kelli Palmer, Nicole De Nisco, Richardson, TX


MP02-04 INVASION AND ASSESSMENT OF INTRACELLULAR BACTERIAL COLONY (IBC) FORMATION IN UROEPITHELIAL CELLS BY UROPATHOGENIC E. COLI (UPEC) OF DIFFERENT PHYLOGENETIC GROUPS SUGGEST ALTERNATE ENTRY MECHANISMS

Jacob Hogins*, Richardson, TX, Philippe Zim-mern, Dallas, TX, Larry Reitzer, Richardson, TX

MP02-05 CDKN2A REGULATES OXIDATIVE STRESS AND AUTOPHAGY IN UROTHELIAL DEFENSE AGAINST URINARY TRACT INFECTION

Yan Liu, Hongying Huang, Herbert Lepor, Xue-Ru Wu, Ellen Shapiro*, New YORK, NY

MP02-06 URINARY TRACT INFECTION ON SOCIAL MEDIA: EXAMINING YOUTUBE CONTENT AS A SOURCE OF PATIENT EDUCATIONAL INFORMATION

Zhenyue Huang*, Rosen Jeong, Edwin Lee, Heng Ruan, Tal Meir Cohen, Jason Kim, Stony Brook, NY


FR

IDA

Y

MP02-07 THE IMPACT OF COVID-19 AND TELEMEDICINE ON EMPIRIC UTI TREATMENT IN WOMEN

Madeline Epsten*, Jennifer Ferraro, Fareesa Khan, Cynthia Brincat, Kristin Jacobs, Chicago, IL

MP02-08 RAPID DETECTION OF BACTERIAL UTIS VIA REPORTER PHAGE-BASED BIOLUMINESCENCE ASSAY

Lorenz Leitner*, Jiemin Du, Susanne Meile, Shawna McCallin, Vera Neumeier, Thomas M. Kessler, Martin J. Loessner, Samuel Kilcher, Matthew Dunne, Zürich, Switzerland

MP02-09 A NOVEL PROPIDIUM MONOAZIDE-BASED PCR ASSAY CAN DETECT VIABLE BUT NON-CULTURABLE BACTERIA IN URINE AFTER ANTIBIOTIC TREATMENT OF UTI

Albert Lee, Olivia Lamanna, Kenji Ishida, Elaise Hill, Michael Hsieh*, Washington, DC

MP02-10 GENUS-LEVEL IDENTIFICATION OF BLADDER-RESIDENT BACTERIA ASSOCIATED WITH RECURRENT URINARY TRACT INFECTION IN POST-MENOPAUSAL WOMEN BY FLUORESCENCE IN-SITU HYBRIDIZATION

Parker R.M. Kenee*, Dallas, TX, Jashkaran Gadhvi, Fatima Khan, Richardson, TX, Alana L. Christie, Dallas, TX, Nicole J. De Nisco, Richard-son, TX, Philippe E. Zimmern, Dallas, TX

MP02-11 CHARACTERIZATION OF COMPLEMENT RESISTANCE FACTOR TRAT ENCODED IN DRUG RESISTANCE PLASMIDS OF UROPATHOGENIC ESCHERICHIA COLI

Chae Hee Lim*, Aryana Bhati, Katelyn Lott, Jazmyn Whitfield, John Land, Tatyana Sysoeva, Huntsville, AL

MP02-12 PRO AND ANTI-INFLAMMATORY CYTOKINES ARE DIFFERENTIALLY ABUNDANT DURING RECURRENT URINARY TRACT INFECTIONS IN POSTMENOPAUSAL WOMEN

Jessica Komarovsky*, Tahmineh Ebrahimzadeh, Richardson, TX, Philippe Zimmern, Dallas, TX, Nicole De Nisco, Richardson, TX

MP02-13 IS CYSTOSCOPY INDICATED IN THE EVALUATION OF FEMALE PATIENTS WITH RECURRENT URINARY TRACT INFECTIONS?

Tanner Corse, Linda Dayan, Hunter Hasley*, Nutley, NJ, Simon Gelman, Hackensack, NJ, Debra Fromer, Nutley, NJ

MP02-14 RE-IMAGINING URINARY TRACT INFECTION IN WOMEN: CLUES FROM THE UROBIOME OF ASYMPTOMATIC HEALTHY CONTROLS VS VACCINATED WOMEN WITH RECURRENT URINARY TRACT INFECTION

J. Curtis Nickel*, R. Christopher Doiron, Ker-ri-Lynn Kelly, Kingston, Canada, Nicolle Diaz, Caleb D. Phillips, Craig D. Tipton, Lubbock, TX

MP02-15 IMPACT OF MV140 ON PATIENT RELATED BURDEN OF DISEASE ASSOCIATED WITH THE MANAGEMENT OF RECURRENT URINARY TRACT INFECTIONS (RUTI)

J. Curtis Nickel*, Kingston, Canada, Stephen Foley, Reading, United Kingdom, Miguel Casa-novas, Raquel Caballero, Madrid, Spain, María Fernanda Lorenzo-Gómez, Salamanca, Spain

MP02-16 LONG-TERM OUTCOMES AFTER ELECTROFULGURATION FOR ANTIBIOTIC-REFRACTORY RECURRENT URINARY TRACT INFECTIONS

Shivani Gaitonde*, Alana L. Christie, Philippe E. Zimmern, Dallas, TX

MP02-17 MOLECULAR ANALYSIS OF CETYLPYRIDINIUM CHLORIDE FOR USE IN BLADDER INSTILLATION THERAPY IN THE ADVANCED MANAGEMENT OF RECURRENT URINARY TRACT INFECTIONS

Samuel Chang*, Namrata Sawant, Richardson, TX, William Warner, Punta Gorda, FL, Philippe Zimmern, Dallas, TX, Nicole De Nisco, Richardson, TX

MP02-18 COMPARING COSTS ASSOCIATED WITH MANAGEMENT OF ANTIBIOTIC-REFRACTORY RECURRENT URINARY TRACT INFECTIONS FOR ONE YEAR PRE- AND POST-ELECTROFULGURATION OF TRIGONITIS

Shivani Gaitonde*, Jacob A. Stevens, Joseph J. Crivelli, Philippe E. Zimmern, Dallas, TX

MP02-19 PROSPECTIVE RANDOMIZED CLINICAL TRIAL TO ASSESS THE UTILITY OF URINALYSIS PRIOR TO OFFICE UROLOGY PROCEDURES

Alexa Rose*, Aleah Warden, Sara Best, Tudor Borza, Vani Tadakala, E. Jason Abel, Daniel D. Shapiro, David F. Jarrard, Kyle A. Richards, Madison, WI

MP02-20 DECREASED RISK OF URINARY INFECTION IS ASSOCIATED WITH SINGLE USE URETEROSCOPES

Rei Unno*, Xavier Cortez, Leslie Charondo, Kevin Chang, Nizar Hakam, Carter Chan, Heiko Yang, Gregory Hosier, Fadl Hamouche, David Bayne, Marshall Stoller, Thomas Chi, San Francisco, CA


30

Friday, May 13, 2022 7:00 am – 8:15 am

Moderated Poster Session 3BLADDER CANCER: INVASIVE I

Room 222 @ Ernest N. Morial Convention CenterModerators: Siamak Daneshmand, S. Machele Donat & Stanley Malkowicz


MP03-01 ROBOT-ASSISTED RADICAL CYSTECTOMY WITH EXTRACORPOREAL URINARY DIVERSION DOES NOT INCREASE URETEROENTERIC STRICTURE RATE: OUTCOMES FROM A RANDOMIZED TRIAL COMPARING OPEN VERSUS ROBOTIC CYSTECTOMY

Chun Huang, Moose Jaw, Canada, Melissa Assel, Benjamin Beech*, Nicole Benfante, Daniel Sjoberg, Jonathan Coleman, Guido Dalbagni, Harry Herr, S. Machele Donat, Vincent Laudone, Andrew Vickers, Bernard Bochner, Alvin Goh, New York, NY

MP03-02 ASSOCIATION BETWEEN VISIBLY COMPLETE TRANSURETHRAL RESECTION OF BLADDER TUMOR AND PATHOLOGIC DOWNSTAGING FOLLOWING NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER

Bryce Baird*, Jacksonville, FL, Augustus Anderson, New Orleans, LA, Christian Ericson, Gianpiero Carames, Paul Young, Timothy Lyon, Jacksonville, FL

MP03-03 TARGETING V1/CHASE TO OVERCOME GEMCITABINE RESISTANCE

Semih Sarcan*, Lübeck, Germany, Daley S. Morera, Augusta, GA, Marie C. Hupe, Lübeck, Germany, Karina Aguilar, Anuj Sharma, Sung Alexander, Joseph McDaniels, Huabin Zhu, Augusta, GA, Martin Hennig, Lübeck, Germany, Martha Terris, Augusta, GA, Axel S. Merse-burger, Lübeck, Germany, Vinata B. Lokeshwar, Augusta, GA

MP03-04 ANALYSIS OF COMPLICATIONS AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY BETWEEN 2005-2020: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM

Holly Houenstein, Umar Iqbal, Zhe Jing, Ahmed S. Elsayed, Yousuf Ramahi*, Buffalo, NY, Michael Stöckle, Homburg, Germany, Carl Wijburg, Arnhem, Netherlands, Abolfazl Hosseini, Peter Wiklund, Solna, Sweden, Eric Kim, St. Louis, MO, Jihad Kaouk, Cleveland, OH, Prokar Dasgupta, Mohammed S. Khan, London, United Kingdom, Andrew A. Wagner, Boston, MA, Johar R. Syed, James O. Peabody, Detroit, MI, Ketan K. Badani, Lee Richstone, New York, NY, Alexandre Mottrie, Aalst, Belgium, Thomas J. Maatman, Wyoming, MI, Derya Balbay, Istanbul, Turkey, Juan P. Redor-ta, Barcelona, Spain, Koon Ho Rha, Seoul, Korea, Republic of, Franco Gaboardi, Milan, Italy, Morgan Roupret, Paris, France, Ahmed Aboumohamed, Bronx, NY, Ahmed A. Hussein, Khurshid A. Guru, Buffalo, NY


MP03-05 HOW DOES THE TYPE OF URINARY DIVERSION AFFECT HEALTH RELATED QUALITY OF LIFE (HRQOL) IN THE COURSE OF FOUR YEARS AFTER RADICAL CYSTECTOMY? - A PROPENSITY SCORE-MATCHED ANALYSIS

Yannic Volz*, Lennert Eismann, Benedikt Ebner, Paulo Pfitzinger, Jan-Friedrich Jokisch, Gerald Schulz, Thilo Westhofen, Alexander Karl, Boris Schlenker, Christian Stief, Alexander Kretschmer, Munich, Germany

MP03-06 PROSPECTIVE STUDY ON FDG-PET/CT FOR ON-TREATMENT ASSESSMENT OF RESPONSE TO NEOADJUVANT OR INDUCTION CHEMOTHERAPY IN INVASIVE BLADDER CANCER

Sarah Einerhand*, Charlotte Voskuilen, Elies Fransen van de Putte, Maarten Donswijk, Anne-marie Bruining, Michiel Van der Heijden, Laura Mertens, Kees Hendricksen, Erik Vegt, Bas van Rhijn, Amsterdam, Netherlands

MP03-07 IMPACT OF PRIOR INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER ON THE EFFICACY OF PEMBROLIZUMAB IN PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA

Rikiya Taoka*, Kagawa, Japan, Takashi Kobayas-hi, Yu Hidaka, Hiroyasu Abe, Satoshi Morita, Osamu Ogawa, Kyoto, Japan, Hiroyuki Nishi-yama, Tsukuba, Japan, Hiroshi Kitamura, Toyama, Japan, Mikio Sugimoto, Kagawa, Japan

MP03-08 ASSOCIATION BETWEEN URETERAL CLAMPING TIME AND ACUTE KIDNEY INJURY DURING ROBOT-ASSISTED RADICAL CYSTECTOMY

Yudai Ishiyama*, Tsunenori Kondo, Hiroki Ishihara, Arakawa, Japan, Kazuhiko Yoshida, Junpei Iizuka, Kazunari Tanabe, Toshio Takagi, Tokyo, Japan

MP03-09 IMPACT OF VARIANT HISTOLOGY AND IMMUNOHISTOCHEMISTRY ON RESPONSE TO ADJUVANT CHEMOTHERAPY IN UROTHELIAL MUSCLE-INVASIVE BLADDER CANCER

Florestan Koll*, Luis Kluth, Felix Chun, Severin Banek, Katrin Bankov, Jens Köllermann, Henning Reis, Peter Wild, Frankfurt am Main, Germany


FR

IDA

Y

MP03-10 LIFE EXPECTANCY IN METASTATIC UROTHELIAL BLADDER CANCER PATIENTS ACCORDING TO RACE/ETHNICITY

Francesco Chierigo*, Genova, Italy, Christoph Würnschimmel, Hamburg, Germany, Rocco Simone Flammia, Rome, Italy, Benedikt Horle-mann, Montreal, Canada, Gabriele Sorce, Milan, Italy, Benedikt Hoeh, Frankfurt, Germany, Zhe Tian, Fred Saad, Montreal, Canada, Markus Graefen, Hamburg, Germany, Michele Gallucci, Rome, Italy, Alberto Briganti, Francesco Montorsi, Milan, Italy, Felix K.H. Chun, Frankfurt, Germany, Shahrokh F. Shariat, Vienna, Austria, Guglielmo Mantica, Maro Borghesi, Nazareno Suardi, Carlo Terrone, Genova, Italy, Pierre I Karakiewicz, Montreal, Canada

MP03-11 HIGH EXPRESSION OF AHNAK2 IS ASSOCIATED WITH BIOLOGICALLY AGGRESSIVE FINDINGS AND POOR SURVIVAL IN PATIENTS TREATED WITH RADICAL CYSTECTOMY

Dai Koguchi*, Kazumasa Matsumoto, Yuriko Shimizu, Noriyuki Amano, Soichiro Shimura, Masaomi Ikeda, Hideyasu Tsumura, Ken Ichi Tabata, Yuichi Sato, Masatsugu Iwamura, Sagamihara, Japan

MP03-12 ASSOCIATION OF USE OF POTASSIUM COMPETITIVE ACID BLOCKERS AND EFFECTIVENESS OF PEMBROLIZUMAB IN PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA

Wataru Fukuokaya*, Takahiro Kimura, Tokyo, Japan, Kazumasa Komura, Taizo Uchimoto, Kazuki Nishimura, Osaka, Japan, Yu Oyama, Hirokazu Abe, Chiba, Japan, Haruhito Azuma, Osaka, Japan, Jun Miki, Shin Egawa, Tokyo, Japan

MP03-13 IDENTIFICATION OF MUSCLE-INVASION STATUS IN BLADDER CANCER PATIENTS USING NATURAL LANGUAGE PROCESSING AND MACHINE LEARNING

Ruixin Yang, Di Zhu, Lauren Howarda, Amanda De Hoedt, Durham, NC, Zachary Klaassen, Au-gusta, GA, Stephen Freedland, Los Angeles, CA, Stephen Williams, Galveston, TX, Ruixin Yang*, Durham, NC

MP03-14 NEOADJUVANT VERSUS ADJUVANT CHEMOTHERAPY IN BLADDER CANCER: A NATIONWIDE COHORT STUDY

Se Young Choi, Taekyu Huh, Joonhee Gook, Jae Hun Shim*, Jong Hyun Tae, Byung Hoon Chi, Jin Wook Kim, In Ho Chang, Tae-Hyoung Kim, Soon Chul Myung, Seoul, Korea, Republic of

MP03-15 PRIMARY VERSUS SECONDARY MUSCLE INVASIVE BLADDER CANCER: COMPARING THE PATHOLOGIC AND ONCOLOGIC OUTCOMES BETWEEN BOTH FORMS OF MUSCLE INVASIVE DISEASE WHEN TREATED WITH STANDARD OF CARE

Tarik Benidir*, Zaeem Lone, Ao Zhang, Carlos Munoz-Lopez, Pranay Hegde, Kevin Fung, Jesse Fajnzylber, Eric Klein, Mohammed Eltemamy, Jihad Kaouk, Georges Pascal-Haber, Nima Almassi, Christopher Weight, Byron Lee, Cleveland, OH

MP03-16 FEASIBILITY, USABILITY AND UTILITY OF A REMOTE SYMPTOM ASSESSMENT TOOL AFTER RADICAL CYSTECTOMY

Heather Huelster*, Logan Zemp, Brian Gonzalez, Heather Jim, Michael Poch, L Robert Gore, Scott Gilbert, Tampa, FL

MP03-17 PATIENT, PHYSICIAN, HOSPITAL FACTORS ASSOCIATED WITH READMISSION AFTER RADICAL CYSTECTOMY

Kassem Faraj*, Lanyu Mi, Mark Tyson, Phoenix, AZ

MP03-18 CHRONOLOGICAL TRANSITION IN OUTCOME OF SECOND-LINE TREATMENT IN PATIENTS WITH METASTATIC UROTHELIAL CANCER AFTER PEMBROLIZUMAB USAGE: A MULTICENTER ANALYSIS

Teruki Isobe*, Taku Naiki, Yosuke Sugiyama, Aya Naiki, Takashi Nagai, Toshiki Etani, Satoshi Nozaki, Keitaro Iida, Yusuke Noda, Nobuhiko Shimizu, Nami Tomiyama, Nagoya City, Japan, Rika Banno, Konan City, Japan, Hiroki Kubota, Yatomi City, Japan, Shuzo Hamamoto, Ryosuke Ando, Noriyasu Kawai, Takahiro Yasui, Nagoya City, Japan

MP03-19 ASSOCIATION BETWEEN IMMUNE-RELATED ADVERSE EVENTS AND SURVIVAL OF PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA TREATED WITH PEMBROLIZUMAB

Kazutaka Nakamura*, Fukushima, Japan, Takagi Toshio, Tokyo, Japan, Yuki Nemoto, Saitama, Japan, Yudai Ishiyama, Hiroki Ishihara, Hideka-zu Tachibana, Hironori Fukuda, Tokyo, Japan, Hiroaki Shinmura, Fukushima, Japan, Yasunobu Hashimoto, Saitama, Japan, Tsunenori Kondo, Kazuhiko Yoshida, Junpei Iizuka, Hideki Ishida, Kazunari Tanabe, Tokyo, Japan

MP03-20 CONTEMPORARY ANALYSIS OF CYSTECTOMY COMPLICATIONS

Kevin Chua*, Hiren Patel, Arnav Srivastava, Sai Krishnaraya Doppalapudi, Benjamin Lichtbroun, Sammy Elsamra, Eric Singer, Thomas Jang, Saum Ghodoussipour, New Brunswick, NJ


32

Friday, May 13, 2022 7:00 am – 9:00 am

Podium Session 1KIDNEY CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY I

Room 252 @ Ernest N. Morial Convention CenterModerator: Peter Clark & Ari Hakimi

ABSTRACTTIME NUMBER TITLE7:00 PD01-01 VHL-MEDIATED UBIQUITINATION OF THE

KINASE MPS1 REGULATES THE MITOTIC CHECKPOINT IN CLEAR CELL RENAL CELL CARCINOMA

Mark Woodford*, Sarah Backe, Rebecca Sager, Oleg Shapiro, Imad Nsouli, Laura Wengert, Gennady Bratslavsky, Dimitra Bourboulia, Mehdi Mollapour, Syracuse, NY

7:10 PD01-02 CITRATE TRANSPORTER – A POTENTIAL TUMOR SUPPRESSOR AND BIOMARKER IN RENAL CELL CARCINOMA

Andre Jordan*, Metairie, LA, Huabin Zhu, Augus-ta, GA, Soum Lokeshwar, New Haven, CT, Semih Sarcan, Karina Aguilar, Anuj Sharma, Martha Terris, Vinata Lokeshwar, Augusta, GA

7:20 PD01-03 ALANINE–SERINE–CYSTEINE TRANSPORTER 2 IN GLUTINE METABOLISM IS A THERAPEUTIC TARGET FOR RENAL CELL CARCINOMA

Yoshinari Muto*, Makoto Sumitomo, Masanobu Saruta, Atsuhiko Yoshizawa, Kiyoshi Takahara, Ryoichi Shiroki, Toyoake, Japan

7:30 PD01-04 GLUTINE BLOCKADE INDUCES CELLULAR SENESCENCE IN RENAL CELL CARCINOMA BY TARGETING SLC1A5

Issei Kawaki*, Hirofumi Yosino, Wataru Fukumo-to, Motoki Tai, Shunsuke Okura, Hideki Enokida, kagoshima, Japan

7:40 PD01-05 MIR-182-5P INHIBITS THE TUMORIGENESIS OF CLEAR CELL RENAL CELL CARCINOMA BY REPRESSING UBE2T

Wu Yucai*, Gong Yanqing, Li Xuesong, Beijing, China, People’s Republic of, Zhou Liqun, Beijing, China, People’s Republic of

7:50 PD01-06 GCN5L1 REGULATES MITOCHONDRIAL ACETYLATION, LIPID ACCUMULATION AND CELL GROWTH IN VHL-DEFICIENT CLEAR CELL RENAL CELL CARCINOMA

Bradley Webster*, Allen Seylani, Michael Danesh-var, Alexis Rompre-Brodeur, Raprasad Srinivasan, Bethesda, MD

8:00 PD01-07 THE TUMOR SUPPRESSOR FLCN REGULATES THE WARBURG EFFECT IN RENAL CELL CARCINOMA THROUGH INHIBITION OF LACTATE DEHYDROGENASE-A

Mark R Woodford, Rebecca A Sager*, Sarah J Backe, Fiza Hashmi, Priyanka Kancherla, Alexan-dr Pinkhasov, Syracuse, NY, W Marston Linehan, Bethesda, MD, Dimitra Bourboulia, Gennady Bratslavsky, Mehdi Mollapour, Syracuse, NY

ABSTRACTTIME NUMBER TITLE8:10 PD01-08 COMPARISON OF MUTATIONAL PROFILE

OF PRIMARY VERSUS ORGAN-SPECIFIC METASTATIC TUMORS IN CLEAR CELL RENAL CELL CARCINOMA

Sari Khaleel*, New York, NY, Renzo DiNatale, Seattle, WA, Benjin Freeman, Ritesh Kotecha, Robert Motzer, Paul Russo, Jonathan Coleman, Eduard Reznik, Ari Hakimi, New York, NY

8:20 PD01-09 PROTEOGENOMIC AND CLINICAL IMPLICATIONS OF RECURRENT SPLICE VARIANTS IN CLEAR CELL RENAL CELL CARCINOMA

Andrew Chang*, Paul Stewart, Nicholas Cha-kiryan, Alex Soupir, Yijun Tian, Dongliang Du, Jie Teer, Youngchul Kim, Philippe Spiess, Jad Chahoud, Yonghong Zhang, John Koomen, Anders Berglund, Timothy Robinson, Liang Wang, Brandon Manley, Tampa, FL

8:30 PD01-10 WHOLE TRANSCRIPTOME SEQUENCING OF CLEAR CELL RENAL CELL CARCINOMA REVEALS A MULTIGENE EXPRESSION PROGNOSTIC SIGNATURE

Srinivas Nallandhighal, Rohit Mehra, Marcin Cieslik, y Kasputis, Brittney Cotta, Todd Morgan, Simpa Sali*, Ann Arbor, MI

8:40 PD01-11 CHARACTERIZATION OF WILMS TUMOR AND HUMAN FETAL KIDNEY USING SPATIAL TRANSCRIPTOMICS

Astgik Petrosyan, Valentina Villani, Paola Aguiari, Matthew Thornton, Zhou Shengmei, Brendan Grubbs, Marie Csete, Roger De Filippo, Kevin Lemley, Sargis Sedrakyan, Stefano Da Sacco, Laura Perin*, Los Angeles, CA

8:50 PD01-12 PAN-CANCER CHARACTERIZATION OF THE TUMOR MICROENVIRONMENT REVEALS STROMA AND IMMUNE ENRICHED SUBTYPE WITH DISTINCT MOLECULAR, CLINICAL, AND PROGNOSTIC FEATURES IN DIFFERENT GENITOURINARY CANCERS

Mark Farha*, Brittney Cotta, Srinivas Nallan-dhighal, Kevin Hu, Ann Arbor, MI, Steven Golden-thal, Columbus, OH, Aaron Udager, Simpa Sali, Ann Arbor, MI



FR

IDA

Y

Friday, May 13, 2022 7:00 am – 9:00 am

Podium Session 2PEDIATRIC UROLOGY: NEUROGENIC BLADDER, RECONSTRUCTION & DSD

Room 255 @ Ernest N. Morial Convention CenterModerator: Courtney Shepard Streur

ABSTRACTTIME NUMBER TITLE7:00 PD02-01 PRENATAL CLOSURE OF

MYELOMENINGOCELE IS ASSOCIATED WITH HIGHER RISK FOR EARLY SECONDARY SPINAL CORD TETHERING

Hsin-Hsiao Wang*, Duncan Morhardt, Benjamin Warf, Lawrence Karlin, Asal Hojjat, Shahram Khoshbin, Erin Mcnamara, Carlos Estrada, Stuart Bauer, Boston, MA

7:10 PD02-02 CHARACTERIZING CLINICAL HETEROGENEITY IN HOSTILE BLADDER CRITERIA AMONG NEUROGENIC BLADDER CHILDREN

Ranveer Vasdev*, Minneapolis, MN, Kenneth Softness, Rachel Saunders, Carlos Estrada, Jr., Scott Wang, Boston, MA

7:20 PD02-03 THE UTILITY OF URODYNAMICS IN YOUNG CHILDREN WITH SPINA BIFIDA

Ruthie Su*, Rocio Goodman, Jennika Finup, Vinaya Bhatia, Ann Byrne, Walid Farhat, Shannon Cannon, Madison, WI

7:30 PD02-04 VARIABILITY IN CYSTATIN C AND CREATININE BASED EQUATIONS FOR CHRONIC KIDNEY DISEASE STAGING IN ADULT SPINA BIFIDA PATIENTS

Meera Ganesh*, Mitali Kini, David Chu, Stephanie Kielb, Diana Bowen, Chicago, IL

7:40 PD02-05 EFFICACY AND SAFETY OF VIBEGRON AS ADJUVANT TREATMENT ON REFRACTORY NEUROGENIC BLADDER DYSFUNCTION IN CHILDREN WITH SPINA BIFIDA

Kazuyuki Nishinaka*, Naoya Masumori, Sapporo, Japan

7:50 PD02-06 COMPARISON OF LONG TERM ADVERSE EVENTS AND RENAL OUTCOMES BETWEEN ILEOVESICOSTOMY AND CONTINENT BLADDER AUGMENTATIONS AT A SINGLE PEDIATRIC INSTITUTION

Viktor Flores*, Mikhael Matthew, Heidi Chen, Ben-jamin Abelson, Abby S Taylor, Stacy T Tanaka, Cyrus M Adams, Mark C Adams, John C Thomas, John C Pope 4th, John W Brock 3rd, Douglass B Clayton, Nashville, TN

ABSTRACTTIME NUMBER TITLE8:00 PD02-07 FINANCIAL TOXICITY OF SPINA BIFIDA:

INITIAL DEVELOPMENT OF A PATIENT-REPORTED OUTCOME MEASURE

Leonid Aksenov*, Kevin Hobbs, Rebecca Fairch-ild, Rohit Tejwani, John Wiener, Jonathan Routh, Durham, NC

8:10 PD02-08 BLADDER CAPACITY AND GROWTH IN CLASSIC BLADDER EXSTROPHY: A NOVEL PREDICTIVE TOOL

Tamir Sholklapper*, Mahir Maruf, Jiafeng Zhu, Jason Michaud, Mohammad Zaman, John Jay-man, Roni Manyevitch, Rachel Davis, Wayland Wu, Thomas Harris, Heather DiCarlo, Gayane Yenokyan, John Gearhart, Baltimore, MD

8:20 PD02-09 DECISIONAL REGRET IN ADULTS WITH SPINA BIFIDA REGARDING SURGERIES THEY HAD AS CHILDREN FOR NEUROGENIC BLADDER

Joshua Roth*, Konrad Szymanski, Rosalia Misseri, Indianapolis, IN

8:30 PD02-10 CHANGES IN THE APPROACH OF SPU MEMBERS TO DSD MANAGEMENT

Barry Kogan*, Albany, NY, Melissa Gardner, Ann Arbor, MI, Kristina Suorsa-Johnson, Ann Arbor, MI, Peter Lee, David Mauger, Hershey, PA, David Sandberg, Ann Arbor, MI

8:40 PD02-11 WHEN AND HOW TO DISCLOSE GENITAL SURGERY TO GIRLS WITH CAH? EXPERIENCES AND PREFERENCES OF WOMEN WITH CAH

Ashley W. Johnston*, Indianapolis, IN, Mimi S. Kim, Paul Kokorowski, Los Angeles, CA, Devon J. Hensel, Indianapolis, IN, Patrice M. Yasuda, Los Angeles, CA, Konrad M. Szymanski, on behalf of Life with Congenital Adrenal Hyperplasia, Indian-apolis, IN

8:50 PD02-12 THE RISK OF GONADAL MALIGNANCY IN PATIENTS WITH ANDROGEN INSENSITIVITY SYNDROME

Pratik Kanabur*, Soo Jeong Kim, Sagar Patel, Lefkothea Karaviti, Paul F Austin, Houston, TX


34

Friday, May 13, 2022 7:00 am – 9:00 am

Podium Session 3PROSTATE CANCER: EPIDEMIOLOGY & NATURAL HISTORY I

Room 245 @ Ernest N. Morial Convention CenterModerator: Christopher Kane

ABSTRACTTIME NUMBER TITLE7:00 PD03-01 MRI AS FIRST INVESTIGATION IN MEN

WITH ELEVATED PSA. POPULATION-BASED COHORT STUDY

David Robinsson*, Eksjö, Sweden, Hans Garmo, Uppsala, Sweden, Delshad Nasrollah, Jönköping, Sweden, Tiago Bonde Miranda, Malmö, Sweden, Pär Stattin, Uppsala, Sweden

7:10 PD03-02 LONG-TERM EFFECTS OF 5α-REDUCTASE INHIBITORS ON PROSTATE CANCER MORTALITY - A LARGE POPULATION-BASED PROSPECTIVE STUDY

Lars Björnebo*, Tobias Nordström, Andrea Discac-ciati, Thorgerdur Palsdottir, Markus Aly, Henrik Grön-berg, Martin Eklund, Anna Lantz, Solna, Sweden

7:20 PD03-03 ASSOCIATION BETWEEN 5α-REDUCTASE INHIBITOR AND INCIDENCE, TUMOR GRADING AND SURVIVAL OF PROSTATE CANCER

Peng-Yen Wu*, Li-Weng Chang, Sheng-Chun Hung, Jian-Ri Li, Kun-Yuan Chiu, Kevin Lu, Shi-an-Shiang Wang, Chuan-Shu Chen, Chen-Kuang Yang, Cheng-Che Chen, Shu-Chi Wang, Chia-Yen Lin, Chen-Li Cheng, Taichung, Taiwan

7:30 PD03-04 SYSTEMATIC REVIEW OF THE IMPACT OF A PLANT-BASED DIET ON PROSTATE CANCER INCIDENCE AND OUTCOMES

Natasha Gupta*, Jacob Taylor, James Borin, New York, NY, Kenneth Jacobsohn, Milwaukee, WI, Stacey Kenfield, San Francisco, CA, Scott Eggener, Chicago, IL, Hiten Patel, Maywood, IL, Carrie Price, Towson, MD, Meena Davuluri, Nataliya Byrne, New York, NY, Trinity Bivalacqua, Philadelphia, PA, Stacy Loeb, New York, NY

7:40 PD03-05 PROGNOSTIC VALUE OF LYMPH NODE COUNT VERSUS LYMPH NODE DENSITY FOR MEN WITH PATHOLOGICAL NODE-POSITIVE PROSTATE CANCER

Aurash Naser-Tavakolian*, Timothy Daskivich, Mi-chael Luu, Zachary Zumsteg, Los Angeles, CA

7:50 PD03-06 GRADE MIGRATION OF PROSTATE CANCER AT DIAGNOSIS FOLLOWING THE US PREVENTIVE SERVICES TASK FORCE RECOMMENDATIONS ON PROSTATE CANCER SCREENING

Leonardo Borregales*, Gina DeMeo, Emily Cheng, Xiagnmei Gu, New York, NY, Jonathan Shoag, Cleveland, OH, Sigrid Carlsson, Andrew Vickers, Jim Hu, New York, NY

8:00 PD03-07 ASSOCIATION BETWEEN ADVERSE SURGICAL PATHOLOGY AND OVERALL SURVIVAL AMONG PATIENTS WITH LOW-RISK PROSTATE CANCER

Grace Lee*, Eileen Lee, Zev Leopold, Sinae Kim, New Brunswick, NJ, Michael S. Leapman, Isaac Y. Kim, New Haven, CT

ABSTRACTTIME NUMBER TITLE8:10 PD03-08 THE IMPACT OF MEDICAID EXPANSION ON

INSURANCE COVERAGE AND METASTATIC DISEASE AT DIAGNOSIS IN PROSTATE CANCER PATIENTS

David Schroeder*, Solange Bassale, Brian Duty, Ryan Kopp, Portland, OR

8:20 PD03-09 THE NATURAL HISTORY OF A DETECTABLE SERUM PSA AFTER RADICAL PROSTATECTOMY

Julie A. Szymaniak*, Samuel L. Washington III, Janet E. Cowan, Matthew R. Cooperberg, Peter E. Lonergan, Hao G. Nguyen, Peter R. Carroll, San Francisco, CA

8:30 PD03-10 EFFECT OF ADVANCES IN TREATMENT ON POPULATION-LEVEL SURVIVAL OF PATIENTS WITH METASTATIC PROSTATE CANCER

Danly O. Omil-Lima, Xian Wu, Mercedes A. Kent, Camilo Arenas Gallo*, Ilon Weinstein, Sarah C. Markt, Jennifer C. Cullen, Lee E. Ponsky, Jorge A. Garcia, Cleveland, OH, Jim C. Hu, Christopher E. Barbieri, New York, NY, Daniel E. Spratt, Jonathan E. Shoag, Cleveland, OH

8:40 PD03-11 PATIENT-REPORTED DELAYS IN TREATMENT FOR UROLOGIC CANCERS DURING THE COVID-19 PANDEMIC: A NATIONAL CROSS-SECTIONAL ANALYSIS

Jacob Lang*, Sree Jambunathan, Toledo, OH, Eashwar Somasundaram, Cleveland, OH, Nagalakshmi Nadiminty, Firas Petros, Ahmed El-Zawahry, Obi Ekwenna, Puneet Sindhwani, Toledo, OH

8:50 PD03-12 COVID-19 DISRUPTION TO PROSTATE CANCER MANAGEMENT IN A UK TERTIARY REFERRAL CENTRE

Matthew Byrne, Nithesh Ranasinha*, Claudia Mercader, Mutie Raslan, Caroline Gordon, Kate Hutton, Sarah Head, Ruth MacPherson, Charlotte Minett, Louise Flaxman, Jessica Smyth, Natasha Young, Fergus Gleeson, Clare Verrill, Richard Colling, Francisco Lopez, Richard Bell, Tom Leslie, Richard Bryant, Freddie Hamdy, Alastair D. Lamb, Oxford, United Kingdom



FR

IDA

Y

Friday, May 13, 2022 7:00 am – 9:00 am

Podium Session 4ADRENAL

Room 244 @ Ernest N. Morial Convention CenterModerators: Amr Fergany, Neal Rowe & Chris Weight

ABSTRACTTIME NUMBER TITLE7:00 PD04-01 CORTISOL REGULATES ADRENALINE

SYNTHESIS VIA PHENYLETHANOLAMINE N-METHYLTRANSFERASE IN SURGICAL SPECIMENS OF PHEOCHROMOCYTOMA

Kazuyuki Numakura*, Yuya Sekine, Yumina Muto, Mizuki Kobayashi, Soki Kashima, Ryohei Yamamoto, Atsushi Koizumi, Taketoshi Nara, Mitsuru Saito, Shintaro Narita, Tomonori Habuchi, Akita, Japan

7:10 PD04-02 THE MALE GENDER AND DIFFERENT CUT-OFF VALUE OF KI-67 INDEX MAY PREDICT METASTASIS RISK OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA

Peng Chen*, Tzu-Chun Wei, Yen-Hwa Chang, Hsiao-Jen Chung, Eric Yi-Hsiu Huang, Tzu-Ping Lin, Alex T.L. Lin, William J. Huang, Taipei, Taiwan

7:20 PD04-03 DIAGNOSTIC DILEMMAS: A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS OF ADRENAL INCIDENTALOMA PATHOLOGY BASED ON RADIOGRAPHIC SIZE

David Zekan*, Morgantown, WV, Robert King, Charleston, WV, Ali Hajiran, Morgantown, WV, Apexa Patel, Samuel Deem, Charleston, WV, Adam Luchey, Morgantown, WV

7:30 PD04-04 THE FATE OF THE INCIDENTAL ADRENAL MASS, CONTINUED SURVEILLANCE VERSUS SURGICAL EXCISION

Wansuk Kim*, Seoul, Korea, Republic of, Stefanie van Uem, Stanford, CA, Francesco Del Giudice, Rome, Italy, Benjamin Chung, Stanford, CA

ABSTRACTTIME NUMBER TITLE7:40 PD04-05 CLINICAL CURE VS A NOVEL TRIFECTA

SYSTEM FOR EVALUATING LONG-TERM OUTCOMES OF MINIMALLY-INVASIVE PARTIAL OR TOTAL ADRENALECTOMY FOR UNILATERAL PRIMARY ALDOSTERONISM: RESULTS OF A MULTICENTRIC SERIES

Umberto Anceschi*, Riccardo Mastroianni, Gabriele Tuderti, Alfredo Maria Bove, Aldo Brassetti, Mariacon-siglia Ferriero, Marilda Mormando, Rome, Italy, Ales-sandro Carrara, Trento, Italy, Bernardino De Concilio, Bassano del Grappa, Italy, Leonardo Misuraca, Rome, Italy, Orazio Zappalà, Trento, Italy, Cristian Fiori, Orb, Italy, Marialuisa Appetecchia, Rome, Italy, Antonio Celia, Bassano del Grappa, Italy, Francesco Porpiglia, Orbassano, Italy, Giuseppe Tirone, Trento, Italy, Michele Gallucci, Giuseppe Simone, Rome, Italy

7:50 PD04-06 PERIRENAL FAT THICKNESS AND TUMOR SIZE ARE INDEPENDENT PREDICTORS FOR PERIOPERATIVE OUTCOMES OF LAPAROSCOPIC ADRENALECTOMY

Michikata Hayashida*, Shotaro Yasuoka, Masashi Koshiba, Makoto Tanaka, Naoto Tanaka, Takahiro Oshina, Suguru Oka, Kazushige Sakaguchi, Shinji Urakami, Tokyo, Japan

8:00 PD04-07 ANALYSIS OF HIGH-RISK FACTORS FOR ADRENAL CRISIS AFTER ADRENAL SURGERY

Quanliang Liu, Yuhua Zou, Xiaofeng Zou*, Guoxi Zhang, Yuanhu Yuan, Rihai Xiao, Gengqing Wu, Biao Qian, Xiaoning Wang, Hui Xu, Ganzhou, China, People’s Republic of


Friday, May 13, 2022 7:00 am – 9:00 am

Video Session 1UPPER TRACT RECONSTRUCTION

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerators: Susan MacDonald, Erick Ramirez Perez & Ryan Mori

ABSTRACTTIME NUMBER TITLE7:00 V01-01 COLON CONDUIT URINARY DIVERSION:

CONSIDERATIONS FOR THE RECONSTRUCTIVE UROLOGIST

Kevin Hebert*, Rano Matta, Kiarad Fendereski, Benjamin McCormick, Jeremy Myers, Salt Lake City, UT

7:10 V01-02 USE OF SPY FLUORESCENT ANGIOGRAPHY DURING URINARY DIVERSION

Grace Prillaman, Clinton Yeaman*, Sumit Isharw-al, Tracey Krupski, Charlottesville, VA

ABSTRACTTIME NUMBER TITLE7:20 V01-03 USE OF INTESTINAL BOWEL

SEGMENTS FOR ADVANCED ROBOTIC RECONSTRUCTIVE SURGERY

Igor Voznesensky*, Raju Thomas, Erik Castle, New Orleans, LA

7:30 V01-04 COMPLETELY INTRACORPOREAL ROBOT-ASSISTED LAPAROSCOPIC BILATERAL ILEAL URETER REPLACEMENT COMBINED WITH ILEAL AUGMENTATION CYSTOPLASTY

Silu Chen, Kunlin Yang, Weijie Zhu, Zhihua Li, Zhenyu Li, Liqun Zhou, Xuesong Li*, Beijing, China, People’s Republic of

36

7:40 V01-05 SINGLE INSTITUTIONAL EXPERIENCE WITH ROBOTIC-ASSISTED LAPAROSCOPIC URINARY TRACT FISTULA REPAIR

Margaret Higgins*, Gary Shahinyan, Brian Flynn, Aurora, CO

7:50 V01-06 OWN FLAP URETEROPLASTY-NEW SOLUTION FOR LONG STRICTURE

Alexander Kheifets*, Ben Valery Sionov, Masha Ben Zvi, Alexander Tsivian, Holon, Israel

8:00 V01-07 SINGLE-PORT ROBOTIC RETROPERITONEAL BUCCAL MUCOSAL GRAFT URETEROPLASTY WITH PERINEPHRIC FAT WRAP

Nathan Cheng*, Hackensack, NJ, Suzannah Sorin, Michael Stifelman, Nutley, NJ

8:10 V01-08 ROBOTIC ANASTOMOTIC STRICTURE REVISION OF THE TRANSPLANT KIDNEY: TECHNICAL CONSIDERATIONS AND OUTCOMES

Felicia Balzano*, Boyd Viers, Rochester, MN

8:20 V01-09 URETEROCALICOSTOMY IN TWO PATIENTS WITH MULTIPLE FAILED PYELOPLASTIES

Michael Gross*, Jason Scovell, Robert Stein, Cleveland, OH

8:30 V01-10 ROBOTIC-ASSISTED LAPAROSCOPIC URETEROCALICOSTOMY AND PYELOLITHOTOMY FOR PROXIMAL URETERAL STRICTURE

Grace Lee*, Hiren V. Patel, Joshua Sterling, Sammy Elsamra, New Brunswick, NJ

8:40 V01-11 ROBOTIC NON TRANSECTING PYELOPLASTY FOR URETEROPELVIC OBSTRUCTION WITH CROSSING VESSEL

Felicia Balzano*, Jonathan Warner, Rochester, MN

8:50 V01-12 ROBOT ASSISTED URETERAL REIMPLANTATION SIDE-TO-SIDE WITH BOARI FLAP

Abdel Bakayoko*, Mehdi El Akri, Lucas Freton, Juliette Hascoet, Zinne-Eddine Khene, Vivien Grafeille, Gregory Verhoest, Andrea Manunta, Mathieu Romain, Karim Bensalah, Rennes, France, Lee Zhao, New York, NY, Benoit Peyronnet, Rennes, France


Friday, May 13, 2022 7:00 am – 12:00 pm

INDIAN AMERICAN UROLOGICAL ASSOCIATION (IAUA)St. James Ballroom @ Hilton New Orleans Riverside

Chairs: Ranjith Ramasamy & Raveen Syan

7:00 CONTINENTAL BREAKFAST & POSTER PRESENTATIONS

7:55 INTRODUCTION AND WELCOME Society President: Puneet SindhwanI

8:00 DEBATE: RENAL STONES—IS ECIRS HYPE OR HOPE?

Moderator: Ravindra Sabnis Hope: Rohit Joshi Hype: Mantu Gupta

8:20 DEBATE: SPERM COUNTS ARE DECLINING—YES OR NO?

Moderator: Sriram Eleswarapu Debater-Pro: Anand Shridharan Debater-Con: Mehul Patel

8:40 DEBATE: PROSTATE CANCER—OLIGOMETASTAT-IC DISEASE ON PSMA PET/CT IN SETTING OF NEGATIVE CONVENTIONAL STAGING STUDIES SHOULD IMPACT TREATMENT DECISION: AGREE OR DISAGREE?

Moderator: Thenappan Chandrasekar Debater-Pro: Nirmish Singla Debater-Con: Sanoj Punnen

9:00 DEBATE: BLADDER CANCER—RADICAL CYSTEC-TOMY VS TRIMODAL THERAPY FOR MUSCLE IN-VASIVE BLADDER CANCER—THE UROLOGIST’S PERSPECTIVE

Moderator: Sima Porten Debater-Pro: Sumeet Bhanvadia Debater-Con: Vikram Narayan

9:20 DEBATE: MALE RECONSTRUCTIVE SURGERY—SLING VERSUS AUS IN THE NON-RADIATED MODERATE SUI MALE PATIENT

Moderator: Jaspreet Sandhu Debaters: Jay Simhan, Krishnan Venkatesan

9:40 DEBATE: PEDIATRIC UROLOGY—ROBOT- ASSISTED LAPAROSCOPIC VERSUS OPEN URETERAL REIMPLANTATION IN THE PEDIATRIC POPULATION

Moderator: Hans Arora Debater-Pro: Sameer Mittal Debater-Con: Kunj Sheth

10:00 BREAK

10:15 DEBATE: TRANSVAGINAL REPAIR OF APICAL PROLAPSE—IS HYSTERECTOMY NECESSARY?

Moderator: Ajay Singla Debater-Pro: Rena Malik Debater-Con: Raveen Syan

10:35 DEBATE: OPTIMAL BPH MANAGEMENT FOR THE 40 GRAM PROSTATE GLAND—ENUCLEATION VERSUS MIST?

Moderator: Ramgopal Satyanarayana Debaters: Nishant Patel, Hemendra Shah

11:05 CHAKRABORTY FELLOWS PODIUM PRESENTATIONS

SURVEILLANCE AFTER REPAIR OF BLADDER EXSTROPHY: ROLE OF URINARY BIOMARKERS

Podium Presenter: Kashish Khanna

ROBOT ASSISTED VESICO-VAGINAL FISTULA REPAIR:OUR TECHNIQUE AND EXPERIENCE

Podium Presenter: Girdhar Singh Bora


FR

IDA

Y

11:15 USI PRESIDENT LECTURE: PCNL IN ANOMALOUS KIDNEY

Ravindra Sabnis

11:25 DEBATE: MANAGEMENT OF STRESS URINARY INCONTINENCE—BULKAMID VERSUS SLING?

Moderator: Sneha Vaish Debater-Pro: Aqsa Khan Debater-Con: Nitya Abraham

11:45 RECOVERY OF SEXUAL AND URINARY FUNC-TION FOLLOWING RADICAL PROSTATECTOMY

Mohit Khera


Friday, May 13, 2022 8:00 am – 4:30 pm

CONFEDERACIÓN AMERICANA DE UROLOGÍA (CAU)LaNouvelle Orleans Ballroom C @ Ernest N. Morial Convention Center

MORNING SESSION Moderator: Jorge Gutierrez-Aceves

STATE-OF-THE-ART LECTURES: UPDATE 2022—ALL YOU NEED TO KNOW

8:00 WELCOME Chair: Jorge Gutierrez-Aceves

8:05 PRIAPISM AND PEYRONIE’S DISEASE: WHAT HAVE I LEARNED?

Tom Lue

8:30 LOWER URINARY TRACT RECONSTRUCTIVE SURGERY

Reynaldo Gomez

8:55 PROSTATE CANCER Peter Carroll

9:20 BLADDER CANCER AND UPPER TRACT TCC Joan Palou

9:45 RENAL CANCER Ketan Badani

10:10 TESTICULAR CANCER Robert Hamilton

10:35 STRESS URINARY INCONTINENCE AND OVERACTIVE BLADDER

W. Stuart Reynolds

11:00 LUTS AND BENIGN PROSTATIC HYPERPLASIA Ricardo Gonzalez

11:25 AUA/CAU REMARKS

11:35 RENAL STONES Manoj Monga

12:00 LUNCH BREAK

AFTERNOON SESSION Moderator: Jorge Gutierrez-Aceves

1:00 COMPLICATIONS IN SURGERY: HOW TO ESCAPE FROM NIGHTMARES

COMPLICATIONS OF ENDOUROLOGY AND STONE TREATMENT

Moderator: Arthur Smith Discussants:Marcelo Baptistussi, Brian Eisner, Stephen Nakada, Margaret Pearle

1:30 CONTROVERSIES IN UROLOGY

PROSTATE BIOPSY: TRANSRECTAL VERSUS TRANSPERINEAL

Debaters: Amir Lebastchi, Samir Taneja

FOCAL THERAPY FOR MODERATE AND HIGH-RISK PROSTATE CANCER

Debater-Pro: Behfar Ehdaie Debater-Con: Michael Cookson

LASER LITHOTRIPSY: MOSES HOYAG VERSUS THULIUM FIBER LASER

Debaters: Khurshid Ghani, Mitchell Humphreys

ROBOTIC SURGERY: SINGLE PORT VERSUS MULTIPLE PORT

Debaters: Mihir Desai, Jihad Kaouk

3:00 NEW TECHNOLOGY

NEW ALTERNATIVE FOR ROBOTIC SURGERY: WHAT IS DIFFERENT?

Ruben Olivares

BURST WAVE LITHOTRIPSY (BWL) Jonathan Harper

3:20 STEP-BY-STEP SURGERY: SEMI-LIVE TIPS AND TRICKS

HOW TO CORRECT GENITOURINARY COMPLICATIONS AFTER GENDER-AFFIRMING SURGERY

Dmitriy Nikolavsky

SINGLE PORT AND MULTIPLE PORT ROBOTIC KIDNEY TRANSPLANT

Mohamed Eltemamy

RADICAL AND PARTIAL NEPHRECTOMY Michael Stifelman

4:25 CLOSING REMARKS


Friday, May 13, 2022 8:00 am – 10:00 am

AQUA FORUM & BREAKFASTRivergate Room @ Ernest N. Morial Convention Center

38

Friday, May 13, 2022 8:00 am – 5:00 pm

SEXUAL MEDICINE SOCIETY OF NORTH AMERICA (SMSNA)Grand Ballroom A @ Hilton New Orleans Riverside

8:00 PRESIDENTIAL WELCOME Society President: Serge Carrier

8:05 CME ACTIVITY ANNOUNCEMENTS Mohit Khera

8:10 SESSION 1: HORMONAL AND MEDICAL THERA-PIES

Moderators: Carlo Bettocchi, Mohit Khera

WHICH TESTOSTERONE THERAPY IS BEST FOR MY PATIENT?

Faysal Yafi

PENILE TRACTION THERAPY AND VACUUM DEVICES IN 2021: WHEN TO USE AND WHAT TO EXPECT

Matthew Ziegelmann

SLEEP APNEA AND MEN’S HEALTH John Mulhall

Q & A

SEXUAL DYSFUNCTION IN PATIENTS WITH MEN-TAL HEALTH DISORDERS

Daniela Wittmann

SEXUAL SUPPLEMENTS: UNDERSTANDING THEIR SAFETY AND EFFICACY

Lawrence Jenkins

Q & A

9:20 BREAK/EXHIBITORS

9:40 SESSION 2: SURGICAL THERAPIES Moderators: Rafael Carrion, Ashley Tapscott

WHAT IS THE BEST WAY TO TREAT HOURGLASS DEFORMITY?

Tom Lue, Jesse Mills, Justin Parker

Q & A

CONTROVERSIAL SURGERIES IN SEXUAL MEDICINE

Barbara Chubak, Laurence Levine, Run Wang

Q & A

THE IMPACT OF PENILE IMPLANT SURGERY ON PATIENT AND PARTNER SATISFACTION

Christian Nelson

DIAGNOSIS AND MANAGEMENT OF PENILE FRACTURE

Omer Raheem

Q & A

11:20 IPP: TRICKS AND TIPS

SST/FLOPPY GLANS Steven Wilson

IMPLANT CHECKLIST PRIOR TO SURGERY (IPPPLAN)

Tobias Kohler

11:40 SUPS PRESIDENTIAL LECTURE

TOPIC: INFECTION PREVENTION STRATEGIES IN PROSTHETIC UROLOGY—WHERE ARE WE NOW, AND WHAT’S COMING?

Ricardo Munarriz

11:50 NON-CME INDUSTRY SPONSORED SYMPOSIUM Location: Grand Salon @Hilton New Orleans Riverside

1:00 SESSION 3: LOW INTENSITY SHOCKWAVE THER-APY—WHERE ARE WE TODAY?

Moderators: Thomas Masterson, Luiz Otavio Torres

ELECTROMAGNETIC VS ELECTROHYDRAULIC: BEST FOR LIST?

Ranjith Ramasamy

TOPIC: SHOCKWAVE THERAPY—IS IT ETHICAL TO OFFER AND CHARGE FOR ERECTILE DYS-FUNCTION OR OTHER SEXUAL DYSFUNCTIONS?

Moderator: James Hotaling Debater-Pro: Gregory Broderick Debater-Con: Gerald Brock

AUA WHITE PAPER UPDATE: LIST Trinity Bivalacqua

Q & A

1:50 SESSION 4: EJACULATORY & PELVIC DYSFUNCTION

Moderators: Petar Bajic, Wayne Hellstrom

CHANGING PARADIGMS IN THE DIAGNOSIS AND MANAGEMENT OF ORGASMIC DISORDERS

Lawrence Hakim, Alan Shindel, Landon Trost

DIAGNOSING AND TREATING MALE NEUROGEN-IC SEXUAL DYSFUNCTION

Stacy Elliott

Q & A

2:40 BREAK/EXHIBITORS

3:00 SESSION 5: STATE-OF-THE ART LECTURES Moderators: Helen Bernie, Nelson Bennett

PRIAPISM: OPTIMAL MANAGEMENT AND PREVENTION AND NEW AUA GUIDELINES

Arthur Burnett

HOW TO USE SOCIAL MEDIA IN SEXUAL MEDICINE

Stacy Loeb

BASIC SCIENCE STATE-OF-THE ART LECTURE: CHRONIC ERECTILE DYSFUNCTION AFTER PROSTATECTOMY: A RACE AGAINST TIME BETWEEN CAVERNOUS NERVE REGENERATION VERSUS IRREVERSIBLE CHANGES TO THE PENILE ARCHITECTURE

Kelvin Davies

Q & A

3:55 SESSION 6: THE IRA SHARLIP LECTURE Moderators: Serge Carrier, Ira Sharlip

TELEMEDICINE AND US: CHALLENGES AND OPPORTUNITIES

Keynote Speaker: Hossein Sadeghi-Nejad

4:10 SESSION 7: ADDRESSING DIVERSITY IN PA-TIENT’S SEXUAL ORIENTATION

Moderators: Gregory Broderick, Amy Pearlman

PSYCHIATRIC ASSESSMENTS/SUPPORT Annamaria Giraldi

SURGERY MALE TO FEMALE Ethan Grober


FR

IDA

Y

SURGERY FEMALE TO MALE Maurice Garcia

HOMOSEXUAL MEN WITH FOCUS ON CANCER SURVIVORSHIP

Raul Fernandez-Crespo

Q & A

4:50 CLOSING REMARKS Serge Carrier


Friday, May 13, 2022 8:45 am – 10:00 am

Moderated Poster Session 4BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY II

Room 228 @ Ernest N. Morial Convention CenterModerators: Jason Hedges & Peter Gilling


MP04-01 IMPACT OF 5-ALPHA REDUCTASE INHIBITORS ON FUNCTIONAL OUTCOMES OF GREENLIGHT PHOTOVAPORIZATION OF THE PROSTATE (PVP): AN ANALYSIS OF 3500 MEN IN THE GLOBAL GREENLIGHT GROUP (GGG) DATABASE

Iman Sadri*, Ville Mont-Royal, Canada, Da-vid-Dan Nguyen, Kyle Law, Adel Arezki, David Bouhadana, Naeem Bhojani, Montreal, Canada, Dean Elterman, Toronto, Canada, Ahmed S. Zakaria, Thunder Bay, Canada, Franck Bruyère, Tours, France, Luca Cindolo, Giovanni Ferrari, Modena, Italy, Carlos Vasquez-Lastra, Mexico City, Mexico, Tiago Borelli-Bovo, Sao Paulo, Brazil, Edgardo F. Becher, Buenos Aires, Argen-tina, Hannes Cash, Maximillian Reimann, Berlin, Germany, Enrique Rijo, Barcelona, Spain, Vincent Misrai, Toulouse, France, Kevin C. Zorn, Montreal, Canada

MP04-02 ANALYSIS OF EX-VIVO HUMAN BPH TISSUE TREATED BY HISTOTRIPSY: DOSE AND PARAMETER EFFECTS

Zorawar Singh*, Albany, NY, Yashwanth N. Kumar, Yak-Nam Wang, Adam Maxwell, Matthew Bruce, Rishi Sekar, Seattle, WA, Eli Vlaisavljevich, Blacksburg, VA, Lawrence D. True, George R. Schade, Seattle, WA

MP04-03 CAN HANDHELD POINT OF CARE ULTRASOUND PROBES RELIABLY MEASURE TRANSABDOMINAL PROSTATE VOLUME? A PROSPECTIVE RANDOMIZED STUDY

Henry Wright*, Chicago, IL, Hermen Brar, Fabrice Henry, Dillon Corrigan, Smita De, Cleveland, OH

MP04-04 RISK FACTORS FOR A FAILED TRIAL WITHOUT CATHETER FOLLOWING CONVECTIVE WATER VAPOR THERMAL THERAPY (REZUM)

Michael Felice*, Kaylin Kim, William Adams, May-wood, IL, Erin Fruth, Chicago, IL, Ahmer Farooq, Kevin McVary, Maywood, IL

MP04-05 INCREASED BLEEDING RISK IS ASSOCIATED WITH 30-DAY MORTALITY AFTER TURP

Zafardjan Dalimov*, Philadelphia, PA, Ellen Lutnick, Emily C. Ellmann, Ali Houjaij, Nader D. Nader, Oussama M. Darwish, Buffalo, NY


MP04-06 INCIDENCE OF URETHRAL STRICTURE FOLLOWING ENDOSCOPIC PROSTATE SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROSPECTIVE, RANDOMIZED TRIALS

Ee Jean Lim*, Vineet Gauhar, Singapore, Singapore, Giacomo Maria Pirola, Arezzo, Italy, Emanuele Rubilotta, Verona, Italy, Marcelo Langer Wroclawski, São Paulo, Brazil, Dong Le Quy Nguyen, Danang, Vietnam, Marilena Gubbiotti, Arezzo, Italy, Vinson Wai, Shun Chan, Leeds, United Kingdom, Mariela Corrales, Paris, France, Esther Garcia Rojo, Madrid, Spain, Thomas R.W. Herrman, Frauenfeld, Switzerland, Jeremy Yuen, Chun Teoh, Hong Kong, Hong Kong, Daniele Castellani, Ancona, Italy

MP04-07 EX-VIVO COMPARISON OF DEPTH OF COAGULATION OF HOLMIUM, MOSESTM AND THULIUM FIBER LASER IN HUMAN PROSTATE TISSUE

Ruben Blachman-Braun*, Jonathan E Katz, Nicholas A Smith, Oleksii Iakymenko, Oleksandr N Kryvenko, Hemendra N Shah, Miami, FL

MP04-08 TRANEXAMIC ACID TO IMPROVE SAME-DAY DISCHARGE RATES AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE: A RANDOMIZED, CONTROLLED PROSPECTIVE TRIAL

Mark Assmus, Matthew Lee*, Meera Ganesh, Jessica Helon, Amy Krambeck, Chicago, IL

MP04-09 TRENDS IN HOLMIUM LASER ENUCLEATION OF THE PROSTATE FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

Tenny R. Zhang*, Mary O. Strasser, Samantha L. Thorogood, Christina Sze, Bilal Chughtai, Alexis Te, Richard K. Lee, Jim C. Hu, New York, NY

MP04-10 RISK OF ORGASMIC FUNCTION IMPAIRMENT AFTER HOLEP – FINDINGS OF A PROSPECTIVE REAL-LIFE TRIAL (EXPHO)

Paolo Capogrosso*, Varese, Italy, Eugenio Ven-timiglia, Giuseppe Fallara, Antonio Costa, Franc-esco Pellegrino, Luigi Candela, Edoardo Pozzi, Federico Belladelli, Mario De Angelis, Gianmarco Colandrea, Walter Cazzaniga, Daniele Cignoli, Nicolò Schifano, Rayan Matloob, Milan, Italy, Federico Dehò, Varese, Italy, Vincenzo Scattoni, Andrea Salonia, Francesco Montorsi, Milan, Italy

40

MP04-11 MOSESTM TECHNOLOGY FOR HOLMIUM ENUCLEATION OF THE PROSTATE: EXTENDED OUTCOMES FROM A PROSPECTIVE DOUBLE-BLIND RANDOMIZED CONTROL TRIAL

Shaan Setia*, Nicholas Kavoussi, Nicole Miller, Nashville, TN

MP04-12 EN-BLOC ENUCLEATION TECHNIQUE WITH EARLY APICAL RELEASE AND URINARY SPHINCTER PRESERVATION USING PULSE MODULATION (VIRTUAL BASKET) VS EN-BLOC HOLEP

Moises Elias Socarras*, Javier Reinoso Elbers, Fabio Esposito, Isabella Greco, Julio Fernandez del Alamo, Vanesa Cuadros Rivera, Diego Carrion Monsalve, Juan Gomez Rivas, Luis Llanes Gon-zalez, Luis Llanes Gonzalez, Fernando Gomez Sancha, Madrid, Spain

MP04-13 ONE-LOBE-TECHNIQUE PROVIDES SUPERIOR SURGICAL EFFICIENCY COMPARED TO THREE-LOBE-TECHNIQUE FOR HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP)

Thilo Westhofen*, Alexander Buchner, Boris Schlenker, Patrick Keller, Melanie Schott, Michael Atzler, Christian G. Stief, Giuseppe Magistro, Munich, Germany

MP04-14 PATIENTS ADHERING TO STANDARDIZED PROTOCOLS FOR PFMT AFTER HOLEP SHOW HIGHER RATES OF POSTOPERATIVE INCONTINENCE: REAL-LIFE IMPLICATIONS FOR A RATIONAL MANAGEMENT WORK-UP

Giuseppe Fallara*, Manuela Tutolo, Valentina Specchio, Donatella Giraudo, Shivani Ghazaleh Mathur, Federico Belladelli, Antonio Costa, Dan-iele Cignoli, Nicolò Schifano, Francesco Pellegri-no, Luigi Candela, Mario De Angelis, Gianmarco Colandrea, Milan, Italy, Paolo Capogrosso, Var-ese, Italy, Eugenio Ventimiglia, Andrea Salonia, Francesco Montorsi, Milan, Italy

MP04-15 PERIOPERATIVE EFFICACY OUTCOMES OF THULIUM LASER VS. VAPOR TUNNEL PULSE-MODULATED HOLMIUM LASER ENUCLEATION OF THE PROSTATE

Ahmed Elshabrawy*, Furkan Dursun, Hanzhang Wang, Harshit Garg, Michael Liss, Ahmed M. Mansour, San Antonio, TX

MP04-16 THULIUM YAG VS THULIUM FIBER LASER ENUCLEATION OF THE PROSTATE (THULEP VS TFLEP): A MULTI-INSTITUTION TRIAL TO COMPARE INTRA AND EARLY POSTOPERATIVE OUTCOMES

Matteo Maltagliati, Lorenzo Berti, Busto Arsizio, Italy, Salvatore Micali, Modena, Italy, Umber-to Besana, Carlo Buizza, Busto Arsizio, Italy, Bernardo Rocco, Maria Chiara Sighinolfi, Milano, Italy, Andrea Pacchetti, Genova, Italy, Jean Bap-tiste Roche, Bordeaux, France, Giorgio Bozzini*, Como, Italy

MP04-17 A MATCHED-PAIRED COMPARISON OF A NOVEL PULSED THULIUM:YAG LASER WITH A CONTINUOUS WAVE THULIUM FIBRE LASER AND A HOLMIUM:YAG LASER FOR ENDOSCOPIC ENUCLEATION OF THE PROSTATE (EEP)

Christopher Netsch*, Benedikt Becker, Clemens Rosenbaum, Andreas Gross, Hamburg, Germany

MP04-18 ROBOT-ASSISTED SIMPLE PROSTATECTOMY VERSUS HOLMIUM LASER ENUCLEATION FOR LARGE PROSTATE GLANDS (>100ML): COMPLICATIONS AND PERIOPERATIVE OUTCOMES

Louis Vignot*, Nice, France, Julien Anract, Paris, France, Imad Bentellis, Nice, France, Albert Semaan, Paris, France, Fabrizio Sartorio, Brann-wel Tibi, Youness Ahallal, Nice, France, Michael Peyromaure, Paris, France, Daniel Chevallier, Nice, France, Nicolas Barry Delongchamps, Paris, France, Matthieu Durand, Nice, France

MP04-19 SINGLE-PORT TRANSVESICAL VS MULTIPORT ROBOTIC SIMPLE PROSTATECTOMY: A MULTI-INSTITUTIONAL MATCHED-PAIR COMPARISON

Mahmoud Abou Zeinab*, Cleveland, OH, Tanner Corse, Hackensack, NJ, Kennedy Okhawere, New York, NY, Luca Morgantini, Chicago, IL, Nour Abdallah, Alp T. Beksac, Ethan Ferguson, Aaron Kaviani, Joao Pedro Emrich Accioly, Cleveland, OH, Robert Harrison, Bilal Khan, Hackensack, NJ, Indu Saini, Chiya Abramowitz, New York, NY, Susan Talamini, Simone Crivellaro, Chicago, IL, Mutahar Ahmed, Michael Stifelman, Hackensack, NJ, Ketan K. Badani, New York, NY, Jihad Kaouk, Cleveland, OH

MP04-20 IMPACT OF OBESITY ON PERI-OPERATIVE AND LONG-TERM FUNCTIONAL OUTCOMES AFTER ROBOTIC ASSISTED SIMPLE PROSTATECTOMY

Alfredo Maria Bove*, Aldo Brassetti, Gabriele Tuderti, Umberto Anceschi, Mariaconsiglia Ferri-ero, Leonardo Misuraca, Riccardo Mastroianni, Giuseppe Simone, Rome, Italy



FR

IDA

Y

Friday, May 13, 2022 8:45 am – 10:00 am

Moderated Poster Session 5STONE DISEASE: BASIC RESEARCH & PATHOPHYSIOLOGY

Room 225 @ Ernest N. Morial Convention CenterModerators: Benjamin Canales & Dean Assimos


MP05-01 VALIDATING THE KIDNEY INJURY TEST (KIT) AS A POINT OF CARE DIAGNOSTIC FOR URINARY STONE RECURRENCE

Xavier Cortez*, San Francisco, CA, Srinka Ghosh, Reuben Sarwal, Nick Titzler, Wanzin Yazar, Brisbane, CA, Marshall Stoller, Minnie Sarwal, Thomas Chi, San Francisco, CA

MP05-02 THE PRELIMINARY EXPLORATION OF ROLES MIRNAS DERIVED FROM URINARY EXOSOMES PLAY IN KIDNEY STONE FORMATION

Yuanyuan Yang*, Senyuan Hong, Shaogang Wang, Wuhan, China, People’s Republic of

MP05-03 HYPOXIA-INDUCIBLE PROLYL HYDROXYLASE INHIBITOR (ROXADUSTAT) SUPPRESSES KIDNEY STONE FORMATION.

Kengo Kawase*, Shuzo Hamamoto, Tatsuya Hattori, Ryosuke Chaya, Tomoki Okada, Yutaro Tanaka, Takeru Sugino, Rei Unno, Kazumi Taguchi, Ryosuke Ando, Atsushi Okada, Takahiro Yasui, Takahiro Yasui, Nagoya, Japan

MP05-04 DISCOVERY OF DRUGS THAT PROMOTE THE PHAGOCYTIC ABILITY OF MACROPHAGES TO CALCIUM OXALATE CRYSTALS USING THE FDA-APPROVED DRUG LIBRARY

Atsushi Okada*, Hiroshi Takase, Masahiko Isogai, Tomoki Okada, Tatsuya Hattori, Ryosuke Chaya, Kengo Kawase, Yutaro Tanaka, Taiki Kato, Ter-uaki Sugino, Rei Unno, Kazumi Taguchi, Shuzo Hamamoto, Ryosuke Ando, Tadahiro Hashita, Keiichi Tozawa, Tamihide Matsunaga, Kenjiro Kohri, Takahiro Yasui, Nagoya, Japan

MP05-05 SODIUM-GLUCOSE COTRANSPORTER (SGLT) INHIBITOR SUPPRESSES RENAL STONE FORMATION - A NOVEL THERAPEUTIC APPROACH FOR NEPHROLITHIASIS

Go Anan*, Takuo Hirose, Daisuke Kikuchi, Chika Takahashi, Seiko Yamakoshi, Makoto Sato, Takefumi Mori, Sendai, Japan

MP05-06 GENETIC ANALYSIS OF KIDNEY STONE DISEASE IN A MULTI-ETHNIC COHORT: INSIGHTS FROM GENOME-WIDE AND PHENOME-WIDE ASSOCIATION STUDIES

Parth Patel*, Vidhya Venkateswaran, Bogdan Pasanuic, Kymora Scotland, Los Angeles, CA

MP05-07 IN VITRO AND IN VIVO ASSESSMENT OF PATHOGENIC PROPERTIES OF PROTEUS MIRABILIS IN URINARY TRACT INFECTION AND STRUVITE STONE FORMATION

Roman Herout*, Sara Khoddami, Alina Reicherz, Ben Chew, Dirk Lange, Vancouver, Canada


MP05-08 POSSIBLE ROLE OF THE MICROBIOTA IN URINARY STONES: A PROSPECTIVE STUDY TO CORRELATE RADIOLOGICAL DENSITY (HOUNSFIELD UNITS) AND CULTURAL EXAMINATION OF URINARY CALCULI

Antonio Luigi Pastore*, Andrea Fuschi, Yazan Al Salhi, Alessia Martoccia, Lorenzo Capone, Silvio Scalzo, Paolo Pietro Suraci, Onofrio Antonio Rera, Fabio Maria Valenzi, Alice Antonioni, Antonio Carbone, Latina, Italy

MP05-09 URETERAL STENT BIOFILMS EXHIBIT COMPLEX INTERACTION NETWORKS AND VARIABLE FORMATION BY SURFACE MATERIAL AND MICROBIAL STRAIN

Glenn T. Werneburg, Daniel Hettel*, Ava Adler, Smita De, Raymond Rackley, Daniel Shoskes, Aaron Miller, Cleveland, OH

MP05-10 MIXING IT UP: ARE PATIENTS WITH MIXED URINE CULTURES AT HIGHER RISK OF POSTOPERATIVE SEPSIS AFTER URETEROSCOPY?

Young Son*, Julia Scali, Stratford, NJ, Ian Mad-ison, Philadelphia, PA, Benjamin Fink, Katelyn Klimowich, Dayna DeVincentz, Paul Chialastri, Thomas Mueller, Stratford, NJ

MP05-11 MULTI-SPECIES, METABOLIC REDUNDANCY IN OXALATE-FORMATE HANDLING IN THE GUT MICROBIOTA

Sromona Mukherjee*, Aaron Miller, Cleveland, OH

MP05-12 DEPENDENT ANTIBIOTIC AND OXALATE INTERACTIONS IMPACT ATHEROSCLEROSIS AND CALCIUM OXALATE STONES IN THE KIDNEYS

Jose Agudelo*, Lucas Osborn, Beckey DeLu-cia, Mark Brown, Ava Adler, Jan Claesen, Jane Nguyen, Aaron Miller, Cleveland, OH

MP05-13 IMPACT OF URETERAL STENTS ON FACTORS CONTRIBUTING TO STRICTURE PATHOGENESIS

Karen Doersch*, Rochester, NY, Khaled Almutairi, Ben Chew, Dirk Lange, Vancouver, Canada

MP05-14 RAISE YOUR GLASS! AMERICAN CHESTNUT LEAVES CAN REDUCE TEA OXALATE CONTENT

Bergen Lemack*, Willim Donelan, Tania Quesa-da, Gainesville, FL, Dakota Matthews, Syracuse, NY, Saeed Khan, Vincent Bird, Gainesville, FL, William Powel, Syracuse, NY, Benjamin Canales, Paul Dominguez-Gutierrez, Gainesville, FL

42

MP05-15 THE GULO(-/-) MOUSE: A USEFUL MODEL FOR STUDYING ENDOGENOUS OXALATE PRODUCTION FROM ASCORBIC ACID TURNOVER

Joseph Crivelli*, Xingsheng Li, Sonia Fargue, Kyle Wood, Dean Assimos, Ross Holmes, John Knight, Birmingham, AL

MP05-16 NEW PERSPECTIVES ON AN OLD GROUPING: THE GENOMIC AND PHENOTYPIC DIFFERENCES OF OXALOBACTER FORMIGENES

John Chmiel*, London, Canada, Robertson Ven-ema, Vancouver, Canada, Charles Carr, Toronto, Canada, Kait Al, London, Canada, Ryan Chanyi, Palmerston North, New Zealand, Sergio Ari Domínguez Romero, Gerrit Stuivenberg, Hassan Razvi, Jennifer Bjazevic, Jeremy Burton, London, Canada

MP05-17 INFLAMMATORY CYTOKINES PROMOTE FIBROSIS IN OBSTRUCTED URETERS

Alina Reicherz*, Felipe Eltit, Khaled Almutairi, Ro-man Herout, Michael Cox, Ben Chew, Dirk Lange, Vancouver, Canada

MP05-18 DOES HYPERTENSION AFFECT THE RECOVERY OF RENAL FUNCTIONS FOLLOWING REVERSIBLE UNILATERAL URETERIC OBSTRUCTION?

Fayez Hammad*, Loay Lubbad, Al Ain, United Arab Emirates

MP05-19 IS THE THULIUM FIBER LASER COST EFFECTIVE COMPARED TO THE HOLMIUM LASER WHEN TREATING RENAL STONES?

Akin S. Amasyali*, Nikoli Brown, Cayde Ritchie, Jason Groegler, Joshua D. Belle, Daniel Baldwin, Mohammad Hajiha, D.Duane Baldwin, Loma Linda, CA

MP05-20 THE HEAT IS ON: MOSES 2.0 POPCORNING IN A NOVEL BENCHTOP 3D KIDNEY MODEL REACHES THERMAL DAMAGE THRESHOLDS RAPIDLY

Zachary Dionise*, Christian Tabib, Sabrina Tran, Francois Soto-Palou, Pei Zhong, Glenn Preminger, Michael Lipkin, Durham, NC


Friday, May 13, 2022 8:45 am – 10:00 am

Moderated Poster Session 6BLADDER CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY I

Room 222 @ Ernest N. Morial Convention CenterModerators: David DeGraff, Philip Abbosh & Leonardo Reis


MP06-01 NON-MUSCLE INVASIVE BLADDER CANCER SUBTYPES WITH DIFFERENTIAL RESPONSE TO INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT

Florus C de Jong*, Rotterdam, Netherlands, Teemu D Laajala, Rotterdam, Finland, Robert F Hoedemaeker, Rotterdam, Netherlands, Sébast-ien Rinaldetti, Luxembourg, Luxembourg, Kimber-ley R Jordan, Denver, CO, Angelique CJ van der Made, Rotterdam, Netherlands, Bart Nieuwkamer, Delft, Netherlands, Deric KE van der Schoot, Breda, Netherlands, Egbert R Boevé, Rotterdam, Netherlands, Emiel AM Janssen, Stavanger, Norway, Tokameh Mahmoudi, Joost L Boormans, Rotterdam, Netherlands, Dan Theodorescu, Los Angeles, CA, James C Costello, Denver, CO, Tahlita CM Zuiverloon, Rotterdam, Netherlands

MP06-02 NON-MUSCLE-INVASIVE MICROPAPILLARY BLADDER CANCER HAS A DISTINCT LNCRNA PROFILE ASSOCIATED WITH UNFAVORABLE PROGNOSIS

Joep de Jong*, Rotterdam, Netherlands, Begoña Valderrama, Sevilla, Spain, Julia Perera, Nuria Juanpere, Barcelona, Spain, Paloma Cejas, Henry Long, Boston, MA, Mar Alba, Barcelona, Spain, Ewan Gibb, Vancouver, Canada, Joaquim Bellmunt, Boston, MA


MP06-03 DISCOVERY AND VALIDATION OF NITROXOLINE AS A NOVEL STAT3 INHIBITOR IN DRUG-RESISTANT UROTHELIAL BLADDER CANCER

Peng Huang*, Wenfeng Lin, Motoo Araki, Masami Watanbe, Yasutomo Nasu, Okayama, Japan

MP06-04 EXPLORING A NOVEL SYNERGISTIC INTRAVESICAL ONCOLYTIC VIROTHERAPY FOR TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER

Woodson Smelser*, Jian Wang, Sam Chang, Austin Kirschner, Nashville, TN

MP06-05 UROTHELIAL CANCER RAPID AUTOPSY PROGRAM: BIOSPECIMENS AND PATIENT-DERIVED PRECLINICAL MODELS

Jose Garcia*, Funda Vakar-Lopez, Martine Roudi-er, Petros Grivas, Evan Y. Yu, Heather Cheng, Mi-chael T. Schweizer, Michael Haffner, John K. Lee, Eva Corey, Bruce Montgomery, Andrew Hsieh, Jonathan L. Wright, Hung-Ming Lam, Seattle, WA

MP06-06 ESTABLISHMENT AND EVALUATION OF A SIMPLIFIED APPROACH TO PATIENT DERIVED BLADDER CANCER ORGANOIDS USING URINE

Paul Pollehne, Ivonne Aidee Montes Mojarro, Johannes Schneider, Bastian Amend, Falko Fend, Arnulf Stenzl, Wilhelm K. Aicher, Niklas Harland*, Tuebingen, Germany


FR

IDA

Y

MP06-07 APPLICATION OF BLADDER CANCER PATIENT-DERIVED ORGANOIDS AS PRE-CLINICAL MODEL FOR PERSONALIZED MEDICINE

Martina Minoli, Mirjam Kiener, Bern, Switzerland, Thomas Cantore, Tarcisio Fedrizzi, Paola Gaspar-ini, Francesca Demichelis, Trento, Italy, George N. Thalmann, Roland Seiler-Blarer, Marianna Kruithof-de Julio*, Bern, Switzerland

MP06-08 SINGLE-CELL SEQUENCING OF PARENTAL BLADDER CANCER AND SUBSEQUENT ORGANOIDS REVEALS DIFFERENTIAL CELL PRESERVATION

Roland Seiler*, Martina Minoli, Bern, Switzerland, Franziaks Singer, Anne Bertolini, Ulrike Menzel, Christian Beisel, Zurich, Switzerland, Marianna Kruithof-de Julio, Bern, Switzerland

MP06-09 SINGLE CELL ANALYSES OF MURINE UROTHELIAL CARCINOMA CELLS REVEAL A ROLE OF TUMOR-ASSOCIATED MACROPHAGES IN RESPONSE TO ANTI-PD1 THERAPY

Dongbo Xu*, Li Wang, Yali Zhang, Yanqing Wang, Xiaojing Zhang, Yue Wu, Gary Smith, Bo Xu, Prashant Singh, Yuesheng Zhang, David Goodrich, Jianmin Wang, Qiang Li, Buffalo, NY

MP06-10 KDM6A DEFICIENCY IN UROTHELIUM PRODUCES A DISTINCT IMMUNE PHENOTYPE IN A MOUSE MODEL OF BLADDER CANCER

Ao Zhang*, Hong Qiu, Timothy Chan, Byron Lee, Cleveland, OH

MP06-11 MAGNITUDE OF STING SIGNALING DETERMINES ANTITUMOR OUTCOMES, AND CD8+ T CELL MEMORY BY BCG-STING IN UROTHELIAL TUMORS

Alok Singh*, Monali Praharaj, Kara Lombar-do, Liang Zhao, Joy Huang, Max Kates, David McConkey, William Bishai, Baltimore, MD, Trinity Bivalacqua, Philadelphia, PA

MP06-12 A WT1 ORAL CANCER VACCINE USING A BIFIDOBACTRERIUM VECTOR SUPPRESSES GROWTH OF ANTI-PD-1 ANTIBODY-RESISTANT MOUSE BLADDER TUMOR

Toshiro Shirakawa*, Koichi Kitagawa, Hideto Ueki, Junya Furukawa, Kobe, Japan, Nobuyuki Hinata, Hiroshima, Japan, Masato Fujisawa, Kobe, Japan

MP06-13 TARGETING THE ANDROGEN RECEPTOR AXIS TO IMPROVE RESPONSE TO BLADDER CANCER IMMUNOTHERAPY

Typhaine Gris*, Marjorie Besançon, France-Hélène Joncas, Valérie Picard, Alain Bergeron, Yves Fradet, Paul Toren, Quebec, Canada

MP06-14 ROLE OF LATROPHILINS AS KEY DOWNSTREAM EFFECTORS OF THE ANDROGEN RECEPTOR IN MODULATING UROTHELIAL TUMORIGENESIS

Takuro Goto*, Yuki Teramoto, Masato Yasui, Guiyang Jiang, Yujiro Nagata, Rochester, NY, George Netto, Birmingham, AL, Hiroshi Miyamoto, Rochester, NY

MP06-15 THE LONG ARM OF CHROMOSOME 9 CONTAINS A GENE THAT REGULATES PPARγ IN BLADDER CANCER

Ryutaro Shimizu*, Masashi Honda, Shogo Tera-oka, Tetsuya Yumioka, Bunya Kawamoto, Noriya Yamaguchi, Hideto Iwamoto, Panagiota Tsounapi, Shuichi Morizane, Katsuya Hikita, Takahito Ohira, Hiroyuki Kugoh, Atsushi Takenaka, Yonago, Japan

MP06-16 CIRCULATING EXTRACELLULAR VESICLES CARRYING FIRMICUTES COULD PREDICT RESPONSE TO PEMBROLIZUMAB IN UROTHELIAL CARCINOMA

Atsunari Kawashima*, Kentaro Jingushi, Daisuke Motooka, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Koichi Okada, Eisuke Tomi-yama, Yoko Koh, Makoto Matsushita, Taigo Kato, Koji Hatano, Motohide Uemura, Hisashi Wada, Norio Nonomura, Suita, Japan

MP06-17 ALPHA-2-MACROGLOBULIN IN URINARY EXTRACELLULAR VESICLES IS A NOVEL PROTEIN MARKER FOR DIAGNOSIS OF HUMAN BLADDER CANCER

Jinsung Park*, Uijeongbu-si, Korea, Republic of, Jisu Lee, Yun Hee Kang, Daejeon, Korea, Re-public of, Ji Young Mun, Daegu, Korea, Republic of, Hyun-Woo Oh, Daejeon, Korea, Republic of, Yoon-Kyoung Cho, Ulsan, Korea, Republic of, Myung-Shin Lee, Daejeon, Korea, Republic of

MP06-18 A GENOMIC URINE ASSAY TO DETECT URINARY TRACT RECURRENCES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADIOTHERAPY

Florus C de Jong*, Iris I Iflé, Denise Kooper, Angelique CJ van der Made, Joep J De Jong, Tahlita CM Zuiverloon, Luca Incrocci, Rotterdam, Netherlands, Wim Van Criekinge, Gent, Belgium, Martine Franckena, Joost L Boormans, Ellen C Zwarthoff, Rotterdam, Netherlands

MP06-19 ANTI-TUMOR EFFECT IN BLADDER CANCER MODEL OF TUMOR VASCULATURE-TARGETED 10B DELIVERY MEDIATED BORON NEUTRON CAPTURE THERAPY

Tohru Yoneyama*, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Hirosaki, Japan, Taku Yoshiya, Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki, Osaka, Japan, Shingo Hachinohe, Kamikita-gun, Japan, Shintaro Ishiyama, Hirosaki, Japan, Mo-tohiro Nonaka, Kyoto, Japan, Michiko N. Fukuda, La jolla, Japan, Chikara Ohyama, Hirosaki, Japan

MP06-20 EFFICACY OF RECOMBINANT BACILLUS CALMETTE-GUÉRIN–DLTA IN THREE-DIMENSIONAL BIOPRINTED BLADDER CANCER-ON-A-CHIP WITH MICROFLUIDIC SYSTEM

Joongwon Choi*, Jung Hoon Kim, Jae Hun Shim, Jong Hyun Tae, Se Young Choi, Byung Hoon Chi, Tae-Hyoung Kim, Tae Young Jung, In Ho Chang, Seoul, Korea, Republic of


44

Friday, May 13, 2022 9:30 am – 11:30 am

Podium Session 5STONE DISEASE: MEDICAL & DIETARY THERAPY

Room 252 @ Ernest N. Morial Convention CenterModerator: Ryan Hsi, Margaret Pearle & TBD

ABSTRACTTIME NUMBER TITLE9:30 PD05-01 ASSOCIATION BETWEEN ON-

TREATMENT FOLLOW-UP TESTING AND MEDICATION ADHERENCE AMONG PATIENTS PRESCRIBED PREVENTIVE PHARMACOLOGIC THERAPY FOR URINARY STONE DISEASE

Joseph Crivelli*, Birmingham, AL, Phyllis Yan, Ann Arbor, MI, Ryan Hsi, Nashville, TN, Vahakn Shahinian, Brian Denton, John Hollingsworth, Ann Arbor, MI

9:40 PD05-02 ADHERENCE AND MEDICATION BELIEFS AMONGST PATIENTS PRESCRIBED THIAZIDES AND ALKALI FOR STONE PREVENTION AND THEIR ASSOCIATION WITH STONE RELATED QUALITY OF LIFE

Christopher Haas*, Shuang Li, Stephen Y. Nakada, Kristina L. Penniston, Madison, WI

9:50 PD05-03 EFFICACY AND SAFETY OF LUMASIRAN IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1: 24-MONTH ANALYSIS OF THE ILLUMINATE-A TRIAL

John Lieske*, Rochester, MN, Jaap Groothoff, Amsterdam, Netherlands, Yaacov Frishberg, Jerusalem, Israel, Anne-Laure Sellier-Leclerc, Bron, France, Hadas Shasha-Lavsky, Nahariya, Israel, Jeffrey Saland, New York, NY, Wesley Hayes, London, United Kingdom, Daniella Magen, Haifa, Israel, Shabbir Moochhala, London, United Kingdom, Martin Coenen, Bonn, Germany, Eva Simkova, Dubai, United Arab Emirates, Taylor Ngo, John Gansner, Cambridge, MA, Sally-Anne Hulton, Birmingham, United Kingdom

10:00 PD05-04 EFFECT OF PHYTATE ON HYPERCALCIURIA SECONDARY TO BONE RESORPTION IN PATIENTS WITH URINARY STONES

Jordi Guimera*, Ana Martinez Moreno, Jose Luis Bauza Quetglas, Pilar Sanchis Cortes, Enrique Pieras Ayala, Feliciano Grases Freixedas, Palma de Mallorca, Spain

10:10 PD05-05 SINGLE CENTRE EXPERIENCE OF CHELATING AGENTS IN CYSTINURIA

Bitar Nadia, Purvor Trevor, Foran Niamh, Wells Hayley, Rottenberg Giles, Game David, Bultitude Matthew*, Thomas Kay, London, United Kingdom

ABSTRACTTIME NUMBER TITLE10:20 PD05-06 PROSPECTIVE RANDOMIZED TRIAL OF 2

WEEKS VS 3 MONTHS OF POSTOPERATIVE ANTIBIOTICS AFTER PERCUTANEOUS NEPHROLITHOTOMY IN COMPLEX PATIENTS WITH INFECTION-RELATED KIDNEY STONES

Ben Chew*, Alina Reicherz, Vancouver, Canada, Amy E. Krambeck, Chicago, IL, Nicole Miller, Ryan Hsi, Nashville, TN, Kymora Scotland, Los Angeles, CA, David Miller, Pittsburgh, PA, Ryan Paterson, Victor KF Wong, Vancouver, Canada, Michelle Semins, Pittsburgh, PA, Dirk Lange, Vancouver, Canada

10:30 PD05-07 THE EFFICACY AND SAFETY OF TRANEXAMIC ACID IN THE MANAGEMENT OF PERIOPERATIVE BLEEDING AFTER PERCUTANEOUS NEPHROLITHOTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF COMPARATIVE STUDIES

Min Joon Lee, Jin K Kim*, Jennifer Tang, Toronto, Canada, Jessica Ming, Albuquerque, NM, Michael Chua, Toronto, Canada

10:40 PD05-08 PHARMACOLOGIC MANAGEMENT OF URETERAL STENT-RELATED SYMPTOMS: A DRUG-CLASS AND DRUG SPECIFIC BAYESIAN NETWORK META-ANALYSIS

David E. Hinojosa-Gonzalez*, Brian H. Eisner, Boston, MA

10:50 PD05-09 IMPROVED STONE QUALITY OF LIFE IN PATIENTS WITH OBSTRUCTING URETERAL STONE ON ALPHA-BLOCKER MEDICAL EXPULSIVE THERAPY

Brijesh Patel*, St. Louis, MO, Tarik Phillips, Joshua Palk, Joel Vetter, St. Loius, MO, Mark Biebel, St. Louis, MO, Alexander Chow, Chicago, IL, Alethea Paradis, Alana Desai, St. Louis, MO, Kenneth Sands, Ramakrishna Venkatesh, St. Loius, MO

11:00 PD05-10 CHARACTERIZATION OF MIXED URINARY STONE COMPOSITION WITH DUAL-SOURCE DUAL-ENERGY COMPUTED TOMOGRAPHY IN VIVO COMPARED WITH INFRARED SPECTROSCOPY

Xianghu Meng*, Xueying Sun, Rong Cong, Liang Qi, Zengjun Wang, Rijin Song, Nanjing, China, People’s Republic of


FR

IDA

Y

11:10 PD05-11 USE OF MINI SIPIT BEHAVIORAL INTERVENTION INCREASES FLUID INTAKE IN PATIENTS WITH KIDNEY STONES

Necole Streeper*, James Marks, Jason Fairbourn, Hershey, PA, Emily Frith, University Park, PA, Edison Thomaz, Austin, TX, Nilam Ram, Stanford, CA, David Conroy, University Park, PA

11:20 PD05-12 WHAT IS THE BEST PLANT-BASED YOGURT FOR PATIENTS WITH KIDNEY STONES AND/OR CHRONIC KIDNEY DISEASE?

James Borin*, New York, NY, John Knight, Ross Holmes, Birmingham, AL, Shivam Joshi, David Goldfarb, Wilson Lin, Stacy Loeb, New York, NY


Friday, May 13, 2022 9:30 am – 11:30 am

Podium Session 6URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: FEMALE INCONTINENCE: THERAPY I

Room 255 @ Ernest N. Morial Convention CenterModerators: Lynn Stothers, Donna Deng & Doreen Chung

ABSTRACTTIME NUMBER TITLE9:30 PD06-01 REAL WORLD OUTCOMES OF URETHRAL

INJECTION OF POLYACRYLAMIDE HYDROGEL (BULKAMID®) FOR STRESS URINARY INCONTINENCE WITH INTRINSIC SPHINCTER DEFICIENCY, PRIOR URETHRAL SURGERY, OR PRIOR MESH SLING EXCISION

Justina Tam*, Hannah Koenig, Shreeya Popat, Deborah Sparks, Alvaro Lucioni, Kathleen Kobashi, Una Lee, Seattle, WA

9:40 PD06-02 LONG-TERM OUTCOMES FROM THE REMEEX SYSTEM® IN FEMALE PATIENTS WITH INTRINSIC SPHINCTERIC DEFICIENCY AND RECURRENT URINARY INCONTINENCE: DATA FROM A MINIMUM OF 12 YEARS OF FOLLOW-UP

Phil Hyun Song*, Jong Gyun Ha, Jae Youn Jang, Yeo-ng Uk Kim, Jae Young Choi, Young Hwii Ko, Ki Hak Moon, Hee Chang Jung, Daegu, Korea, Republic of

9:50 PD06-03 MINDFULNESS BASED-STRESS REDUCTION IS ASSOCIATED WITH DECREASED LEVELS OF PATIENTS′ ANXIETY AFTER URODYNAMICS - A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL

Ruby Kuang*, Sydney Drury, Akin Amasyali, Hillary Wagner, Forrest Jellison, Andrea Staack, Loma Linda, CA

10:00 PD06-04 A DECEPTION STUDY TO AVOID RECALL BIAS FOR 3 VALIDATED QUESTIONNAIRES IN THE OFFICE OR OVER THE PHONE FOR WOMEN WITH OR WITHOUT URINARY INCONTINENCE

Meghana Reddy*, Samuel B. Kusin, Alana L. Christie, Philippe E. Zimmern, Dallas, TX

10:10 PD06-05 FRACTIONAL CARBON DIOXIDE VAGINAL LASER FOR THE TREATMENT OF URINARY SYMPTOMS: 12 MONTHS RESULTS

Ly Hoang Roberts*, Royal Oak, MI, Annah Vollst-edt, Iowa City, IA, Hailey Eisner, Royal Oak, MI, Lauren Tennyson, Fair Haven, NJ, Evelyn Shea, Lisa Vargos, Danielle Tenney, Royal Oak, MI, Ber-nadette Zwaan, Larry Sirls, Priya Padmanabhan, Kenneth Peters, Royal Oak, MI

ABSTRACTTIME NUMBER TITLE10:20 PD06-06 AUTOLOGOUS FASCIAL SLINGS: OFTEN

DISCUSSED, BUT RARELY UTILIZED – A POPULATION-BASED ASSESSMENT OF CALIFORNIA STATEWIDE DATA 2013-2018

Allison Sih*, Seth Cohen, Fornati Bedell, Duarte, CA, Karyn Eilber, Victoria Scott, Los Angeles, CA, Kai Dallas, Duarte, CA

10:30 PD06-07 REAL-WORLD URINARY TRACT INFECTION RATES AND ANTIBIOTIC PRACTICE WITH URETHRAL INJECTION OF POLYACRYLAMIDE HYDROGEL (BULKAMID®)

Shreeya Popat*, Justina Tam, Hannah Koenig, Alvaro Lucioni, Kathleen Kobashi, Una Lee, Seattle, WA

10:40 PD06-08 ROBOTIC FEMALE ARTIFICIAL URINARY SPHINCTER IMPLANTATION VS MALE ARTIFICIAL URINARY SPHINCTER IMPLANTATION FOR NON-NEUROGENIC STRESS URINARY INCONTINENCE

Benoit Peyronnet*, Alexandre Dubois, Valentine Lethuillier, Rennes, France, Imad Bentellis, Nice, France, Quentin Vesval, Camille Haudebert, Claire Richard, Romain Mathieu, Lucas Freton, Mehdi El-Akri, Karim Bensalah, Andrea Manunta, Juliette Hascoet, Rennes, France

10:50 PD06-09 RELATIONSHIPS BETWEEN LONGITUDINAL URINARY SYMPTOMS AND PHYSICAL AND PSYCHOSOCIAL FACTORS IN WOMEN IN THE SYMPTOMS OF LOWER URINARY TRACT DYSFUNCTION RESEARCH NETWORK

Abigail R. Smith*, Sarah A. Mansfield, Ann Arbor, MI, Catherine S. Bradley, Iowa City, IA, Kimberly Kenton, Chicago, IL, Margaret Helmuth, Anne P. Cameron, Ann Arbor, MI, Ziya Kirkali, Bethesda, MD, C. Emi Bretschneider, Chicago, IL, Victor An-dreev, Aruna Sarma, Giulia Lane, Ann Arbor, MI, Sarah Collins, David Cella, Chicago, IL, H. Henry Lai, St. Louis, MO, Kathryn E. Flynn, Milwaukee, WI, Steve Harte, Ann Arbor, MI, James W. Griffith, Chicago, IL

46

11:00 PD06-10 PREDICTORS OF URINARY INCONTINENCE AMONG HISPANIC/LATINA WOMEN IN THE UNITED STATES: FINDINGS FROM THE HISPANIC COMMUNITY HEALTH STUDY/ STUDY OF LATINOS (HCHS/SOL)

Daniel Gonzalez*, Isildinha Reis, Christina Cor-dero, Marc Gellman, Miami, FL, Krista Perreira, Chapel Hill, NC, Martha Daviglus, Olga Gar-cia-Bedoya, Chicago, IL, Katherine Amin, Raveen Syan, Miami, FL

11:10 PD06-11 REVISITING ADHERENCE TO THE AUA PUBLICATION GUIDELINES FOR SUI LITERATURE

Amber Bauer*, Yu Zheng, Daniel Furlong, Eric Rovner, Charleston, SC

11:20 PD06-12 USAGE AND COST OF URINARY INCONTINENCE PRODUCTS IN WOMEN

Leah Chisholm*, Elisabeth Sebesta, Stephanie Gleicher, Melissa Kaufman, Roger Dmochowski, W. Stuart Reynolds, Nashville, TN


Friday, May 13, 2022 9:30 am – 11:30 am

Podium Session 7PROSTATE CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY I

Room 245 @ Ernest N. Morial Convention CenterModerators: K. C. Balaji, Christopher Barbieri & Christian Stief

ABSTRACTTIME NUMBER TITLE9:30 PD07-01 3JC48-3, A NOVEL MYC/MAX DIMERIZATION

INHIBITOR DECREASES GROWTH IN PROSTATE CANCER

Victor Chalfant*, Carlos Riveros, Sanjeev Shukla, Teruko Osumi, KC Balaji, Jacksonville, FL

9:40 PD07-02 TARGETING WNT5A/FZD2 SIGNALING OVERCOMES RESISTANCE TO ENZALUTAMIDE IN ADVANCED PROSTATE CANCER

Shu Ning, Chengfei Liu, Wei Lou, Alan Lombard, leandro D’Abronzo, Aiming Yu, Christopher Evans, Allen Gao*, Sacramento, CA

9:50 PD07-03 AN ORAL FIRST-IN-CLASS SMALL MOLECULE RSK INHIBITOR SUPPRESSES AR VARIANTS AND TUMOR GROWTH IN PROSTATE CANCER

Masaki Shiota*, Miho Ushijima, Takashi Matsu-moto, Eiji Kashiwagi, Junichi Inokuchi, Masatoshi Eto, Fukuoka, Japan

10:00 PD07-04 PRE-CLINICAL STUDIES FOR ADVANCING CIRMTUZUMAB-BASED ANTI-ROR1 THERAPIES IN METASTATIC PROSTATE CANCER

Michelle Muldong, Sanghee Lee, Theresa Mendo-za, Danielle Burner, Christina Wu, Jamillah Mur-tadha, Evodie Koutouan, Naomi Pineda, Gabriel Pineda, Kathleen Lennon, Hao Pham, Karl Willert, La Jolla, CA, Nicholas Cacalano, Los Angeles, CA, Catriona Jamieson, Terry Gaasterland, Chris-topher Kane, Anna Kulidjian, Christina Jamieson*, La Jolla, CA

10:10 PD07-05 IDENTIFICATION OF IDH1 MUTATION AND CANDIDATE DRUG IN PROSTATE ADENOCARCINOMA BY INTEGRATED BIOINFORMATIC ANALYSIS: IMPLICATIONS FOR NEXT GENERATION OF PROSTATE ADENOCARCINOMA MANAGEMENT?

Chen-Yueh Wen*, Wei-Ting Kuo, Chia-Cheng Yu, Jen-Tai Lin, Kaohsiung, Taiwan

ABSTRACTTIME NUMBER TITLE10:20 PD07-06 SPATIAL TRANSCRIPTOMIC PROFILING

OF PROSTATE CANCER REVEALS ZONE SPECIFIC ANDROGEN RECEPTOR SIGNALING AND IMMUNE INFILTRATION

Parth Patel*, Srinivas Nallandhighal, Ann Arbor, MI, David Scoville, Seattle, WA, Lynn Tran, Au-gusta, GA, Brittney Cotta, Aaron Udager, Arvind Rao, Ganesh Palapattu, Vipulkumar Dadhania, Sethu Pitchiaya, Simpa Salami, Ann Arbor, MI

10:30 PD07-07 MOLECULAR SUBTYPING OF >80,000 PROSTATE CANCER TRANSCRIPTOMES IDENTIFIES FOUR CLASSES WITH DISTINCT BIOLOGICAL AND CLINICAL CHARACTERISTICS WITH IMPLICATIONS FOR TARGETED THERAPIES

Adam Weiner*, Chicago, IL, Yang Liu, San Diego, CA, Ashley Ross, Chicago, IL, Felix Feng, San Francisco, CA, Phuoc Tran, Baltimore, MD, Nicholas Zaorsky, Hershey, PA, Angela Jia, Balti-more, MD, Xin Zhao, Alex Hakansson, Vinnie Liu, James Proudfoot, Ewan Gibb, Elai Davicioni, San Diego, CA, Daniel Spratt, Cleveland, OH, Edward Schaeffer, Chicago, IL

10:40 PD07-08 FIBROBLAST ACTIVATION PROTEIN-SPECIFIC MRI PROVIDES IMPROVED TUMOUR MAPPING IN AN ORTHOTOPIC MODEL OF PROSTATE CANCER COMPARED TO PROSTATE SPECIFIC MEMBRANE ANTIGEN

Nicole Dmochowska*, Valentina Milanova, Anil Shetty, Adelaide, Australia, Ramesh Mukkamala, Lafayette, IN, Madduri Srinivasarao, Lafayette, IN, Eric Walser, Galveston, TX, Phil Low, Lafayette, IN, Benjamin Thierry, Adelaide, Australia

10:50 PD07-09 MEIS PROTEINS INHIBIT HOXB13-DEPENDENT PROSTATE CANCER METASTASIS AND ANDROGEN RECEPTOR SIGNALING

Srikanth Perike*, Calvin VanOpstall, Mathias Morales, Sophia Lamperis, Steve Kregel, Ryan Brown, Donald J Vander Griend, Chicago, IL


FR

IDA

Y

11:00 PD07-10 STROMAL ANDROGEN RECEPTOR INHIBITS PROSTATE TUMOR PROGRESSION BY RESTRAINING SECRETORY LUMINAL EPITHELIAL CELLS

Zhu Wang*, Yueli Liu, Santa Cruz, CA, Jiawen Wang, Beijing, China, People’s Republic of, Corrigan Horton, Joshua Stefanson, Qing Xie, Santa Cruz, CA

11:10 PD07-11 VITAMIN D HAS A STRONGER IMPACT ON PROSTATE TUMOR GENE EXPRESSION IN BLACK MEN

Neil Mistry*, Cordero McCall, Chicago, IL, Moray Campbell, Columbus, OH, Adam Murphy, Chicago, IL

11:20 PD07-12 IDENTIFICATION OF CHROMATIN SIGNATURES PREDICTIVE OF PROSTATE CANCER PROGRESSION

Michael Rothberg*, Jacob Enders, Cheyenne Williams, Michael Daneshvar, Nitin Yerram, Sohyoung Kim, Saori Fujiwara, Lorenzo Rinaldi, Songjoon Baek, Luke O’Connor, Qizong Kim, Patrick Gomella, Maria Merino, Bradford Wood, Peter Choyke, Baris Turkbey, Gordon Hager, Peter Pinto, Bethesda, MD


Friday, May 13, 2022 9:30 am – 11:30 am

Podium Session 8INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: INTERSTITIAL CYSTITIS

Room 244 @ Ernest N. Morial Convention CenterModerators: H. Henry Lai, Praveen Thumbikat & John Lavelle

ABSTRACTTIME NUMBER TITLE9:30 PD08-01 B-CELL CLONOTYPE IN PATIENTS WITH

INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME PRESENTING WITH HUNNER LESIONS

Inna Tabansky, Mahasset, NY, Min Liu, New Ha-ven, CT, Robert Moldwin, Manhasset, NY, Souhel Najjar, New York, NY, Derin Keskin, Boston, MA, Vishaan Nursey, Manhasset, NY, Johannes Yeh, Cold Spring Harbor, NY, Vladimir Brusic, Ningbo, China, People’s Republic of, Guanglan Zhang, Boston, MA, Joel N.H. Stern*, Hempstead, NY

9:40 PD08-02 URINARY DIVERSION FOR INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: PREVALENCE AND PERIOPERATIVE COMPLICATION RATE

Paige Kuhlmann*, Los Angeles, CA, Kai Dallas, Duarte, CA, Peris Castaneda, Victoria Scott, Los Angeles, CA, Jennifer Anger, San Diego, CA, Karyn Eilber, Los Angeles, CA

9:50 PD08-03 CAPTURING REAL TIME EVIDENCE OF UROTHELIAL PERMEABILITY IN LIVE RODENT BY MRI

Pradeep Tyagi*, Nishant Singh, Lesley Foley, T. Kevin Hitchens, Jodi Maranchie, Christopher Chermansky, Naoki Yoshimura, Jonathan Kaufman, Pittsburgh, PA

10:00 PD08-04 CYSTOSCOPIC DETECTION OF HUNNER LESIONS ASSISTED WITH MACHINE LEARNING-BASED ALGORITHM IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS) PATIENTS

Tomohiro Ueda*, Kyoto, Japan, Andrey Grush-nikov, Yuki Matsuda, Tokyo, Japan, Naoki Yoshi-mura, Pittsburgh, PA

ABSTRACTTIME NUMBER TITLE10:10 PD08-05 COMPARING CONCENTRATION OF

INFLMATORY CYTOKINES IN IC, OAB, UTI, AND BLADDER CANCER URINE SPLES

Elijah Ward, Sarah Bartolone, Alexander Varabu-lea, Prasun Sharma, Joseph Janicki, Royal Oak, MI, Melissa Laudano, Nitya Abrah, New York, NY, Christopher Smith, Houston, TX, Bernadette Zwaans, Michael Chancellor*, Royal Oak, MI, Laura Lb, Ann Arbor, MI

10:20 PD08-06 PREVALENCE OF URGE URINARY INCONTINENCE ONG WOMEN WITH INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME

Alexandra Dubinskaya*, Beverly Hills, CA, Lauren Tholemeier, Los Angeles, CA, Tyler Erickson, anda De Hoedt, Durh, NC, Kil Barbour, Atlanta, GA, Jayoung Kim, Stephen Freedland, Los Angeles, CA, Jennife Anger, La Jolla, CA

10:30 PD08-07 ANTIFIBROSIS TREATMENT IMPROVES BLADDER DYSFUNCTION AND PAIN PERCEPTION IN A MOUSE MODEL OF BLADDER PAIN WITH CENTRAL SENSITIZATION MIMICKING INTERSTITIAL CYSTITIS

Joonbeom Kwon*, Hye-RI Park, Eun-Ju Lee, Ji-Ae Jang, Hyun-Jung Cho, Daegu, Korea, Republic of, Naoki Yoshimura, Pittsburgh, PA

10:40 PD08-08 IMPROVEMENT IN PAIN CATASTROPHIZING RELATED TO IMPROVED OUTCOMES IN PATIENTS WITH CHRONIC PELVIC PAIN (CPP)

Jacob Gaines*, Daniel Alaiev, Lindsey Nyman, Shashank Pandya, Danielle Wang, Kate Kunkle, Jennifer Fariello-Moldwin, Stephanie Goldstein, Robert Moldwin, Lake Success, NY

48

10:50 PD08-09 THE ROLE OF VIRTUAL SUPPORT GROUPS IN THE MANAGEMENT OF PATIENTS WITH INTERSTITIAL CYSTITIS

David Mauler, Gina Toma*, Aqsa Khan, Phoenix, AZ

11:00 PD08-10 DEHYDRATED HUMAN NION-CHORION MEMBRANES CAN ELIORATE INTERSTITIAL CYSTITIS IN RATS BY DOWN-REGULATING INFLMATORY CYTOKINES AND PROTEIN CODING GENES

Che Hsueh Yang*, Yi Sheng Lin, Wei Chun Weng, Chin Heng Lu, Chao Yu Hsu, Min Che Tung, Chi Chien Lin, Yen Chuan Ou, Taichung, Taiwan

11:10 PD08-11 USING A MOBILE PHONE APPLICATION TO DISCOVER PELVIC PAIN PROFILE CLUSTERS IN UROLOGIC CHRONIC PELVIC PAIN SYNDROME (UCPPS)

Bradley Erickson*, Iowa City, IA, Bayley Taple, Jes Griffith, Chicago, IL, Mengying You, Weng-hseng Guo, Philadelphia, PA, Catherine Bradley, Iowa City, IA, John Farrar, Philadelphia, PA, Priyanka Gupta, Ann Arbor, MI, Karl Kreder, Iowa City, IA, Henry Lai, St. Louis, MO, Bruce Naliboff, Los Angeles, CA, Diane Newman, Philadelphia, PA, Larissa Rodriguez, Los Angeles, CA, Theresa Spitznagle, Siobhan Sutcliffe, St. Louis, MO, Suzette Sutherland, Seattle, WA, Richard Landis, Philadelphia, PA

11:20 PD08-12 EFFICACY OF PERCUTANEOUS TIBIAL NERVE STIMULATION (PTNS) FOR INTERSTITIAL CYSTITIS / BLADDER PAIN SYNDROME (IC/BPS) RELATED LOWER URINARY TRACT AND PELVIC SYMPTOMS

Abdelrahman S. Abdalla*, Sean W. Berquist, Stanford, CA, Chen Shenhar, Tikva, Israel, Ste-fanie van Uem, Ashu Mohmad, Amy D. Dobberfu-hl, Stanford, CA


Friday, May 13, 2022 9:30 am – 11:30 am

Video Session 2BPH/MALE VOIDING DYSFUNCTION/INFECTION/MISC. IMAGING

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerator: Marcelino Rivera, Gregg Eure & Taek Won Kang

ABSTRACTTIME NUMBER TITLE9:30 V02-01 DESIGN AND VALIDATION OF A NON-

BIOHAZARDOUS SIMULATION MODEL FOR HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP)

Ahmed Ghazi*, Rachel Melnyk, John Melnyk, Rajat Jain, Scott Quarrier, Rochester, NY, Amy Krambeck, Chicago, IL, Nicole Miller, Nashville, TN, Narang Gopal, Mitchell Humphreys, Phoenix, AZ

9:40 V02-02 CHARACTERIZATION OF LUMENIS 120H LASER POWER OUTPUT MODES FOR HOLMIUM LASER ENUCLEATION OF PROSTATE

Seung-June Oh*, Hyuk Dal Jung, Min Soo Choo, Seoul, Korea, Republic of, Seong Jin Jeong, Seongnam, Korea, Republic of

9:50 V02-03 TRANSPERINEAL FUSION PROSTATE LASER ABLATION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA: TECHNIQUE AND RESULTS

Fernando Bianco*, Luis Avila, Eusebio Luna, Alberto Lopez-Prieto, Ariel Kaufman, Pedro Gon-zalez, David Cohen, Edward Gheiler, Miami, FL

10:00 V02-04 SINGLE-PORT TRANSVESICAL SIMPLE PROSTATECTOMY FOR BIG MEDIAN LOBE

Mahmoud Abou Zeinab*, Aaron Kaviani, Ethan Ferguson, Alp T. Beksac, Jihad Kaouk, Cleveland, OH

ABSTRACTTIME NUMBER TITLE10:10 V02-05 ROBOTIC TRANSVESICAL SIMPLE

PROSTATECTOMY: OUR EXPERIENCE AND TECHNIQUE

Shirin Razdan*, Burak Ucpinar, Kennedy E. Okhawere, Indu Saini, New York City, NY, Tara Tomy, New York, NY, Ketan K. Badani, New York City, NY

10:20 V02-06 FUNCTIONAL OUTCOMES OF EXTRAPERITONEAL LAPAROSCOPIC ADENOMECTOMY

Roberto Hugo Martinez Rodriguez*, Alberto Robles Samaniego, Cristina Gutierrez Ruiz, Leire Portilla Maediavilla, Valladolid, Spain, Alejandro Garcia Viña, Valladoldi, Spain, Jose H. Amon Sesmero, Valladolid, Spain

10:30 V02-07 LAPAROSCOPIC URETHRA-SPARING SIMPLE PROSTATECTOMY IN AVERAGE SIZE PROSTATES: A PARADIGM SHIFT?

André Barcelos*, Pedro Bargão Santos, Estêvão Lima, Lisbon, Portugal

10:40 V02-08 ARTIFICIAL URINARY SPHINCTER CUFF MODIFICATION AND OTHER “TRICKS OF THE TRADE”

Jane Kurtzman, Preston Kerr*, Steven Brandes, New York City, NY

10:50 V02-09 A NOVEL IMPLANTATION TECHNIQUE FOR THE ADJUSTABLE CONTINENCE THERAPY DEVICE (PROACT)

Hasan Jhaveri*, Kenan Ashouri, Troy Larson, Lawrence Yeung, Gainesville, FL


FR

IDA

Y

11:00 V02-10 LONG TERM EVALUATION OF THE ARGUS-T® ADJUSTABLE MALE SLING: A PROSPECTIVE STUDY

Rafael Zanotti*, André Costa Matos, Felipe Pinho, Claudio Hideki Toi, Sergio Paolillo, Giovani Demartino, Marcel Takada, Bruno Hirata, Luís Gustavo Morato de Toledo, São Paulo, Brazil

11:10 V02-11 NEPHROSTOMY BALLOON & SHEATH SUPRAPUBIC TUBE PLACEMENT: A MINIMALLY INVASIVE APPROACH TO LARGE CALIBER SUPRAPUBIC TUBE PLACEMENT

Kevin Flynn*, Charles Schlaepfer, Faizan Khawa-ja, Bradley Erickson, Iowa City, IA

11:20 V02-12 LARGE VOLUME STONE EXTRACTION FOR THE TREATMENT OF CHRONIC PROSTATITIS

George Koch*, Sarah Flury, Nashville, TN


Friday, May 13, 2022 10:00 am – 5:00 pm

SOCIETY OF GENITOURINARY RECONSTRUCTIVE SURGEONS (GURS)LaNouvelle Orleans Ballroom B @ Ernest N. Morial Convention Center

10:00 PRESIDENTIAL ADDRESS Society President: Francisco Martins

10:10 BRANTLEY SCOTT LECTURE: CONGENITAL UROLOGY

Moderator: Tamsin Greenwell Keynote Speaker: Hadley Wood

Q&A

10:40 TRANSGENDER SURGERY

SURGICAL TECHNIQUES: PENILE PROSTHESIS PLACEMENT IN TRANSMASCULINE SURGERY

Moderators: Marta Bizic, James Hotaling, Joseph Pariser Panelists: Miroslav Djordjevic, Geolani Dy, Lee Zhao

Q&A

KNOWLEDGE GAPS IN GENDER AFFIRMATION SURGERY

Moderators: Brad Figler, Rachel Moses, Dmitriy Nikolavsky Speaker: Richard Santucci

HOW TO SET UP A GENDER-AFFIRMATION SUR-GERY PROGRAM

Moderators: Bradley Figler, Rachel Moses, Dimitry Nikolavsky Speaker: Polina Reyblat

Q&A

TOP 2 INNOVATIVE PAPERS IN RECONSTRUC-TIVE UROLOGY 2021

Bradley Erickson

12:00 LUNCH

1:00 CHARLES DEVINE LECTURE Moderator: Miroslav Djordjevic

GLOBAL UROLOGY Keynote Speaker: Catherine deVries

Q&A

1:30 FOCUS ON SURGICAL MANAGEMENT OF NEUROGENIC BLADDER

1:30 SURGICAL TECHNIQUES: AUGMENTATION CYSTOPLASTY

Moderators: Sean Elliott, Tasmin Greenwell, Judith Hagedorn

SMALL BOWEL AUGMENTATION WITH CATHETERIZABLE CHANNELS IN ADULTS

John Stoffel

CONTINENT CATHETERIZABLE ILEOCECOCYSTOPLASTY AND SIGMOID COLON AUGMENT

Jeremy Myers

CHANNEL REPAIR / REPLACEMENT Lindsay Hampson

LONG-TERM COMPLICATIONS AFTER AUGMENTATION CYSTOPLASTY

Blayne Welk

Q&A

2:20 WHAT IS NEW IN URETHRAL STRICTURES? Moderators: Francisco Martins, O. Lenaine Westney

UPDATE ON RECTAL MUCOSA GRAFTING Alex Vanni

MINIMALLY INVASIVE TREATMENT WITH ANTI-FI-BRINOLYTICS FOR URETHRAL STRICTURES

Ramon Virasoro

SURGICAL TECHNIQUE: NON-TRANSECTING BULBAR URETHROPLASTY

Keith Rourke

Q&A

3:00 BREAK

3:15 URETERAL REPAIR Moderators: Frank Burks, Hadley Wood

EVIDENCE UNDERLYING SPY ANGIOGRAPHY Boyd Viers

ILEAL URETER OUTCOMES Brian Flynn

BUCCAL GRAFT URETERAL RECONSTRUCTION Jill Buckley

APPENDIX ONLAY / SUBSTITUTION Daniel Eun

Q&A

50

4:15 GURS INITIATIVES

YOUNG RECONSTRUCTIVE UROLOGIST’S COMMITTEE

Andrew Cohen

GURS 2ND ANNUAL ACADEMIC CONGRESS: MONTREAL

Francisco Martins

UROLOGY: GURS OFFICIAL JOURNAL Bradley Erickson

PRESENTATION OF 2021 GRADUATING FELLOWS’ DIPLOMAS

Keith Rourke

AWARDS AND RECOGNITION, OUTGOING PRESIDENT AND BOARD MEMBERS

Francisco Martins

APPROVED FOR AMA PRA CATEGORY 1 CREDITTMf

Friday, May 13, 2022 10:30 am – 11:45 am

Moderated Poster Session 7BLADDER & URETHRA: ANATOMY, PHYSIOLOGY & PHARMACOLOGY

Room 228 @ Ernest N. Morial Convention CenterModerator: Rosalyn Adam & Travis Jerde


MP07-01 RESTORATION OF BLADDER, URETHRAL AND ANAL SPHINCTER FUNCTION AFTER SURGICAL REINNERVATION IN LOWER MOTOR NEURON LESIONED CANINES

Ekta Tiwari*, Lucas Hobson, Danielle Porreca, Alan Braverman, Nagat Frara, Geneva Cruz, Dania Giaddui, Philadelphia, PA, Justin Brown, Boston, MA, Michael Mazzei, Michel Pontari, Ida Wagner, Mary Barbe, Michael Ruggieri, Philadelphia, PA

MP07-02 LONG-TERM BLADDER DECENTRALIZATION IN CANINES CHANGES THE LOCATION AND PHARMACOLOGY OF NEUROMUSCULAR NICOTINIC RECEPTORS IN THE INTRAMURAL GANGLION NEURONS

Nagat Frara*, Dania Giaddui, Alan S. Braverman, Danielle S. Porreca, Ekta Tiwari, Lucas J. Hob-son, Courtney L. Testa, Philadelphia, PA, Justin M. Brown, Boston, MA, Michael Mazzei, Ida J. Wagner, Michel A. Pontari, Mary F. Barbe, Michael R. Ruggieri, Sr., Philadelphia, PA

MP07-03 BIOMECHANICAL PROPERTIES OF BLADDER AFTER MID-THORACIC CONTUSION IN RAT MODEL

Jonathan Hu*, Blaine Christiansen, Stephanie Osborn, Tanya Garcia-Nolen, Eric Kurzrock, Sacramento, CA

MP07-04 DEVELOPMENT OF A PORCINE MODEL TO QUANTIFY AFFERENT NERVE SIGNALING: A PRELIMINARY STUDY

Christopher Bednarz*, Michael Shields, Graham Pingree, Abraham Alattar, David Lester, Ashley Cardenas, Sean Bryant, William Visser, John Speich, Adam Klausner, Richmond, VA


MP07-05 BLADDER OXIDATIVE STRESS AND ERK SIGNALING CONTRIBUTE TO BLADDER PAIN MEDIATED BY MACROPHAGE MIGRATION INHIBITORY FACTOR AND HIGH MOBILITY GROUP BOX 1

Shaojing Ye, Fei Ma, Dlovan Mahmood, Lexing-ton, KY, Katherine Meyer-Siegler, St Petersburg, FL, Lin Leng, Richard Bucala, New Haven, CT, Pedro Vera*, Lexington, KY

MP07-06 SPECIALIZED PRO-RESOLUTION MEDIATORS IN THE BLADDER: RECEPTOR EXPRESSION AND RECOVERY OF BLADDER FUNCTION FROM CYSTITIS

Francis Hughes*, Armand Allkanjari, Michael Odom, J. Todd Purves, Durham, NC

MP07-07 5-AMINOLEVULINIC ACID PREVENTS CYCLOPHOSPHAMIDE-INDUCED BLADDER DYSFUNCTION IN RATS

Takahira Kuno*, Takahiro Shimizu, Chiaki Kawa-da, Atsushi Kurabayashi, Zou Suo, Hiroki Moga-wa, Masayuki Tsuda, Motoaki Saito, Keiji Inoue, Kochi, Japan

MP07-08 CD44 EXPRESSION IS REDUCED IN LICHEN SCLEROSUS

Ali Ghasemzadeh*, Brian Walczak, Chad Vezina, Wade Bushman, Wei Huang, Matthew Grimes, Madison, WI

MP07-09 TREATMENT WITH LEVOTHYROXINE AND TESTOSTERONE AFFECT BLADDER CONTRACTILITY AND HISTOMORPHOLOGY DIFFERENTLY IN THE RAT MODEL OF PROPYLTHIOURACIL-INDUCED HYPOTHYROIDISM

Serap Gur*, Didem Yilmaz-Oral, Ankara, Turkey

MP07-10 TRANSVAGINAL ULTRASONOGRAPHY FOR TRIGONITIS DIAGNOSIS IN WOMEN

Leopoldo Ribeiro-Filho*, Natália Doratioto Serrano Faria Braz, Amaury Padilha Balsimelli, Caio Vinícius Suartz, Daniel Imbassahy de Sá Bittencourt Câmara e Silva, William C. Nahas, Sao Paulo, Brazil


FR

IDA

Y

MP07-11 REAL WORLD MEDICATION PERSISTENCE IN TREATMENT OF WOMEN WITH OVERACTIVE BLADDER ACCORDING TO LARGE SCALE PRESCRIPTION CLAIMS DATA

Chen Shenhar*, Petah Tikva, Israel, Karin Lifshitz, Igor Mintz, Yariv Shtabholtz, Ofer Yossepowitch, Tel Aviv, Israel, Jack Baniel, Shachar Aharony, Petah Tikva, Israel

MP07-12 INHIBITION OF SMOOTH MUSCLE CONTRACTION IN ISOLATED HUMAN DETRUSOR TISSUES BY MIRABEGRON REQUIRES CONCENTRATIONS OUT OF THERAPEUTIC RANGE, AND IS LIMITED TO NEUROGENIC CONTRACTIONS

Ru Huang*, Alexander Tamalunas, Raphaela Waidelich, Frank Strittmatter, Christian G. Stief, Martin Hennenberg, Munich, Germany

MP07-13 MEDICATIONS MOSTLY ASSOCIATED WITH HAEMATURIA: ASSESSMENT OF THE EUDRAVIGILANCE (EV) AND FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASES ENTRIES

Lorenzo Maria Rovesti*, Rome, Italy, Antonio Nac-chia, Ferdinando Di Giacomo, Giuseppe Disabato, Rionero in Vulture, Italy, Carmen Gravina, Giaco-mo Gallo, Jordi Stira, Beatrice Turchi, Alessandro Guercio, Riccardo Lombardo, Antonio Cicione, Olivia Alessandra Voglino, Valeria Baldassarri, Giorgio Guarnotta, Elisa Mancini, Antonio Franco, Simone D’Annunzio, Andrea Tubaro, Cosimo De Nunzio, Rome, Italy

MP07-14 DIABETIC BLADDER DYSFUNCTION IN MALE AKITA MICE PROGRESSES DIRECTLY TO AN UNDERACTIVE PHENOTYPE

Armand Allkanjari*, Francis Hughes, J Todd Purves, Durham, NC

MP07-15 THE EFFECTS OF TMEM16A CHLORIDE CHANNEL ACTIVATOR ON CYSTOMETRY IN RATS WITH METABOLIC SYNDROME INDUCED ACONTRACTILE DETRUSOR

Yuh-Chen Kuo, Cheng-An Kuo*, Hong-Chiang Chang, Ju-Ton Hsieh, Taipei, Taiwan

MP07-16 DETRUSOR CONTRACTILITY IN RESPONSE TO PGF2α IS INCREASED IN DIABETIC MICE WITH UAB

Michael Odom*, Francis Hughes, Huixia Jin, J. Todd Purves, Durham, NC

MP07-17 MECHANISMS INVOLVED IN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (NADPH) OXIDASE (NOX)-DERIVED REACTIVE OXYGEN SPECIES (ROS) MODULATION OF MUSCLE FUNCTION IN HUMAN BLADDERS

Nagat Frara*, Dania Giaddui, Alan S. Braverman, Mary F. Barbe, Philadelphia, PA, Changhao Wu, Surrey, United Kingdom, Michael R. Ruggieri, Sr., Philadelphia, PA

MP07-18 IDENTIFICATION OF THE MAJOR NADPH OXIDASE SUBTYPE IN THE MICTURITION CENTRE – PATHOLOGICAL IMPLICATIONS

Qin Wu, Yancheng, China, People’s Republic of, Ayse Gurpinar, Patrizia Camelliti, Maxwell Rob-erts, Guildford, United Kingdom, Michael Ruggieri, Sr., Philadelphia, PA, Changhao Wu*, Guildford, United Kingdom

MP07-19 INCREASED FEMALE DETRUSOR MITOCHONDRIAL RESPIRATION IS REFLECTED IN UPREGULATED MITOCHONDRIAL PROTEOME

Hanna LK. Long*, Elena S. Pak, Kelsey Fisher-Well-man, Johannan L. Hannan, Greenville, NC

MP07-20 CENTRALLY ADMINISTERED CORTICOTROPIN-RELEASING FACTOR INDUCES FACILITATION OF THE RAT MICTURITION VIA BRAIN GLUTAMATERGIC RECEPTORS

Takahiro Shimizu*, Yurika Hata, Suo Zou, Masaki Yamamoto, Hideaki Ono, Yohei Shimizu, Takaaki Aratake, Shogo Shimizu, Youichirou Higashi, Takashi Karashima, Motoaki Saito, Nankoku, Japan


52

Friday, May 13, 2022 10:30 am – 11:45 am

Moderated Poster Session 8PEDIATRIC UROLOGY: PENIS & SCROTUMRoom 225 @ Ernest N. Morial Convention Center

Moderator: Charlotte Wu


MP08-01 OPERATIVE OUTCOMES OF PEDIATRIC NON-CONGENITAL URETHROPLASTY AT A SINGLE TERTIARY CARE INSTITUTION

James Ding*, Sameer Mittal, Jason Van Bata-via, Dana Weiss, Stephen Zderic, Mark Zaontz, Aseem Shukla, Arun Srinivasan, Christopher Long, Robert Kovell, Philadelphia, PA

MP08-02 ARE YOU A MORNING PERSON? THE IMPACT OF MODIFIABLE PERIOPERATIVE AND OPERATIVE VARIABLES ON EARLY POSTOPERATIVE COMPLICATIONS FOLLOWING PRIMARY HYPOSPADIAS REPAIR (HR)

Christopher Cooper*, Douglas Storm, Gina Lock-wood, Megan Bonnett, Benjamin Cooper, Logan Harris, Iowa City, IA

MP08-03 FLOW RATES AND FLOW INDEXES IN PEDIATRIC PATIENTS AFTER HYPOSPADIAS URETHROPLASTY: UROFLOW PARAMETERS IN 458 REPAIRED HYPOSPADIAC AND 1,081 NORMAL FLOWS

Joseph Boroda*, Mineola, NY, Paul Zelkovic, Westchester, NY, Alexander Fang, Jordan Gitlin, Mineola, NY, Israel Franco, New Haven, CT

MP08-04 USE OF PRE-OPERATIVE TESTOSTERONE PRIOR TO DISTAL HYPOSPADIAS REPAIR DOES NOT INCREASE POST-OPERATIVE COMPLICATIONS

Sahar Eftekharzadeh*, Sameer Mittal, Nathan Hyacinthe, Dana A. Weiss, Jason Van Batavia, Aseem R. Shukla, Arun K. Srinivasan, Thomas F. Kolon, Stephen A. Zderic, Douglas A. Canning, Mark R. Zaontz, Christopher J. Long, Philadel-phia, PA

MP08-05 EVALUATING THE QUALITY OF ONLINE HEALTH EDUCATIONAL RESOURCES REGARDING HYPOSPADIAS DIAGNOSIS AND TREATMENT

Yash Shah*, Nathan Hyacinthe, Philadelphia, PA, Nicolas Fernandez, Seattle, WA, Carlos Villanueva, Phoenix, AZ, Paige Bosse, Melise Keays, Ottawa, Canada, Christopher Long, Philadelphia, PA


MP08-06 USE OF A MID-URETHRAL STENT (CONTINENT) FOR HYPOSPADIAS SURGERY IN TOILET-TRAINED CHILDREN

Eyal Kord, Ryan Nasseri, Kobi Stav, Amnon Zisman, Neena Carr*, Beer Yacov, Israel, Martin Koyle, Toronto, Canada, Amos Neheman, Beer Yacov, Israel

MP08-07 LONG TERM CONSEQUENCES OF FAILURE TO REPAIR CORPUS SPONGIOSUM IN DISTAL HYPOSPADIAS

David Ali*, Paterson, NJ, Moneer Hanna, New York, NY

MP08-08 PREDICTORS FOR COSMETIC OUTCOMES IN HYPOSPADIAS REPAIR: PROSPECTIVE ASSESSMENT BASED ON VALIDATED QUESTIONNAIRES

Amos Neheman, Neena Carr*, Ilia Beberash-vili, Amnon Zisman, Beer Yacov, Israel, Yuval Bar-Yosef, Tel Aviv, Israel, Kobi Stav, Beer Yacov, Israel

MP08-09 RECOMMENDATIONS TO IMPROVE NEONATAL CIRCUMCISION TRAINING

Emilie Johnson*, Ilina Rosokija, Ryan Walton, Derek Matoka, Catherine Seager, Max Maizels, Jane Holl, Chicago, IL

MP08-10 DIFFERENTIAL INCENTIVES CREATED BY PRIVATE VERSUS PUBLIC INSURANCE PLAN COVERAGE OF PEDIATRIC CIRCUMCISION

Sophia Kamanzi*, Ryan Walton, Ilina Rosokli-ja, Lauren Corona, Jane Holl, Emilie Johnson, Chicago, IL

MP08-12 IN STATES WERE MEDICAID DOES NOT COVER NEWBORN CIRCUMCISION THERE IS AN INCREASE IN OPERATIVE FORESKIN PROCEDURES AND FORESKIN MORBIDITY

Chung-Yon Lin*, Carlos Villanueva Del Rio, Gwen Grimsby, Phoenix, AZ

MP08-13 SUCCESSFUL ADOLESCENT VARICOCELECTOMY IMPROVES TOTAL MOTILE SPERM COUNT

Michael Kurtz, Boston, MA, Raymond Lay, Roch-ester, NY, Tanya Logvinenko, Saafia Masoom, Ozge Yetistirici, Boston, MA, David Diamond*, Rochester, NY

MP08-14 LONG TERM FERTILITY IMPLICATIONS FOLLOWING ADOLESCENT TESTICULAR TORSION: A RETROSPECTIVE ANALYSIS OF A NEW YORK STATE ALL-PAYER DATABASE

Angela Hacksel-Newmark*, Mountain Home, TN, Alexandr M. Pinkhasov, Anthony Tracey, Matthew Mason, Rachel Yakubov, Jeffrey Villanueva, Syracuse, NY


FR

IDA

Y

MP08-15 ATTITUDES TOWARD FERTILITY-RELATED CARE AND EDUCATION OF YOUTH AND YOUNG ADULTS WITH DIFFERENCES OF SEX DEVELOPMENT: INFORMING FUTURE CARE MODELS

Lauren E Corona*, Josephine Hirsch, Ilina Rosoklija, Elizabeth B Yerkes, Emilie K Johnson, Chicago, IL

MP08-16 NOVEL BIOMATERIAL FOR SLOW-RELEASE DRUG DELIVERY TO THE URETHRA

Courtney K. Rowe*, Hartford, CT, Christopher Foster, Farmington, CT, Wei Ruan, Kelly A. Burke, Storrs, CT

MP08-17 SPINAL ANESTHESIA FOR INFANT OUTPATIENT GENITAL SURGERY

Jack Elder*, Andrew Chen, Jacquelin Peck, Christine Mai, Diana Liu, David August, Chang A Liu, Boston, MA

MP08-18 CAUDAL ANESTHESIA IS NOT ASSOCIATED WITH COMPLICATIONS FOLLOWING DISTAL HYPOSPADIAS REPAIR

Katherine Fischer*, Jason VanBatavia, Nathan Hy-acinthe, Sameer Mittal, Karl Godlewski, Stephen Zderic, Aseem Shukla, Arun Srinivasan, Dana Weiss, Thomas Kolon, Douglas Canning, Mark Zaontz, Christopher Long, Philadelphia, PA

MP08-19 FACTORS AFFECTING ORCHIOPEXY GUIDELINE ADHERENCE

Andrea Balthazar*, Ted Lee, Tanya Logvinenko, Caleb Nelson, Hsin-Hsiao Scott Wang, Caleb Nelson, Boston, MA

MP08-20 THE COMPARISON OF ANXIETY LEVELS IN CHILDREN WHO UNDERWENT INVASIVE OR NON-INVASIVE URODYNAMIC STUDIES

Cagri Akin Sekerci, Onur Can Ozkan*, Yiloren Tanidir, Tufan Tarcan, Selcuk Yucel, Istanbul, Turkey


Friday, May 13, 2022 10:30 am – 11:45 am

Moderated Poster Session 9PROSTATE CANCER: DETECTION & SCREENING I

Room 222 @ Ernest N. Morial Convention CenterModerators: Daniel Barocas & Benjamin Davies


MP09-01 THE ROLE OF PROPHYLACTIC ANTIBIOTICS IN TRANSPERINEAL PROSTATE BIOPSY: A SYSTEMATIC REVIEW AND METANALYSIS

Spyridon Basourakos*, New York, NY, Mark Alshak, Baltimore, MD, Patrick Lewicki, Emily Cheng, Michael Tzeng, Antonio DeRosa, New York, NY, Matthew Allaway, Cumberland, MD, Ashley Ross, Edward Schaeffer, Hiten Patel, Chicago, IL, Jim Hu, New York, NY, Michael Gorin, Cumberland, MD

MP09-02 IS IT CLINICALLY AND ONCOLOGICALLY SAFE TO OMIT PROSTATE BIOPSY IN LOW RISK STRATIFIED PATIENTS?

Henning Bahlburg*, Karl Heinrich Tully, Vincent Hoffmann, Herne, Germany, Julian Hanske, Reck-linghausen, Germany, Nicolas von Landenberg, Florian Roghmann, Rein-Jueri Palisaar, Joachim Noldus, Sebastian Berg, Herne, Germany, Marko Brock, Recklinghausen, Germany

MP09-03 THE EFFICACY OF ADJUVANT AMIKACIN TO ORAL LEVOFLOXACINE FOR PREVENTION OF FEBRILE COMPLICATIONS FOLLOWING TRANSRECTAL PROSTATE BIOPSY

Yoshitsugu Nasu*, Taiki Kanbara, Okayama, Japan


MP09-04 A UNIQUE COMPARISON OF PROSTATE CANCER DETECTION RATES BETWEEN TRANSRECTAL VERSUS TRANSPERINEAL MRI-TRUS FUSION PROSTATE BIOPSY AMONG 794 CASES

Renée Hogenhout*, Henk B. Luiting, Daniël F. Osses, Monique J. Roobol, Rotterdam, Netherlands

MP09-05 COMPREHENSIVE ANALYSIS OF MORBIDITY FOLLOWING TRANSPERINEAL PROSTATE BIOPSY

Vassilios Skouteris*, Athens, Greece, Nelson Stone, New York, NY

MP09-06 PROSTATE CANCER DETECTION AND COMPLICATIONS OF TRANSPERINEAL VERSUS TRANSRECTAL MRI-FUSION GUIDED PROSTATE BIOPSIES

Dylan Buller*, Jessa Sahl, Ilene Staff, Joseph Tortora, Kevin Pinto, Tara McLaughlin, Laura OlivoValintin, Joseph Wagner, Hartford, CT

MP09-07 SAFETY PROFILE OF ROBOTIC-ASSISTED TRANSPERINEAL MRI-US-FUSION GUIDED BIOPSY OF THE PROSTATE

Christian Wetterauer*, Walter Manuel, Pawel Trot-senko, Matthias Marc, Winkel David Jean, Breit Christian, Meyer Anja, Seifert Hans Helge, Basel, Switzerland

54

MP09-08 PATIENT-REPORTED PREFERENCE BETWEEN TRANSRECTAL AND TRANSPERINEAL PROSTATE BIOPSY

Sana N. Siddiqui*, Zorawar Singh, Hugh A. G. Fisher, Ronald P. Junior Kaufman, Badar M. Mian, Albany, NY

MP09-09 THE RESULTS OF TRANSPERINEAL VERSUS TRANSRECTAL PROSTATE BIOPSY: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS

Jindong Dai*, Jiyu Yang, Chengdu, China, People’s Republic of, Xingming Zhang, Chengdu, China, People’s Republic of, Pengfei Shen, Hao Zeng, Chengdu, China, People’s Republic of

MP09-10 QUANTIFICATION OF PERINEURAL INVASION BY PROSTATE CANCER ON NEEDLE CORE BIOPSY: IMPLICATION FOR RISK STRATIFICATION

Yuki Teramoto, Ying Wang, Hiroshi Miyamoto*, Rochester, NY

MP09-11 THE RELATIVE IMPACT OF SPATIAL PARAMETERS ON THE PERFORMANCE OF MRI-US FUSION BIOPSY VS. MRI IN-BORE BIOPSY OF THE PROSTATE

Mitch Hayes*, Solange Bassale, Sudhir Isharwal, Christopher Amling, Bryan Foster, Fergus Coak-ley, Jen-Jane Liu, Portland, OR

MP09-12 PARTIAL PROSTATE GLAND ABLATION: LESION LOCATION USING TRANSPERINEAL MAPPING BIOPSY (TPMB)

Nelson Stone*, New York, NY, Vassilios Skouteris, Athens, Greece

MP09-13 THE VALUE OF [F-18]FLORASTAMINR PROSTATE SPECIFIC MEMBRANOUS ANTIGEN (PSMA) PET/CT AT INITIAL DIAGNOSIS OF PROSTATE CANCER COMPARED WITH MULTI-PARAMETRIC MAGNETIC RESONANCE IMAGING (MPMRI)

Hyeok Jae Kwon*, Chang Eil Yoon, Dongho Shin, Hyong Woo Moon, Yong Hyun Park, Woong Jin Bae, Hyuk Jin Cho, U-Syn Ha, Sung-Hoo Hong, Sae Woong Kim, Ji Youl Lee, Seoul, Korea, Republic of

MP09-14 STIMULATED RAMAN HISTOLOGY ALLOWS FOR RAPID PATHOLOGIC EXAMINATION OF UNPROCESSED, FRESH PROSTATE BIOPSIES

Miles P. Mannas*, Derek Jones, Fang-Ming Deng, Deepthi Hoskoppal, Jonathan Melamed, Daniel Orringer, Samir S Taneja, New York, NY

MP09-15 INVESTIGATION OF FROZEN SECTION BIOPSY UTILIZATION IN MAGNETIC RESONANCE IMAGING–ULTRASONOGRAPHY FUSION-TARGETED PROSTATE BIOPSY FOR HIGH-RISK PROSTATE CANCER

Seung Bin Kim*, Jong Hyun Tae, Hyun Jung Jin, Tae Il Noh, Ji Sung Shim, Seok Ho Kang, Jun Cheon, Jeong Gu Lee, Sung Gu Kang, Seoul, Korea, Republic of

MP09-16 QUALITY OF INFORMATION IN SPANISH ON BRCA AND GENETIC TESTING IN PROSTATE CANCER ON YOUTUBE

Brett Friedman*, Auburn Hills, MI, Kevin Pineault, Tatiana Sanchez Nolasco, New York, NY, Hala Borno, San Francisco, CA, Veda Giri, Philadel-phia, PA, Stacy Loeb, New York, NY

MP09-17 PREDICTING INCIDENCE VERSUS MORTALITY FOR CANCERS ASSOCIATED WITH OVERDIAGNOSIS: AN OVERLOOKED ISSUE FOR POLYGENIC RISK SCORES AND CANCER SCREENING

Andrew Vickers*, New York, NY, Amit Sud, London, United Kingdom, Jonine Bernstein, New York, NY, Richard Houlston, London, United Kingdom

MP09-18 LONGITUDINAL OUTCOMES FOLLOWING IMPLEMENTATION OF BASELINE PSA RISK STRATIFICATION OF MEN IN THEIR FORTIES

Zoe Michael*, Srinath Kotamarti, Rohith Arcot, Kostantinos Morris, Anand Shah, John Ander-son, Andrew Armstrong, Rajan Gupta, Glenn M. Preminger, Judd W. Moul, Kevin Oeffinger, Kevin Shah, Thomas J. Polascik, Durham, NC

MP09-19 PROSTATE CANCER STAGING WITH 18F-PSMA PET/CT AFTER BONE SCINTIGRAPHY IN MEN WITH AN INCREASED RISK OF HAVING METASTATIC DISEASE. A HEAD-TO-HEAD COMPARATIVE ASSESSMENT

Yves Bodar, Wietske Luining*, Amsterdam, Netherlands, Bram Keizer, Hoorn, Netherlands, Dennie Meijer, Amsterdam, Netherlands, Annelies Vellekoop, Amstelveen, Netherlands, Maarten Schaaf, Harry Hendrikse, Jeroen van Moorselaar, Daniela Oprea-Lager, André Vis, Amsterdam, Netherlands

MP09-20 PROSTATE BIOPSY TARGETED TO PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) FOCI

David Kuppermann*, Jeremie Calais, Los Angeles, CA, Wayne Brisbane, Gainesville, FL, Elizabeth Tran, Lorna Herbert, Matthias Benz, Johannes Czernin, Leonard Marks, Los Angeles, CA



FR

IDA

Y

Friday, May 13, 2022 12:30 pm – 4:30 pm

SOCIETY OF URODYNAMICS, FEMALE PELVIC MEDICINE & UROGENITAL RECONSTRUCTION (SUFU)Grand Ballroom C @ Hilton New Orleans Riverside

Chairs: Jaspreet Sandhu & Blayne Welk

12:30 WELCOME AND INTRODUCTION: GUIDELINES APPLICABLE TO SUFU

Chairs: Jaspreet Sandhu, Blayne Welk

12:35 AUA GUIDELINE PROCESS Peter Clark

12:45 DIAGNOSIS AND TREATMENT OF NON-NEURO-GENIC OVERACTIVE BLADDER (OAB) IN ADULTS: AN AUA/SUFU GUIDELINE

Sandip Vasavada

12:55 DEBATE: FIRST LINE MEDICAL THERAPY FOR A 60 YEAR OLD FEMALE WITH OAB—BETA AGO-NISTS VERSUS ANTICHOLINERGICS

Moderator: Sandip Vasavada Debaters: Michael Chancellor, Tomas Griebling

1:10 DEBATE: OPTIMAL THIRD LINE THERAPY FOR OAB FOR SAME WOMAN

Moderator: Sandip Vasavada Debaters: Doreen Chung, Charles Powell

1:30 FEMALE SUI GUIDELINE Kathleen Kobashi

1:40 DEBATE: MANAGEMENT OF RECURRENT SUI POST TVT—REPEAT THE MIDURETHRAL SLING VS NON-MESH SLING

Moderator: Kathleen Kobashi Debaters: Ekene Enemchukwu, Anne Suskind

2:00 DEBATE: HOW TO APPROACH THE WOMAN WHO ISN’T SURE ABOUT THE SAFETY OF A SYNTHET-IC MIDURETHRAL SLING—REASSURE HER VS ENCOURAGE THE ALTERNATIVES

Moderator: Rena Malik Debaters: Anne Pelletier Cameron, W. Stuart Reynolds, Ariana Smith

2:20 BREAK

2:35 URODYNAMICS: WHO REALLY NEEDS URODY-NAMICS

Alan Wein

2:45 URODYNAMICS: MINI-CASES—HIGHLIGHTING THE UTILITY OF URODYNAMICS

Moderator: Alan Wein Debaters: Humphrey Atiemo, Howard Goldman, Richard K. Lee

3:15 INCONTINENCE AFTER PROSTATE TREATMENT: OVERVIEW AND RATIONALE

Kurt McCammon

3:25 DEBATE: INCONTINENCE AFTER PROSTATE TREATMENT—EFFECT OF RADIATION ON PPI (TIMING OF XRT IN PATIENTS CONSIDERING ANTI-INCONTINENCE SURGERY)

Moderator: Kurt McCammon Debaters: Brian Linder, Polina Reyblat, Jaspreet Sandhu

3:40 DEBATE: INCONTINENCE AFTER PROSTATE TREATMENT—ROLE OF URINARY DIVERSION IN PATIENTS WITH MULTIPLE AUS FAILURES AND/OR INTRACTABLE BNC

Moderator: Kurt McCammon Debaters: Melissa Kaufman, Alvaro Lucioni

3:55 RECURRENT UTI IN WOMEN: OVERVIEW AND RATIONALE

Jennifer Anger

4:05 RECURRENT UTI IN WOMEN: 40 YEAR OLD WITH RECURRENT UTI’S TREATED - IS THERE A ROLE FOR CRANBERRY OR OTHER NON-ANTIBIOTIC SOLUTIONS?

Moderator: Jennifer Anger Debaters: A. Ackerman, Katherine Amin, Bilal Chughtai

4:20 RECURRENT UTI IN WOMEN: IS LONG-TERM ANTIBIOTIC PROPHYLAXIS APPROPRIATE FOR A WOMEN WITH RUTI’S?

Moderator: Jennifer Anger Debaters: Nitya Abraham, Toby Chai

4:30 CLOSING REMARKS/ADJOURN Blayne Welk


Friday, May 13, 2022 1:00 pm – 3:00 pm

EDITORIAL WORKSHOP: GETTING PUBLISHED AND BEYONDRoom 345 @ Ernest N. Morial Convention Center

EDITORIAL WORKSHOP: GETTING PUBLISHED AND BEYOND

Panelists: John Davis, John D. Denstedt, J. Stephen Jones, Rena D. Malik, D. Robert Siemens

56

Friday, May 13, 2022 1:00 pm – 5:00 pm

ForumsHISTORY OF UROLOGY FORUM

Room 355 @ Ernest N. Morial Convention Center

ABSTRACTTIME NUMBER TITLE1:00 HISTORY FORUM POSTERS

HF02-01 COVID-19 AND SEX Zachary Seymour*, San Antonio, TX, Michael Moran, Columbia, SC

HF02-02 THOMAS ROWLANDSON AND THE ENGLISH PENII

Michael Moran*, Columbia, SC

HF02-03 ANCIENT AKKADIAN SEX-IMPOTENCE RITUALS

Tyler Bunting*, Michael Moran, Columbia, SC

HF02-04 THE STATISTICS OF HUMAN SEXUALITYHannah Moreland*, Michael Moran, Columbia, SC

HF02-05 FROM STERILE TO CLEAN: DRAMATIC CHANGES IN CATHETERIZATION DURING THE 1970s

Aaron Huang*, Jacob Gaines, Andrew Winer, Brooklyn, NY

HF02-06 THE HISTORY OF THE CATHETERIZABLE CHANNEL

Daniel Tennenbaum*, Brooklyn, NY, Jordan Gitlin, Mineola, NY

HF02-07 HISTORY OF PERIPHERAL TIBIAL NERVE STIMULATION IN UROLOGY

Adam Visca*, Raymond Lay, Annette E. Sessions, Ronald Rabinowitz, Divya Ajay, Rochester, NY

HF02-08 QUANTIFYING THE EDUCATIONAL HISTORY OF THE ENDOUROLOGICAL SOCIETY FELLOWSHIP PROGRAMS IN THE UNITED STATES

Sutchin R. Patel*, Lake Forest, IL, Stephen Y. Nakada, Madison, WI

HF02-09 THE EVOLUTION OF THE DIAGNOSTIC LANDSCAPE OF RENAL MASSES

Elizabeth Ellis*, Edward Messing, Rochester, NY

HF02-10 MEDICAL METALS: A BIOGRAPHY OF CISPLATIN

Arnav Srivastava*, Hiren Patel, Thomas Jang, Eric Singer, Saum Ghodoussipour, New Brunswick, NJ

HF02-11 PROFESSION IGLESIAS – PHYSICIAN, INVENTOR, AND POLITICAL PRISONER

Janmejay Hingu*, Matthew Davis, Newark, NJ, Mubashir Billah, Bloomfield, NJ, Hossein Sadeghi-Nejad, East Orange, NJ

HF02-12 REINHOLD WAPPLER: AN IMMIGRANT ENGINEER WHO TRANSFORMED THE PRACTICE OF UROLOGY

Eric Macdonald*, Ella Taubenfeld, Robert Wald-baum, Lake Success, NY

ABSTRACTTIME NUMBER TITLE HF02-13 A BOHNE FIDE TITAN OF UROLOGY

Isaac Palma-Zamora*, Craig Rogers, James Peabody, Naveen Kachroo, Detroit, MI

HF02-14 HERMAN KRETSCHMER: FROM GENITOURINARY PATHOLOGY TO PRESIDENCY

Alice Cheung*, Albany, NY

1:30 HF01-01 RAINER ENGEL, THE GATEKEEPER OF UROLOGIC HISTORY

Brian Meyerson*, Albany, NY

1:37 HF01-02 MAKING THE PRIVATES PUBLIC: IMPOTENCE TRIALS IN PREREVOLUTIONARY FRANCE

Jacob Gaines*, Robert Moldwin, Lake Success, NY

1:44 HF01-03 SMALLPOX VACCINATION: A PHYSICIAN, A MINISTER AND AN AFRICAN SLAVE WIN THE REVOLUTIONARY WAR

Joseph Hartnett*, Howard Adler, Stony Brook, NY

1:51 HF01-04 THE BIRTH OF UROLOGY AS A SURGICAL SPECIALTY AFTER THE FRENCH REVOLUTION

Philip Van Kerrebroeck*, Berchem, Belgium

1:58 DEBATE: THE INFLATABLE PENILE PROSTHESIS IS FIRST-LINE THERAPY FOR ED

Moderaters: Ronald Rabinowitz, Irwin Goldstein Judges: Barbara Chubak, Kevin Pranikoff, Jennif-er Gordetsky Debaters: Helen Levey Bernie, Gerald Brock

2:18 HF01-05 DYSURIA: THE DOWNFALL OF AN EMPEROR? A UROLOGIC HISTORY OF NAPOLEON BONAPARTE

Charan Mohan*, Robert Waldbaum, Arthur Smith, Arun Rai, New Hyde Park, NY

2:25 HF01-06 JOHN WEISS: FROM HIS DEBUT IN LITHOTRIPSY TO POP CULTURE

Sana N. Siddiqui*, Albany, NY

2:32 HF01-07 SAVE THE CHILDREN: A HISTORY OF FERTILITY PRESERVATION IN MALE CHILDREN AND ADOLESCENTS

Lauren Gochenaur, Alexis Steinmetz, Kit Yuen*, Joseph Gabrielsen, Ronald Rabinowitz, Rochester, NY

2:39 HF01-08 INDIA’S HISTORY OF MASS STERILIZATIONRainjade Chung*, Jane Kurtzman, Steven Brandes, New York, NY

2:46 HF01-09 THE FIRST GERMAN UNIVERSITY LECTURESHIP FOR SEXOLOGY AT KOENIGSBERG (TODAY: KALININGRAD). WHY THERE, WHY JESSNER?

Friedrich Moll*, Cologne, Germany, Thorsten Halling, Richard Kühl, Nils Hansson, Matthis Krischel, Duesseldorf, Germany


FR

IDA

Y

2:53 HF01-10 FRANK B. BICKNELL: PIONEER IN PEDIATRIC UROLOGY AND FOUNDER OF THE AMERICAN UROLOGICAL ASSOCIATION HISTORY FORUM

Sutchin R. Patel*, Madison, WI, David A. Bloom, Ann Arbor, MI, Anthony A. Caldamone, Providence, RI

3:00 2021 RETROSPECTROSCOPE AWARDS Dr. Adam K. Russon of Buffalo Dr. Alexis R. Steinmetz of Rochester (Honorable Mention)

3:05 BICKNELL LECTURE: WORDS MATTER—TRACING THE LANGUAGE OF SEXUAL DYSFUNCTION

Sue Goldstein

3:35 HF01-11 “VAGINA” IS NOT A BAD WORD: HISTORICAL AND CONTEMPORARY CENSORSHIP OF THE WORD “VAGINA”

Shreeya Popat*, Seattle, WA, Rainey Horwitz, St. Louis, MO, Karyn Eilber, Los Angeles, CA, Una Lee, Seattle, WA

3:42 HF01-12 UPDATES TO THE HISTORY OF GENDER-AFFIRMING VAGINOPLASTY TECHNIQUE

Andrew Zilavy*, Albuquerque, NM, Richard San-tucci, Austin, TX, Maxx Gallegos, Albuquerque, NM

3:49 HF01-13 FROM TORTURE TO THERAPY: THE HISTORY OF HUMAN CASTRATION

Antonio Nacchia*, Rionero in Vulture, Italy, Riccar-do Lombardo, Cosimo De Nunzio, Andrea Tubaro, Rome, Italy

3:56 HF01-14 DESCENDING THROUGH THE HISTORY OF CRYPTORCHIDISM AND TESTICULAR TUMORS

Alexis Steinmetz*, Kit Yuen, David Diamond, Ronald Rabinowitz, Rochester, NY

4:03 HF01-15 FIRST SEX - THE NATUFIAN STATUENikil Sairam*, Michael Moran, Columbia, SC

4:10 HF01-16 EVOLUTION OF THE IDEAL PENIS: PENILE PREFERENCES THROUGHOUT THE AGES

Leah Beland*, New Hyde Park, NY

4:17 HF01-17 PENILE STRETCHING PRACTICES THROUGH TIME AND CULTURE

John Sigalos*, Sriram Eleswarapu, Jesse Mills, Los Angeles, CA

4:24 HF01-18 THINK INSIDE THE BOX - REICH’S THEORIES ON ORGASM AND THE ORGONE

Jonathan Xu*, Burlington, MA, Erin Piermarini, Worcester, MA, Octavia Devon, Burlington, MA

4:31 HF01-19 EX MACHINA: HISTORIES OF ROBOTIC SEXLoren Smith*, Michael Moran, Columbia, SC

4:38 HF01-20 THE ARCHER OF MEUDON: THE MYTH OF THE FIRST PYELOLITHOTOMY

Albert Ha*, Gina Badalato, New York, NY

4:45 HF01-21 A BRIEF HISTORY OF THE ARTIFICIAL PENILE PEARL

Adam M. Jenks*, Megan R. McMurray, M. Francesca Monn, Springfield, IL

4:52 HF01-22 REV YOUR ENGINES: HOW AN AUTO WORKER BROUGHT HOPE TO THOSE WITH ERECTILE DYSFUNCTION

William Du Comb*, Steven Allegro, Detroit, MI, Esther Liu, Detroit, MI, Joshua Palka, Detroit, MI

4:59 HF01-23 FREDERICK AUGUSTINE RUPP, M.D. AND LETTERS TO DAUGHTERS - SEX AND THE 2000s

Victoria Stowasser*, Michael Moran, Columbia, SCs

Friday, May 13, 2022 1:00 pm – 2:15 pm

Moderated Poster Session 10EDUCATION RESEARCH I

Room 228 @ Ernest N. Morial Convention CenterModerators: Lee Richstone, Elizabeth Takacs & Peter Wang

ABSTRACTTIME NUMBER TITLE MP10-01 FACTORS IN UROLOGY JOURNALS THAT

DETERMINE FEMALE AUTHORSHIP REPRESENTATION: RETROSPECTIVE REVIEW FROM 2015 TO 2020

Maria Camila Suarez*, Daniel E. Nassau, Miami, FL, Arjun Watane, New Heaven, CT, Aayush Shah, Ranjith Ramasamy, Miami, FL

MP10-02 UROLOGY RESIDENT AUTONOMY COMPARED TO GENERAL SURGERY RESIDENT AUTONOMY

Kunj Jain*, Totowa, NJ, Janmejay Hingu, Anh Nguyen, Devashish Anjaria, Joseph B. Oliver, Hossein Sadeghi-Nejad, Newark, NJ

ABSTRACTTIME NUMBER TITLE MP10-03 SURGICAL AUTONOMY OF UROLOGY

RESIDENTS WITHIN THE VETERANS AFFAIRS HEALTHCARE SYSTEM.

Janmejay Hingu*, Anh Nguyen, Kunj Jain, Newark, NJ, Devashish Anjaria, Joseph Oliver, Hossein Sadeghi-Nejad, East Orange, NJ

MP10-04 IMPLEMENTATION OF ONLINE INSTRUCTIONAL VIDEOS IMPROVES NURSING COMFORT WITH COMMONLY ENCOUNTERED URINARY CATHETER CARE SCENARIOS

Akhil Muthigi*, Christopher Dall, Erin Hays, James Mason, Ryan Hankins, Ross Krasnow, Jordan Alger, Washington, DC

58

MP10-05 TIME TO OPTIMIZE UROLOGY TRAINEE EDUCATION AND PREPARATION FOR SURGERY: VIDEO-BASED SURGICAL LEARNING

Miyad Movassaghi*, Rainjade Chung, New York, NY, Zoe Cohen, New York, NY, Rashed Kosber, Doreen Chung, New York, NY

MP10-06 A NOVEL ONLINE PHYSICIAN GROUP-COACHING PROGRAM TO REDUCE BURNOUT IN FEMALE TRAINEES: A RANDOMIZED CONTROLLED TRIAL

Kerri Thurmon*, Aurora, CO, Pari Shah, Denver, CO, Krithika Suresh, Nathalie Dieujuste, Christine Jones, Adrienne Mann, Tyra Fainstad, Aurora, CO

MP10-07 THE RELATIONSHIP OF TECHNICAL SKILLS AND COGNITIVE WORKLOAD TO ERRORS DURING ROBOTIC SURGICAL EXERCISES

Sidney I Roberts*, Steven Cen, Jessica H Nguyen, Laura C Perez, Luis G Medina, Runzhuo Ma, Los Angeles, CA, Sandra P Marshall, Solana Beach, CA, Rafal Kocielnik, Anima Anandkumar, Pasadena, CA, Andrew J Hung, Los Angeles, CA

MP10-08 LONGITUDINAL COMPARISON OF SURGICAL CASE LOGS BETWEEN FEMALE AND MALE UROLOGY RESIDENTS

Kathryn A Marchetti*, Emma C Bethel, Stephanie Daignault - Newton, Charlie Ferrer, Ann Arbor, MI, Suzanne Merril, Aurora, CO, Thomas Guzzo, Philadelphia, PA, Adam Klausner, Richmond, VA, Richard Lee, New York, NY, John Lynch, Wash-ington, DC, Jay D Raman, Hershey, PA, Adam Reese, Patrick Shenot, Philadelphia, PA, R Hou-ston Thompson, Rochester, MN, Stanley Zaslau, Morgantown, WV, Kate H Kraft, Ann Arbor, MI

MP10-09 ACADEMIC PRODUCTIVITY AMONGST UNDERREPRESENTED MINORITY UROLOGISTS AT ACADEMIC INSTITUTIONS

David Tella*, Bahrom Ostad, Charlottesville, VA, David Barquin, Roanoke, VA, Caleigh Smith, Charlottesville, VA, Rebecca King, Roanoke, VA, Christopher Ballantyne, Tracy Downs, Kirsten Greene, Nora Kern, Charlottesville, VA

MP10-10 HEAD-TO-HEAD COMPARISON OF HYDROGEL MODELS TO CADAVERS FOR INFLATABLE PENILE PROSTHESIS (IPP) TRAINING

Patrick Saba*, Rachel Melnyk, Michael Witthaus, Christopher Wanderling, Tyler Holler, Ahmed Ghazi, Rochester, NY

MP10-11 REPRESENTATION IN UROLOGY RESIDENTS AND FULL-TIME ACADEMIC UROLOGY FACULTY: A SNAPSHOT OF DIVERSITY AND INCLUSION IN MEDICINE AND UROLOGY

Michelle Chen*, Jeffrey Ellis, Justin Friedlander, Philadelphia, PA

MP10-12 A QUALITY IMPROVEMENT STUDY OF RESIDENT & FELLOW EXPERIENCE WITH URINARY CATHETER INSERTION

Peris Castaneda*, Jenna Stelmar, Shannon Smith, Aurash Naser-Tavakolian, Maurice Garcia, Los Angeles, CA

MP10-13 AUTHORSHIP IN UROLOGY: A GENDER REVEAL

Leah Beland*, New Hyde Park, NY, Ginnie Jeng, Uniondale, NY, Tareq Aro, Jessica Kreshover, New Hyde Park, NY

MP10-14 MODELING THE UROLOGY RESIDENCY APPLICATION AND MATCH PROCESS: A MATHEMATICAL ARGUMENT FOR APPLICATION AND INTERVIEW LIMITS

Sameer Farooq*, Akanksha Mehta, Atlanta, GA

MP10-15 BUILDING A REAL-TIME FEEDBACK SYSTEM TO IMPROVE PERFORMANCE ON A ROBOTIC TISSUE DISSECTION TASK

Jasper Laca*, Los Angeles, CA, Rafal Kocielnik, Pasadena, CA, Jessica H Nguyen, Ryan Tsang, Jonathan You, Alvin Hui, Los Angeles, CA, Anima Anandkumar, Pasadena, CA, Andrew J Hung, Los Angeles, CA

MP10-16 INTERACTIVE ONLINE UROLOGY CURRICULUM FOR MEDICAL STUDENTS: A MULTI-INSTITUTIONAL PILOT STUDY

Ezra Margolin*, Jane Kurtzman, Rachel Gordon, Christopher Anderson, Gina Badalato, New York, NY

MP10-17 DEVELOPMENT AND VALIDATION OF THE END-TO-END ASSESSMENT OF SUTURING EXPERTISE (EASE)

Taseen F Haque*, Alvin Hui, Jonathan You, Run-zhuo Ma, Steven Cen, Xiaomeng Li, Monish Aron, Los Angeles, CA, Justin W Collins, London, Unit-ed Kingdom, Hooman Djaladat, Los Angeles, CA, Ahmed Ghazi, Rochester, NY, Kenneth A Yates, Andre L Abreu, Siamak Danseshmand, Mihir M Desai, Los Angeles, CA, Alvin C Goh, Jim C Hu, New York, NY, Amir H Lebastchi, Los Angeles, CA, Thomas S Lendvay, James Porter, Seattle, WA, Anne K Schuckman, Rene Sotelo, Los Ange-les, CA, Chandru P Sundaram, Indianapolis, IN, Jessica H Nguyen, Inderbir Gill, Andrew J Hung, Los Angeles, CA

MP10-18 URETEROSCOPY STANDARDIZATION AND ITS IMPACT ON EFFICIENCY IN THE OPERATING ROOM

Jordan Goldwag*, Laila Bangash, Andrew Harris, Lexington, KY

MP10-19 NEEDS AND EXPERIENCES OF U.S. FEMALE UROLOGY RESIDENTS

Michelle Sheng*, Almira Catic, Dattatraya Patil, Lindsey Hartsell, Akanksha Mehta, Atlanta, GA

MP10-20 MEDICAL MALPRACTICE LAWSUITS INVOLVING UROLOGY TRAINEES

Roei Golan*, Tallahassee, FL, Manish Kuchakulla, New York, NY, Arjun Watane, New Haven, CT, Raghuram Reddy, Miami, FL, Ravi Parikh, New York, NY, Ranjith Ramasamy, Miami, FL



FR

IDA

Y

Friday, May 13, 2022 1:00 pm – 2:15 pm

Moderated Poster Session 11PEDIATRIC UROLOGY: NEUROGENIC BLADDER, RECONSTRUCTION & UROLOGIC EMERGENCIES

Room 225 @ Ernest N. Morial Convention CenterModerators: Deborah Jacobson & Rajeev Chaudhary

ABSTRACTTIME NUMBER TITLE MP11-01 USE OF EDUCATIONAL VIDEO TO

IMPROVE PARENT UNDERSTANDING AND ADHERENCE TO RECOMMENDATIONS IN CHILDREN WITH DYSFUNCTIONAL VOIDING

Eniola Ogundipe*, Marguerite Korber, Gemma Beltran, Alan Quach, Carter Sevick, Vijaya Vemulakonda, AURORA, CO

MP11-02 USE OF A MANUAL TRIGGER WITH A TRADITIONAL MOISTURE ALARM FOR TREATMENT OF PRIMARY MONOSYMPTOMATIC NOCTURNAL ENURESIS

Gina Lockwood*, Denise Juhr, Caitlin Ward, Meg-an Bonnett, Christopher Cooper, Douglas Storm, Iowa City, IA, D. Preston Smith, Knoxville, TN

MP11-03 FALSE POSITIVE PREGNANCY TESTS AMONG PEDIATRIC PATIENTS WITH AUGMENTATION ENTEROCYSTOPLASTIES

Zoë Baker, Arthi Hannallah*, Hannah Dillon, Yud-ing Wang, Evalynn Vasquez, Los Angeles, CA

MP11-04 PELVIC ORGAN PROLAPSE IS NOT UNCOMMON AMONG WOMEN WITH SPINA BIFIDA

Joshua Roth*, Rosalia Misseri, Devon Hensel, Indianapolis, IN, Susan Ernst, Ann Arbor, MI, Melissa Kaufman, Nashville, TN, Raimund Stein, Mannheim, Germany, John Weiner, Durham, NC, Konrad Szymanski, Indianapolis, IN

MP11-05 FACTORS ASSOCIATED WITH PERIOPERATIVE COMPLICATIONS FOLLOWING AUGMENTATION CYSTOPLASTY: A CONTEMPORARY POPULATION-BASED ANALYSIS

Hriday Bhambhvani*, Kritika Sharma, Kunj Sheth, Stanford, CA

MP11-06 ENDOSCOPIC INJECTION OF THE BLADDER NECK USING DEXTRANOMER HYALURONATE (DX/HA) IN THE PEDIATRIC PATIENT: RESULTS OF A SINGLE CENTER ANALYSIS WITH LONG TERM FOLLOW UP

Jennifer M. Lovin*, Nelson Kuete, Shuvro De, Andrew J. Kirsch, Atlanta, GA

MP11-07 A TECHNIQUE TO PREVENT STOMAL STENOSIS IN RECONSTRUCTIVE UROLOGY

Stephen Sekoulopoulos, Akshilkumar Patel, Ellius Kwok, Suzanne Boltz, Ross Decter*, Hershey, PA

MP11-08 RESTRICTED ACCESS TO MIRABEGRON IN CHILDREN WITH NEUROGENIC BLADDER

Christopher Jaeger*, Andrea Balthazar, Caleb Nelson, Tanya Logvinenko, Hsin-Hsiao Scott Wang, Boston, MA

ABSTRACTTIME NUMBER TITLE MP11-09 SURVIVAL ANALYSIS AMONG UTAH

RESIDENTS WITH SPINA BIFIDA BORN BETWEEN 1950 AND 2015

Cynthia Sharadin*, Suzanne Lange, JJ Horns, Chad Wallis, Glen Lau, Anthony Schaeffer, Salt Lake City, UT

MP11-10 SPINA BIFIDA ONLINE EDUCATION FOR TRANSITIONAL PATIENTS IN THE ERA OF COVID-19

Anessa Sax-Bolder*, Alan Quach, Denver, CO, Cindy Buchanan, Ty Higuchi, Aurora, CO

MP11-11 THE DIFFERENCE OF FECAL MICROBIOTA COMPOSITION IN PEDIATRIC PATIENTS WITH SPINA BIFIDA: PROSPECTIVE CASE-CONTROL STUDY

Yong Seung Lee*, Sang Woon Kim, Sowon Park, Hong Koh, Sang Won Han, Seoul, Korea, Republic of

MP11-12 PRENATAL DIAGNOSIS OF BLADDER AND CLOACAL EXSTROPHY OVER 20 YEARS

Ted Lee*, Boston, MA, Dana Weiss, Philadel-phia, PA, Elizabeth Roth, Milwaukee, WI, Sahar Eftekharzadeh, Philadelphia, PA, Saafia Masoom, Boston, MA, Susan Jarosz, John Kryger, Milwau-kee, WI, Aseem Shukla, Philadelphia, PA, Travis Groth, Michael Mitchell, Milwaukee, WI, Richard Lee, Boston, MA, Douglas Canning, Philadelphia, PA, Joseph Borer, Boston, MA

MP11-13 SHORT AND LONG TERM RENAL OUTCOMES IN CLINICALLY MATCHED COHORTS OF NEWBORNS WITH PUV MANAGED BY PRIMARY VESICOSTOMY VERSUS PRIMARY VALVE ABLATION

Nora Haney*, Shwetha Mudalegundi, Angelica Griggs-Demmin, Tamir Sholklapper, Edwin Smith, Charlotte Wu, Baltimore, MD

MP11-14 ACHIEVING GOAL CAPACITY FOR CONTINENCE SURGERY: A CUMULATIVE EVENT ANALYSIS OF BLADDER EXSTROPHY PATIENTS

Preeya Khandge*, Kelly Harris, Wayland Wu, Mahir Maruf, Baltimore, MD, Hiten Patel, Maywood, IL, Heather Di Carlo, John Gearhart, Baltimore, MD

MP11-15 PATIENT REPORTED REASONS FOR DELAYED PRESENTATION TO HOSPITAL WITH TORSION AND IMPACT ON TESTICULAR OUTCOMES

Thawatchai Mangonsrisuk, Nicholas Mitsakakis, Luis Guerra, Melise Keays*, Ottawa, Canada

MP11-16 PREDICTORS FOR TESTICULAR ATROPHY AFTER EMERGENCY ORCHIDOPEXY FOR TESTICULAR TORSION

Thawatchai Mangonsrisuk, Luis Guerra, Nicholas Mitsakakis, Melise Keays*, Ottawa, Canada

60

MP11-17 IMPROVING AWARENESS OF TESTICULAR TORSION AMONG BOYS, THEIR PARENTS AND SCHOOL NURSES TO DECREASE DELAYS IN CARE FOR ACUTE TESTICULAR PAIN

Benjamin Abelson*, Kyle Mason, Cyrus Adams, Mark Adams, John Brock III, John C Pope IV, Stacy Tanaka, John Thomas, Douglass B Clayton, Viktor Flores, Abby S Taylor, Nashville, TN

MP11-18 IS AMBULATORY STATUS ASSOCIATED WITH SEXUAL FUNCTION AND ACTIVITY IN THE YOUNG ADULT SPINA BIFIDA POPULATION?

Shane Batie*, Janelle Traylor, Shaheer Ali, Sam-uel Gold, Yvonne Chan, Bruce Schlomer, Micah Jacobs, Dallas, TX

MP11-19 THE ART OF INTRODUCING CLEAN INTERMITTENT CATHETERIZATION: HOW FAMILIES RESPOND & ADAPT. A QUALITATIVE STUDY

Stuart B Bauer, MD*, Rachel Saunders, BA, Saa-fia Masoom, BA, Lillian Hayes, PhD, Diane Price, MSW, Paige Sable, LICSW, Kennary Choung, RN, Ashley Shimmel, MS, Boston, MA

MP11-20 SIGNIFICANT ANTIBIOTIC USE VARIATIONS IN PEDIATRIC TESTICULAR TORSION SURGERY AMONG US FREE-STANDING CHILDREN’S HOSPITALS

John Panagides*, Dylan Cahill, Rachel Saunders, Hsin-Hsiao Wang, Boston, MA


Friday, May 13, 2022 1:00 pm – 2:15 pm

Moderated Poster Session 12KIDNEY CANCER: ADVANCED (INCLUDING DRUG THERAPY) I

Room 222 @ Ernest N. Morial Convention CenterModerators: Sarah Psutka, Vitaly Margulis & Michael Whalen

ABSTRACTTIME NUMBER TITLE MP12-01 C-REACTIVE PROTEIN KINETICS TO

PREDICT RECURRENCE AFTER RADICAL SURGERY FOR HIGH-RISK RENAL CELL CARCINOMA

Yudai Ishiyama*, Tsunenori Kondo, Hiroki Ishiha-ra, Arakawa, Japan, Kazuhiko Yoshida, Junpei Iizuka, Kazunari Tanabe, Toshio Takagi, Tokyo, Japan

MP12-02 PROSPECTIVE EVALUATION OF CIRCULATING TUMOR DNA (CTDNA) IN DETECTING EARLY PROGRESSION ON IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH ADVANCED GENITOURINARY CANCERS

Albert Jang*, Ellen Jaeger, Grant Rauterkus, Alex Liberman, Isabelle Sussman, Malcolm Light, Minqi Huang, Charlotte Manogue, Sydney Caputo, Pat-rick Miller, Brian Lewis, Jodi Layton, Oliver Sartor, New Orleans, LA, Earle Burgess, Charlotte, NC, Tiffany Farmer, Hayley Widden, Carrie Flippen, Alexey Aleshin, San Carlos, CA, Claud Grigg, New York, NY, Pedro Barata, New Orleans, LA

MP12-03 IL-7 AND CCL19 PRODUCING CAR-T CELLS PREVENT ANTIGEN-LOSS TUMOR RELAPSE AND ENHANCE ANTITUMOR EFFICACY AGAINST SOLID CANCER

Shunsuke Goto*, Fukuoka, Japan, Koji Tamada, Ube, Japan, Masatoshi Eto, Fukuoka, Japan

MP12-04 PREDICTIVE IMPACT OF EARLY CHANGES IN SERUM C-REACTIVE PROTEIN LEVELS IN NIVOLUMAB PLUS IPILIMUMAB THERAPY FOR METASTATIC RENAL CELL CARCINOMA

Hidekazu Tachibana*, Yuki Nemoto, Saitama, Japan, Hiroki Ishihara, Hironori Fukuda, Kazuhiko Yoshida, Junpei Iizuka, Tokyo, Japan, Yasunobu Hashimoto, Saitama, Japan, Tsunenori Kondo, Kazunari Tanabe, Toshio Takagi, Tokyo, Japan

ABSTRACTTIME NUMBER TITLE MP12-05 PSOAS MUSCLE MASS PREDICTS THE

OUTCOME OF NIVOLUMAB TREATMENT FOR RENAL CELL CARCINOMA

Hideto Ueki*, Yasuyoshi Okamura, Yukari Bando, Takuto Hara, Tomoaki Terakawa, Junya Furukawa, Yuzo Nakano, Masato Fujisawa, Kobe, Japan

MP12-06 ONCOLOGIC OUTCOMES IN PATIENTS DIAGNOSED WITH PT3AN0M0 RENAL CELL CANCER ACCORDING TO RENAL VEIN THROMBUS OR FAT INVASION

Giuseppe Fallara, Giuseppe Rosiello, Andrea Necchi, Daniele Raggi, Walter Cazzaniga, Al-berto Martini, Giuseppe Basile*, Daniele Cignoli, Gianmarco Colandrea, Gianfranco Baiamonte, Federico Belladelli, Giacomo Musso, Frances-co Cei, Cristina Giancristofaro, Andrea Ieva, Daniela Canibus, Alberto Briganti, Roberto Bertini, Francesco Montorsi, Andrea Salonia, Alessandro Larcher, Umberto Capitanio, Milan, Italy

MP12-07 THE ANATOMICAL LOCATION OF LYMPHADENOPATHIES AT IMAGING PREDICTS THE RISK OF LYMPH NODE INVASION AT FINAL PATHOLOGY IN PATIENTS WITH RENAL CELL CARCINOMA

Giuseppe Rosiello*, Giuseppe Fallara, Giuseppe Basile, Daniele Cignoli, Francesco De Cobelli, Giorgio Brembilla, Luigi Nocera, Federico Bell-adelli, Gianmarco Colandrea, Daniela Canibus, Giacomo Musso, Francesco Cei, Chiara Re, Cristina Giancristofaro, Alberto Briganti, Roberto Bertini, Andrea Necchi, Daniele Raggi, Milan, Italy, Alexandre Mottrie, Aalst, Belgium, Pierre I. Kar-akiewicz, Montreal, Canada, Francesco Montorsi, Andrea Salonia, Alessandro Larcher, Umberto Capitanio, Milan, Italy


FR

IDA

Y

MP12-08 OUTCOMES OF NEPHRECTOMY FOR RENAL CELL CARCINOMA WITH VENOUS THROMBUS FOLLOWING IMMUNE CHECKPOINT INHIBITOR THERAPY: A MULTICENTER COLLABORATIVE STUDY

Alireza Ghoreifi*, Los Angeles, CA, Thomas Gerald, Dallas, TX, Randall Lee, Philadelphia, PA, Jeffrey Howard, Dallas, TX, Aeen Asghar, Los Angeles, CA, Abhinav Khanna, Rochester, MN, David Quinn, Inderbir Gill, Los Angeles, CA, R Houston Thompson, Rochester, MN, Robert Uzzo, Philadelphia, PA, Vitaly Margulis, Dallas, TX, Hooman Djaladat, Los Angeles, CA

MP12-09 PROGNOSTIC MODEL OF UPFRONT CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH IMMUNE-CHECKPOINT INHIBITORS AND/OR TYROSINE KINASE INHIBITORS

Jun Teishima*, Keisuke Goto, Yohei Sekino, Tetsu-taro Hayashi, Nobuyuki Hinata, Hiroshima, Japan

MP12-10 POTENTIAL SURVIVAL BENEFIT OF DEFERRED NEPHRECTOMY IN PATIENTS TREATED WITH NIVOLUMAB PLUS IPILIMUMAB FOR METASTATIC RENAL CELL CARCINOMA

Maki Yoshino*, Hiroki Ishihara, Tokyo, Japan, Yuki Nemoto, Saitama, Japan, Kazutaka Nakamura, Fukushima, Japan, Hidekazu Tachibana, Satita-ma, Japan, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Tokyo, Japan, Shimmura Hiroaki, Fukushima, Japan, Yasunobu Hashimoto, Saitama, Japan, Toshio Takagi, Tsune-nori Kondo, Kazunari Tanabe, Tokyo, Japan

MP12-11 NEOADJUVANT THERAPY IN THE MANAGEMENT OF LOCAL RETROPERITONEAL RECURRENCE OF RENAL CELL CARCINOMA AFTER RADICAL NEPHRECTOMY

Jiwei Huang*, Yueming Wang, Shanghai, China, People’s Republic of, Cuijian Zhang, Beijing, China, People’s Republic of, Xiaoyi Hu, Shang-hai, China, People’s Republic of, Ping Wang, Hangzhou, China, People’s Republic of, Guohai Shi, Jin Zhang, Wen Kong, Yonghui Chen, Yiran Huang, Dingwei Ye, Shanghai, China, People’s Republic of, Dan Xia, Hangzhou, China, People’s Republic of, Jianming Guo, Shanghai, China, People’s Republic of, Zhisong He, Beijing, China, People’s Republic of, Wei Xue, Shanghai, China, People’s Republic of

MP12-12 SURGICAL MANAGEMENT AND ONCOLOGIC OUTCOMES FOR LOCAL RETROPERITONEAL RECURRENCE OF RENAL CELL CARCINOMA AFTER RADICAL NEPHRECTOMY

Jiwei Huang*, Yueming Wang, Shanghai, China, People’s Republic of, Cuijian Zhang, Beijing, China, People’s Republic of, Xiaoyi Hu, Shang-hai, China, People’s Republic of, Ping Wang, Hangzhou, China, People’s Republic of, Guohai Shi, Liang Dong, Jin Zhang, Wen Kong, Yonghui Chen, Dingwei Ye, Shanghai, China, People’s Republic of, Dan Xia, Hangzhou, China, Peo-ple’s Republic of, Jianming Guo, Wei Xue, Yiran Huang, Shanghai, China, People’s Republic of, Zhisong He, Beijing, China, People’s Republic of

MP12-13 THE ROLE OF NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA IN THE ERA OF IMMUNE-COMBINATION THERAPIES: A META-ANALYSIS

Keiichiro Mori*, Fahad Quhal, Takafumi Yanag-isawa, Satoshi Katayama, Benjamin Pradere, Ekaterina Laukhtina, Pawel Rajwa, Hadi Mosta-faei, Reza Sari Motlagh, Vienna, Austria, Takahiro Kimura, Shin Egawa, Tokyo, Japan, Karim Bensalah, Rennes, France, Pierre Karakiewicz, Montreal, Canada, Manuela Schmidinger, Shahrokh Shariat, Vienna, Austria

MP12-14 SITE-SPECIFIC EARLY RESPONSE PATTERNS IN ADVANCED RCC PATIENTS TREATED WITH NIVOLUMAB AND IPILIMUMAB COMPARED WITH SUNITINIB THERAPY

Renpei Kato*, Tomohiko Matsuura, Shigekatsu Maekawa, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Wataru Obara, Yahaba, Japan

MP12-15 EFFECTS OF FIRST-LINE IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA NOT MEETING TRIAL ELIGIBILITY CRITERIA

Yuki Nemoto*, Saitama, Japan, Hiroki Ishihara, Tokyo, Japan, Kazutaka Nakamura, Fukushima, Japan, Hidekazu Tachibana, Saitama, Japan, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Tokyo, Japan, Hiroaki Shimmura, Fukushima, Japan, Yasunobu Hashi-moto, Saitama, Japan, Kazunari Tanabe, Tsune-nori Kondo, Toshio Takagi, Tokyo, Japan

MP12-16 OPTIMIZING TARGETED DRUG SELECTION IN COMBINATION THERAPY FOR PATIENTS WITH ADVANCED OR METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF SAFETY

Ruiyang Xie*, Bingqing Shang, Weixing Jiang, Chuanzhen Cao, Hongzhe Shi, Jianzhong Shou, Beijing, China, People’s Republic of

MP12-17 IMMUNOTHERAPY-BASED COMBINATIONS IN THE FIRST-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA WITH SARCOMATOID FEATURES: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Fahad Quhal*, Keiichiro Mori, Ekaterina Laukhti-na, Benjamin Pradere, Hadi Mostafaei, Pawel Raj-wa, Shahrokh F. Shariat, Manuela Schmidinger, Vienna, Austria

MP12-18 IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH BETTER SURVIVAL OUTCOMES FOR METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB PLUS IPILIMUMAB

Kazuyuki Numakura*, Akita, Japan, Shingo Ha-takeyama, Hirosaki, Japan, Yuya Sekine, Yumina Muto, Mizuki Kobayashi, Soki Kashima, Ryohei Yamamoto, Atsushi Koizumi, Taketoshi Nara, Mit-suru Saito, Shintaro Narita, Akita, Japan, Chikara Ohyama, Hirosaki, Japan, Tomonori Habuchi, Akita, Japan

62

Friday, May 13, 2022 1:00 pm – 3:00 pm

Podium Session 9INFERTILITY: EPIDEMIOLOGY & EVALUATION I

Room 252 @ Ernest N. Morial Convention CenterModerator: Sarah Vij

ABSTRACTTIME NUMBER TITLE1:00 PD09-01 LOW BIRTH WEIGHT IS ASSOCIATED

WITH SPERM DNA FRAGMENTATION AND ASSISTED REPRODUCTIVE TECHNOLOGY OUTCOMES IN PRIMARY INFERTILE MEN – RESULTS OF A CROSS-SECTIONAL STUDY

Luca Boeri*, Federico Belladelli, Edoardo Pozzi, Gi-useppe Fallara, Massimiliano Raffo, Christian Cors-ini, Luigi Candela, Antonio Costa, Daniele Cignoli, Nicolò Schifano, Alessia d’Arma, Milan, Italy, Paolo Capogrosso, Varese, Italy, Eugenio Ventimiglia, Luca Pagliardini, Enrico Papaleo, Milan, Italy, Vincenzo Mirone, Naples, Italy, Federico Dehò, Varese, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy

1:10 PD09-02 USE OF A NEW EPIGENETIC SPERM QUALITY TEST (SPERMQT) FOR MEN SEEKING FERTILITY CARE

Chad Pollard, Provo, UT, Ryan Miller, Kristin Brogaard, Salt Lake City, UT, Larry Lipshultz*, Houston, TX

1:20 PD09-03 IDENTIFICATION OF Y CHROMOSOME MICRODELETIONS AND ASSOCIATIONS WITH ADVERSE HEALTH OUTCOMES IN THE UK BIOBANK

Dylan J. Peterson*, Michael L. Eisenberg, Stanford, CA

ABSTRACTTIME NUMBER TITLE1:30 PD09-04 INCREASED FREQUENCY OF CYSTIC

FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE CARRIER MUTATIONS IN NON-CBAVD INFERTILE MALES

Thomas Garcia*, J. Sam Fisher, Kenny Kim, Larry Lipshultz, Houston, TX

1:40 PD09-05 USE OF FRESH EJACULATED SEMEN SAMPLES ON THE DAY OF PLANNED MTESE IN MEN WITH “AZOOSPERMIA”

Jessica Marinaro*, Caroline Kang, Nahid Punjani, Peter Schlegel, New York, NY

1:50 PD09-06 ELEVATED FOLLICLE STIMULATING HORMONE (FSH) PREDICTS DECLINE IN SEMEN PARAMETERS AMONG MEN WITH NORMAL INDEX SEMEN ANALYSIS

Richard Fantus*, Minh Pham, Cecilia Chang, Justin Dubin, Robert Brannigan, Joshua Halpern, Chicago, IL

2:00 PD09-07 HYPERESTROGENISM IS ASSOCIATED WITH SEXUAL FUNCTION IMPAIRMENT IN MEN – FINDINGS FROM A CROSS-SECTIONAL, REAL-LIFE STUDY

Luca Boeri*, Milan, Italy, Paolo Capogrosso, Varese, Italy, Giuseppe Fallara, Walter Cazzan-iga, Luigi Candela, Federico Belladelli, Edoardo Pozzi, Massimiliano Raffo, Antonio Costa, Chris-tian Corsini, Daniele Cignoli, Nicolò Schifano, Gianmarco Colandrea, Alessia d’Arma, Eugenio Ventimiglia, Rayan Matloob, Milan, Italy, Federico Dehò, Varese, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy

Friday, May 13, 2022 1:00 pm – 3:00 pm

ForumsAUA ROBOTICS THEATER SPONSORED BY INTUITIVE: MULTIPORT ROBOTIC PROCEDURES—PROSTATE

AND KIDNEY CANCERSS&T Hall C: Booth 311 @ Ernest N. Morial Convention Center

Chair: Ashutosh Tewari

AUA ROBOTICS THEATER: MULTIPORT ROBOTIC PROCEDURES - PROSTATE AND KIDNEY CANCERS

Program Leaders: Ashok Hemal, Mani Menon Panelists: Bocciardi Aldo, Inderbir Gill, Alex Mottrie

MP12-19 ADJUVANT SYSTEMIC TREATMENT FOR RENAL CANCER AFTER SURGERY: A NETWORK META-ANALYSIS

Niranjan Sathianathen*, Marc Furrer, Declan Mur-phy, Parkville, Australia, Christopher Weight, Shil-pa Gupta, Cleveland, OH, Nathan Lawrentschuk, Parkville, Australia

MP12-20 FIRST-LINE IMMUNOTHERAPY-BASED COMBINATIONS FOR METASTATIC RENAL CELL CARCINOMA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Fahad Quhal*, Keiichiro Mori, Ekaterina Laukhti-na, Benjamin Pradere, Hadi Mostafaei, Shahrokh F. Shariat, Manuela Schmidinger, Vienna, Austria



FR

IDA

Y

2:10 PD09-08 PREVALENCE AND PREDICTORS OF TESTOSTERONE DEFICIENCY AMONG ADULT MEN IN THE UNITED STATES.

John Ernandez*, Steven Chang, Martin Kathrins, Boston, MA

2:20 PD09-09 PREDICTORS OF MALE FACTOR INFERTILITY MANAGEMENT BY REPRODUCTIVE ENDOCRINOLOGIST VERSUS REFERRAL TO A NEARBY UROLOGIST

Julie Shabto*, Dattatraya Patil, Katherine Poulose, Mackenzie Bennett, Angel Xiao, Heather Hipp, Jennifer Kawwass, Akanksha Mehta, Atlanta, GA

2:30 PD09-10 SHEAR WAVE ELASTOGRAPHY IN VARICOCELE PATIENTS WITH OLIGO-ASTHENO-TERATOZOOSPERMIA: PROSPECTIVE STUDY TO INVESTIGATE CORRELATION WITH SEMEN PARAMETERS AND HISTOLOGICAL FINDINGS

Antonio Luigi Pastore, Andrea Fuschi*, Yazan Al Salhi, Alessia Martoccia, Lorenzo Capone, Silvio Scalzo, Paolo Pietro Suraci, Onofrio Antonio Rera, Fabio Maria Valenzi, Alice Antonioni, Antonio Carbone, Latina, Italy

2:40 PD09-11 VEIN DIAMETER ON ULTRASOUND AS PREDICTOR OF SEMEN PARAMETER IMPROVEMENT AFTER VARICOCELECTOMY

Leon Telis*, Alan Paniagua Cruz, Kirolos Meilika, New York, NY, Hira Chaudhry, Philadelphia, PA, Michael Huaman, Brooklyn, NY, Boback M. Berookhim, New York, NY

2:50 PD09-12 IS THE SEMEN MICROBIOME PROFILE IN MEN WITH NON-OBSTRUCTIVE AZOOSPERMIA DIFFERENT FROM FERTILE CONTROLS?

Joseph M. Israeli*, Maria Camila Suarez, Daniel E. Nassau, Kevin Y. Chu, Emad Ibrahim, Ranjith Ramasamy, Miami, FL


Friday, May 13, 2022 1:00 pm – 3:00 pm

Podium Session 10BLADDER CANCER: INVASIVE II

Room 255 @ Ernest N. Morial Convention CenterModerator: Zachary Smith, Amlesh Seth & Sanjay Patel

ABSTRACTTIME NUMBER TITLE1:00 PD10-01 DISEASE-FREE SURVIVAL WITH LONGER

FOLLOW-UP FROM THE CHECKMATE 274 TRIAL OF ADJUVANT NIVOLUMAB IN PATIENTS AFTER SURGERY FOR HIGH-RISK MUSCLE-INVASIVE UROTHELIAL CARCINOMA

Matthew Galsky*, New York, NY, Johannes Alfred Witjes, Nijmegen, Netherlands, Jürgen E. Gschwend, Munich, Germany, Michael Schenker, Craiova, Romania, Begoña P Valderrama, Sevilla, Spain, Yoshihiko Tomita, Niigata, Japan, Aris-totelis Bamias, Athens, Greece, Thierry Lebret, Versailles, France, Shahrokh F. Shariat, Vienna, Austria, Se Hoon Park, Seoul, Korea, Republic of, Mads Agerbaek, Aarhus, Denmark, Gautam Jha, Minneapolis, MN, Frank Stenner Stenner, Basel, Switzerland, Sandra Collette, Braine-l’Al-leud, Belgium, Keziban Unsal-Kacmaz, Federico Nasroulah, Joshua Zhang, Princeton, NJ, Dean F. Bajorin, New York, NY

ABSTRACTTIME NUMBER TITLE1:10 PD10-02 AVELUMAB FIRST-LINE MAINTENANCE FOR

ADVANCED UROTHELIAL CARCINOMA: LONG-TERM FOLLOW-UP RESULTS FROM THE JAVELIN BLADDER 100 TRIAL

Petros Grivas, Seattle, WA, Joaquim Bellmunt*, Boston, MA, Se Hoon Park, Seoul, Korea, Re-public of, Eric Voog, Le Mans, France, Claudia Caserta, Terni, Italy, Begoña P. Valderrama, Seville, Spain, Howard Gurney, Sydney, Australia, Yohann Loriot, Villejuif, France, Srikala S. Sridhar, Toronto, Canada, Norihiko Tsuchiya, Yamagata, Japan, Cora N. Sternberg, New York, NY, Jeanny B. Aragon-Ching, Fairfax, VA, Daniel P. Petrylak, New Haven, CT, John A. Blake-Haskins, La Jolla, CA, Robert J. Laliberte, Jing Wang, Cambridge, MA, Nuno Costa, Porto Salvo, Portugal, Thomas Powles, London, United Kingdom

1:20 PD10-03 HRQOL AFTER ROBOTIC-ASSISTED VERSUS OPEN RADICAL CYSTECTOMY: ANALYSIS OF A RCT

Matthew Clements*, Benjamin Beech, Thomas Atkionson, Guido Dalbagni, Yuelin Li, Andrew Vickers, Harry Herr, S. Machele Donat, Jaspreet Sandhu, Daniel Sjoberg, Amy Tin, Jonathan Cole-man, Bruce Rapkin, Vincent Laudone, Bernard Bochner, New York, NY

64

1:30 PD10-04 CHARACTERIZING MALE ERECTILE FUNCTION AFTER RADICAL CYSTECTOMY

Benjamin Beech*, Matthew Clements, Thomas Atkinson, Yuelin Li, Guido Dalbagni, Andrew Vickers, Harry Herr, S. Machele Donat, Daniel Sjoberg, Amy Tin, John Mulhall, New York, NY, Bruce Rapkin, Bronx, NY, Bernard Bochner, New York, NY

1:40 PD10-05 PERIOPERATIVE BLOOD TRANSFUSION IS ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM AFTER RADICAL CYSTECTOMY

Amanda Myers*, Jacksonville, FL, Igor Frank, Paras H. Shah, Robert F. Tarrell, Rochester, MN, Giovanni A Gonzalez, Jacksonville, FL, R. Jeffrey Karnes, Houston Thompson, Matthew K. Tollef-son, Stephen A. Boorjian, Rochester, MN, Timothy D. Lyon, Jacksonville, FL

1:50 PD10-06 A PHASE 1/2 STUDY OF RAPAMYCIN AND CISPLATIN/GEMCITABINE FOR TREATMENT OF PATIENTS (PTS) WITH MUSCLE-INVASIVE BLADDER CANCER (NCT01938573)

Dimitrios Makrakis*, Martine Roudier, Yan Wang, Funda Vakar-Lopez, Jose Garcia, Atreya Dash, Daniel Lin, George Schade, Elahe A Mo-staghel, Heather Cheng, Michael T. Schweizer, Sarah K Holt, John L. Gore, Evan Yu, Hung-Ming Lam, Jonathan L. Wright, Bruce Montgom-ery, Seattle, WA

2:00 PD10-07 UPDATE OF TRUCE-01: NEOADJUVANT TISLELIZUMAB COMBINED WITH NAB-PACLITAXEL FOR MUSCLE-INVASIVE UROTHELIAL BLADDER CARCINOMA

Hailong Hu*, Yuanjie Niu, Haitao Wang, Chong Shen, Gangjian Zhao, La Da, Lili Wang, Zhouliang Wu, Zhi Li, Houyuan Chen, Xuejian Zhan, Zhan Jiang, Zhe Zhang, Tianjin, China, People’s Republic of

2:10 PD10-08 THE IMPACT OF BASELINE HEALTH-RELATED QUALITY OF LIFE ON BLADDER-CANCER-SPECIFIC SURVIVAL IN PATIENTS TREATED WITH RADICAL CYSTECTOMY

Thilo Westhofen*, Lennert Eismann, Alexander Buchner, Boris Schlenker, Clemens Gießen-Jung, Armin Becker, Christian G. Stief, Alexander Kret-schmer, Munich, Germany

2:20 PD10-09 IDENTIFICATION OF A 3-GENE PANEL IN THE PREDICTION AND PROGNOSIS OF BLADDER CANCER

Shiv Verma*, Eswar Shankar, Spencer Lin, Vaib-hav Singh, Ricky Chan, Shufen Cao, Pingfu Fu, Gregory MacLennan, Lee Ponsky, Sanjay Gupta, Cleveland, OH

2:30 PD10-10 SIGNIFICANCE OF PREOPERATIVE COGNITIVE FUNCTION SCREENED BY THE MINI-COG TEST FOR PREDICTING POSTOPERATIVE SELF-CARE ABILITY OF THE UROSTOMY

Shugo Yajima*, Yasukazu Nakanishi, Naoya Oku-bo, Shunnya Matsumoto, Kenji Tanabe, Madoka Kataoka, Kashiwa, Japan

2:40 PD10-11 GLOBAL VARIATION IN QUALITY OF TRANSURETHRAL RESECTION OF BLADDER SURGERY, RESULTS FROM THE RESECT STUDY

Kevin Gallagher*, Edinburgh, United Kingdom, Niki-ta Bhatt, Norfolk, United Kingdom, Keiran Clement, Glasgow, United Kingdom, Eleanor Zimmermann, Plymouth, United Kingdom, Sinan Khadhouri, Aber-deen, United Kingdom, Meghana Kulkarni, London, United Kingdom, Thineskrishna Anbarasan, Edin-burgh, United Kingdom, Vinson Wai-Shun Chan, Leeds, United Kingdom, Alexander Light, London, United Kingdom, Chon Meng Lam, Aqua Asif, Leicester, United Kingdom, Fortis Gaba, Glasgow, United Kingdom, Sabrina Rossi, Cambridge, United Kingdom, Chuanyu Gao, Kent, United Kingdom, Ar-jun Nathan, Tim O’Brien, London, United Kingdom, Steven Maclennan, Aberdeen, United Kingdom, Matthew Nielsen, Chapel Hill, NC, Paramananthan Mariappan, Edinburgh, United Kingdom, Veeru Kasivisvanathan, RESECT STUDY Global collabo-rators, London, United Kingdom

2:50 PD10-12 THE EFFECT OF PERIOPERATIVE BLOOD TRANSFUSION ON THE DEVELOPMENT OF VENOUS THROMBOEMBOLISM AT THE TIME OF RADICAL CYSTECTOMY

Kassem Faraj*, Charlotte Pougnier, Adri Durant, Yu-Hui Chang, Mark Tyson, Phoenix, AZ



FR

IDA

Y

Friday, May 13, 2022 1:00 pm – 3:00 pm

Podium Session 11PROSTATE CANCER: DETECTION & SCREENING II

Room 245 @ Ernest N. Morial Convention CenterModerators: Arturo Mendoza-Valdes & J. Stephen Jones

ABSTRACTTIME NUMBER TITLE1:00 PD11-01 CORRELATION BETWEEN NSAID USE

AND DETECTION RATE IN MEN WHO UNDERWENT PROSTATE BIOPSY. SHOULD WE REDUCE THE PSA CUTOFF FOR MEN IN CHRONIC THERAPY? A MULTICENTER STUDY

Francesco Chierigo*, Guglielmo Mantica, Genova, Italy, Farzana Cassim, Cape Town, South Africa, Rafaela Malinaric, Genova, Italy, Andrea Benelli, Garbagnate Milasene, Italy, Stefano Parodi, Genova, Italy, Federico Dotta, Cape Town, South Africa, Marco Ennas, Martina Beverini, Genova, Italy, Chiara Vaccaro, Garbagnate Milasene, Italy, Salvatore Smelzo, Milano, Italy, Francesca Am-brosini, Stefano Tappero, Genova, Italy, Salvatore Dioguardi, Palermo, Italy, Gioanni Guano, Maro Borghesi, Nazareno Suardi, Carlo Introini, Gen-ova, Italy, Virginia Varca, Garbagnate Milasene, Italy, Alchiede Simonato, Palermo, Italy, Andrea Gregori, Garbagnate Milasene, Italy, Franco Gaboardi, Milano, Italy, Andre Van der Merwe, Cape Town, South Africa, Carlo Terrone, Genova, Italy

1:10 PD11-02 EVALUATION OF VARIETY AND PERFORMANCE BETWEEN PSA ASSAYS AND PHI IN A CLINICAL COHORT OF MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER

Basil Kaufmann*, Paloma Pellegrino, Noémie Lautenbach, Katharina Spanaus, Arnold von Eckardstein, Thomas Hermanns, Cédric Poyet, Zurich, Switzerland

1:20 PD11-03 ACCURACY AND RACIAL/ETHNIC REPRESENTATION OF PROSTATE CANCER SCREENING VIDEOS ON YOUTUBE AND TIKTOK

Max Abramson*, Nathan Feiertag, Darius Javidi, Bronx, NY, Stacy Loeb, New York, NY, Kara Watts, Bronx, NY

1:30 PD11-04 THE LIMITED UTILITY OF PROSTATE HEALTH INDEX IN AFRICAN AMERICAN MEN WITH A PSA 4-10

Kostantinos Morris*, Judd Moul, Srinath Kotamar-ti, Durham, NC

1:40 PD11-05 ACQUIRED AND CONGENITAL SPINAL CORD INJURY IS ASSOCIATED WITH LOWER LIKELIHOOD OF PSA SCREENING

Stacy Jeong*, Cleveland Heights, OH, Glenn Werneburg, Robert Abouassaly, Hadley Wood, Cleveland, OH

ABSTRACTTIME NUMBER TITLE1:50 PD11-06 BASELINE PSA BELOW 1.0 NG/ML, AND

THEN? VERIFICATION OF THE EAU 2021 POSITION AND RECOMMENDATION ON RISK-ADAPTED EARLY DETECTION USING ERSPC ROTTERDAM DATA WITH MORE THAN 20 YEARS OF DETAILED FOLLOW-UP

Monique Roobol*, Sebastiaan Remmers, Renée Hogenhout, Ivo de Vos, ERSPC Rotterdam study group, Rotterdam, Netherlands

2:00 PD11-07 AWARENESS OF RISK OF PROSTATE CANCER (PCA) REMAINS POOR IN FAMILIES WITH GERMLINE MUTATIONS IN DNA-REPAIR GENES

Giuseppe Chiarelli*, Pieve Emanuele, Italy, Rodol-fo Hurle, Paolo Casale, Alberto Saita, Rozzano, Italy, Giovanni Lughezzani, Vittorio Fasulo, Pieve Emanuele, Italy, Alessio Benetti, Rozzano, Italy, Giorgio Guazzoni, Pieve Emanuele, Italy, Mas-simo Lazzeri, Rozzano, Italy, NicolòMaria Buffi, Pieve Emanuele, Italy, Monica Zuradelli, Massimo Lazzeri, Rozzano, Italy

2:10 PD11-08 A COMBINED BIOMARKER/MPMRI APPROACH PROVIDES ENHANCED CLINICAL INFORMATION PRIOR TO PROSTATE BIOPSY

Alexander Kretschmer, MD*, Munich, Germa-ny, Johan Skog, PhD, Waltham, MA, Christian Fischer, PhD, Martinsreid, Germany, Jason Alter, PhD, Waltham, MA, Mikkel Noerholm, PhD, Martinsreid, Germany

2:20 PD11-09 PERIOPERATIVE BLOOD LEVELS OF PROSTATE-SPECIFIC EXTRACELLULAR VESICLES IN LOCALIZED PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY

Ali Arafa*, Yohan Kim, Mohamed Ahmed, Vidhu Joshi, Eugene Kwon, Fabrice Lucien-Matteoni, Rochester, MN

2:30 PD11-10 COMPLICATIONS AFTER TRANSPERINEAL PROSTATE BIOPSY WITHOUT ANTIBIOTIC PROPHYLAXIS: A CONTRIBUTION TO THE EFFORT TO CONTROL THE SPREAD OF ANTIBIOTICS RESISTANCE

Renée Hogenhout*, Henk B. Luiting, Daniël F. Osses, Monique J. Roobol, Rotterdam, Netherlands

66

2:40 PD11-11 A URINARY EXOSOME ASSAY INTERROGATING SMALL NON-CODING RNAS ACCURATELY IDENTIFIES AND STRATIFIES PROSTATE CANCER INTO LOW- INTERMEDIATE- OR HIGH-RISK DISEASE

Laurence Klotz*, Toronto, Canada, Winnie Wang, Rensselaer, NY, Alvin Lopez Pujals, Caguas, Puerto Rico, Deepak Kapoor, New Hyde Park, NY, Rebecca DeVaux, Greg DiRienzo, Rensselaer, NY, Federico Corica, Ann Anderson, San Juan, Puerto Rico, Carl Olsson, New Hyde Park, NY, Alberto Corica, San Juan, Puerto Rico, James Libby, Stockbridge , GA, Martin Tenniswood, Rensselaer, NY

2:50 PD11-12 ASSOCIATIONS OF SERUM-BASED AND URINE-BASED MOLECULAR DIAGNOSTICS WITH HISTOLOGIC SUBTYPING ON PROSTATE BIOPSY

Claire de la Calle*, Nancy Greenland, Janet Cow-an, Vittorio Fasulo, Martina Maggi, Emily Chan, Bradley Stohr, Jeffry Simko, Katsuto Shinohara, Matthew Cooperberg, Peter Carroll, Hao Nguyen, San Francisco, CA


Friday, May 13, 2022 1:00 pm – 3:00 pm

Podium Session 12BLADDER CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY II

Room 244 @ Ernest N. Morial Convention CenterModerators: Byron Lee & Peter Black

ABSTRACTTIME NUMBER TITLE1:00 PD12-01 BLADDER TUMOR MICROBIOME MAY

AUGMENT RESPONSE TO BCG IN NON-MUSCLE INVASIVE BLADDER CANCER

Jacob Knorr*, Glenn Werneburg, Ava Adler, Jose Agudelo, Prithvi Murthy, Rebecca Campbell, Petar Bajic, Nima Almassi, Christopher Weight, Georges-Pascal Haber, Aaron Miller, Byron Lee, Cleveland, OH

1:10 PD12-02 PATIENT-DERIVED BLADDER TUMOR ORGANOIDS FOR INDIVIDUALIZED PRECLINICAL CHARACTERIZATION OF NADOFARAGENE FIRADENEOVEC INTERFERON GENE THERAPY

Tanner Miest, Houston, TX, Jan Rudzinski*, Houston, TX, Sharada Mokkapati, Akshay Sood, Anirban Mitra, Colin Dinney, Houston, TX

1:20 PD12-03 INTERFERON α GENE THERAPY ALTERS TUMOR METABOLISM IN BLADDER CANCER

Sharada Mokkapati, Jan Rudzinski*, Tanner Mi-est, Anirban Mitra, Akshay Sood, David McCon-key, Colin Dinney, Houston, TX

1:30 PD12-04 SURVEY OF B AND PLASMA CELLS IN BLADDER CANCER ACROSS TUMOR MICROENVIRONMENTS

Yuanshuo Wang*, New York, NY, Jorge Daza, Buffalo, NY, Emilie Grasset, New York, NY, Giuli-ana Magri, Barcelona, Spain, Daniel Ranti, Kristin Beaumont, Adam Farkas, Michelle Tran, Li Wang, Rachel Brody, Reza Mehrazin, Peter Wiklund, Robert Sebra, Jun Zhu, Matthew Galsky, Nina Bhardwaj, John Sfakianos, Amir Horowitz, New York, NY

1:40 PD12-05 SPATIAL TRANSCRIPTOMICS PROVIDES EVIDENCE FOR ALTERNATIVE CHECKPOINT AXES IN BCG-TREATED NMIBC

Daniel Ranti*, Yuanshuo Wang, Jorge Daza, Sanjana Shroff, Kristin Beaumont, Amir Horowitz, John Sfakianos, New York, NY

ABSTRACTTIME NUMBER TITLE1:50 PD12-06 DIFFERENTIAL MYELOID INFLAMMATORY

RESPONSE AND TUMORIGENESIS BY GENDER IN MOUSE MODEL OF BLADDER CANCER

Lauren Folgosa Cooley*, Joseph Podojil, Khyati Meghani, Yanni Yu, Stephen Miller, Joshua Meeks, Chicago, IL

2:00 PD12-07 ADDITION OF ANTI-PD-L1 ENHANCES ANTITUMOR EFFICACIES OF BCG AND BCG-STING BY CD8+ T CELL EXPANSION IN A MURINE SYNGENEIC MB49 MODEL OF UROTHELIAL CARCINOMA

Kara Lombardo*, Monali Praharaj, Russell Becker, Kelly Harris, William Bishai, Andres Matoso, Bal-timore, MD, Trinity Bivalacqua, Philadelphia, PA, Alok Singh, Baltimore, MD

2:10 PD12-08 CRYOTHERAPY FOR SUPERFICIAL BLADDER CANCER IN A SWINE MODEL

Gilad Amiel*, Eyal Kochavi, Camille Malshy, Yaron Ofer, Azik Hoffman, Haifa, Israel

2:20 PD12-09 ELEVATED SEMAPHORIN-6A FACILITATES FLT4-MEDITATED TUMOR MIGRATION AND ASSOCIATES WITH IMMUNE SUPPRESSION IN BLADDER CANCER

Wenjie Luo*, Yiping Zhu, Hailiang Zhang, Yuanyu-an Qu, Dingwei Ye, Shanghai, China, People’s Republic of

2:30 PD12-10 URINE COMPREHENSIVE GENOMIC PROFILING OF UROTHELIAL CARCINOMA PATIENTS UNDERGOING INTRAVESICAL THERAPY ENABLES DETECTION OF ACTIONABLE DNA MUTATIONS ASSOCIATED WITH DRUG RESPONSE AND RISK STRATIFICATION

Goran Rac*, Shalin Desai, Hiten D. Patel, Chirag Doshi, Ryan Dornbier, Maywood, IL, Vincent Ca-ruso, Peter Lentz, Brian C. Mazzarella, Kevin G. Phillips, Trevor Levin, South San Francisco, CA, Alan J. Wolfe, Gopal N. Gupta, Maywood, IL


FR

IDA

Y

2:40 PD12-11 CASTRATION IMPACT ON PATTERN RECOGNITION RECEPTORS (PRRS) BOOSTS TOLL-LIKE RECEPTOR-4 EXPRESSION IN AN IMMUNOCOMPETENT BLADDER CANCER MALE MODEL

Leonardo Reis*, Campinas, Brazil

2:50 PD12-12 TUMOR ANTIGEN VACCINE ENHANCES ANTI-TUMOR EFFECTS OF IMMUNE CHECKPOINT INHIBITORS AGAINST REFRACTORY CANCERS

Shohei Ueda*, Miho Ushjima, Fukuoka-shi, Japan, Atsushi Irie, Yasuharu Nishimura, Kumamoto-shi, Japan, Masatoshi Eto, Fukuoka-shi, Japan


Friday, May 13, 2022 1:00 pm – 3:00 pm

Video Session 3UROLITHIASIS/ENDOUROLOGY

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerators: Michele Jo Semins, Necole Streeper & Sung Yong Cho

ABSTRACTTIME NUMBER TITLE1:00 V03-01 AUTOMATED KIDNEY STONE

SEGMENTATION DURING URETEROSCOPY USING COMPUTER VISION TECHNIQUES

Chase Floyd*, Columbia, SC, Zachary Stoebner, Daiwei Lu, Ipek Oguz, Nicholas Kavoussi, Nashville, TN

1:10 V03-02 EX-VIVO URETEROSCOPY FOR THE TREATMENT OF NEPHROLITHIASIS IN A DECEASED DONOR KIDNEY PRIOR TO TRANSPLANTATION

Marcus Jamil*, Jack Vercnocke, Patrick Etta, Adhnan Mohamed, Mohit Butaney, Mahdi Bazzi, Simon Zetuna, Lauren Malinzak, David Leavitt, Detroit, MI

1:20 V03-03 ULTRA-LOW-DOSE INTRAOPERATIVE CT IMAGING DURING PCNL

Xavier Glover*, Eric Ballon-Landa, Mark Sawyer, Denver, CO

1:30 V03-04 IN VIVO FEASIBILITY TEST USING FLEXIBLE URETEROSCOPIC ROBOTIC SYSTEM, EASYURETERO FOR RENAL STONE RETRIEVAL IN PORCINE MODEL

Hyun Ho Han*, Young Joon Moon, Seoul, Korea, Republic of, Hae Do Jung, Gunpo, Korea, Repub-lic of, Joonhwan Kim, Byungsik Cheon, Jungmin Han, Daejeon, Korea, Republic of, Sung Yong Cho, Seoul, Korea, Republic of, Dong-Soo Kwon, Daejeon, Korea, Republic of, Joo Yong Lee, Seoul, Korea, Republic of

1:40 V03-05 SINGLE-PORT ROBOTIC CYSTOLITHOTOMY AND PYELOLITHOTOMY FOR ENCRUSTED URETERAL STENT REMOVAL

Nathan Cheng*, Hackensack, NJ, Jason Elyaguov, Valhalla, NY, Christine Cumarasamy, Mutahar Ahmed, Nutley, NJ

1:50 V03-06 ECTOPIC PYELOLITHOTOMY VIA A COMBINED ROBOTIC AND ENDOSCOPIC APPROACH

Andrew Higgins*, Alex Nourian, Joshua Cohn, Justin Friedlander, Philadelphia, PA

ABSTRACTTIME NUMBER TITLE2:00 V03-07 INTRACORPOREAL ROBOTIC

PYELOLITHOTOMY USING THE BOSTON SCIENTIFIC SWISS LITHOCLAST® TRILOGY LITHOTRIPTER

Micah Levy*, Chih Peng Chin, Krishna T. Ravivarapu, Osama Al-Alao, Michael Palese, New York, NY

2:10 V03-08 MECHANISMS OF LASER LITHOTRIPSY REVEALED WITH ULTRAHIGH-SPEED VIDEO MICROSCOPY OF STONE FRAGMENTATION IN AIR AND WATER

Yuri Pishchalnikov*, William Behnke-Parks, Marshall Stoller, San Francisco, CA

2:20 V03-09 THULIUM FIBER LASER: A UNIVERSAL DEVICE IN UROLOGY. FROM BENCH TO BEDSIDE

Dmitry Enikeev*, Mark Taratkin, Camilla Azil-gareeva, Anastasia Shpikina, Leonid Rapoport, Roman Sukhanov, Petr Glybochko, Moscow, Russian Federation

2:30 V03-10 THULIUM LASER VS DUAL ACTION ULTRASONIC/BALLISTIC CYSTOLITHOLAPAXY

Matthew Beamer*, Scott Weiner, Syracuse, NY

2:40 V03-11 NOVEL USE OF THULIUM LASER FOR THE MANAGEMENT OF BILIARY CALCULI

Akshay Reddy*, Nicholas Freidberg, MD, Patrick Mufarrij, MD, Washington, DC

2:50 V03-12 THULIUM LASER FIBER PERFORMANCE FOR SIMULTANEOUS TREATMENT OF A URETERAL TUMOR, A URETERAL STONE, AND A KIDNEY STONE: THE SKY IS THE LIMIT!

Willian Ito*, Kenneth Schmanke, Bristol Whiles, Wilson Molina, Kansas City, KS


68

Friday, May 13, 2022 2:45 pm – 4:00 pm

Moderated Poster Session 13HEALTH SERVICES RESEARCH: PRACTICE PATTERNS, QUALITY OF LIFE AND SHARED DECISION MAKING I

Room 228 @ Ernest N. Morial Convention CenterModerators: Mark Litwin & Caroline Moore


MP13-01 PATIENT PERSPECTIVES IN GENITAL GENDER-AFFIRMING SURGERY: THE NEED FOR PATIENT REPORTED OUTCOME MEASURES

Nnenaya Agochukwu-Mmonu, Elijah Castle*, Lee Zhao, Asa Radix, Rachel Bluebond-Langner, Daphna Harel, Danil Makarov, New York, NY, Clarissa Ospina-Norvell, San Francisco, CA, Carolyn Berry, New York, NY

MP13-02 PATTERNS OF TELE-HEALTH USAGE AFTER THE COVID-19 PANDEMIC AMONG SURGICAL SPECIALTIES AND UROLOGY

Maheetha Bharadwaj*, Muhieddine Labban, Bjo-ern Langbein, Adam S. Kibel, Steven L. Chang, Quoc-Dien Trinh, Boston, MA

MP13-03 ASSESSMENT OF PATIENT UNDERSTANDING PRIOR TO UROLOGICAL SURGERIES TO IMPROVE PATIENT EDUCATION & QUALITY OF CARE

Alison Schulz*, Priya Dave, Nitya Abraham, Bronx, NY

MP13-04 ONABOTULINUMTOXINA IMPROVES IDIOPATHIC OVERACTIVE BLADDER SYMPTOMS IN PATIENTS REFRACTORY TO ORAL MEDICATIONS

Elisabeth Carlsson Farrelly*, Stockholm, Sweden, Maria-Fernando Lorenzo-Gomez, Salamanca, Spain, Heinrich Schulte-Baukloh, Berlin, Germa-ny, Mariana Nelson, Irvine, CA, Rizwan Hamid, London, United Kingdom

MP13-05 UROLOGIST HIRING PRACTICES: DATA FROM THE AMERICAN UROLOGICAL ASSOCIATION 2020 CENSUS

Christina Shin*, Justin Loloi, Bronx, NY, Raymond Fang, Linthicum, MD, William Meeks, Maryland, MD, Andrew Harris, Lexington, KY, Amanda North, Bronx, NY

MP13-06 PERSONALITY TRAITS AND BURNOUT AMONG PRACTICING UROLOGISTS

Gopal Narang*, Lanyu Mi, Kevin Wymer, Chris-topher Wolter, Mitchell Humphreys, Karen Stern, Phoenix, AZ

MP13-07 PROFESSIONAL BURNOUT OF ADVANCED PRACTICE PROVIDERS BASED ON AUA CENSUS DATA

Kavita Gupta*, Justin Loloi, Bronx, NY, Raymond Fang, Linthicum, MD, Amanda North, Bronx, NY, William Meeks, Linthicum, MD

MP13-08 ADVANCED PRACTICE PROVIDERS AND WAIT TIMES IN UROLOGY PRACTICES: A SECRET SHOPPER STUDY

Armaan Singh*, Jared Lassner, Marc Sleiman, Parth Modi, Chicago, IL


MP13-09 UNDERREPRESENTATION OF MINORITIES AND WOMEN IN 20 YEARS OF GENITOURINARY CANCER CLINICAL TRIALS

Juan Javier-DesLoges*, Arman Walia, Marga-ret Meagher, John Perry, San Diego, CA, Mimi Nguyen, San Diego, CA, Rekha Narasimhan, San Diego, CA, Madison Chakoumakos, San Diego, CA, Ava Saidian, Brent Rose, Maria Elena Mar-tinez, James D. Murphy, Ithaar Derweesh, San Diego, CA

MP13-10 CAN YOU HAVE IT ALL? PARENTING IN UROLOGY AND WORK-LIFE BALANCE SATISFACTION

Catherine S. Nam*, Stephanie Daignault-Newton, Lindsey A. Herrel, Kate H. Kraft, Ann Arbor, MI

MP13-11 EHR-BASED CLINICAL DECISION SUPPORT FOR UROLOGIC SURGERY: USER PERSPECTIVES AND NEEDS

Hung-Jui Tan*, Chapel Hill, NC, Brooke Spratte, Durham, NC, Allison Deal, Antonia Bennett, Susan Blalock, Chapel Hill, NC, Arlene Chung, Durham, NC, David Gotz, Matthew Nielsen, Dan Reuland, Chapel Hill, NC, Alex Sox-Harris, Stanford, CA, Ethan Basch, Chapel Hill, NC

MP13-12 PRACTICE PATTERNS AND PREDICTORS OF URINARY STONE MATERIAL SUBMISSION FOR ANALYSIS FOLLOWING URETEROSCOPY: RESULTS FROM A STATEWIDE SURGICAL COLLABORATIVE

Isaac Palma-Zamora*, Detroit, MI, Stephanie Daig-nault-Newton, Ann Arbor, MI, Mohit Butaney, Grace Yaguchi, David Leavitt, Detroit, MI, Casey Dauw, Khurshid Ghani, Ann Arbor, MI, Naveen Kachroo, Detroit, MI, for the Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI

MP13-13 ASSOCIATION BETWEEN COMPLEXITY OF PELVIC SURGICAL FIELD AND OUTCOMES OF RADICAL CYSTECTOMY WITH URINARY DIVERSION

Leilei Xia*, Raju Chelluri, Ruchika Talwar, Daniel Lee, Thomas Guzzo, Philadelphia, PA

MP13-14 IMPACT OF COVID AND TELEHEALTH UPON CLINIC VISITS BY UNIVERSITY-BASED UROLOGISTS: IMPLICATIONS FOR ACCESS

Kim Thai*, Ryan Terlecki, Winston-Salem, NC

MP13-15 ONE YEAR OF TELEMEDICINE IN THE MANAGEMENT OF GENITOURINARY MALIGNANCIES

Ezra Margolin*, Saveliy Kelebeyev, Luis Pina Martina, Christopher Anderson, New York, NY

MP13-16 THE AUA GUIDELINES: AN EVALUATION OF EVIDENCE GRADE BACKING STATEMENTS

Chris Du*, Kuemin Hwang, John Hill, Howard L. Adler, Stony Brook, NY


FR

IDA

Y

Friday, May 13, 2022 2:45 pm – 4:00 pm

Moderated Poster Session 14STONE DISEASE: SURGICAL THERAPY (INCLUDING ESWL) I

Room 225 @ Ernest N. Morial Convention CenterModerators: Norberto Bernardo, Noah Canvasser & Bodo Knudsen


MP14-01 EVALUATING THE QUALITY OF SOCIAL MEDIA CONTENT ON UROLITHIASIS PROCEDURES

Parris Diaz*, Los Angeles, CA, Rebecca A. Takele, Blacksburg, VA, Sapna Thaker, Karan N. Thaker, Jorge Ballon, Mayra Lucas, Kevin Kunit-sky, Kymora B. Scotland, Los Angeles, CA

MP14-02 THE SOCIAL IMPACT OF SURGERY FOR NEPHROLITHIASIS: RESULTS FROM THE ENDOUROLOGIC SOCIETY TOWER RESEARCH COLLABORATIVE

Amanda Jones*, Christian Rodriguez, George Lin, Hanna Stambakio, Philadelphia, PA, Ben Chew, Vancouver, Canada, Joshua Stern, Park City, UT, Justin Ziemba, Philadelphia, PA

MP14-03 DOES THE POSITION AND SIZE OF THE URETERAL ACCESS SHEATH AFFECT RENAL PRESSURES DURING URETEROSCOPY? INTRARENAL PRESSURE MEASUREMENT USING A CONCEPT SINGLE-USE DIGITAL FLEXIBLE URETEROSCOPE

Ben H. Chew*, Nabil Shalabi, K.F. Victor Wong, Roman Herout, Alina Reicherz, Vancouver, Canada, Naeem Bhojani, Montreal, Canada

MP14-04 IN VIVO AND BENCH TESTING OF A CONCEPT SINGLE USE URETEROSCOPE BSC COMPARED TO REFERENCE SINGLE USE AND REUSABLE URETEROSCOPES

Naeem Bhojani*, Montreal, Canada, Nabil Shalabi, K.F. Victor Wong, Roman Herout, Alina Reicherz, Ben H. Chew, Vancouver, Canada


MP14-05 URETEROSCOPY UNDER CONSCIOUS SEDATION FOR UPPER TRACT PATHOLOGY

Kunal Jain*, Winnipeg, Canada, Esha Jain, St. John’s, Antigua and Barbuda, Ruben Blach-man-Braun, Miami, FL, Amanda Eng, Brian Peters, Premal Patel, Winnipeg, Canada

MP14-06 URETERAL STENTS ASSOCIATED WITH LOWER COMPLICATION RATES VERSUS PERCUTANEOUS NEPHROSTOMY TUBES IN THE TREATMENT OF MATERNAL NEPHROLITHIASIS

Matthew Mason*, Sirpi Nackeeran, Marisa Carino Mason, Miami, FL, Taylor Kohn, Baltimore, MD, Ranjith Ramasamy, Miami, FL

MP14-07 COMPARATIVE RADIATION EXPOSURE FOR PREGNANT PATIENTS WHO REQUIRED INTERVENTION FOR SYMPTOMATIC NEPHROLITHIASIS

Madison Lyon*, Alec Sun, Anup Shah, Natalia Lla-rena, Carrie Bennet, Sri Sivalingam, Juan Calle, Anna Zampini, Smita De, Cleveland, OH

MP14-08 NEONATAL OUTCOMES AFTER INTERVENTION FOR RENAL COLIC IN PREGNANCY

Alec Sun*, Carrie Bennett, Anup Shah, Madison Lyon, Sri Sivalingam, Juan Calle, Anna Zampini, Smita De, Cleveland, OH

MP14-09 ′LOW-DOSE′ FLUOROSCOPY TECHNIQUE DRASTICALLY DECREASES PATIENT RADIATION EXPOSURE DURING PERCUTANEOUS NEPHROLITHOTOMY

Galen Cheng*, Timothy Campbell, Changyong Feng, Scott Quarrier, Rajat Jain, Rochester, NY

MP13-17 COGNITIVE BIAS AGAINST AGE IN THE TREATMENT OF PATIENTS WITH INTERMEDIATE-RISK PROSTATE CANCER

Aaron Brant*, Patrick Lewicki, Tenny Zhang, Christina Sze, Jeffrey Johnson, New York, NY, Anise Bowman, Ilon Weinstein, Jonathan Shoag, Cleveland, OH

MP13-18 IMPACT OF COMPREHENSIVE HEALTH INSURANCE COVERAGE ON QUALITY OF LIFE IN LOW-INCOME MEN WITH PROSTATE CANCER

Allen E. D. Siapno*, Thomas W. Gaither, Megha D. Tandel, Lorna Kwan, Ying-Ying Meng, Sally Maliski, Arlene Fink, Mark S. Litwin, Los Angeles, CA

MP13-19 DISPARITIES IN DISTRESS FOR PATIENTS WITH CANCER

Connor Lough, BS*, Geoffrey Rosen, MD, Cath-erine Muzzey, RN BSN, Edward Johnson, Katie Murray, DO, Columbia, MO

MP13-20 PREOPERATIVE URINE TESTING FOR URETEROSCOPY IN THE STATE OF MICHIGAN: AMERICAN UROLOGICAL ASSOCIATION GUIDELINE ADHERENCE AND CLINICAL IMPLICATIONS

Hyung Joon Kim*, Stephanie Daignault-Newton, John M. DiBianco, Ann Arbor, MI, S. Mohammad Jafri, Royal Oak, MI, J. Rene Frontera, Saint Claire Shores, MI, Brian Seifman, Royal Oak, Troy, MI, Khurshid R. Ghani, Casey A. Dauw, for the Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI


70

MP14-10 MECHANISMS OF PULSE MODULATED HOLMIUM:YAG LITHOTRIPSY: PULSE TRANSMISSION AND SHOCK WAVE PRESSURE

Jason King*, Austin, TX, Nitesh Katta, Irvine, CA, Joel Teichman, Vancouver, Canada, James Tunnell, Austin, TX, Thomas Milner, Irvine, CA

MP14-11 PROPENSITY SCORE-MATCHED ANALYSIS COMPARING RETROGRADE INTRARENAL SURGERY WITH PERCUTANEOUS NEPHROLITHOTOMY IN ANOMALOUS KIDNEYS

Ee Jean Lim*, Singapore, Singapore, Jeremy Yuen-Chun Teoh, Hong Kong, China, People’s Republic of, Khi Yung Fong, Singapore, Sin-gapore, Esteban Emiliani, Barcelona, Spain, Nariman Gadzhiev, Dmitry Gorelov, Saint-Pe-tersburg, Russian Federation, Yiloren Tanidir, Istanbul, Turkey, Fabio Sepulveda, San Paulo, Brazil, Abdullah Al-Terki, Kuwait, Kuwait, Sanjay Khadgi, Lalitpur, Nepal, Abhay Mahajan, Aurang-abad, India, Deepak Ragoori, Banjara Hills, India, Govindarajan Ramalingam, Tamil Nadu, India, Vaddi Chandra Mohan, Hyderabad, India, Arvind Prakash Ganpule, Gujarat, India, Santosh Kumar, Vellore, India, Daniele Castellani, Ancona, Italy, Manoj Monga, California, CA, Scoffone Cesare, Turin, Italy, Fabio Vicentini, São Paulo, Brazil, Olivier Traxer, Paris, France, Bhaskar Kumar Somani, Southampton, United Kingdom, Vineet Gauhar, Singapore, Singapore

MP14-12 SPONTANEOUS PASSAGE RATE OF URETERAL STONES AND PREDICTIVE FACTORS AFTER PRE-STENTING

Yasmin Trachsel*, Beat Förster, Hubert John, Christoph Schregel, Winterthur, Switzerland

MP14-13 PREDICTING FACTORS AND STONE FREE RATE OF IMPACTED URETERAL STONES

Tae Hoon Oh, Seung Chul Park, Ill Young Seo*, Iksan, Korea, Republic of

MP14-14 MINI-PCNL OUTCOMES IN THE OBESE POPULATION, A RETROSPECTIVE REVIEW

Austen Slade*, Tim Large, Erica Sahm, Marcelino Rivera, Indianapolis, IN

MP14-15 PREDICTORS OF SUCCESSFUL SECOND LOOK FLEXIBLE NEPHROSCOPY AFTER PERCUTANEOUS NEPHROLITHOTOMY

Jessica Dai*, Hersh Trivedi, Vineeth Kommidi, Brett Johnson, Jodi Antonelli, Margaret Pearle, Dallas, TX

MP14-16 POST-OPERATIVE PAIN AND RECOVERY IN PATIENTS WITH NEPHROLITHIASIS: RESULTS FROM THE ENDOUROLOGIC SOCIETY TOWER RESEARCH COLLABORATIVE

Amanda Jones*, Christian Rodriguez, George Lin, Hanna Stambakio, Philadelphia, PA, Ben Chew, Vancouver, Canada, Joshua Stern, Park City, UT, Justin Ziemba, Philadelphia, PA

MP14-17 MORTALITY ASSOCIATED WITH SEPSIS POST-URETEROSCOPY AMONG A US-BASED COMMERCIAL POPULATION

Naeem Bhojani*, Montreal, Canada, Brian Eisner, Boston, MA, Manoj Monga, San Diego, CA, Rutu-gandha Paranjpe, Benjamin Cutone, Boston, MA, Ben H. Chew, Vancouver, Canada

MP14-18 ROBOTIC-ASSISTED ELECTROMAGNETIC GUIDANCE IMPROVES SUCCESS IN GAINING PERCUTANEOUS ACCESS FOR NEPHROLITHOTOMY BY NOVICES

Mitchell Humphreys*, Kevin Wymer, Phoenix, AZ, Ben Chew, Vancouver, Canada, Janet Zhen, Red-wood City, CA, Fuad Elkhoury, Los Angelas, CA, Sri Sivalingam, Cleveland, OH, Matthew Dunn, Santa Monica, CA, Michael Borofsky, Minneapolis, MN

MP14-19 MAGNETIC CLEARANCE OF KIDNEY STONE FRAGMENTS: INITIAL IN VITRO EXPERIENCE

Tianjia Jessie Ge*, Timothy Chang, Kathy Mach, Shan Wang, Kunj Sheth, Simon Conti, Joseph Liao, Palo Alto, CA

MP14-20 COMPARISON OF THE EFFECT OF ACTIVE SURGICAL TREATMENT OF UROLITHIASIS IN PREGNANT PATIENTS COMPARED WITH SERIAL URETERAL STENTING ON THE PROBABILITY OF NATURAL DELIVERY

Pavel Nizin, Sergey Kotov*, Perov Roman, Moscow, Russian Federation



FR

IDA

Y

Friday, May 13, 2022 2:45 pm – 4:00 pm

Moderated Poster Session 15PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY I

Room 222 @ Ernest N. Morial Convention CenterModerators: Neil Fleshner, Kara Babaian & Jim Hu


MP15-01 LONGITUDINAL PATIENT-REPORTED OUTCOMES MEASURES DEMONSTRATE CONTINUED IMPROVEMENTS IN URINARY AND ERECTILE FUNCTION AFTER RADICAL PROSTATECTOMY THROUGH 30 MONTHS

Daniel Frendl, Wesley Chou*, Matthew Wszolek, Francis McGovern, Adam Feldman, Michael Blute, Jeffrey Twum-Ampofo, Marcela del Carmen, Marilyn Heng, Rachel Sisodia, Douglas Dahl, Boston, MA

MP15-02 DEEP LEARNING USING MRI AND INTRAOPERATIVE VIDEO IMAGES STRONGLY PREDICTS RECOVERY OF URINARY CONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY

Makoto Sumitomo*, Atsushi Teramoto, Wataru Nakamura, Kenji Zennami, Takuhisa Nukaya, Masashi Takenaka, Kosuke Fukaya, Manabu Ichino, Kiyoshi Takahara, Hitomi Sasaki, Ryoichi Shiroki, Toyoake, Japan

MP15-03 PROGNOSTIC VALUE OF LYMPHOVASCULAR INVASION IN PATIENTS TREATED WITH SALVAGE RADICAL PROSTATECTOMY FOR RADIATION-RECURRENT PROSTATE CANCER

Stephan Brönimann*, Fahad Quhal, Ekaterina Laukhtina, Benjamin Pradere, Vienna, Austria, Al-berto Briganti, Milan, Italy, Pawel Rajwa, Vienna, Austria, Axel Heidenreich, Cologne, Germany, Shahrokh F. Shariat, Vienna, Austria

MP15-04 SAFETY AND FEASIBILITY OF SALVAGE RADICAL PROSTATECTOMY FOLLOWING PRIMARY IRE TREATMENT FOR RECURRENT LOCALIZED PROSTATE CANCER: AN INTERNATIONAL AND MULTICENTER ANALYSIS

Luigi A.M.J.G. van Riel*, Amsterdam, Nether-lands, Alexander Blazevski, Darlinghurst, Austral-ia, Ertunc Kabaktepe, Amsterdam, Netherlands, Bart Geboers, Darlinghurst, Australia, Daan Reesink, Pascal Stijns, Nieuwegein, Netherlands, Philip D. Stricker, Darlinghurst, Australia, Juan Casanova, Jose Luis Dominguez-Escrig, Valencia, Spain, Theo M. de Reijke, Matthijs J. Scheltema, Jorg R. Oddens, Amsterdam, Netherlands


MP15-05 TOPOGRAPHIC DESCRIPTION OF THE SITE OF POSITIVE MPMRI AND IMPACT ON THE RISK OF POSITIVE SURGICAL MARGINS AT ROBOT-ASSISTED NERVE SPARING RADICAL PROSTATECTOMY. IMPLICATIONS FOR ACCURATE SURGICAL APPROACHES

Francesco Barletta*, Giorgio Gandaglia, Giuseppe Rosiello, Simone Scuderi, Armando Stabile, Elio Mazzone, Milano, Italy, Nicola Fossati, Andrea Gallina, Lugano, Switzerland, Emanuele Zaffuto, Umberto Capitanio, Alessandro Larcher, Milan, It-aly, Andrea Salonia, Milano, Italy, Federico Dehò, Varese, Italy, Pierre I. Karakiewicz, Montreal, Canada, Shahrokh F. Shariat, Vienna, Austria, Vincenzo Mirone, Napoli, Italy, Francesco Montor-si, Alberto Briganti, Milano, Italy

MP15-06 RISK OF ADVERSE RADICAL PROSTATECTOMY OUTCOMES IN PATIENTS DIAGNOSED WITH IUSP ≤ 2 PROSTATE CANCER ON MRI/TRUS FUSION BIOPSY

Claudia Kesch*, Vlad Pantea, Essen, Germany, Timo Soeterik, Nieuwegein-Utrecht, Nether-lands, Alessandro Marquis, Turin, Italy, Giulia La Bombarda, Allesandro Morlacco, Padova, Italy, Francesco Barletta, Milan, Italy, Felix Preisser, Frankfurt, Germany, Fabio Zattoni, Padova, Italy, Giancarlo Marra, Turin, Italy, Roderik C. N. van den Bergh, Nieuwegein-Utrecht, Netherlands, Jan Philipp Radtke, Boris Hadaschik, Essen, Germa-ny, Giorgio Gandaglia, Milan, Italy

MP15-07 IMIPRAMINE DELAYS CLINICAL PROGRESSION OF PROSTATE CANCER

Seung-hwan Jeong*, Jang Hee Han, Hyeo-ng-Dong Yuk, Chang-Wook Jeong, Hyeon-Hoe Kim, Ja-Hyeon Ku, Cheol Kwak, Seoul, Korea, Republic of

MP15-08 PATHOLOGICAL, FUNCTIONAL AND ONCOLOGICAL BEST-CASE SCENARIOS AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY, CAN WE IMPROVE QUALITY OF LIFE?

Theodoros Karagiotis*, Jorn H. Witt, Mikolaj Men-drek, Christian Wagner, Andreas Schuette, Nikola-os Liakos, Pawel Rachubinski, Katarina Urbano-va, Matthias Oelke, Sami-Ramzi Leyh-Bannurah, Gronau, Germany

MP15-09 SURVIVAL ESTIMATES OF MEN WITH BIOCHEMICALLY RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY IN A NATIONAL COHORT

Kristian Stensland*, Jennifer Burns, Jordan Sparks, Varsha Vedapudi, Christina Chapman, Megan Caram, Chris Shin, Alexander Zaslavsky, Alexander Tsodikov, Ted Skolarus, Ann Arbor, MI

72

MP15-10 IMPACT OF DISEASE STATUS HETEROGENEITY OF THE STAMPEDE TRIAL ARM J POPULATION ON ONCOLOGICAL OUTCOMES IN HIGH-RISK NONMETASTATIC PROSTATE CANCER

Shingo Hatakeyama*, Toshikazu Tanaka, Takuma Narita, Daisuke Noro, Teppei Okamoto, Noritaka Ishi, Ryuma Tanaka, Takuya Oishi, Hikari Miura, Takahiro Yoneyama, Chikara Ohyama, Hirosaki, Japan

MP15-11 OUTCOMES OF SALVAGE ROBOT-ASSISTED RADICAL PROSTATECTOMY ( S-RARP) POST FOCAL ABLATION FOR PROSTATE CANCER IN COMPARISON WITH PRIMARY ROBOT-ASSISTED RADICAL PROSTATECTOMY (RARP); A MATCHED ANALYSIS

Seetharam Bhat, Celebration, FL, Marcio Covas Moschovas*, kissimee, FL, Jonathan Noel, Travis Rogers, Roshane Pereira, Sunil Reddy, Vipul Pa-tel, Celebration, FL, Marco Sandri, Milan, Italy

MP15-12 EFFICACY OF THE OPENED LEGS POSITION FOR PREVENTING POSTOPERATIVE RHABDOMYOLYSIS AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY(RARP)

Hiroshi Matsuzaki*, Kazuna Tsubouchi, Naotaka Gunge, Takeshi Miyazaki, Yu Okabe, Nobuyuki Nakamura, Hirofumi Matsuoka, Nobuhiro Haga, fukuoka-shi, Japan

MP15-13 OUTCOMES COMPARISON BETWEEN THE ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPH NODE DISSECTION AND NEOADJUVANT CHEMOHORMONAL THERAPY WITHOUT EXTENDED PELVIC LYMPH NODE DISSECTION IN PATIENTS WITH ORGAN CONFINED HIGH-RISK PROSTATE CANCER

Shingo Hatakeyama*, Hirosaki, Japan, Ryuji Tabata, Daiji Fujimori, Mamoru Fukuda, Tetsuo Shinozaki, Ageo, Japan, Hiromichi Iwamura, Teppei Okamoto, Takahiro Yoneyama, Hirosa-ki, Japan, Satoshi Sato, Ageo, Japan, Chikara Ohyama, Hirosaki, Japan

MP15-14 PRESERVATION OF ENDOPELVIC FASCIA, PUBOPROSTATIC LIGAMENTS, DORSAL VENOUS COMPLEX AND HYDRODISSECTION OF THE NEUROVASCULAR BUNDLES IMPROVE RATES AND TIME TO CONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY: A PROPENSITY-SCORE MATCHED ANALYSIS

Ahmed S. Elsayed, Yousuf Ramahi*, Ayat A. Shah, Hannah B. Ely, Zhe Jing, Holly Houenstein, Julian Joseph, Sharifeh Almasaid, Gaybrielle James, Buffalo, NY, James O. Peabody, Detroit, MI, Ahmed A. Hussein, Khurshid A. Guru, Buffalo, NY

MP15-15 IS POSTOPERATIVE PELVIC PAIN AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY ASSOCIATED WITH SUTURE MATERIAL USED FOR SEWING THE ANASTOMOSIS? A PROSPECTIVE RANDOMIZED TRIAL

Beatrice Breu*, Beat Förster, Donat Jost, Roman Rechner, Hubert John, Zurich, Switzerland

MP15-16 VALIDATION OF EAU RECOMMENDATION FOR SALVAGE RADICAL PROSTATECTOMY CANDIDATES

Felix Preisser*, Frankfurt, Germany, Christoph Würn-schimmel, Randi Marisa Pose, Alexander Heinze, Thomas Steuber, Michl Uwe, Georg Salomon, Ham-burg, Germany, Felix K H Chun, Frankfurt, Germany, Markus Graefen, Derya Tilki, Hamburg, Germany

MP15-17 RETZIUS-SPARING ROBOT ASSISTED RADICAL PROSTATECTOMY HAS SIMILAR 1-YEAR FUNCTIONAL AND ONCOLOGICAL OUTCOMES AS STANDARD ROBOT-ASSISTED RADICAL PROSTATECTOMY: RESULTS FROM A HIGH VOLUME UK CENTRE

Paolo Umari*, Tushar Aditya Narain, Dominic Eden, Declan Cahill, Christopher Eden, Prasanna Sooriakumaran, London, United Kingdom

MP15-18 RATES OF SOCIAL CONTINENCE AND SEXUAL FUNCTION IN HIGH-RISK PROSTATE CANCER PATIENTS: RESULTS FROM A STATEWIDE COLLABORATIVE

Kyle Johnson*, Ji Qi, Stephanie Ferrante, Ann Ar-bor, MI, Keving Ginsburg, Detroit, MI, Brian Lane, Grand Rapids, MI, Arvin George, Alice Semerjian, for the Michigan Urological Surgery Improvement Collaborative”, Ann Arbor, MI

MP15-19 CAN LOW RISK DISEASE OUTSIDE THE INDEX LESION BE LEFT UNTREATED IN MEN SUITABLE FOR FOCAL THERAPY? DEVELOPMENT OF NOVEL CRITERIA TO IDENTIFY POTENTIAL CANDIDATES FOR FOCAL THERAPY AMONG PATIENTS WITH INTERMEDIATE RISK PROSTATE CANCER AND POSITIVE MULTI-PARAMETRIC MRI

Armando Stabile*, Giorgio Gandaglia, Elio Mazzone, Francesco Barletta, Daniele Robesti, Giuseppe Cirulli, Donato Cannoletta, Francesco Pellegrino, Luigi Nocera, Gabriele Sorce, Milan, Italy, Thomas Seisen, Morgan Roupret, Paris, France - Metropolitan, Jeffrey R. Karnes, Roches-ter, MN, Vito Cucchiara, Giuseppe Rosiello, Milan, Italy, Nicola Fossati, Lugano, Switzerland, Naza-reno Suardi, Genoa, Italy, Francesco De Cobelli, Antonio Esposito, Giorgio Brembilla, Milan, Italy, Shahrokh Shariat, Vienna, Austria, Francesco Montorsi, Alberto Briganti, Milan, Italy

MP15-20 SURVIVAL AFTER RADICAL PROSTATECTOMY VS. RADIATION THERAPY IN DUCTAL CARCINOMA OF THE PROSTATE

Francesco Chierigo*, Genova, Italy, Christoph Würnschimmel, Hamburg, Germany, Rocco Simone Flammia, Rome, Italy, Benedikt Horle-mann, Montreal, Canada, Gabriele Sorce, Milan, Italy, Benedikt Hoeh, Frankfurt, Germany, Zhe Tian, Fred Saad, Montreal, Canada, Markus Graefen, Hamburg, Germany, Michele Gallucci, Rome, Italy, Alberto Briganti, Francesco Montorsi, Milan, Italy, Felix K.H. Chun, Frankfurt, Germany, Shahrokh F. Shariat, Vienna, Austria, Guglielmo Mantica, Maro Borghesi, Nazareno Suardi, Carlo Terrone, Genova, Italy, Pierre I Karakiewicz, Mon-treal, Canada



FR

IDA

Y

Friday, May 13, 2022 3:30 pm – 5:30 pm

Podium Session 13PROSTATE CANCER: EPIDEMIOLOGY & NATURAL HISTORY II

Room 252 @ Ernest N. Morial Convention CenterModerators: James Eastham, Ashley Ross & Steven Joniau

ABSTRACTTIME NUMBER TITLE3:30 PD13-01 THE CONTINUING IMPACT OF THE COVID-19

PANDEMIC ON PROSTATE CANCER MANAGEMENT: A POPULATION BASED ANALYSIS

Marlon Perera*, Nathan Papa, Melbourne, Aus-tralia, Matthew Roberts, Brisbane, Australia

3:40 PD13-02 AGE-INDEPENDENT SECULAR BASELINE PSA POPULATION TRENDS AMONG YOUNG LATIN AMERICAN MALES

Diego M. Capibaribe, Walker W. Laranja, Wilmar Azal Neto, Danilo L. Andrade, Rodrigo G. Bocos, Natássia C. C. Truzzi, Campinas, Brazil, José C.C.I. Truzzi, Sao Paulo;, Brazil, Leonardo Reis*, Campinas, Brazil

3:50 PD13-03 LACK OF AWARENESS AND UNDERUTILIZATION OF GENETIC TESTING IN PROSTATE CANCER

Sameer Thakker*, Stacy Loeb, New York, NY, Veda Giri, Philadelphia, PA, Richard Matulewicz, New York, NY

4:00 PD13-04 TRENDS IN DIAGNOSIS AND TREATMENT OF T1A, T1B PROSTATE CANCER IN THE UNITED STATES, 2010-2017

Eyal Kord*, Hannah Koenig, On Ho, John Paul Flores, Christopher Porter, Seattle, WA

4:10 PD13-05 CHANGES WITH TIME IN PROGNOSTIC FACTORS IN LOCALIZED PROSTATE CANCER SURVIVORS AFTER LOW-DOSE-RATE PERMANENT SEED IMPLANT BRACHYTHERAPY WITH IODINE-125; CONDITIONAL SURVIVAL ANALYSIS

Masanori Hasegawa*, Kanagawa, Japan, Shiro Saito, Atsunori Yorozu, Monma Tetsuo, Toru Nishiyama, Yasuto Yagi, Keisuke Shigeta, Tokyo, Japan, Sunao Shoji, Akira Miyajima, Kanagawa, Japan

4:20 PD13-06 COMPREHENSIVE RETROSPECTIVE ASSESSMENT OF CLINICAL OUTCOMES WITH RADICAL PROSTATECTOMY AND RADIOTHERAPY IN PROSTATE CANCER REVEALS INADEQUACIES IN OBSERVATIONAL DATASETS

Udit Singhal*, Stephanie Daignault-Newton, Allison K.C. Furgal, Ann Arbor, MI, Yilun Sun, Cleveland, OH, Jeffrey J. Tosoian, Nashville, TN, Lauren J. Beesley, Robert T. Dess, William C. Jackson, Brent K. Hollenbeck, Ann Arbor, MI, Daniel A. Hamstra, Houston, TX, Ganesh S. Palapattu, Ann Arbor, MI, Felix Y. Feng, San Fran-cisco, CA, Jeremy M.G. Taylor, Ann Arbor, MI, Daniel E. Spratt, Cleveland, OH, Todd M. Morgan, Ann Arbor, MI

ABSTRACTTIME NUMBER TITLE4:30 PD13-07 COST-EFFECTIVENESS ANALYSIS OF

ARTERIAL CATHETER INSERTION ON ROBOTIC-ASSISTED LAPAROSCOPIC PROSTATECTOMY

Rogelio Valdez*, Cleveland, OH, Johnathan Drevik, Philadelphia, PA, Ilaha Isali, Cleveland, OH, Alexander Kutikov, Philadelphia, PA, Mohit Sindhani, Delhi, India, Megan Prunty, Adam Cala-way, Lee Ponsky, Cleveland, OH, Alberto Castro Bigalli, Laura Bukavina, Philadelphia, PA

4:40 PD13-08 A PROSPECTIVE AND LONGITUDINAL COHORT STUDY ASSESSING MENTAL WELLBEING IN PROSTATE CANCER: PRELIMINARY ANALYSIS OF THE MIND-P STUDY

Oliver Brunckhorst*, Callum James, Jack Fan-shawe, Mohamed Hammadeh, London, United Kingdom, Madeleine Williams, Robert Thomas, Bedford, United Kingdom, Shahid Khan, Redhill, United Kingdom, Matin Sheriff, Gillingham, United Kingdom, Hashim Ahmed, Mieke Van Hemelri-jck, Robert Stewart, Prokar Dasgupta, Kamran Ahmed, London, United Kingdom

4:50 PD13-09 TRENDS IN SURVIVAL FOR MEN WITH DE NOVO METASTATIC PROSTATE CANCER

Nina Wyatt*, Christopher Filson, Atlanta, GA

5:00 PD13-10 DIABETES AND PROSTATE CANCER OUTCOMES IN MEN WITH NONMETASTATIC CASTRATE-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH COHORT

Andrei Sergeyev*, Lin Gu, Amanda De Hoedt, Dur-ham, NC, Christopher Amling, Portland, OR, William Aronson, Los Angeles, CA, Matthew Cooperberg, San Francisco, CA, Christopher Kane, San Diego, CA, Zachary Klaassen, Martha Terris, Augusta, GA, Lourdes Rivera, San Juan, Puerto Rico, Stephen Freedland, Ilona Csizmadi, Los Angeles, CA

5:10 PD13-11 DISEASE TRAJECTORIES AND OUTCOMES FOR MEN WITH CASTRATION RESISTANT PROSTATE CANCER BY USE OF NATION-WIDE POPULATION-BASED OBSERVATIONAL DATA

Eugenio Ventimiglia*, Milan, Italy, Anna Bill-Axel-son, Uppsala, Sweden, Markus Aly, Gothenburg, Sweden, Martin Eklund, Stokholm, Sweden, Par Stattin, Hans Garmo, Uppsala, Sweden

5:20 PD13-12 DUCTAL AND INTRADUCTAL CARCINOMA OF THE PROSTATE AT RADICAL PROSTATECTOMY: DIAGNOSTIC ACCURACY OF BIOPSY, MRI-VISIBILITY, AND OUTCOMES

Gaurav Pahouja*, Shalin Desai, Hiten D. Patel, Goran Rac, Teresa Cheng, Yudai Okabe, Alexander Gorbonos, Marcus L. Quek, Robert C. Flanigan, Maria M. Picken, Gopal N. Gupta, Maywood, IL


74

Friday, May 13, 2022 3:30 pm – 5:30 pm

Podium Session 14BLADDER CANCER: EPIDEMIOLOGY & EVALUATION I

Room 255 @ Ernest N. Morial Convention CenterModerators: Hung-Jui (Ray) Tan, Edward Messing & Marco Moschini

ABSTRACTTIME NUMBER TITLE3:30 PD14-01 RETROSPECTIVE REVIEW OF PATIENTS

PRESENTING TO THE EMERGENCY DEPARTMENT WITH GROSS HEMATURIA AND NEWLY DIAGNOSED GENITOURINARY MALIGNANCY: NOT AS COMMON AS WE THOUGHT?

Deepansh Dalela*, Stephen Wertheimer, Jackson Darling, Callie Bartkowiak, Humphrey Atiemo, Detroit, MI

3:40 PD14-02 CRITICAL EVALUATION OF THE 2020 MICROHEMATURIA GUIDELINES: ARE WE STILL WORKING UP TOO MANY PATIENTS?

Eric Macdonald*, Jacob Gaines, Max Kuster, Michelle Ou, Ella Taubenfeld, Adam Diamond, Tavya Benjamin, Michael Diefenbach, Manish Vira, Simon Hall, Lake Success, NY

3:50 PD14-03 ANALYSIS OF TWO INDEPENDENT RISK STRATIFICATION EVALUATION TOOLS IN A COHORT OF PATIENTS WITH MICROSCOPIC HEMATURIA

Thomas Williams*, Lake Success, NY, Eric Mac-donald, Max Kuster, Michelle Ou, Tavya Benjamin, Manish Vira, Simon Hall, New Hyde Park, NY

4:00 PD14-04 INTERRUPTIONS IN BLADDER CANCER CARE DURING THE COVID-19 PUBLIC HEALTH EMERGENCY

Jason Reynolds*, Kristin Follmer, Michael Nash, On Ho, Bryan Comstock, Larry Kessler, Erika Wolff, Seattle, WA, Angela Smith, Chapel Hill, NC, John Gore, CISTO Collaborative, Seattle, WA

4:10 PD14-05 LONG-TERM FOLLOW-UP OF INTRAVESICAL GEMCITABINE AND DOCETAXEL AS RESCUE THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER

Phani T. Chevuru*, Ian M. McElree, Alexander C. Martin, Jordan R. Richards, Sarah L. Mott, Paul T. Gellhaus, Kenneth G. Nepple, Ryan L. Steinberg, Michael A. O’Donnell, Vignesh T. Packiam, Iowa City, IA

4:20 PD14-06 IS A RESTAGING TURBT NECESSARY IN HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER IF THE INITIAL TURBT WAS PERFORMED USING BLUE LIGHT?

Muhannad Alsyouf*, Sanam Ladi Seyedian, Los Angeles, CA, Badrinath Konety, Minneapolis, MN, Kamal Pohar, Columbus, OH, Jeffrey M. Holzbeier-lein, Kansas City, KS, Max Kates, Baltimore, MD, Brian Willard, West Columbia, SC, Jennifer M. Taylor, Houston, TX, Joseph C Liao, Palo Alto, CA, Hristos Z. Kaimakliotis, Indianapolis, CA, Sima P. Porten, San Francisco, CA, Gary D. Steinberg, New York, NY, Mark D. Tyson, Phoenix, AZ, Yair Lotan, Dallas, TX, Siamak Daneshmand, Los Angeles, CA

ABSTRACTTIME NUMBER TITLE4:30 PD14-07 LONG-TERM CYSTOSCOPY SURVEILLANCE

OF PATIENTS WITH NON-RECURRING NMIBC: IDENTIFYING THE POINT OF DIMINISHING RETURNS

Daniel Ranti*, Ralph Grauer, Yuanshuo Wang, New York, NY, Linda Dey, Lotta Renström, Gunnar Steinbeck, Abolfazl Hosseini, Stockholm, Sweden, Peter Wiklund, Reza Mehrazin, John Sfakianos, Nikhil Waingankar, New York, NY

4:40 PD14-08 COMPARATIVE OUTCOMES OF PRIMARY AND RECURRENT HIGH GRADE NON-MUSCLE INVASIVE AND PRIMARY AND PROGRESSIVE MUSCLE-INVASIVE BLADDER CANCER AFTER RADICAL CYSTECTOMY: RESULTS FROM A RETROSPECTIVE MULTICENTER STUDY

Nico Grossmann*, Lucerne, Switzerland, Benjamin Pradere, Frederik König, Pawel Rajwa, Fahad Quhal, Hadi Mostafaei, Ekaterina Laukhtina, Keiichi-ro Mori, Reza Motlagh, Satoshi Katayama, Vienna, Austria, Christian Fankhauser, Zurich, Switzerland, Agostino Mattei, Lucerne, Switzerland, Marco Moschini, Milan, Italy, Piotr Chlosta, Krakow, Poland, Bas van Rhijn, Amsterdam, Netherlands, Jeremy Teoh, Hong Kong, China, People’s Republic of, Eva Compérat, Vienna, Austria, Marek Babjuk, Prague, Czech Republic, Mohammad Abufaraj, Amman, Jordan, Pierre Karakiewicz, Montreal, Canada, Shahrokh Shariat, Vienna, Austria

4:50 PD14-09 ANALYZING DIFFERENCES IN SOMATIC MUTATIONS IN LOCALIZED BLADDER CANCER PATIENTS BY RACE AND SEX: AN ANALYSIS OF DATA FROM THE CBIOPORTAL FOR CANCER GENOMICS

Kelsey Baker*, Yaw Nyame, Mary Redman, Robert Montgomery, Petros Grivas, Jonathan Wright, Seattle, WA

5:00 PD14-10 PROSPECTIVE EVALUATION OF A COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) IN MULTIDISCIPLINARY BLADDER CANCER CARE: FEASIBILITY AND IMPACT ON DECISIONAL CONFLICT

Sarah Psutka*, John Gore, Sarah Holt, Erin Dwyer, George Schade, Petros Grivas, Andrew Hsieh, John Lee, R. Bruce Montgomery, Michael Schweiz-er, Todd Yezefski, Evan Yu, Jonathan Chen, Jay Liao, Emily Weg, Jing Zeng, Tristan Alving, Samia Jannat, Jonathan Wright, Seattle, WA


FR

IDA

Y

Friday, May 13, 2022 3:30 pm – 5:30 pm

Podium Session 15KIDNEY CANCER: EPIDEMIOLOGY & EVALUATION/STAGING/SURVEILLANCE I

Room 245 @ Ernest N. Morial Convention CenterModerators: Gopal Gupta, Ithaar Derweesh & Masatoshi Eto

ABSTRACTTIME NUMBER TITLE3:30 PD15-01 EVALUATING 99M TC-SESTAMIBI

SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY/COMPUTED TOMOGRAPHY CONCORDANCE WITH SURGICAL PATHOLOGY FOR RENAL MASSES

Shilpa Argade*, Carrie Ronstrom, Joel Vetter, Brijesh Patel, Mark Biebel, Joyce Mhlanga, Robert Figenshau, St. Louis, MO

3:40 PD15-02 PEAK EARLY ENHANCEMENT RATIO RELIABLY DIFFERENTIATES BENIGN ONCOCYTIC RENAL TUMORS FROM CHROMOPHOBE RENAL CELL CARCINOMA

Hiten D. Patel, Kevin Huai, Deanna L. Thorson, Nicholas Elliott*, Goran Rac, Maria M. Picken, Marcus L. Quek, Davide Bova, Gopal N. Gupta, Maywood, IL

3:50 PD15-03 AVOIDANCE OF BENIGN RENAL ONCOCYTOMA RESECTION USING BIOPSY CD117 IMMUNOSTAIN WITH RADIOGRAPHIC TUMOR:CORTEX PEER SCORE: 8-YEAR EXPERIENCE

Jorge Daza*, Arun Menon, Ahmed A. Hussein, Tash-ionna White, Gaybrielle James, Michael Petroziello, Bo Xu, Charles Roche, Eric C Kauffman, Buffalo, NY

4:00 PD15-04 GENOTYPE-PHENOTYPE CHARACTERIZATION OF LYNCH SYNDROME ASSOCIATED UPPER TRACT UROTHELIAL CARCINOMA (UTUC)

Craig Labbate*, Donika Saporito, Mehrad Adibi, Maureen Mork, Eduardo Vilar Sanchez, Bogdan Czerniak, Charles Guo, Eric Jonasch, Surena Matin, Houston, TX

ABSTRACTTIME NUMBER TITLE4:10 PD15-05 PROGNOSTIC VALUE OF EARLY DYNAMIC

CHANGE OF NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN PATIENTS WITH UPPER-TRACT UROTHELIAL CARCINOMA (UTUC) TREATED WITH NEPHROURETERECTOMY

Natalie Kowshiga George*, Yasmin Abu-Ghanem, Ko Ko Zayar Toe, Akinlolu Oluwole-Ojo, Elsie Men-sah, Ramesh Thurairaja, Shamim Khan, Sachin Malde, Rajesh Nair, London, United Kingdom

4:20 PD15-06 ELEVATED HEMOGLOBIN:CREATININE RATIO IS A NOVEL PREOPERATIVE MARKER FOR WORSENED SURVIVAL OUTCOMES IN UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS FROM THE ROBUUST REGISTRY

Margaret Meagher*, San Diego, CA, Riccardo Autorino, Richmond, VA, Reza Mehrazin, New York, NY, Daniel Eun, Philadelphia, PA, Vitaly Margulis, Dallas, TX, Robert Uzzo, Philadelphia, PA, James Porter, Seattle, WA, Chandru Sundaram, Indianapo-lis, IN, Firas Abdollah, Detroit, MI, Alexandre Mottrie, Aalst, Belgium, Andrea Minervini, Florence, Italy, Matteo Ferro, Milan, Italy, Hooman Dialadat, Los Angeles, CA, Zhenjie Wu, Shanghai, China, Peo-ple’s Republic of, Kevin Hakimi, Ava Saidian, Arman Walia, San Diego, CA, Riccardo Tellini, Philadelphia, PA, Alessandro Veccia, Richmond, VA, Koon Rha, Seoul, Korea, Republic of, Mark Gonzalgo, Miami, FL, Ithaar Derweesh, San Diego, CA

5:10 PD14-11 USE OF A PHYSICAL ACTIVITY MONITOR TO TRACK PERIOPERATIVE ACTIVITY OF RADICAL CYSTECTOMY PATIENTS: OUR FIRST GLIMPSE AT WHAT OUR PATIENTS ARE REALLY DOING BEFORE AND AFTER SURGERY

Alex Zhu, DO*, Joel Berends, MD, Stephanie Daignault-Newton, MS, Ann Arbor, MI, Deborah Kaye, MD, Durham, NC, Christine Schafer, BS, Steven Thelen-Perry, BS, Chrissy Parker, MS, Heidi Iglay-Reger, PhD, Yongmei Qin, MD, Todd M. Morgan, MD, Alon Z. Weizer, MD, Samuel D. Kaffenberger, MD, Lindsey A. Herrel, MD, Khaled Hafez, MD, Ann Arbor, MI, Cheryl T. Lee, MD, Columbus, OH, Ted A. Skolarus, MD, Michael Englesbe, MD, Jeffrey S. Montgomery, MD, Ann Arbor, MI

5:20 PD14-12 ARE UROLOGIC MALIGNANCIES IN PATIENTS WITH LYNCH SYNDROME ASSOCIATED WITH AN INCREASED RISK OF DEATH AND SHOULD MORE PATIENTS UNDERGO RIGOROUS UROLOGIC SCREENING?

Christian Ericson*, Anthony Compton, Bryce Baird, Raymond Pak, Jacksonville, FL


76

4:30 PD15-07 RENAL CELL CARCINOMA PARANEOPLASTIC SYNDROME SCORE: CONSTRUCTION AND VALIDATION

Shady Soliman*, La Jolla, CA, Sabrina Noyes, Grand Rapids, MI, Margaret Meagher, Joel Rosenberg, Aus-tin Leonard, Kevin Hakimi, Julia Yuan, Arman Walia, Ava Saidian, Fady Ghali, Juan Javier-Desloges, Devin Patel, Rana McKay, Ithaar Derweesh, La Jolla, CA, Brian Lane, Grand Rapids, MI

4:40 PD15-08 WHEN TO DE-INTENSIFY ONCOLOGIC SURVEILLANCE SCHEME FOR NON-CLEAR CELL RENAL CELL CARCINOMA

Alberto Martini, Daniele Cignoli, Giuseppe Ros-iello, Giuseppe Fallara, Giuseppe Basile, Luigi Nocera, Federico Belladelli, Gianmarco Colan-drea*, Daniela Canibus, Chiara Re, Giacomo Musso, Francesco Cei, Francesco De Cobelli, Giorgio Brembilla, Alberto Briganti, Andrea Nec-chi, Daniele Raggi, Roberto Bertini, Francesco Montorsi, Andrea Salonia, Alessandro Larcher, Umberto Capitanio, Milan, Italy

4:50 PD15-09 UPDATED OUTCOMES FOR ACTIVE SURVEILLANCE RECOMMENDED TO ALL SMALL RENAL MASS PATIENTS LACKING PROGRESSION CRITERIA FOR INTERVENTION

Muammer Altok, Arun Menon, Ahmed Aly, Tash-ionna White, James Gaybriella, Bo Xu, Michael Petroziello, Charles Roche, Eric Kauffman*, Buffalo, NY

5:00 PD15-10 LONG TERM FOLLOW UP IN PATIENTS UNDERGOING RENAL BIOPSY - SEEDING IS NOT ANECDOTAL

Michael Staehler*, Melaine Schott, Alexander Tamalunas, Chistian Stief, Annabel Graser, Sever-in Rodler, Munich, Germany

5:10 PD15-11 TRANSLOCATION RCC: PROGRESSION-FREE AND OVERALL SURVIVAL BY TUMOR STAGE AND SURGICAL PROCEDURE AT A HIGH-VOLUME ACADEMIC CENTER

Jason Farrow*, Nate Hollowell, Connor Drake, Leo Song, Clint Cary, Clinton Bahler, Ronald Boris, Chandru sundaram, Indianapolis, IN

5:20 PD15-12 IMPACT OF THE AFFORDABLE CARE ACT ON SOCIOECONOMIC DISPARITIES IN DIAGNOSIS AND SURVIVAL OF RENAL CELL CARCINOMA

Chih Peng Chin*, Micah Levy, Evan Garden, Krishna Ravivarapu, Joseph Sewell Araya, New York, NY, Alexander Small, Bronx, NY, Michael Palese, New York, NY


Friday, May 13, 2022 3:30 pm – 5:30 pm

Podium Session 16BENIGN PROSTATIC HYPERPLASIA: BASIC RESEARCH & PATHOPHYSIOLOGY

Room 244 @ Ernest N. Morial Convention CenterModerators: Gail Prins & Brian Helfand

ABSTRACTTIME NUMBER TITLE3:30 PD16-01 THE DIVERSITY OF PROSTATIC MICROBIOTA IS

ASSOCIATED WITH PROSTATE ENLARGEMENTKoihic Okada*, Takahiro Imanaka, Sohei Kuribayashi, Yosuke Sekii, Kentaro Takezawa, Shinichiro Fukuhara, Hiroshi Kiuchi, Norio Nono-mura, Suita, Japan

3:40 PD16-02 ULTRASTRUCTURAL FINDINGS OF COVID-19 INFECTION IN THE PROSTATE

Rohit Reddy*, Eliyahu Kresch, Natoli Farber, Parris Diaz, Ranjith Ramasamy, Miami, FL

3:50 PD16-03 INVOLVEMENT OF YES-ASSOCIATED PROTEIN 1 IN INFLAMMATION-INDUCED BENIGN PROSTATIC HYPERPLASIA

Dongxu Lin*, Zhong Chen, Wuhan, China, Peo-ple’s Republic of

4:00 PD16-04 THE PROTECTIVE EFFECTS OF CSF-1R INHIBITION ON BLADDER OUTLET OBSTRUCTION (BOO) INDUCED REMODELING

Wei Wang*, Xiaoshuai Gao, Liao Peng, Lede Lin, Kaiwen Xiao, Liang Zhou, Chengdu, China, People’s Republic of

ABSTRACTTIME NUMBER TITLE4:10 PD16-05 LOSS OF OSTEOPONTIN IMPROVES

URINARY FUNCTION AND ALTERS THE PROSTATIC IMMUNE ENVIRONMENT

Petra Popovics*, Kegan O. Skalitzky, Elise Schroeder, Asha Jain, Chad M. Vezina, William A. Ricke, Madison, WI

4:20 PD16-06 SHIFT CHANGE OF THE ACTIVATED COMPLEMENT PATHWAY IN THE FIBROTIC PROCESS ASSOCIATED WITH PROGRESSION OF BENIGN PROSTATIC HYPERPLASIA

Junya Hata*, Yusuke Kirihana, Tomoyuki Kumeka-wa, Hiroki Natsuya, Yusuke Hakozaki, Syunsuke Yoshioka, Hitomi Imai, Kanako Matsuoka, Tomoyuki Koguchi, Yuichi Sato, Hidenori Akaihata, Masao Kataoka, Yoshiyuki Kojima, Fukushima, Japan

4:30 PD16-07 REASSESSMENT OF THE EFFECT OF LOWER URINARY TRACT OBSTRUCTION ON UROTHELIAL TISSUE: EVALUATION VIA HOLEP AND ANIMAL STUDY

Young-min Yang*, Katsumi Shigemura, Koki Maeda, Yuzo Nakano, Masato Fujisawa, Kobe, Japan


FR

IDA

Y

4:40 PD16-08 ALTERNATE ANDROGEN-INDEPENDENT ESTROGEN SIGNALING FOR PROSTATIC GROWTH

Christina Sharkey*, Boston, MA, Xingbo Long, Guangzhou, China, People’s Republic of, Ra’ad Al-Faouri, Zongwei Wang, Aria F. Olumi, Boston, MA

4:50 PD16-09 THE ROLE OF GPER SIGNALING IN DEVELOPMENT OF PROSTATIC ENLARGEMENT IN HIGH FAT DIET INDUCED OBESITY RAT MODEL

Shinsuke Mizoguchi*, Kenichi Mori, Toshitaka Shin, Hiromitsu Mimata, Yufu, Japan

5:00 PD16-10 5-ALPHA REDUCTASE INHIBITORS SUPPRESS DIHYDROTESTOSTERONE IN BENIGN PROSTATE HYPERPLASIA REQUIRING SURGERY, AND CAUSE STEROIDOGENESIS VIA 5ARI INDUCED PATHWAY

Connor Forbes*, Nicole L Miller, Thomas Case, Nashville, TN, Douglas Strand, Dallas, TX, Qi Liu, Marisol Ramirez-Solano, Justin M Cates, Ned A Porter, Hye-Young H Kim, Phillip Wages, Nash-ville, TN, James L Mohler, Buffalo, NY, Robert J Matusik, Ren Jie Jin, Nashville, TN

5:10 PD16-11 TRANS-ETHNIC GENOME-WIDE ASSOCIATION STUDY REVEALS NEW THERAPEUTIC TARGETS FOR BENIGN PROSTATIC HYPERPLASIA

Michael Ng, Oxford, United Kingdom, Koichi Matsuda, Chizu Tanikawa, Tokyo, Japan, Chikashi Terao, Yokohama, Japan, Yoichiro Kamatani, Tokyo, Japan, Wei Wang, Adam Auton,* 23and-me Research Team, Sunnyvale, CA, Benjamin Turney, Richard Bryant*, Dominic Furniss, Oxford, United Kingdom

5:20 PD16-12 AGE AND RACE SPECIFIC GENE SIGNATURE: AN INDEPENDENT PREDICTOR OF PROSTATE CANCER IN RACIALLY DIVERSE MILITARY COHORT OF AFRICAN AND CAUCASIAN AMERICAN PATIENTS

Shashwat Sharad*, Bethesda, MD, Darryl Nou-some, Frederick, MD, Gregory Chesnut, Hua Li, Bethesda, MD


Friday, May 13, 2022 4:30 pm – 5:45 pm

Moderated Poster Session 16HEALTH SERVICES RESEARCH: QUALITY IMPROVEMENT & PATIENT SAFETY I

Room 228 @ Ernest N. Morial Convention CenterModerators: Timothy Averch, Roger Dmochowski & Christopher Filson


MP16-01 EFFECT OF SURGERY-SPECIFIC FINANCIAL INCENTIVE ON OPIOID PRESCRIBING PRACTICES: OUTCOMES OF A STATEWIDE SURGICAL COLLABORATIVE

John Michael DiBianco*, Stephanie Daignault-New-ton, Bronson Conrado, Ann Arbor, MI, David Wenzler, Royal Oak, MI, Hector Pimentel, Grand Rapids, MI, S. Mohammad Jafri, Royal Oak, MI, Rebn Frontera, Rochester Hills, MI, Jessica Phelps, John Hollingsworth, Khurshid R. Ghani, Casey A. Dauw, for the Michigan Urological Surgery Improve-ment Collaborative, Ann Arbor, MI

MP16-02 IMPLEMENTATION AND USABILITY OF AN ELECTRONIC MEDICAL RECORD BASED STENT TRACKER TO DECREASE COMPLICATIONS AFTER URETERAL STENT PLACEMENT AT A DIVERSE URBAN ACADEMIC CENTER

Kavita Gupta*, Daniel Jacobs, Angela Alaimo, Kara Watts, Alexander Small, Bronx, NY

MP16-03 STONE MANAGEMENT IN THE SOLITARY KIDNEY, ARE WE DOING THINGS DIFFERENTLY? RESULTS FROM A STATEWIDE CLINICAL REGISTRY

Mohit Butaney*, Detroit, MI, Stephanie Daig-nault-Newton, Ann Arbor, MI, Isaac Palma-Zamora, Grace Yaguchi, David Leavitt, Detroit, MI, Casey Dauw, Khurshid Ghani, Ann Arbor, MI, Naveen Kachroo, Detroit, MI, for the Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI

ABSTRACTTIME NUMBER TITLE MP16-04 PRACTICE-LEVEL VARIATION IN RATES

POSITIVE SURGICAL MARGINS AT PARTIAL NEPHRECTOMY: A MUSIC-KIDNEY ANALYSIS

Mohit Butaney*, Detroit, MI, Sonia Bhayani, St. Lou-is, MO, Ji Qi, Anna Johnson, Ann Arbor, MI, Sara Perkins, Detroit, MI, Sabrina Noyes, Grand Rapids, MI, Alon Weizer, Ann Arbor, MI, Lewis Johnson, Kal-amazoo, MI, Amit Patel, Detroit, MI, Alice Semerjian, Ypsilanti, MI, Brian Lane, Grand Rapids, MI, Craig Rogers, Detroit, MI, for the Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI

MP16-05 QUALITY IMPROVEMENT OF SURGICAL TEAM COMMUNICATION OF REQUIRED PERCUTANEOUS NEPHROLITHOTOMY EQUIPMENT

Mark Assmus*, Matt Lee, Jessica Helon, Amy Krambeck, Chicago, IL

MP16-06 FOLEY CATHETER BALLOON RUPTURE AND RISK OF FREE FRAGMENT FORMATION

Jason L. Lui*, Nathan M. Shaw, Nizar Hakam, Behnam Nabavizadeh, Behzad Abassi, Patrick Low, Kevin D. Li, Benjamin N. Breyer, San Francisco, CA

MP16-07 FRAILTY AS A PREDICTOR OF SACRAL NEUROMODULATION OUTCOMES

Colby Souders*, Dallas, TX, Mary Enoh Adakama, Riverside, CA, Allison Sih, Seth Cohen, San Fran-cisco, CA, Maude Carmel, Dallas, TX, Jennifer Anger, La Jolla, CA, Karyn Eilber, Los Angeles, CA, Kai Dallas, San Francisco, CA

78

MP16-08 MAJOR SHIFT IN ANTIBIOTIC PROPHYLAXIS PATTERNS FOLLOWING IMPLEMENTATION OF GUIDELINES BASED CYSTOSCOPY SURVEY

Kelly R. Pekala*, Danielle Sharbaugh, Jonathan G. Yabes, Adam J. Sharbaugh, Michelle Yu, Valentina Grajales, Oluwaseun Orikogbo, Her-moon Worku, Jordan M. Hay, Toby S. Zhu, Kody M. Armann, Chandler N. Hudson, Benjamin J. Davies, Bruce L. Jacobs, Pittsburgh, PA

MP16-09 DETERMINING THE PREVALENCE OF INAPPROPRIATE PATIENT BEHAVIOR IN THE OUTPATIENT UROLOGY CLINIC

Caroline Lu*, James Kearns, Myra Robinson, Sarah Matthews, Elizabeth Korede, Maxim McKibben, Charlotte, NC

MP16-10 EXPLORING THE VALUE OF USING PATIENT-ORIENTED MRI REPORTS IN CLINICAL PRACTICE

Nathan Perlis, Antonio Finelli, Mike Lovas, Alexis Lund*, Amelia DiMeo, Katherine Lajkosz, Alejandro Berlin, Janet Papadakos, Sangeet Ghai, Dominik Deniffel, Eric Meng, David Wiljer, Shabbir Alibhai, Vasiliki Bakas, Adam Badzynski, Odelia Lee, Jo-seph Cafazzo, Masoom Haider, Toronto, Canada

MP16-11 VALIDATION OF A SINGLE ITEM SCREENING MEASURE OF UROLOGIC PATIENT FINANCIAL DISTRESS

Daniel Au*, Jared Starkey, Jessica Hamilton, Jeff-ery Thompson, William Parker, Kansas City, KS

MP16-12 PREDICTORS OF PATIENT-REPORTED OUTCOMES COMPLETION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND ASSOCIATIONS BETWEEN RESPONSE FREQUENCY AND FUNCTIONAL OUTCOMES

Daniel Frendl, Wesley Chou*, Douglas Dahl, Jeffrey Twum-Ampofo, Adam Feldman, Francis McGovern, Michael Blute, Marcela del Carmen, Marilyn Heng, Rachel Sisodia, Matthew Wszolek, Boston, MA

MP16-13 CAN WE USE THE PROSTATE HEALTH INDEX TO AVOID A PROSTATE BIOPSY IN AFRICAN AMERICAN MEN?

Kostantinos Morris*, Srinath Kotamarti, Judd Moul, Durham, NC

MP16-14 APIXABAN VERSUS ENOXAPARIN FOR POST-SURGICAL EXTENDED DURATION VTE PROPHYLAXIS: A PROSPECTIVE QUALITY IMPROVEMENT STUDY

Mary Westerman*, New Orleans, LA, Kelly Bree, Cheryl Mantaring, Innocent Rukundo, Martha Garcia-Gonzalez, Ashlee Lafleur, Robbie Best, Colin Dinney, Ashish Kamat, Neema Navai, Louis Pisters, Christopher Wood, Jose Karam, John Papadopoulos, Lisly Chery, Mehrad Adibi, Brian Chapin, John Ward, Curtis Pettaway, John Davis, Justin Gregg, William Graber, Thomas Smith, O. Lenaine Westney, Desiree Valle, LaShena Crump, Raji Varghese, Miguel Saucedo, Jeff Cunning-ham, Kelly Casteel, Surena Matin, Houston, TX

MP16-15 LOW MEDICATION COMPLIANCE IN NEW FEMALE UROGYNECOLOGY PATIENTS

Crystal Cisneros*, Tamara Grisales, Ja-Hong Kim, Victor W. Nitti, Amy E. Rosenman, Christopher M. Tarnay, A. Lenore Ackerman, Los Angeles, CA

MP16-16 WORK-RELATED PAIN AND ERGONOMICS EDUCATION AMONG UROLOGISTS: A SURVEY STUDY

Jennifer Chyu*, Edward Chang, Erin Dwyer, Sarah Holt, Atreya Dash, Mathew Sorensen, Seattle, WA

MP16-17 MULTIMODAL PAIN CONTROL UTILIZING BUPRENORPHINE FOR ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY: A QUALITY IMPROVEMENT COMPARISON TO CONVENTIONAL OPIOID MANAGEMENT

Jo Ann Johnson, Ivan Muchiutti, Sonia Wraich, Aviram Assidon, Akin S. Amasyali, Mohammad Hajiha*, Donna Lien, Ruth Belay, Jonathan Maldonado, Ashley Li, Mohamed Keheila, Kanha Shete, Gary Stier, Leonard Soloniuk, Patrick Hogue, Brian Hu, D. Duane Baldwin, Herbert Ruckle, Loma Linda, CA

MP16-18 SURVIVORSHIP DISPARITIES AMONG PATIENTS <65 YEARS UNDERGOING A RADICAL CYSTECTOMY BASED ON INSURANCE STAUTS

Yousef Rafati*, Aditya Srinivasan, Jacques Baillargeon, Stephen Williams, Laith Alzweri, Galveston, TX

MP16-19 CAN ARTIFICIAL INTELLIGENCE ENHANCE CLINICAL OUTCOMES AND PATIENT FLOW IN A UROLOGY WALK-IN CLINIC?

Jonathan Miles Charnock*, Olesya Kovyzhenko, Tet Yap, Raveen Sandher, London, United Kingdom

MP16-20 PREDICTORS OF DISCHARGE TO HOME FOLLOWING MAJOR SURGERY FOR UROLOGIC MALIGNANCIES

Nehizena Aihie*, Deukwoo Kwon, Matthew Ma-son, Helen Yang Hougen, Dimple Chananmolu, Sanoj Punnen, Bruno Nahar, Dipen Parekh, Mark Gonzalgo, Chad Ritch, MIAMI, FL



FR

IDA

Y

Friday, May 13, 2022 4:30 pm – 5:45 pm

Moderated Poster Session 17PEDIATRIC UROLOGY: UPPER & LOWER URINARY TRACT

Room 225 @ Ernest N. Morial Convention CenterModerators: Nicolette Janzen & Berk Burgu


MP17-01 ARE PRE-OPERATIVE URINE CULTURES AND CYSTOSCOPIES BEFORE URETERAL REIMPLANTATION CLINICALLY USEFUL OR COST EFFECTIVE?

Mark Quiring*, Erin Davis, Dawson Hinkley, Tyler Hamby, Kristy Reyes, Kirk Pinto, Fort Worth, TX

MP17-02 PREDICTIVE FACTORS FOR IMPROVEMENT/RESOLUTION OF VESICOURETERAL REFLUX IN DUPLEX KIDNEYS

Clinton Yeaman*, Kathryn Morgan, Fionna Sun, Charlottesville, VA, Sherry Ross, Jamie Michael, Chapel Hill, NC, Rebecca Zee, Richmond, VA, Hans Pohl, Daniel Casella, Bruce Sprague, Wash-ington, DC, C.D. Anthony Herndon, Richmond, VA, Nora Kern, Charlottesville, VA

MP17-03 COMPLICATION RATES AMONG DIFFERENT TREATMENT MODALITIES FOR THE SURGICAL MANAGEMENT OF VESICOURETERAL REFLUX IN CHILDREN

Andres Guillen Lozoya*, Candace Granberg, Patricio Gargollo, Rochester, MN

MP17-04 PILOT STUDY OF MACHINE LEARNING IN THE TASK OF DISTINGUISHING HIGH AND LOW GRADE HYDRONEPHROSIS IN CHILDREN ON ULTRASOUND

Matthew Sloan*, Clark Judge, Hui Li, Li Lan, Ma-son Vierra, Gabriel Kaufmann, Maryellen Giger, Mohan Gundeti, Chicago, IL

MP17-05 CONFIGURATION AND VALIDATION OF THE TORONTO NOMOGRAM OF ANTENATAL ULTRASOUND INDEX GENERATED FROM BAYESIAN META-REGRESSION ANALYSIS IN PREDICTING POSTERIOR URETHRAL VALVES (PUV)

Michael Chua, Jin Kyu (Justin) Kim*, Tim Van Miegham, Joana Dos Santos, Eric Mackay, Lau-ren Erdman, Marta Skreta, Daniel Keefe, Marisol Lolas, Priyank Yadav, Armando Lorenzo, Mandy Rickard, Toronto, Canada

MP17-06 EVALUATION OF RENAL MEASUREMENTS OF ISOLATED HIGH-GRADE CONGENITAL HYDRONEPHROSIS (HGH) IN BOTH SUPINE AND PRONE POSITIONS

Amr Hodhod*, Carolina Fermin-Risso, Mutaz Farhad, Anthony Cook, Jarrah Aburezeq, Steven Lu, Bryce Weber, Calgary, Canada

MP17-07 IMPACT OF DELAY IN SURGICAL INTERVENTION ON FUNCTIONAL OUTCOME IN CHILDREN WITH UNILATERAL URETERO-PELVIC JUNCTION OBSTRUCTION

Mohamed Soltan*, Ahmed Abdelhalim, Ahmed Elkashef, Mohamed Edwan, Ahmed Atwa, Mohamed Abou-El_Ghar, Tamer Helmy, Ashraf Tarek, Mo-hamed Dawaba, Ahmed Shokier, Mansoura, Egypt


MP17-08 ATTAINING COMPETENCY AND PROFICIENCY IN OPEN PYELOPLASTY: A LEARNING CURVE CONFIGURATION USING CUMULATIVE SUM ANALYSIS

Jin Kyu (Justin) Kim*, Michael Chua, Mandy Rickard, Toronto, Canada, Karen Milford, Johan-nesburg, South Africa, Daniel Keefe, Armando Lorenzo, Toronto, Canada

MP17-09 OUTCOMES AND LESSONS LEARNT FROM PRACTICE OF RETROGRADE INTRARENAL SURGERY (RIRS) IN A PAEDIATRIC SETTING OF VARIOUS AGE GROUPS: A GLOBAL STUDY ACROSS 8 CENTRES

Ee Jean Lim*, Singapore, Singapore, Olivier Traxer, Paris, France, Yesica Quiroz Madarriaga, Barce-lona, Spain, Daniele Castellani, Ancona, Italy, Khi Yung Fong, Singapore, Singapore, Vinson Wai Shun Chan, Leeds, United Kingdom, Anna Bujons Tur, Barcelona, Spain, Amelia Pietropaolo, South-amptom, United Kingdom, Deepak Ragoori, Banjara Hills, India, Anil Shrestha, Kathmandu, Nepal, Chandra Mohan Vaddi, Hyderabad, India, Tanuj Paul Bhatia, Haryana, India, Mriganka Mani, Patrick Juliebø-Jones, Stephen Griffin, Southamptom, United Kingdom, Esther García Rojo, Madrid, Spain, Mariela Corrales, Paris, France, Cagri Akin Sekerci, Yiloren Tanidir, Istanbul, Turkey, Jeremy Yuen-Chun Teoh, Hong Kong, China, People’s Republic of, Vineet Gauhar, Singapore, Singapore, Bhaskar Kumar Somani, Southampton, United Kingdom

MP17-10 INCREASED LITHOGENIC RISK IN PLANT-BASED MEAT PRODUCTS FOR CHILDREN AND INFANTS

Garrett Ungerer*, Christine Liaw, Aaron Potretzke, David Sas, Patricio Gargollo, Candace Granberg, Kevin Koo, Rochester, MN

MP17-11 USE OF LOW DOSE COMPUTED TOMOGRAPHY IN CHILDREN WITH NEPHROLITHIASIS: A MULTI- INSTITUTIONAL ANALYSIS

Ashley Pittman*, Wauwatosa, WI, Neil Paloian, Madison, WI, Amy Pan, Liyun Zhang, Andrea Moyer, Robert Medairos, Pooja Thakrar, Wauwa-tosa, WI, Jonathan Ellison, Wauwatosa, WI

MP17-12 PROXIMITY TO FOOD DESERTS INCREASES RISK OF PEDIATRIC NEPHROLITHIASIS

Arthi Hannallah*, Aurash Naser-Tavakolian, Zoë Baker, Shirley Saker, Thalia Bajakian, Nadine Khouzam, Andrew Freedman, S. Scott Sparks, Los Angeles, CA

MP17-13 EVALUATION OF RENAL FUNCTION IN PEDIATRIC PATIENTS UNDERGOING UROLOGIC SURGERY USING NSQIP-P DATA

Victor Chalfant*, Carlos Riveros, Andrew Stec, Jacksonville, FL

80

MP17-14 IS EXCRETORY PHASE COMPUTERIZED TOMOGRAPHY IMPORTANT FOR EVALUATION OF HIGH GRADE RENAL TRAUMA?: RESULTS FROM THE TRAUMATIC RENAL INJURY COLLABORATION FOR KIDS (TRICK)

Ching Man Carmen Tong*, Birmingham, AL, Jacob Lucas, Philadelphia, PA, Albert Lee, Washington D.C., DC, Vinaya Bhatia, Houston, TX, Benjamin Abelson, Nashville, TN, Christopher Long, Dana Weiss, Philadelphia, PA, Christina Ho, Washington D.C., DC, Jeffrey Ellis, Philadel-phia, PA, Harold Lovvorn, Nashville, TN, Teressa Duong, Birmingham, AL, Jonathan Gerber, Hou-ston, TX, Gabriella Crane, Nashville, TN, Xiaoyi Zhuo, Houston, TX, Robert Russell, Birmingham, AL, Soo Kim, Ming-Hsien Wang, Houston, TX, Douglass Clayton, Nashville, TN, David Kitchens, Birmingham, AL

MP17-15 PEDIATRIC INGUINAL HERNIA MANAGEMENT BETWEEN PEDIATRIC SURGEONS AND PEDIATRIC UROLOGISTS

Teressa Duong*, Vincent Mortellaro, David Kitch-ens, David Joseph, Ching Man Carmen Tong, Birmingham, AL

MP17-16 LONG-TERM OUTCOMES FOR PATIENTS WITH ANAPLASTIC BILATERAL WILMS TUMORS ENROLLED ON COG AREN0534

Rodrigo LP Romao*, Halifax, Canada, Jennifer H Aldrink, Columbus, OH, Brett Tornwall, Gaines-ville, FL, Kathleen Kieran, Seattle, WA, Andrew Murphy, Andrew Davidoff, Memphis, TN, Daniel Benedetti, Nashville, TN, Jeffrey Dome, Wash-ington DC, DC, Elizabeth Perlman, Chicago, IL, Ethan Smith, Cincinnati, OH, Conrad Fernandez, Halifax, Canada, James Geller, Cincinnati, OH, Jack Brzezinski, Toronto, Canada, Lindsay Renf-ro, Monrovia, CA, Marcus Malek, Pittsburgh, PA, David Mansur, Cleveland, OH, Elizabeth Mullen, Boston, MA, Nicholas Cost, Denver, CO, Robert C Shamberger, Boston, MA, Peter F Ehrlich, Ann Arbor, MI

MP17-17 PREDICTION OF WILMS’ TUMOR RELAPSE RISK USING GENETIC AND METABOLOMIC MARKERS

Ahmed Abdelhalim*, Mariam AbdelMonem, Asmaa Ahmed, Amira Awadalla, Mohamed Ab-delhameed, Mansoura, Egypt, Ranim Mahmoud, Masnoura, Egypt, Om Ali El-khawaga, Ashraf Hafez, Mansoura, Egypt

MP17-18 A PIPE DREAM? OPIOID-FREE ANESTHESIA IN PEDIATRIC UROLOGY

Michael Richman*, Yuanting Zha, Annie Galloway, Daniel Low, Paul Merguerian, Seattle, WA

MP17-19 PARENTAL PERCEPTIONS ON CONTRAST ENHANCED VOIDING ULTRASONOGRAPHY VS VOIDING CYSTOURETHROGRAPHY

Dylan Hutchison*, Sean Corbett, Susie Leroy, Kathryn Morgan, Reza Daugherty, Grace Prilla-man, Nora Kern, Charlottesville, VA

MP17-20 THE NATURAL HISTORY OF CHILDREN WITH ANTENATAL HYDRONEPHROSIS AND ASYMPTOMATIC VESICOURETERAL REFLUX INCLUDING VCUG ORDERING PRACTICES

Jeremy Goodman*, Walid Farhat, Madison, WI, Fardod O’Kelly, Dublin, Ireland, Jennika Finup, Ryan McAdams, Kara Gill, Matthew W Harer, Madison, WI


Friday, May 13, 2022 4:30 pm – 5:45 pm

Moderated Poster Session 18URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: NON-NEUROGENIC

VOIDING DYSFUNCTION IRoom 222 @ Ernest N. Morial Convention CenterModerators: Maude Carmel & Michael Kennelly


MP18-01 THE EFFECT OF AGING ON URINE NATRIURETIC PEPTIDES IN NOCTURIA AND NOCTURNAL POLYURIA

Lakshay Khosla*, Joseph U. Boroda, Joshua Salama, Brooklyn, NY, Syed N. Rahman, New Haven, CT, Danielle J. Gordon, Brooklyn, NY, Matthew W. Moy, Westlake, OH, Yonatan Akivis, Alla Akivis, Jason M. Lazar, Jeffrey P. Weiss, Brooklyn, NY, Lori A. Birder, Pittsburgh, PA


MP18-02 EFFECT OF NOCTURIA IN PATIENTS WITH DIFFERENT SEVERITY OF OBSTRUCTIVE SLEEP APNEA ON POLYSOMNOGRAPHY

YuFeng Chuang*, Chin-Heng Lu, Chao-Yu Hsu, Min-Che Tung, Yen-Chuan Ou, Taichuang, Taiwan

MP18-03 PHENOTYPING PATIENTS WITH POLYURIAGeorge Fisch, Tel Aviv-Yafo, Israel, Alexander Fang*, Connelly Miller, Claire Choi, New York, NY, Thomas Monaghan, Dallas, TX, Edward Smith, Learta Prishtina, Jeffrey Weiss, Jerry Blaivas, New York, NY


FR

IDA

Y

MP18-04 ENURESIS AND LOWER URINARY TRACT DYSFUNCTION: A RELATIONSHIP NOT TRULY DISCUSSED

Ana Castro, Glicia Abreu, Bruna Venturini, Eliakim Massuqueto, Ubirajara Barroso Jr*, Salvador, Brazil

MP18-05 EXTRA VOIDS IN PATIENTS WITH OVERACTIVE BLADDER

Kevin Rychik, New York, NY, Max Edeson, Nutley, NJ, Edward Smith*, New York, NY, Jeffrey Weiss, Brooklyn, NY, Wade Bushman, Madison, WI, Jerry Blaivas, New York, NY

MP18-06 EFFICACY OF PULSED ELECTROMAGNETIC FIELD (PEMF) THERAPY FOR PELVIC PAIN REDUCTION AND SYMPTOM IMPROVEMENT IN INTERSTITIAL CYSTITIS: A PILOT STUDY

Dylan T. Wolff*, Peyton Lee, Christina Ross, Robert J. Evans, Gopal Badlani, Tyler Overholt, Raymond Xu, Catherine A. Matthews, Stephen J. Walker, Winston-Salem, NC

MP18-07 ASSESSMENT OF BLADDER ‘PRESSURE’ AND ‘DISCOMFORT’ SYMPTOMS – HOW DO OVERACTIVE BLADDER DIFFER FROM INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME PATIENTS?

Angelíca Gousse, Joel Vetter, H. Henry Lai*, St Louis, MO

MP18-08 NOVEL MACHINE LEARNING ALGORITHMS ARE ACCURATE AND NONINFERIOR TO HUMAN EXPERTS IN PREDICTING SUBJECTIVE PATIENT OUTCOMES FOLLOWING THIRD LINE THERAPY FOR OVERACTIVE BLADDER

Glenn T. Werneburg*, Cleveland, OH, Eric Werneburg, Stony Brook, NY, Howard Goldman, Cleveland, OH, Andrew Mullhaupt, Stony Brook, NY, Sandip Vasavada, Cleveland, OH

MP18-09 DOES SOCIOECONOMIC STATUS IMPACT CONTINUATION OF ONABOTULINUM TOXIN THERAPY FOR URGENCY URINARY INCONTINENCE?

Zhina Sadeghi*, Emma C Bethel, Stephanie Daig-nault-Newton, Paholo G Barboglio Romo, Anne P Cameron, J Quentin Clemens, Priyanka Gupta, Yooni Yi, John T Stoffel, Ann Arbor, MI

MP18-10 EVALUATION OF CLINICAL PERFORMANCE AND SAFETY FOR THE RECHARGEABLE INTERSTIMTM MICRO IN OVERACTIVE BLADDER SUBJECTS: 3-MONTH RESULTS FROM THE GLOBAL POST-MARKET ELITE STUDY

Keith Xavier, Arlington, TX, Colin Goudelocke*, New Orleans, LA, Barry Pecha, Jeffersonville, IN, Kimberly Burgess, Greenville, SC, Marie-Aimée Perrouin-Verbe, Nantes, France, Ryan Krlin, New Orleans, LA, Jodi Michaels, Woodbury, MN, Sagar Shah, Jacksonville, FL, Benoît Peyronnet, Rennes, France, Stanley Zaslau, Morgantown, WV, Bianca Papi, Katie Bittner, Minneapolis, MN, Dean Elterman, Toronto, Canada, Victor Nitti, Los Angeles, CA

MP18-11 URGE URINARY INCONTINENCE IS ASSOCIATED WITH FOOD INSECURITY

Chihiro Okada*, Joseph Kim, Nicole Roselli, Priyanka Kadam Halani, Nitya Abraham, Bronx, NY

MP18-12 ASSESSING THE UTILIZATION OF THE HEALTHCARE SYSTEM IN PATIENTS WITH OVERACTIVE BLADDER

Elisabeth Sebesta*, Stephanie Gleicher, Melissa Kaufman, Roger Dmochowski, W. Stuart Reyn-olds, Nashville, TN

MP18-13 THE SENSATION METER: A NOVEL NON-INVASIVE APPROACH TO UNDERSTANDING BLADDER SENSATION EVENTS

Elizabeth Rourke*, New Orleans, LA, W. Stuart Reynolds, Nashville, TN

MP18-14 METFORMIN IN THE TREATMENT OF OVERACTIVE BLADDER – A RETROSPECTIVE NESTED CASE-CONTROL, POPULATION-BASED ANALYSIS

Sarah Neu*, Jennifer Locke, Toronto, Canada, Rano Matta, Salt Lake City, UT, Natalie Troke, Mina Tadrous, Refik Saskin, Robert Nam, Sender Herschorn, Toronto, Canada

MP18-15 REAL WORLD MALE VOIDING BEHAVIOR AND VARIABILITY USING AN AUDIO-BASED UROFLOWMETRY APPLICATION

Ramy Goueli*, Dallas, TX, Min Gyeong Kim, San Francisco, CA, Kenneth Goldberg, Dallas, TX, Catherine Song, San Francisco, CA, Claus Roehr-born, Dallas, TX

MP18-16 VOIDING TIME AS A PROXY FOR URINARY OBSTRUCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS

Gaurav Pahouja*, Parth Patel, Enrique Blanco Martinez, Kevin T. McVary, Maywood, IL

MP18-17 THE MICROSCOPIC STRUCTURAL CHANGES OF PROSTATE REFLECTED BY THE APPARENT DIFFUSION COEFFICIENT VALUE AFFECT LOWER URINARY TRACT FUNCTION

Hidenori Akaihata*, Yusuke Hakozaki, Hiroki Nat-suya, Tomoyuki Kumekawa, Shunsuke Yoshioka, Hitomi Imai, Akifumi Onagi, Kanako Matsuoka, To-moyuki Koguchi, Junya Hata, Yuichi Sato, Masao Kataoka, Yoshiyuki Kojima, Fukushima, Japan

MP18-18 STATISTICAL SHAPE MODELING OF VIDEO URODYNAMICS: FROM FORM TO FUNCTION

Kelsey Gallo*, Lindsey Burnett, San Diego, CA, Megan Routzong, La Jolla, CA, Marianna Alperin, Yahir Santiago-Lastra, San Diego, CA

MP18-19 URODYNAMICS (UDS) USAGE FOR BENIGN PROSTATIC HYPERPLASIA (BPH)

Samantha L. Thorogood*, Tenny R. Zhang, Christina Sze, Mary O. Strasser, Gina DeMeo, Richard K. Lee, Bilal Chughtai, Alexis Te, Jim C. Hu, New York, NY

MP18-20 EVALUATION OF QUALITY OF LIFE, VOIDING, AND SEXUAL DYSFUNCTION IN PATIENTS FOLLOWING ROBOT-ASSISTED VESICOVAGINAL FISTULA REPAIR

Pawan Kaundal, Ravimohan Mavuduru*, Girdhar Bora, Shrawan K Singh, Chandigarh, India




Saturday, May 14, 2022 Plenary: Prime Time Saturday Morning Session 7:30 am – 11:30 am


7:30 HOW I DO IT: COMMON UROLOGIC PROCEDURES Moderator: Gopal Badlani Panelists: Li-Ping Xie, John Wei, Jaspreet Sandhu

8:30 WHEN DISASTER STRIKES: PREVENTING AND MANAGING NIGHTMARE CASES IN UROLOGY Moderator: Randall Meacham Panelists: Brian Cross, Rene Sotelo, Tobias Kohler, Lindsay Hampson

9:30 RAMON GUITERAS LECTURE: HOW TO REACH EXCELLENCE IN UROLOGY: CHALLENGES AND OPPORTUNITIES

Presenter: Francesco Montorsi

9:55 JOHN K. LATTIMER LECTURE: TESTOSTERONE, SCIENCE AND HUMAN DIGNITY Presenter: Abraham Morgentaler

10:20 JOURNAL OF UROLOGY LECTURE: ENGAGING PATIENTS: A CHALLENGE TO OUR CARE DELIVERY AND RESEARCH PRIORITIES

Presenter: Angela Smith

10:40 PRESIDENTIAL ADDRESS AUA President: Raju Thomas

11:05 PRESENTATION OF HONORARY MEMBERS & SECRETARY COMMENDATIONS FOR GLOBAL LEADERSHIP AUA Past President: Scott Swanson AUA Secretary: John Denstedt

11:15 UROLOGY CARE FOUNDATION PRESIDENTIAL ADDRESS UCF President: Harris Nagler

Saturday, May 14, 2022 Plenary: Prime Time Saturday Afternoon Session 1:00 pm – 4:00 pm


1:00 STATE-OF-THE-ART LECTURE: SINGLE-USE URETEROSCOPES AND NEW TECHNOLOGY: WHAT IS IN STORE? Presenter: Ben Chew

1:15 STATE-OF-THE-ART LECTURE: THULIUM FIBER LASER LITHOTRIPSY: IS IT LIVING UP TO THE HYPE? Presenter: Dmitry Enikeev

1:30 PANEL DISCUSSION: RESIDUAL FRAGMENTS AFTER STONE SURGERY: LEAVE OR CHASE? Moderator: Daron Smith Panelists: Thomas Tailly, Amy Krambeck

1:50 CROSSFIRE: CONTROVERSIES IN UROLOGY DEBATE: DO WE REALLY NEED STONE ANALYSIS AND METABOLIC URINE TESTING?

Moderator: Glenn Preminger Debaters: Justin Friedlander, Sara Best, Ryan Hsi, Kymora Scotland

2:20 PANEL DISCUSSION: PRESSURE IRRIGATION IN URETEROSCOPY Moderator: Olivier Traxer Panelists: Alex Meller, Michelle Semins, Helene Jung, Etienne Keller

2:50 SECOND OPINION CASES: TREATMENT OF SYMPTOMATIC NON-OBSTRUCTING CALYCEAL CALCULI: TO TREAT OR NOT

Moderator: Nicole Miller Panelists: Francis Keeley, Manoj Monga, Naeem Bhojani, Marianne Brehmer

3:10 STATE-OF-THE-ART LECTURE: GENETIC TESTING FOR EARLY ONSET KIDNEY STONE DISEASE Presenter: Gregory Tasian

3:25 PANEL DISCUSSION: STENT ASSOCIATED SYMPTOMS AFTER URETEROSCOPY: INSIGHTS FROM THE USDRN STENTS STUDY

Moderator: Necole Streeper Panelists: Alana Desai, Henry Lai, Charles Scales

SA

TU

RD

AY

86

Saturday, May 14, 2022 7:00 am – 8:15 am

Moderated Poster Session 19EDUCATION RESEARCH II

Room 228 @ Ernest N. Morial Convention CenterModerators: Andrew Hung & Jennifer Taylor

ABSTRACT NUMBER TITLE MP19-01 RACIAL AND ETHNIC DIFFERENCES IN

MEDICAL STUDENT TIMING AND PERCEIVED QUALITY OF EXPOSURE TO UROLOGY

Efe Chantal Ghanney Simons*, Natalia Garcia Peñaloza, Los Angeles, CA, Kassandra E. Zaila Ardines, Cleveland, OH, Serena Does, Utrecht, Netherlands, Samuel L. Washington III, San Fran-cisco, CA, Megha Tandel, Clarence H. Braddock III, Los Angeles, CA, Tracy M. Downs, Charlottes-ville, VA, Christopher Saigal, Los Angeles, CA

MP19-02 ADDRESSING MEDICAL EDUCATION CURRICULUM GAPS IN UROLOGICAL CARE FOR LGBTQIA PATIENTS: A CERTIFICATE TO ADVANCE TRAINING IN GENDER AND SEXUAL MINORITY HEALTH

Caleb Bercu*, Joseph Nickel, Scott Rhodes, Winston-Salem, NC, Bradley Figler, Chapel Hill, NC, Ram Pathak, Winston-Salem, NC

MP19-03 TRENDS IN RACE AND ETHNICITY AMONG APPLICANTS TO US UROLOGY RESIDENCY PROGRAMS

Efe Chantal Ghanney Simons*, Parris A. Diaz, Los Angeles, CA, Rebecca Takele, Blacksburg, VA, Serena Does, Utrecht, Netherlands, Samuel L. Washington III, San Francisco, CA, Benjamin N. Breyer, San Francisco, CA, Holly Wilhalme, Los Angeles, CA, Tracy M. Downs, Charlottes-ville, VA, Christopher Saigal, Los Angeles, CA

MP19-04 PEDIATRIC UROLOGY ACROSS US RESIDENCY PROGRAMS: A SURVEY OF RESIDENCY PROGRAM DIRECTORS TO IDENTIFY DIFFERENCES IN EDUCATION

Daniel Tennenbaum*, Brooklyn, NY, Lane Palmer, New Hyde Park, NY

MP19-05 LANDSCAPE ANALYSIS OF THE USE OF HOLISTIC REVIEW IN THE UROLOGY RESIDENCY MATCH PROCESS

Efe Chantal Ghanney Simons*, Parris A. Diaz, Los Angeles, CA, Rebecca Takele, Blacksburg, VA, Serena Does, Utrecht, Nether-lands, Nicholas J. Jackson, Los Angeles, CA, Samuel L. Washington III, San Francisco, CA, Benjamin N. Breyer, San Francisco, CA, Tracy M. Downs, Charlottesville, VA, Christopher Saigal, Los Angeles, CA

MP19-06 PROSPECTIVE EVALUATION OF POSTOPERATIVE PAIN AND OPIOID USE AFTER MINOR UROLOGIC SURGERY

Bonnie Liu*, Kevin Feng, Jeffrey Campbell, London, Canada

ABSTRACT NUMBER TITLE MP19-07 CHARACTERIZING THE USE OF TWITTER

AMONGST ACADEMIC UROLOGISTS Alberto Castro Bigalli*, Philadelphia, PA, Clara

Sun, Ilaha Isali, Cleveland, OH, Andrew Gi-anakopoulos, Justin Dubin, Chicago, IL, Seyed Behzad Jazayeri, Jacksonville, FL, Mohit Sind-hani, New Delhi, India, Laura Bukavina, Philadelphia, PA

MP19-08 AN ANALYSIS EXPLORING SELF-IDENTIFIED GENDER AMONG UROLOGISTS INCLUDED IN TOP DOCTOR MAGAZINE LISTS

Elizabeth Adams*, Chicago, IL, Marne Louters, Ann Arbor, MI, Brandon Ansbro, Chicago, IL, Simone Thavaseelan, Providence, RI, Stephanie Kielb, Chicago, IL

MP19-09 OPEN ACCESS JOURNALS HAVE HIGHER METRICS THAN NON-OPEN ACCESS JOURNALS: ANALYSIS OF EUROPEAN UROLOGY AND JOURNAL OF UROLOGY METRICS

Riccardo Lombardo*, Antonio Cicione, Rome, Italy, Antonio Nacchia, Rionero in Vulture, Italy, Beatrice Turchi, Giacomo Gallo, Carmen Gravina, Alessandro Guercio, Jordi Stira, Lorenzo Maria Rovesti, Antonio Franco, Giorgio Guarnotta, Elisa Mancini, Olivia Alessandra Voglino, Valeria Bal-dassarri, Simone D’Annunzio, Sara Riolo, Andrea Tubaro, Cosimo De Nunzio, Rome, Italy

MP19-10 DETERMINING THE EFFECTIVENESS OF A DELIBERATE PRACTICE TRAINING PLATFORM IN A VIRTUAL REALITY (VR) URETHROVESICAL ANASTOMOSIS CURRICULUM

Kit Yuen*, Alexis Steinmetz, Rachel Melnyk, Na-than Schuler, Galen Cheng, Dennis Phan, Ahmed Ghazi, Rochester, NY

MP19-11 VIRTUAL CLASSROOM PROFICIENCY BASED PROGRESSION FOR ROBOTIC SURGERY TRAINING (VROBOT): A PROSPECTIVE, CROSS-OVER, EFFECTIVENESS STUDY

Alexander Ng*, Arjun Nathan, Sonam Patel, Maria Georgi, London, United Kingdom, Monty Fricker, Newcastle, United Kingdom, Kien Hang, London, United Kingdom, William Mullins, Cambridge, United Kingdom, Aqua Asif, Leicester, United Kingdom, Alexander Light, Nader Francis, John Kelly, Justin Collins, Ashwin Sridhar, London, United Kingdom


SA

TU

RD

AY

MP19-12 THE LEARNING CURVE FOR ROBOT-ASSISTED RADICAL CYSTECTOMY: A SYSTEMATIC REVIEW

Andrey Morozov*, Diana Babaevskaya, Mark Taratkin, Jasur Inoyatov, Ekaterina Laukhtina, Moscow, Russian Federation, Marco Moschini, Milan, Italy, Nirmish Singla, Baltimore, MD, Juan Gomez Rivas, Madrid, Spain, Jeremy Teoh, Hong Kong, China, People’s Republic of, Petr Glyboch-ko, Dmitry Enikeev, Moscow, Russian Federation

MP19-13 HAND DOMINANCE DECISION-MAKING AND OPERATING ROOM CHALLENGES EXPERIENCED BY LEFT-HANDED UROLOGY TRAINEES

Christopher Tam*, Maia Anderson, Mary Byrnes, Julian Wan, Bryan Sack, Ann Arbor, MI

MP19-14 A NOVEL GENITOURINARY MEDICINE FELLOWSHIP PROGRAM, OUR EXPERIENCE AND FUTURE VISION

Tareq Aro*, Louis Kavoussi, Lloyd Minsky, Michael Ziegelbaum, New Hyde Park, NY

MP19-15 NEW YORK CITY COVID-19 CONSULTS: AN ALGORITHM FOR SAFE, EFFICIENT, QUALITY CARE

Benjamin Eilender*, Joseph Baiocco, Conner Brown, Vannita Simma-Chiang, Jay A. Motola, New York, NY

MP19-16 EXAMINING THE 1-YEAR IMPACT OF COVID-19 ON UROLOGY RESIDENT SURGICAL EXPERIENCE: AN ANALYSIS OF NATIONAL SURGICAL CASE LOGS

Travis LeBlanc*, Rourke Keith, Edmonton, Canada

MP19-17 DEMAND FOR EXPANDED VIRTUAL EDUCATION EVIDENT AMONG UROLOGY TRAINEES TWO YEARS INTO COVID-19

Kyle Blum*, Lauren Conroy, Justin Mehr, Skyler Howell, Leyla Akhverdiyeva, David Tuke, Steven Canfield, Houston, TX

MP19-18 NOMOGRAM PREDICTING RENAL FUNCTION RECOVERY POST DIVERSION IN PATIENTS WITH OBSTRUCTIVE UROPATHY

Gopal Sharma*, Sudheer K. Devana, Ravimohan S. Mavuduru, Kalpesh M. Parmar, Chandigarh, India

MP19-19 PREDICTING PROFICIENCY DURING ROBOTIC PROSTATECTOMY OF UROLOGY TRAINEES USING A NOVEL, SYSTEMIC SURGICAL TRAINING PROGRAM

Rand Wilcox Vanden Berg*, Ashwin Ramaswamy, Emily Vertosick, Eugene Cha, Jonathan Coleman, Timothy Donahue, James Eastham, Behfar Ehdaie, Vincent Laudone, Eugene Pietzak, Robert Smith, Alvin Goh, New York, NY

MP19-20 EFFECTIVENESS OF A NEWLY-DEVELOPED TRAINING MODULE USING 3D PRINTING FOR THE NAVIGATION DURING RETROGRADE INTRARENAL SURGERY

Gyoohwan Jung, Seongnam, Korea, Republic of, Yongseok Kho*, Sung Yong Cho, Seoul, Korea, Republic of



Moderated Poster Session 20TRAUMA/RECONSTRUCTION/DIVERSION: EXTERNAL GENITALIA RECONSTRUCTION AND UROTRAUMA

(INCLUDING TRANSGENDER SURGERY) IRoom 225 @ Ernest N. Morial Convention CenterModerators: Steven Brandes & Reynaldo Gomez

ABSTRACT NUMBER TITLE MP20-01 OPIOID AND MULTIMODAL ANALGESIA USE

FOLLOWING UROLOGICAL TRAUMA Mary Rostom*, Andrew Gabrielson,

Ryan Fransman, Shirley Wang, Albert Holler, Isabella Pan, Nikita Gupta, Joseph Sakran, Andrew Cohen, Baltimore, MD

MP20-02 PROTECTIVE ROLE OF METFORMIN IN ACUTE RENAL ISCHEMIC REPERFUSION INJURY

Junrong Zou, Xiaofeng Zou*, Guoxi Zhang, Kecheng Lou, Shangzhi Feng, Guancheng Xiao, Hailan He, Ganzhou, China, People’s Republic of

ABSTRACT NUMBER TITLE MP20-03 SELECT INTERMEDIATE-GRADE BLUNT

RENAL INJURIES ARE APPROPRIATE FOR EARLY DISCHARGE

George Koch*, Madeleine Ball, Craig Hill, Jackson Cabo, Helen Gambrah, Abimbola Ayangbesan, Rohan Bhalla, Niels Johnsen, Nashville, TN

MP20-04 GRADE V RENAL TRAUMA: SUCCESS ROLE FOR CONSERVATIVE MANAGEMENT IN THE NATIONAL TRAUMA DATABANK

Nizar Hakam*, Nathan Shaw, Jason Lui, Behnam Nabavizadeh, Kevin Li, Patrick Low, Benjamin Breyer, San Francisco, CA

88

MP20-05 LATE COMPLICATIONS AFTER BLUNT RENAL TRAUMA: A FRENCH MULTICENTER STUDY

Godefroi Brenot, Saint Mandé, France, Inès Dominique, Paris, France, Benoît Peyronnet, Rennes, France, Pierre-Henri Savoie, Toulon, France, Paul Chiron*, Saint Mandé, France

MP20-06 PERIRENAL FAT THICKNESS IS ASSOCIATED WITH RENAL TRAUMA INJURY GRADE

Nizar Hakam*, Jason Lui, Nathan Shaw, Behnam Nabavizadeh, Patrick Low, Kevin Li, Benjamin Breyer, San Francisco, CA

MP20-07 UROLOGY CONSULTATION IS ASSOCIATED WITH ADHERENCE TO IMAGING GUIDELINES AND DECREASED NEPHRECTOMY IN HIGH GRADE RENAL TRAUMA

Shirley Wang, Pranjal Agrawal*, Mary Rostom, Nikita Gupta, Albert Holler, Isabelle Pan, Kent Stevens, Raymond Fang, Elliott Haut, Ryan Fransman, Renu Berry, Andrew Cohen, Baltimore, MD

MP20-08 THE EFFECT OF COLPECTOMY ON LOWER URINARY TRACT FUNCTION IN TRANSGENDER MEN

Brechje L. Ronkes, Freek P.W. de Rooij, Freek A. Groenman, Mark-Bram Bouman, Jakko A. Nieu-wenhuijzen, R. Jeroen A. van Moorselaar, Garry L.S. Pigot*, Amsterdam, Netherlands

MP20-09 COMPARISON OF CLINICAL OUTCOMES AFTER PHALLOPLASTY WITH VERSUS WITHOUT URETHRAL LENGTHENING IN TRANSGENDER MEN

Freek P.W. de Rooij, Wouter B. van der Sluis, Brechje L. Ronkes, Thomas D. Steensma, Muhammed Al-Tamimi, R. Jeroen A. van Moorselaar, Mark-Bram Bouman, Garry L.S. Pigot*, Amsterdam, Netherlands

MP20-10 A PILOT STUDY OF OUTCOMES AFTER ROBOT-ASSISTED SIGMOID VAGINOPLASTY FOR GENDER DYSPHORIA

Tatyana Yatsenko*, Brooklyn, NY, Peter Wiklund, Rajveer Purohit, Miroslav Djordjevic, New York, NY

MP20-11 A NOMOGRAM TO PREDICT VAGINAL DEPTH, BASED ON AVAILABLE PENILE AND SCROTAL SKIN, FOR PENILE INVERSION VAGINOPLASTY: A USEFUL TOOL FOR DECISION MAKING AND SURGICAL PLANNING

Shannon Smith*, Los Angeles, CA, Nance Yuan, Pasadena, CA, Michael Zaliznyak, Jenna Stelmar, Maurice Garcia, Los Angeles, CA

MP20-12 ASSESSMENT OF NEOPHALLUS LENGTH FOLLOWING METOIDIOPLASTY

Hannah Glick*, Stephanie Diagnault-Newton, Miriam Hadj-Moussa, Ann Arbor, MI

MP20-13 QUANTIFYING TIME TO ORGASM AFTER GENDER AFFIRMING VAGINOPLASTY

Gaines Blasdel*, Elijah Castle, New York, NY, Carmen Kloer, Durham, NC, Augustus Parker, Rachel Bluebond-Langner, Lee Zhao, New York, NY

MP20-14 URETHRAL COMPLICATIONS AFTER MUSCULOCUTANEOUS LATISSIMUS DORSI PHALLOPLASTY IN TRANSGENDER MEN

Borko Stojanovic*, Marko Bencic, Marta Bizic, Miroslav L. Djordjevic, Belgrade, Serbia

MP20-15 DELAYED PRIMARY CLOSURE OF POST-DEBRIDEMENT FOURNIER’S GANGRENE WOUNDS REDUCES COST

Andrew Zilavy, Peter Sam*, Carolyn Ice, Maxx Gallegos, Albuquerque, NM

MP20-16 CLINICAL TRANSLATION OF ENGINEERED PENILE TISSUE

Sita Somara, Teresa Burnette, Namrata Sangha, Lindsey Creahan, Tsghe Abraha, Kathryn Krupp, Tiana Stewart, Torie Westendorf, Brad Damratoski, Lisa Hinshaw, Todd Meinecke, Darren Hickerson, Cynthia Wilkins-Port, Ryan Terlecki, James Yoo, Julie Allickson, Anthony Atala, John Jackson*, Winston Salem, NC

MP20-17 CORPOROPLASTY: A SIMPLIFIED TECHNIQUE FOR CLITOROPLASTY

Ubirajara Barroso Jr*, Marcelo Villalta, Leidy Casas, Eliakim Massuqueto, Bruna Venturini, Salvador, Brazil

MP20-18 HEINEKE-MIKULICZ PREPUTIOPLASTY: SURGICAL TECHNIQUE AND OUTCOMES

Alex Xu*, Kirtishri Mishra, Lee Zhao, New York, NY

MP20-19 EARLY ENDOSCOPIC REALIGNMENT OF POST TRAUMATIC URETHRAL DISRUPTION

Camille Haudebert*, Juliette Hascoet, Vivien Graffeille, Karim Bensalah, Gregory Verhoest, Zine Eddine Khene, Romain Mathieu, Andrea Manunta, Benoit Peyronnet, Lucas Freton, Rennes, France

MP20-20 HIGH 30-DAY COMPLICATIONS AFTER BURIED PENIS REPAIR SUGGEST ROLE FOR PREOPERATIVE OPTIMIZATION

Ethan Matz*, Rahul Dutta, Nicholas Deebel, Justin Refugia, Kim Thai, Ryan Terlecki, Winston-Salem, NC



SA

TU

RD

AY


Moderated Poster Session 21SEXUAL FUNCTION/DYSFUNCTION: EVALUATION I

Room 222 @ Ernest N. Morial Convention CenterModerator: Ranjith Ramasamy

ABSTRACT NUMBER TITLE MP21-01 CONTEMPORARY COMORBIDITY PROFILE

OF MEN WITH ERECTILE DYSFUNCTION Garrick Greear*, Tristan Nicholson, Sarah Holt,

Marah Hehemann, Hunter Wessells, Thomas Walsh, Seattle, WA

MP21-02 PREDICTORS OF CORPORO-VENOCCLUSIVE DYSFUNCTION (CVOD) IN MEN WITH BILATERAL NERVE-SPARING RADICAL PROSTATECTOMY (RP)

Jose M Flores*, Carolyn A Salter, Nicole Benfante, Elizabeth Schofield, John P Mulhall, NYC, NY

MP21-03 USING DATA MINING TO IDENTIFY CLINICAL PREDICTORS OF DELAYED EJACULATION

Evan Mulloy*, Michael Eisenberg, Amy Zhang, Palo Alto, CA

MP21-04 TRENDS OF REPORTING PREMATURE EJACULATION AMONG MEN WITH ERECTILE DYSFUNCTION – FINDINGS FROM A REAL-LIFE CROSS-SECTIONAL STUDY

Edoardo Pozzi*, Giuseppe Fallara, Federico Belladelli, Christian Corsini, Massimiliano Raffo, Luigi Candela, Antonio Costa, Daniele Cignoli, Nicolò Schifano, Alessia d’Arma, Paolo Capo-grosso, Luca Boeri, Eugenio Ventimiglia, Rayan Matloob, Milan, Italy, Vincenzo Mirone, Naples, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy

MP21-05 PERCEPTIONS OF MARIJUANA USE ON MALE HEALTH AMONG REDDIT USERS: NATURAL LANGUAGE PROCESSING AND THEMATIC ANALYSIS

Gary Shahinyan*, Denver, CO, Ming-Yeah Hu, Tommy Jiang, Vadim Osadchiy, John Sigalos, Jesse Mills, Los Angeles, CA, Naveen Kachroo, Detroit, MI, Sriram Eleswarapu, Los Angeles, CA

MP21-06 IMPACT OF SEXUAL DYSFUNCTION ON QUALITY OF LIFE IN WOMEN AFTER PELVIC FRACTURE

Helen Gambrah*, Niels Vass Johnsen, MD, MPH, Nashville, TN

MP21-07 EXPLORING SEXUAL HEALTH OF TRANSFEMININE INDIVIDUALS: AN OPPORTUNITY TO EDUCATE MEDICAL PROVIDERS

Andrew Denisenko*, Andrew Salib, Jessica Bulafka, Sabina Spigner, Vishal Swaminathan, Peyton Stauffer, Cassra B. Clark, Andrew Shumaker, Rosemary Frasso, Paul H. Chung, Philadelphia, PA

ABSTRACT NUMBER TITLE MP21-08 MASTURBATORY ORGASM PARAMETERS OF

SEXUALLY ACTIVE CISGENDER MEN AND WOMEN

Jenna Stelmar*, Michael Zaliznyak, Los Angeles, CA, Dylan Isaacson, Chicago, IL, Erin Duralde, Boston, MA, Thomas Gaither, Shannon Smith, Nance Yuan, Los Angeles, CA, Kimberly Topp, San Francisco, CA, Maurice Garcia, Los Angeles, CA

MP21-09 DRUG-RELATED SEXUAL DYSFUNCTION ISSUES AMONG PATIENTS UNDER TREATMENT OR PREVIOUSLY EXPOSED TO SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) – A MANAGEMENT CHALLENGE?

Nicolò Schifano*, Milan, Italy, Paolo Capogrosso, Varese, Italy, Giuseppe Fallara, Edoardo Pozzi, Federico Belladelli, Luigi Candela, Christian Corsini, Massimiliano Raffo, Antonio Costa, Daniele Cignoli, Alessia d’Arma, Luca Boeri, Eugenio Ventimiglia, Rayan Matloob, Milan, Italy, Vincenzo Mirone, Naples, Italy, Federico Dehò, Varese, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy

MP21-10 WHEN GENITO-PELVIC DYSESTHESIA DOES NOT ORIGINATE IN THE GENITO-PELVIC REGION: MANAGEMENT OF PATIENTS WITH SACRAL RADICULOPATHY

Irwin Goldstein*, Choll Kim, Sue Goldstein, Maria Uloko, Noel Kim, San Diego, CA, Barry Komisaruk, Newark, NJ

MP21-11 SEVERITY OF PENILE CURVATURE IN PEYRONIE’S DISEASE DOES NOT CORELATE WITH SHIM OR PDQ SCORES

Thomas Masterson*, Isaac Zucker, Pranusha Atuluru, Emad Ibrahim, Manuel Molina, Bruce Kava, Ranjith Ramasamy, Miami, FL

MP21-12 STILL ONE OUT OF FIVE MEN PRESENTING FOR ERECTILE DYSFUNCTION ARE YOUNG THAN 40 YEARS OF AGE: FINDINGS OF A REAL-LIFE CROSS-SECTIONAL STUDY OVER LAST DECADE

Edoardo Pozzi*, Milan, Italy, Paolo Capogrosso, Varese, Italy, Giuseppe Fallara, Luca Boeri, Christian Corsini, Daniele Cignoli, Massimiliano Raffo, Luigi Candela, Nicolò Schifano, Alessia d’Arma, Rayan Matloob, Milan, Italy, Federico Dehò, Varese, Italy, Vincenzo Mirone, Naples, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy

90

MP21-13 OBESITY IMPAIRS HYPOGONADISM COMPENSATION LEADING TO AGE-RELATED TESTOSTERONE DECLINE

Taciana Tiraboschi, Feira de Santana, Brazil, Eduardo Miranda*, Fortaleza, Brazil, Monique No-vaes, Caroline Silva, Jean Zambrano-Contreras, Anna Ribeiro, Neyara Oliveira, Matheus Pauferro, Rodolfo Pimenta, Ricardo Figueiredo, Feira de Santana, Brazil, Jose Murillo Netto, Juiz de Fora, Brazil, Cristiano Gomes, Sao Paulo, Brazil, Jose Bessa Jr, Feira de Santana, Brazil

MP21-14 U-SHAPED ASSOCIATION BETWEEN SECONDARY HYPOGONADISM AND BODY MASS INDEX: A RETROSPECTIVE ANALYSIS OF MEN WITH TESTOSTERONE DEFICIENCY

Aaron A. Gurayah*, Miami, FL, John M. Mas-terson, Los Angeles, CA, Atil Y. Kargi, Ranjith Ramasamy, Miami, FL

MP21-15 PREDICTORS OF LOW TOTAL TESTOSTERONE (TT) LEVELS AFTER RADICAL ORCHIECTOMY (RO) FOR TESTIS CANCER (TC)

Jose M Flores*, Nicole Benfante, John P Mulhall, NYC, NY

MP21-16 DEMOGRAPHICS AND INCIDENTAL DIAGNOSES OF MEN WITH PRIAPISM

Evan Mulloy*, Shufeng Li, Michael Eisenberg, Palo Alto, CA

MP21-17 THE EFFECT OF SURGICAL TREATMENT OF URETHRAL STRICTURE ON ERECTILE FUNCTION

Alexey Klimenko*, Sergei Kotov, Michael Iritsyan, Moscow, Russian Federation

MP21-18 NEW FINDINGS REGARDING SURGEON VARIATIONS IN PERIOPERATIVE EVALUATION OF PENILE PROSTHESIS PATIENTS

David Barham*, Orange, CA, Martin Gross, Lebanon, NH, Aubrey Reeves, Colton, CA, Cobi Reisman, Amsterdam, Netherlands, Eric Chung, Brisbane St Lucia, Australia, Faysal Yafi, Orange, CA

MP21-19 AN ALGORITHM TO PREDICT PENILE DOPPLER ULTRASOUND FINDINGS IN MEN WITH ERECTILE DYSFUNCTION

Federico Belladelli*, Massimiliano Raffo, Gi-useppe Fallara, Edoardo Pozzi, Luigi Candela, Antonio Costa, Christian Corsini, Daniele Cignoli, Nicolò Schifano, Alessia d’Arma, Milan, Italy, Pao-lo Capogrosso, Varese, Italy, Luca Boeri, Eugenio Ventimiglia, Rayan Matloob, Milan, Italy, Vincenzo Mirone, Naples, Italy, Francesco Montorsi, An-drea Salonia, Milan, Italy

MP21-20 EXPLORING ERECTILE HEMODYNAMICS IN MEN COMPLAINING OF HARD-FLACCID SYNDROME (HFS)

John Sullivan*, Dublin, NY, Carolyn Salter, Jose Flores, Pat Guhring, Marilyn Parker, John Mulhall, New York, NY



SA

TU

RD

AY


Podium Session 17PROSTATE CANCER: DETECTION & SCREENING III

Room 252 @ Ernest N. Morial Convention CenterModerators: Adam Kibel, Stacy Loeb & Andres Arley-Vargas

ABSTRACTTIME NUMBER TITLE7:00 PD17-01 DERIVATION AND EXTERNAL VALIDATION

OF A RAPID RISK SCORE FOR PREDICTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN MEN WITH AN MRI VISIBLE LESION: A MULTINATIONAL COHORT STUDY

Max Peters*, Utrecht, Netherlands, David El-dred-Evans, London, United Kingdom, Piet Kurv-er, Utrecht, Netherlands, Ugo Giovanni Falagario, Foggia, Italy, Martin J. Connor, London, United Kingdom, Joost J.C. Verhoeff, Utrecht, Nether-lands, Giuseppe Carrieri, Luigi Cormio, Foggia, Italy, Pekka Taimen, Hannu J Aronen, Juha Knaa-pila, Ileana Montoya Perez, Otto Ettala, Turku, Finland, Armando Stabile, Giorgio Gandaglia, Nicola Fossati, Alberto Martini, Vito Cucchiara, Alberto Briganti, Milan, Italy, Anna Lantz, Solna, Sweden, Wolfgang Picker, Oslo, Norway, Erik Haug, Tønsberg, Norway, Tobias Nordström, Stockholm, Sweden, Mariana Bertoncelli Tanaka, Feargus Hosking-Jervis, Deepika Reddy, Edward Bass, London, United Kingdom, Peter SN van Rossum, Utrecht, Netherlands, Suchita Joshi, Elizabeth Pegers, Kathie Wong, Henry Tam, David Hrouda, London, United Kingdom, Stuart McCraken, Sunderland, United Kingdom, Mathias Winkler, Stephen Gordon, Hasan Qazi, London, United Kingdom, Peter J. Boström, Ivan Jambor, Turku, Finland, Hashim U. Ahmed, London, United Kingdom

7:10 PD17-02 COST IMPLICATIONS OF INFECTIOUS COMPLICATIONS FOLLOWING PROSTATE BIOPSIES IN THE UNITED STATES

Sharon White*, Eric Ballon-Landa, MD, Michael Bronsert, Denver, CO, Boris Gershman, Boston, MA, Peter Clark, Charlotte, NC, Granville Lloyd, Jeffrey Morrison, Rodrigo Rodrigues-Pessoa, Denver, CO, Marc Smaldone, Philadelphia, PA, Anessa Sax-Bolder, Simon Kim, Denver, CO

7:20 PD17-03 COMPARATIVE ANALYSES OF MICRO-ULTRASOUND VERSUS MRI-TARGETED BIOPSY FOR THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER. PRELIMINARY RESULTS FROM THE PROSPECTIVE US-MIRROR TRIAL

Simone Scuderi*, Armando Stabile, Gabriele Sorce, Mario De Angelis, Luigi Nocera, Franc-esco Pellegrino, Francesco Barletta, Milan, Italy, Andrea Salonia, Milano, Italy, Giuseppe Cirulli, Milan, Italy, Lucia D’Ambrosio, Milano, Italy, Giorgio Gandaglia, Vito Cucchiara, Elio Maz-zone, Giuseppe Rosiello, Milan, Italy, Riccardo Leni, Donato Cannoletta, Milano, Italy, Antony Pellegrino, Milan, Italy, Nicola Fossati, Lugano, Switzerland, Shahrokh Shariat, Vienna, Austria, Francesco Montorsi, Alberto Briganti, Milan, Italy

ABSTRACTTIME NUMBER TITLE7:30 PD17-04 PROSTATE CANCERS DETECTED AT MULTI-

PARAMETRIC MRI TARGETED VERSUS SYSTEMATIC BIOPSIES: ARE THEY EQUAL? RESULTS FROM A LARGE MULTI-INSTITUTIONAL SERIES

Francesco Barletta*, Milano, Italy, Elio Mazzone, Giorgio Gandaglia, Milan, Italy, Guillaume Plous-sard, Razvan-George Rahota, Toulouse, France, Massimo Valerio, Lausanne, Switzerland, Riccar-do Campi, Andrea Mari, Florence, Italy, Agostino Mattei, Lucerne, Switzerland, Giancarlo Marra, Turin, Italy, Jean Baptiste Beauval, Mathieu Rou-miguiè, Toulouse, France, Luca Afferi, Lucerne, Italy, Marco Moschini, Lucerne, Switzerland, Paolo Gontero, Turin, Italy, Roderick van den Bergh, Utrecht, Netherlands, Junlong Zhuang, Hongqian Tuo, Jiangsu, China, People’s Republic of, Armando Stabile, Milan, Italy, Nicola Fossati, Lugano, Switzerland, Francesco De Cobelli, Antonio Esposito, Giorgio Brembilla, Francesco Montorsi, Alberto Briganti, Milan, Italy

7:40 PD17-05 CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH PIRADS 5 LESIONS AND NEGATIVE BIOPSIES

Eric Li*, Mohammad Siddiqui, Jonathan Aguiar, Brandon Ansbro, Parth Shah, Moataz Soliman, Jordan Rich, Jasmine Lin, Johan Alfaro Carballo, Mary Kate Keeter, Quan Mai, Edward Schaeffer, Ashley Ross, Chicago, IL

7:50 PD17-06 ACTIVE SURVEILLANCE DISCONTINUATION AMONG LOW-RISK PROSTATE CANCER PATIENTS: RESULTS FROM A LARGE NATIONAL DATABASE

Rashid Sayyid*, Augusta, GA, Laurence Klotz, Toronto, Canada, John Benton, Martha Terris, Au-gusta, GA, Christopher Wallis, Toronto, Canada, Zachary Klaassen, Augusta, GA

8:00 PD17-07 PSA TESTING AND COLORECTAL CANCER SCREENING TRENDS FROM 2012 TO 2020: ANALYSIS OF THE CDC BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM (BRFSS)

Anh Nguyen*, John Fastenau, Gabriel Fernan-dez, Courtney Berg, Amjad Alwaal, Evan Kovac, Robert Weiss, Newark, NJ

8:10 PD17-08 RACIAL AND ETHNIC DISPARITIES MAGNIFIED AFTER U.S. PREVENTATIVE SERVICES TASK FORCE CATEGORY D RECOMMENDATION FOR PSA SCREENING

Caleb Bercu*, Ram Pathak, Adam Cohen, Timo-thy Craven, Ashok Hemal, Winston-Salem, NC

92

8:20 PD17-09 DISPARITIES REGARDING SHARED DECISION-MAKING IN PROSTATE CANCER SCREENING

Michael Basin*, Alina Basnet, Oleg Shapiro, Joseph Jacob, Gennady Bratslavsky, Hanan Goldberg, Syracuse, NY

8:30 PD17-10 PROSTATE SPECIFIC ANTIGEN SCREENING ON A NATIONWIDE LEVEL: FEATURING THE CONTRIBUTION OF RACE AND LIFE EXPECTANCY IN DECISION MAKING

Nicholas J. Corsi*, Deepansh Dalela, Austin Piontkowski, Ivan Rakic, Sami E. Majdalany, Shravan Morisetty, Detroit, MI, Taylor Malchow, Dayton, OH, Marcus Jamil, Detroit, MI, Akshay Sood, Houston, TX, Sohrab Arora, Craig Rogers, Detroit, MI, Mara Schonberg, Boston, MA, Firas Abdollah, Detroit, MI

8:40 PD17-11 COMPARISON BETWEEN TARGET VS TARGET PLUS STANDARD BIOPSY FOR PROSTATE CANCER DIAGNOSIS IN BIOPSY NAÏVE PATIENTS: A RANDOMIZED CONTROLLED TRIAL

Enrico Checcucci, Matteo Manfredi, Sabrina De Cillis, Daniele Amparore, Federico Piramide, Alberto Piana, Gabriele Volpi, Michele Sica, Paolo Verri, Stefano Granato, Stefano Piscitello, Mariano Burgio, Ola Luciano, Beatrice Carbonaro, Davide Zamengo, Alberto Quarà, Marcello Della Corte, Edoardo Dibilio, Paolo Alessio, Angela Pecoraro, Ilaria Sturia, Orbassano (Turin), Italy, Giuseppe Migliaretti, Turin, Italy, Cristian Fiori, Stefano De Luca, Francesco Porpiglia*, Orbassano (Turin), Italy

8:50 PD17-12 EXTENDED - TARGETED-PLUS-REGIONAL - MRI-DIRECTED BIOPSY APPROACH IN PROSTATE CANCER DIAGNOSIS – A SYSTEMATIC REVIEW AND META-ANALYSIS

Marinus Hagens*, Mar Fernandez Salamanca, Amsterdam, Netherlands, Anwar Padhani, Northwood, United Kingdom, Pim van Leeuwen, Henk van der Poel, Ivo Schoots, Amsterdam, Netherlands

APPROVED FOR AMA PRA CATEGORY 2 CREDITSTM


Podium Session 18KIDNEY CANCER: EPIDEMIOLOGY & EVALUATION/STAGING/SURVEILLANCE II

Room 255 @ Ernest N. Morial Convention CenterModerators: J. Stuart Wolf, Deborah Kaye & M. Pilar Laguna

ABSTRACTTIME NUMBER TITLE7:00 PD18-01 CYTOREDUCTIVE NEPHRECTOMY IN

PATIENTS RECEIVING TKI THERAPY VERSUS IMMUNE CHECKPOINT INHIBITOR THERAPY: ANALYSIS OF THE REMARCC REGISTRY

Margaret Meagher*, San Diego, CA, Andrea Minervini, Florence, Italy, Maria Mir, Giacomo Rebez, Valencia, Spain, Riccardo Autorino, Richmond, VA, Riccardo Campi, Florence, Italy, Maximilian Kriegmair, Mannheim, Germany, Es-tefania Linares, Vital Hevia, Madrid, Spain, Mireia Musquera, Mauricio D’Anna, Barcelona, Spain, Eduard Rousel, Maarten Albersen, Leuven, Belgium, Nicola Pavan, Francesco Claps, Trieste, Italy, Alessandro Antonelli, Verona, Italy, Michele Marchioni, Chieti, Italy, Selcuk Erdem, Istanbul, Turkey, Ithaar Derweesh, San Diego, CA

ABSTRACTTIME NUMBER TITLE7:10 PD18-02 EXTERNAL VALIDATION OF THE ASSURE

MODEL TO PREDICT ONCOLOGICAL OUTCOMES AFTER RESECTION OF HIGH-RISK RENAL CELL CARCINOMAS

Zine-Eddine Khene*, Rennes, France, Alessandro Larcher, Milan, Italy, Jean-Christophe Bernhard, Bordeaux, France, Nicolas Doumerc, Toulouse, France, Romain Boissier, Marseille, France, Idir Ouzaid, Paris, France, Philippe Barthelemy, Strasbourg, France, Morgan Roupret, Paris, France, Francesco Montorsi, Milan, Italy, Pierre Bigot, Angers, France, Karim Bensalah, Rennes, France


SA

TU

RD

AY

7:20 PD18-03 PROPOSAL FOR RECLASSIFICATION OF T1 AND T2A RENAL CELL CARCINOMA: RESULTS OF A MULTI-INSTITUTIONAL ANALYSIS

Margaret Meagher*, Ava Saidian, San Diego, CA, Riccardo Autorino, Richmond, VA, Brian Lane, Grand Rapids, MI, Yasuhisa Fujii, Tokyo, Japan, Michele Marchioni, Chieti, Italy, Hajime Tanaka, Tokyo, Japan, Dattatraya Patil, Atlanta, GA, Francesco Porpiglia, Turin, Italy, Sabrina Noyes, Grand Rapids, MI, Ryan Nasseri, San Diego, CA, Chandru Sundaram, Indianapolis, IN, James Porter, Seattle, WA, Andrea Minervini, Florence, Italy, Umberto Capitanio, Francesco Montorsi, Milan, Italy, Viraj Master, Atlanta, Georgia, Ithaar Derweesh, San Diego, CA

7:30 PD18-04 HAZARD OF DEATH IN VON HIPPEL-LINDAU DISEASE PATIENTS DEPENDS ON GENOTYPE AND ONSET AGE AS WELL AS FIRST AFFECTED LESION

Kaifang Ma*, Lin Cai, Kan Ging, Beijing, China, People’s Republic of

7:40 PD18-05 CLINICAL CHARACTERISTICS AND RISK FACTORS FOR SURVIVAL IN AFFECTED OFFSPRING OF VON HIPPEL-LINDAU DISEASE PATIENTS

kenan Zhang*, Cai Lin, wuping Yang, Kan Gong, Yawei Xu, Beijing, China, People’s Republic of

7:50 PD18-06 NEPHROMETRY SCORES PREDICTING VALUE OF TRIFECTA ACHIEVEMENT IN A MULTICENTER ANALYSIS (ROSULA DATABASE) OF ROBOTIC PARTIAL NEPHRECTOMY FOR TOTALLY ENDOPHYTIC DEEP RENAL MASSES

Gabriele Tuderti*, Riccardo Mastroianni, Umberto Anceschi, Alfredo Maria Bove, Aldo Brassetti, Mariaconsiglia Ferriero, Leonardo Misuraca, Salvatore Guaglianone, Rome, Italy, Riccardo Autorino, Richmond, VA, Jihad Kaouk, Cleveland, OH, Clayton Lau, Duarte, CA, Francesco Por-piglia, Turin, Italy, Ithaar Derweesh, Ava Saidian, Mimi Nguyen, San Diego, La Jolla, CA, Alexandre Mottrie, Aalst, Belgium, Andrea Mari, Florence, Italy, Manuela Costantini, Roma, Italy, Andrea Minervini, Florence, Italy, Michele Gallucci, Giuseppe Simone, Roma, Italy

8:00 PD18-07 PERFORMANCE OF GFR CALCULATORS: CKD-EPI 2021, CKD-EPI 2009, AND MDRD IN ESTIMATION OF KIDNEY FUNCTION PRIOR TO NEPHRECTOMY

Maria Antony*, Aditi Chaurasia, Nikhil Gopal, Pouria Yazdian, Zach Kozel, Sandeep Gurram, Marston Linehan, Mark Ball, Bethesda, MD

8:10 PD18-08 PROGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO FOR SMALL RENAL CELL CARCINOMAS AFTER IMAGE-GUIDED CRYOABLATION (CRYO) OR RADIO-FREQUENCY ABLATION (RFA)

Aqua Asif*, Leicester, United Kingdom, Filzah Hanis Osman, Jasmine Sze-Ern Koe, Leeds, United Kingdom, Alexander Ng, London, United Kingdom, Jon Cartledge, Michael Kimuli, Naveen Vasudev, Christy Ralph, Satinder Jagdev, Selina Bhattarai, Jonathan Smith, James Lenton, Vinson Wai-Shun Chan, Tze Min Wah, Leeds, United Kingdom

8:20 PD18-09 A NOVEL PROGNOSTIC BIOMARKER TO PREDICT TUMOR MUTATION BURDEN BASED ON DEEP LEARNING FROM SLIDE IMAGES

Jian Lu*, Ji De He, Ye Yan, Zhen Yu Liu, Xue Hua Zhu, Jie Tian, Ze Nan Liu, Jian Gang Liu, Xiang Yu Liu, Beijing, China, People’s Republic of

8:30 PD18-10 GERMLINE TESTING IN RENAL CELL CARCINOMA: CAN ENRICHMENT FEATURES HELP PREDICT GERMLINE ALTERATIONS?

Alexis Rompre-Brodeur*, Nikhil Gopal, Jeunice Owens-Walton, Bradley Webster, Michael Dane-shvar, Christopher Ricketts, Cathy Vocke, Laura Schmidt, Beth Ryan, W. Marston Linehan, Mark W. Ball, Bethesda, MD

8:40 PD18-11 FIRST IN-HUMAN RESULTS OF 68GA-EMP-100 PET FOR IMAGING C-MET EXPRESSION IN RENAL CELL CARCINOMA

Michael Staehler*, Melanie Schott, Alexander Tamalunas, Chistian Stief, Annabel Graser, Severin Rodler, Lena Unterrainer, Peter Bartenstein, Munich, Germany

8:50 PD18-12 INVESTIGATION OF RACE AND ASSOCIATED SOCIOECONOMIC FACTORS IN SURVIVAL OUTCOMES FOR PATIENTS WITH RENAL CELL CARCINOMA

Ridwan Alam*, Mary Rostom, Sunil Patel, Baltimore, MD, Solomon Woldu, Dallas, TX, Yasser Ged, Nirmish Singla, Baltimore, MD


94


Podium Session 19STONE DISEASE: SURGICAL THERAPY (INCLUDING ESWL) II

Room 245 @ Ernest N. Morial Convention CenterModerators: Pablo Contreras & Jorge Gutierrez Aceves

ABSTRACTTIME NUMBER TITLE7:00 PD19-01 RANDOMIZED CONTROLLED TRIAL (RCT)

COMPARING HOLMIUM LASER WITH MOSES TECHNOLOGY AND SUPERPULSED LASER SYSTEM WITH THULIUM LASER FOR RENAL AND URETERAL STONES: PRELIMINARY SINGLE CENTER RESULTS

Christopher Haas*, Margaret Knoedler, Shuang Li, Kristina L. Penniston, Sara Best, Stephen Y. Nakada, Madison, WI

7:10 PD19-02 COMPARISON OF SUPERPULSE THULIUM FIBER LASER VS. HOLMIUM LASER FOR ABLATION OF RENAL CALCULI IN AN IN VIVO PORCINE MODEL

Andrew Afyouni*, Zhamshid Okhunov, Pengbo Jiang, Sohrab Ali, Hosseini Sharifi, Linda Huynh, Nina Kar, Douglas Schneider, Maged Ayad, Krista Larson, Roshan Patel, Jaime Landman, Ralph Clayman, Orange, CA

7:20 PD19-03 ASSESSMENT OF FACTORS INVOLVED IN LASER FIBER DEGRADATION WITH THULIUM FIBER LASER

Thibault Germain, Laurent Berthe, Frédéric Pan-thier, Cyril Gorny, Olivier Traxer, Steeve Doizi*, Paris, France

7:30 PD19-04 NOBODY LIKES BURNT POPCORN: THE MOST EFFICIENT POPCORNING SETTINGS IN A NOVEL 3D-KIDNEY MODEL THAT LIMITS THERMAL INJURY

Christian Tabib*, Zachary Dionise, Sabrina Tran, Francois Soto-Palou, Pei Zhong, Glenn Preminger, Michael Lipkin, Durham, NC

7:40 PD19-05 BASKETING VERSUS DUSTING LITHOTRIPSY FOR KIDNEY STONES DURING FLEXIBLE URETEROSCOPY: RANDOMIZED CONTROLLED TRIAL AND COMPUTERIZED TOMOGRAPHY FOLLOW UP

Alex Meller*, Rafael Astolfi, Gustavo Freschi, Raphael Carrera, Marcus Sadi, São Paulo, Brazil

7:50 PD19-06 URETERAL STENT DECOMPRESSION IS ASSOCIATED WITH DECREASED LENGTH OF STAY IN OBSTRUCTIVE, INFECTED URETERAL STONES: A MULTICENTER, RETROSPECTIVE CASE CONTROL STUDY

Albert S Ha*, Gregory W Hruby, David S Han, Rainjade Chung, Jeffrey Johnson, Isaac H Michaels, Aaron Brant, Christina Sze, Annanias Motta Burgos, Spyridon Basourakos, Patrick Lewicki, Timothy McClure, Ojas Shah, New York, NY

ABSTRACTTIME NUMBER TITLE8:00 PD19-07 ARE PATIENTS STENTED FOR SEPTIC

URETERAL STONES MORE LIKELY TO EXPERIENCE INFECTIOUS COMPLICATIONS AT TIME OF DEFINITIVE MANAGEMENT THAN THOSE STENTED FOR NON-INFECTIOUS INDICATIONS?

Ginnie Jeng*, Hempstead, NY, Simon J Hall, New Hyde Park, NY

8:10 PD19-08 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME AND QUICK SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE FOR PREDICTION OF SEPTIC SHOCK AFTER PERCUTANEOUS NEPHROLITHOTOMY: A SUB-ANALYSIS OF A MULTI-CENTER PROSPECTIVE TRIAL FROM THE EDGE CONSORTIUM

Jillian J. Gerrity*, Jonathan H. Berger, San Diego, CA, Naren Nimmagadda, Nicholas Kavoussi, Nashville, TN, Tony T. Chen, San Diego, CA, Amy E. Krambeck, Chicago, IL, Tim Large, Indianap-olis, IN, Seth K. Bechis, San Diego, CA, David F. Friedlander, Chapel Hill, NC, Manoj Monga, San Diego, CA, Ryan S. Hsi, Nicole L. Miller, Nash-ville, TN, Ben H. Chew, Dirk Lange, Vancouver, Canada, Bodo Knudsen, Michael W. Sourial, Columbus, OH, Mitchell R. Humphreys, Karen L. Stern, Scottsdale, AZ, Ojas Shah, New York, NY, Joel E. Abbott, Garen Abedi, Roger L. Sur, San Diego, CA

8:20 PD19-09 SEEING IS BELIEVING: OPTIMIZING RENAL PELVIC PRESSURE IMPROVES VISUALIZATION DURING ENDOSCOPIC COMBINED INTRARENAL SURGERY

Cayde Ritchie*, John Hartman, Akin Amasyali, John Jung, Aviram Assidon, Joshua Belle, D. Duane Baldwin, Loma Linda, CA

8:30 PD19-10 DOES POWER MATTER? A COMPARISON OF HOLMIUM LASERS IN AN AUSTRALIAN TERTIARY CENTRE

Romy Mondschein*, Prahran, Australia, Philip McCahy, Clayton, Australia

8:40 PD19-11 NARCOTIC FREE URETEROSCOPIC LASER LITHOTRIPSY: A PROSPECTIVE RANDOMIZED STUDY

Jacob Bamberger*, Brooklyn, NY, Blair Gallante, Anna Zampini, William M Atallah, Johnathan A Khusid, Areeba S Sadiq, Alan Yaghoubian, Mantu Gupta, New York, NY



SA

TU

RD

AY


Podium Session 20INFERTILITY: EPIDEMIOLOGY & EVALUATION II

Room 244 @ Ernest N. Morial Convention CenterModerators: Akanksha Mehta & Sidney Glina

ABSTRACTTIME NUMBER TITLE7:00 PD20-01 AGE AT PRESENTATION OF INFERTILE

MEN HAS STABLY INCREASED OVER THE LAST TWO DECADES: ANALYSIS FROM A LONGITUDINAL STUDY

Luca Boeri*, Milan, Italy, Paolo Capogrosso, Varese, Italy, Giuseppe Fallara, Federico Belladelli, Edoardo Pozzi, Massimiliano Raffo, Christian Corsini, Luigi Candela, Antonio Costa, Daniele Cignoli, Nicolò Schifano, Alessia d’Arma, Eugenio Ventimiglia, Luca Pagliardini, Enrico Papaleo, Milan, Italy, Vincenzo Mirone, Naples, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy

7:10 PD20-02 SEMEN QUALITY IMPROVEMENT BY PRE-CONCEPTION CARE FOR MALE PARTNERS OF INFERTILITY COUPLES

Akira Komiya*, Mayuko Kato, Tomokazu Sazuka, Yusuke Imamura, Shinichi Sakamoto, Tomohiko Ichikawa, Makiko Tajima, Yuko Takayanagi, Yurie Nako, Kenichiro Hiraoka, Nozomi Uchida, Saki Ichikawa, Kiyotaka Kawai, Chiba-shi, Japan

7:20 PD20-03 ALDH2 EXPRESSION, ALCOHOL INTAKE, AND SEMEN PARAMETERS AMONG EAST ASIAN MEN

Daniel R. Greenberg*, Chicago, IL, Hriday P. Bhambhvani, Satvir S. Basran, Brett P. Salazar, Sin-Jin Li, Che-Hong Chen, Daria Mochly-Rosen, Michael L. Eisenberg, Stanford, CA

7:30 PD20-04 DOES AIR POLLUTION IMPACT ON SEMEN PARAMETERS: FINDINGS FROM A REAL-LIFE CROSS-SECTIONAL STUDY IN WHITE-EUROPEAN INFERTILE MEN

Federico Belladelli*, Giuseppe Fallara, Edoardo Pozzi, Massimiliano Raffo, Christian Corsini, Luigi Candela, Antonio Costa, Daniele Cignoli, Nicolò Schifano, Alessia d’Arma, Milan, Italy, Paolo Cap-ogrosso, Varese, Italy, Luca Boeri, Eugenio Ven-timiglia, Rayan Matloob, Luca Pagliardini, Enrico Papaleo, Milan, Italy, Vincenzo Mirone, Naples, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy

7:40 PD20-05 HIGH PREVALENCE OF HORMONAL ABNORMALITIES IN MEN WITHOUT OLIGOSPERMIA

Matthew Hudnall*, Bailey Goyette, Minh Pham, Jeremy Lai, Justin Dubin, Chicago, IL, Richard Fantus, Evanston, IL, James Wren, Nelson Bennett, Robert Brannigan, Joshua Halpern, Chicago, IL

ABSTRACTTIME NUMBER TITLE7:50 PD20-06 CHALLENGING THE EAU GUIDELINES ON

SPERM DNA FRAGMENTATION TESTING IN PRIMARY INFERTILE MEN

Edoardo Pozzi*, Giuseppe Fallara, Federico Belladelli, Christian Corsini, Massimiliano Raffo, Luigi Candela, Antonio Costa, Daniele Cignoli, Nicolò Schifano, Alessia d’Arma, Milan, Italy, Paolo Capogrosso, Varese, Italy, Luca Boeri, Luca Pagliardini, Eugenio Ventimiglia, Rayan Matloob, Francesco Montorsi, Andrea Salonia, Milan, Italy

8:00 PD20-07 ELEVATED ROS LEVELS AND DNA FRAGMENTATION IN SPERM FROM CONVALESCENT MEN IN SARS-COV-2 INFECTION

Jorge Hallak*, Felipe Bernardes, Thiago Afonso Carvalho Celestino Teixeira, Paulo Hilario Nascimento Saldiva, Esper Georges Kallas, Elia Tamaso Espin Garcia Caldini, Amaro Nunes Duarte Neto, Heloisa Faquineti, Vinicius Luiz Menezes Jesus, São Paulo, Brazil, Raul Segundo Sanchez Gutierrez, Temuco, Chile, Joel R Drevet, Clermont-Ferrand, France

8:10 PD20-08 CONCERNS ABOUT FERTILITY: A MAJOR CAUSE OF COVID-19 VACCINE HESITANCY IN THE UNITED STATES

Parris Diaz*, John Zizzo, Navin C. Balaji, Rohit Reddy, Kajal Khodamoradi, Miami, FL, Jesse Ory, Halifax, Canada, Ranjith Ramasamy, Miami, FL

8:20 PD20-09 VARICOCELE IS UNDERDIAGNOSED IN MEN EVALUATED FOR INFERTILITY: EXAMINATION OF MULTI-CENTER LARGE SCALE ELECTRONIC HEALTH RECORD DATA

Chase Carto, Vinayak Madhusoodanan*, Sirpi Nackeeran, Ranjith Ramasamy, Miami, FL

8:30 PD20-10 MICROSURGICAL VARICOCELECTOMY IS ASSOCIATED WITH IMPROVEMENT IN CAP-SCORETM AND PROBABILITY OF GENERATING A PREGNANCY IN INFERTILE MEN

Jessica Marinaro*, Aaron Brant, Christopher Gaffney, Philip Xie, Nahid Punjani, Caroline Kang, Gianpiero Palermo, James Kashanian, New York, NY

8:40 PD20-11 WOMEN IN MEDICINE: CAREER VS FAMILY. CAN WE HAVE BOTH?

Niki Parikh*, Manaf Alom, Mohamed Ahmed, Maraika Robinson, Sarah McGriff, Elizabeth Ol-ive, Tobias Kohler, Matthew Ziegelmann, Sevann Helo, Rochester, MN

8:50 PD20-12 VASECTOMY REVERSAL SEARCH TRENDS AND ADVERTISING IN THE UNITED STATES

Vivian Hua*, Lin Chen, Scott Lundy, Sarah Vij, Cleveland, OH


96


Podium Session 21INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: KIDNEY & BLADDER II

Room 243 @ Ernest N. Morial Convention CenterModerators: Anne Suskind & J. Todd Purves

ABSTRACTTIME NUMBER TITLE7:00 PD21-01 PATHOLOGICAL CHANGES IN THE KIDNEYS

IN PATIENTS WITH ACUTE RENAL INJURY DUE TO CORONAVIRUS INFECTION

Valentin Pavlov*, Dmitry Vishnyakov, Anushavan Papoyan, Aleksandr Alekseev, Ildar Kabirov, Ufa, Russian Federation

7:10 PD21-02 NOVEL MECHANISMS OF INJURY IN MEMBRANOUS NEPHROPATHY

Qi Zhang, Los Angeles, CA, Paolo Cravedi, New York, NY, Astgik Petrosyan, Valentina Villani, Roger De Filippo, Laura Perin, Stefano Da Sacco*, Los Angeles, CA

7:20 PD21-03 A NOVEL PHOTO-CROSSLINKABLE KIDNEY ECM-DERIVED BIOINK FOR RENAL TISSUE REGENERATION

Sang Jin Lee, Gabriel Carreno Galeano, Mohamed Ali, John Jackson*, James Yoo, Anthony Atala, Winston Salem, NC

7:30 PD21-04 UNDERUTILIZATION OF THE BOSNIAK CLASSIFICATION SYSTEM FOR DESCRIPTION OF RENAL CYSTS

Caleb S Miller*, Austin Martin, Danica N May, Jill Jones, David A Duchene, Kansas City, KS

7:40 PD21-05 EVALUATION OF EARLY SCORING PREDICTORS FOR EXPEDITED CARE IN A LARGE PROSPECTIVE PATIENTS’ COHORT WITH EMPHYSEMATOUS PYELONEPHRITIS

Arun Chawla, Sunil Pillai, Ravi Taori, Arun Chawla*, Manipal, India

7:50 PD21-06 INFLAMMATORY MYOFIBROBLASTIC TUMOR OF THE GENITOURINARY TRACT: A SYSTEMATIC REVIEW

Nikolas Moring*, Daniel Swerdloff, Mahmut Akgul, Tipu Nazeer, Badar Mian, Albany, NY

8:00 PD21-07 OBESITY INFLUENCE ON BLADDER INFLAMMATION: A CYSTITIS MODEL

Cristiano T. de Andrade, Marina Z. C. dos Santos, Guilherme Z. Rocha, Karen L. Ferrari, Campinas, Brazil, Rodolfo B. dos Reis, Ribeirão Preto, Brazil, Leonardo Reis*, Campinas, Brazil

8:10 PD21-08 THE INCIDENCE OF NEW OR WORSENING OAB SYMPTOMS IN PATIENTS WITH PRIOR SARS COV-2 INFECTION

Ly Hoang Roberts*, Bernadette Zwaan, Michael Chancellor, Kenneth Peters, Priya Padmanabhan, Royal Oak, MI

ABSTRACTTIME NUMBER TITLE8:20 PD21-09 IDENTIFICATION OF KEY MOLECULAR

PLAYERS IN THE DEVELOPMENT OF RADIATION CYSTITIS THROUGH RNA SEQUENCING

Elijah Ward*, Alexander Carabulea, Sarah Bartolone, Laura Lamb, Michael Chancellor, Bernadette Zwaans, Royal Oak, MI

8:30 PD21-10 HETEROGENEITY IN THE MANAGEMENT OF RADIATION-INDUCED HEMORRHAGIC CYSTITIS

Brendan K. Wallace*, Anton M. Gillespie, George W. Moran, Michael B. Smigelski, Christopher B. Anderson, New York, NY

8:40 PD21-11 WITHIN STATE VARIABILITY OF ANTIMICROBIAL SUSCEPTIBILITY: MISSOURI AS AN ARCHETYPE TO ASSESS GUIDELINES FOR ANTIMICROBIAL PROPHYLAXIS FOR TRANSURETHRAL PROCEDURES

Corbin Wright, Geoffrey Rosen*, Shubham Kanake, Mojgan Golzy, Katie Murray, Columbia, MO

8:50 PD21-12 MICROBIOTA AND METABOLITES ARE CONSISTENTLY PRESENT ON IMPLANTED UROLOGICAL DEVICES AND DIFFER SIGNIFICANTLY BASED ON INFECTION STATUS AND DEVICE TYPE

Glenn T. Werneburg*, Ava Adler, Sandip Vasavada, Howard Goldman, Raymond Rackley, Daniel Hettel, Bradley Gill, Kenneth Angermeier, Hadley Wood, Petar Bajic, Smita De, Daniel Shoskes, Jacqueline Zillioux, Aaron Miller, Cleveland, OH



SA

TU

RD

AY


Video Session 4LOWER TRACT RECONSTRUCTION

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerators: Justin Han, Cooper Benson & Tamsin Greenwell

ABSTRACTTIME NUMBER TITLE7:00 V04-01 TRANSANAL APPROACH TO ROBOTIC

REPAIR OF A RECTOURETHRAL FISTULA Jennifer Rosen*, J. Patrick Selph, Daniel Chu,

Birmingham, AL

7:10 V04-02 SIMULTANEOUS REPAIR OF RECTOVESICAL FISTULA WITH BLADDER NECK CONTRACTURE AFTER RADICAL PROSTATECTOMY. A NOVEL ROBOTIC TECHNIQUE

Aref S. Sayegh*, Laura C. Perez, Anibal La Riva, David G. Ortega, Luis G. Medina, Edward For-syth, Ryan Powers, Christine Hsieh, Rene Sotelo, Los Angeles, CA

7:20 V04-03 PATIO REPAIR FOR URETHROCUTANEOUS FISTULA

Sabrina Stair*, Kirtishri Mishra, Christopher Agocs, Lee Zhao, New York, NY

7:30 V04-04 NEW SURGICAL TECHNIQUE: A SINGLE LONG SPIRAL PREPUTIAL GRAFT FOR PANURETHRAL STRICTURE

Pankaj Joshi*, Marco Bandini, Shreyas Bhad-ranawar, Vipin Sharma, Sandeep Bafna, Sanjay Kulkarni, Pune, India

7:40 V04-05 POST TURP OBLITERATIVE STRICTURES Pankaj Joshi*, Vipin Sharma, Sandeep Bafna,

Shreyas Bhadranawar, Marco Bandini, Sanjay Kulkarni, Pune, India

7:50 V04-06 TRANSPERINEAL BULBOVESICAL ANASTOMOSIS AND STAGED ARTIFICIAL URINARY SPHINCTER IMPLANTATION FOR EXTENSIVE POSTERIOR URETHRAL STENOSES

Akio Horiguchi*, Masayuki Shinchi, Kenichiro Ojima, Yusuke Hirano, Ryuichi Azuma, Keiichi Ito, Saitama, Japan

8:00 V04-07 SURGICAL EXCISION OF NEAR-CIRCULAR FEMALE URETHRAL DIVERTICULUM AND CIRCULAR URETHRAL WRAP WITH MARTIUS FLAP

Anna V. van Lingen*, J.L.H. Ruud Bosch, Ronald I. Nooter, Rotterdam, Netherlands

ABSTRACTTIME NUMBER TITLE8:10 V04-08 ROBOT-ASSISTED REPAIR OF BENIGN

DISTAL URETEROENTERIC STRICTURES FOLLOWING RADICAL CYSTECTOMY

Victoria Maxon*, Honolulu, HI, Alvin Goh, New York, NY

8:20 V04-09 UNDOUBLED BLADDER IN THE SAGITTAL PLANE WITH ONE EXSTROPHIC BLADDER: A CASE REPORT ON RECONSTRUCTIVE TECHNIQUE

Wietse Claeys*, Caroline Jamaer, Camille Berquin, Irina Verbakel, Achilles Ploumidis, Erik Van Laecke, Piet Hoebeke, Anne-Françoise Spinoit, Ghent, Belgium

8:30 V04-10 GENDER-AFFIRMING PHALLOPLASTY WITH ANTEROLATERAL THIGH FLAP

Ömer Acar*, Alexi Millman, Luca Morgantini, Loren Schechter, Ervin Kocjancic, Chicago, IL

8:40 V04-11 COMBINATION OF ROBOTIC-ASSISTED LAPAROSCOPIC PEDICLED PERITONEAL FLAP VAGINOPLASTY WITH PENILE SKIN INVERSION TECHNIQUE IN MALE-TO-FEMALE TRANSGENDER SURGERY. INSTRUCTIVE VIDEO-ARTICLE

Eusebio Luna*, Sidhbh Gallagher, Edward Gheiler, Ariel Kaufman, Luanda Perez, Dailianys Barrios, Melanie Milanes, Fernando Bianco, Miami, FL

8:50 V04-12 A SINGLE STAGE URETHROPLASTY FOR PRIMARY PENOSCROTAL ADULT HYPOSPADIAS

Pankaj Joshi*, Vipin Sharma, Sandeep Bafna, Shreyas Bhadranawar, Marco Bandini, Sanjay Kulkarni, Pune, India


98


ForumsUROLOGIC CARE FOR THE ADVANCED PRACTICE PROVIDER


8:00 WELCOME/INTRODUCTION Co-Course Directors: Anne Lizardi-Calvaresi,

James Kovarik

8:10 PRE-TEST #1 Co-Course Directors: Anne Lizardi-Calvaresi,

James Kovarik

8:15 TESTICULAR CANCER UPDATE FOR APPS Co-Course Director: Anne Lizardi-Calvaresi

8:55 PODIUM PRESENTATION: AN ADVANCED PRACTICE PROVIDER CAN DECREASE HOSPITAL LENGTH OF STAY FOR PATIENTS UNDERGOING UROLOGIC ONCOLOGY SURGERY

Speaker: Michael Humphrey

9:10 UNDERSTANDING BIOMARKERS FOR PROSTATE CANCER

Faculty: Rachel Hastings

10:05 PODIUM PRESENTATION: ADVANCED PRACTICE PROVIDER-LED TRANSPERINEAL PROSTATE BIOPSY CLINIC: INITIAL EXPERIENCE AND OUTCOMES

Speaker: Alex O’Hara

10:20 OVERACTIVE BLADDER FUNDAMENTALS Faculty: Susan Flick

11:00 INTERSTITIAL CYSTITIS: UPDATES IN MEDICAL MANAGEMENT

Faculty: Christina Hicks

11:40 PODIUM PRESENTATION: PREVENTION OF LOW-ER URINARY TRACT SYMPTOMS (PLUS): ROLE OF AN APP IN NIH-FUNDED RESEARCH

Speaker: Diane Newman

11:55 PODIUM PRESENTATION: A DEHISCED PERINE-AL URETEROSTOMY WALKS INTO THE UROLOGY CLINIC: TIPS FOR OPTIMIZING COMPLEX-GENI-TOURINARY WOUND HEALING

Speaker: Erika Orban

12:10 POST-TEST #1 Co-Course Directors: Anne Lizardi-Calvaresi,

James Kovarik

1:35 AUAUNIVERSITY UPDATE Co-Course Director: James Kovarik

1:45 PRE-TEST #2 Co-Course Directors: Anne Lizardi-Calvaresi,

James Kovarik

1:50 BPH GUIDELINE UPDATE FOR APPS Co-Course Director: James Kovarik

2:30 EJACULATORY DYSFUNCTION GUIDELINE (2021) UPDATE

Faculty: Alan Shindel

3:25 GETTING AHEAD OF THE CURVE—DIAGNOSIS AND TREATMENT FOR PEYRONIE’S DISEASE

Faculty: Lynn Allmond

4:05 PODIUM PRESENTATION: SETTING THE MOOD: IMPROVING SATISFACTION FOR MALE PATIENTS DURING PENILE ASSESSMENT

Speaker: Elise Tentis

4:20 PODIUM PRESENTATION: PENILE AMPUTATION—BEGINNING TO END—AN INFORMATIVE CASE STUDY WITH MULTIDISCIPLINARY CARE

Speaker: Hillary Durstein

4:35 PODIUM PRESENTATION: PENILE CALAPHYLAXIS Speaker: Maria Pinnock

4:50 POST-TEST #2 Co-Course Directors: Anne Lizardi-Calvaresi,

James Kovarik


SOCIETIES FOR PEDIATRIC UROLOGY (SPU)Grand Ballroom CD @ Hilton New Orleans Riverside

7:55 WELCOME Chairs: Gina Lockwood, Rosalia Misseri Society President: C.D. Anthony Herndon

8:00 NEUROGENIC BLADDER…BEYOND SPINA BIFIDA Moderator: Travis Groth

CEREBRAL PALSY Sean Elliott

TRANSVERSE MYELITIS Micah Jacobs

SPINAL CORD INJURY Jennifer Hagerty

DISCUSSION

8:45 LANDMARK PAPERS IN PEDIATRIC UROLOGY: REFLECTIONS FROM THE AUTHORS

Moderator: John Thomas

MODIFIED TUBULARIZED TRANSVERSE PREPU-TIAL ISLAND FLAP REPAIR FOR SEVERE PROXI-MAL HYPOSPADIAS

Doug Canning

THE VALVE BLADDER SYNDROME: PATHOPHYS-IOLOGY AND TREATMENT WITH NOCTURNAL BLADDER EMPTYING

Stephen Koff

TRANS-APPENDICULAR CONTINENT CYSTOSTO-MY IN THE MANAGEMENT OF THE NEUROGENIC BLADDER INTERVIEW WITH PAUL MITROFANOF

Matthieu Peycelon

DISCUSSION


SA

TU

RD

AY

9:30 PEDIATRIC ONCOLOGY WORKING GROUP Moderator: Nicholas Cost

INTRODUCTION AND BROAD OVERVIEW OF COG RENAL TUMOR COMMITTEE

Nicholas Cost

DISCUSSION OF CURRENT STANDARDS OF CARE FOR UNILATERAL WILMS

Rodrigo Romao

DISCUSSION OF CURRENT STANDARDS OF CARE FOR BILATERAL WILMS/UNILATERALLY PREDISPOSED

Kathleen Kieran

SPECIFIC DISCUSSION ABOUT ROLE OF BIOPSY AND HOW THAT IMPACTS TREATMENT OF WILMS

Amanda Saltzman

DISCUSSION

10:15 BREAK—VISIT EXHIBITS

10:45 PRESENTATION OF SPU RESEARCH GRANT Linda Baker

10:55 WHEN SHOULD THE BALL DROP? CONSEQUENCES OF CRYPTORCHIDISM

Moderator: Dana Giel

TUMOR Clint Cary

TIMING Christopher Bayne

FERTILITY Richard Yu

DISCUSSION

11:35 SPU PRESIDENTIAL ADDRESS: UPDATE ON SPU Society President: C.D. Anthony Herndon

12:00 LUNCH ON OWN

1:15 MEREDITH CAMPBELL LECTURE Moderator: C.D. Anthony Herndon

PEER REVIEW, OPEN ACCESS, PREDATORY JOURNALISM AND THE FUTURE OF SCIENTIFIC COMMUNICATION

Keynote Speaker: Anthony Caldamone

2:15 CONTROVERSIES IN THE SURGICAL MANAGE-MENT OF THE INFANT NON-REFLUXING MEGAURETER

Moderator: Armando Lorenzo

REFLUXING URETEROVESICOSTOMY Armando Lorenzo

ENDOSCOPIC APPROACHES Diana Bowen

LAPAROSCOPIC AND ROBOTIC APPROACHES Renea Sturm

DISCUSSION

2:40 BREAK—VISIT EXHIBITS

3:00 WHAT IS YOUR NEXT STEP? POINT/COUNTER-POINT WITH AUDIENCE PARTICIPATION

Moderator: Vijaya Vemulakonda

BLADDER NECK RECONSTRUCTION Dominic Frimberger, Brian VanderBrink

HIGH INTRA-ABDOMINAL TESTICLE Seth Alpert, Casey Seideman

TECHNIQUES FOR UTI PREVENTION IN NGB Douglas Storm, Stacy Tanaka

DISCUSSION

3:50 EVOLUTION OF ROBOTIC SURGERY IN PEDIAT-RIC UROLOGY: WHERE ARE WE NOW?

Moderator: Miguel Castellan

UPPER TRACT Benjamin Whittam

LOWER TRACT Aseem Shukla

EVOLUTION Kate Kraft

DISCUSSION

4:25 NON-HYPOSPADIAS PENILE ANOMALIES: THE BENT, OBSCURE, AND TWISTED

Moderator: Hillary Copp

PENILE CURVATURE Nicolas Fernandez

BURIED PENIS AND PENILE TORSION Anne-Françoise Spinoit

DISCUSSION

5:00 SPU RECEPTION


100


SOCIETY FOR BASIC UROLOGIC RESEARCH/SOCIETY OF UROLOGIC ONCOLOGY (SBUR/SUO)LaNouvelle Orleans Ballroom C @ Ernest N. Morial Convention Center

Chairs: Daniel Lin & William Ricke

8:00 WELCOME AND INTRODUCTORY REMARKS Chairs: Daniel Lin, William Ricke

8:05 DON COFFEY LECTURESHIP: AGING HALL-MARKS IN NORMAL AGING AND DISEASE PRO-GRESSION—THE SCIENCE AND THE TRAINING

Keynote Speaker: Judy Campisi

9:05 SENESCENCE PROMOTES AGING AND CANCER Darren Baker

9:35 SENESCENT CELLS IN THE LOWER URINARY TRACT AND CANCER: CLINICAL AND BASIC SCI-ENCE APPROACHES

David Jarrard

10:05 THE AGING BLADDER, MITOCHONDRIAL DYS-FUNCTION, AND CANCER

Cathy Mendelsohn

10:35 BREAK

10:45 MECHANISM OF CASTRATION RESISTANCE IN CANCER PROGRESSION

Colm Morrissey

11:15 ANDROGEN RECEPTOR FUNCTION IN CASTRA-TION RESISTANT PROSTATE CANCERS

Amina Zoubeidi



AMERICAN COLLEGE OF OSTEOPATHIC SURGEONS (ACOS)Room 260 @ Ernest N. Morial Convention Center

Chair: W. Britt Zimmerman

8:00 MAJOR DEPRESSIVE ORDERS IN UROLOGIC ONCOLOGY

Nathan Hale

8:45 MICHIGAN UROLOGICAL SURGERY IMPROVE-MENT COLLABORATIVE MUSIC

Richard Sarle

9:30 UPDATES ON KIDNEY TUMOR MANAGEMENT Craig Rogers

10:15 UPDATE ON FEMALE UROLOGY ISSUES Humphrey Atiemo

11:00 TRANSGENDER SURGERY DETAILS FOR THE PRAC-TICING UROLOGIST: WHAT YOU NEED TO KNOW

Richard Santucci

11:45 LUNCH

1:00 ANTIBIOTIC TALK Bruce Jacobs

1:45 PROSTATE CANCER RISK STRATIFICATION IN THE ERA OF MRI

Michael Stencel

2:45 UPDATES IN URETHRAL RECONSTRUCTION W. Britt Zimmerman

3:30 ADVANCES IN KIDNEY STONE MANAGEMENT Kenneth Sands

4:30 MANAGEMENT OF SMALL ADRENAL MASSES Samuel Deem



Moderated Poster Session 22TRAUMA/RECONSTRUCTION/DIVERSION: URETHRAL RECONSTRUCTION (INCLUDING STRICTURE, DIVERTICULUM) I

Room 228 @ Ernest N. Morial Convention CenterModerators: Jennifer Anger, Kenneth Angermeier & Miroslav Djordjevic

ABSTRACT NUMBER TITLE MP22-01 PREDICTIVE FACTOR0S OF RECURRENCE

OF URETHRAL STRICTURES AFTER A FIRST INTERNAL URETROTOMY

Skander Zouari*, Saadi Ahmed, Marouene Chakroun, Selim Zaghbib, Setti Boubaker Nouha, Hamza Boussaffa, Abderrazek Bouzouita, Amine Derouiche, Riadh Ben Slama, Haroun Ayed, Mohamed Chebil, Tunis, Tunisia

MP22-02 MODIFIED USS PROM FOR DVIU AND NON TRANSECTING URETHROPLASTY FOR SHORT BULBAR URETHRAL STRICTURES

Arun Chawla*, Suraj Jaidev Reddy, Sitaram Mum-malaneni, Manipal, India

ABSTRACT NUMBER TITLE MP22-03 URETHRAL CATHETER VS SUPRAPUBIC

CATHETER: WHICH DRAINS MORE COMPLETELY AND WHY?

Aurash Naser-Tavakolian*, John Masterson, Jer-emiah Dallmer, Catherine Bresee, Hanson Zhao, Maurice Garcia, Los Angeles, CA

MP22-04 DOES A PREEMPTIVE QUALITY OF LIFE CLINIC INCREASE UTILIZATION OF TREATMENT OPTIONS FOLLOWING RADICAL PROSTATECTOMY?

P. Walker Prillaman*, Elizabeth Roger, Franc-esca Monn, Gregory Mansour, Jessica DeLong, Ramon Virasoro, Kurt McCammon, Norfolk, VA


SA

TU

RD

AY

MP22-05 DOES STARTING PELVIC FLOOR PHYSICAL THERAPY PRIOR TO RADICAL PROSTATECTOMY IMPROVE POST-OPERATIVE CONTINENCE RATES?

P. Walker Prillaman*, Elizabeth Roger, Franc-esca Monn, Gregory Mansour, Jessica DeLong, Ramon Virasoro, Kurt McCammon, Norfolk, VA

MP22-06 THE IMPACT OF PROSTATE CANCER DISEASE PROGRESSION AND SALVAGE OR ADJUVANT TREATMENT ON ARTIFICIAL URINARY SPHINCTER DEVICE OUTCOMES

Shree Agrawal*, Hanson Zhao, Joao Pedro Em-rich Accioly, Hadley Wood, Kenneth Angermeier, Cleveland, OH

MP22-07 OUTCOMES OF DORSAL ONLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY IN PATIENTS WITH POST-PROSTATECTOMY, POST-RADIATION ANASTOMOTIC CONTRACTURE

Joshua Sterling*, Alex Wang, Kelly Crane, Syracuse, NY, Javier C. Angulo, Madrid, Spain, Wagner Franca, Sao Paulo, Brazil, Brian Flynn, Denver, CO, Francisco Martins, Lisbon, Portu-gal, Erick A. Ramirez, Mexico City, Mexico, Paul Rusilko, Pittsburgh, PA, Jay Simhan, Daniel Swerdloff, Philadelphia, PA, Dmitriy Nikolavsky, Syracuse, NY

MP22-08 LESS IS MORE IN THE MANAGEMENT OF PROXIMAL STRICTURE DISEASE AFTER PROSTATE CANCER TREATMENT

Peris Castaneda*, Kai Dallas, Los Angeles, CA, Hanson Zhao, Cleveland, OH, Jennifer Anger, San Diego, CA

MP22-09 URETHRAL STRICTURE/STENOSIS AS A COMPLICATION OF HIGH INTENSITY FOCUSED ULTRASOUND OF THE PROSTATE: WHAT IS THE OVERALL PATIENT EXPERIENCE?

David Barham*, Orange, CA, John Barnard, Morgantown, WV, Joel Gelman, Orange, CA

MP22-10 HOW IS HEALTH-RELATED QUALITY OF LIFE AFFECTED BY SALVAGE CYSTECTOMY AND URINARY DIVERSION AS A LAST-LINE OPTION FOR BENIGN DISEASE

Yannic Volz, Lennert Eismann*, Paulo Pfitzinger, Jan-Friedrich Jokisch, Gerald Schulz, Severin Rodler, Alexander Buchner, Boris Schlenker, Christian Stief, Alexander Kretschmer, Munich, Germany

MP22-11 SUCCESSFUL TRANSURETHRAL ENGRAFTMENT OF BUCCAL MUCOSAL CELLS EXPANDED IN VITRO, TRANSPLANTED IN A POLYMER SCAFFOLD CARRIER IN A RABBIT URETHRAL STRICTURE MODEL, AND PROVEN WITH IMMUNOHISTOCHEMICAL BIOMARKERS

Akio Horiguchi*, Toshihiro Kushibiki, Kenichiro Ojima, Masayuki Shinchi, Yusuke Hirano, Yoshine Mayumi, Keiichi Ito, Kosuke Miyai, Saitama, Japan, Ichiro Miura, Hokkaido, Japan, Masayuki Takeda, Masaru Iwasaki, Yamanashi, Japan, Sho-jiro Kato, Senthilkumar Rajappa, Tokyo, Japan, Samuel JK Abraham, Yamanashi, Japan

MP22-12 CLINICAL APPLICATION OF DOUBLE-MODIFIED SULFATED BACTERIAL CELLULOSE SCAFFOLD MATERIAL LOADED WITH FGFR2-MODIFIED ADIPOSE STEM CELLS IN LOWER URINARY TRACT RECONSTRUCTION

Zhenpeng Zhu*, Jiayu Yang, Xing Ji, Yudong Zheng, Jian Lin, Liqun Zhou, Beijing, China, People’s Republic of

MP22-13 OFF THE SHELF ACELLULAR FETAL SKIN SCAFFOLD AS A NOVEL ALTERNATIVE TO BUCCAL MUCOSA GRAFT: THE DEVELOPMENT AND CHARACTERIZATION OF HUMAN TISSUE ENGINEERED FETAL DERMAL MATRIX IN RABBIT MODEL OF HYPOSPADIASIS

Abdol-Mohammad Kajbafzadeh, Soheila Sobhani*, Fahimeh Jafarnezhad-Ansariha, Tehran, Islamic Republic of Iran

MP22-14 A MIXED METHODS APPROACH TO EXPLORING PATIENT MOTIVATIONS FOR DELAYING DEFINITIVE TREATMENT OF URETHRAL STRICTURE DISEASE

Abimbola Ayangbesan*, George Koch, Helen Gambrah, Rohan Bhalla, Jackson Cabo, Stephen Hill, Niels Johnsen, Nashville, TN

MP22-15 THE EFFECT OF TOBACCO USE ON BUCCAL MUCOSA: AN EVALUATION OF HISTOLOGIC CHANGES

Connor Policastro*, Joshua Sterling, Daniel Zaccarini, Baylee Porter, Guanqun Li, Gennady Bratslavsky, Dmitriy Nikolavsky, Syracuse, NY

MP22-16 AFFIRMING LONG-TERM STRICTURE-FREE RATES AND PATIENT SATISFACTION AFTER URETHROPLASTY: THE NEGATIVE IMPACT OF PANURETHRAL, LICHEN SCLEROSUS, RADIATION AND INFECTIOUS STRICTURES

Kai Fender*, Keith Rourke, Nathan Hoy, Edmonton, Canada

MP22-17 DEFINING THE OPTIMAL MANAGEMENT OF LICHEN SCLEROSUS INDUCED PENILE URETHRAL STRICTURES: A COMPARISON OF SINGLE-STAGE URETHROPLASTY, STAGED URETHROPLASTY AND PERINEAL URETHROSTOMY

Alexander Hengel*, Nathan Hoy, Keith Rourke, Edmonton, Canada

MP22-18 REVISION URETHROPLASTY AFTER FAILED EXCISION AND PRIMARY ANASTOMOSIS AND TISSUE TRANSFER REPAIR FOR BULBAR URETHRAL STRICTURES: OUTCOME ANALYSIS

David Barham*, Orange, CA, Aron Liaw, Detroit, MI, Joel Gelman, Orange, CA

102

MP22-19 OUTCOMES OF PRIMARY AND RE-DO EPISPADIAS REPAIR IN PEDIATRIC AND ADULT POPULATION

Marta Bizic*, Borko Stojanovic, Marko Bencic, Miroslav L. Djordjevic, Belgrade, Serbia

MP22-20 IS SUPRACRURAL REROUTING (STEP 4 ANASTOMOTIC URETHROPLASTY) BECOMING ANECDOTICAL IN THE MANAGEMENT OF PELVIC FRACTURE URETHRAL INJURY?

Christian Yepes*, Marco Bandini, Pankaj Joshi, Shreyas Bhadranavar, Sandeep Bafna, Sanjay B Kulkarni, Pune, India



Moderated Poster Session 23BLADDER CANCER: INVASIVE III

Room 225 @ Ernest N. Morial Convention CenterModerators: Katie Murray & Alan Nieder

ABSTRACT NUMBER TITLE MP23-01 URETHRECTOMY AT THE TIME OF

RADICAL CYSTECTOMY FOR NON-METASTATIC UROTHELIAL CARCINOMA OF THE BLADDER: A COLLABORATIVE MULTICENTER STUDY

Ekaterina Laukhtina*, Vienna, Austria, Axelle Boe-hm, Tours, France, Benoit Peyronnet, Rennes, France, Carlo Andrea Bravi, Milan, Italy, Jose Batista Da Costa, Créteil, France, Francesco Soria, Torino, Italy, David D’Andrea, Fahad Quhal, Pawel Rajwa, Reza Sari Motlagh, Takafumi Yanagisawa, Frederik König, Maximilian Pallauf, Hadi Mostafaei, Tatsushi Kawada, Vienna, Aus-tria, Dmitry Enikeev, Moscow, Russian Federa-tion, Alexandre Ingels, Créteil, France, Gregory Verhoest, Rennes, France, Frederiek D’Hondt, Alexandre Mottrie, Aalst, Belgium, Hendrik Van Poppel, Leuven, Belgium, Alexandre De La Taille, Créteil, France, Franck Bruyère, Tours, France, Karim Bensalah, Rennes, France, Shahrokh F. Shariat, Benjamin Pradere, Vienna, Austria

MP23-02 EARLY ONCOLOGIC OUTCOMES OF OPEN VS ROBOT-ASSISTED RADICAL CYSTECTOMY WITH TOTALLY INTRACORPOREAL URINARY DIVERSION: SINGLE CENTRE PROSPECTIVE RANDOMISED CONTROLLED TRIAL

Riccardo Mastroianni*, Gabriele Tuderti, Umberto Anceschi, Alfredo Maria Bove, Aldo Brassetti, Mariaconsiglia Ferriero, Leonardo Misuraca, Sal-vatore Guaglianone, Michele Gallucci, Giuseppe Simone, Rome, Italy

MP23-03 INITIAL EXPERIENCE USING INDOCYANINE GREEN IN ROBOTIC-ASSISTED URETEROENTERIC ANASTOMOSIS

Monica Peradejordi Font*, Alba Sierra del Rio, Claudia Mercader Barrull, Alberto Tello Delsors, Raul Martos Calvo, Barcelona, Spain, Jaime Durruti, Santiago de Chile, Chile, Joan Sureda Riera, Antoni Vilaseca Cabo, Laura Izquierdo Reyes, Maria Jose Ribal Caparros, Antonio Alcaraz Asensio, Mireia Musquera Felip, Barcelona, Spain

ABSTRACT NUMBER TITLE MP23-04 BENEFIT OF NEOADJUVANT

CHEMOTHERAPY FOR INVASIVE BLADDER CANCER PATIENTS TREATED WITH RADIATION-BASED THERAPY: AN INVERSE PROBABILITY TREATMENT WEIGHTED ANALYSIS

Ronald Kool*, Alice Dragomir, Montreal, Canada, Girish Kulkarni, Toronto, Canada, Gautier Marcq, Montreal, Canada, Rodney Breau, Ottawa, Can-ada, Michael Kim, Toronto, Canada, Ionut Busca, Hamidreza Abdi, Ottawa, Canada, Mark Dawidek, Vancouver, Canada, Michael Uy, Hamilton, Can-ada, Gagan Fervaha, Kingston, Canada, Nimira Alimohamed, Calgary, Canada, Jonathan Izawa, London, Canada, Claudio Jeldres, Sherbrooke, Canada, Ricardo Rendon, Halifax, Canada, Bobby Shayegan, Hamilton, Canada, Robert Sie-mens, Kingston, Canada, Peter Black, Vancouver, Canada, Wassim Kassouf, Montreal, Canada

MP23-05 EFFECT OF NEOADJUVANT CHEMOTHERAPY IN IMPROVING OVERALL SURVIVAL OF T2-4AN0M0 BLADDER CANCER PATIENTS: A SYSTEMIC REVIEW AND META-ANALYSIS ACCORDING TO EAU COVID-19 RECOMMENDATION

Dong Hyuk Kang*, Incheon, Korea, Republic of, Jae Yong Jeong, Young Joon Moon, Seoul, Korea, Republic of, Doo Yong Chung, Incheon, Korea, Republic of, Hyun Ho Han, Seoul, Korea, Republic of, Hae Do Jung, Gunpo, Korea, Repub-lic of, Kang Su Cho, Joo Yong Lee, Seoul, Korea, Republic of

MP23-06 NEOADJUVANT CHEMOTHERAPY BEFORE RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER: PATIENT, PROVIDER, AND CLINICAL ETIOLOGIES FOR LACK OF UTILIZATION

Hiten D. Patel, Ushasi Naha*, Victor S. Chen, Caitlyn Ko, Rachel Yang, Maywood, IL, Alek-sander Druck, Tampa, FL, Goran Rac, Marcus L. Quek, Maywood, IL


SA

TU

RD

AY

MP23-07 PREVALENCE AND IMPACT OF FEAR OF RECURRENCE ON BLADDER CANCER PATIENTS AFTER RADICAL CYSTECTOMY

Justin Badal*, Brady Miller, Nora Ruel, Airybelle Uchida, Kelly Franklin, Sumanta Pal, Bertram Yuh, Duarte, CA

MP23-08 ADVERSE PATHOLOGICAL OUTCOMES OF PATIENTS WITH DE NOVO MUSCLE INVASIVE BLADDER CANCER IN NORTHERN ONTARIO

Vahid Mehrnoush, Shahrzad Keramati, Asmaa Ismail, Ahmed Zakaria, Hazem Elmansy, Walid Shahrour, Owen Prowse, Walid Shabana, Ahmed Kotb*, Thunder Bay, Canada

MP23-09 ACUTE KIDNEY INJURY AND ITS DURATION IN PATIENTS TREATED WITH RADICAL CYSTECTOMY IN THE ENHANCED RECOVERY AFTER SURGERY ERA: OPTIMIZING THE SELECTION OF PATIENTS FOR RESTRICTIVE FLUID THERAPY

Alberto Martini, Riccardo Leni*, Francesco Pel-legrino, Giuseppe Basile, Simone Scuderi, Mario De Angelis, Luigi Nocera, Giuseppe Rosiello, Giorgio Gandaglia, Milan, Italy, Andrea Gallina, Lugano, Switzerland, Francesco Montorsi, Alberto Briganti, Marco Moschini, Milan, Italy

MP23-10 LONGITUDINAL ASSESSMENT OF 1-YR HEALTH RELATED QUALITY OF LIFE OUTCOMES: HEAD TO HEAD COMPARISON BETWEEN OPEN AND ROBOT-ASSISTED RADICAL CYSTECTOMY WITH TOTALLY INTRACORPOREAL URINARY DIVERSION FROM A SINGLE CENTER RANDOMISED CONTROLLED TRIAL


MP23-11 PERIOPERATIVE COMPLICATIONS AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: AN INTERNATIONAL MULTICENTER COLLABORATION

Chiara Lonati*, Brescia, Italy, Luca Afferi, Lucerne, Switzerland, Ettore Di Trapani, Milan, Italy, Stefania Zamboni, Claudio Simeone, Brescia, Italy, Alberto Briganti, Francesco Montorsi, Milan, Italy, Giuseppe Simone, Rome, Italy, Francesco Soria, Turin, Italy, M. Carmen Mir, Valencia, Spain, Rafael Sanchez-Salas, Paris, France, Mathieu Roumiguié, Toulouse, France, Alessandro Antonelli, Verona, Italy, Kees Hen-dricksen, Amsterdam, Netherlands, Agostino Mat-tei, Christian D. Fankhauser, Roberto Carando, Lucerne, Switzerland, Jeremy Y.C. Teoh, Hong Kong, China, People’s Republic of, Shahrokh F. Shariat, Vienna, Austria, Simone Albisinni, Bruxelles, Belgium, Rodolfo Hurle, Milan, Italy, Angelo Peroni, Brescia, Italy, Evanguelos Xylinas, Paris, France, Wojciech Krajewski, Wroclaw, Poland, Morgan Roupret, Paris, France, Marco Moschini, Milan, Italy

MP23-12 EMOTIONAL FUNCTION AND EARLY BODY IMAGE ACCEPTANCE AS INDEPENDENT PREDICTORS OF IMPROVED LONG-TERM HEALTH-RELATED QUALITY OF LIFE IN PATIENTS RECEIVING RADICAL CYSTECTOMY WITH URINARY DIVERSION: IMPLICATIONS FOR PERIOPERATIVE COUNSELLING


MP23-13 ASSESSMENT OF BASELINE FUNCTIONAL STATUS AND RECOVERY FOLLOWING ROBOT-ASSISTED RADICAL CYSTECTOMY WITH INTRACORPOREAL URINARY DIVERSION

Rand Wilcox Vanden Berg*, Ashwin Ramaswamy, Bernard Bochner, Alvin Goh, New York, NY

MP23-14 REDUCING READMISSIONS FOLLOWING RADICAL CYSTECTOMY THROUGH QUALITY IMPROVEMENT

Lee White*, Caleb Seufert, Stanford, CA, Bogda-na Schmidt, Salt Lake City, UT, Peter Dy, Stacy Cox, Mia Singh, Joanne Meneses, Eila Skinner, Stanford, CA

MP23-15 IMPACT OF PREVIOUS TREATMENTS FOR PROSTATE CANCER ON PERIOPERATIVE AND ONCOLOGICAL OUTCOMES IN PATIENTS TREATED WITH RADICAL CYSTECTOMY FOR BLADDER CANCER

Stefano Tappero*, Stefano Parodi, Guglielmo Mantica, Marco Borghesi, Genoa, Italy, Cristian Fiori, Matteo Manfredi, Turin, Italy, Marco Bandini, Milan, Italy, Andrea Mari, Francesca Valastro, Florence, Italy, Maria Angela Cerruto, Alessan-dra Gozzo, Verona, Italy, Francesco Chessa, Riccardo Schiavina, Bologne, Italy, Alberto Briganti, Milan, Italy, Andrea Minervini, Florence, Italy, Alessandro Antonelli, Verona, Italy, Franc-esco Porpiglia, Turin, Italy, Eugenio Brunocilla, Bologne, Italy, Francesco Montorsi, Milan, Italy, Nazareno Suardi, Carlo Terrone, Genoa, Italy

MP23-16 CIRCULATING TUMOR DNA IS A STRONG PREDICTOR IN PATIENTS TREATED WITH SYSTEMIC THERAPY FOR UROTHELIAL CARCINOMA

Ekaterina Laukhtina*, Melanie R. Hassler, Benja-min Pradere, Maximilian Pallauf, David D’An-drea, Vienna, Austria, Dmitry Enikeev, Moscow, Russian Federation, Shahrokh F. Shariat, Vienna, Austria

104

MP23-17 PROGNOSTIC AND PREDICTIVE VALUE OF PREOPERATIVE VASCULAR CELL ADHESION MOLECULE-1 PLASMA LEVELS IN UROTHELIAL CARCINOMA OF THE BLADDER TREATED WITH RADICAL CYSTECTOMY

Keiichiro Mori*, Victor Schuettfort, Satoshi Katay-ama, Ekaterina Laukhtina, Benjamin Pradere, Fahad Quhal, Reza Sari Motlagh, Hadi Mostafaei, Pawel Rajwa, Vienna, Austria, Jeremy Teoh, Hong Kong, Hong Kong, Marco Moschini, Lu-cerne, Switzerland, David D’Andrea, Mohammad Abufaraj, Vienna, Austria, Shin Egawa, Tokyo, Japan, Pierre Karakiewicz, Montreal, Canada, Yair Lotan, Dallas, TX, Douglas Scherr, New York, NY, Eva Compérat, Shahrokh Shariat, Vienna, Austria

MP23-18 PRELIMINARY RESULTS OF A URINE-BASED DNA METHYLATION TEST TO MONITOR RESPONSE TO NEOADJUVANT THERAPY IN MUSCLE-INVASIVE BLADDER CANCER

Seyedeh Sanam Ladi Seyedian*, Los Angeles, CA, Saum Ghodoussipour, New Brunswick, CA, Hamed Ahmadi, Ryan Lee, Alireza Ghoreifi, Michael Basin, Los Angeles, CA, Paolo Piatti, Taikun Yamada, Benjamin Jara, Lucy Sanossian, Irvine, CA, Hooman Djaladat, Anne Schuckman, Sumeet Bhanvadia, Gangning Liang, Siamak Daneshmand, Los Angeles, CA

MP23-19 PROSPECTIVE VALIDATION OF THE ROL SYSTEM IN SUBSTAGING PT1 HIGH-GRADE BLADDER CANCER: A CONFIRMATORY PROGRESSION RISK ANALYSIS TO EASE DECISION MAKING

Marina Valeri, Roberto Contieri, Vittorio Fasulo, Miriam Cieri, Grazia M Elefante, Massimo Lazzeri, Rozzano Milan, Italy, Gianluigi Taverna, Castellan-za Varese, Italy, Luigi M Terracciano, Rodolfo Hurle, Piergiuseppe Colombo*, Rozzano Milan, Italy



Moderated Poster Session 24KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY I

Room 222 @ Ernest N. Morial Convention CenterModerators: Riccardo Autorino & Monish Aron

ABSTRACT NUMBER TITLE MP24-01 RACE BASED EQUATIONS FOR ESTIMATING

KIDNEY FUNCTION MAY CONTRIBUTE TO RACIAL DISPARITIES IN PARTIAL NEPHRECTOMY UTILIZATION AMONG BLACK PATIENTS WITH KIDNEY TUMORS

Nour Abdallah*, Tarik Benidir, Martin Hofmann, Eiftu Haile, Diego Aguilar Palacios, Venkatesh Krishnamurthi, Samuel Haywood, Mohamed Eltemamy, Jihad Kaouk, Robert Abouassaly, Steven Campbell, Christopher Weight, Cleveland, OH

MP24-02 SURVEY BASED STUDY OF EMERGING MANAGEMENT STRATEGIES FOR VHL

Neal Patel*, Aileen Arvelo, Los Angeles, CA, Gen-nady Bratslavsky, Syracuse, NY, Chandra Clark, Boston, MA, Othon Iliopoulos, Charlestown, MA, Eric Jonasch, Houston, TX, Sandy Liu, Los Ange-les, CA, Joshua Mann, Boston, MA, Peter Muraki, Brian Shuch, Los Angeles, CA

ABSTRACT NUMBER TITLE MP24-03 LOCAL RECURRENCE FOLLOWING PARTIAL

NEPHRECTOMY IN PATIENTS WITH RENAL CELL CARCINOMA: A MULTICENTER STUDY

Shohei Fukuda*, Hajime Tanaka, Kenji Tanabe, Tokyo, Japan, Takashi Tamiya, Saitama, Japan, Masaki Kobayashi, Tokyo, Japan, Shugo Yajima, Chiba, Japan, Yuki Nakamura, Saitama, Japan, Motohiro Fujiwara, Tokyo, Japan, Yudai Ishikawa, Ibaraki, Japan, Takanobu Yamamoto, Tokyo, Ja-pan, Saori Araki, Chiba, Japan, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Yukihiro Otsu-ka, Fumitaka Koga, Yasuhisa Fujii, Tokyo, Japan

MP24-04 C-REACTIVE PROTEIN AND RISK OF MAJOR COMPLICATIONS AND MORTALITY OUTCOMES IN PATIENTS UNDERGOING SURGERY FOR RENAL CELL CARCINOMA

John Perry*, La Jolla, CA, Hajime Tanaka, Tokyo, Japan, Arman Walia, Ava Saidian, Rekha Nar-asimhan, Mimi Nguyen, Madison Chakoumakos, Margaret Meagher, Juan Javier-Desloges, La Jolla, CA, Kazutaka Saito, Yasuhisa Fujii, Tokyo, Japan, Ithaar Derweesh, La Jolla, CA


SA

TU

RD

AY

MP24-05 OUTCOMES OF PARTIAL NEPHRECTOMY FOR NON-METASTATIC CT2 RENAL TUMORS: RESULTS FROM A CANADIAN MULTI-INSTITUTIONAL COLLABORATIVE

Rahul Bansal*, Ryan Sun, Winnipeg, Canada, Frederic Pouliot, Quebec City, Canada, Ranjeeta Mallick, Ottawa, Canada, Simon Tanguay, Mon-treal, Canada, Darrel Drachenberg, Winnipeg, Canada, Richard Rendon, Halifax, Canada, Alan So, Vancouver, Canada, Luke Lavallee, Ottawa, Canada, Antonio Finelli, Toronto, Canada, Lucas Dean, Edmonton, Canada, Anil Kapoor, Hamilton, Canada, Bimal Bhindi, Calgary, Canada, Lori Wood, Halifax, Canada, Naveen Basappa, Ed-monton, Canada, Rodney Breau, Ottawa, Canada

MP24-06 INCIDENCE OF BENIGN RENAL MASSES IN A CONTEMPORARY COHORT OF PATIENTS RECEIVING PARTIAL NEPHRECTOMY FOR PRESUMED RENAL CELL CARCINOMA

Varun Vijay*, Dora Jericevic, James Wysock, Samir Taneja, William Huang, New York, NY

MP24-07 ADVERSE RADIOLOGIC AND PATHOLOGIC FEATURES IMPACT SURVIVAL OUTCOMES FOR SMALL RENAL MASSES FOLLOWING NEPHRECTOMY

Sari Khaleel*, Hong Truong, Song Jiang, Benja-min Davelman, Jonathan Coleman, Ari Hakimi, Paul Russo, New York, NY

MP24-08 REAL-TIME ESTIMATION OF NEPHRON ACTIVITY WITH A LINEAR MEASUREMENT SYSTEM (RENAL-MS) OBVIATES THE NEED FOR NUCLEAR MEDICINE SCANS TO PREDICT GLOMERULAR FILTRATION RATE AFTER NEPHRECTOMY

Jared Schober*, Matthew Loecher, David Strauss, Eric Cho, Alberto Castro Bigalli, Kevin Ginsburg, Alexander Kutikov, Philadelphia, PA, Marshall Strother, Portland, OR

MP24-09 RISK OF PSEUDOANEURYSM AND COMPLICATIONS AFTER PARTIAL NEPHRECTOMY: COMPARISON OF TUMOR ENUCLEATION TO STANDARD MARGIN TECHNIQUE

Nicholas Elliott, Jae Han Lee*, Hiten Patel, Whitney Halgrimson, Keshava Gali, Nicholas Lanzotti, Goran Rac, Marcus Quek, Gopal Gupta, Maywood, IL

MP24-10 IMPACT OF HEMOSTATIC AGENTS ON SURGICAL COMPLICATIONS AND HOSPITAL COSTS IN PATIENTS UNDERGOING PARTIAL NEPHRECTOMY IN THE UNITED STATES

Kendrick Yim*, Jose I Nolaazco, Yuzhe Tang, Marie-Therese Valovska, Kevin R Melnick, Logan Briggs, Boston, MA, Benjamin I Chung, Stanford, CA, Steven L Chang, Boston, MA

MP24-11 IS PATHOLOGICAL UPSTAGING TO T3 RENAL CELL CARCINOMA ASSOCIATED WITH A SIMILAR PROGNOSIS TO NON-UPSTAGED PATHOLOGIC T3 DISEASE? A MULTICENTER ANALYSIS

Ryan Nasseri*, Kevin Hakimi, Ava Saidian, San Diego, CA, Riccardo Autorino, Richmond, VA, Bri-an Lane, Grand Rapids, MI, Yasuha Fujii, Tokyo, Japan, Michele Marchioni, Chieti, Italy, Hajime Tanaka, Tokyo, Japan, Dattatraya Patil, Atlanta, GA, Francesco Porpiglia, Torino, Italy, Sabrina Noyes, Grand Rapids, MI, Chandru Sundaram, Indianapolis, IN, James Porter, Seattle, WA, An-drea Minervini, Florence, Italy, Umberto Capitia-nio, Francesco Montorsi, Milan, Italy, Viraj Master, Atlanta, GA, Ithaar Derweesh, San Diego, CA

MP24-12 RISKS ASSESSMENT OF SIGNIFICANT RENAL FUNCTION DETERIORATION AFTER PARTIAL NEPHRECTOMY AND CALL FOR RECONSIDERING THE IMPERATIVE SETTING

Umberto Anceschi*, Rome, Italy, Andrea Min-ervini, Andrea Mari, Antonio Andrea Grosso, Florence, Italy, Cristian Fiori, Francesco Porpiglia, Orbassano, Turin, Italy, Gabriele Tuderti, Alfredo Maria Bove, Aldo Brassetti, Leonardo Misuraca, Riccardo Mastroianni, Mariaconsiglia Ferriero, Rome, Italy, Daniele Amparore, Orbassano, Italy, Riccardo Autorino, Richmond, VA, Alessan-dro Veccia, Brescia, Italy, Chandru Sundaram, Indianapolis, IN, Daniel Eun, Philadelphia, IN, Jennifer Lee, Philadelphia, PA, Ithaar Derweesh, San Diego, CA, Umberto Capitanio, Alessandro Larcher, Francesco Montorsi, Milan, Italy, Michele Gallucci, Giuseppe Simone, Rome, Italy

MP24-13 IMPACT OF PRIMARY TUMOR SIZE ON CANCER-SPECIFIC AND ALL-CAUSE MORTALITY IN PATIENTS UNDERGOING CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: ANALYSIS FROM THE INTERNATIONAL MARKER CONSORTIUM FOR RENAL CANCER [INMARC]

Ryan Nasseri*, San Diego, CA, Viraj Master, At-lanta, GA, Yasuhisa Fujii, Tokyo, Japan, Margaret Meagher, Kevin Hakimi, Ava Saidian, San Diego, CA, Dattatraya Patil, Atlanta, GA, Kazutaka Saito, Tokyo, Japan, Ithaar Derweesh, San Diego, CA

MP24-14 A PROPENSITY MATCHED COMPARISON OF THE PERIOPERATIVE OUTCOMES BETWEEN SINGLE-PORT AND MULTI-PORT ROBOTIC ASSISTED PARTIAL NEPHRECTOMY

Kennedy E. Okhawere*, New York City, NY, Alp Tuna Beksac, Cleveland, OH, Michael Wilson, Ta-lia G. Korn, Kirolos N Meilika, New York City, NY, Robert Harrison, Hackensack, NJ, Luca Morgan-tini, Chicago, IL, Mutahar Ahmed, Hackensack, NJ, Reza Mehrazin, New York City, NJ, Ronney Abaza, Columbus, OH, Daniel D. Eun, Philadel-phia, PA, Akshay Bhandari, Miami, FL, Ashok K. Hemal, Winston-Salem, NC, James Porter, Seat-tle, WA, Michael D. Stifelman, Hackensack, NJ, Jihad Kaouk, Cleveland, OH, Simone Crivellaro, Chicago, IL, Ketan K. Badani, New York City, NY

106

MP24-15 POSITIVE SURGICAL MARGINS AFTER ROBOT-ASSISTED PARTIAL NEPHRECTOMY (RAPN): DOES IT REALLY MATTER? (MARGINS STUDY – UROCCR 96)

Arnoult Morrone*, Imad Bentellis, Nice, France, Jean-Christophe Bernhard, Bordeaux, France, Karim Bensalah, Rennes, France, Cécile Champy, Paris, France, Franck Bruyère, Tours, France, Nicolas Doumerc, Toulouse, France, Olivier Jonathan, Lille, France, François Audenet, Bastien Parier, Martin Brenier, Paris, France, Jean-Alexandre Long, Grenoble, France, Thomas Charles, Poitiers, France, Evanguelos Xylinas, Paris, France, Thibaut Waeckel, Caen, France, Florie Gomez, Paris, France, Romain Boissier, Marseille, France, Benjamin Rouget, Libourne, France, Daniel Chevallier, Damien Ambrosetti, Matthieu Durand, Nice, France

MP24-16 3D VIRTUAL MODELS ASSISTANCE DURING LAPAROSCOPIC PARTIAL NEPHRECTOMY WITH ICON3D TECHNOLOGY: THE SURGEON’S INTRAOPERATIVE TOUCHLESS INTERACTION

Daniele Amparore*, Federico Piramide, Enrico Checcucci, Paolo Verri, Angela Pecoraro, Sabrina De Cillis, Alberto Piana, Gabriele Volpi, Michele Sica, Mariano Burgio, Davide Zamengo, Paolo Alessio, Marcello Della Corte, Giovanni Busacca, Andrea Bellin, Matteo Manfredi, Cristian Fiori, Francesco Porpiglia, Orbassano (Turin), Italy

MP24-17 PROSPECTIVE VALIDATION AND COMPARISON OF DIFFERENT SCORING SYSTEMS FOR THE PREDICTION OF SURGICAL OUTCOME OF ROBOT-ASSISTED PARTIAL NEPHRECTOMY

Cesare Saitta*, Pietro Diana, Alessandro Uleri, Vittorio Fasulo, Andrea Gobbo, Paola Arena, Edoardo Beatrici, Giuseppe Chiarelli, Roberto Contieri, Nicola Frego, Pier Paolo Avolio, Davide Maffei, Alberto Saita, Paolo Casale, Giorgio Guazzoni, Massimo Lazzeri, Rodolfo Hurle, Gio-vanni Lughezzani, Nicolò Maria Buffi, Milano, Italy

MP24-18 THE EFFECT OF VIRTUAL 3D MODELS ON ROBOTIC PARTIAL NEPHRECTOMY: SECONDARY ANALYSIS OF A RANDOMIZED CLINICAL TRIAL

Joseph Shirk*, Los Angeles, CA, David Thiel, Jacksonville, FL, Eric Wallen, Chapel Hill, NC, Jennifer Linehan, Santa Monica, CA, Wesley White, Knoxville, TN, Ketan Badani, Ney York, NY, James Porter, Seattle, WA

MP24-19 COMPARISON OF ONE-YEAR HEALTHCARE EXPENDITURE AND UTILIZATIONS BETWEEN ROBOTIC-ASSISTED VERSUS LAPAROSCOPIC SURGERY AMONG PATIENTS UNDERGOING PARTIAL AND RADICAL NEPHRECTOMY

Kennedy Okhawere*, New York, NY, Gediwon Milky, I-Fan Shih, Yanli Li, Sunnyvale, CA, Ketan Badani, New York, NY

MP24-20 ANALYSIS OF PREDICTORS OF SCKD PROGRESSION AFTER MINIMALLY-INVASIVE IMPERATIVE PARTIAL NEPHRECTOMY IN PATIENTS WITH PREOPERATIVE CKD STAGE 3A: RESULTS OF A MULTI-INSTITUTIONAL COLLABORATIVE SERIES

Umberto Anceschi*, Rome, Italy, Andrea Min-ervini, Andrea Mari, Antonio Andrea Grosso, Florence, Italy, Cristian Fiori, Francesco Porpiglia, Orbassano, Turin, Italy, Gabriele Tuderti, Alfredo Maria Bove, Aldo Brassetti, Leonardo Misuraca, Riccardo Mastroianni, Mariaconsiglia Ferriero, Rome, Italy, Daniele Amparore, Orbassano, Italy, Riccardo Autorino, Richmond, VA, Alessan-dro Veccia, Brescia, Italy, Chandru Sundaram, Indianapolis, IN, Daniel Eun, Philadelphia, IN, Jennifer Lee, Philadelphia, PA, Ithaar Derweesh, San Diego, CA, Umberto Capitanio, Alessandro Larcher, Francesco Montorsi, Milan, Italy, Michele Gallucci, Giuseppe Simone, Rome, Italy



SA

TU

RD

AY


Podium Session 22PROSTATE CANCER: LOCALIZED: RADIATION THERAPY

Room 252 @ Ernest N. Morial Convention CenterModerators: A. Oliver Sartor, Mack Roach & John Davis

ABSTRACTTIME NUMBER TITLE9:30 PD22-01 ONCOLOGICAL OUTCOMES OF SENTINEL

LYMPH NODE PROCEDURE-GUIDED RADIOTHERAPY VERSUS IMAGING-GUIDED RADIOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER – A MULTICENTER, RETROSPECTIVE, PROPENSITY SCORE WEIGHTED COMPARISON

Hilda de Barros*, Amsterdam, Netherlands, Niko-laos Grivas, Ioannina, Greece, Jan Duin, Daan Mulder, Vincent van der Noort, Amsterdam, Neth-erlands, Arjen Noordzij, Hoofddorp, Netherlands, Esther Wit, Eva Schaake, Pim van Leeuwen, Henk van der Poel, Amsterdam, Netherlands

9:40 PD22-02 RESTAGING PROSTATE-SPECIFIC MEMBRANE ANTIGEN POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IS ASSOCIATED WITH IMPROVED ONCOLOGICAL OUTCOME IN MEN WHO UNDERWENT SALVAGE RADIATION THERAPY FOR BIOCHEMICALLY RECURRENT PROSTATE CANCER

Dennie Meijer*, Amsterdam, Netherlands, Wietse Eppinga, Utrecht, Netherlands, Roos Mohede, Amsterdam, Netherlands, Ben Vanneste, Maas-tricht, Netherlands, Philip Meijnen, Otto Meijer, Laurien Daniels, Amsterdam, Netherlands, Rod-erick Van den Bergh, Nieuwegein, Netherlands, Anne Lont, Amersfoort, Netherlands, Rosemarijn Ettema, Amsterdam, Netherlands, Frederik Oudshoorn, Hoofddorp, Netherlands, Pim van Leeuwen, Henk Van der Poel, Maarten Donswijk, Daniela Oprea-Lager, Eva Schaake, André Vis, Amsterdam, Netherlands

9:50 PD22-03 URINARY FUNCTION FOLLOWING HIGH DOSE INTENSITY MODULATED RADIOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER

Shannon McNall*, Nathan Colin Wong, Valhalla, NY, Shawn Zimberg, John Rescigno, Hartsdale, NY

10:00 PD22-04 IMMEDIATE RADIOTHERAPY VERSUS OBSERVATION IN PATIENTS WITH NODE-POSITIVE PROSTATE CANCER AFTER RADICAL PROSTATECTOMY

Christian Schaufler*, Sumedh Kaul, Aaron Fleishman, Ruslan Korets, Peter Chang, Andrew Wagner, Boston, MA, Simon Kim, Aurora, CO, Joaquim Bellmunt, Irving Kaplan, Aria F. Olumi, Boris Gershman, Boston, MA

ABSTRACTTIME NUMBER TITLE10:10 PD22-05 COMPARISON OF LOW-DOSE-RATE

BRACHYTHERAPY VERSUS RADICAL PROSTATECTOMY IN PATIENTS WITH INTERMEDIATE-RISK PROSTATE CANCER: A PROPENSITY-MATCHED MULTI-INSTITUTIONAL STUDY

Hideyasu Tsumura*, Sagamihara, Japan, No-bumichi Tanaka, Kashihara, Japan, Tomohiko Oguchi, Nagano, Japan, Takuya Owari, Yas-ushi Nakai, Isao Asakawa, Kashihara, Japan, Kazuyoshi Iijima, Haruaki Kato, Iwao Hashida, Nagano, Japan, Ken-ichi Tabata, Takefumi Satoh, Hiromichi Ishiyama, Sagamihara, Japan

10:20 PD22-06 SALVAGE RADIOTHERAPY GUIDED BY FUNCTIONAL IMAGING FOR MACROSCOPIC LOCAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY: A MULTICENTRIC RETROSPECTIVE STUDY

Nicolas Benziane*, Bordeaux, France, Thomas Zilli, Genève, Switzerland, Antoine Giraud, Bor-deaux, France, Gianluca Ingrosso, Perugia, Italy, Mario Di Staso, L’Aquila, Italy, Fabio Trippa, Terni, Italy, Emmanuel Meyer, Caen, France, Giulio Francolini, Florence, Italy, Ulrike Schick, Brest, France, Jean Marc Cosset, La Garenne Colombe, France, Etienne Martin, Dijon, France, Victoria Ferrari, Nice, France, Vérane Achard, Genève, Switzerland, Nicolas Giraud, Bordeaux, France, Corentin Pasquier, Toulouse, France, Inga Mihoci, L’Aquila, Italy, Beatrice detti, Florence, Italy, Hind Zaine, Lille, France, Pascal Pommier, Osman Osman, Lyon, France, Tanguy Perennec, Nantes, France, Khemara Gnep, Rennes, France, Nicolas Magné, Saint Etienne, France, David Pasquier, Lille, France, Stephane Supiot, Nantes, France, Paul Sargos, Bordeaux, France

10:30 PD22-07 BASELINE SELF-REPORTED FATIGUE PREDICTS OVERALL SURVIVAL AFTER STEREOTACTIC BODY RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER

Rishabh Simhal*, Tamir Sholklapper, Washington, DC, Anish Simhal, New York City, NY, Alan Zwart, Malika Danner, Washington, DC, Deepak Kumar, Durham, NC, Nima Aghdam, Boston, MA, Simeng Suy, Ryan Hankins, Keith Kowalczyk, Sean Col-lins, Washington, DC

10:40 PD22-08 RISK OF RADIATION-INDUCED FISTULA IS LOW AND MAY BE INCREASED IN PATIENTS WITH PRIOR PELVIC RADIATION OR CONCURRENT CHEMOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS

Michael Sadighian*, Nizar Hakam, Gregory Amend, Nathan Shaw, Peggy Tahir, Isabel Elaine Allen, Behnam Nabavizadeh, Jordan Holler, Wil-liam Shibley, Kevin Li, Behzad Abbasi, Alexander Bell, Osama Mohamad, Benjamin Breyer, San Francisco, CA

108

10:50 PD22-09 DISTINGUISHING BETWEEN PROSTATE SPECIFIC ANTIGEN BOUNCE AND BIOCHEMICAL RECURRENCE FOLLOWING STEREOTACTIC BODY RADIOTHERAPY FOR PROSTATE CANCER

Ashley Monaco*, Glen Head, NY, Jessica Sommer, Garden City, NY, Jordan Mendelson, Jonathan Haas, Mineola, NY, Anthony Corcoran, Aaron Katz, Garden City, NY

11:00 PD22-10 HIGH VOLUME BIOPSY CORE INVOLVEMENT PREDICTS FOR ELEVATED PSA NADIR FOLLOWING DEFINITIVE SBRT IN INTERMEDIATE RISK PROSTATE CANCER

Jonathan Lischalk*, Astrid Sanchez, Christopher Mendez, Todd Carpenter, Moses Tam, Anthony Corcoran, Matthew Witten, Seth Blacksburg, Aaron Katz, Jonathan Haas, New York, NY

11:10 PD22-11 SUBCLINICAL INFLAMMATION AS A PREDICTOR FOR ERECTILE DYSFUNCTION AFTER BRACHYTHERAPY FOR LOCALIZED PROSTATE CANCER

Laurianne Rita Garabed*, Daniel Taussky, Guila Delouya, Daniel Liberman, Montreal, Canada

11:20 PD22-12 COMPARATIVE STUDY OF RARP AND CARBON ION RADIOTHERAPY SEXUAL FUNCTIONAL CHANGES FOR PROSTATE CANCER USING THE PROPENSITY SCORE MATCHING METHOD

Yoshiyuki Miyazawa*, Daisuke Oka, Hidekazu Koike, Hidemasa Kawamura, Yuhei Miyasaka, Seiji Arai, Yoshitaka Sekine, Masashi Nomura, Hi-roshi Matsui, Kazuhiro Suzuki, Maebashi, Japan



Podium Session 23SEXUAL FUNCTION/DYSFUNCTION: PEYRONIE’S DISEASE

Room 255 @ Ernest N. Morial Convention CenterModerators: Gerald Brock, Gregory Broderick & Serge Carrier

ABSTRACTTIME NUMBER TITLE9:30 PD23-01 IMPROVED PEYRONIE’S DISEASE

CURVATURE OUTCOMES USING A MORE AGGRESSIVE COLLAGENASE TECHNIQUE

Alissa Tyler*, Benjamin Green, Joshua Savage, Klinton Brearton, Landon Trost, Orem, UT

9:40 PD23-02 COMPARISON OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM TO SURGERY FOR THE MANAGEMENT OF PEYRONIE’S DISEASE: A RANDOMIZED TRIAL

Benjamin Green*, Megan Francis, Joshua Sav-age, Klinton Brearton, Alissa Tyler, Landon Trost, Orem, UT

9:50 PD23-03 INCREMENTAL TREATMENT RESPONSE BY CYCLE WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR PEYRONIE’S DISEASE: A POOLED ANALYSIS OF TWO PHASE 3 TRIALS

Matthew Ziegelmann*, Rochester, MN, Qinfang Xiang, Yiqun Hu, Malvern, PA, Landon Trost, Rochester, MN

10:00 PD23-04 EXPLORING ACTINIDIN AS A NOVEL COLLAGENASE TO TREAT HUMAN PEYRONIE’S DISEASE CELLS

Kevin Feng, Wongsakorn Kiattiburut, London, Canada, Duane Hickling, ottawa, Canada, Jere-my Burton, Jeffrey Campbell*, London, Canada

10:10 PD23-05 PATIENT REFERRAL TRENDS AND OUTCOMES OF PENILE PLICATION IN THE CONTEMPORARY ERA: IS XIAFLEX® DRIVING PATIENTS TO SURGERY?

Sam Kusin, Shervin Badkhshan*, Samantha Nealon, Gregory Joice, Sarah Sanders, Steven Hudak, Allen Morey, Dallas, TX

ABSTRACTTIME NUMBER TITLE10:20 PD23-06 OUTCOMES OF PENILE PLICATION IN

PEYRONIE’S DISEASE - FUNCTIONAL PENILE LENGTH: “EMPHA-SIZING” WHAT MATTERS

Sarah Christianson*, Philadelphia, PA, Laura Douglass, Laura Kidd, Matthew Loecher, Michael Metro, Philadelphia, PA

10:30 PD23-07 PATIENTS’ COMPLIANCE WITH SURGERY FOR PEYRONIE DISEASE: A MULTICENTRE EUROPEAN STUDY

Paolo Capogrosso*, Varese, Italy, Luigi Can-dela, Milan, Italy, Georgios Hatzichristodoulou, Würzburg, Germany, Juan I. Martinez Sala-manca, Madrid, Spain, Andrea Cocci, Florence, Italy, Marco Falcone, Turin, Italy, Edoardo Pozzi, Nicolò Schifano, Milan, Italy, Giorgio Ivan Russo, Catania, Italy, Andrea Salonia, Milan, Italy

10:40 PD23-08 POSTOPERATIVE PROGRESS OF MODIFIED GRID INCISION AND SEALING WITH COLLAGEN FLEECE FOR TREATMENT OF PEYRONIE’S DISEASE; CLINICAL AND ULTRASONOGRAPHY OUTCOME

Sun Tae Ahn*, Sun Bum Cho, Hyun Soo Lee, Da Eun Han, Jong Wook Kim, Mi Mi Oh, Hong Seok Park, Du Geon Moon, Seoul, Korea, Republic of

10:50 PD23-09 AUXETIC EXPANSION OF THE TUNICA ALBUGINEA FOR PENILE LENGTH AND GIRTH RESTORATION WITHOUT A GRAFT: A CASE SERIES

Alexandre Miranda*, Rio de Janeiro, Brazil


SA

TU

RD

AY

11:00 PD23-10 PEYRONIE’S DISEASE: A FAMILIAL, HERITABLE CONDITION

Michael Christensen*, Kristy Allen-Brady, Alexan-der Pastuszak, Salt Lake City, UT

11:10 PD23-11 UNCOVERING THE GENETIC PATHWAYS OF PEYRONIE’S FIBROSIS: SINGLE CELL TRANSCRIPTOMIC ANALYSIS OF PEYRONIE’S PLAQUE

Luke Witherspoon*, Reza Soltani, Meghan Rob-inson, Faraz Hach, Ryan Flannigan, Vancouver, Canada

11:20 PD23-12 A DETAILED CHARACTERIZATION OF MEN WITH PEYRONIE’S DISEASE AND NO ASSOCIATED RISK FACTORS

Christian Corsini*, Milan, Italy, Paolo Capogrosso, Varese, Italy, Edoardo Pozzi, Federico Belladelli, Giuseppe Fallara, Massimiliano Raffo, Daniele Cignoli, Luigi Candela, Nicolò Schifano, Alessia d’Arma, Luca Boeri, Eugenio Ventimiglia, Rayan Matloob, Milan, Italy, Federico Dehò, Varese, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy



Podium Session 24URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: NEUROGENIC VOIDING DYSFUNCTION

Room 245 @ Ernest N. Morial Convention CenterModerator: E. Ann Gormley

ABSTRACTTIME NUMBER TITLE9:30 PD24-01 DIFFERENTIAL TRANSCRIPTOMIC CHANGES

IN THE CENTRAL NERVOUS SYSTEM AND NEUROGENIC BLADDERS OF MICE INFECTED WITH A CORONAVIRUS

Taylor Clarkson, Alison Xie, Naoko Iguchi, Anna Malykhina*, Aurora, CO

9:40 PD24-02 NEUROGENIC BLADDER MANAGEMENT IN AWAKE CHRONIC SPINAL CORD INJURED CATS BY AN IMPLANTABLE PUDENDAL NERVE STIMULATOR

Jialiang Chen, Guangzhou, China, People’s Re-public of, Yihua Zhong, Beijing, China, People’s Republic of, Jun Zhao, Xian, China, People’s Republic of, Anand Mohapatra*, Bing Shen, Jicheng Wang, William de Groat, Changfeng Tai, Pittsburgh, PA

9:50 PD24-03 PATIENTS WITH SEVERE POST-STROKE LOWER URINARY TRACT SYMPTOMS EXHIBIT INCREASED CORTICAL ACTIVATION DURING URGENCY AND VOIDING INITIATION

Aref Sayegh*, Evgeniy Kreydin, Rita Jen, Laura Perez, Enanyeli Rangel, Aidin Abedi, Charles Liu, David Ginsberg, Kay Jann, Los Angeles, CA

10:00 PD24-04 DETECTION OF PELVIC FLOOR MUSCLE ACTIVITY AND QUANTIFICATION OF OXYGEN KINETICS IN WOMEN WITH SPINAL CORD INJURY AND NEUROGENIC LOWER URINARY TRACT DYSFUNCTION

Lynn Stothers*, Andrew Macnab, Vancouver, Canada

10:10 PD24-05 BLADDER MANAGEMENT AND QUALITY OF LIFE BY GENDER AFTER SPINAL CORD INJURY: RESULTS FROM 40 YEARS OF FOLLOW-UP

Paige Nichols*, Rochester, MN, Brian Goh, Boston, MA, Elizabeth Bearrick, Rochester, MN, Stuart Hershman, Boston, MA, Katherine Ander-son, Rochester, MN

ABSTRACTTIME NUMBER TITLE10:20 PD24-06 BLADDER RELATED QUALITY OF LIFE IN

WOMEN WITH SPINAL CORD INJURY Ann Dekalo*, London, Canada, Jeremy Myers,

Salt Lake City, UT, Michael Kennelly, Charlotte, NC, Blayne Welk, London, Canada

10:30 PD24-07 FAILURE RATES OF BLADDER OUTLET SURGERIES FOR STRESS URINARY INCONTINENCE IN WOMEN WITH NEUROGENIC LOWER URINARY TRACT DYSFUNCTION: A MULTICENTER NEUROGENIC BLADDER RESEARCH GROUP STUDY DYSFUNCTION (NLUTD)

Javier Santiago*, Ann Arbor, MI, Min Soo Choo, Seoul, Korea, Republic of, Anne Cameron, Ann Arbor, MI, Richard Mora, Evgeniy Kreydin, David A Ginsberg, Los Angeles, CA, Natalia Hernan-dez, Paola Bustillos, Rose Khavari, Houston, TX, Stephanie Daignault-Newton, John Stoffel, Ann Arbor, MI

10:40 PD24-08 ROBOT ASSISTED BLADDER NECK ARTIFICIAL URINARY SPHINCTER IMPLANTATION IN NEUROLOGICAL MALE PATIENTS: PRELIMINARY RESULTS

Benoit Peyronnet*, Rennes, France, Thibault Tricard, Strasbourg, France, Thibaut Brierre, Tou-louse, France, Juliette Hascoet, Rennes, France, Thomas Prudhomme, Toulouse, France, Baptiste Poussot, Strasbourg, France, Andrea Manunta, Rennes, France, Evelyne Castel-Lacanal, Tou-louse, France, Christian Saussine, Strasbourg, France, Xavier Gamé, Toulouse, France

10:50 PD24-09 INITIAL TRAINING OF AN AI INTEGRATED INTRA URETHRAL CATHETER PUMP PROSTHESIS

William Hendricks, Sylvie M Kalikoff, Hannah A McKenney, Patricia Thai, Musa Ozturk, Alexis Hoyos, Alex Arevalos, Houston, TX, Kunj Sheth*, Palo Alto, CA

110

11:00 PD24-10 FAILURE OF COST CONTAINMENT IN NEUROGENIC BLADDER CARE: UPDATED ANALYSIS OF THE NATIONAL EMERGENCY DEPARTMENT SAMPLE 2012-2017

Deepansh Dalela*, Detroit, MI, Hei-Kit Chan, Matthew Davis, Argyrios Stampas, Houston, TX, Humphrey Atiemo, Detroit, MI

11:10 PD24-11 NATIONAL TRENDS IN READMISSIONS OF NEUROGENIC BLADDER PATIENTS UNDERGOING URINARY DIVERSION IN THE UNITED STATES 2016-2017: AN ANALYSIS USING THE NATIONAL READMISSIONS DATABASE

Jazzmyne Montgomery*, Tiffany Damm, M. Francesca Monn, Springfield, IL

11:20 PD24-12 PATIENTS WITH ALZHEIMER’S DISEASE AND NEUROGENIC BLADDER DYSFUNCTION HAVE ALTERED URINE HEPATOCYTE GROWTH FACTOR

Yao-Chi Chuang*, Kaohsiung, Taiwan, Sarah Bartolone, Elijah Ward, Royal Oak, MI, Tsu-Kung Lin, Chinug-Chih Chang, Kaohsiung, Taiwan, Bernadette Zwaans, Michael Chancellor, Royal Oak, MI



Podium Session 25HEALTH SERVICES RESEARCH: PRACTICE PATTERNS, QUALITY OF LIFE AND SHARED DECISION MAKING II

Room 244 @ Ernest N. Morial Convention CenterModerators: Jonathan Bergman & David Penson

ABSTRACTTIME NUMBER TITLE9:30 PD25-01 SOCIAL DETERMINANTS OF HEALTH

AND OVERACTIVE BLADDER IN A LARGE NATIONWIDE CROSS-SECTIONAL STUDY

Elisabeth Sebesta*, Stephanie Gleicher, Melissa Kaufman, Roger Dmochowski, W. Stuart Reynolds, Nashville, TN

9:40 PD25-02 UTILIZATION OF ECONSULT AND CLINICAL INTEGRATION TO MAXIMIZE ACCESS TO UROLOGIC CARE IN THE SAFETY NET: OUTCOMES FROM THE LARGEST ECONSULT EXPERIENCE IN THE UNITED STATES

Jonathan Bergman*, Katherine Fero, Jamal Nab-hani, Jeremy Blumberg, Kiran Gollapudi, Stanley Frencher, Paul Giboney, Los Angeles, CA

9:50 PD25-03 ASSOCIATION BETWEEN FINANCIAL BURDEN AND TREATMENT REGRET IN MEN WITH LOCALIZED PROSTATE CANCER

Daniel D. Joyce*, Rochester, MN, Christopher J.D. Wallis, Toronto, Canada, Li-Ching Huang, Nashville, TN, Karen E. Hoffman, Houston, TX, Zhiguo Zhao, Tatsuki Koyama, Ralph Conwill, David F. Penson, Daniel A. Barocas, Nashville, TN

10:00 PD25-04 PERCEPTIONS OF GENDER EQUITY BY UROLOGIC SUBSPECIALTY

Roxanne Haslam*, Rebecca Agnor, Austin Collins, Leigh Martin, Solange Bassale, Casey Seideman, Portland, OR

10:10 PD25-05 CHANGES IN HEALTH BEHAVIORS AMONG LOW-INCOME UNINSURED MEN WITH PROSTATE CANCER

Allen E. D. Siapno*, Megha D. Tandel, Lorna Kwan, Mark S. Litwin, Los Angeles, CA

ABSTRACTTIME NUMBER TITLE10:20 PD25-06 VARIATION IN COMMUNICATION OF

COMPETING RISKS OF MORTALITY IN PROSTATE CANCER TREATMENT CONSULTATIONS

Aurash Naser-Tavakolian*, Rebecca Gale, Michael Luu, Abhishek Venkataramana, Los An-geles, CA, Dmitry Khodyakov, Santa Monica, CA, Jennifer Anger, Edwin Posadas, Howard Sandler, Brennan Spiegel, Stephen Freedland, Timothy Daskivich, Los Angeles, CA

10:30 PD25-07 RACIAL DISPARITIES IN SURGICAL TREATMENT OF RENAL MASSES: INITIAL ANALYSIS OF A STATEWIDE REGISTRY

Mohit Butaney*, Detroit, MI, Ji Qi, Stephanie Daignault-Newton, Randy Vince, Anna Johnson, Ann Arbor, MI, Amit Patel, Detroit, MI, Susan Linsell, Simpa Salami, Ann Arbor, MI, Firas Abdollah, Detroit, MI, Khurshid Ghani, Ann Arbor, MI, Humphrey Atiemo, Detroit, MI, Brian Lane, Grand Rapids, MI, Craig Rogers, Detroit, MI, for the Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI

10:40 PD25-08 ADVANCED PRACTICE PROVIDERS AND UROLOGIC PROCEDURES: AN ANALYSIS OF MEDICARE AND COMMERCIAL CLAIMS

Max Hyman, Parth Modi*, Chicago, IL

10:50 PD25-09 18-YEAR POPULATION TRENDS DEPICT UROLOGIST ACCESS WORSENING FOR RURAL MALES AND IMPROVING FOR METROPOLITAN FEMALES

Stephen Pittman*, Shachi Patel, Jeffrey Thompson, Ajay Nangia, Kansas City, KS


SA

TU

RD

AY

11:00 PD25-10 EVALUATION OF UROLOGIC PATIENT REPORTED PERI-OPERATIVE FINANCIAL TOXICITY

Daniel Au*, Jared Starkey, Jeffery Thompson, William Parker, Kansas City, KS

11:10 PD25-11 EVALUATING WHY PATIENTS SELECT TELEPHONE VISITS OVER VIDEO VISITS IN AN OUTPATIENT UROLOGY PRACTICE

Daniel Jacobs*, Denzel Zhu, Kara Watts, Bronx, NY

11:20 PD25-12 URBAN FAMILIES AMELIORATE RURAL GENITOURINARY CANCER DISPARITIES

Jeffrey Vehawn*, Mouneeb Choudry, Trevor Hunt, Christopher Martin, Jacob Ambrose, Benjamin Haaland, Jonathan Chipman, Heidi A. Hanson, Brock O’Neil, Salt Lake City, UT



ForumsYOUNG UROLOGISTS FORUM


10:00 INTRODUCTION Chair: Sammy Elsamra

10:05 YU of the Year Awards

10:15 PANEL DISCUSSION

GLOBAL PERSPECTIVE: PROMISE AND PITFALLS OF SOCIAL MEDIA

Stacy Loeb

CHOOSING A PLATFORM (INSTAGRAM, YOUTUBE, TIKTOK): WHAT PLATFORM IS A RIGHT FIT? DILEMAS ON SOCIAL MEDIA

Rena Malik

NUTS & BOLTS OF PODCASTS, DEFINING SUC-CESS WITH SOCIAL MEDIA, PASSION PROJECT

Aditya Bagrodia

WHY YOU SHOULD UTILIZE SOCIAL MEDIA, EXPERIENCE WITH TWITTER, PASSION PROJECT TO AVOID BURNOUT

Justin Dubin

11:15 Q&A SESSION WITH AUDIENCE

11:30 FUJIFILM SPONSORSHIP TALK AND LUNCH


Moderated Poster Session 25TRAUMA/RECONSTRUCTION/DIVERSION: URETER (INCLUDING PYELOPLASTY) AND BLADDER RECONSTRUCTION (INCLUDING

FISTULA), AUGMENTATION, SUBSTITUTION, DIVERSIONRoom 228 @ Ernest N. Morial Convention Center

Moderators: Ronak Gor, Judith Hagedorn & Arnulf Stenzl

ABSTRACT NUMBER TITLE MP25-01 INTRACORPOREAL URETEROCUTANEOUS

URINARY DIVERSION AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY: OUTCOMES AND COMPLICATIONS

Serena Tolani*, Etienne Lavallee, John Sfakianos, Reza Mehrazin, Nikhil Waingankar, New York, NY, Sebastian Edeling, Hanover, Germany, Carl Wijburg, Velp, Netherlands, Karel Decaesteck-er, Ghent, Belgium, Alberto Martini, Francesco Montorsi, Milan, Italy, Abolfazl Hosseini, Peter Wiklund, Stockholm, Sweden

MP25-02 RADICAL CYSTECTOMY AND URINARY DIVERSION OUTCOMES IN PATIENTS WITH SINGLE VS. DOUBLE KIDNEY: A 2:1 MATCHED-PAIR ANALYSIS

Alireza Ghoreifi*, Richard Mora Jr, Sanam La-di-Seyedian, Farshad Sheybaee Moghaddam, Jie Cai, Gus Miranda, Monish Aron, Anne Schuck-man, Mihir Desai, Inderbir Gill, Siamak Danesh-mand, Hooman Djaladat, Los Angeles, CA

ABSTRACT NUMBER TITLE MP25-03 ORTHOTOPIC NEOBLADDER IN FEMALE

PATIENTS WITH BLADDER CANCER: LONG-TERM FUNCTIONAL OUTCOMES AND THE ROLE OF SURGICAL TECHNIQUE

Seyedeh Sanam Ladi Seyedian*, Mitchell Gold-enburg, Muhannad Alsyouf, Sumeet Bhanvadia, Hooman Djaladat, Anne Schuckman, David Gins-berg, Siamak Daneshmand, Los Angeles, CA

MP25-04 IMPACT OF SELF-CLEAN INTERMITTENT CATHETERIZATION IN ORTHOTOPIC ILAEL NEOBLADDER: FUNCTIONAL OUTCOMES, CONTINENCE STATUS AND URINARY TRACT INFECTIONS

Antonio Luigi Pastore*, Andrea Fuschi, Yazan Al Salhi, Alessia Martoccia, Lorenzo Capone, Silvio Scalzo, Paolo Pietro Suraci, Onofrio Antonio Rera, Fabio Maria Valenzi, Alice Antonioni, Anto-nio Carbone, Latina, Italy

112

MP25-05 URINARY DIVERSION WITH OR WITHOUT CONCOMITANT BENIGN CYSTECTOMY FOR RADIOGENIC AND NON-RADIOGENIC CONDITIONS: A COMPARATIVE MORBIDITY ASSESSMENT ACCORDING TO THE UPDATED EAU GUIDELINES ON STANDARDIZED COMPLICATION REPORTING

Malte W. Vetterlein*, Hang Yu, Hamburg, Ger-many, Maria Buhné, Lübeck, Germany, Philipp Gild, Mara Kölker, Armin Soave, Roland Dahlem, Margit Fisch, Michael Rink, Hamburg, Germany

MP25-06 LONG-TERM FOLLOW UP OF PATIENTS WITH CEREBRAL PALSY UNDERGOING CATHETERIZABLE CHANNEL CREATION WITHOUT CONCURRENT BLADDER AUGMENTATION

Molly DeWitt-Foy*, Rachael Gotlieb, Sean Elliott, Minneapolis, MN

MP25-07 INCIDENCE OF HIGH GRADE COMPLICATIONS AND ASSOCIATED READMISSION RATES FOLLOWING COLON CONDUIT URINARY DIVERSION

Kevin Hebert*, Ryan Anderson, Rano Matta, Benjamin McCormick, Jeremy Myers, Salt Lake City, UT

MP25-08 URINARY TRACT RECONSTRUCTION WITH ENTEROCYSTOPLASTY AFTER RADIATION FOR PELVIC CANCER

Sender Herschorn*, Jenn Locke, Toronto, Canada

MP25-09 MULTI-INSTITUTIONAL COMPARISON OF NON-TRANSECTING VERSUS TRANSECTING PRIMARY ROBOTIC PYELOPLASTY FOR URETEROPELVIC JUNCTION OBSTRUCTION: THE COLLABORATIVE OF RECONSTRUCTIVE ROBOTIC URETERAL SURGERY (CORRUS) EXPERIENCE

David Strauss*, Matthew Lee, Philadelphia, PA, Ziho Lee, Chicago, IL, Aeen Asghar, Randall Lee, Philadelphia, PA, Lee Zhao, New York, NY, Michael Stifelman, Hackensack, NJ, Daniel Eun, Philadelphia, PA

MP25-10 PREVENTION AND DETECTION OF IATROGENIC URETERAL INJURY DURING ABDOMINAL OR PELVIC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS

Takafumi Yanagisawa*, Vienna, Austria, Keiichiro Mori, Tokyo, Japan, Reza Sari Motlagh, Tatsushi Kawada, Hadi Mostafaei, Fahad Quhal, Ekaterina Laukhtina, Pawel Rajwa, Frederik König, Maximil-ian Pallauf, Benjamin Pradere, Vienna, Austria, Jun Miki, Takahiro Kimura, Shin Egawa, Tokyo, Japan, Shahrokh F. Shariat, Vienna, Austria

MP25-11 PREDICTORS OF SURGICAL SUCCESS FOR ROBOTIC URETERAL RECONSTRUCTION OF PROXIMAL AND MIDDLE URETERAL STRICTURES

Matthew Lee*, Philadelphia, PA, Ziho Lee, Chicago, IL, Randall Lee, David Strauss, Rohit Reddy, Philadelphia, PA, Lee C Zhao, New York, NY, Michael D Stifelman, Hackensack, NJ, Daniel Eun, Philadelphia, PA

MP25-12 ROBOTIC BUCCAL GRAFT URETEROPLASTY WITHOUT URETERAL REST

Shellee Ogawa*, Wesley Baas, Kushan Radad-ia, Alexander Parker, Kefu Du, Eric Kim, Robert Figenshau, Gregory Murphy, St Louis, MO

MP25-13 TRANSURETHRAL VESICAL FISTULA REPAIR, NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY (NOTES): A NOVEL TECHNIQUE CASE SERIES

Alexandra Mendoza*, Laura Cuello, Oriana Arias, Manuel Duque, Cali, Colombia

MP25-14 A MULTI-INSTITUTIONAL EXPERIENCE UTILIZING BOARI FLAP IN ROBOTIC URINARY RECONSTRUCTION

Kunj Jain, Kevin Alter, Nathan Cheng, Hacken-sack, NJ, Tanner Corse*, Nutley, NJ, Naveen Krishnan, Matthew Lee, Randall Lee, Philadel-phia, PA, Kirtishri Mishra, New York, NY, David Strauss, Daniel Eun, Philadelphia, PA, Lee Zhao, New York, NY, Michael Stifelman, Nutley, NJ

MP25-15 NATIONAL TRENDS AND OUTCOMES IN THE USE OF INTRAVESICAL BOTULINUM TOXIN AND ENTEROCYSTOPLASTY AMONG PATIENTS WITH SPINA BIFIDA

Rano Matta*, Salt Lake City, UT, Joshua Horns, Salt Lake City, UT, Deborah Jacobson, Anthony Schaeffer, M. Chad Wallis, Glen Lau, Salt Lake City, UT

MP25-16 CLINICAL IMPLICATIONS OF THE URINARY DIVERSION MICROBIOME AFTER RADICAL CYSTECTOMY

Saum Ghodoussipour, New Brunswick, CA, Seye-deh Sanam Ladi Seyedian*, David Nusbaum, Shane Pearce, Los Angeles, CA, Hiren Patel, Aishani Prem, Wendy Ullmer, Irvine, CA, Sumeet Bhanvadia, Hooman Djaladat, Anne Schuckman, Gangning Liang, Siamak Daneshmand, Los Angeles, CA

MP25-17 PELVIC INSUFFICIENCY FRACTURE—AN UNDERRECOGNIZED CAUSE OF PAIN AFTER PUBECTOMY

Molly DeWitt-Foy*, Ranveer Vasdev, Sean Elliott, Minneapolis, MN

MP25-18 SEPARATE ABDOMINAL CLOSURE TRAYS SIGNIFICANTLY IMPROVE CYSTECTOMY SURGICAL SITE INFECTION; OUTCOMES FROM A PRE-POST IMPLEMENTATION NATIONAL SURGICAL QUALITY INPATIENT PROGRAM (NSQIP) PROJECT

Kevin Krughoff*, Christopher Mantyh, Charles D Scales, Andrew C. Peterson, Durham, NC


SA

TU

RD

AY

MP25-19 COMPARISON OF COMPLICATIONS, OPERATING TIME AND COSTS IN DOUBLE-LAYERED HAND-SEWN VS. MECHANICAL STAPLED ILEO-ILEAL ANASTOMOSIS DURING RADICAL CYSTECTOMY

Gabriele Tulone*, Palermo, Italy, Nicola Pavan, Trieste, Italy, Sofia Giannone, Palermo, Italy, Giuseppe Alario, Messina, Italy, Alberto Abrate, Sondrio, Italy, Mirko Pinelli, Piero Mannone, Palermo, Italy, Francesco Claps, Trieste, Italy, Davide Baiamonte, Rosa Giaimo, Marco Vella, Carlo Pavone, Palermo, Italy, Vincenzo Ficarra, Messina, Italy, Alchiede Simonato, Palermo, Italy

MP25-20 DEMUSOCALIZED DETRUSOR MUSCLE FLAPS FOR COMPLEX URETHRAL FISTULA

Matthew Loecher*, Ramphis Morales-Lopez, Michael Metro, Philadelphia, PA



Moderated Poster Session 26STONE DISEASE: EPIDEMIOLOGY & EVALUATION I

Room 225 @ Ernest N. Morial Convention CenterModerators: Casey Dauw & Glenn Preminger

ABSTRACT NUMBER TITLE MP26-01 COMPLETENESS OF 24-HOUR URINE

TESTING AMONG US VETERANS WITH URINARY STONE DISEASE

Ryan Hsi*, Nashville, TN, Autumn Valicevic, Sanjeevkumar Patel, John Hollingsworth, Vahakn Shahinian, Ann Arbor, MI

MP26-02 PREVALENCE OF 24-HOUR URINE ABNORMALITIES AMONG OLDER ADULTS WITH URINARY STONE DISEASE

Ryan Hsi*, Nashville, TN, Mary Oerline, Ann Ar-bor, MI, Joseph Crivelli, Birmingham, AL, Vahakn Shahinian, John Hollingsworth, Ann Arbor, MI

MP26-03 24-HOUR URINE TEST CONTRIBUTES TO THE DECREASED RISK OF RECURRENT STONE EVENTS

Rei Unno*, Xavier Cortez, Leslie Charondo, Kevin Chang, Nizar Hakam, Carter Chan, Heiko Yang, Gregory Hosier, Fadl Hamouche, David Bayne, Marshall Stoller, Thomas Chi, San Francisco, CA

MP26-04 24-HOUR URINE COLLECTIONS PERFORMED IN THE IMMEDIATE POST-OPERATIVE PERIOD ARE ACCURATE FOR METABOLIC STONE EVALUATION

Emily Serrell*, Margaret Knoedler, Shuang Li, Sean Hedican, Sara Best, Kristina Penniston, Stephen Nakada, Madison, WI

MP26-05 CHARACTERISTICS OF PATIENTS WITH AND WITHOUT MALABSORPTION ACCORDING TO 24-HOUR URINE OXALATE EXCRETION

Kyle Wood*, Birmingham, AL, Marja Puurunen, Kyra Mulder, Cambridge, MA, James MacDou-gall, Haverhill, MA, Caroline Kurtz, Aoife Brennan, Gary Curhan, Cambridge, MA

ABSTRACT NUMBER TITLE MP26-06 PREVALENCE OF KIDNEY STONE DISEASE

IN U.S. HISPANIC/LATINO ADULTS: FINDINGS FROM THE HISPANIC COMMUNITY HEALTH STUDY/STUDY OF LATINOS (HCHS/SOL)

Marcelino Rivera*, Indianapolis, IN, Jinsong Chen, Ana Ricardo, Chicago, IL, Robert Burk, Bronx, NY, Jianwen Cai, Chapel Hill, NC, Martha Daviglus, James Lash, Chicago, IL

MP26-07 PREVALENCE OF SYMPTOMATIC PEDIATRIC NEPHROLITHIASIS AT AN EMERGENCY DEPARTMENT IN SOUTH-EASTERN UNITED STATES - EXPERIENCE OVER LAST 15 YEARS

Shirley Zhang*, Birmingham, AL, Joshua Colling-wood, Dothan, AL, Ayaka Fujihashi, Kai He, Lauren Oliver, Pankaj Dangle, Birmingham, AL

MP26-08 PREVALENCE OF SYMPTOMATIC PEDIATRIC STONE DISEASE AT THE EMERGENCY DEPARTMENT – A REVIEW OF NATIONAL PHIS DATABASE

Joshua Collingwood, Cole Arnold*, Dothan, AL, Shelby Mize, Kalamazoo, MI, Pankaj Dangle, Birmingham, AL

MP26-09 ACCURACY OF DIAGNOSTIC CODES IN A CLINICAL RESEARCH NETWORK TO IDENTIFY PRIMARY HYPEROXALURIA PATIENTS

Christina Ching, Columbus, OH, Kim Dickinson*, Hanieh Razzaghi, Nicole Marchesani, Brian Augelli, Levon Utidjian, Philadelphia, PA, Lisa Mu-cha, Nuno Antunes, John Karafilidis, Cambridge, MA, Karyn Yonekawa, Seattle, WA, Doug Coplen, St. Louis, MO, Samina Muneeruddin, Wilmington, DE, Bob DeFoor, Cincinnati, OH, Kyle Rove, Denver, CO, Christopher Forrest, Gregory Tasian, Philadelphia, PA

114

MP26-10 CLINICAL AND METABOLIC FACTORS AFFECTING RELATIVE PROPORTION OF CALCIUM OXALATE MONOHYDRATE AND DIHYDRATE IN PURE CALCIUM OXALATE STONES

Mohammad Hout*, Vedant Acharya, Madhumita Parmar, Ruben Blachman Braun, Jonathan Katz, Robert Marcovich, Hemendra Shah, Miami, FL

MP26-11 CALCIUM PHOSPHATE STONE COMPOSITION VARIES BASED ON WHETHER STONE ANALYSES ARE WHOLE STONES VERSUS STONE FRAGMENTS

Margaret Knoedler*, Shuang Li, Stephen Nakada, Sara Best, Sean Hedican, Kristina Penniston, Madison, WI

MP26-12 CHANGING NATIONAL TRENDS IN OPIOID PRESCRIPTIONS FOR PAIN MANAGEMENT IN ACUTE KIDNEY STONE DISEASE

Chinmayee Katragadda, Alexis Steinmetz*, Alex-ander Cranwell, Rajat Jain, Rochester, NY

MP26-13 INCIDENCE AND TRENDS IN THE TREATMENT OF KIDNEY STONES IN CANADA: A POPULATION-BASED COHORT STUDY

Michael Ordon*, Toronto, Canada, Andrea Lantz Powers, Halifax, Canada, Ben Chew, Vancouver, Canada, Jason Lee, Michael Kogon, Toronto, Canada, Sri Sivalingam, Cleveland, OH, Shubha De, Edmonton, Canada, Naeem Bhojani, Sero Andonian, Montreal, Canada

MP26-14 ASSOCIATIONS OF FOOD ACCESS AND NEIGHBORHOOD WALKABILITY WITH URINARY RISK FACTORS FOR KIDNEY STONE DISEASE

Joseph Crivelli*, David Redden, Birmingham, AL, Naim Maalouf, Dallas, TX, Kyle Wood, Dean Assimos, Gabriela Oates, Birmingham, AL

MP26-15 RURAL HOSPITAL LOCATION IS ASSOCIATED WITH HIGHER REPORTED PRICES FOR URETEROSCOPY WITH LASER LITHOTRIPSY AMONG COMMERCIALLY INSURED PATIENTS

Ian Berger*, Vishnukamal Golla, Marcelo Cerullo, Yuqi Zhang, Michael E. Lipkin, Gary J. Faerber, Deborah R. Kaye, Charles D. Scales Jr., Durham, NC

MP26-16 THE FINANCIAL BURDEN OF PATIENTS WITH KIDNEY STONES AND ASSOCIATION WITH HEALTH-RELATED QUALITY OF LIFE

Jackson Cabo*, Ryan Hsi, Nashville, TN

MP26-17 FINANCIAL TOXICITY OF NEPHROLITHIASIS: AN ASSESSMENT OF THE ECONOMIC BURDEN OF STONE DISEASE TREATMENT IN A DIVERSE, URBAN POPULATION

Benjamin Green*, Nathan Feiertag, Kavita Gupta, Jillian Donnelly, Kara Watts, Alexander Small, Bronx, NY

MP26-18 UNDERINSURANCE IS ASSOCIATED WITH INCREASED RISK OF MULTIPLE PROCEDURES FOR KIDNEY STONES

Cameron Hicks*, David Bayne, San Francisco, CA, Sudarshan Srirangapatanam, Orlando, FL, Manuel Armas-Phan, Atlanta, GA, Efstathios Gennatas, Johsias Maru, San Francisco, CA

MP26-19 THE SMALL ACUTE URETERAL STONE PROTOCOL: LONGITUDINAL OUTCOMES

Conrad Bayley*, Tim Wollin, Shubha De, Sentil Senthilselvan, Trevor Schuler, Edmonton, Canada

MP26-20 IMPACT OF COVID-19 ON THE MANAGEMENT OF URETERIC STONES IN THE UK: THE COVID STONES STUDY

Matthew Byrne*, Oxford, United Kingdom, Fanourios Georgiades, Cambridge, United Kingdom, Catherine Lovegrove, Oxford, United Kingdom, Tobias Klatte, Berlin, Germany, Kasra Saeb-Parsy, Cambridge, United Kingdom, Rajeev Kumar, Oxford, United Kingdom, Alexander Light, Cambridge, United Kingdom, Josephine Rahman, Bristol, United Kingdom, Catherine Dominic, London, United Kingdom, Senthooran Kathi-ravelupillai, Cambridge, United Kingdom, Sarah Howles, Oxford, United Kingdom, Grant Stewart, Cambridge, United Kingdom, Ben Turney, Oxford, United Kingdom, Oliver Wiseman, Cambridge, United Kingdom,. COVID Stones Collaborative, Oxford, United Kingdom



SA

TU

RD

AY


Moderated Poster Session 27PROSTATE CANCER: ADVANCED (INCLUDING DRUG THERAPY) I

Room 222 @ Ernest N. Morial Convention CenterModerators: R. Jeffrey Karnes, Daniel Petrylak & Neal Shore

ABSTRACT NUMBER TITLE MP27-01 TIME ON TREATMENT WITH ABIRATERONE

IN MEN WITH DE NOVO METASTATIC CASTRATION SENSITIVE PROSTATE CANCER

Pär Stattin*, Hans Garmo, Uppsala, Sweden, Camilla Thellenberg-Karlsson, Umeå, Sweden, Giuseppe Fallara, Milan, Italy, Johan Styrke, Umeå, Sweden, Ingela Franck Lissbrant, Gothenburg, Sweden, Rolf Gedeborg, Uppsala, Sweden

MP27-02 NOT ALL ADVERSE PATHOLOGY FEATURES ARE EQUAL: IDENTIFYING OPTIMAL CANDIDATES FOR ADJUVANT RADIOTHERAPY AMONG PATIENTS WITH ADVERSE PATHOLOGY AT RADICAL PROSTATECTOMY

Elio Mazzone*, Giorgio Gandaglia, Armando Stabile, Milan, Italy, Nicola Fossati, Andrea Gallina, Lugano, Switzerland, Emanuele Zaffuto, Marta Picozzi, Francesco Barletta, Simone Scuderi, Riccardo Leni, Luigi Nocera, Gabriele Sorce, Francesco Pellegrino, Giuseppe Rosiello, Umberto Capitanio, Alessandro Larcher, Milan, Italy, Roberta Lucianò, Milano, Italy, Alessia Ci-madamore, Ancona, Italy, Federico Dehò, Varese, Italy, Rodolfo Montironi, Ancona, Italy, Pierre I. Karakiewicz, Montreal, Canada, Shahrokh F. Sha-riat, Vienna, Austria, Francesco Montorsi, Alberto Briganti, Milano, Italy

MP27-03 DELAYING POST-OPERATIVE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY IS ASSOCIATED WITH INCREASED FUNCTIONAL OUTCOMES: RESULTS FROM A LARGE SINGLE, REFERRAL CENTER SERIES

Mario de Angelis*, Elio Mazzone, Milano, Italy, Giorgio Gandaglia, Armando Stabile, Milan, Italy, Simone Scuderi, Francesco Barletta, Daniele Robesti, Milano, Italy, Luigi Nocera, Milan, Italy, Riccardo Leni, Milano, Italy, Vito Cucchiara, Mi-lan, Italy, Marco Bandini, Milano, Italy, Emanuele Zaffuto, Milan, Italy, Nazareno Suardi, Genoa, Italy, Andrea Necchi, Milano, Italy, Shahrokh F. Shariat, Vienna, Austria, Francesco Montorsi, Alberto Briganti, Milano, Italy

MP27-04 ONCOLOGIC OUTCOMES IN MEN WITH ADVERSE PATHOLOGY AND BIOCHEMICAL PERSISTENCE AFTER RADICAL PROSTATECTOMY

Marlon Perera, Amy Tin, Benjamin Beech*, Daniel Sjoberg, Nicole Benfante, Jaspreet Sandhu, Vin-cent Laudone, Behfar Ehdaie, James Eastham, Peter Scardino, Karim Touijer, New York, NY

ABSTRACT NUMBER TITLE MP27-05 EFFICACY AND SAFETY OF DAROLUTAMIDE

IN NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITH AND WITHOUT PRIOR LOCAL THERAPY WITH RADICAL PROSTATECTOMY OR RADIOTHERAPY

David Robert Siemens*, Kingston, Canada, Karim Fizazi, Villejuif, France, Neal D. Shore, Myrtle Beach, SC, Matthew R. Smith, Boston, MA, Jorge Ortiz, Whippany, NJ, Anja Schmall, Berlin, Ger-many, Shankar Srinivasan, Whippany, NJ, Frank Verholen, Basel, Switzerland, Matthias Saar, Aachen, Germany

MP27-06 CHARACTERISTICS AND PROGRESSION-FREESURVIVAL OF AFRO-CARIBBEAN MEN WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) AT THE TIME OF DIAGNOSIS

Laurent Brureau*, Pointe-A-Pitre, France, Thiba-ult Rossignol, Yvane Sadreux, Gilles Gourtaud, Cédric Senechal, Virginie Roux, Pascal Blanchet, Pointe-À-Pitre, Guadeloupe

MP27-07 COMPARISON OF CLINICAL OUTCOMES BETWEEN ANDROGEN DEPRIVATION THERAPY WITH UP-FRONT ABIRATERONE AND BICALUTAMIDE FOR JAPANESE PATIENTS WITH LATITUDE HIGH-RISK PROSTATE CANCER IN A REAL-WORLD MULTICENTER ANALYSIS

Taku Naiki*, Kiyoshi Takahara, Nagoya, Japan, Toshiki Ito, Hamamatsu, Japan, Keita Nakane, Gifu, Japan, Yosuke Sugiyama, Nagoya, Japan, Takuya Koie, Gifu, Japan, Ryoichi Shiroki, Nago-ya, Japan, Hideaki Miyake, Hamamatsu, Japan, Takahiro Yasui, Nagoya, Japan

MP27-08 EVALUATING THE EFFICACY OF A NOVEL AKR1C3 INHIBITOR IN PATIENT-DERIVED PROSTATE CANCER CELL LINE AND XENOGRAFT MODELS

Joy C. Yang, Shu Ning, Sacramento, CA, Hans Adomat, Martin Gleave, Vancouver, Canada, Al-len C. Gao, Christopher P. Evans, Chengfei Liu*, Sacramento, CA

MP27-09 IMPACT OF TROUGH CONCENTRATIONS OF ABIRATERONE AND D4A ON THE CLINICAL OUTCOMES OF PATIENTS WITH METASTATIC CASTRATION-SENSITIVE AND CASTRATION-RESISTANT PROSTATE CANCER

Yoshiko Takahashi*, Shintaro Narita, Akita, Japan, Masaki Shiota, Fukuoka, Japan, Soki Kashima, Ryohei Yamamoto, Atsushi Koizumi, Kazuyuki Numakura, Mitsuru Saito, Akita, Japan, Masatoshi Eto, Fukuoka, Japan, Masatomo Miura, Tomonori Habuchi, Akita, Japan

116

MP27-10 CLINICAL UTILITY OF NEXT-GENERATION SEQUENCING FOR PROSTATE CANCER IN THE CONTEXT OF A CHANGING TREATMENT LANDSCAPE

Jacqueline R. Griffin, MS, PhD*, Tomi Jun, MD, Sunny Guin, PhD, Stamford, CT, Bobby Chi-Hung Liaw, MD, Vaibhav G. Patel, MD, Brooklyn, NY, Che-Kai Tsao, MD, Astoria, NY, Michael R. Rossi, PhD, Rong Chen, PhD, Xiang Zhou, PhD, Feras Hantash, MD, MS, PhD, Stamford, CT, William K. Oh, MD, New York, NY

MP27-11 INCREASED CYTOKINE GENE EXPRESSION AND INFLAMMATORY MARKERS ASSOCIATED WITH ANDROGEN DEPRIVATION THERAPY

Shiv Verma, Vaibhav Singh, Eswar Shankar, Sanjay Gupta*, Cleveland, OH

MP27-12 DEVELOPMENT OF EXOSOME-BASED PLASMA RNA BIOMARKERS FOR HIGH-RISK PROSTATE CANCER

Sandra Gaston*, Benjamin Spieler, Alan Dal Pra, Radka Stoyanova, Miami, FL, Yevgenia Khodor, Sudipto Chakrabortty, Vasisht Tadigotla, Seth Yu, Grannum Sant, Waltham, MA, Christian Fischer, Martinsried, Germany, Sanoj Punnen, Miami, FL, Johan Skog, Waltham, MA, Alan Pollack, Miami, FL

MP27-13 LONG-TERM SAFETY OF DAROLUTAMIDE AMONG PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO RECEIVED MORE THAN 4 YEARS OF THERAPY

Robert Hugh Jones*, Cardiff, United Kingdom, Karim Fizazi, Villejuif, France, Nicholas D. James, Birmingham, United Kingdom, Teuvo L. Tam-mela, Tampere, Finland, Nobuaki Matsubara, Chiba, Japan, Frank Priou, La Roche-Sur-Yon, France, Phillipe Beuzeboc, Paris, France, Thierry Lesimple, Rennes, France, Petri Bono, Helsinki, Finland, Vesa Kataja, Kuopio, Finland, Jorge A. Garcia, Cleveland, OH, Andrew Protheroe, Oxford, United Kingdom, John Aspegren, Heikki Joensuu, Espoo, Finland, Iris Kuss, Silke Thiele, Berlin, Germany, Sabine Fiala-Buskies, Wupper-tal, Germany, Eglis Vjaters, Riga, Latvia

MP27-14 OVERALL SURVIVAL IN PATIENTS WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER TREATED WITH ENZALUTAMIDE OR PLACEBO PLUS ANDROGEN DEPRIVATION THERAPY WHO HAD PRIOR LOCAL THERAPY: POST HOC ANALYSIS OF THE PHASE 3 ARCHES TRIAL

Taro Iguchi*, Ishikawa, Japan, Arnauld Villers, Lil-le, France, Neal D Shore, Myrtle Beach, SC, Arun A Azad, Melbourne, Australia, Russell Z Szmule-witz, Chicago, IL, Jeffrey Holzbeierlein, Kansas City, KS, Antonio Alcaraz, Barcelona, Spain, Boris Alekseev, Moscow, Russian Federation, Francisco Gomez-Veiga, Salamanca, Spain, Brad Rosbrook, San Diego, CA, Ho-Jin Lee, Gabriel P Haas, Northbrook, IL, Andrew J Armstrong, Durham, NC, Arnulf Stenzl, Tübingen, Germany

MP27-15 SABIZABULIN HAS BOTH CYTOTOXIC AND CYTOSTATIC ACTIVITY IN PHASE 1B/2 CLINICAL OF MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER WHO PROGRESSED ON ANDROGEN RECEPTOR TARGETING AGENTS

Mark Markowski*, Mario Eisenberger, Baltimore, MD, Christopher Pieczonka, Syracuse, NY, Robert Getzenberg, Domingo Rodriguez, K. Gary Barnette, MItchell Steiner, Miami, FL, Daniel Saltzstein, San Antonio, TX, Emmanuel Antonar-akis, Baltimore, MD, Ronald Tutrone, Towson, MD

MP27-16 ORAL RELUGOLIX FOR ANDROGEN DEPRIVATION THERAPY IN ADVANCED PROSTATE CANCER: DETAILED SAFETY ANALYSIS FROM THE RANDOMIZED PHASE 3 HERO STUDY

Bryan Mehlhaff*, Springfield, OR, Neal D. Shore, Myrtle Beach, SC, Daniel J. George, Durham, NC, Michael S. Cookson, Oklahoma City, OK, Daniel R. Saltzstein, San Antonio, TX, Ronald Tutrone, Towson, MD, James L. Bailen, Jefferson-ville, IN, Bruce Brown, Andria G.M. Langenberg, Mark Fallick, Sophia Lu, Brisbane, CA, Sarah Hanson, New York, NY, Bertrand Tombal, Brus-sels, Belgium, Fred Saad, Montreal, Canada

MP27-17 NIRAPARIB WITH ABIRATERONE ACETATE AND PREDNISONE FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE PHASE 2 QUEST STUDY

Kim Chi*, Vancouver, Canada, Neil Fleshner, Toronto, Canada, Vincenzo Emanuele Chiuri, Scar-anos, Lecce, Italy, Siska Van Bruwaene, Kortrijk, Belgium, Jason Hafron, West Bloomfield Township, MI, Douglas G. McNeel, Madison, WI, Peter De Porre, Beerse, Belgium, R. Scott Maul, Los An-geles, CA, Mahesh Daksh, Raritan, NJ, Xiaogang Zhong, College Park, MD, Gary E. Mason, Spring House, PA, Ronald Tutrone, Towson, MD

MP27-18 PRACTICE PATTERNS IN MANAGEMENT OF HORMONE SENSITIVE METASTATIC AND CASTRATE-RESISTANT NON-METASTATIC PROSTATE CANCER

Daniel D. Joyce*, Vidit Sharma, Andrew Zganjar, Eugene D. Kwon, R. Jeffrey Karnes, Rochester, MN

MP27-19 COMPARATIVE OUT-OF-POCKET COSTS OF TREATMENT OPTIONS IN PRIVATELY INSURED PATIENTS WITH ADVANCED PROSTATE CANCER

Daniel D. Joyce*, Vidit Sharma, David H. Jiang, Holly K. Van Houten, Lindsey R. Sangaraling-ham, Eugene D. Kwon, Rochester, MN, David F. Penson, Stacie B. Dusetzina, Nashville, TN, Jon C. Tilburt, Scottsdale, AZ, Stephen A. Boorjian, Rochester, MN

MP27-20 ANALYZING MEDICAL MARIJUANA’S EFFECT ON NARCOTIC PAIN MEDICATION CONSUMPTION IN PATIENTS WITH PROSTATE CANCER

Young Son*, Benjamin Fink, Katelyn Klimowich, Stratford, NJ, Ian Madison, Philadelphia, PA, Julia Scali, Dayna DeVincentz, Paul Chialastri, Thomas Mueller, Gordon Brown, Stratford, NJ



SA

TU

RD

AY

Saturday, May 14, 2022 12:25 pm – 5:05 pm

Society of Urologic Oncology (SUO)LaNouvelle Orleans Ballroom C @ Ernest N. Morial Convention Center

12:25 WELCOME AND INTRODUCTION Chairs: Brian Cross, Stacy Loeb

12:30 SUO AWARDS Society President: Jeffrey Holzbeierlein

12:40 INTRODUCTION TO THE WHITMORE LECTURE Jeffrey Holzbeierlein

12:45 WHITMORE LECTURE Keynote Speaker: Eila Skinner

1:10 KIDNEY CANCER Moderator: Jose Karam

TIPS AND TRICKS IN IVC THROMBECTOMY Stephen Boorjian

IS CYTOREDUCTIVE NEPHRECTOMY DEAD OR ALIVE IN 2022?

E. Jason Abel

SHOULD EVERYONE RECEIVE ADJUVANT THER-APY AFTER RESECTION OF HIGH-RISK RCC?

Viraj Master

THREE PAPERS IN THE PAST YEAR THAT INFLU-ENCED MY PRACTICE

Kara Babaian

2:05 UROTHELIAL CANCER Moderator: Katie Murray

ONCOLYTIC VIROTHERAPY IN THE TREATMENT OF BLADDER CANCER

Roger Li

RESCUE THERAPY AND BCG ALTERNATIVES IN NON-MUSCLE INVASIVE BLADDER CANCER

Max Kates

ADJUVANT THERAPY AFTER NEPHROURE-TERECTOMY FOR HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA

Sima Porten

THREE PAPERS IN THE PAST YEAR THAT INFLUENCED MY PRACTICE

LaMont Barlow

2:45 BREAK

2:55 ADDRESSING RACIAL DISPARITIES IN UROLOGIC CANCER

Randy Vince

3:15 PROSTATE CANCER Moderator: Kelvin Moses

DE-INTENSIFYING ACTIVE SURVEILLANCE FOR PROSTATE CANCER

Daniel Lin

IMPLEMENTATION OF GERMLINE TESTING IN PROSTATE CANCER

Veda Giri

UPDATE ON CLINICAL TRIALS IN PROSTATE CANCER

A. Oliver Sartor

THREE PAPERS IN THE PAST YEAR THAT INFLUENCED MY PRACTICE

Andres Correa

4:00 TECHNOLOGY IN UROLOGIC ONCOLOGY PANEL Moderator: Prokar Dasgupta

ARTIFICIAL INTELLIGENCE IN UROLOGIC ONCOLOGY

Andrew Hung

SIMULATION AND 3D PRINTING IN UROLOGIC ONCOLOGY

Ahmed Ghazi

SOCIAL MEDIA IN UROLOGIC ONCOLOGY Kara Watts

4:35 HEALTH SERVICES Moderator: Bruce Trock

PITFALLS & BEST PRACTICES IN REPORTING UROLOGIC ONCOLOGY RESEARCH

Melissa Assel

REGISTRIES AND DASHBOARDS IN UROLOGIC ONCOLOGY

David Robinson

INFORMED CONSENT FOR CLINICAL TRIALS Andrew Vickers


118


Moderated Poster Session 28HEALTH SERVICES RESEARCH: PRACTICE PATTERNS, QUALITY OF LIFE AND SHARED DECISION MAKING III

Room 228 @ Ernest N. Morial Convention CenterModerators: Amanda North, Kevan Sternberg & John Wei

ABSTRACT NUMBER TITLE MP28-01 SMOKING CESSATION COUNSELING

IN PATIENTS PRESENTING WITH ASYMPTOMATIC HEMATURIA: ARE UROLOGISTS DOING ENOUGH?

Michael Goedde*, Thomas Barefoot, Kellen Choi, Louisville, KY

MP28-02 MEASURING THE IMPACT OF THE VETERANS CHOICE LEGISLATION ON PROSTATE CANCER CARE FOR RURAL VETERANS IN THE VETERANS ADMINISTRATION HEALTHCARE SYSTEM

Bradley Erickson*, Richard Hoffman, Jason Wachsmuth, Hayden Warner, Mary Vaughan- Sarrazin, Iowa City, IA

MP28-03 EVALUATING AN INFORMED/SHARED DECISION-MAKING PROGRAM FOR PROSTATE CANCER SCREENING AMONG MEMBERS OF THE WORLD TRADE CENTER HEALTH PROGRAM: RESULTS FROM AN IMPLEMENTATION STUDY

Michael Diefenbach*, Thomas Mistretta, Manhas-sett, NY, Simon Hall, Manish Vira, New Hyde Park, NY, Allison Marzilliano, Manhassett, NY, An-drea Yacoub, Manhasset, NY, Mayer Bellehsen, Manhassett, NY, Jason Kornrich, New Hyde Park, NY, Jacqueline Moline, Manhasset, NY

MP28-04 VALIDATION OF A SURGICAL DECISION AID FOR PATIENTS WITH NEPHROLITHIASIS: SHOCKWAVE LITHOTRIPSY VERSUS URETEROSCOPY

John Michael DiBianco*, Stephanie Daig-nault-Newton, Bronson Conrado, Sarah T. Hawley, Giulia Lane, Khurshid R. Ghani, Casey A. Dauw, for the Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI

MP28-05 STONE SURGERY TRENDS FROM 2012-2019 WITHIN THE MEDICARE UTILIZATION AND PAYMENT DATA: SHARP GROWTH IN URETEROSCOPY UTILIZATION WITH DIMINISHING SWL UTILIZATION

Christopher Haas*, Margaret Knoedler, Kristina L. Penniston, Stephen Y. Nakada, Madison, WI

MP28-06 NATIONAL TRENDS IN THE PRESCRIPTION OF NARCOTICS IN THE EMERGENCY DEPARTMENT IN PATIENTS WITH NEPHROLITHIASIS

Spencer Liem*, Timothy Demus, Miami Beach, FL, Alexandra Perez, Fort Lauderdale, FL, Crystal Lee, Philadelphia, PA, Kevin George, Miami, FL, Alejandra Perez, Miami Beach, FL, Luigi Cubed-du, Fort Lauderdale, FL, Jorge Pereira, Miami Beach, FL

ABSTRACT NUMBER TITLE MP28-07 ASSOCIATION BETWEEN BASELINE BONE

MINERAL DENSITY TESTING AND THE RISK OF FRACTURES IN MEN INITIATING ANDROGEN DEPRIVATION THERAPY: POPULATION-BASED STUDY

Jason Hu*, Armen Aprikian, Alice Dragomir, Montreal, Canada

MP28-08 BURDEN OF DEPRESSION AND ANXIETY IN MEN WITH HIGH-RISK, INTERMEDIATE-RISK OR LOW-RISK PROSTATE CANCER

Sumedha Chhatre*, S Bruce Malkowicz, Ravis-hankar Jayadevappa, Philadelphia, PA

MP28-09 IMPACT OF SPIRITUALITY ON QUALITY OF LIFE IN LOW-INCOME MEN WITH PROSTATE CANCER

Thomas Gaither*, Mark Litwin, Los Angeles, CA

MP28-10 10-YEAR OUTCOMES IN WORK LOSS, PHYSICAL FUNCTION, AND MENTAL HEALTH OF 6,693 MEN UNDERGOING PRIMARY TREATMENT FOR PROSTATE CANCER

Samuel Washington*, San Francisco, CA, Peter Lonergan, Dublin, Ireland, Janet Cowan, Shoujun Zhao, Scott Greenberg, Jenny Broering, Nynikka Palmer, Robert Parker, Alexander Bell, Matthew Cooperberg, Peter Carroll, San Francisco, CA

MP28-11 IMPLICIT BIAS IN COMMUNICATION OF RISK IN PROSTATE CANCER TREATMENT CONSULTATIONS

Aurash Naser-Tavakolian*, Rebecca Gale, Michael Luu, Abhishek Venkataramana, Los An-geles, CA, Dmitry Khodyakov, Santa Monica, CA, Edwin Posadas, Howard Sandler, Jennifer Anger, Stephen Freedland, Brennan Spiegel, Timothy Daskivich, Los Angeles, CA

MP28-12 PROLIFERATION OF PHYSICIAN DISPENSING AMONG LARGE SINGLE-SPECIALTY MEDICAL ONCOLOGY AND UROLOGY PRACTICES

Lillian Lai*, Samuel Kaufman, Mary Oerline, Megan Caram, Avinash Maganty, Chad Ellimoottil, Vahakn Shahinian, Brent Hollenbeck, Ann Arbor, MI

MP28-13 LARGE VARIATIONS IN INSURANCE CHARGES AND CASH FEES FOR COMMON UROLOGICAL PROCEDURES

Cailey Guercio*, Danielle Sharbaugh, Daniel Pelzman, Emily Hacker, Levi Bowers, Ifunanya Anyaeche, Ashti Shah, Michael Stencel, Bruce Jacobs, Benjamin Davies, Pittsburgh, PA

MP28-14 UTILITY OF RENAL MASS BIOPSY IN SHARED DECISION MAKING FOR RENAL MASS TREATMENT

Jane Kurtzman*, Connie Wang, New York, NY, Luis Pina Martina, Bronx, NY, Rainjade Chung, Christopher Anderson, New York, NY


SA

TU

RD

AY

MP28-15 DECISION MAKING FACTORS IN TRANSMASCULINE GENITAL RECONSTRUCTION SURGERY: A MIXED METHODS STUDY

Rebecca Butcher, Kaylee Luck*, Lebanon, NH, Gaines Blasdel, New York, NY, Linda Kinney, Benjamin Boh, Karen Schifferdecker, Lebanon, NH, Jeremy Myers, Salt Lake City, UT, Rachel Moses, Lebanon, NH

MP28-16 HEALTH CARE DISPARITIES IN THE TRANSGENDER POPULATION

Niki Parikh*, Patricio Gargollo, Candace Granberg, Rochester, MN

MP28-17 CHARACTERIZING THE CHALLENGES TRANSFEMININE INDIVIDUALS FACE IN SEEKING UROLOGICAL CARE

Andrew Denisenko*, Andrew Salib, Jessica Bulafka, Sabina Spigner, Vishal Swaminathan, Peyton Stauffer, Cassra B. Clark, Andrew Shumaker, Rosemary Frasso, Paul H. Chung, Philadelphia, PA

MP28-18 RELATIONSHIP BETWEEN INSURANCE STATUS AND PENILE SQUAMOUS CELL CARCINOMA SURVIVORSHIP: A POPULATION BASED STUDY

Yousef Rafati*, Daniel Millian, Laith Alzweri, Galveston, TX

MP28-19 CONTEMPORARY TREND ANALYSIS OF INTRA-DETRUSOR BOTOX INJECTION AND AUGMENT CYSTOPLASTY FOR SPINA BIFIDA POPULATION IN US FREE-STANDING CHILDRENS HOSPITALS

Hsin-Hsiao Wang, Kenneth Softness*, John Pa-nagides, Dylan Cahill, Rachel Saunders, Boston, MA, Ranveer Vasdev, Minneapolis, MN, Tanya Logvinenko, Carlos Estrada, Boston, MA

MP28-20 STATEWIDE OPIOID STEWARDSHIP POLICIES ASSOCIATED WITH MINIMAL CHANGES IN OPIOID PRESCRIBING FOLLOWING UROLOGIC SURGERY

Tudor Borza, Jeremy Goodman*, Manasa Venkatesh, Emi Serrell, Elise Lawson, Sudha Quamme, Kyle Richards, E. Jason Abel, David Jarrard, Caprice Greenberg, Corrine Voils, Jessi-ca Schumacher, Madison, WI



Moderated Poster Session 29BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY III

Room 225 @ Ernest N. Morial Convention CenterModerators: Alexis Te, Thomas Lynch & Mario Gonzalez

ABSTRACT NUMBER TITLE MP29-01 COMPARISON OF POSTOPERATIVE

OUTCOMES OF TRANSURETHRAL RESECTION OF THE PROSTATE, LASER VAPORIZATION OR LASER ENUCLEATION FOR BENIGN PROSTATIC HYPERPLASIA TREATMENT USING THE AMERICAN COLLEGE OF SURGEONS NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (ACS-NSQIP) DATASET

Christian Ayoub*, Rachelle Haber, Reem Amine, Diana Mikati, Albert El Hajj, Beirut, Lebanon

MP29-02 SALVAGE VERSUS PRIMARY HOLMIUM LASER ENUCLEATION FOR BPH: AN OUTCOMES AND SAFETY ANALYSIS

Adri Durant*, Sandeep Voleti, Sarah Wu, Phoenix, AZ, Jonathan Moore, Davis, CA, Gopal Narang, Scott Cheney, Mitchell Humphreys, Phoenix, AZ

MP29-03 IS SIMPLE PROSTATECTOMY AFTER PRIOR MINIMALLY INVASIVE SURGICAL THERAPIES FOR BENIGN PROSTATIC HYPERPLASIA AS EFFICACIOUS AS PRIMARY SIMPLE PROSTATECTOMY

Ram Pathak, Bridget Krol*, Nikhil Crain, Ashok Hemal, Winston-Salem, NC

ABSTRACT NUMBER TITLE MP29-04 EFFECT OF SURGEON VOLUME AND

FACILITY VOLUME ON OUTCOMES OF BENIGN PROSTATIC HYPERPLASIA SURGERY

David-Dan Nguyen*, David Bouhadana, Montreal, Canada, Michelina Stoddard, Xinyan Zheng, Jialin Mao, New York, NY, Naeem Bhojani, Montreal, Canada, Bilal Chughtai, New York, NY

MP29-05 PROPENSITY-SCORE ANALYSIS COMPARING PERIOPERATIVE AND FUNCTIONAL OUTCOMES BETWEEN XPS 180 W PHOTOVAPORIZATION AND GREENLIGHT LASER ENUCLEATION OF THE PROSTATE: REASONS TO DISCARD VAPORIZATION AND MOVE TO ENUCLEATION

Anis Gasmi*, Zine-Eddine Khene, Sonia Guérin, Karim Bensalah, Benoit Peyronnet, Romain Mathieu, Rennes, France, Morgan Rouprêt, Paris, France, Enrique Rijo, Barcelona, Spain, Benja-min Pradère, Rennes, France, Vincent Misrai, Toulouse, France

120

MP29-06 INITIAL COMPARISON OF TECHNIQUE CHANGE FROM THREE LOBE TO EARLY APICAL RELEASE IN HOLMIUM LASER ENUCLEATION OF THE PROSTATE IN A HIGH-VOLUME CENTER

Christian Ericson*, Bryce Baird, Chandler Dora, Jacksonville, FL

MP29-07 FIVE-YEAR OUTCOMES AFTER AQUABLATION COMPARED TO TURP: THE FINAL WATER STUDY RESULTS

Peter Gilling*, Tauranga, New Zealand

MP29-08 AQUABLATION FOR BENIGN PROSTATIC HYPERPLASIA IN LARGE PROSTATES (80-150CC): 4-YEAR RESULTS

Naeem Bhojani*, Montreal, Canada

MP29-09 AQUABLATION: MULTI-PASS IMPACT Thorsten Bach*, Hamburg, Germany, Steven

Kaplan, New York, NY

MP29-10 AQUABLATION IN VERY LARGE PROSTATES (>150ML): TECHNIQUE AND MULTICENTER CASE SERIES

Alexander Glaser*, Brian Helfand, Glenview, IL, Ali Kasraeian, Jacksonville, FL, Steve Sterious, Philadelphia, PA, Pooja Talaty, Glenview, IL, Miguel Alcantara, Kaitlyn Alcantara, Jacksonville, FL, Andrew Higgins, Eric Ghiraldi, Philadelphia, PA, Dean Elterman, Toronto, Canada

MP29-11 HOLMIUM LASER ENUCLEATION OF PROSTATE VERSUS MINIMALLY INVASIVE SIMPLE PROSTATECTOMY FOR LARGE VOLUME (≥ 120 ML) PROSTATE GLANDS: A PROSPECTIVE MULTICENTER RANDOMIZED STUDY

Andrea Fuschi*, Yazan Al Salhi, Alessia Martoc-cia, Lorenzo Capone, Silvio Scalzo, Paolo Pietro Suraci, Onofrio Antonio Rera, Fabio Maria Valen-zi, Alice Antonioni, Latina, Italy, Filippo Annino, Arezzo, Italy, Mario Falsaperla, Catania, Italy, Antonio Carbone, Antonio Luigi Pastore, Latina, Italy

MP29-12 TRANSURETHRAL BIPOLAR ENUCLEATION (TUBE): IMPROVED OUTCOMES VERSUS STANDARD BIPOLAR TRANSURETHRAL PROSTATE RESECTION (TURIS) WITHOUT A SIGNIFICANT LEARNING CURVE MAY EASE ADOPTION OF ENUCLEATION TECHNIQUES INTO CLINICAL PRACTICE

Zachary Tully*, Brian Barnes, Ryan Steinberg, Bradley Erickson, Iowa City, IA

MP29-13 OVERCOMING THE LEARNING CURVE: A SINGLE INSTITUTION REVIEW OF HOLEP COMPLICATIONS AND HOW TO MANAGE THEM

Cassra Clark*, Jared Raikin, Anthony Tokarski, Abhay Singh, Patrick Shenot, Akhil Das, Philadel-phia, PA

MP29-14 OFFICE VERSUS OPERATING ROOM REZUM PROSTATE ABLATION: PATIENTS’ SELECTION AND POSTOPERATIVE OUTCOMES

Engy Habashy*, Ajay Gopalakrishna, Sevann Helo, Matthew Ziegelmann, Tobias Kohler, Rochester, MN

MP29-15 COMPARISON OF PERIOPERATIVE OUTCOMES BETWEEN TRANSVESICAL SINGLE PORT AND INTRAVESICAL MULTIPORT ROBOTIC ASSISTED SIMPLE PROSTATECTOMY: A SINGLE CENTER STUDY

Bilal Ahmed Khan, Hackensack, NJ, Tanner Corse, Jay Zaifman, Nutley, NJ, Ruth Sanchez De La Rosa, Sarah Brink*, Janmejay Hingu, Suzan-nah Sorin, Hackensack, NJ, Ravi Munver, Michael Stifelman, Mutahar Ahmed, Nutley, NJ

MP29-16 SAME-DAY HOME RECOVERY TRANSURETHRAL RESECTION OF THE PROSTATE IS NOT ASSOCIATED WITH INCREASED URGENT CARE OR EMERGENCY DEPARTMENT RETURN RATES IN AN INTEGRATED HEALTH CARE DELIVERY SYSTEM

Krystal DePorto*, Trevor Cesar, Los Angeles, CA, Eugene Rhee, San Diego, CA, Steven Crain, Woodland Hills, CA, Gary Chien, Polina Reyblat, Christopher Tenggardjaja, Los Angeles, CA

MP29-17 RECOVERY ROOM TIME AND LENGTH-OF-STAY ARE SIMILAR AFTER SPINAL AND GENERAL ANAESTHESIA FOR BPH SURGERY

Kirby R. Qin*, William Wang, Damien Bolton, Gregory Jack, Melbourne, Australia

MP29-18 POST-OPERATIVE BLADDER PRESSURE MONITORING FOR SAME DAY CATHETER REMOVAL AFTER HOLEP

Gopal Narang*, Charlotte Pougnier, Lanyu Mi, Kevin Wymer, Mitchell Humphreys, Scott Cheney, Phoenix, AZ

MP29-19 PROSPECTIVE RANDOMIZED TRIAL ASSESSING THE SEVERITY OF IRRITATIVE SYMPTOMS AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) VERSUS THULIUM FIBER LASER ENUCLEATION OF THE PROSTATE (THUFLEP)

Dmitry Enikeev*, Mark Taratkin, Diana Babae-vskaya, Vladislav Petov, Mikhail Enikeev, Roman Sukhanov, Evgeny Shpot, Denis Chinenov, Moscow, Russian Federation, Thomas Herrmann, Hannover, Germany

MP29-20 BLADDER NECK AND URETHRAL STENOSIS AFTER THULIUM LASER ENUCLEATION OF THE PROSTATE: A MULTICENTRIC COHORT STUDY

Michele Antonucci, Rome, Italy, Daniele Castel-lani, Ancona, Italy, Marta Signoretti, Marco Carilli, Matteo Vittori, Francesco Maiorino, Chiara Cip-riani, Valerio Iacovelli, Riccardo Bertolo*, Rome, Italy, Marco Dellabella, Ancona, Italy, Pierluigi Bove, Rome, Italy



SA

TU

RD

AY


Moderated Poster Session 30GLOBAL HEALTH/HUMANITARIAN

Room 222 @ Ernest N. Morial Convention CenterModerators: John Lynch, Gopal Badlani & Graham Watson

ABSTRACT NUMBER TITLE MP30-01 IMPACT AT 20 YEARS: IVUMED BY THE

NUMBERS Jacob Knorr*, Cleveland, OH, Danielle Sweeney,

Christina Ching, Ashley Westrum, Frank Burks, Heidi Stephany, Eric Richter, Joseph Costa, Scott Eggener, Maahum Haider, Benjamin Davies, Jo-seph Smith, Kurt McCammon, Francis Schneck, Ian Metzler, Salt Lake City, UT

MP30-02 THE IVU VIRTUAL VISITING PROFESSORSHIP PROGRAM: YOUTUBE AND ITS IMPACT ON GLOBAL HEALTH EDUCATION

Dzhuliyan (Jay) Vasilev*, Scottsdale, AZ, Danielle D Sweeney, Ashley M Westrum, Austin, TX, Christina B. Ching, Columbus, OH, Francis X Schneck, Pittsburg, PA, Ian S. Metzler, Portland, OR

MP30-03 EVALUATION OF AUGMENTED REALITY TECHNOLOGY IN GLOBAL UROLOGIC SURGERY

Georgina Dominique*, Inglewood, CA, Kevin Kunitsky, Kansas City, MO, Gilles Natchagande, Michel Michaël Agounkpe, Fred D. Hodonou, Dodji Magloire Ines Yevi, Josué D. G. Avakoudjo, Cotonou, Benin, Kurt McCammon, Norfolk, VA, Graham Watson, East Sussex, United Kingdom, Kymora Scotland, Los Angeles, CA

MP30-04 REINTEGRATING A GLOBAL HEALTH PROGRAM TO ON-SITE VISITS DURING THE COVID-19 PANDEMIC

Christina B Ching*, Columbus, OH, Danielle D Sweeney, Ashley M Westrum, Austin, TX, Janelle Fox, Pittsburgh, PA, Maahum A Haider, Seattle, WA, Kurt A McCammon, Virginia Beach, VA, Ian S Metzler, Portland, OR, Francis X Schneck, Pittsburgh, PA

MP30-05 THE PROJECTED IMPACT OF COVID-19 ON GLOBAL HEALTH SERVICES: TAXING AN ALREADY CRITICALLY LIMITED RESOURCE

Christina B Ching*, Columbus, OH, Danielle D Sweeney, Ashley M Westrum, Austin, TX, Frank N Burks, Royal Oak, MI, Patricia Christensen, Salt Lake City, UT, Joseph A Costa, Jacksonville, FL, Benjamin Davies, Pittsburgh, PA, Scott E Eggener, Chicago, IL, Maahum A Haider, Seattle, WA, Kurt A McCammon, Virginia Beach, VA, Ian S Metzler, Portland, OR, Eric R Richter, Pueb-lo, CO, Joseph A Smith, Nashville, TN, Heidi A Stephany, Irvine, CA, Francis X Schneck, Pitts-burgh, PA

MP30-06 FINANCIAL IMPACT OF UROLOGIC CONDITIONS IN MEN AND WOMEN IN BELIZE

Clinton Yeaman*, Devang Sharma, Raj Desai, Rajesh Balkrishnan, David Rapp, Charlottesville, VA

ABSTRACT NUMBER TITLE MP30-07 CONDUCTING UROLOGY RESEARCH

DURING COVID-19: SOCIAL MEDIA-BASED CROWDSOURCING OF URINE SAMPLES FOR BIOMARKER DEVELOPMENT

Elijah Ward*, Sarah Bartolone, Alexander Varab-ulea, Joseph Janicki, Hannah Peters, Kenneth Peters, Royal Oak, MI, Nitya Abraham, Melissa Laudano, New York, NY, Christopher Smith, Hou-ston, TX, Bernadette Zwaans, Michael Chancel-lor, Royal Oak, MI, Laura Lamb, Ann Arbor, MI

MP30-08 ANTIBODY RESPONSES TO BNT162B2 MRNA COVID-19 VACCINE IN HEALTHCARE WORKERS AND PATIENTS WITH UROLOGICAL DISEASES IN JAPAN

Shingo Hatakeyama*, Tohru Yoneyama, Tomoko Hamaya, Kyo Togashi, Takuma Narita, Naoki Fu-jita, Hirosaki, Japan, Hayato Yamamoto, Hirosaki, Japan, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama, Hirosaki, Japan

MP30-09 DEVELOPMENT OF A NOVEL DIAGNOSTIC MODEL FOR UROLOGICAL CANCERS USING COMPREHENSIVE N-GLYCAN SIGNATURES OF SERUM IMMUNOGLOBULINS WITH A MACHINE LEARNING APPROACH

Hiromichi Iwamura*, Tohru Yoneyama, Hirotake Kodama, Kai Ozaki, Yusuke Ozaki, Kazutaka Okita, Sakae Konishi, Takuma Narita, Naoki Fujita, Yuta Kojima, Teppei Okamoto, Yuki Tobisawa, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama, Hirosaki, Japan

MP30-10 UROLOGICAL CANCERS DURING COVID-19: ANALYSES OF SHORT-TERM OUTCOMES FROM THE COVIDSURG-CANCER STUDY

Vinson Wai-Shun Chan*, Leeds, United Kingdom, COVIDSurg Cancer Collaborators, Birmingham, United Kingdom, British Urology Researchers in Surgical Training (BURST) Collaborators, London, United Kingdom

MP30-11 COVID-19 VACCINATION IN AN INNER-CITY UROLOGY POPULATION FROM SEPTEMBER - OCTOBER 2021

Meher Pandher*, Courtney Berg, Gabriel Fer-nandez, Chrystal Chang, Amjad Alwaal, Robert Weiss, Newark, NJ

MP30-12 VALIDATION OF MOBILE APPLICATION MEASURING VOIDED VOLUME: A PILOT PROSPECTIVE STUDY

Hwanik Kim, Jin Hyuck Kim, Changhee Ye*, Gyoohwan Jung, Jung Kwon Kim, Hakmin Lee, Seong Jin Jeong, Sangchul Lee, Seongnam, Korea, Republic of

122

MP30-13 TRAINING AND IMPLEMENTATION OF HANDHELD ULTRASOUND TECHNOLOGY AT GEORGETOWN PUBLIC HOSPITAL CORPORATION: A LOW-COST INTERVENTION TO IMPROVE DIAGNOSTIC EVALUATION IN A RESOURCE-LIMITED UROLOGY CLINIC

Michelle Bui*, Adrian Fernandez, San Francis-co, CA, Budheshwar Ramsukh, Georgetown, Guyana, Onika Noel, Sacramento, CA, Chris Prashad, Georgetown, Guyana, David Bayne, San Francisco, CA

MP30-14 ENVIRONMENTAL IMPACT OF TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY

Michael Leapman*, NEW HAVEN, CT, Cassandra Thiel, New York, NY, Ilyssa Gordon, Cleveland, OH, Adam Nolte, Miami, FL, Aaron Perecman, Burlington, MA, Michael Overcash, Wichita, KS, Jodi Sherman, New Haven, CT

MP30-15 ASSOCIATION BETWEEN BODY MASS INDEX, METABOLIC SYNDROME, AND UROLOGIC CONDITIONS: RESULTS FROM A MULTI-INSTITUTIONAL DATABASE FROM THE UNITED STATES

Maxwell Towe*, Sirpi Nackeeran, Mohammad Hout, Abhishek Bhat, Ranjith Ramasamy, Hemendra Shah, Miami, FL

MP30-16 THE BURDEN OF BLADDER OUTLET OBSTRUCTION IN MEN IN RURAL UGANDA: A CROSS SECTIONAL SURVEY AND FURTHER VALIDATION OF THE VISUAL PROSTATE SYMPTOM SCORE (VPSS)

Lynn Stothers*, Andrew Macnab, Vancouver, Canada

MP30-17 ASSOCIATIONS BETWEEN TOILET AND SANITATION INSECURITY, PSYCHOSOCIAL BURDEN, AND LOWER URINARY TRACT SYMPTOMS IN A SAMPLE OF U.S. ADULTS

Elisabeth Sebesta*, LeChey Hibbler, Stephanie Gleicher, Roger Dmochowski, Lindsey McKernan, W. Stuart Reynolds, Nashville, TN

MP30-18 COMPARING OUTCOMES OF PELVIC FRACTURE URETHRAL INJURY REPAIR IN THIRD WORLD COUNTRIES VERSUS UNITED STATES

Jacob Stephens*, Frank Burks, Royal Oak, MI

MP30-19 THE RAKAI SCORE: A NOVEL TOOL FOR PAIN MEASUREMENT DURING EARLY INFANT MALE CIRCUMCISION WITH THE SHANGRING

Aaron Brant, Christina Sze, Jeffrey Johnson*, Spyridon Basourakos, Quincy Nang, New York, NY, Stephen Kiboneka, Joseph Kagayi, Kali-sizo, Uganda, Alice Christensen, Dar Es Alaam, Tanzania-United Republic, Mark Barone, Marc Goldstein, Kaylee Ho, Karla Ballman, Philip Li, New York, NY, Godfrey Kigozi, Kalisizo, Uganda, Richard Lee, New York, NY

MP30-20 SHANGRING USE BY NON-PHYSICIAN PROVIDERS IN MALE INFANTS: SAFETY AND EFFICACY FROM A LARGE FIELD STUDY

Aaron Brant, Christina Sze, Jeffrey Johnson*, Spyridon Basourakos, Quincy Nang, Kaylee Ho, New York, NY, Stephen Kiboneka, Joseph Kagayi, Kalisizo, Uganda, Alice Christensen, Dar Es Alaam, Tanzania-United Republic, Godfrey Kigozi, Kalisizo, Uganda, Mark Barone, Karla Ballman, Marc Goldstein, Philip Li, Richard Lee, New York, NY



Podium Session 26BLADDER CANCER: NON-INVASIVE I

Room 252 @ Ernest N. Morial Convention CenterModerators: Ashish Kamat & Rajeev T.P.

ABSTRACTTIME NUMBER TITLE1:00 PD26-01 EN-BLOC VERSUS CONVENTIONAL

TRANSURETHRAL RESECTION OF BLADDER TUMORS: SINGLE-CENTER PROSPECTIVE RANDOMIZED TRIAL

Andrea Gallioli*, Pietro Diana, Matteo Fontana, Angelo Territo, Alberto Piana, Ferran Algaba, Óscar Rodriguez-Faba, Asier Marcadé, Alejandra Bravo, Antonio Rosales, Josep Maria Gaya, Joan Palou, Alberto Breda, Barcelona, Spain

1:10 PD26-02 REAL-TIME BLADDER TUMOR DETECTION AT CLINICS IN FLEXIBLE CYSTOSCOPY WITH WHITE LIGHT AND NARROW BAND IMAGING USING DEEP LEARNING

Atsushi Ikeda*, Shogo Takaoka, Hirokazu Nosato, Hiromitsu Negoro, Hidenori Sakanashi, Masahiro Murakawa, Hiroyuki Nishiyama, Tsukuba, Japan

ABSTRACTTIME NUMBER TITLE1:20 PD26-03 SEQUENTIAL INTRAVESICAL GEMCITABINE

AND DOCETAXEL FOR BCG-NAÏVE HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER

Ian M. McElree*, Ryan L. Steinberg, Alexander C. Martin, Jordan Richards, Sarah L. Mott, Paul T. Gellhaus, Kenneth G. Nepple, Michael A. O’Don-nell, Vignesh T. Packiam, Iowa City, IA

1:30 PD26-04 A RANDOMIZED STUDY TO COMPARE OUTCOMES OF INTRAVESICAL CHEMOHYPERTHERMIA WITH MITOMYCIN C VS INTRAVESICAL BCG FOR INTERMEDIATE AND HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER(NMIBC)

Karandeep Guleria*, Rajeev Sood, Hemant Goel, Umesh Sharma, Anurag Singla, New Delhi, India


SA

TU

RD

AY

1:40 PD26-05 HOW LONG SHOULD WE FOLLOW LOW GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)? A LARGE RETROSPECTIVE SINGLE INSTITUTION ANALYSIS

Eunice Villegas, Christian Vitug, Katherine La-jkosz, Cynthia Kuk, Bruce Gao, Otto Hemminiki, Dhiral Kot, Shayan Din, Jimmy Misurka, Girish S. Kulkarni, Michael Jewett, Neil E. Fleshner, The-odorus H. van der Kwast, Alexandre R. Zlotta*, Toronto, Canada

1:50 PD26-06 ADJUVANT CHEMOTHERAPY PLUS RADIOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR LOCALLY ADVANCED BLADDER CANCER AFTER RADICAL CYSTECTOMY

John Ernandez*, Sumedh Kaul, Aaron Fleishman, Ruslan Korets, Peter Chang, Andrew Wagner, Boston, MA, Simon Kim, Aurora, CO, Joaquim Bellmunt, Irving Kaplan, Aria Olumi, Boris Gersh-man, Boston, MA

2:00 PD26-07 SEQUENTIAL ENDOLUMINAL CABAZITAXEL AND GEMCITABINE WITH PEMBROLIZUMAB FOR DOCETAXEL-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE UPPER AND LOWER URINARY TRACTS

Vignesh T. Packiam*, Ian McElree, Ryan L. Steinberg, Adam Prescott, Rohan Garje, Yousef Zakharia, Michael A. O’Donnell, Iowa City, IA

2:10 PD26-08 LOW-GRADE UROTHELIAL CARCINOMA RECURS AT A TEMPO THAT NATURALLY ACCELERATES FROM ADAGIO TO ALLEGRO

Alex Sankin*, Bronx, NY, Louise-Rae Cherrill, Re-becca H. Boucher, Birmingham, United Kingdom, Maurice P. Zeegers, Maastricht, Netherlands, K. K. Cheng, Birmingham, United Kingdom, Nich-olas D. James, London, United Kingdom, Mark Schoenberg, Ilir Agalliu, Bronx, NY, Richard T. Bryan, Birmingham, United Kingdom

2:20 PD26-09 PRIMARY TA HIGH GRADE BLADDER TUMORS: DETERMINATION OF THE RISK OF PROGRESSION

Fahad Quhal*, Keiichiro Mori, Ekaterina Laukhti-na, Benjamin Pradere, Vienna, Austria, Franc-esco Soria, Turin, Italy, Marco Moschini, Luzern, Switzerland, Alberto Briganti, Milan, Italy, Pierre I. Karakiewicz, Montreal, Canada, Shahrokh F. Shariat, Vienna, Austria

2:30 PD26-10 COMPARISON OF INTRAVESICAL THERAPY AND SURGERY AS TREATMENT OPTIONS FOR RECURRENT BLADDER CANCER (CISTO): UPDATE ON AN ONGOING MULTICENTER PRAGMATIC STUDY

John Gore*, Erika Wolff, Bryan Comstock, Kristin Follmer, Michael Nash, On Ho, Seattle, WA, Stephanie Chisolm, Bethesda, MD, Doug MacLean, Jenney Lee, Sarah Lawrence, Seattle, WA, Danielle Lavallee, Vancouver, Canada, Yair Lotan, Dallas, TX, Gary Steinberg, New York, NY, Sima Porten, San Francisco, CA, Larry Kessler, Seattle, WA, Angela Smith, Chapel Hill, NC, CIS-TO Collaborative, Seattle, WA

2:40 PD26-11 DOES SURGEON’S OPINION DURING THE PRIMARY TRANSURETHRAL RESECTION OF BLADDER TUMOR SURROGATE THE NEED FOR REPEATED RESECTION? A PRELIMINARY RESULTS

Yasser Osman*, Mansoura, Egypt, M Elbaset, Cairo, Egypt, Ahmed Harraz, Mohamed Ramez, Islam M Hawash, Abdullah A Sobh, Ahmed Elghareeb, Ahmed Elhussein Abolazm, R.F. Elbaz, Ahmed Elkarta, Ahmed Lashin, Rasha T Abouelkheir, Ahmed Mosbah, Mansoura, Egypt

2:50 PD26-12 HIVEC-E: SPANISH MULTICENTER PROSPECTIVE EXPERIENCE WITH RECIRCULANT HYPERTHERMIC MMC WITH COMBAT BRS HIVEC SYSTEM

Ana Plata Bello*, La Laguna-Santa Cruz de Tenerife, Spain, Felix Guerrero-Ramos, Madrid, Spain, Carlos García, La Laguna-Santa Cruz de Tenerife, Spain, Alejandro González Diaz, Ignacio González-Valcárcel, Jose Manuel De la Morena-Gallego, Francisco Javier Diaz Goizueta, Madrid, Spain, Julio Fernández-Alamo, Torrejon de Ardoz, Spain, Victoria Gonzalo, Javier Mon-tero, Burgos, Spain, Alejandro Sousa-Escandon, Juan Leon, Monforte de Lemos, Spain, Jose Luis Pontones, Francisco Delgado, Valencia, Spain, Miguel Adriazola, Angela Pascual, Palencia, Spain, Jesus Calleja, Ana Ruano, Valladolid, Spain, Luis Martinez-Piñeiro, Javier Angulo-Cues-ta, Madrid, Spain


124


Podium Session 27PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY II

Room 255 @ Ernest N. Morial Convention CenterModerators: Sanoj Punnen & Andreas Gross

ABSTRACTTIME NUMBER TITLE1:00 PD27-01 PREDICTING EXTRA-PROSTATIC EXTENSION

(EPE) FOR SURGICAL GUIDANCE IN PROSTATE CANCER: A COMPARISON OF BIOPSY PATHOLOGY, MULTIPARAMETRIC MRI, AND PSMA-PET

Clinton Bahler*, Mark Green, Mark Tann, Katrina Collins, Jordan Swensson, Eric Brocken, Liang Cheng, Carla Mathias, Indianapolis, IN, David Alexoff, Hank Kung, Philadelphia, PA, Gary Hutchins, Michael Koch, Indianapolis, IN

1:10 PD27-02 IS CAPSULAR ABUTMENT ON MRI A PREDICTOR OF EXTRAPROSTATIC EXTENSION (EPE) ON RADICAL PROSTATECTOMY?

Mohammad Siddiqui*, Jonathan Aguiar, Eric Li, Brandon Ansbro, Moataz Soliman, Mary-Kate Keeter, Quan Mai, Edward Schaeffer, Ashley Ross, Chicago, IL

1:20 PD27-03 FEASIBILITY OF NONLINEAR MICROSCOPY TECHNIQUE FOR EVALUATING PROSTATECTOMY MARGINS IN REAL TIME

May Jean Counsilman*, Yuchen Liu, Yue Sun, Seymour Rosen, Boston, MA, Lucas Cahill, Tadayuki Yoshitake, James Fujimoto, Cam-bridge, MA, Yubo Wu, Allison Kleeman, Jeffrey Sun, Boston, MA, Timothy Weber, Sagar Doshi, Cambridge, MA, Peter Chang, Andrew Wagner, Boston, MA

1:30 PD27-04 ROBOT-ASSISTED PSMA-RADIOGUIDED SALVAGE SURGERY IN RECURRENT PROSTATE CANCER USING A DROP-IN GAMMA PROBE - A PROSPECTIVE FEASIBILITY STUDY

Hilda de Barros*, Amsterdam, Netherlands, Matthias van Oosterom, Leiden, Netherlands, Maarten Donswijk, Jeroen Hendrikx, André Vis, Amsterdam, Netherlands, Tobias Maurer, Ham-burg, Germany, Fijs van Leeuwen, Leiden, Neth-erlands, Henk van der Poel, Pim van Leeuwen, Amsterdam, Netherlands

1:40 PD27-05 RELIABILITY OF 68GA-PSMA PET/CT IN ASSESSING REAL NODAL BURDEN IN MEN WITH CN1 DISEASE: CLINICAL IMPLICATIONS FOR PATIENT COUNSELLING AND MULTI-MODAL TREATMENTS

Daniele Robesti*, Elio Mazzone, Milano, Italy, Giorgio Gandaglia, Armando Stabile, Milan, Italy, Carlo Andrea Bravi, Andrea Necchi, Daniele Raggi, Laura Marandino, Milano, Italy, Giuseppe Cirulli, Milan, Italy, Nazareno Suardi, Genoa, Italy, Eleonora Balestrazzi, Stefano Fanti, Andrea Farolfi, Lorenzo Bianchi, Bologna, Italy, Shahrokh F. Shariat, Vienna, Austria, Riccardo Schiavina, Bologna, Italy, Francesco Montorsi, Alberto Brig-anti, Milano, Italy

ABSTRACTTIME NUMBER TITLE1:50 PD27-06 INCREASED AWARENESS OF SURGICAL

OUTCOMES IMPROVES LONG-TERM FUNCTIONAL OUTCOMES AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY. A PROSPECTIVE ASSESSMENT FOLLOWING IMPLEMENTATION OF PROSPECTIVE DATA COLLECTION

Giuseppe Cirulli*, Milan, Italy, Giuseppe Rosiel-lo, Elio Mazzone, Milano, Italy, Nicola Fossati, Lugano, Switzerland, Francesco Barletta, Simone Scuderi, Daniele Robesti, Milano, Italy, Gior-gio Gandaglia, Milan, Italy, Lorenzo Toneatto, Gianmarco Colandrea, Riccardo Leni, Lucia D’Ambrosio, Antony Pellegrino, Leonardo Quarta, Milano, Italy, Andrea Gallina, Lugano, Switzer-land, Vito Cucchiara, Milan, Italy, Alberto Martini, Milano, Italy, Sabrina Comana, Milan, Italy, Armando Stabile, Milano, Italy, Enrico Camisassa, Milan, Italy, Federico Dehò, Varese, Italy, Franc-esco Montorsi, Alberto Briganti, Milano, Italy

2:00 PD27-07 PROSTATE VOLUME, BASELINE URINARY SYMPTOMS, AND THEIR ASSOCIATION WITH POST-TREATMENT URINARY FUNCTION IN MEN TREATED FOR LOCALIZED PROSTATE CANCER

Jacob Tallman*, Christopher Wallis, Li-Ching Huang, Zhiguo Zhao, David Penson, Tatsuki Koyama, Ralph Conwill, Nashville, TN, Michael Goodman, Atlanta, GA, Ann Hamilton, Los Ange-les, CA, Xiao-Cheng Wu, New Orleans, LA, Lisa Paddock, Antoinette Stroup, New Brunswick, NJ, Matthew Cooperberg, San Francisco, CA, Mia Hashibe, Brock O’Neil, Salt Lake City, UT, Sherrie Kaplan, Sheldon Greenfield, Irvine, CA, Karen Hoffman, Houston, TX, Daniel Barocas, Nashville, TN

2:10 PD27-08 PREDICTORS AND TRENDS OF OPIOID-SPARING RADICAL PROSTATECTOMY FROM A LARGE NATIONAL COHORT

Aaron Brant*, Patrick Lewicki, Alec Zhu, Christina Sze, Jeffrey Johnson, Christopher Gaffney, New York, NY, Ilon Weinstein, Anise Bowman, Jonathan Shoag, Cleveland, OH

2:20 PD27-09 PRELIMINARY FINDINGS OF A PROSPECTIVE, RANDOMIZED CONTROLLED PILOT STUDY EVALUATING THE RECOVERY OF POTENCY AND CONTINENCE FOLLOWING ROBOTIC PROSTATECTOMY WITH AND WITHOUT UMBILICAL CORD ALLOGRAFT

Tanner Corse*, Mutahar Ahmed, Linda Dayan, Jay Zaifman, Nutley, NJ, Michael Degen, Hackensack, NJ, Ravi Munver, Michael Stifelman, Nutley, NJ


SA

TU

RD

AY

2:30 PD27-10 ORGASMIC DYSFUNCTION FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A SINGLE CENTER PREVALENCE STUDY

Masashi Honda*, Ryutaro Shimizu, Shogo Terao-ka, Tetsuya Yumioka, Noriya Yamaguchi, Hideto Iwamoto, Shuichi Morizane, Katsuya Hikita, Atsushi Takenaka, Yonago, Japan

2:40 PD27-11 PREREHABILITATION CAN IMPROVE URINARY CONTINENCE IN PATIENTS AFTER LAPAROSCOPIC RADICAL PROSTATECTOMY

Aleksandra Juszczak*, Tomasz Konecki, Piotr Ku-twin, Łowicki Roman, Marcin Cichocki, Zbigniew Jabłonowski, Łódz, Poland

2:50 PD27-12 ASSESSING THE ROLE OF FRAILTY STATUS ON ONCOLOGIC AND FUNCTIONAL OUTCOMES IN PATIENTS TREATED WITH ROBOT-ASSISTED RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER

Giuseppe Rosiello*, Simone Scuderi, Giorgio Gandaglia, Elio Mazzone, Francesco Barletta, Daniele Robesti, Riccardo Leni, Lorenzo Toneat-to, Antony Pellegrino, Leonardo Quarta, Armando Stabile, Milano, Italy, Vito Cucchiara, Milan, Italy, Gianmarco Colandrea, Milano, Italy, Sabrina Comana, Enrico Camisassa, Milan, Italy, Nicola Fossati, Lugano, Switzerland, Federico Dehò, Va-rese, Italy, Francesco Montorsi, Alberto Briganti, Milano, Italy



Podium Session 28SEXUAL FUNCTION/DYSFUNCTION: SURGICAL THERAPY I

Room 245 @ Ernest N. Morial Convention CenterModerators: Wayne Hellstrom, David Ralph & Tobias Kohler

ABSTRACTTIME NUMBER TITLE1:00 PD28-01 HOW ACCURATE ARE WE WHEN PLACING

SUBMUSCULAR RESERVOIRS DURING MULTI-COMPONENT PENILE IMPLANT SURGERY

Bruce Kava*, Amanda Levine, Thomas Master-son, Nicholas Hauser, Ranjith Ramasamy, Miami, FL

1:10 PD28-02 MULTICENTER COMPARISON OF SINGLE DILATION VERSUS SEQUENTIAL DILATION IN PRIMARY INFLATABLE PENILE PROSTHESIS PLACEMENT

Daniel Swerdloff*, Zafardjan Dalimov, Phila-delphia, PA, David Barham, Irvine, CA, Joshua Ghoulian, Glendale, AZ, Robert Andrianne, Thom-as Deprez, Liege, Belgium, Zachary Dionise, Dur-ham, NC, Martin Gross, Lebanon, NH, Georgios Hatzichristodolou, Nuremberg, Germany, Hossein Sadeghi-Nejad, Hackensack, NJ, Sherry Huang, Los Angeles, CA, Aaron Lentz, Durham, NC, Jeffrey Loh-Doyle, Los Angeles, CA, Jake Miller, Irvine, CA, Koenraad van Renterghem, Leuven, Belgium, Sung Hun Park, Seoul, Korea, Republic of, Maxime Sempels, Liege, Belgium, Jonathan N Warner, Rochester, MN, Faysal A Yafi, Irvine, CA, Jay Simhan, Philadelphia, PA

1:20 PD28-03 THE PENOSCROTAL APPROACH TO PENILE IMPLANTATION RESULTS IN INCREASED PENILE, NOT SCROTAL PAIN: IMPORTANT CONSIDERATIONS FOR PROSTHETIC UROLOGISTS

Avery Braun*, Daniel Swerdloff, Hira Chaudry, Alice Xiang, Michelle Chen, Philadelphia, PA, Martin Gross, Lebanon, NH, Jay Simhan, Philadelphia, PA

ABSTRACTTIME NUMBER TITLE1:30 PD28-04 RESERVOIR DISTANCE FROM CRITICAL

PELVIC STRUCTURES: RADIOGRAPHIC COMPARISON OF HIGH SUBMUSCULAR AND SPACE OF RETZIUS INFLATABLE PENILE PROSTHESIS PLACEMENT TECHNIQUES

Mehraban Kavoussi*, Grayden Cook, Shaun Nordeck, Shervin Badkhshan, Samantha Nealon, Benjamin Dropkin, Gregory Joice, Sarah Sand-ers, Jeffrey Pruitt, Steven Hudak, Allen Morey, Dallas, TX

1:40 PD28-05 3-PIECE INFLATABLE PENILE IMPLANT PUMP MALFUNCTION: MANAGEMENT USING PUMP REPLACEMENT ALONE

Hisanori Taniguchi*, John Sullivan, Jose Flores, Carolyn Salter, Helen Bernie, Lawrence Jenkins, John Mulhall, New York, NY

1:50 PD28-06 COMPLICATION PROFILE OF 3-PIECE (3P) INFLATABLE PENILE IMPLANT (IPP) SURGERY AFTER RADICAL CYSTOPROSTATECTOMY (RC)

John Sullivan*, Jose Flores, Serkan Deveci, Josep Torremade, Nicole Benfante, Pat Guhring, Marilyn Parker, John Mulhall, New York, NY

2:00 PD28-07 UROLOGY RESIDENT AUTONOMY IN PERFORMING PENILE PROSTHESES IN THE VETERANS AFFAIRS (VA) HOSPITALS

Anh Nguyen*, Jacob Veliky, John Fastenau, Newark, NJ, Devashish Anjaria, Joseph Oliver, Hossein Sadeghi-Nejad, East Orange, NJ

2:10 PD28-08 BACK TO THE FUTURE: TWO NOVEL TECHNIQUES FOR LOW SUBMUSCULAR RESERVOIR PLACEMENT

Mohamed Ahmed*, Rochester, MN, Mohit Khera, Houston, TX, Matthew (Matt) Ziegelmann, Sevann Helo, Tobias Köhler, Rochester, MN

126

2:20 PD28-09 SINGLE PERINEAL INCISION IN SIMULTANEOUSLY PLACED PENILE IMPLANT AND ARTIFICIAL SPHINCTER: A COMPARISON OF COMPLICATIONS AND DEVICE LONGEVITY

Kirema Macharia, Kyle Blum*, Travis Green, Justin Mehr, Leyla Akhverdiyeva, Alex Leonard, Run Wang, Houston, TX

2:30 PD28-10 CONCOMITANT UROLOGIC PROCEDURES DURING PENILE PROSTHESIS SURGERY

Jason Levy*, Ridwan Alam, Baltimore, MD, Wil-liam Ducomb, Detroit, MI, Arthur Burnett, Baltimore, MD

2:40 PD28-11 VALUE OF ROUTINE PRE-OPERATIVE CYSTOSCOPY PRIOR TO INSERTION OF PENILE PROSTHESIS

Leonid Aksenov*, Zachary Dionise, Durham, NC, Faysal Yafi, Newport Beach, CA, Aaron Lentz, Durham, NC

2:50 PD28-12 MODIFIED TEP: A NOVEL WAY TO OPTIMIZE PENILE GIRTH AND LENGTH ENHANCEMENT POST IPP

Shirin Razdan*, Ariel Zisman, Robert Valenzuela, New York, NY



Podium Session 29TRAUMA/RECONSTRUCTION/DIVERSION: EXTERNAL GENITALIA RECONSTRUCTION AND UROTRAUMA

(INCLUDING TRANSGENDER SURGERY) IIRoom 244 @ Ernest N. Morial Convention Center

Moderators: Richard Santucci, Frank Burks & Andre van der Merwe

ABSTRACTTIME NUMBER TITLE1:00 PD29-01 SELECTIVE ANGIOEMBOLIZATION

IS ASSOCIATED WITH NEED FOR HEMODIALYSIS AFTER HIGH-GRADE RENAL TRAUMA

Stephen Hill*, George Koch, Jackson Cabo, Rohan Bhalla, Abimbola Ayangbesan, Helen Gambrah, Niels Johnsen, Nashville, TN

1:10 PD29-02 RISK OF HYPERTENSION AFTER RENAL TRAUMA

Matthew S Swallow*, Odinachi I Moghalu, Joshua J Horns, Benjamin J McCormick, Jeremy B My-ers, Salt Lake City, UT

1:20 PD29-03 IMPACT OF HOSPITAL VOLUME ON THE OUTCOMES OF RENAL TRAUMA MANAGEMENT

Paul Baloche, Nicolas Szabla, Caen, France, Lu-cas Freton, Rennes, France, Marine Hutin, Mont-pellier, France, Marina Ruggiero, Paris, France, Inès Dominique, Lyon, France, Clémentine Millet, Clermont Ferrand, France, Sébastien Berger-at, Strasbourg, France, Paul Panayotopoulos, Angers, France, Reem Betari, Amiens, France, Xavier Matillon, Lyon, France, Ala Chebbi, Rouen, France, Thomas Caes, Lille, France, Pierre-Ma-rie Patard, Toulouse, France, Nicolas Brichart, Orléans, France, Laura Sabourin, Clermont Ferrand, France, Charles Dariane, Paris, France, Michael Baboudjian, Bastien Gondran-Tellier, Nantes, France, Cédric Lebacle, Paris, France, François-Xavier Madec, Nantes, France, François-Xavier Nouhaud, Rouen, France, Xavier Rod, Nantes, France, Gaelle Fiard, Grenoble, France, Benjamin Pradere, Tours, France, Benoit Peyronnet*, Rennes, France

ABSTRACTTIME NUMBER TITLE1:30 PD29-04 COMPARISON OF STRICTURE

CHARACTERISTICS AND URETHROPLASTY SUCCESS RATES CAUSED BY EXTERNAL VERSUS INTERNAL URETHRAL TRAUMA

Faizan Khawaja*, Kevin Flynn, Iowa City, IA, Shawn Grove, Minneapolis, MN, Nejd Alsikafi, Gurnee, IL, Joshua Broghammer, Kansas City, KS, Jill Buckley, San Diego, CA, Sean Elliott, Min-neapolis, MN, Jeremy Myers, Salt Lake City, UT, Andrew Peterson, Durham, NC, Keith Rourke, Edmonton, Canada, Thomas Smith III, Houston, TX, Alex Vanni, Burlington, MA, Lee Zhao, New York City, NY, Bradley Erickson, Iowa City, IA

1:40 PD29-05 THE EFFECT OF BIKE SEAT MODELS ON PERINEAL PRESSURE DURING CYCLING: IMPLICATIONS FOR PATIENTS AFTER URETHRAL SURGERY

Behnam Nabavizadeh*, San Francisco, CA, Gregory Amend, New York, NY, Anthony Enri-quez, Nizar Hakam, Jason Lui, Kevin Li, Patrick Low, Behzad Abbasi, Nathan Shaw, Benjamin Breyer, San Francisco, CA

1:50 PD29-06 AN ANALYSIS OF COMBAT-RELATED UROLOGIC INJURIES

Shane Kronstedt*, Piscataway, NJ, Andrew Fish-er, Albuquerque, NM, Joseph Boyle, Piscataway, NJ, Daniel Grabo, Morgantown, WV, Michael April, Fort Carson, CO, Steven Schauer, San Antonio, TX

2:00 PD29-07 THE MANAGEMENT AND OUTCOMES OF VESICOVAGINAL FISTULA REPAIR

Rachel Barratt*, Alejandro Mercado Campero, Jeremy Ockrim, Tamsin Greenwell, London, United Kingdom

2:10 PD29-08 PENUMA© IMPLANT SURGERY - A SAFETY AND EFFICACY TRIAL

Ariel Zisman*, Alexandra Siegal, Shirin Razdan, Robert Valenzuela, New York, NY


SA

TU

RD

AY

2:20 PD29-09 PRIMARY CLOSURE IS SUPERIOR TO SECONDARY INTENTION FOR TREATING FOURNIER GANGRENE

Peter Sam*, Andrew Zilavy, Carolyn Ice, Maxx Gallegos, Albuquerque, NM

2:30 PD29-10 RETROSPECTIVE ANALYSIS OF PHALLOPLASTY BY A SPECIALIZED TRANSGENDER SURGERY CENTER

Brenna Briles*, Houston, TX, Jessica Gondran, Austin, TX, Emma R. Linder, Chicago, IL, Michael Safir, Curtis Crane, Richard Santucci, Austin, TX

2:40 PD29-11 INTRA-ABDOMINAL COMPLICATIONS FOLLOWING PERITONEAL FLAP VAGINOPLASTY

Isabel Robinson*, Rachel Bluebond-Langner, Lee Zhao, New York, NY

2:50 PD29-12 IS A BMI CUTOFF FOR GENDER AFFIRMATION SURGERY SCIENTIFICALLY SUPPORTED?

Erin Carter*, Salt Lake City, UT, Michael Safir, San Francisco, CA, Ashley DeLeon, Curtis Crane, Richard Santucci, Austin, TX


Podium Session 30EDUCATION RESEARCH III

Room 243 @ Ernest N. Morial Convention CenterModerators: Simone Thavaseelan & Kirsten Greene

ABSTRACTTIME NUMBER TITLE1:00 PD30-01 OBSERVED DIFFERENCES IN UROLOGY

RESIDENT OPERATIVE AUTONOMY ASSOCIATED WITH PATIENT RACE

Anh Nguyen*, Jacob Veliky, John Fastenau, Newark, NJ, Devashish Anjaria, Joseph Oliver, Anastasia Kunac, Hossein Sadeghi-Nejad, East Orange, NJ

1:10 PD30-02 ASSESSING THE PERCEIVED IMPORTANCE OF SELECTION CRITERIA FOR UROLOGY RESIDENCY BY UNDER-REPRESENTED IN MEDICINE APPLICANTS

Efe Chantal Ghanney Simons*, Parris A. Diaz, Los Angeles, CA, Rebecca Takele, Blacksburg, VA, Serena Does, Utrecht, Netherlands, Nicholas J. Jackson, Los Angeles, CA, Samuel L. Wash-ington III, San Francisco, CA, Benjamin N. Breyer, San Francisco, CA, Tracy M. Downs, Charlottes-ville, VA, Christopher Saigal, Los Angeles, CA

1:20 PD30-03 TOTAL FINANCIAL BURDEN OF INCREASING UROLOGY RESIDENCY APPLICATIONS ON APPLICANTS AND PROGRAMS

Kevin Koo*, Elizabeth Bearrick, Bridget Findlay, Candace Granberg, Rochester, MN

1:30 PD30-04 THE FATE OF THE UNMATCHED UROLOGY APPLICANT

Rebecca Takele*, Annandale, VA, Nishant Patel, Charlottesville, VA, Ryan Dobbs, Chicago, IL

1:40 PD30-05 INTERNATIONAL MEDICAL GRADUATES IN UROLOGY: TRACKING SUCCESS THROUGH RESEARCH EXPERIENCE

David E. Hinojosa-Gonzalez*, Anton Wintner, Dimitar V. Zlatev, Boston, MA, Wesley A. Mayer, Houston, TX, Ruslan Korets, Brian H. Eisner, Boston, MA

ABSTRACTTIME NUMBER TITLE1:50 PD30-06 TRENDS IN PUBMED-INDEXED RESEARCH IN

MATCHED UROLOGY APPLICANTS: YEARLY ANALYSIS OF THE 2017-2021 MATCH CYCLES

David E. Hinojosa-Gonzalez*, Dimitar V. Zlatev, Anton Wintner, Boston, MA, Wesley A. Mayer, Houston, TX, Ruslan Korets, Brian H. Eisner, Boston, MA

2:00 PD30-07 THE USE OF USMLE STEP 1 AND USMLE STEP 2 REQUIRED MINIMUM SCORES IN SCREENING UROLOGY RESIDENCY APPLICANTS FOR INTERVIEW OFFERS

Efe Chantal Ghanney Simons*, Parris A. Diaz, Los Angeles, CA, Rebecca Takele, Blacksburg, VA, Serena Does, Utrecht, Netherlands, Nicholas J. Jackson, Los Angeles, CA, Samuel L. Wash-ington III, San Francisco, CA, Benjamin N. Breyer, San Francisco, CA, Tracy M. Downs, Charlottes-ville, VA, Christopher Saigal, Los Angeles, CA

2:10 PD30-08 UROLOGIC TRAINEE SURGICAL ASSESSMENT TOOLS: SEEKING STANDARDIZATION

Lauren Conroy*, Kyle Blum, Hannah Slovacek, Phillip Mann, Steven Canfield, Houston, TX

2:20 PD30-09 IMPACT AND IMPLICATIONS OF THE COVID-19 PANDEMIC ON UROLOGIC TRAINING

Brandon Piyevsky, Dayton, OH, John Maclean*, Anqing Li, Stephen Rhodes, Megan Prunty, Erin Jesse, Anood Alfahmy, Ramy Abou-Ghayda, Michael Zell, Michael Callegari, Cleveland, OH


128

2:30 PD30-10 ARE ACADEMIC MEDICINE SOCIAL MEDIA INFLUENCERS ACTUALLY INFLUENCING CITATION RATES?

Shirley Wang*, Baltimore, MD, Christopher Meilchen, Galveston, TX, Pranjal Agrawal, Mary Rostom, Gaurish Agrawal, Baltimore, MD, Justin M Dubin, Chicago, IL, Andrew T Gabrielson, Taylor P Kohn, Baltimore, MD

2:40 PD30-11 CHARACTERIZATION OF GENDER DIFFERENCES IN H-INDEX WITHIN UROLOGIC SUBSPECIALTIES

Bridget Findlay*, Rochester, MN, Timothy Lyon, Jacksonville, FL, Maraika Robinson, Elizabeth Bearrick, Boyd Viers, Rochester, MN, Colleen Ball, Jacksonville, FL, Katherine Anderson, Rochester, MN

2:50 PD30-12 COMPARISON OF UROGYNECOLOGICAL TRAINING AMONG US UROLOGY AND OBSTETRICS AND GYNECOLOGY RESIDENTS AND THE IMPACT FPMRS FELLOWSHIP AND DEDICATED ROTATION TIME HAVE ON TRAINING

Michael Hung*, Ashley Huber, Rosen Jeong, Jason Kim, Stony Brook, NY



Video Session 5MISC. BENIGN/TRANSPLANT/RENOVASCULAR

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerators: Marc Bjurlin, Ronald Boris & Sero Andonian

ABSTRACTTIME NUMBER TITLE1:00 V05-01 3D AUGMENTED REALITY-GUIDED ROBOTIC-

ASSISTED KIDNEY TRANSPLANTATION: REVEALING THE CONCEALED

Alberto Piana*, Gallioli Andrea, Pietro Diana, Angelo Territo, Josep Maria Gaya, Pavel Gavrilov, Óscar Rodriguez Faba, Jordi Huguet, Lluis Guira-do, Carme Facundo, Barcelona, Spain, Riccardo Campi, Florence, Italy, Andrea Bellin, Daniele Amparore, Turin, Italy, Sergio Serni, Florence, Ita-ly, Joan Palou, Alberto Breda, Barcelona, Spain

1:10 V05-02 SINGLE PORT ROBOT-ASSISTED EXTRAPERITONEAL KIDNEY TRANSPLANTATION: TIPS AND TRICKS

Aaron Kaviani*, Jihad Kaouk, Mahmoud Abou Zeinab, Alp Tuna Beksac, Ethan Ferguson, Yi-Chia Lin, Alvin Wee, Mohamed Eltemamy, Cleveland, OH

1:20 V05-03 NEAR MISS IN UROLOGICAL SURGERY: DEFINITION AND TIPS FOR PREVENTING UNEXPECTED COMPLICATIONS

Stefano Parodi, Stefano Tappero*, Giovanni Guano, Andrea Pacchetti, Francesco Chierigo, Guglielmo Mantica, Marco Borghesi, Nazareno Suardi, Carlo Terrone, Genoa, Italy

1:30 V05-04 ROBOTIC MANAGEMENT OF SURGICAL COMPLICATIONS AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY WITH INTRACORPOREAL DIVERSION

Leonardo Misuraca*, Riccardo Mastroianni, Ga-briele Tuderti, Umberto Anceschi, Aldo Brassetti, Mariaconsiglia Ferriero, Alfredo Maria Bove, Sal-vatore Guaglianone, Michele Gallucci, Giuseppe Simone, Rome, Italy

ABSTRACTTIME NUMBER TITLE1:40 V05-05 REPAIR OF ENTERO-CONDUIT FISTULA

USING ROBOT-ASSISTED LAPAROSCOPY Aeen Asghar*, David Strauss, Daniel Eun, Phila-

delphia, PA

1:50 V05-06 ROBOTIC BILATERAL PELVIC URETERAL SUBSTITUTION AND AUGMENTATION CYSTOPLASTY WITH ILEAL LOOP FOR DISTAL URETERAL STRICTURE AND RADIATION CYSTITIS: RESULTS AFTER 1-YEAR FOLLOW UP

Francesca Ambrosini*, Nicolò Testino, Enrico Vecchio, Flavia Carlini, Marco Borghesi, Naza-reno Suardi, Giovanni Camerini, Carlo Terrone, Genova, Italy

2:00 V05-07 ROBOTIC-ASSISTED LAPAROSCOPIC LEFT RENAL VEIN TRANSPOSITION FOR TREATMENT OF NUTCRACKER SYNDROME

Robert Harrison*, Tanner Corse, Michael Stifel-man, Hackensack, NJ

2:10 V05-08 ROBOTIC-ASSISTED LAPAROSCOPIC LEFT SEMINAL VESICULECTOMY AND DISTAL LEFT URETERECTOMY FOR A PATIENT WITH ZINNER SYNDROME

Safiya-Hana Belbina*, Scott Spivey-Provencio, Rachel Wallace, Aaron Laviana, Austin, TX

2:20 V05-09 VIRTUAL LEARNING AND COLLABORATIVE WORKING IN A PANDEMIC - HOW TO CHANGE A SUPRAPUBIC CATHETER

Damiete Harry*, Barking, United Kingdom


SA

TU

RD

AY

2:30 V05-10 ACTIVSIGHT LASER SPECKLE CONTRAST IMAGING COMPARED TO INDOCYANINE GREEN IN RENAL PERFUSION OF AN ANIMAL MODEL

Jonathan Noël, Celebration, FL, Anya Mascar-enhas, Boston, MA, Chibueze Nwaiwu, Yao Liu, Providence, RI, Vasiliy Buharin, John Oberlin, Alyson Dechert, Boston, MA, Marcio Moschovas*, Celebration, FL, Peter Kim, Providence, RI, Vipul Patel, Celebration, FL

2:40 V05-11 LAPAROSCOPIC MANAGEMENT OF XANTHOGRANULOMATOUS PYELONEPHRITIS – COMPARISON OF TWO DIFFERENT YET SIMILAR CASES

Catarina Laranjo Tinoco*, Andreia Cardoso, Ricardo Matos Rodrigues, Sara Anacleto, Ana Sofia Araújo, Mário Cerqueira Alves, Emanuel Carvalho-Dias, Braga, Portugal

2:50 V05-12 ROBOTIC-ASSISTED LAPAROSCOPIC EXCISION OF RETROPERITONEAL GANGLIONEUROMA

Jeffery Lin*, David Ortega, Edward Forsyth, Inderbir Gill, Los Angeles, CA



ASOCIACIÓN ESPAÑOLA DE UROLOGÍA (AEU)Room 214 @ Ernest N. Morial Convention Center

1:00 WELCOME MESSAGE AUA Secretary: John Denstedt Society President: José Luis Álvarez-Ossorio

1:05 CURRENT STATUS IN MHSPC Moderator: Ana Plata Neal Shore

1:25 URODYNAMIC NEWS Moderator: Luis Prieto Victor Nitti

1:45 RECENT ADVANCES IN CRPC Moderator: Alfredo Rodríguez Antolín Eric Small

2:05 IMMUNOTHERAPY IN UROLOGY Moderator: José Manuel Cózar José Antonio Karam

2:30 ARE THERE LIMITS TO ROBOTIC SURGERY? Moderator: Joan Palou René Sotelo


SOCIETY FOR BASIC UROLOGIC RESEARCH (SBUR)Marlborough Room @ Hilton New Orleans Riverside

Chair: William Ricke

1:00 WELCOME AND INTRODUCTORY REMARKS Chair: William Ricke

1:05 MITOCHONDRIAL DYSFUNCTION IN THE AGED PROSTATE AND LOWER URINARY TRACT DYSFUNCTION

Teresa Liu

1:25 AGING AND INFLAMMATION: MECHANISMS IN BLADDER DYSFUNCTION

Indira Mysorekar

1:45 IMPACT OF PNPASE DYSREGULATION IN THE AGING LOWER URINARY TRACT

Lori Birder

2:05 THE EFFECT OF RADIATION ON AGING HALLMARKS, INFLAMMATION AND FIBROSIS, IN BLADDER FUNCTION

Bernadette Zwaans

2:25 BREAK

2:35 NONCANONICAL AR FUNCTION IN THE DEVELOPMENT OF CASTRATION RESISTANCE

Haojie Huang

2:55 MECHANISMS AND MODELS OF CASTRATION RESISTANCE

Petra Popovics

3:15 5ARI-INDUCED LINEAGE PLASTICITY IN HUMAN BPH

Douglas Strand

3:35 NEW MECHANISMS INVOLVED IN THE DEVELOP-MENT OF CASTRATION RESISTANT PROSTATE CANCER

Scott Dehm


130


BRAZILIAN/PORTUGUESE UROLOGY PROGRAM (BPUP)Room 345 @ Ernest N. Morial Convention Center

Chair: Fernando Kim

1:00 WELCOME AND INTRODUCTIONS

1:05 INTRODUCTION OF AUA-SBU SCHOLARS AND SBU LEADERSHIP

Alfredo Canalini, Fernando Kim

1:10 SESSION I: URO-ONCOLOGY

PROSTATE CANCER Angela Smith

DISCUSSION WITH BRAZILIAN PANEL Panelists: Gustavo Carvalhal, Marcus Sadi

BLADDER CANCER Raj Pruthi

DISCUSSION WITH PANEL Panelists: Rafael Coelho, Felipe Lott

2:30 SESSION II: MEN’S HEALTH OR BPH/LUTS

MEN’S HEALTH Jesse Mills

DISCUSSION WITH BRAZILIAN PANEL Panelists: Marcello Gava, Luiz Otavio Torres

BPH Steven Kaplan

DISCUSSION WITH PANEL Panelists: Thiago Hota, Daniel Moser

3:50 SESSION III: UROLOGIC RECONSTRUCTION

ERECTILE DYSFUNCTION POST PROSTATECTO-MY UPDATE

Arthur Burnett

DISCUSSION WITH PANEL Panelists: Leonardo Seligra Lopes, Alexandre Miranda

4:30 CLOSING REMARKS



KOREAN WORLD UROLOGIC CONGRESS (KWUC)St. James Ballroom @ Hilton New Orleans Riverside

Chair: Sung Kyu Hong

1:00 WELCOME ADDRESS BY KUA PRESIDENT & AUA Society President: Sang Don Lee

1:10 PROSTATE CANCER Moderators: Jun Hyuk Hong, Isaac Kim

GENETIC TESTING IN ADVANCED PROSTATE CANCER: WHEN? HOW? AND WHOM?

Seok-Soo Byun

ROBOTIC RADICAL PROSTATECTOMY USING HUGO SYSTEM: TECHNIQUES AND TIPS

James Porter

EVOLVING ROLE OF PSMA PET/CT IN LOCALIZED PROSTATE CANCER

Ji Youl Lee

DISCUSSION Panelists: Hong Koo Ha, Taek Won Kang, Brian McNeill,

James Porter

2:00 BREAK

2:05 ANDROLOGY & PEDIATRICS Moderators: Sang Don Lee, Chester Koh

IS PENILE REHABILITATION STILL VALUABLE FOR PATIENTS AFTER PROSTATECTOMY?

Robert Kovell

POST-FINASTERIDE SYNDROME & SEXUAL HEALTH IN YOUNG MEN; IS IT REALLY DANGEROUS?

Min Chul Cho

THE ROLE OF BETA-3 ADRENOCEPTOR AGONIST FOR THE TREATMENT OF BLADDER DYSFUNC-TION IN CHILDREN

Joan Ko

DISCUSSION Panelists: Byunghoon Kim, Joan Ko, Robert Kovell,

Hwancheol Son

2:55 BREAK

3:00 KIDNEY CANCER Moderator: Seongil Seo

PREDICTING AGGRESSIVE BEHAVIOR IN SMALL RENAL MASSES BEFORE THE TREATMENT: RADIOMICS APPLICATION

Ashok Hemal

CURRENT AND FUTURE OF ADJUVANT THERAPY IN ADVANCED RCC?

WHICH APPROACH IS BETTER FOR 1ST LINE THERAPY IN METASTATIC RCC? IO+IO VS IO+TKI

Chan Ho Lee

3:30 DISCUSSION Panelists: Ashok Hemal, Sung-Hoo Hong, Jung Ki Jo


SA

TU

RD

AY


Moderated Poster Session 31HEALTH SERVICES RESEARCH: QUALITY IMPROVEMENT & PATIENT SAFETY II

Room 228 @ Ernest N. Morial Convention CenterModerators: Timothy Daskivich & Ted Skolarus

ABSTRACTTIME NUMBER TITLE MP31-01 MINIMIZING NARCOTICS: A RANDOMIZED-

CONTROLLED TRIAL COMPARING PERCOCET TO KETOROLAC AFTER KIDNEY STONE SURGERY

Mathew Demasi, Cleveland, OH, Michal Segall*, Nathan Feiertag, Amanda Mengotto, Pablo Cuar-tas, Justin Loloi, Bronx, NY, Jordan Ahn, Boston, MA, Josh Stern, Melissa Laudano, Kara Watts, Bronx, NY

MP31-02 DECREASED OPIOID USE & EQUIVALENT PAIN SCORE OUTCOMES AFTER UROLOGIC ROBOTIC SURGERY USING A SIMPLIFIED OPIOID MINIMIZATION PROTOCOL: A PROSPECTIVE, NON-INFERIORITY STUDY

Sofia Gereta*, Safiya-Hana Belbina, Elizabeth Blankenship, J. Stuart Wolf Jr., E. Charles Osterberg, Aaron A. Laviana, Austin, TX

MP31-03 A PROSPECTIVE INTERVENTION OF NO OPIOIDS PRESCRIPTIONS AT DISCHARGE AFTER SURGERY (NOPIODS) IN UROLOGIC ONCOLOGY

Zorawar Singh*, Kevin Carnes, Leanne Lorenz, Paul Feustel, Hugh Fisher, Ronald Kaufman, Theodore Cangero, Badar Mian, Albany, NY

MP31-04 PASSIVE OPIOID STEWARDSHIP INITIATIVES ASSOCIATED WITH SIGNIFICANT CHANGE IN OPIOID PRESCRIBING FOLLOWING UROLOGIC SURGERY

Tudor Borza, Emily Serrell*, Manasa Ven-katesh, Jeremy Goodman, Elise Lawson, Sudha Quamme, Kyle Richards, David Jarrard, Madison, WI, Caprice Greenberg, Augusta, GA, Corrine Voils, Jessica Schumacher, Madison, WI

MP31-05 LARGE SCALE IMPLEMENTATION OF OPIOID PRESCRIPTION REDUCTION AFTER ROBOTIC PROSTATECTOMY – 2 YEAR EVALUATION FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATIVE (PURC)

Thenappan Chandrasekar*, Philadelphia, PA, Ne-cole Streeper, Charles Keith, Hershey, PA, Andrea Quin, Kaynaat Syed, Alexander Kutikov, Phila-delphia, PA, John Danella, Danville, PA, Thomas Lanchoney, Paoli, PA, Jeffrey Tomaszewski, Camden, NJ, Edouard Trabulsi, Adam Reese, Marc Smaldone, Robert Uzzo, Thomas Guzzo, Philadelphia, PA, Jay Raman, Hershey, PA, Adrien Bernstein, Daniel Lee, Philadelphia, PA

MP31-06 REAL-TIME MEASUREMENT OF PATIENT REPORTED OUTCOMES AND OPIOID USE FOLLOWING UROLOGIC PROCEDURES USING AUTOMATED TEXT MESSAGING

Daniel Lee*, Anish Agarwal, Zarina Ali, Ruiying Xiong, Evan Spencer, Jessica Hemmons, Kit Delgado, Philadelphia, PA

ABSTRACTTIME NUMBER TITLE MP31-07 ATTITUDES TOWARDS THE USE OF

MEDICAL MARIJUANA AMONG HEALTH CARE WORKERS: A PILOT STUDY

Leah Beland*, Darius Paduch, New Hyde Park, NY

MP31-08 USE OF SMOKING CESSATION PHARMACOTHERAPY FOLLOWING CYSTECTOMY AMONG SMOKERS WITH BLADDER CANCER

Eli Rapoport*, New York, NY, Marc Bjurlin, Chapel Hill, NC, Helena Furberg, Timothy Donahue, Bernard Bochner, Jamie Ostroff, Richard Matulewicz, New York, NY

MP31-09 DECREASED URETERAL STENT DURATION AFTER RADICAL CYSTECTOMY AND ILEAL CONDUIT URINARY DIVERSION IS ASSOCIATED WITH DECREASED RATE OF 30 AND 90-DAY COMPLICATIONS

David Miller*, Danielle Sharbaugh, Cameron Jones, John Myrga, Jennifer Mihalo, Michelle Yu, Tatum Tarin, Robert Turner, Bishoy Gayed, Benjamin Davies, Bruce Jacobs, Pittsburgh, PA

MP31-10 SYSTEMATIC REVIEW AND META-ANALYSIS OF FRAILTY INDICES IN UROLOGIC SURGERY: RISK PREDICTION OF POSTOPERATIVE COMPLICATIONS

Jane Kurtzman*, Preston Kerr, Rashed Kosber, Steven Brandes, New York, NY

MP31-11 THE GERIATRIC NUTRITIONAL RISK INDEX PREDICTS POSTOPERATIVE COMPLICATIONS IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY FOR RENAL CANCER: A PROPENSITY SCORE-MATCHED ANALYSIS

Carlos Riveros*, Victor Chalfant, Ahmed Elshafei, KC Balaji, Jacksonville, FL

MP31-12 HIGH LEVELS OF HIDDEN SEGREGATION EXIST FOR BLACK AND WHITE PATIENTS UNDERGOING CANCER SURGERY WITHIN THE SAME HOSPITAL

Lillian Lai*, Addison Shay, Sitara Murali, Phyllis Yan, John Hollingsworth, Ann Arbor, MI

MP31-13 DISPARITIES IN RACE AND ETHNICITY REPORTING IN CONTEMPORARY CLINICAL TRIALS LEADING TO NEW DRUG APPROVALS IN UROLOGY

Andres Guillen Lozoya*, Vidit Sharma, Bradley Leibovich, Candace Granberg, Patricio Gargollo, Kevin Koo, Rochester, MN

132

MP31-14 VARIATION IN COMMUNICATION OF SIDE EFFECTS IN PROSTATE CANCER TREATMENT CONSULTATIONS

Aurash Naser-Tavakolian*, Rebecca Gale, Michael Luu, Abhishek Venkataramana, Los An-geles, CA, Dmitry Khodyakov, Santa Monica, CA, Edwin Posadas, Howard Sandler, Jennifer Anger, Brennan Spiegel, Stephen Freedland, Timothy Daskivich, Los Angeles, CA

MP31-15 TELEUROLOGY: EXPANDING HORIZONS TO INPATIENT ECONSULTS

Nathan Feiertag*, Benjamin Green, Justin Loloi, Brendon Hopgood, Farzaan Kassam, Olsjon Shperdheja, Priya Dave, Jubin Matloubieh, Jen-nifer Nauheim, Mustufa Babar, Max Abramson, Alex Sankin, Nitya Abraham, Ahmed Aboumo-hamed, Alexander Small, Jillian Donnelly, Frank Lowe, Melissa Laudano, Kara Watts, Bronx, NY

MP31-16 FEASIBILITY AND ACCEPTABILITY OF SHARED MEDICAL APPOINTMENTS UTILIZING TELEHEALTH MEDICINE FOR KIDNEY STONE PREVENTION

Necole Streeper*, Rachael Smith, Megan Beyer, Hershey, PA

MP31-17 THE COVID-19 EXPERIENCE WITH TELEHEALTH FOR MALE HYPOGONADISM: A CAUTIONARY TALE

John Fisher*, Jorge Rivera-Mirabal, Hudson Pierece, Kenny Kim, Larry Lipshultz, Houston, TX

MP31-18 MOBILISING THE CLINIC: PERFORMING TRIALS WITHOUT CATHETERS WITHIN THE COMMUNITY

Anne Hong*, Cheryl Yeo, Henry Yao, Damien Bolton, Melbourne, Australia

MP31-19 REDUCING CATHETER ASSOCIATED-URINARY TRACT INFECTIONS WITH STERILE, CONTINUOUSLY CLOSED DRAINAGE SYSTEMS DOES NOT HAVE TO BE COSTLY

Janelle Fox*, Suffolk, VA, Christina Jockel, Leslie Konyk, Shaina Thomas, Omar Ayyash, Rajeev Chaudhry, Glenn Cannon, Francis Schneck, Dan-iel Pelzman, Lindsay Montoya, Pittsburgh, PA

MP31-20 REPROCESSING EFFECTIVENESS FOR FLEXIBLE URETEROSCOPES: A LOOK AT THE EVIDENCE

Seth Bechis*, San Diego, CA, Krystina Hopkins, Cori Ofstead, St Paul, MN


Saturday, May 14, 2022 2:45 pm - 4:00 pm

Moderated Poster Session 32SURGICAL TECHNOLOGY & SIMULATION: INSTRUMENTATION & TECHNOLOGY I

Room 225 @ Ernest N. Morial Convention CenterModerators: William Roberts, Prokar Dasgupta & D. Duane Baldwin

ABSTRACT NUMBER TITLE MP32-01 COMPARISON OF 1.9MM TRILOGY PROBE

AND MOSES HOLMIUM LASER IN MINI-PERCUTANEOUS NEPHROLITHOTOMY

Daniel Rosen*, Hanover, MD, Max Drescher, Baltimore, MD, Julio Davalos, Hanover, MD

MP32-02 DEVELOPMENT OF AN AUTOMATED IRRIGATION SYSTEM SYNCHRONIZED WITH AN ULTRA-MINIATURE FIBER-OPTIC PRESSURE SENSOR FOR REGULATING INTRAPELVIC PRESSURE DURING URETEROSCOPY: AN EX VIVO PRECLINICAL STUDY

Takashi Yoshida*, Osaka, Japan, Tadao Matsu-naga, Tottori, Japan, Noriko Tsuruoka, Sendai, Japan, Hidefumi Kinoshita, Osaka, Japan, Youichi Haga, Sendai, Japan

MP32-03 AUTOMATED SEGMENTATION OF KIDNEY STONES DURING URETEROSCOPY USING COMPUTER VISION TECHNIQUES

Shaan Setia*, Zachary Stoebner, Daiwei Lu, Ipek Oguz, Nicholas Kavoussi, Nashville, TN

ABSTRACT NUMBER TITLE MP32-04 ANOTHER ONE BITES THE DUST:

EVALUATING THE EFFICACY OF THE EXTENDED FREQUENCY RANGE OF THE MOSES 2.0 LASER SYSTEM IN AN IN VITRO STONE DUSTING MODEL

Patrick Whelan, Christopher Kim, Christian Tabib*, Pei Zhong, Glenn Preminger, Michael Lipkin, Durham, NC

MP32-05 BENCHTOP EVALUATION OF MINIATURE PERCUTANEOUS NEPHROLITHITOMY LITHOTRITES

Patrick Whelan, Christopher Kim, Christian Ta-bib*, Durham, NC, Russell Terry, Gainesville, FL, Glenn Preminger, Michael Lipkin, Durham, NC

MP32-06 FEASIBILITY OF LASER LITHOTRIPSY USING ROBOTIC RETROGRADE INTRARENAL SURGERY SYSTEM EASYURETERO AND AURIGA XL HOLMIUM LASER IN PORCINE MODEL

Hyun Ho Han*, Young Joon Moon, Seoul, Korea, Republic of, Hae Do Jung, Gunpo, Korea, Repub-lic of, Joonhwan Kim, Byungsik Cheon, Jungmin Han, Daejeon, Korea, Republic of, Sung Yong Cho, Seoul, Korea, Republic of, Dong-Soo Kwon, Daejeon, Korea, Republic of, Joo Yong Lee, Seoul, Korea, Republic of


SA

TU

RD

AY

MP32-07 THERMAL EFFECTS OF THE SUPER-PULSE THULIUM FIBER LASER DURING URETERAL STONE LASER LITHOTRIPSY: AN IN-VIVO PORCINE STUDY

Kalon L. Morgan*, Pengbo Jiang, Akhil Peta, Maged Ayad, Rohit Bhatt, Andrew Brevik, Krista Larson, Zhamshid Okhunov, Ted Farzeneh, Ros-han M. Patel, Jaime Landman, Ralph V. Clayman, Orange, CA

MP32-08 DEVELOPMENT OF A SAFE ALTERNATIVE TO FOLEY CATHETER (SAFECATH) TO REDUCE CATHETER-INDUCED TRAUMA

Hersh Bendre*, Graham Lieberman, Jonathan Kusner, Amy Hao, Francis McGovern, Boston, MA

MP32-09 PATIENT CONTROLLED URETHRAL HYDRODISTENTION REDUCES PAIN DURING MALE FLEXIBLE CYSTOSCOPY

Daniel Wagner*, Chicgo, IL, William Lin, Chicago, IL

MP32-10 SINGLE PORT ROBOTIC UROLOGIC SURGERY: FEWER PORTS, HIGHER COSTS

Mark Biebel*, St. Louis, MO, Brijesh Patel, Ramakrishna Venkatesh, St. Loius, MO, Robert Figenshau, St. Louis, MO

MP32-11 FREE-HAND VERSUS GRID-ASSISTED TRANSPERINEAL ULTRASOUND MRI-FUSION PROSTATE BIOPSY: AN INITIAL EXPERIENCE

Jacob Enders*, Nicole Varble, Michael Rothberg, Zach Kozel, Sheng Xu, Patrick Gomella, Michael Daneshvar, Reza Seifabadi, Maria Merino, Baris Turkbey, Bradford Wood, Peter Pinto, Bethesda, MD

MP32-12 LAPAROSCOPIC RENAL SURGERY USING MULTI DEGREE-OF-FREEDOM ARTICULATING LAPAROSCOPIC INSTRUMENTS IN A PORCINE MODEL

Jong Keun Kim*, Hwaseong, Korea, Republic of, Bosik Kang, Yu Seon Kim, Yujin Yun, Myoung Jin Jang, Seoul, Korea, Republic of, Donghwan Bae, Seongnam, Korea, Republic of, Dalsan You, Seoul, Korea, Republic of

MP32-13 TRANSPERITONEAL RADICAL PROSTATECTOMY USING THE SENHANCE ROBOTIC SYSTEM: INITIAL CASE SERIES, LEARNING CURVE AND COST ANALYSIS

Yen-Chun Lin*, Lun-Hsiang Yuan, Shi-Wei Huang, Yu-Wen Huang, Yunlin, Taiwan, Chao-Yuan Huang, Taipei, Taiwan

MP32-14 IN VITRO TESTING OF UNTETHERED THERMAL-ACTUATED MICROGRIPPERS AS A NOVEL DIAGNOSTIC TOOL FOR UROTHELIAL TISSUE

Ridwan Alam*, Wangqu Liu, Ezra Baraban, Brian Matlaga, Andres Matoso, David Gracias, Balti-more, MD, Jared Winoker, New York City, NY

MP32-15 MORTALITY RELATED TO THE USE OF STAPLER DEVICES AND CLIP APPLIERS: ANALYSIS OF THE FDA MAUDE DATABASE

Balaji Reddy*, Miami, FL, Shirin Razdan, New York, NY, Sanjay Razdan, Miami, FL

MP32-16 COMPARISON OF PERIOPERATIVE OUTCOMES OF SINGLE-PORT DA VINCI SP AND MULTIPORT DA VINCI XI ROBOTIC SYSTEMS IN ROBOTIC-ASSISTED UROLOGIC SURGERIES

Christopher Dennis*, Luca Morgantini, Marcin Zu-berek, Simone Francavilla, Ryan Trippel, Simone Crivellaro, Chicago, IL

MP32-17 EFFECTIVITY OF A NOVEL IMPLANTABLE DEVICE (STIMROUTER) FOR THE TREATMENT OF OVERACTIVE BLADDER SYNDROME: 30 MONTHS RESULTS OF A MULTI-CENTRE STUDY

Mohammad Khaneshi*, Heerlen, Netherlands, Mohammad Sajjad Rahnama’i, Aachen, Germany, Sakineh Haj Ebrahimi, Tabriz, Islamic Republic of Iran

MP32-18 DEVICE-RELATED COMPLICATIONS DURING RENAL CRYOABLATION: INSIGHTS FROM THE MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE (MAUDE) DATABASE

Srinath Kotamarti*, Zoe Michael, Durham, NC, David Silver, Ervin Teper, Brooklyn, NY, Alireza Aminsharifi, Hershey, PA, Thomas Polascik, Dur-ham, NC, Ariel Schulman, Brooklyn, NY

MP32-19 BRIDGING THE GAP – BUILDING SURGICAL SUBSPECIALTY TELEMEDICINE CLINICS IN THE RURAL SETTING

Chris Ferrari, Indianapolis, IN, Katharina Mitchell*, Chad Crigger, Shirley Zupper, Amy Wildasin, Michael Ost, Brian Hendricks, Osama Al-Omar, Morgantown, WV

MP32-20 LAPAROSCOPIC VERSUS ULTRASOUND GUIDED TRANSVERSUS ABDOMINIS PLANE (TAP) BLOCK FOR POSTOPERATIVE ANALGESIA AFTER RADICAL PROSTATECTOMY: A RANDOMIZED CONTROLLED TRIAL

Angelo Civitella*, Francesco Prata, Piergiorgio Tuzzolo, Luca Romei, Vito Giuseppe Crimi, Francesco Tedesco, Alberto Ragusa, Noemi Deanesi, Antonio Testa, Loris Cacciatore, Gerardo Paolo Flammia, Antonio Alcini, Annamaria Salerno, Rome, Italy, Salvatore Mario Prata, Sora, Italy, Francesco Esperto, Roberto Mario Scarpa, Rocco Papalia, Rome, Italy


134


SOCIEDAD COLOMBIANA DE UROLOGÍASt. Charles Ballroom @ Hilton New Orleans Riverside

3:00 INAUGURATION Society President: Jaime Cajigas

3:05 A NEW PROPOSAL IN FENO AND GENO TIPIFICA-TION IN HIPOSPADIAS AND ITS IMPACT IN THE SURGERY TECNICHS: USE OF NEW TECHNOLO-GIES AND ARTFICIAL INTELIGENCE

Nicolas Fernandez

3:25 MODERN TREATMENT FOR VESICO URETERIC REFLUX

Pablo Gomez

3:40 SCROTAL APPROACH FOR NO DESCENDED TESTIS: EXPERIENCE AFTER 1,000 CASES

Juan Carlos Prieto

4:01 MOLECULAR SUBTIPIFICATION OF MUSCLE INVASIVE BLADDER CANCER; CLINIC PERSPECTIVES AND LIMITATIONS

Jorge Daza

4:15 NEOADJUVANT PROSTATE CANCER: PRESENT AND FUTURE PERSPECTIVES

Adriana Pedraza

4:30 Q&A

4:35 ROBOTIC SURGERY IN FEMALE UROLOGY FOR PROLAPSES, VESICOVAGINAL FISTULAS, VESI-CO URETERAL REIMPLANTATION AND INCONTI-NENCE (ARTIFICIAL SPHINCTER FOR WOMEN)

Natalia Hernandez

4:50 Q&A

4:55 FINAL REMARKS William Quiroga


ForumsCLINICAL CONTROVERSIES IN MEN’S HEALTH

Room 267 @ Ernest N. Morial Convention CenterChairs: Michael Eisenberg & Larry Lipshultz

3:00 ARE SPERM COUNTS DECLINING? Debater-Pro: Kevin Campbell Debater-Con: Dolores Lamb

DISCUSSION

3:40 THE FUTURE OF MALE PENILE PROSTHESES: WHAT IS NEEDED AND WHAT LIES AHEAD

WHAT IS NEEDED Tobias Kohler

WHAT IS PLANNED Dean Knoll

DISCUSSION

4:20 EMERGING OPTIONS FOR THE ORAL TREATMENT OF MALE HYPOGONADISM: PANEL DISCUSSION

PRO: ORAL PREPARATIONS ARE NEEDED AND THE NEW ORALS APPEAR TO BE JUST WHAT THE DOCTOR ORDERED

Adrian Dobs

CON: THE NEW ORALS MAY BE DIFFICULT TO TITRATE AND MAY NOT GIVE PATIENTS WHAT THEY WANT: LIMITATIONS AND CONCERNS

John Mulhall



ForumsAUA ROBOTICS THEATER SPONSORED BY INTUITIVE: MULTIPORT BENIGN INNOVATION AND

SURGICAL PROCEDURES - RECONSTRUCTION AND BLADDER CANCERS&T Hall C: Booth 311 @ Ernest N. Morial Convention Center

Chair: Ashutosh Tewari

AUA ROBOTICS THEATER: MULTIPORT BENIGN INNOVATION AND SURGICAL PROCEDURES – RECONSTRUCTION AND BLADDER CANCER

Program Leaders: Craig Rogers, Chandru Sundaram Panelists: Rajesh Alhawat, Dipen Parikh, James Porter


SA

TU

RD

AY


Podium Session 31TRAUMA/RECONSTRUCTION/DIVERSION: URETHRAL RECONSTRUCTION (INCLUDING STRICTURE, DIVERTICULUM) II

Room 252 @ Ernest N. Morial Convention CenterModerators: Sean Elliott, Sanjay Kulkarni & Jerilyn Latini

ABSTRACTTIME NUMBER TITLE3:30 PD31-01 TRANSURETHRAL CATHETERISATION

SAFETY VALVE (TUCSV©) FOR THE PREVENTION OF CATHETER BALLOON INFLATION INJURY OF THE URETHRA - A PROSPECTIVE MULTI-INSTITUTIONAL STUDY

Eabhann O’Connor, Stefanie Croghan*, Dublin, Ireland, Olivia Baird, John Fallon, Peter Lough-man, Jibraan Esoof, Limerick, Ireland, Robert Keenan, James Ryan, Dublin, Ireland, Subhasis Giri, Limerick, Ireland

3:40 PD31-02 MULTI-CENTERED ASSESSMENT OF FACTORS ASSOCIATED WITH EXPLANTATION OF 3RD GENERATION ADJUSTABLE TRANSOBTURATOR MALE SYSTEM (ATOMS)

Elizabeth Naud*, Edmonton, Canada, Genevieve Nadeau, Quebec, Canada, Le-Mai Tu, Sher-brooke, Canada, Christopher Doiron, Stephen Steele, Kingston, Canada, Sender Herschorn, Jennifer Locke, Toronto, Canada, Conrad Macie-jewski, Ottawa, Canada, Neil Dwyer, Moncton, Canada, Lysanne Campeau, Montreal, Canada, Kevin Carlson, Calgary, Canada, Keith Rourke, Edmonton, Canada

3:50 PD31-03 BLADDER OUTLET SURGERIES FOR MEN WITH STRESS URINARY INCONTINENCE AND NEUROGENIC LOWER URINARY TRACT DYSFUNCTION: A MULTICENTER NEUROGENIC BLADDER RESEARCH GROUP STUDY

Javier Santiago*, Ann Arbor, MI, Min Soo Choo, Seoul, Korea, Republic of, Richard Mora, Evgeniy Kreydin, David A Ginsberg, Los Angeles, CA, Na-talia Hernandez, Paola Bustillos, Rose Khavari, Houston, TX, Stephanie Daignault-Newton, John Stoffel, Ann Arbor, MI

4:00 PD31-04 LOWER URINARY TRACT MICROBIOTA DYSBIOSIS IS ASSOCIATED WITH URETHRAL FIBROSIS

Michael Witthaus*, Valmik Bhargava, Jill Buckley, Mahadevan Rajasekaran, San Diego, CA

4:10 PD31-05 REPEATED TRANSURETHRAL INTERVENTIONS INCREASE ELASTIN DEGRADATION AND STRICTURE SEVERITY

Michael Witthaus*, San Diego, CA, Jathin Bandari, Rochester, NY, Thomas Will Fuller, Seattle, WA, Valmik Bhargava, Jill Buckley, Ma-hadevan Rajasekaran, San Diego, CA

ABSTRACTTIME NUMBER TITLE4:20 PD31-06 EXPRESSION AND LOCALIZATION OF MIR-

146A-5P AND MIR-142-3P IN URETHRAL SUBMUCOSA OF PATIENTS WITH LICHEN SCLEROSUS-INDUCED URETHRAL STRICTURE DISEASE

Aaron Perecman*, Harjivan Kohli, Brandon Childs, Travis Sullivan, Burlington, MA, Myrtha Constant, Eric Burks, Boston, MA, Kimberly Rieg-er-Christ, Alex Vanni, Burlington, MA

4:30 PD31-07 DOES ORAL HEALTH AND GRAFT HISTOLOGY PREDICT POSTOPERATIVE OUTCOMES FOLLOWING ORAL GRAFT URETHROPLASTY?

Jane Kurtzman*, Preston Kerr, Rashed Kosber, Carlos Pagan, Mahveesh Chowdhury, Steven Brandes, New York, NY

4:40 PD31-08 LONG-TERM OUTCOMES OF URETHRAL STRICTURE TREATMENT WITH THE OPTILUME PACLITAXEL-COATED BALLOON: 4-YEAR RESULTS FROM THE ROBUST I STUDY

Sean Elliott*, Minneapolis, MN, Ramon Vira-soro, Norfolk, VA, Rafael Estrella, Santiago de los Caballeros, Dominican Republic, Merycarla Pichardo, Santo Domingo, Dominican Republic, Ramon Rodríguez Lay, Gustavo Espino, Panama City, Panama, Jessica DeLong, Norfolk, VA

4:50 PD31-09 PROSPECTIVE ASSESSMENT OF GENITAL PAIN IN PATIENTS UNDERGOING URETHROPLASTY: INCIDENCE, ASSOCIATIONS AND IMPACT OF SURGERY

Declan Rourke*, Jordan Bekkema, Keith Rourke, Edmonton, Canada

5:00 PD31-10 PATIENT AND STRICTURE VARIABLES ASSOCIATED WITH FAILURE AFTER URETHROPLASTY FOR BULBAR URETHRAL STRICTURES

Kevin Flynn*, Iowa City, IA, Shawn Grove, Min-neapolis, MN, Nejd Alsikafi, Gurnee, IL, Joshua Broghammer, Kansas City, KS, Jill Buckley, San Diego, CA, Sean Elliott, Minneapolis, MN, Jeremy Myers, Salt Lake City, UT, Andrew Peterson, Durham, NC, Keith Rourke, Edmonton, Canada, Thomas Smith III, Houston, TX, Alex Vanni, Burl-ington, MA, Lee Zhao, New York City, NY, Bradley Erickson, Iowa City, IA

136

5:10 PD31-11 PATIENT, STRICTURE, AND URETHROPLASTY PREDICTORS OF ERECTILE DYSFUNCTION AFTER URETHROPLASTY FOR BULBAR URETHRAL STRICTURES

Justin Drobish*, Iowa City, IA, Shawn Grove, Min-neapolis, MN, Nejd Alsikafi, Gurnee, IL, Joshua Broghammer, Kansas City, KS, Jill Buckley, San Diego, CA, Sean Elliott, Minneapolis, MN, Jeremy Myers, Salt Lake City, UT, Andrew Peterson, Durham, NC, Keith Rourke, Edmonton, Canada, Thomas Smith III, Houston, TX, Alex Vanni, Burl-ington, MA, Lee Zhao, New York City, NY, Bradley Erickson, Iowa City, IA

5:20 PD31-12 EVALUATING PREDICTIVE TOOLS FOR ANTERIOR URETHROPLASTY OUTCOMES: A COMPARISON OF THE TURNS LSE SYSTEM AND U-SCORE

Jane Kurtzman*, Rashed Kosber, Preston Kerr, Steven Brandes, New York, NY



Podium Session 32INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: KIDNEY & BLADDER III

Room 255 @ Ernest N. Morial Convention CenterModerators: Kymora Scotland & Michel Pontari

ABSTRACTTIME NUMBER TITLE3:30 PD32-01 CARBAPENEM-RESISTANT

ENTEROBACTERIACAE ISOLATES FROM DUKE UNIVERSITY HOSPITAL CHARACTERIZED VIA WHOLE GENOME SEQUENCING

Lauren Elam, Chae Hee Lim, Krishnan Chittur, Huntsville, AL, Rachel Addison, Sarah S. Lewis, Becky A. Smith, Deverick Anderson, Durham, NC, Tatyana Sysoeva*, Huntsville, AL

3:40 PD32-02 POPULATION BASED STUDY ON THE INCIDENCE AND RISKS OF MULTIDRUG-RESISTANT ORGANISMS IN PATIENTS WITH URETERIC STENTS

Runhan Ren*, Zoe Hsu, Erik Youngson, Shubha De, Edmonton, Canada

3:50 PD32-03 TEBIPENEM IN VITRO ACTIVITY AGAINST A COLLECTION OF PATHOGENS RESPONSIBLE FOR URINARY TRACT INFECTIONS IN THE UNITED STATES

S.J. Ryan Arends*, North Liberty, IA, Ian Critch-ley, Nicole Cotroneo, Cambridge, MA, Jennifer Streit, Helio Sader, Mariana Castanheira, Rodrigo Mendes, North Liberty, IA

4:00 PD32-04 D-MANNOSURIA LEVELS MEASURED ONE HOUR AFTER D-MANNOSE INTAKE SELECT OUT FAVORABLE RESPONDERS

Ethan Fan*, Jorge Fuentes, Dallas, TX, Marjan Ganjali Dashti, Larry Reitzer, Richardson, TX, Alana L. Christie, Philippe E. Zimmern, Dallas, TX

4:10 PD32-05 RATE OF PROGRESSION TO SEPSIS FOLLOWING PRESENTATION FOR ACUTE CYSTITIS

Daniela Kaefer*, Jeffrey Chiang, A. Lenore Ackerman, Los Angeles, CA

ABSTRACTTIME NUMBER TITLE4:20 PD32-06 THE ROLE OF PRESEPSIN AS PREDICTIVE

FACTOR FOR SEPSIS IN PATIENTS WITH URINARY TRACT INFECTION ASSOCIATED WITH URINARY CALCULI

Yeong Uk Kim*, Jong Gyun Ha, Jae Youn Jang, Jae Young Choi, Young Hwii Ko, Phil Hyun Song, Ki Hak Moon, Hee Chang Jung, Daegu, Korea, Republic of

4:30 PD32-07 MICROBIAL EXPOSURE REDUCES SUSCEPTIBILITY TO UROPATHOGENIC E. COLI (UPEC)-INDUCED UROSEPSIS

Matthew Martin*, Whitney Swanson, Tamara Ku-caba, Minneapolis, MN, Vladimir Badovinac, Iowa City, IA, Molly Ingersoll, Paris, France, Thomas Griffith, Minneapolis, MN

4:40 PD32-08 ELEVATED THROMBIN-ANTITHROMBIN COMPLEX IS A RISK FACTOR OF SEVERE ACUTE KIDNEY INJURY IN PATIENTS WITH UROLOGICAL SEPSIS

Masaki Momota*, Hirosaki, Japan

4:50 PD32-09 COMPARISON OF GUIDANCE UTI® AND STANDARD URINE CULTURE FOR RATES OF SEPSIS, HOSPITALIZATION AND OTHER ADVERSE OUTCOMES IN COMPLICATED URINARY TRACT INFECTIONS

Aparna Ashok*, Dicken Ko, Providence, RI, Emily Lukacz, La Jolla, CA, Annah Vollstedt, Iowa City, IA, Iver Juster, San Rafael, CA, Timothy Niecko, Tierra Verde, FL, David Baunoch, Trabuco Can-yon, CA, Mohit Mathur, Irvine, CA

5:00 PD32-10 KIDNEY STONE ENDOTOXIN CONCENTRATION CORRELATES WITH POST-OPERATIVE SEPSIS FOLLOWING PERCUTANEOUS NEPHROLITHOTOMY

David T. Tzou*, Farhan Anwar, Ava C. Wong, David T. Harris, Tucson, AZ, Thomas Chi, San Francisco, CA, Gayatri Vedantam, Tucson, AZ


SA

TU

RD

AY

5:10 PD32-11 RENAL PELVIS URINE SAMPLING IN PATIENTS WITH INFECTED, OBSTRUCTING STONES – A NEW STANDARD PRACTICE?

Majid Mirzazadeh*, Parth Udayan Thakker, Raymond Xu, Winston Salem, NC

5:20 PD32-12 RADICAL CYSTECTOMY FOR THE TREATMENT OF PELVIC RADIATION CYSTITIS: A SINGLE HIGH-EXPERIENCE CENTER STUDY

Alberto Piana*, Jordi Huguet, Antoni Sanchez-Puy, Angelo Territo, Pietro Diana, Andrea Gallioli, Francesco Sanguedolce, Alejandra Bravo, Anto-nio Rosales, Ruben Parada, Joan Palou, Alberto Breda, Barcelona, Spain



Podium Session 33KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY II

Room 245 @ Ernest N. Morial Convention CenterModerators: Jeffrey Campbell & Alberto Briganti

ABSTRACTTIME NUMBER TITLE3:30 PD33-01 COMPREHENSIVE MANAGEMENT OF RENAL

MASSES IN SOLITARY KIDNEYS Yosuke Yasuda*, JJ Zhang, Nityam Rathi,

Gustavo Roversi, Ao Zhang, Diego Palacios, Jihad Kaouk, Georges-Pascal Haber, Venkatesh Krishnamurthi, Robert Abouassaly, Christopher Weight, Steven Campbell, Cleveland, OH

3:40 PD33-02 EVALUATION OF AN UNCOMPLICATED RECOVERY AFTER NEPHRECTOMY: MUSIC-KIDNEY NOTES (NOTABLE OUTCOMES AND TRACKABLE EVENTS AFTER SURGERY)

Mohit Butaney*, Detroit, MI, Anna Johnson, Ji Qi, Ann Arbor, MI, Amit Patel, Detroit, MI, Sabrina Noyes, Christopher Brede, Grand Rapids, MI, Brian Seifman, West Bloomfield, MI, Thomas Maatman, Wyoming, MI, Craig Rogers, Detroit, MI, Brian Lane, Grand Rapids, MI, for the Michi-gan Urological Surgery Improvement Collabora-tive, Ann Arbor, MI

3:50 PD33-03 IS ANGIOTENSIN SYSTEM INHIBITOR USE ASSOCIATED WITH IMPROVED OUTCOMES IN PATIENTS WITH LOCALIZED CLEAR CELL RCC?

Paige Nichols*, Andrew Zganjar, Christine Lohse, Sounak Gupta, John Cheville, Cameron Britton, Aaron Potretzke, Stephen Boorjian, Houston Thompson, Bradley Leibovich, Vidit Sharma, Rochester, MN

ABSTRACTTIME NUMBER TITLE4:00 PD33-04 PRIOR SURGICAL EXPERIENCE AND THE

IMPACT ON PERIOPERATIVE OUTCOMES IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY: A MULTICENTER ANALYSIS WITH 2,500 PATIENTS

Nina N. Harke*, Hannover, Germany, Frank Schiefelbein, Andreas Schneller, Wuerzburg, Germany, Georg Schoen, Munich, Germany, Clemens G. Wiesinger, Jacob Pfuner, Wels, Austria, Boris A. Hadaschik, Jan Philipp Radt-ke, Mulham Al Nader, Essen, Germany, Daniar Osmonov, Ahmed Eraky, Kiel, Germany, Burkhard Ubrig, Simon Gloger, Bochum, Germany, Jorn H. Witt, Nikolaos Liakos, Christian Wagner, Gronau, Germany, Florian Imkamp, Stephan Huusmann, Markus A. Kuczyk, Hannover, Germany, Stefan Siemer, Michael Stoeckle, Philip Zeuschner, Homburg/Saar, Germany

4:10 PD33-05 INCIDENCE AND SIGNIFICANCE OF 20% DECREASE FROM NEW BASELINE ESTIMATED GLOMERULAR FILTRATION RATE AFTER RADICAL AND PARTIAL NEPHRECTOMY

Bo Fan*, Minato Yokoyama, Yosuke Yasuda, Yuki Nakamura, Yusuke Uchida, Shohei Fukuda, Sho Uehara, Hajime Tanaka, Soichiro Yoshida, Yoh Matsuoka, Yasuhisa Fujii, Tokyo, Japan

4:20 PD33-06 SPLIT RENAL FUNCTION IMPROVES PREDICTION OF GFR AFTER RADICAL NEPHRECTOMY

Nityam Rathi*, Yosuke Yasuda, Diego Aguilar Palacios, Cleveland, OH, Hajime Tanaka, Tokyo, Japan, Yunlin Ye, Guangzhou, China, People’s Republic of, Jianbo Li, Cleveland, OH, Bimal Bhindi, Calgary, Canada, Robert Houston, Roch-ester, MN, Michael Liss, San Antonio, TX, Ithaar Derweesh, La Jolla, CA, Christopher Weight, Mohammed Eltemamy, Robert Abouassaly, Steven Campbell, Cleveland, OH

138

4:30 PD33-07 IMPACT OF AGE ON FUNCTIONAL DECLINE FOLLOWING RADICAL NEPHRECTOMY: ANALYSIS OF THE INTERNATIONAL MARKER CONSORTIUM FOR RENAL CANCER (INMARC)

Mimi Nguyen*, Arman Walia, Ava Saidian, Margaret Meagher, John Matthew Perry, Rekha Narasimhan, Madison Chakoumakos, La Jolla, CA, Viraj Master, Atlanta, GA, Kazutaka Saito, Tokyo, Japan, Dattatraya Patil, Atlanta, GA, Juan Javier-DesLoges, La Jolla, CA, Yasuhisa Fujii, Tokyo, Japan, Ithaar Derweesh, La Jolla, CA

4:40 PD33-08 COMPARISON OF PERIOPERATIVE OUTCOMES BETWEEN SINGLE-PORT AND MULTIPORT RETROPERITONEAL ROBOT-ASSISTED PARTIAL NEPHRECTOMIES

Arnold Palacios*, Luca Morgantini, Ryan Trippel, Simone Crivellaro, Chicago, IL, Michael Abern, Durham, NC

4:50 PD33-09 MULTI-INSTITUTIONAL REPORT OF PATIENT CHARACTERISTICS AND ONCOLOGIC OUTCOMES FOLLOWING MICROWAVE ABLATION OF BIOPSY-PROVEN RENAL CELL CARCINOMA

Leo Dreyfuss*, New York, NY, Arighno Das, Mad-ison, WI, Kimberly Maciolek, Charlottesville, VA, Rand Wilcox Vanden Berg, New York, NY, Glenn Allen, Madison, WI, Jonathan Fainberg, New York, NY, Tudor Borza, Shane Wells, Madison, WI, Stephen Culp, Charlottesville, VA, E. Jason Abel, Madison, WI, Timothy McClure, New York, NY

5:00 PD33-10 NEPHROMETRY AND CUMULATIVE MORBIDITY AFTER PARTIAL NEPHRECTOMY: A STANDARDIZED ASSESSMENT OF COMPLICATIONS IN THE CONTEXT OF R.E.N.A.L. AND PADUA SCORES

Dejan K. Filipas*, Hang Yu, Clemens Spink, Michael Rink, Silke Riechardt, Philipp Gild, Phillip Marks, Margit Fisch, Roland Dahlem, Hamburg, Germany, Christian P. Meyer, Herford, Germany, Malte W. Vetterlein, Hamburg, Germany

5:10 PD33-11 IMPACT OF ADHESIVE PERINEPHRIC FAT ON SURGICAL PLANNING AND PERIOPERATIVE OUTCOMES IN PARTIAL NEPHRECTOMY

Nina N. Harke*, Hannover, Germany, Frank Schiefelbein, Andreas Schneller, Wuerzburg, Germany, Georg Schoen, Munich, Germany, Olga Katzendorn, Christoph A.J. von Klot, Hannover, Germany, Julia K. Mühlbauer, Philipp Nuhn, Maximilian C. Kriegmair, Margarete T. Walach, Mannheim, Germany

5:20 PD33-12 PRE-OPERATIVE RISK CALCULATOR OF THE PROBABILITY OF COMPLETING NEPHRON-SPARING SURGERY FOR KIDNEY CANCER BASED ON TUMOUR COMPLEXITY AND SURGICAL APPROACH

Alessandro Larcher, Francesco Cei, Giuseppe Rosiello, Giacomo Musso, Giuseppe Fallara, Chiara Re, Daniele Cignoli, Giuseppe Basile*, Gianmarco Colandrea, Gianfranco Baiamonte, Isaline Rowe, Daniela Canibus, Milan, Italy, Fed-erico Dehò, Varese, Italy, Andrea Gallina, Milan, Italy, Alexandre Mottrie, Aalst, Belgium, Cristina Giancristofaro, Francesco De Cobelli, Giorgio Brembilla, Alberto Briganti, Roberto Bertini, Francesco Montorsi, Andrea Salonia, Umberto Capitanio, Milan, Italy



Podium Session 34URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: FEMALE INCONTINENCE: THERAPY II

Room 244 @ Ernest N. Morial Convention CenterModerators: Anne Cameron, Karyn Eilber & Priyanka Gupta

ABSTRACTTIME NUMBER TITLE3:30 PD34-01 SACRAL NEUROMODULATION DEVICES

CONSISTENTLY HARBOR BACTERIA AND POSSESS A UNIQUE MICROBE AND METABOLITE PROFILE

Glenn T. Werneburg*, Ava Adler, Daniel Hettel, Sandip Vasavada, Raymond Rackley, Howard Goldman, Jacqueline Zillioux, Bradley Gill, Daniel Shoskes, Aaron Miller, Cleveland, OH

ABSTRACTTIME NUMBER TITLE3:40 PD34-02 CHEMOKINE THERAPY FOR ANAL

SPHINCTER INJURY: DEVELOPMENT OF A RAT MODEL OF CHRONIC INJURY

Amr El Haraki*, Shannon Lankford, Wencheng Li, Catherine Matthews, Koudy Williams, Winston-Salem, NC, Gopal Badlani, Winston Salem, NC


SA

TU

RD

AY

3:50 PD34-03 MACHINE LEARNING ALGORITHMS ARE ACCURATE AND NON-INFERIOR TO HUMAN EXPERTS IN PREDICTING MEDICALLY-REFRACTORY OVERACTIVE BLADDER TREATMENT OUTCOMES

Glenn Werneburg*, Cleveland, OH, Eric Wer-neburg, Stony Brook, NY, Howard Goldman, Cleveland, OH, Andrew Mullhaupt, Stony Brook, NY, Sandip Vasavada, Cleveland, OH

4:00 PD34-04 IMPACT OF COGNITIVE FUNCTION IN OLDER PATIENTS UNDERGOING SACRAL NEUROMODULATION FOR OVERACTIVE BLADDER: A PROSPECTIVE STUDY

Jacqueline Zillioux*, Sarah Martin, Lauren Gleich, Glenn T. Werneburg, Emily Slopnick, Raymond R. Rackley, Sandip Vasavada, Bradley Gill, Howard B. Goldman, Cleveland, OH

4:10 PD34-05 DOES COGNITIVE IMPAIRMENT IMPACT SACRAL NEUROMODULATION IN OLDER PATIENTS WITH OVERACTIVE BLADDER?

Jacqueline Zillioux*, Kevin Lewis, Daniel Hettel, Sarah Martin, Lauren Gleich, Howard B. Gold-man, Bradley Gill, Cleveland, OH

4:20 PD34-06 ROBOT-ASSISTED ARTIFICIAL URINARY SPHINCTER IMPLANTATION IN FEMALE PATIENTS: AN INTERNATIONAL MULTICENTER SERIES OF 182 PATIENTS

Benoit Peyronnet*, Rennes, France, Jean-Nicolas Cornu, Rouen, France, Olivier Belas, Le Mans, France, Grégoire Capon, Bordeaux, France, Xavier Biardeau, Lille, France, Pierre Lecoanet, Nancy, France, Luis Castro-Sader, Barcelona, Spain, Shahed Borojeni, Paris, France, Rainer Hein, Magdeburg, Germany, Juliette Hascoet, Rennes, France, Frederic Thibault, Metz, France, Frederic Dubois, Rennes, France, Vincent Cardot, Paris, France, Adrien Vidart, Suresnes, France, Aurélien Descazeaud, Limoges, France, Georges Fournier, Brest, France, Frank van der Aa, Leuven, Belgium

4:30 PD34-07 PREDICTORS OF SLINGS AFTER URETHRAL DIVERTICULECTOMY: A 5-YEAR LARGE POPULATION ANALYSIS

Allison Sih*, Seth Cohen, Fornati Bedell, Duarte, CA, Karyn Eilber, Victoria Scott, Los Angeles, CA, Kai Dallas, Duarte, CA

4:40 PD34-08 PIVOTAL STUDY OF A LEADLESS TIBIAL NERVE STIMULATOR FOR URGENCY URINARY INCONTINENCE (UUI): 2-YEAR OUTCOMES FROM A SINGLE SITE

Alexandra Rogers*, Santa Barbara, CA

4:50 PD34-09 VESICO-VAGINAL FISTULA PREVALENCE AND REPAIR PATTERNS: A LARGE RETROSPECTIVE POPULATION-BASED COHORT ANALYSIS

Sarah Neu*, Jennifer Locke, Bo Zhang, Refik Saskin, Sender Herschorn, Toronto, Canada

5:00 PD34-10 DO MEDICAID PATIENTS HAVE ACCESS TO THIRD LINE THERAPIES IN OAB? A STATE-BY-STATE ANALYSIS

Kelly Ieong*, Stony Brook, NY, Wai Lee, Lake Success, NY, Jason Kim, Stony Brook, NY

5:10 PD34-11 EFFECTS OF AGE AND MULTIPLE VAGINAL BIRTHS ON URINARY BLADDER, SPHINCTER STRUCTURE, FUNCTION AND PELVIC SUPPORT IN NONHUMAN PRIMATES

J. Koudy Williams*, Shannon Lankford, Gopal Badlani, Winston-Salem, NC

5:20 PD34-12 STRESS URINARY INCONTINENCE RECOVERY AFTER A SIMULATED DUAL INJURY CHILDBIRTH MODEL IS DEPENDENT ON BRAIN-DERIVED NEUROTROPHIC FACTOR

Brian Balog, Kangli Deng, Tessa Askew, Brett Hanzlicek, Margot Damaser*, Cleveland, OH



Video Session 6FEMALE VOIDING DYSFUNCTION/PELVIC FLOOR DISORDERS/INCONTINENCE/NEURO-UROLOGY

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerators: Ryan Krlin, Ajay Singla & Sender Herschorn

ABSTRACTTIME NUMBER TITLE3:30 V06-01 SURGICAL TECHNIQUE AND OUTCOMES OF

MALONE ANTEGRADE CONTINENCE ENEMA Natalia Hernandez*, Hunter Flores, Julie N Stew-

art, Rose Khavari, Houston, TX

3:40 V06-02 SINGLE PORT ROBOTIC ASSISTED LAPAROSCOPIC SACROCOLPOPEXY: NEW FRONTIER IN MINIMALLY INVASIVE ABDOMINAL REPAIR OF PELVIC ORGAN PROLAPSE

David Ali*, Paterson, NJ, Mubashir Billah, Muta-har Ahmed, Hackensack, NJ

ABSTRACTTIME NUMBER TITLE3:50 V06-03 VARIATIONS IN PROMONTORY

ANATOMY COMPLICATING ROBOTIC SACROCOLPOPEXY

Colby P. Souders*, Ramy Goueli, Hersh Trivedi, Gaurav Khatri, Philippe E. Zimmern, Dallas, TX

4:00 V06-04 EXCISION OF ERODED VAGINAL MESH SLING WITH OBLITERATION OF URETHRA REQUIRING CONCURRENT URETHROPLASTY

Matthew Mikula*, Justin Han, Wai Lee, New Hyde Park, NY

140


ForumsMEDICAL STUDENT FORUM


4:10 V06-05 OFFICE REMOVAL OF SACRAL NEUROMODULATION- WELL TOLERATED, SAFE AND EFFECTIVE

Sarah Martin*, Cleveland Heights, OH, Jacque-line Zillioux, Lauren Gleich, Howard Goldman, Cleveland, OH

4:20 V06-06 ROBOTIC ARTIFICIAL URINARY SPHINCTER EXPLANTATION AND CONCOMITANT FASCIAL SING INSERTION IN CASE OF BLADDER NECK CUFF EXTRUSION FOR FEMALE PATIENTS

Camille Haudebert*, Juliette Hascoet, Lucas Freton, Claire Richard, Karim Bensalah, Gregory Verhoest, Zine Eddine Khene, Romain Mathieu, Andrea Manunta, Benoit Peyronnet, Rennes, France

4:30 V06-07 MANAGEMENT OF VAULT PROLAPSE INCLUDING A BOWEL OBSTRUCTION: EXPANDING THE ROLE OF TRANSVAGINAL SURGERY

Elizabeth J. Olive*, Rochester, MN, Cassandra K. Kisby, Durham, NC, Scott R. Kelley, Brian J. Linder, Rochester, MN

4:40 V06-08 MODIFIED MARTIUS FLAP URETHROPLASTY Jacob Rust, MD*, Christian Twiss, MD, FACS,

Tucson, AZ

4:50 V06-09 DORSAL ONLAY LINGUAL MUCOSA GRAFT URETHROPLASTY FOR FEMALE URETHRAL STRICTURE

Claire Richard*, Benoit Peyronnet, RENNES, France, Alice Drain, New York, NY, Juliette Hascoet, Rennes, France, Nirit Rosenblum, New York, NY, Rachael Sussman, Washington, DC, Lucas Freton, Rennes, France, Lee C Zhao, New York, NY, Victor W Nitti, Los Angeles, CA, Benja-min Brucker, New York, NY

5:00 V06-10 ROBOTIC UTEROSACRAL LIGAMENT PLICATION AT TIME OF BENIGN CYSTECTOMY

Jacqueline Zillioux*, Emily Slopnick, Nima Almas-si, Sandip Vasavada, Cleveland, OH

5:10 V06-11 ROBOT-ASSISTED MITROFANOFF APPENDICOVESICOSTOMY

Camille Haudebert*, Juliette Hascoet, Lucas Fre-ton, Claire Richard, Caroline Voiry, Emmanuelle Samson, Karim Bensalah, Gregory Verhoest, Zine Eddine Khene, Romain Mathieu, Rennes, France, Emmanuelle Bryckaert, Le Mans, France, Benoit Peyronnet, Rennes, France

5:20 V06-12 LAPAROSCOPIC MITROFANOFF APPENDICOVESICOSTOMY: AN OPTION IN COMPLEX ADULT PATIENT TO ACCESS TO THE BLADDER

Roberto Hugo Martinez Rodriguez*, Cristina Gutierrez Ruiz, Leire Portilla Maediavilla, Fatima Castroviejo, Jose H. Amon Sesmero, Valladolid, Spain



SA

TU

RD

AY


Moderated Poster Session 33URORADIOLOGY I

Room 228 @ Ernest N. Morial Convention CenterModerators: Christopher Porter, Edouard Trabulsi & Craig Smith

ABSTRACT NUMBER TITLE MP33-01 “THAT CAN’T BE A STONE!”:

PREDICTORS OF FALSE POSITIVITY FOR NEPHROLITHIASIS ON RADIOLOGIC REPORTS OF RENAL SONOGRAMS

Dylan Z. Taylor*, Garrett E. Smith, Scott V. Wiener, Syracuse, NY

MP33-02 AUTOMATED STONE VOLUME DETERMINATION: TRAINING AN ARTIFICIALLY INTELLIGENT ALGORITHM TO SEGMENT KIDNEY STONES ON CT AND CALCULATE 3D VOLUME

Kalon L. Morgan*, Rohit Bhatt, Sina Soltanzadeh Zarandi, Kelvin Vo, Minh-Chau Vu, Paul Piedras, Akhil Peta, Andrew Brevik, Rajiv Karani, Lillian Xie, Pengbo Jiang, Sohrab Ali, Roshan M. Patel, Jaime Landman, Ralph V. Clayman, Orange, CA

MP33-03 DIAGNOSTIC PERFORMANCE OF UPPER TRACT IMAGING PERFORMED FOR HEMATURIA SCREENING: REAL-WORLD RESULTS FROM A NATIONAL PRIVATELY INSURED COHORT

Alex Hannemann*, Simon Kim, Aurora, CO, Peter Clark, Charlotte, NC, Michael Bronsert, Aurora, CO, Boris Gershman, Boston, MA, Granville Lloyd, Rodrigo Rodrigues Pessoa, Jeffrey Morri-son, Aurora, CO, Marc Smaldone, Philadelphia, PA, Eric Ballon-Landa, Aurora, CO

MP33-04 CONTRAST-ENHANCED ULTRASONOGRAPHY FOR THE EVALUATION OF COMPLEX RENAL CYSTS

Cassra Clark*, Corinne Wessner, Shuo Wang, Andrew Denisenko, Andrew Shumaker, Joonyau Leong, Andrea Quinn, Erica Mann, Lydia Glick, Timothy Han, Kibo Nam, Katherine Smentkowski, John Eisenbrey, Leonard Gomella, Edouard Trabulsi, Costas Lallas, Mark Mann, James Mark, Flemming Forsberg, Andrej Lyshchik, Ethan Halpern, Thenappan Chandrasekar, Philadelphia, PA

MP33-05 DIAGNOSTIC PARAMETERS OF 99MTC-SESTAMIBI SPECT/CT FOR RENAL ONCOCYTOMAS AND HYBRID ONCOCYTIC/CHROMOPHOBE TUMORS: COMBINED PROSPECTIVE TRIAL DATA

Alexa Meyer*, Hiten Patel, Lilja Solnes, Reema Goel, Mehrbod Javadi, Phillip Pierorazio, Chris-tian Pavlovich, Mohamad Allaf, Michael Gorin, Steven Rowe, Baltimore, MD

ABSTRACT NUMBER TITLE MP33-06 PREDICTING RENAL TUMOR GROWTH IN

VON HIPPEL-LINDAU (VHL) PATIENTS FROM MAGNETIC RESONANCE IMAGING (MRI) FEATURES: A PILOT STUDY OF THE KIDNEY IMAGING SURVEILLANCE SCORING SYSTEM (KISSS)

Nikhil Gopal*, Pouria Yazdian, Aditi Chaurasia, Maria Antony, Safa Samimi, Rabindra Gautam, Elizabeth Jones, Mark Ball, W. Marston Linehan, Evrim Turkbey, Ashkan Malayeri, Bethesda, MD

MP33-07 MRI-BASED SEGMENTATION OF PREOPERATIVE RENAL PARENCHYMA IN VON HIPPEL LINDAU DISEASE TO PREDICT POSTOPERATIVE RENAL FUNCTIONAL DECLINE

Maria Antony*, Pouria Yazdian, Aditi Chaurasia, Nikhil Gopal, Zach Kozel, Mina Dehghani Firou-zabadi, Maryam Homayounieh, Safa Samimi, Rabindra Gautam, Sandeep Gurram, Ashkan Malayeri, Marston Linehan, Mark Ball, Bethesda, MD

MP33-08 DEEP LEARNING RENAL VOLUME ANALYSIS TO PREDICT LONG-TERM RENAL FUNCTION AFTER PARTIAL AND RADICAL NEPHRECTOMY

Abhinav Khanna*, Vidit Sharma, Adriana Gregory, Christine Lohse, Harrison C. Gottlich, Theodora Potretzke, R. Houston Thompson, Stephen A. Boorjian, Bradley Leibovich, Timothy Kline, Aaron Potretzke, Rochester, MN

MP33-09 RADIOGENOMIC CORRELATES OF CLINICALLY RELEVANT CLEAR CELL RENAL CELL CANCER BIOMARKERS

Derek Liu, Bino Varghese, Darryl Hwang, Xiaomeng Lei, Afshin Azadikhah, Komal Dani, Alex Raman, Steven Cen, Manju Aron, Harris Zahoor, Imran Siddiqi, Inderbir Gill, Vinay Duddal-war*, Los Angeles, CA

MP33-10 EVALUATION OF BLADDER SHAPE COMPLIANCE USING ABDOMINAL COMPRESSIONS DURING URODYNAMICS

Adam Vossenberg, Richmond, VA, Sarah Koda-ma, Richmond, WV, Ria Khandpur, Jared Dunlap, Abraham Alattar, William Visser, Christopher Bed-narz*, Linda Burkett, Lauren Siff, Adam Klausner, John Speich, Richmond, VA

MP33-11 DEVELOPMENT OF A URINARY TRACT ATLAS USING CONVOLUTIONAL NEURAL NETWORKS

Katherine Fischer*, Yuemeng Li, Benjamin Schur-hamer, Justin Ziemba, Yong Fan, Gregory Tasian, Philadelphia, PA

142

MP33-12 DYNAMIC COMPRESSION OF THE URETHRA- MECHANISM OF ACTION OF A MALE TRANSOBTURATOR SLING WITH 5-YEAR IMAGING FOLLOW-UP

Joshua Makary*, Thomas Jarvis, Vincent Tse, Lewis Chan, Sydney, Australia

MP33-13 IMPACT OF PROSTATIC URETHRAL LIFT DEVICE ON PROSTATE MR IMAGE QUALITY

Tarik Benidir*, Ryan Ward, Justin Ream, Ethan Austhof, Eric Klein, Cleveland, OH, Ismail Turkbey, Bethesda, MD, Andrei Purysko, Cleveland, OH

MP33-14 EXAMINATION OF SCROTAL ULTRASOUND INDICATIONS IN THE UNITED STATES

Joey Fougerousse*, Gerald McGwin, Jr., Peter Kolettis, Birmingham, AL

MP33-15 A STUDY OF PROGNOSTIC VALUE OF SERUM ALKALINE PHOSPHATASE AND ITS CORRELATION WITH BONE SCAN IN UROLOGICAL MALIGNANCIES

Rohit Ranjan*, Shivcharan Navriya, Ankur Mittal, Arup Kumar Mandal, Rishikesh, India

MP33-16 BIPARAMETRIC QUANTITATIVE MRI FOR PROSTATE CANCER DETECTION

Hari Vigneswaran*, Meltem Uyanik, Karen Xie, Virgilia Macias, Andre Balla, Richard Magin, Kejia Cai, Fred Damen, Xiaohong Zhou, Peter Gann, Michael Abern, Chicago, IL

MP33-17 TRANSPERINEAL FUSION BIOPSIES WITH SOFTWARE REGISTRATION: CANCER DETECTION BY PIRADS V2

Eusebio Luna*, Gloria Egui-Benatuil, Alberto Lopez-Prieto, Edward Gheiler, Kaufman Ariel, Miami, FL, Farshad Shafizadeh, New York, NY, Luis Avila, Barrios Dailianys, Miami, FL, Juan Martinez-Salamanca, Madrid, Spain, Fernando Bianco, Miami, FL

MP33-18 ASSOCIATION OF PATIENT AND IMAGING-RELATED FACTORS WITH FALSE NEGATIVE FUSION BIOPSIES OF PI-RADS 4 AND 5 LESIONS ON MRI

Miyad Movassaghi*, Firas Ahmed, Hanisha Patel, Lyndon Luk, New York, NY, Elias Hyams, Prov-idence, RI, Sven Wenske, Hiram Shaish, New York, NY

MP33-19 INTRADUCTAL CARCINOMA OF THE PROSTATE IN THE ERA OF MPMRI-TARGETED PROSTATE BIOPSIES: CLINICAL, PATHOLOGIC AND MRI CHARACTERISTICS

Jonathan Fainberg*, Christine Chen, Johnson Chen, Adithya Balasubramanian, Christopher Barbieri, Leo Dreyfus, Beerinder Karir, Francesca Khani, Daniel Margolis, Timothy McClure, Himan-shu Nagar, Brian Robinson, New York, NY

MP33-20 UTILITY OF ADDITIONAL TARGETED AND SYSTEMIC BIOPSIES IN THE PRESENCE OF AN INDEX PI-RADS 5 LESION

Ahmad Alzubaidi*, Hershey, PA, Michael Maidaa, Gainesville, FL, Mohammad Said, Iowa City, IA, Grant Owens, Max Yudovich, Hershey, PA, R.Scott Grant, Camphill, PA, Thomas F. Stringer, Gainesville, FL, Chad Tracy, Iowa City, IA, Jay D. Raman, Hershey, PA



Moderated Poster Session 34INFERTILITY: THERAPY

Room 225 @ Ernest N. Morial Convention CenterModerators: Jay Sandlow, Christopher Deibert & William J. Huang

ABSTRACT NUMBER TITLE MP34-01 IS TESTIS SPARING SURGERY A SAFE

APPROACH IN PATIENTS WITH SMALL TESTICULAR LESIONS REFERRING TO A FERTILITY CENTER? A RETROSPECTIVE ANALYSIS REPORTING LONG-TERM ONCOLOGICAL OUTCOMES AND FACTORS ASSOCIATED WITH MALIGNANCY

Andrea Gobbo*, Vittorio Fasulo, Cesare Saitta, Pietro Diana, Paola Arena, Giuseppe Chiarelli, Roberto Contieri, Nicola Frego, Davide Maffei, Alberto Saita, Paolo Casale, Giorgio Guazzoni, Massimo Lazzeri, Pier Paolo Avolio, Giovanni Lughezzani, Rodolfo Hurle, Nicolò Maria Buffi, Renzo Benaglia, Paolo Levi, Luciano Negri, Milano, Italy

ABSTRACT NUMBER TITLE MP34-02 OPIOID PRESCRIBING FOLLOWING MALE

INFERTILITY SURGERY IS ASSOCIATED WITH PERSISTENT OPIOID USE - ANALYSIS OF A U.S. CLAIMS DATABASE

Corey Able*, Galveston, TX, Andrew T Gabri-elson, Baltimore, MD, Christopher Meilchen, Galveston, TX, Jaden R Kohn, Taylor P Kohn, Baltimore, MD

MP34-03 VASECTOMY IN CHILDLESS MEN: IS REGRET MORE LIKELY?

David Charles*, Danyon Anderson, Peter Dietrich, Jay Sandlow, Milwaukee, WI


SA

TU

RD

AY

MP34-04 SYSTEMATIC EVALUATION OF YOUTUBE CONTENT ON TESTOSTERONE THERAPY: THE PROLIFERATION OF BRO-SCIENCE

Zhenyue Huang*, Heng Ruan, Rosen Jeong, Eileen Zhou, Tal Meir Cohen, Jason Kim, William T. Berg, Stony Brook, NY

MP34-05 IMPACT OF NASAL, INTRAMUSCULAR, AND SUBCUTANEOUS TESTOSTERONE PELLETS ON INTRATESTICULAR TESTOSTERONE: EVALUATION OF DATA FROM TWO RANDOMIZED CLINICAL TRIALS

Parris Diaz*, Rohit Reddy, Ruben Blach-man-Braun, Alexandra Dullea, Isaac J. Zucker, Daniel C. Gonzalez, Eliyahu Kresch, Ranjith Ramasamy, Miami, FL

MP34-06 PREDICTORS OF SUCCESS AFTER BILATERAL VASOEPIDIDYMOSTOMY PERFORMED DURING VASECTOMY REVERSAL: A MULTI-INSTITUTIONAL ANALYSIS

Joshua White*, Jesse Ory, Halifax, Canada, Sirpi Nackeeran, Miami, FL, Udi Blankstein, Hamilton, Canada, Justin Dubin, Chicago, MI, Aditya Sathe, Memphis, TN, Ethan Grober, Toronto, Canada, Sheldon Marks, Tuscon, AZ, Ranjith Ramasamy, Miami, FL

MP34-07 VASECTOMY REVERSAL OUTCOMES AND MANAGEMENT OF PATIENTS ON TESTOSTERONE REPLACEMENT THERAPY

Jasper C Bash*, Akash Kapadia, Malachi Mason, Jason C Hedges, Portland, OR

MP34-08 TWO-LAYER VASOVASOTOMY TECHNIQUE IS ASSOCIATED WITH IMPROVED PREGNANCY RATES AS COMPARED TO MODIFIED ONE-LAYER TECHNIQUE

Matt Kasson*, Ashley Pittman, David Charles, Jacqueline Sehring, Peter Dietrich, Jay Sandlow, Milwaukee, WI

MP34-09 VASECTOMY REVERSAL FOLLOWING PERCUTANEOUS EPIDIDYMAL SPERM ASPIRATION (PESA): OPERATIVE IMPLICATIONS AND POST-OPERATIVE OUTCOMES

Udi Blankstein*, Hamilton, Canada, Joseph Mory-ousef, Montreal, Canada, Ethan Grober, Toronto, Canada

MP34-10 MALE AGE IN IN VITRO FERTILIZATION RESULTS: DOES IT MATTER?

Mariangela Badalotti, Isadora Badalotti-Teloken, Victória Campos Dornelles, Marta Ribeiro Hentschke, Fernando Badalotti, Natalia Vascon-celos, Alvaro Petracco, Claudio Teloken*, Porto Alegre, Brazil

MP34-11 EFFECT OF ANASTROZOLE ON SPERM CONCENTRATION IN MALE PATIENTS WITH IDIOPATHIC INFERTILITY

Bryan Naelitz*, Carlos Munoz-Lopez, Neel Parekh, Scott Lundy, Sarah Vij, Cleveland, OH

MP34-12 OPEN TESTICULAR MAPPING TECHNIQUE FOR SPERM RETRIEVAL IN MEN WITH NON-OBSTRUCTIVE AZOOSPERMIA

Leonardo Lopes*, Rodrigo Silva, Santo Andre, Brazil, Joaquim Lorenzetti, Parana, Brazil, Winter Figueiredo, Thais Feitosa, Rafaella Medugno, Ivan Yoshida, Caio Barbosa, Roberto Juliano, Sidney Glina, Santo Andre, Brazil

MP34-13 THE OUTCOMES OF EX-VIVO TESTIS SPERM EXTRACTION AT THE TIME OF RADICAL ORCHIECTOMY IN TESTIS CANCER PATIENTS

Jose M Flores*, Joshua Jue, Nicole Benfante, John P Mulhall, New York, NY

MP34-14 EFFECTS OF RADIATION THERAPY ON MICROSURGICAL TESTICULAR SPERM EXTRACTION FOR MEN WITH NON-OBSTRUCTIVE AZOOSPERMIA

Aaron Brant*, Nahid Punjani, Peter Schlegel, New York, NY

MP34-15 DISCORDANT TESTICULAR PATHOLOGY IS COMMON IN MEN WITH NON-OBSTRUCTIVE AZOOSPERMIA UNDERGOING BILATERAL MTESE

Scott Lundy*, Sarah Vij, Cleveland, OH

MP34-16 ARTIFICIAL INTELLIGENCE BASED MACHINE LEARNING MODELS PREDICT SPERM PARAMETER UPGRADING AFTER MICROSURGICAL VARICOCELE REPAIR: A MULTI-INSTITUTIONAL ANALYSIS

Jesse Ory*, Halifax, Canada, Michael B Tradewell, Miami, FL, Udi Blankstein, Hamilton, Canada, Thiago Lima, Sirpi Nackeeran, Daniel C Gonzales, Elie Nwefo, Vinayak Madhusoodanan, Miami, FL, Susan Lau, Keith Jarvi, Toronto, Canada, Ranjith Ramasamy, Miami, FL

MP34-17 INSTANTANEOUS TRACKING OF POST-VARICOCELECTOMY RECOVERY DYNAMICS USING THE HOME-BASED SEMEN QUALITY MONITORING DEVICE LENSHOOKE® X1

Cheng-Han Tsai*, Taipei, Taiwan, George C. Hsu, Han-Ching Tsai, Cheng-Teng Hsu, Taichung, Taiwan, William J. Huang, Taipei, Taiwan

MP34-18 PRE-OPERATIVE IMAGING IS NOT NECESSARY WHEN OFFERING VARICOCELECTOMY FOR SCROTAL PAIN

Muhammad Alkazemi, Joel Vetter, Alethea Paradis, Marjorie Hosto, Dane Johnson*, St Louis, MO

MP34-19 EFFECT OF SURGICAL AND RADIOLOGICAL MANAGEMENT OF RECURRENT VARICOCELE ON FERTILITY POTENTIAL: A RETROSPECTIVE STUDY AND METANALYSIS

Mohammed Mahdi*, Haitham Elbardisi, Ahmad Majzoub, Mohamed Arafa, Doha, Qatar


144


Moderated Poster Session 35SEXUAL FUNCTION/DYSFUNCTION: MEDICAL, HORMONAL & NON-SURGICAL THERAPY I

Room 222 @ Ernest N. Morial Convention CenterModerator: Amy Pearlman

ABSTRACT NUMBER TITLE MP35-01 PREVALENCE OF SECONDARY

ERYTHROCYTOSIS IN MEN RECEIVING TESTOSTERONE THERAPY: A MATCHED COHORT ANALYSIS OF INJECTIONS, INTRANASAL GEL, AND PELLETS

Rohit Reddy*, Parris Diaz, Ruben Blach-man-Braun, Isaac J. Zucker, Alexandra Dullea, Eliyahu Kresch, Daniel Gonzalez, Ranjith Ramasamy, Miami, FL

MP35-02 COMPARISON OF PREVALENCE OF POLYCYTHEMIA BETWEEN NASAL TESTOSTERONE GEL VS INTRAMUSCULAR TESTOSTERONE CYPIONATE: EVALUATION OF DATA FROM AN ONGOING PHASE IV, OPEN-LABEL, RANDOMIZED CLINICAL TRIAL

Parris Diaz*, Daniel C. Gonzalez, Miami, FL, Jesse Ory, Halifax, Canada, Navin C. Balaji, Rohit Reddy, Manuel Molina, Ranjith Ramasamy, Miami, FL

MP35-03 THE BROAD REACH OF SOCIAL MEDIA AS A HEALTH RESOURCE FOR TESTOSTERONE INFORMATION

Justin Dubin*, Daniel Greenberg, Chicago, IL, Richard Fantus, Evanston, IL, Minh Pham, Mat-thew Hudnall, Nelson Bennett, Robert Brannigan, Joshua Halpern, Chicago, IL

MP35-04 TESTOSTERONE REPLACEMENT THERAPY: PATIENT REPORTED PREFERENCES

Charles Loeb*, Jake Miller, Douglas Schneider, Faysal Yafi, Orange, CA

MP35-05 COST ANALYSIS OF DIRECT-TO-CONSUMER TELEHEALTH PLATFORMS OFFERING TESTOSTERONE THERAPY

Erin Jesse, Nicholas Sellke*, Wade Muncey, Ramy Abou Ghayda, Aram Loeb, Nannan Thiru-mavalavan, Cleveland, OH

MP35-06 SIGNIFICANT DECREASE IN SEX HORMONE BINDING GLOBULIN WITH USE OF TESTOSTERONE UNDECANOATE CAPSULES (JATENZO) IN MEN WITH HYPOGONADISM

Alyssa Yee*, Maria Uloko, Irwin Goldstein, San Diego, CA

MP35-07 COMPARISON OF THREE DIFFERENT TADALAFIL REGIMES FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN DIABETES MELLITUS PATIENTS WITH MICROVASCULAR COMPLICATIONS

Goksel Bayar*, Hatay, Turkey, Caglar Yildirim, Mardin, Turkey

ABSTRACT NUMBER TITLE MP35-08 INVESTIGATION OF GROWTH FACTORS

CONCENTRATION IN PLATELET RICH PLASMA (PRP) OBTAINED FROM MEN WITH ERECTILE DYSFUNCTION

Kajal Khodamoradi*, Miami, FL, Alexandra Dullea, Spokane, WA, Roei Golan, Tallahassee, FL, Manuel Leyba Molina, Thomas Masterson, Himanshu Arora, Ranjith Ramasamy, Miami, FL

MP35-09 LINEAR RELATIONSHIP BETWEEN THE TIME OF DOSING AND 24-HOUR AVERAGE CONCENTRATION OF TOTAL TESTOSTERONE IN MEN TREATED WITH AN ORAL TESTOSTERONE UNDECANOATE CAPSULE (JATENZO®)

Ronald Swerdloff, Torrance, CA, Jason Kovac*, Indianapolis, IN, Christina Wang, Torrance, CA, Marc Gittelman, Aventura, FL, B. Woun Seo, Jay Newmark, Northbrook, IL, Nestor Rohowsky, LaGrange, IL, Robert Dudley, Northbrook, IL

MP35-10 THE IMPACT OF PAP THERAPY ON HEMATOCRIT IN OSA AND POLYCYTHEMIA: A PILOT STUDY

Mustafa Jafri*, Gabrielle Rosa-Acosta, Jose Flores Martinez, Elizabeth Schofield, Cy Wilkins, John Mulhall, Miranda Tan, New York, NY

MP35-11 LUTS, ED, AND QOL IMPROVE UNDER LONG-TERM TESTOSTERONE THERAPY IN OBESE MEN WITH FUNCTIONAL HYPOGONADISM

Ahmad Haider*, Karim Sultan Haider, Bremer-haven, Germany, Gheorghe Doros, Abdulmaged Traish, Boston, MA

MP35-12 LOWER URINARY TRACT SYMPTOMS AND QUALITY OF LIFE IMPROVE UNDER LONG-TERM TESTOSTERONE THERAPY IN HYPOGONADAL MEN WITH TYPE 2 DIABETES

Karim Sultan Haider*, Ahmad Haider, Bremer-haven, Germany, Gheorghe Doros, Abdulmaged Traish, Boston, MA

MP35-13 ANABOLIC-ANDROGENIC STEROID USE IS ASSOCIATED WITH DEPRESSION AND SUICIDALITY: ANALYSIS OF A NATIONAL FEDERATED DATABASE

Sirpi Nackeeran, Mehul Patel*, Devi Nallakumar, Miami, FL, Jesse Ory, Halifax, Canada, Taylor Kohn, Baltimore, MD, Christopher Deibert, Oma-ha, NE, Ranjith Ramasamy, Miami, FL

MP35-14 PATIENT SATISFACTION AFTER SWITCHING TO ORAL TESTOSTERONE UNDECANOATE IN MEN CURRENTLY RECEIVING TESTOSTERONE THERAPY: AN OPEN-LABEL SINGLE-CENTER PHASE IV CLINICAL TRIAL

Rohit Reddy, Mehul Patel*, Ranjith Ramasamy, Miami, FL


SA

TU

RD

AY

MP35-15 DO STATINS CAUSE TESTOSTERONE DEFICIENCY IN MEN? SYSTEMATIC REVIEW AND META ANALYSIS

Felipe Glina, Leonardo Seligra Lopes*, Rodrigo Spinola e Silva, Eduardo Augusto Correa Barros, Santo André, São Paulo, Brazil, Bruno Biselli, São Paulo, Brazil, Sidney Glina, Santo André, São Paulo, Brazil

MP35-16 IMPROVING QUALITY OF LIFE FOR PATIENTS WITH CHRONIC PELVIC AND GENITAL PAIN THROUGH AN INTERDISCIPLINARY PAIN REHABILITATION PROGRAM

Kevin Hanna, M.D.*, Matthew Ziegelmann, M.D., Hannah Betcher, M.D., Sevann Helo, M.D., Elizabeth Kacel, Ph.D., Wesley Gilliam, Ph.D., Rochester, MN

MP35-17 ONLINE USER TRENDS FOR TESTICULAR AND PELVIC PAIN

Garrick Greear*, Sarah Holt, Tristan Nicholson, Hunter Wessells, Thomas Walsh, Marah Hehe-mann, Seattle, WA

MP35-18 CHARACTERISTICS OF SYSTEMIC TESTOSTERONE THERAPY FOR FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER - A CLAIMS DATABASE ANALYSIS

Pranjal Agrawal*, Kathryn Dumas, Taylor P Kohn, Jaden R Kohn, Marisa Clifton, Baltimore, MD

MP35-19 EFFECTS OF BALLOON ANGIOPLASTY FOR PATIENTS WITH ARTERIOGENIC ERECTILE DYSFUNCTION

Cheng-Han Tsai*, Shu-Huei Shen, Hsien-Tzu Liu, William J. Huang, Taipei, Taiwan

MP35-20 ANDROGEN REPLACEMENT THERAPY FOR CANCER-RELATED SYMPTOMS IN MALE ADVANCED CANCER PATIENTS

Kouji Izumi*, Atshushi Mizokami, Kanazawa, Japan




SU

ND

AY

Sunday, May 15, 2022 Plenary: Prime Time Sunday Morning Session 7:30 am – 11:30 am


7:30 PANEL DISCUSSION: REGENERATIVE MEDICINE IN PEDIATRICS Moderator: Walid Farhat Panelists: Roger De Filippo, Carlos Estrada

7:50 EUROPEAN ASSOCIATION OF UROLOGY (EAU) LECTURE: IS ENDOCRINE TREATMENT FOR UNDESCENDED TESTIS OF ANY BENEFIT AT ALL?

Presenter: Christian Radmayr

8:05 PANEL DISCUSSION: RENAL AND URETERAL DUPLICATIONS Moderator: Douglas Coplen Panelists: Mohan Gundeti, Luis Guerra

8:25 SECOND OPINION CASES: URETEROCELES Moderator: Rosalia Misseri Panelists: Miguel Castellan, Melise Keays, Sang Don Lee

8:45 JOHN DUCKETT MEMORIAL LECTURE: LIFELONG LEARNING, WHAT’S IN IT FOR ME? Presenter: David Joseph

9:05 SOCIÉTÉ INTERNATIONALE D’UROLOGIE (SIU) LECTURE: RESEARCH IN COST CONSTRAINT ENVIRONMENTS Presenter: Andre van der Merwe

9:25 STATE-OF-THE-ART LECTURE: SHOCKWAVE THERAPY FOR ERECTILE DYSFUNCTION AND PEYRONIE’S DISEASE: LEGITIMACY, EFFICACY, AND REGULATORY COMMENTARY

Presenter: Ranjith Ramasamy

9:40 PANEL DISCUSSION: HEALTH RISKS NO PROVIDER SHOULD MISS IN MEN PRESENTING WITH SEXUAL DYSFUNCTION OR INFERTILITY

Moderator: Landon Trost Panelists: Mohit Khera, Serge Carrier, Alan Shindel

10:00 PANEL DISCUSSION: THE IMPACT OF THE INTERNET ON SEXUAL MEDICINE Moderator: Gregory Broderick Panelists: Hossein Sadeghi-Nejad, Irwin Goldstein, Christian Nelson

10:20 PANEL DISCUSSION: PEYRONIE’S DISEASE MANAGEMENT: TIPS AND TRICKS Moderator: Lawrence Hakim Panelists: Matthew Ziegelmann, Wayne Hellstrom, Laurence Levine, Run Wang, Faysal Yafi

10:40 CROSSFIRE: CLINICAL CONTROVERSIES IN UROLOGY DEBATE: TELEMEDICINE IS GOOD FOR PATIENTS AND PROVIDERS IN SEXUAL MEDICINE

Moderator: Nelson Bennett Debaters: John Mulhall, Gerald Brock

11:10 AUA GUIDELINES: PRIAPISM Presenter: Trinity Bivalacqua

Sunday, May 15, 2022 Plenary: Prime Time Sunday Afternoon Session 1:00 pm – 4:30 pm


1:00 PANEL DISCUSSION: MOLECULAR URINARY TRACT INFECTION TESTING Moderator: Una Lee Panelists: Duane Hickling, A. Ackerman, Sonali Advani

1:20 PANEL DISCUSSION: CARE FOR TRANSGENDER/NON-BINARY PATIENT: WHAT EVERY UROLOGIST NEEDS TO KNOW IN 2022

Moderator: Polina Reyblat Panelists: Kamran Sajadi, Geolani Dy

1:40 PANEL DISCUSSION: FEMALE URETHRA: SHORT BUT NOT SIMPLE Moderator: Eric Rovner Panelists: Anne Pelletier Cameron, Nitya Abraham, Melissa Kaufman

2:00 POINT-COUNTERPOINT DEBATE: SHOULD WE BE USING ANTICHOLINERGICS IN 2022? Panelists: Yahir Santiago-Lastra, Anne Suskind, Blayne Welk

2:20 PANEL DISCUSSION: UROLOGIC PAIN MANAGEMENT IN THE NON-NARCOTIC ERA Moderator: Jennifer Robles Panelists: Casey Duaw, Larissa Rodriguez, Greg Auffenberg

150

2:50 STATE-OF-THE-ART LECTURE: THE ROLE OF NEUTRACEUTICALS IN THE MANAGEMENT OF LUTS IN GERIATRIC PATIENTS

Presenter: Claus Roehrborn

3:05 STATE-OF-THE-ART LECTURE: ECONOMICS OF OFFICE-BASED BPH TREATMENTS Presenter: Richard Levin

3:20 SEMI-LIVE SURGERIES/SURGICAL TECHNIQUES: BPH Surgeon: Bilal Chughtai

4:20 CROSSFIRE: CONTROVERSIES IN UROLOGY: SUI IN THE OBESE PATIENT Moderator: Tracey Wilson Panelists: Tamsin Greenwell, Ekene Enemchukwu

Sunday, May 15, 2022 7:00 am – 11:30 am

ForumsRESIDENTS FORUM


RESIDENTS FORUM SPONSORED BY INTUITIVE

7:00 REGISTRATION AND BREAKFAST

7:15 WELCOME Chairs: Michael Ernst, Ruchika Talwar

7:20 BREAKFAST & TALK SPONSORED BY INTUITIVE

7:50 ABU UPDATE J. Brantley Thrasher

8:00 EQIPS UPDATE Justin Ziemba

8:10 FINANCIAL TALK Dave Canes

8:55 RFC ESSAY CONTEST PRIZE WINNERS (2021 AND 2022)

9:05 RFC TEACHING AWARD WINNERS (2021 AND 2022)

9:15 AUA EDUCATION COUNCIL UPDATE Jay Raman

9:25 SOCIAL MEDIA: DOS AND DONT’S Justin Dubin, Matt Nielsen, Courtney Rowe, Ashley Winter

9:55 YOUNG UROLOGISTS COMMITTEE UPDATE Sammy Elsamra

10:05 BREAK

10:15 BEYOND WELLNESS: SUSTAINABLE SOLUTIONS TO AVOID BURNOUT Moderator: Rachel Mann Panelists: Chris Jaeger, Betsy Kohne, Amanda North, Phil Pierorazio, Angie Smith

10:45 GRANT WRITING 101 Panelists: Trinity Bivalacqua,Todd Morgan, Yaw Nyame, Anne Suskind, Greg Tasian


SU

ND

AY

Sunday, May 15, 2022 7:00 am – 8:15 am

Moderated Poster Session 36RENAL TRANSPLANTATION & VASCULAR SURGERY

Room 228 @ Ernest N. Morial Convention CenterModerator: Nicholas Cowan


MP36-01 KIDNEY TRANSPLANTATION WITH COVID-19 POSITIVE DONORS: A SERIES OF 55 CASES

Yi-Chia Lin*, Mazhar Kahlil, Mohamed Eltemamy, Hannah Kerr, Venkatech Krishnamurthi, David Goldfarb, Alvin Wee, Cleveland, OH

MP36-02 SINGLE PORT ROBOTIC VERSUS OPEN KIDNEY TRANSPLANTATION: A COMPARISON OF OUTCOMES

Aaron Kaviani*, Mohamed Eltemamy, Yi-Chia Lin, Mahmoud Abou Zeinab, Alp Tuna Beksac, Ethan Ferguson, Alvin Wee, Jihad Kaouk, Cleveland, OH

MP36-03 ERECTILE FUNCTION 5-YEARS FOLLOWING SUCCESSFUL PENIS TRANSPLANTATION

Meredith Wasserman*, Gabriella Avellino, Priyan-ka Bearelly, Providence, RI, Rachel Goldstein, Houston, TX, Rachel Greenberg, Mark Sigman, Providence, RI, Branko Bojovic, Curtis Cetrulo, Jr., Boston, MA, Dicken Ko, Providence, RI

MP36-04 THE “CANNIBALIZATION” OF ALTRUISTIC KIDNEY DONATION BY VOUCHER-BASED KIDNEY TRANSPLANTATION

Nima Nassiri*, Torey Averick, Jeffrey Veale, Los Angeles, CA

MP36-05 A NOVEL METHOD OF CD31 COMBINED ABO CARBOHYDRATE ANTIGEN MICROARRAY PREDICTS ACUTE ANTIBODY MEDIATED REJECTION IN ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION

Masayuki Tasaki*, Niigata, Japan, Hiroaki Tateno, Takashi Sato, Azusa Tomioka, Hiroyuki Kaji, Hisashi Narimatsu, Tsukuba, Japan, Kazuhide Saito, Toshinari Aoki, Masami Kamimura, Takashi Ushiki, Yutaka Yoshida, Niigata, Japan, Kota Takahashi, Tokyo, Japan, Yoshihiko Tomita, Niigata, Japan

MP36-06 CHARACTERISTICS AND OUTCOMES OF DE NOVO PROSTATE CANCER IN THE SOLID ORGAN TRANSPLANT POPULATION AT THE UNIVERSITY OF MINNESOTA

Brent Cleveland*, Andrew Gardeck, Matthew Holten, Scott Jackson, Timothy Pruett, Christo-pher Warlick, Minneapolis, MN

MP36-07 MAG-3 SCAN REVEALS SIMULTANEOUS LIVER-KIDNEY TRANSPLANTATION IS ACCOMPANIED BY SIGNIFICANT RETURN OF NATIVE RENAL FUNCTION

Glenn T. Werneburg, David Goldfarb, Daniel Hettel*, Alvin Wee, Cleveland, OH

MP36-08 RCC IN KIDNEY TRANSPLANT RECIPIENTS: INCIDENCE, TRENDS, CLINICAL MANAGEMENT AND OUTCOMES

Jason Lee*, Michelle Minkovich, Rebecca Wong, Olusegun Famure, Yanhong Li, Joseph Kim, Toronto, Canada


MP36-09 VALIDATION OF A URINARY EXOSOME MRNA SIGNATURE FOR THE DIAGNOSIS OF HUMAN KIDNEY TRANSPLANT REJECTION

Rania El Fekih*, Boston, MA, Kurt Franzen, Brian Cole, James Hurley, Sonia Kumar, Johan Skog, Waltham, MA, Jamil Azzi, Boston, MA

MP36-10 COMPARATIVE ANALYSIS OF PERIOPERATIVE COMPLICATIONS IN KIDNEY TRANSPLANT PATIENTS WITH CORONARY ARTERY DISEASE ON DUAL ANTIPLATELET DRUGS

Amit Bansal, Pratik Garg, Pawan Kandhari, Ruchir Maheshwari, Samit Chaturvedi, Harshit Garg, Ayush Singh, ANANT KUMAR*, New Delhi, India

MP36-11 INDUCTION OF IMMUNE TOLERANCE AFTER HAPLOIDENTICAL LIVING DONOR KIDNEY TRANSPLANT

Nima Nassiri*, Erik Lum, Monica Mead, Gabriel Danovitch, H. Albin Gritsch, Neil Kogut, Jeffrey Veale, Los Angeles, CA

MP36-12 AN IMMUNOSUPPRESSIVE REGIMEN CONTAINING EVEROLIMUS DECREASES THE INTERSTITIAL FIBROSIS FORMATION OF KIDNEY ALLOGRAFT BY SUPPRESSING MTOR-RELATED PROTEIN EXPRESSION

Takuro Saito*, Mitsuru Saito, Yu Aoyama, Ryuichi-ro Sagehashi, Ryohei Yamamoto, Soki Kashima, Atsushi Koizumi, Taketoshi Nara, Kazuyuki Nu-makura, Shintaro Narita, Shigeru Satoh, Tomonori Habuchi, Akita, Japan

MP36-13 ANALYSIS OF PRIMARY NON-FUNCTION, DELAYED GRAFT FUNCTION AND OVERALL GRAFT SURVIVAL FOR EXPANDED CRITERIA DONORS’ KIDNEYS

Monica Peradejordi Font*, Antoni Vilaseca Cabo, Lluis Peri Cusi, Mireia Musquera Felip, Tarek Ajami Fardoun, Claudia Mercader Barrull, Angel Ruiz Arranz, David Paredes Zapata, Fritz Diek-mann, Antonio Alcaraz Asensio, Barcelona, Spain

MP36-14 THE EFFECT OF RENAL TRANSPLANTATION ON ERECTILE FUNCTIONS IN PATIENTS WITH END-STAGE RENAL DISEASE

Serdar Karadag*, Istanbul, Turkey

MP36-15 ROBOTIC SINGLE-PORT VERSUS LAPAROSCOPIC DONOR NEPHRECTOMY: AN INSTITUTIONAL ANALYSIS

Chih Peng Chin*, Evan Garden, Micah Levy, Kr-ishna Ravivarapu, Osama Al-Alao, Joseph Sewell Araya, Sander Florman, Antonios Arvelakis, Daniel Herron, Edward Chin, Michael Palese, New York, NY

152

MP36-16 VIRTUAL IMAGING 3D ANATOMICAL MODELING CAN FACILITATE LAPAROSCOPIC OR ROBOTIC DONOR NEPHRECTOMY IN PATIENTS WITH COMPLEX RENAL ANATOMY THAT WERE PRECLUDED FROM DONATION BASED ON COMPUTED TOMOGRAPHY ANGIOGRAPHY OR MAGNETIC RESONANCE IMAGING

Ravi Munver*, Jennifer Kuo, Michael Degen, Hackensack, NJ

MP36-17 ROBOTIC BILATERAL NEPHRECTOMY FOR LARGE KIDNEYS WITH ADULT POLYCYSTIC KIDNEY DISEASE WITH DA VINCI XI AND DA VINCI SP

Hanson Zhao, Lior Taich, John M. Masterson*, Aurash Naser-Tavakolian, Hayley Johnson, Reiad Najjar, Irene Kim, Amit Gupta, Los Angeles, CA

MP36-18 ADVANCED TERTIARY LYMPHOID TISSUES ARE ASSOCIATED WITH PROGRESSIVE GRAFT DYSFUNCTION IN KIDNEY TRANSPLANT RECIPIENTS

Mitsuru Saito*, Akita, Japan, Yu Ho Lee, Yuki Sato, Kyoto, Japan, Nobuhiro Fujiyama, Shigeru Satoh, Akita, Japan, Motoko Yanagita, Kyoto, Japan, Tomonori Habuchi, Akita, Japan

MP36-19 PROSTACYCLIN (TREPROSTINIL) THERAPY IMPROVES RENAL HEMODYNAMICS DURING RAT RENAL ISCHEMIA-REPERFUSION INJURY

Frances Kazal*, Providence, RI, Meiwen Ding, Kingston, RI, Dicken Ko, Reginald Gohh, Provi-dence, RI, Nisanne Ghonem, Kingston, RI

MP36-20 MULTI-PHOTON MICROSCOPY FOR THE EVALUATION OF INTERSTITIAL FIBROSIS IN EXTENDED CRITERIA DONOR KIDNEYS: A PROOF-OF-CONCEPT PILOT STUDY

Wei Zheng So*, Jirong Lu, Benjamin Yen Seow Goh, Rachel Zui Chih Teo, Anantharaman Vathsa-la, Ho Yee Tiong, Kent Ridge, Singapore


Sunday, May 15, 2022 7:00 am – 8:15 am

Moderated Poster Session 37INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: PROSTATE & GENITALIA

Room 225 @ Ernest N. Morial Convention CenterModerators: Robert Moldwin, J. Curtis Nickel & Claire Yang


MP37-01 PILOT TRIAL FOR PIVOT: PREVENTION OF RECURRENT URINARY TRACT INFECTION USING VAGINAL TESTOSTERONE

Mariela Martinez*, Arshia Sandozi, Jeffrey Lee, Liliya Vafina, Brooklyn, NY, Cassandra Pond, Robert Adelson, Manhasset, NY, Elie Kaplan-Ma-rans, Katiana Vazquez-Rivera, Brooklyn, NY, Annette Lee, Manhasset, NY, Allison Polland, Brooklyn, NY

MP37-02 HYPERTENSION AND LOW CHOLESTEROL AS RISK FACTORS FOR INFECTION AFTER PENILE PROSTHESIS SURGERY IN A DIVERSE, URBAN ACADEMIC CENTER

Justin Loloi*, Jubin Matloubieh, Bronx, NY, Catie Riley, Waterville, ME, David Melendez, Kara Watts, Pedro Maria, Bronx, NY

MP37-03 EXTRACORPOREAL SHOCKWAVE THERAPY IMPROVES CP/CPPS BY DOWN-REGULATING NLPR3 INFLAMMASOME IN A PROSTATITIS RAT MODEL

Dongho Shin*, Chang Eil Yoon, Hyeok Jae Kwon, Hyong Woo Moon, Yong Hyun Park, Hyuk Jin Cho, U-syn Ha, Sung-Hoo Hong, Sae Woong Kim, Ji Youl Lee, Woong Jin Bae, Seoul, Korea, Republic of


MP37-04 PROSTATE ABSCESS: CLINICAL FEATURES, MANAGEMENT, AND OUTCOMES OF A “MASKED” INFECTION IN COVID 19 PERIOD: A CASE SERIES

Harmanmeet Singh*, JVS Prakash, PV Thiruvarul, Vetrichandar S, Arasi KV, Natarajan V, ArunKumar Paranjothi, Chennai, India

MP37-05 A SYSTEMATIC REVIEW AND META-REGRESSION OF PLACEBO EFFECT IN CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME

Andrey Morozov*, Andrey Bazarkin, Diana Babae-vskaya, Mark Taratkin, Vasiliy Kozlov, Aleksandr Suvorov, Leonid Spivak, Jonathan Mcfarland, Moscow, Russian Federation, Giorgio Russo, Catania, Italy, Dmitry Enikeev, Moscow, Russian Federation

MP37-06 ANTIMICROBIAL RESISTANCE AND MICROBIAL PATTERNS WITHIN THE CHRONIC PROSTATITIS UROBIOME COMPARED TO ASYMPTOMATIC HEALTHY CONTROLS

J. Curtis Nickel*, Kingston, Canada, Niccole Diaz, Craig D. Tipton, Lubbock, TX, E. David Crawford, San Diego, CA, Rick Martin, Caleb D. Phillips, Lubbock, TX


SU

ND

AY

MP37-07 DOES VASECTOMY INDUCE SEMEN MICROBIOME DYSBIOSIS?

Maria Camila Suarez*, Joseph M. Israeli, Kajal Khodamoradi, Ranjith Ramasamy, Miami, FL

MP37-08 URINARY MICROBIOME AS A BIOMARKER FOR PROSTATE CANCER

Michael Liss*, John Lee, San Antonio, TX, James White, Baltimore, MD, Teresa Johnson-Pais, Zhao Lai, San Antonio, TX, Dean Troyer, Norfolk, VA, Robin Leach, Brian Wickes, San Antonio, TX

MP37-09 PROSTATE BIOPSY TISSUE CORES OBTAINED FROM THE TRANSPERINEAL APPROACH HARBOR FEWER MICROBIAL SPECIES AND LOWER MICROBIAL RESEMBLANCE TO THE RECTAL FLORA RELATIVE TO THOSE OBTAINED TRANSRECTALLY

Glenn T. Werneburg*, Aaron Miller, Ava Adler, Samuel Haywood, Eric A. Klein, Cleveland, OH

MP37-10 ETIOLOGY OF ACUTE EPIDIDYMITIS (AE) IN YOUNG PATIENTS UNDER 35 YEARS

Anan Hussein*, Michael Cohen, Michael gross, Genady Zlitschinko, Arnon Lavi, Bishara Ibrahim, Rashad Abu leil, Afula, Israel, Tarek Taha, Safed, Israel, Yanovskay Anna, Chazan Bibiana, Afula, Israel

MP37-11 WHOLE EXOME SEQUENCING IDENTIFIES A RARE MUTATION IN NACAD AS A POSSIBLE CAUSE OF COVID ORCHITIS IN BROTHERS

Rohit Reddy*, Efimenko Iakov, Kajal Khodamora-di, Willy Chertman, Himanshu Arora, Parris Diaz, Ranjith Ramasamy, Miami, FL

MP37-12 COVID-19 VACCINATION IS ASSOCIATED WITH A DECREASED RISK OF ORCHITIS AND/OR EPIDIDYMITIS IN MEN

Chase Carto*, Sirpi Nackeeran, Ranjith Ramasamy, Miami, FL

MP37-13 MEAN PLATELET VOLUME IS THE MOST VALUABLE HEMATOLOGIC PARAMETER IN DIFFERENTIATING TESTICULAR TORSION FROM EPIDIDYMITIS WITHIN THE GOLDEN TIME

Chung Ho Seok*, Yu Seong Hyeon, Hwang Eu Chang, Kim Sun-Ouck, Oh Kyung Jin, Jung Seung Il, Kang Taek Won, Kwon Dongdeuk, Park Kwangsung, Gwangju, Korea, Republic of

MP37-14 A DOSE-ESCALATING PHASE I STUDY OF AN INJECTION OF LIDOCAINE PASTE FOR PROLONGED SPERMATIC CORD BLOCK IN MEN WITH CHRONIC SCROTAL CONTENT PAIN

Luke Witherspoon*, Claudia Kesch, Veronika Schmitt, Graeme Boniface, Colin Lundeen, Vancouver, Canada, J. Curtis Nickel, Kingston, Canada, Ryan Paterson, Martin Gleave, Ryan Flannigan, Vancouver, Canada

MP37-15 A MULTICENTER RETROSPECTIVE STUDY ASSESSING RISK OF COMPLICATIONS IN HYDROCELE SURGERY

Lauri Mäki-Lohiluoma*, Tuomas P. Kilpeläinen, Petrus Järvinen, Henna K. Söderström, Kari A.O. Tikkinen, Jukka Sairanen, Helsinki, Finland

MP37-16 HYDROCELE ASPIRATION AND SCLEROSIS; IS SODIUM TETRADECYL SULPHATE SUPERIOR?

Jacob Nelson*, Matthew Kasson, Peter Dietrich, Jay Sandlow, Milwaukee, WI

MP37-17 PREVALENCE OF HPV AWARENESS AMONG YOUNG SEXUALLY ACTIVE MALE

Francesco Esperto, Francesco Prata*, Francesco Tedesco, Alberto Ragusa, Noemi Deanesi, Anto-nio Testa, Angelo Civitella, Piergiorgio Tuzzolo, Luca Romei, Vito Giuseppe Crimi, Loris Cac-ciatore, Gerardo Paolo Flammia, Antonio Alcini, Annamaria Salerno, Rome, Italy, Salvatore Mario Prata, Sora, Italy, Roberto Mario Scarpa, Rocco Papalia, Rome, Italy

MP37-18 NO RELATIONSHIP BETWEEN HPV AND PROSTATE CANCER

Cristina Minasola*, Marco Vella, Gabriele Tulone, Mirko Pinelli, Palermo, Italy, Alberto Abrate, Sondrio, Italy, Gianpaolo Di Gregorio, Sonia Maria Agiato, Rosellina Giaimo, Carlo Pavone, Giuseppina Capra, Chiara Mascarella, Alchiede Simonato, Palermo, Italy

MP37-19 RATE AND PROGNOSTIC VALUE OF NEW DIAGNOSES OF DIABETES WITH FOURNIER’S GANGRENE

Christopher Staniorski*, Michael Pintauro, Emily Hacker, Jen Mihalo, Benjamin Davies, Bruce Jacobs, Michelle Yu, Paul Rusilko, Pittsburgh, PA

MP37-20 OUTCOMES AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN LONG-TERM SURVIVORS OF FOURNIER’S GANGRENE

Laila Schneidewind*, Vanessa Roßberg, Desiree L. Dräger, Rostock, Germany, Joachim Steffens, Eschweiler, Germany, Oliver W. Hakenberg, Ros-tock, Germany, Jennifer Kranz, Aachen, Germany


154

Sunday, May 15, 2022 7:00 am – 8:15 am

Moderated Poster Session 38SEXUAL FUNCTION/DYSFUNCTION: BASIC RESEARCH & PATHOPHYSIOLOGY

Room 222 @ Ernest N. Morial Convention CenterModerators: Trinity Bivalacqua & Jeffrey Campbell


MP38-01 BIOACTIVE FIBROUS MEMBRANE CONTAINING ENDOGENOUS NERVE GROWTH FACTOR PROMOTES CELLULAR AND FUNCTIONAL RECUPERATION OF IMPAIRED CAVERNOUS NERVE: AN IN VIVO ANIMAL STUDY

Paulo Mota, Cabeceiras de Basto, Portugal, Marta Casanova, Braga, Portugal, Helena Vala, Carmen Nóbrega, Vila Real, Portugal, Alain Morais, Braga, Portugal, Catarina Silva, Guimarães, Portugal, Sara Anacleto*, Braga, Portugal, Alexandre Barros, Guimarães, Portugal, Rui Reis, Braga, Portugal, Estêvão Lima, Cabeceiras de Basto, Portugal, Albino Martins, Nuno Neves, Braga, Portugal

MP38-02 IMPAIRED NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) MEDIATING ENDOTHELIUM-INDEPENDENT RELAXATION WITH AGING ON HUMAN CORPUS CAVERNOSUM

Serap Gur*, Ankara, Turkey, Suresh C. Sikka, Sudha Talwar, New Orleans, LA, Didem Yil-maz-Oral, Adana, Turkey, Asim Abdel-Mageed, Wayne JG Hellstrom, New Orleans, LA

MP38-03 COMBINATION TREATMENT WITH A JNK INHIBITOR AND HEPATOCYTE GROWTH FACTOR FOR RESTORATION OF ERECTILE FUNCTION IN A RAT MODEL OF CAVERNOSAL NERVE INJURY: COMPARISON WITH A JNK INHIBITOR ALONE OR HEPATOCYTE GROWTH FACTOR ALONE

Junghoon Lee*, Sangjun Yoo, Min Soo Choo, Hwancheol Son, Hyeon Jeong, Soo Woong Kim, Min Chul Cho, Seoul, Korea, Republic of

MP38-04 TUMOR NECROSIS FACTOR ALPHA (TNF- α) AND RHO-KINASE 2 (ROCK2) INHIBITORS IMPROVE ERECTILE FUNCTION IN A BILATERAL CAVERNOUS NERVE INJURY RAT MODEL

James Liu*, Kara Lombardo, Alok Singh, Monali Praharaj, Serkan Karakus, Arthur Burnett, Balti-more, MD, Trinity Bivalacqua, Philadelphia, PA

MP38-05 TARGETED LIQUID CHROMATOGRAPHY MASS SPECTROMETRY QUANTIFICATION OF EXCRETED URINARY ESTROGENS AMONG POSTMENOPAUSAL WOMEN USING DIFFERENT ESTROGEN HORMONE THERAPY MODALITIES

Michael L. Neugent*, Neha Hulyalkar, Richardson, TX, Vladimir Shulaev, Denton, TX, Philippe E. Zimmern, Dallas, TX, Nicole J. De Nisco, Richardson, TX


MP38-06 SONIC HEDGEHOG SIGNALING IN CORPORA CAVERNOSAL CELLS FROM PROSTATECTOMY, DIABETIC, HYPERTENSION AND PEYRONIE’S PATIENTS WITH ERECTILE DYSFUNCTION

Sarah Martin, Timothy Searl, Samuel Ohlander, Chicago, IL, Kevin McVary, Maywood, IL, Carol Podlasek*, Chicago, IL

MP38-07 VASCULAR, NEUROLOGIC AND HORMONAL ABNORMALITIES IN MEN WITH PERSISTENT SEXUAL DYSFUNCTION AFTER DISCONTINUATION OF FINASTERIDE

Marvin Carlisle*, Maria Uloko, Alyssa Yee, Sue Goldstein, Irwin Goldstein, San Diego, CA

MP38-08 HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS AMELIORATE ERECTILE DYSFUNCTION IN TYPE I AND TYPE II DIABETES MELLITUS RATS THROUGH THE ATTENUATION OF FERROPTOSIS BY SLC7A11/GPX4/ACSL4 PATHWAY

Huan Feng*, Tao Wang, Jihong Liu, Wuhan, China, People’s Republic of

MP38-09 MAGNETIC INDUCTION WAND DESIGN FOR NOVEL PENILE PROSTHESIS

Shannon Roney, Michael Mendoza, Maya McKen-zie, Gail Baura, Chicago, IL, Brian Le, Madison, WI, Kevin McVary, Alberto Colombo*, Chicago, IL

MP38-10 TENSILE STRENGTH OF PENILE TUNICA ALBUGINEA IN A HUMAN MODEL

Alexander M. Kandabarow*, Eric Chuang, May-wood, IL, Kevin McKenna, Chicago, IL, Brian Le, Madison, WI, Kevin McVary, Alberto Colombo, Maywood, IL

MP38-11 GENERATION OF LEYDIG CELLS DERIVED FROM HUMAN IPS CELLS

Katsuya Sato*, Masato Fujisawa, Takashi Aoi, Kobe, Japan

MP38-12 EFFECT OF LI-ESWT ON TESTICULAR TISSUE AND FUNCTION IN AGING RATS

Dongho Shin*, Seung Hwan Jeon, Hyuk Jin Cho, U-syn Ha, Sung-Hoo Hong, Ji Youl Lee, Wen Jie Tian, Jun Jie Piao, Sae Woong Kim, Woong Jin Bae, Seoul, Korea, Republic of, Mahadevan Raj Rajasekaran, San Diego, CA

MP38-13 DATA MINING AND BIOINFORMATIC ANALYSIS REVEAL DYSREGULATION OF ANDROGEN BIOSYNTHESIS AND SIGNALING PATHWAYS IN TESTIS OF SARS-COV-2 INFECTED MEN

Manesh Kumar Panner Selvam*, Saradha Bas-karan, New Orleans, LA, Peter Natesan Push-paraj, Jeddah, Saudi Arabia, Suresh Sikka, New Orleans, LA


SU

ND

AY

MP38-14 GUT MICROBIOME ASSOCIATED WITH BLOOD TESTOSTERONE LEVELS IN ELDERLY MEN

Kazutoshi Fujita*, Osakasayama, Japan, Makoto Matsushita, Koji Hatano, Suita, Japan, Mitsu-hisa Nishimoto, Osakasayama, Japan, Daisuke Motooka, Suita, Japan, Eri Banno, Osakasayama, Japan, Junya Hata, Fukushima, Japan, Takafumi Minami, Masahiro Nozawa, Osakasayama, Japan, Shota Nakamura, Suita, Japan, Akira Tsujimu-ra, Urayasu, Japan, Wataru Obara, Morioka, Japan, Kazuhiro Yoshimura, Hirotsugu Uemura, Osakasayama, Japan, Norio Nonomura, Suita, Japan

MP38-15 LEPTIN INDUCED LEYDIG CELL DIFFERENTIATION AND TESTOSTERONE PRODUCTION IS INFLUENCED DIFFERENTIALLY WITH RESPECT TO BMI

Deepa Seetharam*, Kajal Khodamoradi, Alexan-dra Dullea, Issa Isabelle Catherine, Natoli Farber, Himanshu Arora, Ranjith Ramasamy, Maimi, FL

MP38-16 IS IT TIME FOR FPMRS TO PRESCRIBE VIBRATORS?

Alexandra Dubinskaya*, Beverly Hills, CA, Rainey Horrwitz, St Louis, MO, Poone Shoureshi, Beverly Hills, CA, Jennife Anger, La Jolla, CA, Victoria Scott, Karyn Eilber, Beverly Hills, CA

MP38-17 CURRENT CLINICAL RESEARCH IN ERECTILE DYSFUNCTION

Arshia Sandozi*, Benjamin Shpeen, Ariel Schul-man, Brooklyn, NY

MP38-18 ANDROGEN RECEPTOR SIGNALING IN CORPUS CAVERNOSUM IS SIMILAR IN MEN WITH SERUM TESTOSTERONE LEVELS ABOVE 200 NG/DL

Kajal Khodamoradi, Alexandra Dullea*, Miami, FL, Roei Golan, Tallahassee, FL, Jesse Ory, Halifax, Canada, Himanshu Arora, Ranjith Ramasamy, Miami, FL

MP38-19 PREVALENCE OF TESTOSTERONE DEFICIENCY AND SECONDARY POLYCYTHEMIA IN MEN WITH OBSTRUCTIVE SLEEP APNEA

Chase Carto*, Sirpi Nackeeran, Ranjith Ramasamy, Miami, FL

MP38-20 SEXUAL DYSFUNCTION ISSUES AMONG MEN WITH PSYCHIATRIC COMORBIDITIES: A MANAGEMENT CHALLENGE?

Nicolò Schifano*, Milan, Italy, Paolo Capogrosso, Varese, Italy, Giuseppe Fallara, Edoardo Pozzi, Federico Belladelli, Luigi Candela, Christian Cors-ini, Massimiliano Raffo, Antonio Costa, Daniele Cignoli, Alessia d’Arma, Luca Boeri, Eugenio Ventimiglia, Rayan Matloob, Milan, Italy, Vincenzo Mirone, Naples, Italy, Federico Dehò, Varese, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy


Sunday, May 15, 2022 7:00 am – 9:00 am

Podium Session 35PROSTATE CANCER: ADVANCED (INCLUDING DRUG THERAPY) II

Room 252 @ Ernest N. Morial Convention CenterModerators: Sam Chang, Stephen Freedland & Judd Moul

ABSTRACTTIME NUMBER TITLE7:00 PD35-01 WHICH PATIENTS WITH CN1 DISEASE AT

PET/CT ARE AFFECTED BY SYSTEMIC DISEASE? IMPLICATIONS FOR TAILORED TREATMENT APPROACHES BASED ON A LARGE MULTI-INSTITUTIONAL SERIES

Elio Mazzone*, Milano, Italy, Giorgio Gandaglia, Armando Stabile, Milan, Italy, Daniele Robesti, Antony Pellegrino, Andrea Necchi, Daniele Raggi, Laura Marandino, Simone Scuderi, Francesco Barletta, Milano, Italy, Vito Cucchiara, Emanuele Zaffuto, Milan, Italy, Nazareno Suardi, Genoa, Italy, Shahrokh F. Shariat, Vienna, Austria, Franc-esco Montorsi, Alberto Briganti, Milano, Italy

ABSTRACTTIME NUMBER TITLE7:10 PD35-02 WHEN IS NEOADJUVANT ANDROGEN

DEPRIVATION THERAPY BENEFICIAL FOR HIGHLY AGGRESSIVE PROSTATE CANCER CANDIDATES TO RADICAL PROSTATECTOMY? IMPLICATIONS FOR MULTI-MODAL TAILORED APPROACHES AND TRIALS DESIGN

Francesco Barletta*, Giorgio Gandaglia, Simone Scuderi, Giuseppe Ottone Cirulli, Elio Mazzone, Milano, Italy, Armando Stabile, Milan, Italy, Andrea Necchi, Laura Marandino, Daniele Raggi, Milano, Italy, Vito Cucchiara, Milan, Italy, Daniele Robesti, Milano, Italy, Emanuele Zaffuto, Luigi Nocera, Mi-lan, Italy, Donato Cannoletta, Milano, Italy, Mario De Angelis, Milan, Italy, Pierre I. Karakiewicz, Montreal, Canada, Francesco Montorsi, Alberto Briganti, Milano, Italy

156

7:20 PD35-03 THE SIGNIFICANCE OF DE-RITIS RATIO IN PATIENTS WITH RADIATION-RECURRENT PROSTATE CANCER UNDERGOING SALVAGE RADICAL PROSTATECTOMY

Fahad Quhal*, Ekaterina Laukhtina, Benjamin Pradere, Pawel Rajwa, Vienna, Austria, Axel Heidenreich, Cologne, Germany, Shahrokh F. Shariat, Vienna, Austria

7:30 PD35-04 QUANTITATIVE PIFLUFOLASTAT F18 (PSMA) SCAN INDICES AS A RESPONSE IMAGING-BIOMARKER TO ANDROGEN DEPRIVATION THERAPY IN VETERANS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER

Nicholas Nickols*, Gholam Berenji, Nathanael Kane, Los Angeles, CA, Karl Sjöstrand, Aseem Anand, Lund, Sweden, Clayton Smith, Jeremie Calais, Matthew Rettig, Los Angeles, CA

7:40 PD35-05 INITIAL EXPERIENCE OF [177LU]LUDOTADIPEP TREATMENT IN PATIENTS WITH [18F]PSMA PET CT POSITIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: PRELIMINARY STUDY

Dongho Shin*, Chang Eil Yoon, Hyeok Jae Kwon, Hyong Woo Moon, Yong Hyun Park, Woong Jin Bae, Hyuk Jin Cho, U-syn Ha, Sung-Hoo Hong, Sae Woong Kim, Ji Youl Lee, Seoul, Korea, Republic of

7:50 PD35-06 HEALTH-RELATED QUALITY OF LIFE IN LOW-INCOME MEN AFTER SURGICAL CASTRATION FOR METASTATIC PROSTATE CANCER

Thomas Gaither*, Mark Litwin, Los Angeles, CA

8:00 PD35-07 ANALYSIS OF DISCONTINUATION RATES AND CAUSES OF EARLY DISCONTINUATION OF NOVEL ORAL HORMONE THERAPY IN MEN WITH ADVANCED PROSTATE CANCER

David Gangwish*, Bernadette Zwaans, Royal Oak, MI, Paul Miriani, Wesley Dejoie, Andrina Ajo, Connor Ervin, Jeff Sarazin, Jason Hafron, Troy, MI

8:10 PD35-08 ORAL RELUGOLIX FOR ANDROGEN DEPRIVATION THERAPY IN ADVANCED PROSTATE CANCER: POOLED SAFETY ANALYSES FROM RANDOMIZED CONTROLLED STUDIES

James L. Bailen*, Jeffersonville, IN, Fred Saad, Montreal, Canada, Daniel J. George, Durham, NC, Bryan Mehlhaff, Springfield, OR, Michael S. Cookson, Oklahoma City, OK, Daniel R. Saltzstein, San Antonio, TX, Ronald Tutrone, Tow-son, MD, Bruce Brown, Andria G.M. Langenberg, Sophia Lu, Jina Lee, Brisbane, CA, Sarah Han-son, New York, NY, Bertrand Tombal, Brussels, Belgium, Neal D. Shore, Myrtle Beach, SC

8:20 PD35-09 HOMOLOGOUS RECOMBINATION DEFICIENCY (HRD) SCORE IN CHINESE AGGRESSIVE PROSTATIC ADENOCARCINOMA WITH OR WITHOUT INTRADUCTAL CARCINOMA OF THE PROSTATE

Sha Zhu*, Hao Zeng, Chengdu, China, People’s Republic of

8:30 PD35-10 PROGNOSTIC SIGNIFICANCE OF RISK STRATIFICATION IN CHAARTED AND LATITUDE STUDIES AMONG JAPANESE MEN WITH CASTRATION-RESISTANT PROSTATE CANCER

Masaki Shiota*, Sotaro Chikamatsu, Leandro Blas, Takashi Matsumoto, Eiji Kashiwagi, Junichi Inokuchi, Ken-ichiro Shiga, Akira Yokomizo, Ma-satoshi Eto, Fukuoka, Japan

8:40 PD35-11 THE IMPACT OF OLDER AGE ON THE ONCOLOGICAL OUTCOMES FOR HIGH-RISK METASTATIC HORMONE-SENSITIVE PROSTATE CANCER TREATED WITH UPFRONT INTENSIVE THERAPY

Shingo Hatakeyama*, Hirosaki, Japan, Shintaro Narita, Akita, Japan, Takahiro Kimura, Kenichi Hata, Takafumi Yanagisawa, Tokyo, Japan, Norihiko Tsuchiya, Senji Hoshi, Yamagata, Japan, Shigeto Ishidoya, Sendai, Japan, Sadafumi Kawa-mura, Natori, Japan, Akihiro Ito, Sendai, Japan, Shin Egawa, Tokyo, Japan, Tomonri Habuchi, Akita, Japan, Chikara Ohyama, Hirosaki, Japan

8:50 PD35-12 ASSOCIATION BETWEEN USE OF SECOND-GENERATION ANTIANDROGENS AND OVERALL SURVIVAL IN PATIENTS WITH METASTATIC PROSTATE CANCER – A POPULATION-BASED STUDY

Isaac Kim Jr.*, Providence, RI, Nikita Nikita, Joshua Banks, Scott Keith, Philadelphia, PA, Isaac Kim, New Haven, CT, Grace Lu-Yao, Philadelphia, PA



SU

ND

AY

Sunday, May 15, 2022 7:00 am – 9:00 am

Podium Session 36INFERTILITY: BASIC RESEARCH & PATHOPHYSIOLOGY

Room 255 @ Ernest N. Morial Convention CenterModerators: Peter Schlegel & Kathleen Hwang

ABSTRACTTIME NUMBER TITLE7:00 PD36-01 BIOINFORMATIC ANALYSIS OF RNA

SEQUENCING DATA OF TESTIS FROM SARS-COV-2 INFECTED MEN REVEALS MOLECULAR ALTERATION OF GERM CELL-SERTOLI CELL JUNCTION SIGNALING PATHWAY

Manesh Kumar Panner Selvam*, New Orleans, LA, Peter Natesan Pushparaj, Jeddah, Saudi Arabia, Saradha Baskaran, Suresh Sikka, New Orleans, LA

7:10 PD36-02 HISTOLOGICAL EVIDENCE OF SPERMATOGENIC FAILURE IN MEN WITH HIGH SPERM DNA FRAGMENTATION INDEX

Taras Shatylko*, Inessa Telezhnikova, Safar Gamidov, Alikhan Tambiev, Alina Popova, Vlada Kometova, Moscow, Russian Federation

7:20 PD36-03 CHRONIC MARIJUANA USE IMPACTS TESTICULAR VOLUME AND MALE REPRODUCTIVE HEALTH IN RHESUS MACAQUES

Jasper C. Bash*, Jason C. Hedges, Emily R. Boniface, Victoria HJ Roberts, Carol B. Hannah, Jamie O. Lo, Portland, OR

7:30 PD36-04 AROMATIZATION OF ENDOGENOUS TESTOSTERONE OCCURS PRIMARILY IN TESTICULAR LEYDIG CELLS

Caroline Kang*, Nahid Punjani, Jessica Marinaro, Peter Schlegel, New York, NY

7:40 PD36-05 LOSS-OF-FUNCTION IN PHF7 CAUSE MALE INFERTILITY BY IMPAIRING HISTONE-TO-PROTAMINE EXCHANGE DURING SPERMIOGENESIS

Jianxing Cheng*, Mengyang Cao, Zhongjie Zheng, Haocheng Lin, Beijing, China, People’s Republic of

7:50 PD36-06 PROSPECTIVE TWO-ARM STUDY OF FERTILITY IN MEN WITH COVID-19

Dmitry Enikeev*, Mark Taratkin, Andrey Morozov, Vladislav Petov, Dmitry Korolev, Anastasia Shpiki-na, Leonid Spivak, Svetlana Kharlamova, Shched-rina Irina, Oleg Mestnikov, Dmitry Fiev, Timur Ganzha, Marina Geladze, Aichurok Mambetova, Evgenia Kogan, Nikolay Zharkov, Gregoriy Demy-ashkin, Moscow, Russian Federation, Shahrokh Shariat, Vienna, Austria, Petr Glybochko, Moscow, Russian Federation

ABSTRACTTIME NUMBER TITLE8:00 PD36-07 DISCOVERY OF A EPIGENETIC BIOMARKER

PREDICTIVE OF MALE INFERTILITYChad Pollard, Provo, UT, Ryan Miller, Salt Lake City, UT, Tim Jenkins, Provo, UT, Kristin Bro-gaard*, Salt Lake City, UT

8:10 PD36-08 BLOOD TESTIS BARRIER-MIMETIC DROPLET INTERFACE BILAYERS (DIBS) FOR PASSIVE PERMEABILITY PREDICTION

Jaime Korner*, Victoria, Canada, Meghan Robin-son, Vancouver, Canada, Katherine Elvira, Victo-ria, Canada, Ryan Flannigan, Vancouver, Canada, Stephanie Willerth, Victoria, Canada

8:20 PD36-09 DIFFERENTIAL EXPRESSION OF SEMINAL PLASMA PROTEINS IN RESPONDERS AND NON-RESPONDERS TO VARICOCELE TREATMENT

Timur Bitsoev, Vitaliy Chagovets, Taras Shatylko*, Alisa Tokareva, Safar Gamidov, Natalia Starodubt-seva, Alina Popova, Vladimir Frankevich, Moscow, Russian Federation

8:30 PD36-10 THE MAMMALIAN REPRODUCTIVE GENETICS DATABASE, VERSION 2 (MRGDV2)

Ricardo Deras, Vivek Ramanathan, Xingquan Lu, Uma Ramamurthy, Martin Matzuk, Larry Lipshultz, Thomas Garcia*, Houston, TX

8:40 PD36-11 MUTATION AND MICRODELETIONS IN PRSS50 AFFECT MALE FERTILITY

Hunter Flores*, Abhishek Seth, Juan Bournat, Carolina Jorgez, Houston, TX

8:50 PD36-12 ABNORMALITIES IN BOTH SOMATIC AND GERM CELLS DIFFERENTIATE NOA TESTES FROM NORMAL CONTROLS USING SINGLE CELL RNA SEQUENCING

Arina Piechka*, Ghazal Ebrahimi, Meghan Robin-son, Anton Afanassiev, Geoffrey Schiebinger, Eric Belanger, Faraz Hach, Ryan Flannigan, Vancou-ver, Canada


158

Sunday, May 15, 2022 7:00 am – 9:00 am

Podium Session 37SURGICAL TECHNOLOGY & SIMULATION: INSTRUMENTATION & TECHNOLOGY II

Room 245 @ Ernest N. Morial Convention CenterModerators: Stephen Nakada, Robert Sweet & Ahmed Ghazi

ABSTRACTTIME NUMBER TITLE7:00 PD37-01 A RANDOMIZED, SINGLE-CENTER,

CLINICAL TRIAL COMPARING ROBOTIC-ASSISTED FLUOROSCOPIC-GUIDED WITH ULTRASOUND-GUIDED RENAL ACCESS FOR PERCUTANEOUS NEPHROLITHOTOMY

Kazumi Taguchi*, Shuzo Hamamoto, Takahiro Yanase, Yasuhito Sue, Tatsuya Hattori, Teruaki Sugino, Teruaki Sugino, Atsushi Okada, Takahiro Yasui, Nagoya, Japan

7:10 PD37-02 ROBOTIC-ASSISTED PERCUTANEOUS NEPHROLITHOTOMY AND URETEROSCOPY WITH THE MONARCH® PLATFORM, UROLOGY COMPARES FAVORABLY AGAINST CONVENTIONAL TECHNIQUES

Thomas Chi*, San Francisco, CA, Lauren Hathaway, Rachel Chok, Redwood City, CA, Marshall Stoller, San Francisco, CA

7:20 PD37-03 DETERMINING THE THRESHOLD OF SAFETY FOR INTRARENAL PRESSURE DURING FLEXIBLE URETEROSCOPY USING AN IN VIVO PIG MODEL

Matthew Lee*, Chicago, IL, Deepak Agarwal, Minneapolis, MN, Bret Connors, Indianapolis, IN, Mark Assmus, Chicago, IL, James Williams, Tim Large, Indianapolis, IN, Amy Krambeck, Chicago, IL

7:30 PD37-04 MOSES 2.0 OR MASTERPULSE? AN IN-VITRO COMPARISON OF TWO NOVEL LASER SYSTEMS FOR DUSTING AND FRAGMENTING IN A BENCHTOP MODEL

Harmenjit Brar*, Glenn Werneburg, Sriharan Sivalingam, Cleveland, OH

7:40 PD37-05 NOVEL SYPHON URETERIC ACCESS SHEATH HAS THE POTENTIAL TO IMPROVE RENAL PRESSURES AND IRRIGANT FLOW

John Lazarus*, Lisa Kaestner, Cape Town, South Africa

7:50 PD37-06 COMPARISON OF COMPUTATIONAL SIMULATION AND HYDROGEL KIDNEY PHANTOMS FOR IN VIVO ASSESSMENT OF INTRARENAL PRESSURE (IRP) DYNAMICS DURING URETEROSCOPY UNDER VARIOUS EXPERIMENTAL CONDITIONS

Ahmed Ghazi*, Rachel Melnyk, Andrew Cook, Nitin Sharma, Hana Kalco, Tran Phuc, David Foster, Rochester, NY

8:00 PD37-07 THULIUM FIBER VS THULIUM YAG LASER EFFECT ON UPPER URINARY TRACT SOFT TISSUE: AN EX VIVO STUDY

Luis Rico*, Silvia Proietti, Maria Pia Pavia, Milan, Italy, Leandro Blas, Buenos Aires, Argentina, Roberta Lucianò, Nazario Pio Tenace, Milan, Italy, Pablo Contreras, Buenos Aires, Argentina, Andrea Benedetto Galosi, Ancona, Italy, Franco Gaboardi, Guido Giusti, Milan, Italy

ABSTRACTTIME NUMBER TITLE8:10 PD37-08 3D MODELING OF RENAL TUMORS FOR

PLANNING AND GUIDANCE OF SELECTIVE CLAMPING AND UCS SUTURE

Riccardo Schiavina*, Lorenzo Bianchi, Laura Cercenelli, Barbara Bortolani, Pietro Piazza, Sara Boschi, Matteo Droghetti, Angelo Mottaran, Franc-esco Costa, Francesco Chessa, Amelio Ercolino, Andrea Angiolini, Simone Lodi, Alessandro Pis-savini, Luca Fontanella, Luca Spinozzi, Riccardo Melloni, Federico Bevilacqua, Danilo Cangemi, Caterina Gaudiano, Beniamino Corcioni, Rita Golfieri, Emanuala Marcelli, Eugenio Brunocilla, Bologna, Italy

8:20 PD37-09 PREDICTIVE VALIDITY OF IRISTM 3D ANATOMICAL MODELS DURING ROBOT ASSISTED PARTIAL NEPHRECTOMY

Nitin Sharma*, Thomas Osinski, Thomas Frye, William Tabayoyong, Jonathan Bloom, Hani Rashid, Ahmed Ghazi, Jean Joseph, Rochester, NY

8:30 PD37-10 COMPARATIVE ANALYSIS OF FUNCTIONAL OUTCOMES OF OPEN, LAPAROSCOPIC AND ROBOTIC PARTIAL NEPHRECTOMY STRATIFIED BY TUMOR COMPLEXITY: A MULTI-CENTER STUDY

Ava Saidian*, Arman Walia, Juan Javier-De-sloges, Ithaar Derweesh, La Jolla, CA

8:40 PD37-11 INTERIM RESULTS FROM A MULTICENTER CLINICAL TRIAL EVALUATING A DROP-IN GAMMA PROBE FOR SENTINEL LYMPH NODE DISSECTION IN PROSTATE CANCER

Jose Maria Abascal Junquera, Nuria Juanpere, Marta Corcoy, Maria Yolanda Aguilar, Barcelona, Spain, Jochen Christoph Walz, Marseille, France, Wouter Everaerts, Karolien Goffin, Leuven, Belgium, Maarten Ruben Grootendorst, Amster-dam, Netherlands, Francesca Oldfield, Chesham, United Kingdom, Antoni Mestre Fusco, Girona, Spain, Sergi Vidal-Sicart, Lluis Fumado*, Barce-lona, Spain

8:50 PD37-12 MUTLICENTER DEVELOPMENT AND VALIDATION OF A CONSENSUS BASED NON-BIOHAZARDOUS SIMULATION MODEL FOR HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP)

Rachel Melnyk, Christopher Wanderling, Rajat Jain, Scott Quarrier, Rochester, NY, Amy Kram-beck, Chicago, IL, Nicole Miller, Nashville, TN, Gopal Narang, Mitchell Humphreys, Phoenix, AZ, Ahmed Ghazi*, Rochester, NY


SU

ND

AY

Sunday, May 15, 2022 7:00 am – 9:00 am

Podium Session 38URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: NON-NEUROGENIC

VOIDING DYSFUNCTION IIRoom 244 @ Ernest N. Morial Convention Center

Moderators: Gary Lemack, Eric Rovner & Priya Padmanabhan

ABSTRACTTIME NUMBER TITLE7:00 PD38-01 FEASIBILITY, SAFETY AND EFFICACY

RESULTS OF THE SUFU FOUNDATION OPEN LABEL CLINICAL TRIAL OF ULTRASOUND CONFIRMED TRANSVAGINAL BOTULINUM TOXIN A (BTA) FOR REFRACTORY OVERACTIVE BLADDER (OAB)

Sean W. Berquist*, Stanford, CA, Chen Shenhar, Tikva, Israel, Stefanie van Uem, Ashu Moham-mad, Abdelrahman S. Abdalla, Craig V. Comiter, Stanford, CA, Raveen Syan, Miami, FL, Eboo Versi, New Brunswick, NJ, Amy D. Dobberfuhl, Stanford, CA

7:10 PD38-02 10-YEAR FOLLOW-UP OBSERVATION OF IDIOPATHIC DETRUSOR UNDERACTIVITY IN THE ELDERLY LIVING IN COMMUNITY: TREATMENT AND URODYNAMIC CHANGES

Seong Jin Jeong*, Seongnam, Korea, Republic of, Ji Seok Kim, Seoul, Korea, Republic of, Sang Hun Song, Hakju Kim, Jin Hyuck Kim, Changhee Ye, Seongnam, Korea, Republic of, Sang Wook Lee, Jeong Hyun Kim, Chuncheon, Korea, Republic of, Hwanik Kim, Seongnam, Korea, Republic of

7:20 PD38-03 ROLE OF POST-VOIDED RESIDUAL RATIO IN PATIENTS WITH DETRUSOR UNDERACTIVITY: A PRESSURE-FLOW STUDY ANALYSIS

Cosimo De Nunzio, Riccardo Lombardo, Rome, Italy, Antonio Nacchia*, Rionero in Vulture, Italy, Antonio Maria Cicione, Rome, Italy, Simon Carter, London, United Kingdom, Carlo Vicentini, L’Aquila, Italy, Beatrice Turchi, Carmen Gravina, Jordi Stira, Alessandro Guercio, Giacomo Gallo, Valeria Baldassarri, Olivia Alessandra Voglino, Antonio Franco, Lorenzo Maria Rivesti, Sara Riolo, Simone D’Annunzio, Elisa Mancini, Giorgio Guarnotta, Andrea Tubaro, Rome, Italy

7:30 PD38-04 A COMMUNITY-BASED EDUCATION PROGRAM FOR OVERACTIVE BLADDER IN A PREDOMINANTLY MINORITY OLDER FEMALE POPULATION: A PILOT STUDY

Susana Martinez Diaz*, Hudson Pierce, John Lee, Tirsit Asfaw, Andrew Abram, New York, NY, Naeem Bhojani, Montreal, Canada, Dean Elterman, Toronto, Canada, Kevin Zorn, Montreal, Canada, Bilal Chughtai, New York, NY

7:40 PD38-05 EXCESSIVE VISCERAL FAT IN MEN IS ASSOCIATED WITH THE PRESENCE AND SEVERITY OF OVERACTIVE BLADDER

Tomohiro Matsuo*, Yasuyoshi Miyata, Hidenori Ito, Hiroki Kurata, Masahito Masato, Kensuke Mitsunari, Kojiro Ohba, Hideki Sakai, Nagasaki, Japan

ABSTRACTTIME NUMBER TITLE7:50 PD38-06 TURPUDU TRIAL- A PROSPECTIVE

STUDY EVALUATING THE EFFECT OF TRANSURETHRAL RESECTION OF PROSTATE ON URODYNAMIC PARAMETERS IN PATIENTS OF BENIGN ENLARGEMENT OF PROSTATE WITH UPPER URINARY TRACTS DILATATION

Shantanu Tyagi*, Kalpesh Parmar, Shrawan Sin-gh, Chandigarh, India

8:00 PD38-07 HIGH FLOW BLADDER OUTLET OBSTRUCTION IN MEN

Aaron Huang*, Brooklyn, NY, Kevin Rychik, Tel-Aviv, Israel, Max Edeson, Nutley, NJ, Wade Bush-man, Madison, WI, Jerry Blaivas, New York, NY

8:10 PD38-08 EFFICACY OF LOW-INTENSITY SHOCK WAVE THERAPY ON PERSISTENT STORAGE SYMPTOMS AFTER TRANSURETHRAL SURGERY FOR BENIGN PROSTATIC OBSTRUCTION: PRELIMINARY RESULTS OF A RANDOMIZED CONTROLLED TRIAL

Mohammed Hegazy*, Khaled Zaky Sheir, Mohamed Ahmed Gaballah, Ahmed Mohamed Elshal, Mansoura, Egypt

8:20 PD38-09 AUA-SYMPTOM SCALE IS NOT RELIABLE FOR USE IN MEASURING STORAGE PHASE DYSFUNCTION

Taylor Y. Sadun*, Nicholas J. Jackson, A. Lenore Ackerman, Los Angeles, CA

8:30 PD38-10 UPRIGHT OPEN MRI WITH STANDING YOGA POSES INDICATES THAT POSTURAL EFFECTS ON THE BLADDER NECK AND URETHRA OCCUR RELEVANT TO FEMALE URINARY INCONTINENCE

Lynn Stothers*, Andrew MacNab, Vancouver, Canada

8:40 PD38-11 LONG-TERM EFFICACY AND SAFETY OF VIBEGRON FOR OVERACTIVE BLADDER IN PATIENTS ≥65 YEARS OLD: ANALYSIS FROM THE EMPOWUR EXTENSION TRIAL

Jeffrey Frankel*, Burien, WA, Susann Varano, Milford, CT, Heather Greene, Elizabeth Thomas, Irvine, CA, David Staskin, Boston, MA

8:50 PD38-12 LONG-TERM PATIENT-REPORTED OUTCOMES OF VIBEGRON FOR OVERACTIVE BLADDER: ANALYSES FROM THE EMPOWUR EXTENSION TRIAL

David Staskin*, Boston, MA, Susann Varano, Milford, CT, Heather Greene, Elizabeth Thomas, Irvine, CA, Jeffrey Frankel, Burien, WA


160

Sunday, May 15, 2022 7:00 am – 9:00 am

Podium Session 39BENIGN PROSTATIC HYPERPLASIA: EPIDEMIOLOGY, EVALUATION & MEDICAL NON-SURGICAL THERAPY

Room 243 @ Ernest N. Morial Convention CenterModerators: Bilal Chughtai & Zeph Okeke

ABSTRACTTIME NUMBER TITLE7:00 PD39-01 PSA DENSITY IS CORRELATED WITH BPH

CELLULAR COMPOSITIONLiwei Jia, Douglas Strand, Claus Roehrborn, Ryan Mauck*, Dallas, TX

7:10 PD39-02 DOES RACE INFLUENCE THE SURGICAL TREATMENT FOR BENIGN PROSTATIC HYPERPLASIA? - AN ANALYSIS OF 30,000 MEDICARE LIVES

Gopal L. Narang*, Scottsdale, AZ, Sirikan Rojanasarot, Michael Murphy, Ben Cutone, Marlborough, MA, Mitchell R. Humphreys, Scottsdale, AZ

7:20 PD39-03 POST-VOIDED RESIDUAL URINE RATIO IS A PREDICTOR OF BLADDER OUTLET OBSTRUCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS: DEVELOPMENT OF A CLINICAL NOMOGRAM

Cosimo De Nunzio*, Riccardo Lombardo, Rome, Italy, Antonio Nacchia, Rionero in Vulture, Italy, Antonio Cicione, Beatrice Turchi, Giacomo Gallo, Carmen Gravina, Alessandro Guercio, Jordi Stira, Lorenzo Maria Rivesti, Antonio Franco, Giorgio Guarnotta, Elisa Mancini, Olivia Alessandra Vogli-no, Valeria Baldassarri, Simone D’Annunzio, Sara Riolo, Rome, Italy, Simon Carter, London, United Kingdom, Carlo Vicentini, L’Aquila, Italy, Andrea Tubaro, Rome, Italy

7:30 PD39-04 COMPREHENSIVE ANALYSIS OF CLINICAL RISK FACTORS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA IN THE UK BIOBANK

Steven A Sidelsky*, Chicago, IL, Alexander P. Glaser, Richard J. Fantus, Jun Wei, Shi Zhuqing, Brian T. Helfand, Jianfeng Xu, Evanston, IL

7:40 PD39-05 PROSTATE MEASUREMENT ON COMPUTED TOMOGRAPHY: VARIANCE DECREASES AS PROSTATE VOLUME INCREASES

Anastasija Useva, Bethany Regan, Michael Iorga*, Alexandr Pinkhasov, Timothy Byler, Scott Wiener, Syracuse, NY

7:50 PD39-06 FACTORS ASSOCIATED WITH NON-ELECTIVE TURPS: PATIENTS, PAYORS, AND HOSPITALS

Zafardjan Dalimov*, Philadelphia, PA, Nicole Alavi-Dunn, Ellen Lutnick, Ali Houjaij, Oussama M. Darwish, K. Kent Chevli, Buffalo, NY

ABSTRACTTIME NUMBER TITLE8:00 PD39-07 MEDICARE NATIONAL AND REGIONAL

TRENDS IN BPH SURGERY, 2013–2019Alan Paniagua Cruz*, Tammer Yamany, New York, NY

8:10 PD39-08 IMPLEMENTATION OF A SIMPLE CLINICAL PATHWAY INCREASES RELEVANCE OF INPATIENT CONSULTS FOR URINARY RETENTION

Luke Griffiths*, Darian Andreas, Shannon Smith, Aaron Smith, Hollie Brown, Jessica Kreshover, Justin Han, New Hyde Park, NY

8:20 PD39-09 PREDICTORS OF EXTENDED LENGTH OF STAY FOLLOWING HOMIUM LASER PROSTATE SURGERY FOR BENIGN PROSTATIC HYPERPLASIA

Victor Chalfant*, Carlos Riveros, Ahmed Elshafei, K.C. Balaji, Jacksonville, FL

8:30 PD39-10 SOCIODEMOGRAPHIC DISPARITIES IN ACCESS TO HIGH-VOLUME PROVIDERS AND FACILITIES FOR SIMPLE PROSTATECTOMY: A NEW YORK STATEWIDE ANALYSIS

Krishna Ravivarapu*, Olamide Omidele, Evan Garden, Chih Peng Chin, Micah Levy, Alexander Small, Joseph Sewell Araya, Michael Palese, New York, NY

8:40 PD39-11 EVALUATING FACTORS THAT INFLUENCE HEALTHCARE RESOURCE UTILIZATION IN TRANSURETHRAL RESECTION OF PROSTATE

Rebecca Edwins*, Amber Bettis, Andrew Harris, MD, Lexington, KY

8:50 PD39-12 A PROSPECTIVE TRIAL OF MULTIPARAMETRIC MAGNETIC RESONANCE OF THE PROSTATE USE TO AVOID BIOPSIES IN PATIENTS WITH ELEVATED PROSTATE SPECIFIC ANTIGEN AND SURGICAL INDICATION FOR BENIGN PROSTATIC HYPERPLASIA

Marcelo Wroclawski, Lucas Takemura*, Felipe Gushiken, Breno Amaral, Paulo Kayano, Ronaldo Baroni, Bianca Bianco, Arie Carneiro, Gustavo Lemos, Sao Paulo, Brazil



SU

ND

AY

Sunday, May 15, 2022 7:00 am – 9:00 am

Video Session 7PROSTATE, PENILE, TESTIS & MISC. ONCOLOGY I

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerators: David Chen, Francesco Montorsi & Clinton Bahler

ABSTRACTTIME NUMBER TITLE7:00 V07-01 SINGLE-PORT TRANSVESICAL ROBOTIC

RADICAL PROSTATECTOMY: DESCRIPTION OF TECHNIQUE

Alp T. Beksac*, Mahmoud Abou Zeinab, Aaron Kaviani, Ethan Ferguson, Jihad Kaouk, Cleveland, OH

7:10 V07-02 SINGLE PORT ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY: INITIAL EXPERIENCE AND TECHNIQUE AT NORTHWELL HEALTH

Alexa Meyer*, Leon Telis, Bertie Zhang, Jared Winoker, Michael Feuerstein, New York, NY, Jay Bishoff, Michael Schwartz, Manish Vira, Louis Kavoussi, New Hyde Park, NY, Lee Richstone, New York, NY

7:20 V07-03 SOLVING CLINICAL CHALLENGES IN PROSTATECTOMY USING SINGLE-PORT ROBOT SYSTEM: A CASE SERIES

Alison Levy*, Mohit Butaney, Wooju Jeong, Craig Rogers, Detroit, MI

7:30 V07-04 SINGLE PORT TRANSVESICAL PARTIAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER

Ethan Ferguson*, Mahmoud Abou Zeinab, Alp Tuna Beksac, Aaron Kaviani, Christopher Weight, Eric Klein, Jihad Kaouk, Cleveland, OH

7:40 V07-05 HOW WE SURVIVED OUR FIRST 50 RETZIUS SPARING PROSTATECTOMIES: TIPS AND PITFALLS OF ROUNDING THE LEARNING CURVE

Ben Schurhamer*, Daniel Lee, Phil Mucksavage, Philadelphia, PA

7:50 V07-06 RETZIUS-SPARING ROBOT-ASSISTED RADICAL PROSTATECTOMY IN HIGH-RISK PROSTATE CANCER PATIENTS

Paolo Dell’Oglio*, Milan, Italy, Stefano Tappero, Genova, Italy, Mattia Longoni, Carlo Buratto, Piet-ro Scilipoti, Silvia Secco, Alberto Olivero, Michele Barbieri, Erika Palagonia, Giancarlo Napoli, Elena Strada, Giovanni Petralia, Dario Di Trapani, Angelo Vanzulli, Aldo Massimo Bocciardi, Antonio Galfano, Milan, Italy

ABSTRACTTIME NUMBER TITLE8:00 V07-07 ANATOMICAL ROBOTIC-ASSISTED RADICAL

PROSTATECTOMY: STEP-BY-STEP NERVE-SPARING TECHNIQUE FOR DIFFERENT GRADES OF PRESERVATION

Marcio Covas Moschovas*, Travis Rogers, Jonathan Noel, Jaber Abdel, Seetharam Bhat, Vipul Patel, Celebration, FL

8:10 V07-08 FEASIBILITY AND CLINICAL OUTCOMES OF ROBOT-ASSISTED RADICAL PROSTATECTOMY BY LATERAL APPROACH

Javier Reinoso Elbers*, Moises Rodríguez Socarras, Luis Llanes González, Juan Gómez Rivas, Diego Carrion Monsalve, Julio Fernán-dez del Álamo, Madrid, Spain, Richard Gaston, Bourdeaux, France, Fernando Gómez Sancha, Madrid, Spain

8:20 V07-09 ROBOTIC-ASSISTED LAPAROSCOPIC PROSTATECTOMY AND URETHRAL PULL THROUGH OF MEMBRANOUS URETHRA TO BLADDER

Safiya-Hana Belbina*, Scott Spivey-Provencio, Pegah Taheri, E. Charles Osterberg, Aaron A. Laviana, Austin, TX

8:30 V07-10 FULL URETHRAL PRESERVATION DURING LAPAROSCOPIC RADICAL PROSTATECTOMY (FUP-LRP)

Catarina Tinoco*, Andreia Cardoso, Ricardo Ma-tos Rodrigues, Sara Anacleto, Ana Sofia Araújo, Mário Cerqueira Alves, Emanuel Carvalho-Dias, Braga, Portugal

8:40 V07-11 VARYING APPROACHES TO THE PROSTATE APEX TO OPTIMIZE URETHRAL STABILITY AND EARLY CONTINENCE RECOVERY AFTER ROBOTIC RADICAL PROSTATECTOMY

Claudia Mercader*, J. Francisco Lopez, Nitesh Ranasinha, Mutie Raslan, Ruth McPherson, Richard Bell, Tom Leslie, Richard Bryant, Freddie Hamdy, Alastair Lamb, Oxford, United Kingdom

8:50 V07-12 ROBOTIC PROSTATECTOMY WITH WIDE EXCISION FOR LOCALLY ADVANCED PROSTATE CANCER

Jeffrey Vehawn*, Mouneeb Choudry, Austen Slade, Jacob Ambrose, Alejandro Sanchez, Christopher Dechet, Salt Lake City, UT


162

Sunday, May 15, 2022 7:30 am – 10:00 am

SOCIETY OF WOMEN IN UROLOGY (SWIU)Jefferson Ballroom @ Hilton New Orleans Riverside

7:30 BREAKFAST OPENS

7:45 SWIU 2022 ANNUAL BUSINESS MEETING (SWIU MEMBERS ONLY)

PRESIDENT’S WELCOME Anne P. Cameron

8:15 AUA UPDATE AUA President-Elect: Edward Messing

8:30 R. FRANK JONES UROLOGICAL SOCIETY UPDATE

Linda McIntire

8:45 SWIU AWARD PRESENTATIONS

9:30 NETWORKING WITH COLLEAGUES

Sunday, May 15, 2022 7:30 am – 11:30 am

ForumsCHALLENGES FOR UROLOGIC RESEARCH SYMPOSIUM

Rivergate Room @ Ernest N. Morial Convention Center

CHALLENGES FOR UROLOGIC RESEARCH SYMPOSIUM: TRACKING OUTCOMES FOR GENDER-AFFIRMING SURGERY IN TRANSGENDER & GENDER NON- BINARY PATIENTS

Chairs: Geolani Dy, Dmitriy Nikolavsky, Lee Zhao

7:30 WELCOME AND OPENING REMARKS Chair: Lee Zhao

7:40 SESSION ONE: CURRENT OUTCOMES IN GENDER-AFFIRMING SURGERY

Moderator: Polina Reyblat

SEXUAL DIVERSITY AND SEXUAL HEALTH NEEDS IN TRANS/NON-BINARY INDIVIDUALS

Maurice Garcia

ERECTILE DEVICES IN TRANSMASCULINE INDIVIDUALS AFTER PHALLOPLASTY

Mang Chen

URETHRAL COMPLICATIONS AFTER MASCULIN-IZING GENITAL SURGERY

Dmitriy Nikolavsky

CREATION OF THE TRANSGENDER AND NON- BINARY SURGERY (TRANS) REGISTRY

Geolani Dy

Q&A AND DISCUSSION WITH SESSION SPEAKERS

8:35 SESSION TWO: LIFELONG UROLOGIC NEEDS OF TRANSGENDER PATIENTS

Moderator: Miriam Hadj-Moussa

FERTILITY PRESERVATION IN THE TRANSGENDER POPULATION

James Hotaling

PROSTATE CANCER IN TRANSGENDER WOMEN/NON-BINARY INDIVIDUALS

Amanda Chi

GURS FELLOWSHIP: TRAINING THE NEXT GENERATION OF UROLOGISTS IN GENDER- AFFIRMING SURGERY

Daniel Dugi


9:30 SESSION THREE: HEALTH SERVICES AND PATIENT-CENTERED RESEARCH IN GENDER- AFFIRMING SURGERY

Moderator: Gaines Blasdel

DECISION MAKING IN MASCULINIZING GENDER- AFFIRMING GENITAL SURGERY

Rachel Moses

STUDYING THE TRANS POPULATION AND GEN-DER-AFFIRMING HEALTHCARE UTILIZATION IN ADMINISTRATIVE DATASETS

Jae Downing

BUILDING A NEW CULTURE OF GENDER-AF-FIRMING SURGERY RESEARCH: COMMUNITY ENGAGEMENT AND PATIENT-CENTERED OUTCOMES RESEARCH

Gaines Blasdel, Geolani Dy

PATIENT-REPORTED OUTCOMES IN GENDER- AFFIRMING SURGERY

Nnenaya Mmonu


10:30 SESSION FOUR: SURGICAL AND TECHNICAL INNOVATIONS

Moderator: Joseph Pariser

ERECTILE DEVICE DEVELOPMENT FOR PHALLOPLASTY

Curtis Crane, Bryan Kansas

PENILE TRANSPLANTATION IN TRANSGENDER INDIVIDUALS

Arthur Burnett

ROBOTICS IN GENDER-AFFIRMING SURGERY Lee Zhao


11:20 CLOSING REMARKS Chair: Lee Zhao



SU

ND

AY

Sunday, May 15, 2022 7:50 am – 12:15 pm

ENGINEERING AND UROLOGY SECTION OF THE ENDOUROLOGY SOCIETY (EUS)Grand Ballroom A @ Hilton New Orleans Riverside

7:50 WELCOME Chair: Lee Richstone

8:00 AUTONOMOUS ROBOTIC SURGERY (ARS): FUTURE OR FANTASY?

DOMO ARIGATO MR ROBOTO: WHY STRIVE TOWARDS AUTOMOUS ROBOTIC SURGERY?

Louis Kavoussi

DEAR DR. FANTASY: AUTONOMOUS ROBOTIC SURGERY IS A FOOL’S ERRAND!

Jaime Landman

CLASSIFICATION SYSTEMS, LEVELS OF AUTON-OMY AND MEANINGFUL HUMAN CONTROL

Duke Herrell, III

PARANOID ANDROID: ETHICAL, REGULATORY AND LEGAL CONSIDERATIONS OF AUTONO-MOUS ROBOTICS AND ARTIFICIAL INTELLI-GENCE

Sammy Elsamra

Q&A FOR PANEL

9:15 AUTONOMOUS ROBOTIC SURGERY (ARS): BUILDING BRICKS IN THE WALL

ACHIEVEMENTS IN ARS: FROM INDUSTRY TO SURGERY, FROM RIGID TO SOFT TISSUE

Pete C.W. Kim

AUTONOMOUS SURGICAL ROBOTS: WILL FU-TURE SURGEONS NEED CAFFEINE OR 120V?

Axel Krieger

MINIATURIZATION: MICROBOTS, NANOBOTS, AND MEMS

Sijo Parekattil

Q&A FOR PANEL

10:15 AUTONOMOUS ROBOTIC SURGERY (ARS): MYSTERIOUS ACHIEVEMENTS

PLANNING AND SKILL MODELING

INTELLIGENT CONTROL: FROM NEURAL NETWORKS TO FUZZY LOGIC

Andrew Hung

REAL TIME TRACKING AND NAVIGATION Bradford Wood

IMAGING AND REGISTRATION (RIGID AND SOFT TISSUE)

Tom Calef

DEFINING PROPERTIES OF NORMAL AND ABNORMAL TISSUE

Lauren Poniatowski

END EFFECTORS NOW AND IN THE FUTURE Danyal Fer

Q&A FOR PANEL

12:00 AWARDS PRESENTATION Presenter: Dan Stoianovici

1:00 EUS POSTER SESSION Location: Grand Salon Ballroom

POSTER SESSION 1 Moderators: Zhamshid Okhunov, Arun Rai

POSTER SESSION 2 Moderator: Alexa Meyer

Sunday, May 15, 2022 8:00 am – 11:50 am

AMERICAN SOCIETY FOR MEN’S HEALTH (ASMH)Grand Ballroom B @ Hilton New Orleans Riverside

8:00 INTRODUCTION Society President: Joel Heidelbaugh

8:05 THE MEN’S HEALTH CHECKLIST: IS THERE RE-ALLY A NEED TO UPDATE IT AT THIS TIME?

Martin Miner

8:15 RACIAL DISPARITIES IN MEN’S HEALTH Kelvin Moses

8:40 IS THERE A TRUE PREVENTION STRATEGY IN MEN’S HEALTH AND HOW DO WE GET YOUNGER MALE PATIENTS TO SEE US EARLIER?

Jesse Mills

8:55 CANCER SCREENINGS DECADE BY DECADE: WHAT UROLOGISTS AND MEN’S HEALTH EX-PERTS NEED TO KNOW

Bruce Kava

9:20 RECOGNIZING HYPERTENSION AND DYSLIPI-DEMIA: WHAT UROLOGISTS NEED TO KNOW

Stephen Kopecky

9:40 ADULT IMMUNIZATIONS: WHAT MEN’S HEALTH EXPERTS SHOULD KNOW IN 2022

10:00 MENTAL HEALTH UPDATE: WHY ARE SUICIDE AND DEPRESSION INCREASING DISPROPOR-TIONATELY IN MEN - WHAT CAN WE DO TO IDENTIFY AND ALTER THIS?

Penny Jensen

10:15 COVID-19 UPDATE David Mushatt

10:30 BREAK

10:45 SEXUALITY UPDATE 2021: CURRENT TRENDS IN THE MANAGEMENT OF ERECTILE DYSFUNCTION, PREMATURE EJACULATION, AND PEYRONIE’S DISEASE

Faysal Yafi

11:05 DEVELOPING A PERSONALIZED BPH STRATEGY Steven Kaplan

11:15 PSA SCREENING

164

PRO: DON’T ASK DON’T TELL A REASONABLE APPROACH

CON: DON’T ASK DON’T TELL IS A COPOUT Matthew Cooperberg

11:35 ANNUAL BUSINESS MEETING


Sunday, May 15, 2022 8:30 am – 3:45 pm

ForumsUROLOGIC CARE FOR THE ADVANCED PRACTICE PROVIDER


9:00 WELCOME/INTRODUCTION Co-Course Directors: Anne Lizardi-Calvaresi, James Kovarik

9:10 PRE-TEST #3 Co-Course Directors: Anne Lizardi-Calvaresi, James Kovarik

9:15 THE PRE-TRANSPLANT UROLOGIC EVALUATION Faculty: Gwendolyn Zilinskas

9:55 RATIONALE AND STRATEGIES FOR REDUCING POST-OPERATIVE OPIOD PRESCRIBING (WHITE PAPER)

Faculty: Jennifer Robles

10:50 RADIOLOGY 101 Faculty: Daniel Costa

11:30 POST-TEST #3 Co-Course Directors: Anne Lizardi-Calvaresi, James Kovarik

11:40 APP OF THE YEAR AWARD Speaker: Tricia Zubert

11:50 NON-CME LUNCHTIME SYMPOSIUM

1:05 PRE-TEST #4 Co-Course Directors: Anne Lizardi-Calvaresi, James

Kovarik

1:10 BILLING & CODING FOR APPS; IMPLICATIONS FOR TELEMEDICINE

Faculty: Mark Painter

1:50 UAPA LECTURE: PEARLS FOR A SUCCESSFUL PHYSICIAN/PA TEAM

Faculty: Adam Mogil

2:10 SUNA LECTURE: ONBOARDING AND ROLE CON-SIDERATIONS FOR THE UROLOGY APP

Faculty: Susanne Quallich

2:35 PANEL DISCUSSION: BREAKING DOWN BAR-RIERS IN ADULT AND PEDIATRIC UROLOGY IN PRIVATE AND ACADEMIC UROLOGY PRACTICES

Faculty: Benjamin Dillon, Diane Newman, Gwendolyn Zilinskas, Kaity Colon-Sanchez, Pamela Ellsworth

4:05 POST-TEST #4 Co-Course Directors: Anne Lizardi-Calvaresi, James

Kovarik

4:15 CLOSING REMARKS/COURSE ADJOURNS Co-Course Directors: Anne Lizardi-Calvaresi, James

Kovarik

Sunday, May 15, 2022 8:45 am – 10:00 am

Moderated Poster Session 39HEALTH SERVICES RESEARCH: VALUE OF CARE: COST AND OUTCOMES MEASURES

Room 228 @ Ernest N. Morial Convention CenterModerators: Yair Lotan, Mark Edney & Danil Makarov


MP39-01 TELEMEDICINE SATISFACTION AND OUTCOMES FOR ADULT UROLOGICAL POSTOPERATIVE CARE: RESULTS FROM THE RANDOMIZED EVALUATION AND METRICS OBSERVING TELEMEDICINE EFFICACY (REMOTE) TRIAL

Mustufa Babar*, Denzel Zhu, Justin Loloi, Melissa Laudano, Erin Ohmann, Nitya Abraham, Alexan-der Small, Kara Watts, Bronx, NY

MP39-02 LONG TERM COST COMPARISONS OF RADICAL CYSTECTOMY VERSUS TRIMODAL THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER

Vishnukamal Golla*, Durham, NC, Yong Shan, Elias Farran, Courtney Stewart, Kevin Vu, Alexan-der Yu, Galveston, TX, Ali Raza Khaki, Stanford, CA, Kirk Keegan, Nashville, TN, Ashish Kamat, Houston, TX, Douglas S. Tyler, Galveston, TX, Stephen J. Freedland, Los Angeles, CA, Stephen B. Williams, Galveston, TX


MP39-03 A COST AND TIME ANALYSIS OF PARTICIPANT RECRUITMENT AND URINE SAMPLE COLLECTION THROUGH SOCIAL MEDIA OPTIMIZATION

Prasun Sharma*, Sarah Bartolone, Elijah Ward, Alexander Varabulea, kenneth Peters, Joseph Janicki, Royal Oak, MI, Nitya Abraham, Melissa Laudano, New York, NY, Christopher Smith, Hou-ston, TX, Bernadette Zwaans, Michael Chancellor, Royal Oak, MI, Laura Lamb, Ann Arbor, MI

MP39-04 COMPARISON OF ONE-YEAR HEALTHCARE EXPENDITURE AND UTILIZATIONS BETWEEN MINIMALLY INVASIVE AND OPEN SURGICAL APPROACHES AMONG PATIENTS UNDERGOING NEPHRECTOMY

Kennedy Okhawere*, New York, NY, Gediwon Milky, I-Fan Shih, Yanli Li, Sunnyvale, CA, Ketan Badani, New York, NY


SU

ND

AY

MP39-05 UROLOGY ADVANCED PRACTICE PROVIDERS IN RURAL AMERICA: AN OPPORTUNITY TO PROVIDE CARE

Jennifer Nauheim*, Bronx, NY, Raymond Fang, William Meeks, Keonna Confesor, Linthicum, MD, Amanda North, Bronx, NY

MP39-06 EVALUATING THE REAL-WORLD PAYER AND PATIENT COSTS OF BPH SURGICAL MANAGEMENT

Kevin Wymer*, Gopal Narang, Phoenix, AZ, Austen Slade, Indianapolis, IN, Vidit Sharma, Viengneesee Thao, Bijan Borah, Rochester, MN, Marcelino Rivera, Indianapolis, IN, Scott Cheney, Mitchell Humphreys, Phoenix, AZ

MP39-07 THE IMPACT OF PATIENT AND PROVIDER DEMOGRAPHICS ON PRESS GANEY® RATINGS IN UROLOGY: WHO IS AT RISK OF BIAS?

Jane Kurtzman, Connie Wang*, Edwin Melendez, Julia Finkelstein, Christina Carpenter, New York, NY

MP39-08 IMPACT OF SARS-COV-2 PANDEMIC ON THE DIAGNOSIS AND SURGICAL INTERVENTION OF COMMON UROLOGICAL CONDITIONS: RESULTS FROM A MULTI-INSTITUTIONAL DATABASE FROM THE UNITED STATES

Maxwell Towe*, Sirpi Nackeeran, Mohammad Hout, Abhishek Bhat, Ranjith Ramasamy, Hemen-dra Shah, Miami, FL

MP39-09 COMPARISON OF ALVIMOPAN VERSUS NALOXEGOL FOR ENHANCING POSTOPERATIVE RECOVERY FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER

Peter Kirk*, Austin Wang, Dima Raskolnikov, Sarah Psutka, George Schade, John Gore, Yaw Nyame, Janet Kelly, Jonathan Wright, Seattle, WA

MP39-10 MANAGEMENT, SURVEILLANCE PATTERNS, AND COSTS ASSOCIATED WITH LOW-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER

Kelly Bree*, Houston, TX, Yong Shan, Galveston, TX, Patrick Hensley, Niyati Lobo, Houston, TX, Chengrui Hu, Douglas Tyler, Galveston, TX, Karim Chamie, Los Angeles, CA, Ashish Kamat, Hou-ston, TX, Stephen Williams, Galveston, TX

MP39-11 COST-EFFECTIVENESS OF HOLMIUM LASER ENUCLEATION OF THE PROSTATE: INSIGHTS FROM A MARKOV MODEL COMPARING BPH SURGICAL OPTIONS FOR GLANDS <80 G

Kevin Wymer*, Gopal Narang, Phoenix, AZ, Aus-ten Slade, Indianapolis, IN, Vidit Sharma, Viengn-eesee Thao, Bijan Borah, Bijan Borah, Rochester, MN, Marcelino Rivera, Indianapolis, IN, Scott Cheney, Mitchell Humphreys, Phoenix, AZ

MP39-12 REDUCING POST-OPERATIVE EMERGENCY DEPARTMENT VISITS AND READMISSIONS AFTER NEPHRECTOMY: AN INITIAL EVALUATION OF THE MUSIC-KIDNEY REGISTRY

Mohit Butaney*, Detroit, MI, Anna Johnson, Asha Bulusu, David Gandham, Ji Qi, Ann Arbor, MI, Mar-cus Jamil, Amit Patel, Detroit, MI, Sabrina Noyes, John Anema, Grand Rapids, MI, Michael Levin, Mt Clemens, MI, Bradley Rosenberg, Royal Oak, MI, Brian Lane, Grand Rapids, MI, Craig Rogers, Detroit, MI, for the Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI

MP39-13 COST-EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY REGIMENS PRIOR TO RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER

Daniel D. Joyce*, Rochester, MN, Kevin M. Wymer, Scottsdale, AZ, Vidit Sharma, James P. Moriarty, Bijan J. Borah, Rochester, MN, Daniel M. Geynisman, Elizabeth R. Plimack, Philadelphia, PA, Brian A. Costello, Lance C. Pagliaro, Stephen A. Boorjian, Rochester, MN

MP39-14 COMPARING HEALTHCARE UTILIZATION AND COSTS ACCORDING TO RENAL PRESERVATION VERSUS RADICAL NEPHROURETERECTOMY MANAGEMENT FOR PATIENTS WITH NON-METASTATIC UPPER TRACT UROTHELIAL CARCINOMA

Kathryn Fero, Los Angeles, CA, Yong Shan, Giri Movva, Jacques Baillargeon, Douglas Tyler, Galveston, TX, Karim Chamie, Los Angeles, CA, Stephen Williams*, Galveston, TX

MP39-15 RESTORATIVE THERAPY CLINICAL TRIALS FOR ERECTILE DYSFUNCTION: A SCOPING REVIEW OF ENDPOINT MEASURES

Russell Saltzman, Miami, FL, Roei Golan*, Tallahassee, FL, Thomas Masterson, Ranjith Ramasamy, Miami, FL

MP39-16 IMPACT OF HIGH-GRADE RADIATION INJURY FOLLOWING PROSTATE CANCER RADIATION ON HEALTHCARE COST AND UTILIZATION

Kevin Hebert*, Joshua Horns, Nathan Driggs, Rupam Das, Rano Matta, Benjamin McCormick, Salt Lake City, UT, James Hotaling, Salt Lake City, UT, Jeremy Myers, Salt Lake City, UT

MP39-17 ADVANCED PRACTICE PROVIDERS AND PATIENT ACCESS IN ACADEMIC MEDICAL CENTERS: A SECRET SHOPPER STUDY

Armaan Singh*, Jared Lassner, Ashley Diaz, Marc Sleiman, Parth Modi, CHICAGO, IL

MP39-18 SAME DAY DISCHARGE AFTER ROBOTIC PARTIAL NEPHRECTOMY: IS IT WORTH IT?

Andrew Wood, Eitan Katlowitz*, Elie Kaplan- Marans, Marc Lubin, Ervin Teper, David Silver, Ariel Schulman, Brooklyn, NY

MP39-19 INTERSTATE TELEMEDICINE FOR UROLOGIC ONCOLOGY CARE DURING THE COVID-19 PANDEMIC

Jason Reynolds*, Adam Gadzinski, Erin Dwyer, Blair Stewart, Isabelle Abarro, Sarah Holt, John Gore, Seattle, WA

MP39-20 ACCESS TO DEFINITIVE TREATMENT AND SURVIVAL FOR INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER AT HOSPITALS SYSTEMS SERVING HEALTH DISPARITY POPULATIONS (HSDPS)

David-Dan Nguyen*, Muhieddine Labban, Logan Briggs, Alexander P. Cole, Stuart R. Lipsitz, Hari S. Iyer, Timothy R. Rebbeck, Joel S. Weissman, Quoc-Dien Trinh, Boston, MA


166

Sunday, May 15, 2022 8:45 am – 10:00 am

Moderated Poster Session 40BLADDER CANCER: UPPER TRACT TRANSITIONAL CELL CARCINOMA I

Room 225 @ Ernest N. Morial Convention CenterModerators: Mario Fernandez, Michael Grasso & Mantu Gupta


MP40-01 COST AND DIAGNOSTIC YIELD OF UPPER TRACT IMAGING IN HIGH RISK MICROHEMATURIA; ARE WE STILL DOING TOO MUCH?

Clay Martin*, Eric Macdonald, Ella Taubenfeld, Simon Hall, New Hyde Park, NY

MP40-02 CAN THE PRESENTATION OF UPPER TRACT UROTHELIAL CANCER GUIDE US ON HOW TO IMAGE NON-VISIBLE HAEMATURIA?: A REVIEW OF 10 YEARS

Kirolos Michael*, Navin Ravindranath, Thomas Riley, Annette German, Andreas Bourdoumis, Raveendra Surange, Rochdale, United Kingdom

MP40-03 THE ADDED VALUE OF SYSTEMATIC BIOPSIES IN THE DIAGNOSIS AND CHARACTERIZATION OF UPPER TRACT UROTHELIAL CANCER

Andrea Gallioli*, Pietro Diana, Angelo Terri-to, Josep Maria Gaya, Alberto Piana, Pavel Gavrilov, Francesco Sanguedolce, Julio Francis-co Calderón, Antoni Sánchez-Puy, Joan Palou, Alberto Breda, Barcelona, Spain

MP40-04 PREDICTIVE RISK FACTORS FOR EARLY RECURRENCE AFTER RADICAL NEPHROURETERECTOMY FOR LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA

Heather Huelster*, Alyssa Bilotta, Jacob Britt, Nicholas Russo, Wade Sexton, Michael Poch, Scott Gilbert, Alice Yu, Philippe Spiess, Roger Li, Tampa, FL

MP40-05 RISK FACTORS OF SUBSEQUENT UPPER URINARY TRACT CARCINOMA TREATED WITH INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR NON-MUSCLE-INVASIVE BLADDER CANCER: FROM MULTIPLE JAPANESE HOSPITALS

Kazuyuki Numakura*, Akita, Japan, Makito Miyake, Nara, Japan, Yuya Sekine, Yumina Muto, Mizuki Kobayashi, Akita, Japan, Rikiya Taoka, Kagawa, Japan, Takashi Kobayasi, Kyoto, Japan, Takahiro Kojima, Tsukuba, Japan, Hiroshi Kitamu-ra, Toyama, Japan, Hiroyuki Nishiyama, Tsukuba, Japan, Kiyohide Fujimoto, Nara, Japan, Tomonori Habuchi, Akita, Japan


MP40-06 ROLE OF NEOADJUVANT CHEMOTHERAPY IN PATHOLOGICAL DOWNSTAGING DURING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (ROBUUST COLLABORATIVE GROUP)

Nicholas Corsi*, Marcus Jamil, Sohrab Arora, Deepansh Dalela, Detroit, MI, Riccardo Auturino, Richmond, VA, Chandru Sundaram, Indianapolis, IN, Robert Uzzo, Philadelphia, PA, Alex Mottrie, Aalst, Belgium, James Porter, Seattle, WA, Daniel Eun, Philadelphia, PA, Koon Rha, Seoul, Korea, Republic of, Amit Satish Bhattu, Miami, FL, Zhenjue Wu, Shanghai, China, People’s Republic of, Andrea Minervini, Florence, Italy, Matteo Ferro, Milan, Italy, Giuseppe Simone, Rome, Italy, Ithaar Derweesh, La Jolla, CA, Vitaly Margulis, Dallas, TX, Hooman Djaladat, Los Angeles, CA, Andrew Katims, New York, NY, Firas Abdollah, Detroit, MI

MP40-07 THE EFFECTS OF ADJUVANT CHEMOTHERAPY FOR UPPER URINARY TRACT UROTHELIAL CARCINOMA FOR JAPANESE PATIENTS IN REAL WORLD IN MULTICENTER

Tetsuya Yumioka*, Masashi Honda, Ryutaro Shimizu, Shogo Teraoka, Noriya Yamaguchi, Bun-ya Kawamoto, Shuichi Morizane, Katsuya Hikita, Atsushi Takenaka, Yonago, Japan

MP40-08 NOVEL ENDOSCOPIC MANAGEMENT FOR LOCALIZED UPPER URINARY TRACT CARCINOMA USING A PHOTODYNAMIC DIAGNOSIS-GUIDED DUAL LASER ABLATION TECHNIQUE: 3-YEAR FOLLOW-UP RESULTS

Takashi Yoshida*, Tadashi Matsuda, Chisato Ohe, Hidefumi Kinoshita, Osaka, Japan

MP40-09 THE SYSTEMIC IMMUNE–INFLAMMATION INDEX (SII) AS PREDICTOR FACTOR OF SURVIVAL IN PATIENTS UNDERGOING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA

Skander Zouari*, Saadi Ahmed, Setti Boubak-er Nouha, Bilel Saidani, Marouene Chakroun, Khadija Medddeb, Mouna Ayadi, Meriem Ksontini, Ahlem Blel, Hamza Boussaffa, Abderrazek Bouzouita, Amine Derouiche, Riadh Ben Slama, Ksontini Feriel, Amel Mezlini, Soumaya Rammeh, Haroun Ayed, Mohamed Chebil, Tunis, Tunisia

MP40-10 SURVIVAL OUTCOMES OF UPPER TRACT UROTHELIAL CARCINOMA PATIENTS TREATED WITH THERAPEUTIC ENDOSCOPIC MANAGEMENT

Wesley Yip*, Peter Reisz, Amy Tin, Nicole Ben-fante, Eugene Cha, Eugene Pietzak, Ari Hakimi, Jonathan Coleman, New York, NY


SU

ND

AY

MP40-11 RENAL FUNCTION VARIATION AFTER NEPHROURETERECTOMY FOR UPPER URINARY TRACT CARCINOMA: EVALUATION IN A LARGE MULTICENTER COHORT (RADICAL NEPHROURETERECTOMY OUTCOMES (RANEO) RESEARCH CONSORTIUM)

Alessandro Tafuri, Lecce, Italy, Michele Marchioni, Chieti, Italy, Clara Cerrato*, Katia Ododrizzi, Ve-rona, Italy, Andrea Mari, Riccardo Tellini, Firenze, Italy, Alessandro Veccia, Mantova, Italy, Daniele Amparore, Orbassano, Torino, Italy, Federica Di Cosmo, Lecce, Italy, Umberto Carbonara, Bari, It-aly, Federica Trovato, Catania, Italy, Michele Cas-tellani, Letizia M. I. Janello, Milano, Italy, Lorenzo Bianchi, Bologna, Italy, Giacomo Novara, Fabrizio Dal Moro, Padova, Italy, Riccardo Schiavina, Bologna, Italy, Elisa De Lorenzis, Milano, Italy, Paolo Parma, Mantova, Italy, Sebastiano Cimino, Catania, Italy, Ottavio De Cobelli, Milano, Italy, Francesco Maiorino, Pierluigi Bove, Roma, Italy, Fabio Crocerossa, Francesco Cantiello, Catanza-ro, Italy, David D’Andrea, Vienna, Austria, Franc-esco Porpiglia, Orbassano, Torino, Italy, Pasquale Ditonno, Bari, Italy, Emanuele Montanari, Milano, Italy, Francesco Soria, Paolo Gontero, Torino, Italy, Giovanni Liguori, Carlo Trombetta, Trieste, Italy, Marco Borghesi, Carlo Terrone, Genova, Italy, Luigi Schips, Chieti, Italy, Francesco Del Giudice, Alessandro Sciarra, Roma, Italy, Andrea Galosi, Ancona, Italy, Marco Moschini, Matteo Ferro, Milano, Italy, Shahrokh F. Shariat, Vienna, Austria, Marta Di Nicola, Marta Di Nicola, Chieti, Italy, Michele Battaglie, Bari, Italy, Andrea Minerv-ini, Firenze, Italy, Maria Angela Cerruto, Verona, Italy, Vincenzo Pagliarulo, Lecce, Italy, Alessandro Antonelli, Verona, Italy

MP40-12 THE KEYHOLE TECHNIQUE FOR RESECTION OF THE DISTAL URETER AND BLADDER CUFF DURING ROBOTIC RADICAL NEPHROURETERECTOMY

Luis G. Medina*, Muhannad Alsyouf, Alireza Ghoreifi, Aref S. Sayegh, Kailyn Koh, Wenhao Yu, Sina Sobhani, Antoin Douglawi, Hooman Djaladat, Los Angeles, CA

MP40-13 ARE METACHRONOUS BLADDER TUMORS PREDICTIVE OF UPPER TRACT UROTHELIAL CARCINOMA RECURRENCE IN PATIENTS TREATED WITH RADICAL OR ENDOSCOPIC SURGERY

Christian Ericson*, Anthony Compton, Bryce Baird, Raymond Pak, Jacksonville, FL

MP40-14 OVERALL SURVIVAL AMONG ELDERLY PATIENTS WITH LOCALIZED UPPER TRACT UROTHELIAL CARCINOMA RECEIVING OBSERVATION VERSUS DEFINITIVE TREATMENT

Syed Rahman*, Jamil Syed, Soum Lokesh-war, Benjamin Press, New Haven, CT, Thomas Monaghan, Dallas, TX, Michael Leapman, New Haven, CT

MP40-15 ASSOCIATION BETWEEN DAILY BEHAVIORAL HABITS OF FLUID-INTAKING AND URINATION AND THE RISK OF UPPER TRACT UROTHELIAL CARCINOMA: A CASE-CONTROL STUDY

Chunru Xu*, Zhihua Li, Ying Liu, Hua Guan, Xinyan Che, Meng Zhang, Yanbo Huang, Liqun Zhou, Xuesong Li, Chunde Li, Beijing, China, People’s Republic of

MP40-16 EXPRESSION ANALYSIS AND MUTATIONAL STATUS OF HISTONE METHYLTRANSFERASE KMT2D IN UPPER TRACT UROTHELIAL CARCINOMA

Ekaterina Laukhtina*, Ursula Lemberger, Andreas Bruchbacher, Dafina Ilijazi, David D’Andrea, Martin Susani, Vienna, Austria, Dmitry Enikeev, Moscow, Russian Federation, Eva Compérat, Shahrokh F. Shariat, Melanie R. Hassler, Vienna, Austria

MP40-17 LNCRNA SNHG16 MEDIATE CISPLATIN AND GEMCITABINE RESISTANCE IN UPPER TRACT UROTHELIAL CARCINOMA CELLS BY SPONGING OF MIR-31-5P

Wei-Chi Hsu*, Wei-Ming Li, A-Mei Huang, Lin-Li Chang, Hui-Hui Lin, Wen-Jeng Wu, Ching-Chia Li, Hung-Lung Ke*, Kaohsiung City, Taiwan

MP40-18 OFFICE-BASED FLEXIBLE URETEROSCOPY FOR ACTIVE SURVEILLANCE FOR UPPER TRACT UROTHELIAL CARCINOMA FOLLOWING NEPHRON-SPARING SURGERY

Nathan Colin Wong*, Sameh Naim, Jonathan Wagmeister, Ariel Schulman, Bertie Zhang, John Phillips, Muhammad Choudhury, Majid Eshghi, Valhalla, NY

MP40-19 HOW TO IDENTIFY PATIENTS SUITABLE FOR CONSERVATIVE MANAGEMENT OF UPPER TRACT UROTHELIAL CARCINOMA (UTUC) ACCORDING TO TUMOR SIZE: IMPLICATIONS FOR CLINICAL GUIDELINES

Eugenio Ventimiglia*, Christian Corsini, Margher-ita Fantin, Mario de Angelis, Pietro Dioni, Marco Moschini, Daniele Raggi, Maurilio Ponzoni, Um-berto Capitanio, Andrea Necchi, Roberta Lucianò, Milan, Italy, Olivier Traxer, Paris, France, Alberto Briganti, Francesco Montorsi, Luca Villa, Andrea Salonia, Milan, Italy


168

ºSunday, May 15, 2022 9:30 am – 11:30 am

Podium Session 40URORADIOLOGY II

Room 252 @ Ernest N. Morial Convention CenterModerators: Pat Fulgham & Daniel Rukstalis

ABSTRACTTIME NUMBER TITLE9:30 PD40-01 ACCURACY OF CYSTOGRAPHY IN CHILDREN

UNDER GENERAL ANESTHESIA WITH SUSPECTED VESICOURETERAL REFLUX

Michael Frumer*, Bezalel Sivan, Tal May, Roy Morag, Dmitry Khunovich, David Ben Meir, Petah Tikva, Israel

9:40 PD40-02 A RANDOMIZED STUDY USING COMBINATION OF STATIN AND ASCORBIC ACID FOR PREVENTION OF CONTRAST-INDUCED NEPHROPATHY (NCT03391830)

Abdelwahab Hashem*, Mahmoud Laymon, Mostafa Elgamal, Ahmed M. Lashin, Mohamed Ramez, Refaie Huda, Yasser Osman, Mansoura, Egypt

9:50 PD40-03 DIGITAL PATHOLOGY LABELS PERFORM BETTER THAN RADIOLOGIST LABELS FOR TRAINING DEEP LEARNING MODELS TO DETECT PROSTATE CANCER ON MRI

Indrani Bhattacharya*, David Lim, Christian Kunder, Han Lin Aung, Xingchen Liu, Wei Shao, Simon Soerensen, Richard Fan, Pejman Ghanouni, Katherine To’o, James Brooks, Mirabe-la Rusu, Geoffrey Sonn, Palo Alto, CA

10:00 PD40-04 HOW DOES MAGNETIC FIELD STRENGTH IN MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING AFFECT SIGNIFICANT PROSTATE CANCER DETECTION?: A MULTICENTER PROPENSITY SCORE–MATCHED ANALYSIS

Sunao Shoji*, Kumpei Takahashi, Soichiro Yuzuri-ha, Tatsuo Kano, Izumi Hanada, Takahiro Ogawa, Tatsuya Umemoto, Mayura Nakano, Masayoshi Kawakami, Masahiro Nitta, Masanori Hasegawa, Akira Miyajima, Isehara, Japan

10:10 PD40-05 DEEP LEARNING BASED ASSESSMENT OF PROSTATE LESION DYNAMICS ON MULTIPARAMETRIC MRI DURING ACTIVE SURVEILLANCE

Michael Daneshvar*, Stephanie Harmon, Tim Phelps, Michael Rothberg, Jacob Enders, Nitin Yerram, Luke O’Connor, Alex Wang, Sherif Mehralivand, Samira Masoudi, Bethesda, MD, Dong Yang, Ziyue Xu, Daguang Xu, Santa Clara, CA, Maria Merino, Bradford Wood, Peter Choyke, Peter Pinto, Baris Turkbey, Bethesda, MD

ABSTRACTTIME NUMBER TITLE10:20 PD40-06 USEFULNESS OF PROSTATE SPECIFIC

ANTIGEN–GLYCOSYLATION ISOMER FOR SIGNIFICANT CANCER DETECTION AND PATHOLOGICAL FINDINGS OF INDEX PROSTATE CANCERS ON MAGNETIC RESONANCE IMAGING–TRANSRECTAL ULTRASOUND FUSION IMAGE-GUIDED BIOPSY: A PROSPECTIVE MULTICENTER STUDY

Sunao Shoji*, Mayura Nakano, Isehara, Japan, Kohei Uemura, Bunkyo-Ku, Japan, Kumpei Takahashi, Tatsuo Kano, Soichiro Yuzuriha, Izumi Hanada, Takahiro Ogawa, Tatsuya Umemoto, Masayoshi Kawakami, Masahiro Nitta, Masanori Hasegawa, Isehara, Japan, Terumitsu Hasebe, Hachioji, Japan, Akira Miyajima, Isehara, Japan

10:30 PD40-07 CLINICAL DECISION ALGORITHM USING RESTRICTION SPECTRUM IMAGING AND BIOMARKERS TO PREDICT UPGRADING IN ACTIVE SURVEILLANCE

Stefan Eng, Los Angeles, CA, Benjamin Basasie, San Antonio, TX, Alfonso Lam, Los Angeles, CA, John Semmes, Dean Troyer, Norfolk, VA, Geoffrey Clarke, Abhijit Sunnapwar, Robin Leach, Teresa Johnson-Pais, San Antonio, TX, Lori Sokoll, Daniel Chan, Baltimore, MD, Jeffrey To-soian, Javed Siddiqui, Arul Chinnaiyan, Ann Arbor, MI, Paul Boutros, Los Angeles, CA, Michael Liss*, San Antonio, TX

10:40 PD40-08 RENAL COLIC IMAGING PRACTICE PATTERNS IN ONTARIO: A POPULATION-BASED STUDY

Danielle Jenkins*, Kingston, Canada, Greg Hosier, San Franscisco, CA, Marlo Whitehead, Rebecca Griffiths, Thomas McGregor, D. Robert Siemens, Kingston, Canada

10:50 PD40-09 EVOLUTION OF BIIF RENAL CYSTS AND THE IMPACT OF THE 2019 BOSNIAK CLASSIFICATION

Félix Couture*, Montreal, Canada, Sarah Hadj-Mi-moune, Sherbrooke, Canada, Stéphane Michael, Quebec City, Canada, Maxime Noël-Lamy, Patrick Richard, Sherbrooke, Canada


SU

ND

AY

11:00 PD40-10 FORMAL VALIDATION AT FINAL PATHOLOGY AFTER RADICAL NEHRECTOMY OF NEPHROMETRY SCORES: DISCORDANCE RATES AND OVERTREATMENT RISK

Francesco Cei*, Giacomo Musso, Giuseppe Rosiel-lo, Giuseppe Fallara, Daniele Cignoli, Giuseppe Ba-sile, Gianmarco Colandrea, Gianfranco Baiamonte, Federico Belladelli, Isaline Rowe, Daniela Canibus, Chiara Re, Roberta Lucianò, Maurizio Colecchia, Francesco De Cobelli, Giorgio Brembilla, Milan, It-aly, Federico Dehò, Varese, Italy, Vincenzo Mirone, Naples, Italy, Alberto Briganti, Roberto Bertini, Francesco Montorsi, Andrea Salonia, Alessandro Larcher, Umberto Capitanio, Milan, Italy

11:10 PD40-11 COMPARING RADIATION DOSE AND IMAGE QUALITY IN THREE DIFFERENT FLAT-PANEL DETECTOR C-ARMS DURING SIMULATED PCNL

Daniel R. Peverini, Akin S. Amasyali*, Avi Assi-don, Ricky Chen, John C. Hartman, Eun Hye Joo, Catalina Baas, Cayde Ritchie, Joshua D. Belle, Elizabeth Baldwin, D. Duane Baldwin, Loma Linda, CA

11:20 PD40-12 ROBOTIC-ASSISTED ELECTROMAGNETIC GUIDANCE MINIMIZES RADIATION EXPOSURE IN GAINING PERCUTANEOUS ACCESS FOR NEPHROLITHOTOMY: A CADAVERIC STUDY WITH NOVICES

Mitchell Humphreys*, Kevin Wymer, Phoenix, AZ, Ben Chew, Vancouver, Canada, Janet Zhen, Red-wood City, CA, Fuad Elkhoury, Los Angelas, CA, Sri Sivalingam, Cleveland, OH, Matthew Dunn, Santa Monica, CA, Michael Borofsky, Minneapo-lis, MN


Sunday, May 15, 2022 9:30 am – 11:30 am

Podium Session 41PROSTATE CANCER: DETECTION & SCREENING IV

Room 255 @ Ernest N. Morial Convention CenterModerators: Armando Stabile, Karim Touijer & Fred Saad

ABSTRACTTIME NUMBER TITLE9:30 PD41-01 DETECTION OF OCCULT PROSTATE

ADENOCARCINOMA USING STEREOTACTIC TRANSPERINEAL BIOPSY FOLLOWING NEGATIVE TRANSRECTAL ULTRASOUND-GUIDED BIOPSIES

Russell Maxwell*, Philadelphia, PA, Roksana Tech, Westmont, IL, Manuj Agarwal, Philadelphia, PA, Brian Moran, Westmont, IL

9:40 PD41-02 DIAGNOSIS OF PROSTATE CANCER IN MEN TREATED WITH 5-ALPHA-REDUCATES INHIBITORS WITH MULTIPARAMETRIC MRI: RESULTS OF A MULTICENTER INTERNATIONAL COLLABORATION

Ugo Falagario*, Foggia, Italy, Anna Lantz, Stock-holm, Sweden, Ivan Jambor, Turku, Finland, Luca Carmignani, Emanuele Montanari, Milan, Italy, Pierluigi Bove, Rome, Italy, Paolo Gontero, Turin, Italy, Alessandro Sciarra, Rome, Italy, Pasquale Di Tonno, bari, Italy, Carlo Trombetta, trieste, Italy, Pierfrancesco Bassi, Giuseppe Simone, Rome, Italy, vincenzo Mirone, Naples, Italy, Alessandro Antonelli, Verona, Italy, Luigi Schips, Chieti, Italy, Gian Maria Busetto, Foggia, Italy, Matteo Ferro, Milan, Italy, Peter Bostrom, Turku, Finland, Tobias Nordström, Stockholm, Sweden, Ottavio de Co-belli, Milan, Italy, Luigi Cormio, Giuseppe Carrieri, Foggia, Italy

ABSTRACTTIME NUMBER TITLE9:50 PD41-03 ANTIBIOTIC-FREE TRANSPERINEAL

PROSTATE BIOPSY: UROLOGY’S CONTRIBUTION TO RESPONSIBLE ANTIMICROBIAL STEWARDSHIP

Kevin B. Ginsburg, Johnathan Drevik, Jared P. Schober, Alberto A. Castro Bigalli, Jeffrey L. Ellis*, Avery Braun, Kaynaat Syed, Philadelphia, PA, John Danella, Danville, PA, Serge Ginzburg, Philadelphia, PA, Laurence Belkoff, Bala Cynwyd, PA, Adam C. Reese, Philadelphia, PA, Jeffrey Tomaszewski, Camden, NJ, Edouard Trabulsi, Phiadelphia, PA, Eric A. Singer, New Brunswick, NJ, Bruce Jacobs, Pittsburgh, PA, Jay D. Raman, Hershey, PA, Thomas Guzzo, Robert G. Uzzo, Marc C. Smaldone, Andres F. Correa, Philadel-phia, PA

10:00 PD41-04 DISTRIBUTION OF NATIONAL COMPREHENSIVE CANCER NETWORK RISK CLASSIFICATIONS USING MAGNETIC RESONANCE IMAGING-ULTRASOUND FUSION VERSUS SYSTEMIC 12 CORE BIOPSIES

Ghazal Khajir*, Benjamin Press, Preston Sprenkle, New Haven, CT, Samuel Washington, Matthew Cooperberg, San Francisco, CA, Michael Leapman, New Haven, CT

170

10:10 PD41-05 BIOPSY TECHNIQUE (TRANSPERINEAL VS. TRANSRECTAL) IS NOT ASSOCIATED WITH POSITIVE SURGICAL MARGINS OR PERIOPERATIVE MORBIDITY FOLLOWING RADICAL PROSTATECTOMY

Kevin Ginsburg, Johnathan Drevik*, Alberto Andres Castro Bigalli, Jeffrey Ellis, Avery Braun, Kaynaat Syed, Philadelphia, PA, John Danella, Danville, PA, Serge Ginzburg, Laurence Belkoff, Adam Reese, Philadelphia, PA, Jeffrey Tomasze-wski, Camden, NJ, Edouard Trabulsi, Philadel-phia, PA, Eric Singer, New Brunswick, NJ, Bruce Jacobs, Pittsburg, PA, Jay Raman, Hershey, PA, Thomas Guzzo, Robert Uzzo, Marc Smaldone, Andres Correa, Philadelphia, PA

10:20 PD41-06 TRANSPERINEAL PROSTATE BIOPSIES USING MICRO-ULTRASOUND, MRI-GUIDED AND SYSTEMATIC BIOPSIES (MADRID PROTOCOL), AN UPDATE WITH 482 PATIENTS

Moises Elias Socarras*, Javier Reinoso Elbers, Fabio Esposito, Isabella Greco, Julio Fernandez del Alamo, Vanesa Cuadros Rivera, Diego Carrion Monsalve, Juan Gomez Rivas, Luis Llanes Gon-zalez, Luis Llanes Gonzalez, Fernando Gomez Sancha, Madrid, Spain

10:30 PD41-07 LEARNING CURVE FOR TRANSPERINEAL ULTRASOUND/MRI FUSION BIOPSY FOR THE DETECTION OF PROSTATE CANCER

Yuval Elkun*, Henry Dumke, Vincent Wong, Dan-iel Bassily, Nathan Wong, Valhalla, NY, Christo-pher Dixon, Suffern, NY

10:40 PD41-08 THE ROLE OF MICRO-ULTRASOUND AMONG PATIENTS WITH A PIRADS 5 LESION AT MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING

Marco Paciotti*, Milan, Italy, Davide Maffei, Pier Paolo Avolio, Cesare Saitta, Vittorio Fasulo, Nicola Frego, Roberto Contieri, Alessandro Uleri, Alberto Saita, Rodolfo Hurle, Massimo Lazzeri, Paolo Casale, Rozzano, Milan, Italy, Giorgio Guazzoni, Nicolò Buffi, Giovanni Lughezzani, Milan, Italy

10:50 PD41-09 MOVING BEYOND PSA: IDENTIFYING THE OPTIMAL DIAGNOSTIC STRATEGY TO ASSESS PROSTATE CANCER RISK

Douglas Cheung*, Diana Magee, Toronto, Can-ada, Thomas Stonier, London, United Kingdom, Andrew Briggs, Bart Ferket, New York, NY, Antonio Finelli, Girish Kulkarni, Toronto, Canada, Andrew Vickers, Sigrid Carlsson, James Eastham, New York, NY

11:00 PD41-10 THE UTILITY OF PSA DENSITY IN PATIENTS WITH PI-RADS 3 LESIONS ACROSS A LARGE MULTI-INSTITUTIONAL COLLABORATIVE

Johnathan Drevik*, Zafardjan Dalimov, Kaynaat Syed, Philadelphia, PA, John Danella, Danville, PA, Laurence Belkoff, Adam Reese, Philadelphia, PA, Jeffrey Tomaszewski, Camden, NJ, Edouard Trabulsi, Philadelphia, PA, Eric Singer, New Brunswick, NJ, Bruce Jacobs, Pittsburg, PA, Jay Raman, Hershey, PA, Thomas Guzzo, Andres Correa, Marc Smaldone, Robert Uzzo, Serge Ginzburg, Philadelphia, PA

11:10 PD41-11 UPDATE FROM THE PEDAL TRIAL: A PROSPECTIVE SINGLE ARM PAIRED COMPARISON OF ABILITY TO DIAGNOSE AND LOCATE PROSTATE CANCER BETWEEN MULTIPARAMETRIC MRI AND 18F-PSMA-PET/CT

Vy Tran*, Thomas Sutherland, Kim Taubman, Su-Faye Lee, Daniel Lenaghan, Niall Corcoran, Nathan Lawrentschuk, Melbourne, Australia, Henry Woo, Lisa Tarlinton, Sydney, Australia, Tim Spelman, Lauren Thomas, Russell Booth, Melbourne, Australia, Elisa Perry, Justin Hegar-ty, Christchurch, New Zealand, Lih-Ming Wong, Melbourne, Australia

11:20 PD41-12 FROM BIOPSY TO DIAGNOSIS IN 30 MIN: REMOTE INSTANT PROSTATE PATHOLOGY BASED ON ARTIFICIAL INTELLIGENCE ENHANCED ULTRASOUND (AI-US)

Hamza Aljabali, Jakob Heidborn, Turkan Hajili, Kristina Greimelmaier, Jeremias Wohlschläger, Flensburg, Germany, Stephan Kruck, Pforzheim, Germany, Gerd Reis, Kaiserslautern, Germany, Tillmann Loch, Flensburg, Germany



SU

ND

AY

Sunday, May 15, 2022 9:30 am – 11:30 am

Podium Session 42BLADDER CANCER: INVASIVE IV

Room 245 @ Ernest N. Morial Convention CenterModerators: Khurshid Guru & D. Robert Siemens

ABSTRACTTIME NUMBER TITLE9:30 PD42-01 PROPENSITY MATCHED COMPARISON OF

RADICAL CYSTECTOMY WITH TRIMODALITY THERAPY FOR MUSCLE INVASIVE BLADDER CANCER (MIBC): A MULTI-INSTITUTIONAL STUDY

Alexandre R. Zlotta*, Toronto, Canada, Leslie K. Ballas, Los Angeles, CA, Andrzej Niemierko, Bos-ton, MA, Katherine Lajkosz, Cynthia Kuk, Toronto, Canada, Gus Miranda, Los Angeles, CA, Michael Drumm, Boston, MA, Andrea Mari, Florence, Italy, Ethan Thio, Los Angeles, CA, Neil E. Fleshner, Girish S. Kulkarni, Peter Chung, Toronto, Canada, Robert Bristow, Manchester, United Kingdom, Ale-jandro Berlin, Srikala S. Sridhar, Toronto, Canada, Adam S. Feldman, Matthew Wszolek, Richard Lee, Anthony Zietman, William Shipley, Philip Saylor, Boston, MA, Siamak Daneshmand, Los Angeles, CA, Jason A. Efstathiou, Boston, MA

9:40 PD42-02 RESULTS OF THE INTRACORPOREAL ROBOTIC VS OPEN CYSTECTOMY (IROC) MULTI-CENTRE RANDOMISED TRIAL

Pramit Khetrapal*, London, United Kingdom, James Catto, Sheffield, United Kingdom, Gareth Ambler, Frederico Ricciardi, Shamim Khan, An-drew Feber, London, United Kingdom, Simon Dix-on, Sheffield, United Kingdom, Norman Williams, London, United Kingdom, Imran Ahmed, Glasgow, United Kingdom, Philip Charlesworth, Reading, United Kingdom, Marcus Cumberbatch, Syed Hussain, Aidan Noon, Sheffield, United King-dom, Sanjeev Kotwal, Leeds, United Kingdom, Edward Rowe, Anthony Koupparis, Bristol, United Kingdom, John McGrath, Exeter, United Kingdom, Nikhil Vasdev, Stevenage, United Kingdom, Chris Brew-Graves, Daryl Hagan, John Kelly, iROC Trial Study Group, London, United Kingdom

9:50 PD42-03 ONCOLOGIC SURVEILLANCE INTENSITY FOR VARIANT HISTOLOGY VERSUS PURE UROTHELIAL CARCINOMA OF THE BLADDER AFTER RADICAL CYSTECTOMY

Alberto Martini, Riccardo Leni, Giuseppe Basile*, Simone Scuderi, Mario De Angelis, Luigi Nocera, Giuseppe Rosiello, Giorgio Gandaglia, Milan, Italy, Chiara Lonati, Luca Afferi, Lucerne, Switzerland, Vincenzo Mirone, Naples, Italy, Andrea Gallina, Lugano, Switzerland, Francesco Montorsi, Alberto Briganti, Marco Moschini, Milan, Italy

10:00 PD42-04 PREDICTIVE VALUE OF SERUM LEVELS OF SQUAMOUS CELL CARCINOMA ASSOCIATED ANTIGEN, CARCINOEMBRYONIC ANTIGEN, AND CARBOHYDRATE ANTIGEN 19-9 IN UROTHELIAL CANCER OF THE URINARY BLADDER

Yasuyoshi Miyata*, Yuta Mukae, Yuichiro Na-kamura, Kensuke Mitsunari, Tomohiro Matsuo, Kojiro Ohba, Hideki Sakai, Nagasaki, Japan

ABSTRACTTIME NUMBER TITLE10:10 PD42-05 EXPANDING THE USE OF TARGETED

THERAPY FOR UROTHELIAL BLADDER CANCER (UBC): NON-FGFR3 RECEPTOR TYROSINE KINASE (RTK) GENE REARRANGEMENTS (REAR) AND FUSIONS (FUS)

Andrea Necchi*, Milan, Italy, Dean Pavlick, Cam-bridge, MA, Gennady Bratslavsky, Joseph Jacob, Oleksandr Kravtsov, New York, NY, Philippe Spiess, Tampa, FL, Petros Grivas, Seattle, WA, Vamsi Parini, Brennan Decker, Lin Douglas, Danziger Natalie, Levy Mia Alyce, Jeffrey Ross, Cambridge, MA

10:20 PD42-06 THE ACCURACY OF VESICAL IMAGING-REPORTING AND DATA SYSTEM (VI-RADS): AN UPDATED COMPREHENSIVE MULTI-INSTITUTIONAL, MULTI-READERS SYSTEMATIC REVIEW AND META-ANALYSIS FROM DIAGNOSTIC EVIDENCE INTO FUTURE CLINICAL RECOMMENDATIONS

Francesco Del Giudice*, Rocco Simone Flammia, Martina Pecoraro, Rome, Italy, Marco Moschini, Milan, Italy, David D’Andrea, Vienna, Austria, Benjamin I. Chung, Stanford, CA, Lucia Martina Pisciotti, Alessandro Sciarra, Ettore De Berardinis, Valeria Panebianco, Rome, Italy

10:30 PD42-07 RADICAL VS PARTIAL CYSTECTOMY FOR URACHAL CARCINOMA: A POPULATION-BASED ANALYSIS

Rocco Simone Flammia*, Rome, Italy, Francesco Chierigo, Genova, Italy, Benedikt Hoeh, Frankfurt, Germany, Gabriele Sorce, Milan, Italy, Christoph Würnschimmel, Hamburg, Germany, Zhe Tian, Montreal, Canada, Costantino Leonardo, Rome, Italy, Derya Tilki, Hamburg, Germany, Felix Chun, Frankfurt, Germany, Carlo Terrone, Genova, Italy, Francesco Montorsi, Milan, Italy, Shahrokh Sha-riat, Wien, Austria, Michele Gallucci, Rome, Italy, Pierre karakiewicz, Montreal, Canada

10:40 PD42-08 REAL-WORLD PERFORMANCE OF MRI AFTER TURBT IN PREDICTING FINAL PATHOLOGIC OUTCOMES IN BLADDER CANCER

Michael Chandra*, Fort Worth, TX, Thomas Gerald, Suzanne Cole, Liwei Jia, Jeffrey Howard, Dallas, TX, Aditya Bagrodia, San Diego, CA, Xia-osong Meng, Vitaly Margulis, Yair Lotan, Alberto Diaz de Leon, Solomon Woldu, Dallas, TX

10:50 PD42-09 DO PROPHYLACTIC ANTIBIOTICS REDUCE URINARY TRACT INFECTIONS FOLLOWING ROBOT-ASSISTED RADICAL CYSTECTOMY? A RANDOMIZED CONTROL TRIAL

Holly Houenstein, Yousuf Ramahi, Ayat A. Shah*, Philippa Doherty, Kristopher Attwood, Zhe Jing, Qiang Li, Ahmed A. Hussein, Khurshid A. Guru, Buffalo, NY

172

11:00 PD42-10 INDEPENDENT PREDICTORS AND PATTERNS OF EARLY AND LATE RECURRENCE AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: A MULTICENTER COLLABORATION

Chiara Lonati*, Brescia, Italy, Roberto Carando, Lucerne, Switzerland, Alberto Martini, Milan, Italy, Claudio Simeone, Stefania Zamboni, Bres-cia, Italy, Giuseppe Simone, Rome, Italy, Luca Afferi, Christian D. Fankhauser, Agostino Mattei, Lucerne, Switzerland, Mario Álvarez-Maestro, Ma-drid, Spain, Alberto Briganti, Francesco Montorsi, Marco Moschini, Milan, Italy

11:10 PD42-11 COMPARISON OF COMPREHENSIVE COMPLICATION INDEX AND CLAVIEN-DINDO CLASSIFICATION TO ESTIMATE PERIOPERATIVE MORBIDITY IN BLADDER CANCER PATIENTS WITH COMPLETE INTRACORPOREAL ROBOT-ASSISTED RADICAL CYSTECTOMY

Mikolaj Mendrek*, Jorn H. Witt, Gronau, Germany, Sergey Sarychev, Frauenfeld, Switzerland, Nikolaos Liakos, Gronau, Germany, Mustapha Addali, Siegen, Germany, Christian Wagner, Theodoros Karagiotis, Andreas Schuette, Gronau, Germany, Armin Soave, Margit Fisch, Hamburg, Germany, Julian Reinisch, Thomas Herrmann, Frauenfeld, Switzerland, Malte W. Vetterlein, Hamburg, Germa-ny, Sami-Ramzi Leyh-Bannurah, Gronau, Germany

11:20 PD42-12 MODELING THE CONTRIBUTION OF PREOPERATIVE VI-RADS SCORE TO PREDICT FINAL PATHOLOGIC LYMPH-NODES INVOLVEMENT IN PATIENTS WITH MIBC UNDERGONE RADICAL CYSTECTOMY

Francesco Del Giudice*, Martina Pecoraro, Maurizio Del Monte, Marco Bicchetti, Emanuele Messina, Ailin Dehghanpour, Rome, Italy, Benja-min I. Chung, Stanford, CA, Ettore De Berardinis, Alessandro Sciarra, Carlo Catalano, Valeria Panebianco, Rome, Italy


Sunday, May 15, 2022 9:30 am – 11:30 am

Podium Session 43KIDNEY CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY II

Room 244 @ Ernest N. Morial Convention CenterModerators: Jodi Maranchie & Simon Tanguay

ABSTRACTTIME NUMBER TITLE9:30 PD43-01 PEVONEDISTAT SENSITIZES RENAL

MEDULLARY CARCINOMA CELLS TO CARBOPLATIN BY DISRUPTING DNA DAMAGE REPAIR MECHANISMS

Daniel Shapiro*, Madison, WI, Niki Millward Zach-arias, Durga Tripathi, Jean-Philippe Bertocchio, Melinda Soeung, Rong He, Jianjun Gao, Priya Rao, Truong Lam, Luigi Perelli, Alessandro Caru-go, Timothy Heffernan, Cheryl Walker, Giannicola Genovese, Nizar Tannir, Christopher Wood, Jose Karam, Pavlos Msaouel, Houston, TX

9:40 PD43-02 THERAPEUTIC EFFICACY OF YM155 TO REPRESS AN EPIGENETIC ENZYME AND EVEROLIMUS RESISTANCE IN RCC

Seong Hwi Hong*, Hyun Ji Hwang, Na Gyeong Ha, Sung Yul Park, Hong Sang Moon, Young Eun Yoon, Seoul, Korea, Republic of

9:50 PD43-03 MCT INHIBITION SYNERGIZES WITH TYROSINE KINASE AND MTOR INHIBITOR TREATMENT IN RENAL CELL CARCINOMA

Bhaghyasree Jambunathan, Abdo Dergham, Sayani Bhattacharjee, Rebecca Wynn, Puneet Sindhwani, Firas Petros, Nagalakshmi Nadiminty*, Toledo, OH

ABSTRACTTIME NUMBER TITLE10:00 PD43-04 PD-L1 LOCALIZATION WITHIN EXOSOMES:

A PRE-CLINICAL STUDY ON EXOSOME TARGETING THERAPIES TO COMBAT DRUG RESISTANCE IN RENAL CELL CARCINOMA

Jacob W. Greenberg*, Hogyoung Kim, Ahmed A. Moustafa, Asim B. Abdel-Mageed, L. Spencer Krane, New Orleans, LA

10:10 PD43-05 A NOVEL SIRNA-BASED NANOTHERAPY AGAINST METASTATIC CLEAR CELL RENAL CELL CARCINOMA

Jan Rudzinski*, Houston, TX, Natasha Govin-dasamy, Konstantin Stoletov, Katia Carmine-Sim-men, Arun Raturi, John Lewis, Edmonton, Canada

10:20 PD43-06 EZH2 INHIBITION AS THERAPEUTIC STRATEGY TO DYSREGULATE LATS1 IN RCC

Seong Hwi Hong*, Hyun Ji Hwang, Na Gyeong Ha, Sung Yul Park, Hong Sang Moon, Young Eun Yoon, Seoul, Korea, Republic of

10:30 PD43-07 TKI-INDUCED TREATMENT RESISTANCE OF RCC VIA MODULATING THE LONG NON-CODING RNA-ECVSR/ERβ/HIF2-α SIGNALING

Yixi Hu*, Miao He, Huan Yang, Rochester, NY, Minfeng Chen, Changsha, China, People’s Republic of, Chawnshang Chang, Jean Joseph, Edward M Messing, Shuyuan Yeh, Rochester, NY


SU

ND

AY

10:40 PD43-08 DEVELOPMENT OF PATIENT-DERIVED KIDNEY CANCER ORGANOID; APPLICATION TO DRUG SCREENING MODELS AND ITS CHALLENGES

Akira Kazama*, Vladimir Bilim, Yoshihiko Tomita, Niigata, Japan

10:50 PD43-09 PHENOTYPICAL SCREENING ONMETASTATIC PRCC-TFE3 FUSIONTRANSLOCATION RENAL CELL CARCINOMA ORGANOIDS REVEALSPOTENTIAL THERAPEUTIC AGENTS

Chuanzhen Cao*, Xiaomei Lan, Weixing Jiang, Lei Guo, Xingang Bi, Shan Zheng, Aiping Zhou, Zhijian Sun, Jianzhong Shou, Beijing, China, People’s Republic of

11:00 PD43-10 CANCER-ASSOCIATED ADIPOSE-DERIVED MESENCHYMAL STEM CELLS PROMOTE MIGRATION AND INVASION IN KIDNEY CANCER

Yumina Muto*, Kazuyuki Numakura, Yuya Se-kine, Mizuki Kobayashi, Soki Kashima, Ryohei Yamamoto, Atsushi Koizumi, Taketoshi Nara, Mitsuru Saito, Shintaro Narita, Yasufumi Omori, Tomonori Habuchi, Akita, Japan

11:10 PD43-11 METHYLATION HETEROGENEITY IN CCRCC OFFERS INSIGHTS INTO TUMORIGENESIS AND BIOMARKER DEVELOPMENT

Sabrina Rossi*, Cambridge, United Kingdom, Victoria Dombrowe, Berlin, Germany, Sara Pita, Christopher Smith, Grant Stewart, Cambridge, United Kingdom, Roland Schwarz, Berlin, Germa-ny, Charlie Massie, Cambridge, United Kingdom

11:20 PD43-12 BIOMARKS FOR KIDNEY CANCER DIFFERENTIATION

Melanie von Brandenstein, Jan Herden, Barbara Köditz*, Manuel Huerta, Tim Nestler, Jochen Fries, Axel Heidenreich, Cologne, Germany


Sunday, May 15, 2022 9:30 am – 11:30 am

Podium Session 44URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: PELVIC PROLAPSE

Room 243 @ Ernest N. Morial Convention CenterModerators: O. Lenaine Westney & Sandip Vasavada

ABSTRACTTIME NUMBER TITLE9:30 PD44-01 IS THERE AN ADDED VALUE FOR DYNAMIC

MRI OF THE PELVIC FLOOR, TO THE CLINICAL POP-Q EXAMINATION BEFORE MANAGEMENT OF PELVIC ORGAN PROLAPSE IN FEMALES: A DOUBLE BLINDED PROSPECTIVE STUDY IN A TERTIARY CARE CENTER

Ahmed Fathy Hussein*, Ranya Farouk Elsayed, Noha Mahfouz, Ahmed Yehya Abdelziz, Amr Mostafa Zahran, Hussein Ali Hussein, Mohamed Salah Abdel Azim, Cairo, Egypt

9:40 PD44-02 CHANGES TO THE UPPER URINARY TRACT IN PELVIC ORGAN PROLAPSE

Olesya Snurnitsyna*, Alexandr Nikitin, Mikhail Lobanov, Leonid Rapoport, Dmitry Enikeev, Mikhail Enikeev, Moscow, Russian Federation

9:50 PD44-03 TO HYST OR NOT: CONCURRENT VAGINAL HYSTERECTOMY AT TIME OF COLPOCLEISIS

Oluwarotimi Nettey*, Kai Dallas, Anne Lenore Ackerman, Los Angeles, CA

10:00 PD44-04 NATIVE TISSUE REPAIR OF ANTERIOR COMPARTMENT PROLAPSE FROM MULTIPLE INSTITUTIONS IS DURABLE OVER 3 YEARS

Ramzy Burns*, Leo Song, Indianapolis, IN, Feras Alhalabi, Dallas, TX, Lauren Snodgrass, Indianap-olis, IN, Philippe Zimmern, Dallas, TX, CR Powell, Indianapolis, IN

ABSTRACTTIME NUMBER TITLE10:10 PD44-05 ROBOT ASSISTED SACROCOLPOPEXY: PRE-

AND PERIOPERATIVE FACTORS ASSOCIATED WITH A SHORTER LENGTH OF STAY

Chris Du*, Kuemin Hwang, John Hill, Kelly Ieong, Kerry Adler, Igor Inoyatov, Steven Weissbart, Jason Kim, Stony Brook, NY

10:20 PD44-06 PUDENDAL BLOCK ANALGESIA WITH VAGINAL SURGERY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL

Emily Slopnick*, Graham Chapman, David D Sheyn, Sarah Sears, Megan Abrams, Kasey M Roberts, Robert Pollard, Jeffrey Mangel, Cleve-land, OH

10:30 PD44-07 EVALUATING THE LONG-TERM IMPACT OF IMPLEMENTING STANDARDIZED POSTOPERATIVE OPIOID PRESCRIBING GUIDELINES FOLLOWING PELVIC ORGAN PROLAPSE SURGERY

Elizabeth J. Olive*, Amy E. Glasgow, Elizabeth B. Habermann, John B. Gebhart, John A. Occhino, Emanuel C. Trabuco, Brian J. Linder, Rochester, MN

10:40 PD44-08 POSTOPERATIVE OUTCOMES AFTER ROBOTIC SACROCOLPOPEXY WITH CONCURRENT RECTOPEXY IN WOMEN WITH MULTICOMPARTMENT PELVIC ORGAN PROLAPSE

Shivani Gaitonde*, Jessie Chen, Craig Olson, Philippe Zimmern, Maude Carmel, Dallas, TX

174

10:50 PD44-09 RATES AND RISK FACTORS FOR PELVIC ORGAN PROLAPSE RECURRENCE REQUIRING RE-OPERATION AFTER ROBOTIC SACROCOLPOPEXY

Paige Kuhlmann*, Los Angeles, CA, Lisa Ro-go-Gupta, Stanford, CA, Karyn Eilber, Los Ange-les, CA, Jennifer Anger, San Diego, CA, Victoria Scott, Los Angeles, CA, Kai Dallas, Duarte, CA

11:00 PD44-10 URODYNAMIC PROFILE OF VOIDING IN PELVIC ORGAN PROLAPSE PATIENTS AFTER SURGERY: A SYSTEMATIC REVIEW WITH META-ANALYSIS

Hugo Santos*, Danilo Lourenço, Alexandre Partezani, Saulo Teles, Lucas Takemura, Felipe Gushiken, Guilherme Andrade, Bianca Bianco, Luis Rios, Gustavo Lemos, Arie Carneiro, São Paulo, Brazil

11:10 PD44-11 UNDERSTANDING PATIENT PELVIC ORGAN EXPERIENCE COMPARING DIGITAL ETHNOGRAPHY AND FOCUS GROUPS—WHICH ONE DOES BETTER?

Gabriela Gonzalez*, Sacramento, CA, Kristina Vaculik, Beverly Hills, CA, Corey Arnold, Los An-geles, CA, Christopher Almario, Brennan Spiegel, Beverly Hills, CA, Jennifer Anger, La Jolla, CA

11:20 PD44-12 VAGINAL ESTROGEN THERAPY FOR GENITOURINARY SYNDROME OF MENOPAUSE (GSM) IN WOMEN WITH A PERSONAL HISTORY OF BREAST CANCER- A CLAIMS DATABASE ANALYSIS

Kathryn Dumas*, Sajya Singh, Jaden R Kohn, Taylor P Kohn, Marisa Clifton, Baltimore, MD


Sunday, May 15, 2022 9:30 am – 11:30 am

Video Session 8PEDIATRICS

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerator: Mohan Gundeti

ABSTRACTTIME NUMBER TITLE9:30 V08-01 LEVERAGING ROBOTICS, IRIS, AND

SELECTIVE CLAMPING TO MANAGE COMPLEX ENDOPHYTIC LESIONS IN A PEDIATRIC PATIENT WITH WILMS TUMORS

Robert Harrison*, Tanner Corse, Michael Stifel-man, Hackensack, NJ

9:40 V08-02 PEDIATRIC ROBOT-ASSISTED HEMINEPHRECTOMY UTILIZING INDOCYANINE GREEN

Akhil Saji*, Ashley Dixon, Miriam Harel, Richard Schlussel, Valhalla, NY

9:50 V08-03 COMPLEX RIGHT POST-CHEMOTHERAPY LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION

Sebastiano Nazzani*, Stefano Chiaravalli, Monica Terenziani, Luigi Piva, Mario Catanzaro, Nicola Nicolai, Davide Biasoni, Milan, Italy

10:00 V08-04 PARTIAL ORCHIECTOMY FOR TESTICULAR MASS IN A PEDIATRIC PATIENT: TECHNIQUE AND OUTCOMES

Katherine Fischer*, Ruchika Talwar, Karl God-lewski, Alice Xiang, Aseem Shukla, Arun Srini-vasan, Christopher Long, Thomas Kolon, Sameer Mittal, Philadelphia, PA

10:10 V08-05 THE ANATOMIC BLADDER NECK TAILORING IN CPRE: THE PATH TO NORMAL ANATOMY

Dana Weiss*, Philadelphia, PA, Elizabeth Roth, Travis Groth, John Kryger, Milwaukee, WI, Richard Lee, Boston, MA, Aseem Shukla, Philadelphia, PA, Joseph G, Boston, MA, Michael Mitchell, Milwau-kee, WI, Douglas Canning, Philadelphia, PA

10:20 V08-06 REDO ROBOTIC LEFT URETERAL REIMPLANT USING THE EXTRAVESICAL LUAA TECHNIQUE

Clark Judge*, Anastasia Gliatis, Amrita Mohanty, Mohan Gundeti, Chicago, IL

ABSTRACTTIME NUMBER TITLE10:30 V08-07 ROBOTIC PYELOPLASTY OF LOWER POLE

MOIETY IN A 2 MONTH OLD INFANT WITH CUTANEOUS PYELOURETERAL (CPU) STENT

Amrtia Mohanty*, Clark Judge, Anastasia Gliatis, Tony Da Lomba, Mohan Gundeti, Chicago, IL

10:40 V08-08 MANAGEMENT OF URETHRAL DUPLICATIONPatrick Curtin*, Yu Zheng, Jessica Connor, Shumyle Alam, Charleston, SC

10:50 V08-09 SERIES OF MISSED FIBROEPITHELIAL POLYPS IN THE PEDIATRIC POPULATION

Aznive Aghababian*, John Weaver, Sahar Eft-ekharzadeh, Sonam Saxena, Iqra Nadeem, Pooja Unadkat, Katherine Fischer, Karl Godlewski, Sameer Mittal, Christopher Long, Dana Weiss, Arun Srinivasan, Aseem Shukla, Philadelphia, PA

11:00 V08-10 ROBOTIC ASSISTED LAPAROSCOPIC CALYCEAL DIVERTICULECTOMY: A SAFE AND FEASIBLE TECHNIQUE

Alejandra Guevara*, Miami Beach, FL, Cinthia S. Galvez, Daniel Nassau, Andrew Labbie, Miguel Castellan, Miami, FL

11:10 V08-11 ROBOTIC EXCISION OF A MASSIVE CALYCEAL DIVERTICULUM

Jennifer M. Lovin*, Andrew J. Kirsch, Atlanta, GA

11:20 V08-12 ROBOTIC-ASSISTED LAPAROSCOPIC BLADDER AUGMENTATION ILEOCYSTOPLASTY AND MITROFANOFF APPENDICOVESICOSTOMY (RALIMA) WITH CONCURRENT BLADDER NECK RECONSTRUCTION AND CECAL FLAP ANTEGRADE COLONIC ENEMA (ACE) CHANNEL CREATION

Steven A Sidelsky*, Chicago, IL, Ankita Nallani, Columbia, MO, Mohan S Gundeti, Chicago, IL



SU

ND

AY

Sunday, May 15, 2022 8:00 am – 1:00 pm

ForumsINTERNATIONAL PROSTATE FORUM

LaNouvelle Orleans Ballroom C @ Ernest N. Morial Convention CenterChairs: John Davis & Neal Shore

1:00 IPF INTRODUCTIONS Chairs: John Davis, Neal Shore

8:05 SESSION I: EARLY DISEASE Moderators: John Davis, Badar Mian, Rick Popert

PROSTATE CANCER PREVENTION AND EARLY DISEASE NON-PROGRESSION: UPDATE AND DIET, EXERCISE, SUPPLEMENTS

Justin Gregg

Q&A: MODERATORS/AUDIENCE WITH DR. GREGG

TESTOSTERONE REPLACEMENT: UPDATE ON MANAGEMENT FOR PCA SCREENING, SURVEIL-LANCE, AND TREATED PATIENTS

Run Wang

Q&A: MODERATORS/AUDIENCE WITH DR. WANG

PANEL DISCUSSION: CHALLENGING CASES IN PROSTATE CANCER SCREENING

Panelists: Stacey Loeb, Kelly Stratton

9:15 SESSION II: ADVANCES IN DIAGNOSTICS Moderators: Brian Chapin, , Brusabhanu Nayak, Weranja

Ranasinghe

MRI UTILIZATION: EVIDENCE REVIEW, GUIDE-LINES STATEMENTS, AND HOW I USE IT

Behfar Ehdaie

Q&A: MODERATORS/AUDIENCE WITH DR. EH-DAIE

PSMA IS HERE IN THE U.S. - NOW WHAT? Yam Nyame

Q&A: MODERATORS/AUDIENCE WITH DR. NYAME

PANEL DISCUSSION: CASES WHERE IMAGING CHANGED EVERYTHING…

Panelists: Tharak Bathala, Arvin George, Rob Reiter

10:25 BREAK

10:40 SESSION III: LOCALIZED DISEASE—SURGICAL FORUM

Moderators: Prokar Dasgupta, Katie Murray Derya Tilki

RARP MODIFICATIONS THAT ENHANCE CONTI-NENCE RETURN

Kirsten Greene

Q&A: MODERATORS/AUDIENCE WITH DR. GREENE

NEWER ROBOTS, SMALLER ROBOTS, CHEAPER ROBOTS—WHERE IS THE TECHNOLOGY HEAD-ED?

Isaac Kim

PANEL DISCUSSION: SOLVING EXTREME INDICA-TIONS FOR ROBOTICS

Panelists: Vip Patel, Jean Joseph, Matthew Tollefson

11:45 SESSION IV: RECURRENT/ADVANCED DISEASE Moderators: Alicia Morgans, Neal Shore

SALVAGE BRACHYTHERAPY: AN ALTERNATIVE TO SALVAGE RP

Q&A: MODERATORS/AUDIENCE

ADVANCED PROSTATE CANCER TREATMENTS: THE LARGE UROLOGY GROUP PRACTICE MODEL

Jason Hafron

ADVANCED PROSTATE CANCER TREATMENTS: THE ACADEMIC MODEL

Pedro Barata

Q&A: MODERATORS/AUDIENCE WITH DRS. HA-FRON AND BARATA

PANEL DISCUSSION WITH 5 MINUTE UPDATES: OPTIMIZED TESTING AND THERAPEUTICS IN ADVANCED PROSTATE CANCER

Panelists: Pedro Barata, Alicia Morgans, Oliver Sartor

UPDATE: GENOMIC PROFILING Oliver Sartor

UPDATE: METASTATIC CASTRATE SENSITIVE DISEASE

Pedro Barata

UPDATE:METASTATIC CASTRATE RESISTANT DISEASE

Alicia Morgan


176

Sunday, May 15, 2022 10:30 am – 11:45 am

Moderated Poster Session 41SURGICAL TECHNOLOGY & SIMULATION: TRAINING & SKILLS ASSESSMENT

Room 228 @ Ernest N. Morial Convention CenterModerators: Jaime Landman, Khurshid Ghani & Michael Borofsky


MP41-01 DISSECTION ASSESSMENT FOR ROBOTIC TECHNIQUE (DART) TO EVALUATE NERVE-SPARE OF ROBOT-ASSISTED RADICAL PROSTATECTOMY

Runzhuo Ma*, Alvin Hui, Jiashu Xu, Aditya Desai, Los Angeles, CA, Michael Tzeng, Emily Cheng, New York, NY, Loc Trinh, Jessica H Nguyen, Los Angeles, CA, Anima Anandkumar, Pasadena, CA, Jim C. Hu, New York, NY, Andrew J. Hung, Los Angeles, CA

MP41-02 NOVEL ROBOTIC-ASSISTED ELECTROMAGNETIC GUIDANCE FOR PRECISION PERCUTANEOUS ACCESS: A CADAVERIC STUDY OF NOVICES VERSUS AN EXPERT

Mitchell Humphreys*, Kevin Wymer, Phoenix, AZ, Ben Chew, Vancouver, Canada, Janet Zhen, Redwood City, CA, Fuad Elkhoury, Los Angelas, CA, Sri Sivalingam, Cleveland, OH, Matthew Dunn, Santa Monica, CA, Michael Borofsky, Minneapolis, MN

MP41-03 COMPUTER VISION FOR SURGICAL ERRORS DETECTION DURING ROBOTIC TISSUE DISSECTION

Rafal Kocielnik*, Inhoo Lee, Pasadena, CA, Jas-per Laca, Sidney I. Roberts, Jessica H. Nguyen, Los Angeles, CA, Idris O. Sunmola, Evanston, IL, De-An Huang, Santa Clara, CA, Sandra P. Marshall, Solana Beach, CA, Anima Anandkumar, Pasadena, CA, Andrew J. Hung, Los Angeles, CA

MP41-04 MOTION METRICS AND MACHINE LEARNING-BASED FEEDBACK IN WET-LAB LAPAROSCOPIC SURGICAL TRAINING

Takashige Abe*, Koki Ebina, Kiyohiko Hotta, Madoka Higuchi, Jun Furumido, Naoya Iwaha-ra, Masafumi Kon, Kou Miyaji, Sayaka Shibuya, Yan Lingbo, Suhnsuke Komizunai, Yo Kurashi-ma, Hiroshi Kikuchi, Ryuji Matsumoto, Takahiro Osawa, Sachiyo Murai, Sapporo, Japan, Teppei Tsujita, Yokosuka, Japan, Kazuya Sase, Taga-jo, Japan, Xiaoshuai Chen, Hirosaki, Japan, Atsushi Konno, Nobuo Shinohara, Sapporo, Japan

MP41-05 EVALUATING THE EFFICACY OF TISSUE DISSECTION GESTURES DURING ROBOTIC SIMULATION TASK

Daniel Inouye*, Runzhuo Ma, Jessica H. Nguyen, Jasper Laca, Los Angeles, CA, Rafal Kocielnik, Anima Anandkumar, Pasadena, CA, Andrew J. Hung, Los Angeles, CA


MP41-06 A PROSPECTIVE, RANDOMIZED, MULTI-CENTRE TRIAL ON THE EFFICIENCY AND EFFECTIVENESS OF PROFICIENCY BASED PROGRESSION ROBOTIC SURGICAL SKILLS TRAINING

Stefano Puliatti*, Marco Amato, Modena, Italy, Rui Farinha, Ghent, Belgium, Artur paludo, Porto Alegre, Brazil, Giuseppe Rosiello, Milan, Italy, Ruben De Groote, Aalst, Belgium, Laura Langhendries, Maxime Lassel, Leuven, Belgium, Andrea Mari, Florence, Italy, Lorenzo Bianchi, Pietro Piazza, Bologna, Italy, Ben Van Cleynenbreugel, Leuven, Belgium, Elio Mazzone, Milan, Italy, Kobe Van Hove, Simon Meganck, Léonore Maertens, Louis-Philippe Boret, Ghent, Belgium, Filippo Migliorini, Verona, Italy, Saverio Forte, Bari, Italy, Bernardo Rocco, Milan, Ita-ly, Salvatore Micali, Modena, Italy, Alexandre Mottrie, Aalst, Belgium, Anthony Gallagher, Melle, Belgium

MP41-07 PRESENTATION SKILLS IN THE VIRTUAL MEETING ERA – AN ANALYSIS OF #EAU21

Kenneth Chen, Jonathan O’Brien*, Pocharapong Jenjitranant, Omar Alghazo, Brian Kelly, Renu Eapen, Daniel Moon, Nathan Lawrentschuk, Declan Murphy, Melbourne, Australia

MP41-08 ADVANCED TECHNIQUES TO IMPROVE VIDEO-BASED AUTOMATION OF SUTURING SKILLS ASSESSMENT

Andrew J Hung*, Los Angeles, CA, Richard Bao, Pasadena, CA, Idris O Sunmola, Evanston, IL, De-An Huang, Santa Clara, CA, Jessica H. Nguyen, Los Angeles, CA, Anima Anandkumar, Pasadena, CA

MP41-09 COMBINING VIDEO AND FORCE SENSOR DATA WITHIN A MULTILABEL MULTIMODAL DEEP LEARNING ALGORITHM TO PROVIDE AUTOMATED FEEDBACK FOR ROBOT ASSISTED RADICAL PROSTATECTOMY SIMULATIONS

Patrick Saba*, Beilei Xu, Rachel Melnyk, Christo-pher Wanderling, Ahmed Ghazi, Rochester, NY

MP41-10 USING CUSTOMIZED FEEDBACK TO EXPEDITE THE ACQUISITION OF ROBOTIC SUTURING SKILLS

Runzhuo Ma*, Jessica H. Nguyen, Andrew Cow-an, Ryan S. Lee, Taseen Haque, Jonathan You, Sidney I. Roberts, Steven Cen, Los Angeles, CA, Anthony Jarc, Norcross, GA, Andrew J. Hung, Los Angeles, CA

MP41-11 ANALYSIS OF FLEXIBLE URETEROSCOPIC MOTION AND KINEMATIC EFFICIENCY-A SIMULATION-BASED PILOT STUDY

Marie-Therese Valovska*, Gricelda Gomez, Boston, MA, Richard Fineman, William Woltmann, Cambridge, MA, Leia Stirling, Ann Arbor, MI, Daniel Wollin, Boston, MA


SU

ND

AY

MP41-12 EFFECTIVENESS OF VIRTUAL REALITY SIMULATION OF RENAL PUNCTURE FOR ENDOSCOPIC-COMBINED INTRARENAL SURGERY

Atsushi Okada*, Kazuya Ohashi, Yusuke Noda, Tomoki Okada, Ryosuke Chaya, Kengo Kawase, Taiki Kato, Kazumi Taguchi, Shuzo Hamamoto, Keiichi Tozawa, Kenjiro Kohri, Takahiro Yasui, Nagoya, Japan

MP41-13 DOES QUALITY ASSURED ELEARNING PROVIDE ADEQUATE PREPARATION FOR ROBOTIC SURGICAL SKILLS; A PROSPECTIVE, RANDOMIZED AND MULTI-CENTER STUDY

Stefano Puliatti*, Marco Amato, Modena, Italy, Rui Farinha, Ghent, Belgium, Artur paludo, Porto Alegre, Brazil, Giuseppe Rosiello, Milan, Italy, Ruben De Groote, Aalst, Belgium, Andrea Mari, Florence, Italy, Lorenzo Bianchi, Pietro Piazza, Bologna, Italy, Ben Van Cleynenbreugel, Leuven, Belgium, Elio Mazzone, Milan, Italy, Simon Meg-anck, Léonore Maertens, Louise Callens, Ghent, Belgium, Filippo Migliorini, Verona, Italy, Saverio Forte, Bari, Italy, Bernardo Rocco, Milan, Italy, Salvatore Micali, Modena, Italy, Alexandre Mottrie, Aalst, Belgium, Anthony Gallagher, Melle, Belgium

MP41-14 THE LEARNING CURVE OF RADICAL NEPHRECTOMY FOR KIDNEY CANCER: IMPLICATIONS FOR SURGICAL TRAINING

Federico Belladelli*, Giuseppe Fallara, Giuseppe Rosiello, Daniele Cignoli, Giuseppe Basile, Gianmarco Colandrea, Giacomo Musso, Franc-esco Cei, Daniela Canibus, Walter Cazzaniga, Gianfranco Baiamonte, Chiara Re, Andrea Ieva, Milan, Italy, Pierre I. Karakiewicz, Montreal, Can-ada, Federico Dehò, Varese, Italy, Patrizio Rigatti, Giorgio Guazzoni, Milan, Italy, Andrea Gallina, Lugano, Switzerland, Alexandre Mottrie, Aalst, Belgium, Francesco Montorsi, Roberto Bertini, An-drea Salonia, Alberto Briganti, Umberto Capitanio, Alessandro Larcher, Milan, Italy

MP41-15 PCNL ACCESS PLANNING USING A NOVEL OPTIMIZATION ALGORITHM

Moiz Khan, Boston, MA, Filipe De Carvalho Pedrosa, Lexuan Wang, London, Canada, Borna Dabiri, Boston, MA, Rajni Patel, London, Canada, Jayender Jagadeesan, Dianne Sacco*, Boston, MA

MP41-16 EVALUATION OF MIXED REALITY (MR) TECHNOLOGIES FOR REMOTE GUIDANCE DURING TRANSRECTAL ULTRASOUND BIOPSY (TRUS-BX) SIMULATION: A PROSPECTIVE, RANDOMIZED COMPARATIVE TRIAL

Rachel Melnyk, John Melnyk, Christopher Wanderling, Scott Quarrier, Hani Rashid, Ahmed Ghazi*, Rochester, NY

MP41-17 USING A MULTI-TASK CONVOLUTIONAL NEURAL NETWORK TO PREDICT SURGEON SKILL IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY

Hal Kominsky*, Yihao Wang, Jessica Dai, Tara Morgan, Alaina Garbens, Jeffrey Gahan, Eric Larson, Dallas, TX

MP41-18 DIFFICULT FOLEY? A LOOK INTO DIFFICULT FOLEY CONSULTS

Katharina Mitchell*, Amr Elbakry, Caitlyn Patton, John Barnard, Morgantown, WV, Chad Morley, Morgantown, WV

MP41-19 PHASE I NCT03738488. FEASIBLE 3D PRINTED MODELS OF RENAL CELL CARCINOMA WITH VENOUS THROMBUS EXTENSION FOR SURGICAL PLANNING AND SIMULATION

Ines Rivero Belenchon*, Carmen Belen Congre-gado Ruiz, Gorka Gomez Ciriza, Seville, Spain, Victoria Gomez Dos Santos, Madrid, Spain, Cristina Asensio, Seville, Spain, Cristina Gonzalez Gordaliza, Madrid, Spain, Ignacio Osman Garcia, Jose Manuel Conde Sanchez, Seville, Spain, Francisco Javier Burgos Revilla, Madrid, Spain, Rafael Antonio Medina Lopez, Seville, Spain

MP41-20 COST-EFFECTIVE AND READILY REPLICABLE SURGICAL SIMULATION MODEL IMPROVES TRAINEE PERFORMANCE IN URETHROVESICAL ANASTOMOSIS

Stacy Jeong*, Cleveland Heights, OH, Maxx Caveney, Jacob Knorr, Rebecca Campbell, Daniel Santana, Christopher Weight, Nima Almassi, Steven Campbell, Cleveland, OH


178

Sunday, May 15, 2022 10:30 am – 11:45 am

Moderated Poster Session 42BLADDER CANCER: EPIDEMIOLOGY & EVALUATION II

Room 225 @ Ernest N. Morial Convention CenterModerators: Karim Chamie, John Gore & Eila Skinner


MP42-01 COMPARISON OF MICROSCOPIC HEMATURIA INCIDENCE AND GRADE BETWEEN MICROSCOPIC AND IRIS™ AUTOMATED URINALYSIS METHODS

Aleem Khan*, Jani Alkesh, Mark Sawyer, Denver, CO

MP42-02 URINARY HUMAN PAPILLOMA VIRUS INFECTION AND BLADDER CANCER RISK: A SYSTEMATIC REVIEW AND A PRISMA-COMPLIANT META-ANALYSIS

Dario Garcia-Rojo*, Jesus Muñoz-Rodriguez, Clara Centeno, Angel Prera, Carlos Abad, Edu-ardo Vicente, Jose Luis Gonzalez-Sala, Naim Hannaoui, Arturo Dominguez-Garcia, Marta Capdevila, Leticia de Verdonces, Anna Ferran, Carmina Pla, Paula Azuara, Silvia Cuadrench, Maria Eugenia Zegri, Juan Prats, Sabadell, Spain

MP42-03 5α-REDUCTASE INHIBITORS AND THE RISK OF BLADDER CANCER IN A LARGE, POPULATION-BASED COHORT

Snir Dekalo*, Eric McArthur, Jeff Campbell, Michael Ordon, Nicholas Power, Blayne Welk, London, Canada

MP42-04 FINANCIAL BURDEN OF BLADDER CANCER CARE: CDC NATIONAL HEALTH SURVEY ANALYSIS

Laura Bukavina*, Alberto Castro Bigalli, Philadel-phia, PA, Thomas Cwalina, Caleb Curry, Michael Callegari, Megan Prunty, Ilaha Isali, Cleveland, OH, Mohit Sindhani, New Delhi, India, Adam Calaway, Lee Ponsky, Cleveland, OH, Andres Correa, Alexander Kutikov, Philadelphia, PA, Sarah Psutka, Seattle, WA

MP42-05 USE OF INTRAVESICAL CHEMOTHERAPY IN THE UNITED STATES FOLLOWING PUBLICATION OF A RANDOMIZED TRIAL

Alec Zhu*, Patrick Lewicki, New York, NY, Camilo Arenas-Gallo, Cleveland, OH, Aaron Brant, Spyridon Basourakos, Yuqing Qiu, New York, NY, Megan Prunty, Cleveland, OH, Douglas Scherr, New York, NY, Jonathan Shoag, Cleveland, OH

MP42-06 IMPACT OF EXERCISE ON PHYSICAL HEALTH STATUS IN BLADDER CANCER PATIENTS

Mara Koelker*, Khalid Alkhatib, Muhieddine Lab-ban, Mark A. Preston, Timothy N. Clinton, Steven L. Chang, Quoc-Dien Trinh, Matthew Mossanen, Boston, MA

MP42-07 EFFECTS OF LIFESTYLE AND ENVIRONMENTAL FACTORS ON STAGE OF BLADDER CANCER AT INITIAL PRESENTATION

Ayat A. Shah*, Nighat Sofi, Holly Houenstein, Yousuf Ramahi, Zhe Jing, Ahmed A. Hussein, Khurshid A. Guru, Buffalo, NY


MP42-08 CAN VESICAL IMAGING-REPORTING AND DATA SYSTEM DIFFERENTIATE T1 AND T2 BLADDER TUMORS? A META-ANALYSIS

Seyed Behzad Jazayeri*, Hojat Dehghanbanada-ki, Seyed Behnam Jazayeri, Mahdie Hosseini, Pourya Taghipour, Muhammad Umar Alam, KC Balaji, Mark Bandyk, Jacksonville, FL

MP42-09 NEIGHBORHOOD DISADVANTAGE CORRELATES WITH OUTCOMES IN MUSCLE INVASIVE BLADDER CANCER

Devon Langston*, Sarah Beebe, Tasha Posid, Victor Heh, Kamal Pohar, Columbus, OH

MP42-10 TREATMENT AND ASSOCIATED SURVIVAL TRENDS FOR LOCALIZED SMALL CELL CARCINOMA OF THE BLADDER

Woodson Smelser*, Wilson Sui, Nashville, TN, Christopher Wallis, Toronto, Canada, Sam Chang, Nashville, TN

MP42-11 THE IMPACT OF PSYCHIATRIC DIAGNOSES ON PERIOPERATIVE OUTCOMES FOLLOWING RADICAL CYSTECTOMY IN THE STATE OF FLORIDA

Bryce Baird*, Tiara Taylor, Shalmali Borkar, Laura Geldmaker, Christian Ericson, Emily Brennan, Jacksonville, FL, Augustus Anderson, New Orleans, LA, Stephen Boorjian, Rochester, MN, Shehzad Niazi, Dorin Colibaseanu, Aaron Spauld-ing, Timothy Lyon, Jacksonville, FL

MP42-12 HIGHER PREOPERATIVE EGFR IS A PREDICTOR OF WORSE RENAL FUNCTION DECLINE AFTER ROBOTIC ASSISTED RADICAL CYSTECTOMY

Shirin Razdan*, Benjamin Eilender, John Pfail, Mariely Garcia, Daniel Ranti, Shoshana Rosen-zweig, New York, NY, Abolfazl Hosseini, Jari Radros, Stockholm, Sweden, Reza Mehrazin, Peter Wiklund, John Sfakianos, New York, NY

MP42-13 PELVIC LYMPHADENECTOMY FOR BLADDER CANCER: DOES A THOROUGH DISSECTION STILL MATTER?

Arnav Srivastava*, Hiren Patel, Kevin Chua, Sai Krishnaraya Doppalapudi, Akshay Thaper, Sammy Elsamra, New Brunswick, NJ, Isaac Kim, New Haven, CT, Eric Singer, Thomas Jang, Saum Ghodoussipour, New Brunswick, NJ

MP42-14 CHARACTERISTICS CONTRIBUTING TO SURVIVAL DIFFERENCES BETWEEN BLACK AND WHITE PATIENTS FOLLOWING RADICAL CYSTECTOMY

Shoshana Rosenzweig*, John Sfakianos, Reza Mehrazin, Peter Wiklund, Nikhil Waingankar, New York, NY


SU

ND

AY

MP42-15 UROTHELIAL CARCINOMA OF THE BLADDER WITH ISOLATED LYMPH NODE METASTASIS: NATURAL HISTORY AND OUTCOMES FOLLOWING SURGICAL RESECTION

Ernest Morton*, Grand Rapids, MI, Sumedh Kaul, Aaron Fleishman, Ruslan Korets, Peter Chang, Andrew Wagner, Boston, MA, Simon Kim, Aurora, CO, Joaquim Bellmunt, Irving Kaplan, Aria Olumi, Boris Gershman, Boston, MA

MP42-16 VARIOUS INCIDENCE RISKS OF SUBSEQUENT MALIGNANCIES IN URINARY TRACT AFTER INITIAL BLADDER CANCER DIAGNOSIS STRATIFIED BY LATENCIES

Shu Wang*, Ryan Russell, Michael Phelan, M. Minhaj Siddiqui, Baltimore, MD

MP42-17 CONDITIONAL SURVIVAL FOLLOWING RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER

Maria F. Moreno*, Sumedh Kaul, Aaron Fleish-man, Ruslan Korets, Peter Chang, Andrew Wagner, Boston, MA, Simon Kim, Aurora, CO, Joaquim Bellmunt, Irving Kaplan, Aria F. Olumi, Boris Gershman, Boston, MA

MP42-18 SOCIAL AND ENVIRONMENTAL RISK FACTORS FOR UNDERGOING RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA IN RHODE ISLAND: 2000-2020

Borivoj Golijanin*, Sarah Andrea, Justin Bessette, Rebecca Ortiz, Philip Caffery, Timothy O’Rourke, Christopher Tucci, Ali Amin, Dragan Golijanin, Providence, RI


Sunday, May 15, 2022 10:30 am – 11:45 am

Moderated Poster Session 43PROSTATE CANCER: LOCALIZED: ACTIVE SURVEILLANCE

Room 222 @ Ernest N. Morial Convention CenterModerators: Joseph Smith, Sung Kyu Hong & Peter Carroll


MP43-01 CLINICAL SIGNIFICANCE OF DETECTION OF PERINEURAL INVASION IN LOW-RISK MEN ON ACTIVE SURVEILLANCE

Claire de la Calle*, Mufaddal Mamawala, Patricia Landis, Jonathan Epstein, Bruce Trock, Ballentine Carter, Christian Pavlovich, Baltimore, MD

MP43-02 PREFERENCE ELICITATION AND TREATMENT DECISION MAKING AMONG MEN DIAGNOSED WITH LOCALIZED PROSTATE CANCER: RESULTS FROM THE HEALIUM TRIAL

Michael Diefenbach*, Simon Hall, Manish Vira, Mi-chael Schwartz, New Hyde Park, NY, Erin Tagai, Alexander Kutikov, Andres Correa, Philadelphia, PA, Halie Pfister, Andrea Yacoub, Manhasset, NY, Suzanne Miller, Philadelphia, PA

MP43-03 ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER: TIME TRENDS AND VARIATION IN THE AUA QUALITY (AQUA) REGISTRY

Matthew Cooperberg*, San Francisco, CA, William Meeks, Raymond Fang, Baltimore, MD, Franklin Gaylis, San Diego, CA, William Catalona, Chicago, IL, Danil Makarov, New York, NY

MP43-04 COMPARISON OF 4K SCORE, PROSTATE HEALTH INDEX, AND PSA DENSITY IN ACTIVE SURVEILLANCE

Bruce Trock*, Mufaddal Mamawala, Patricia Lan-dis, Yasin Bhanji, Baltimore, MD, Andrew Vickers, New York, NY, Christian Pavlovich, Baltimore, MD


MP43-05 UPFRONT MRI IS THE NEW STANDARD, HAVE CONFIRMATORY BIOPSIES BECOME OBSOLETE?

Henk Luiting, Ivo Izaak de Vos*, Sebastiaan Rem-mers, Egbert Boevé, Chris Bangma, Rotterdam, Netherlands, Riccardo Valdagni, Milan, Italy, Peter Chiu, Hong Kong, Hong Kong, Axel Semjonow, Münster, Germany, Viktor Berge, Oslo, Norway, Karl Tully, Herne, Germany, Antti Rannikko, Hel-sinki, Finland, Frédéric Staerman, Reims, France, Monique Roobol, Rotterdam, Netherlands

MP43-06 COMPARING MRI/US FUSION TO STANDARD PROSTATE BIOPSY IN DETERMINING GRADE RECLASSIFICATION AT CONFIRMATORY BIOPSY IN A MULTI-INSTITUTIONAL ACTIVE SURVEILLANCE COHORT: A PENNSYLVANIA UROLOGY REGIONAL COLLABORATIVE (PURC) ANALYSIS

David Strauss*, Rohit Reddy, Matthew Loecher, Philadelphia, PA, Kaynaat Syed, Philadelphia, PA, John Danella, Danville, PA, Serge Ginzburg, Philadelphia, PA, Laurence Belkoff, Bala Cynwyd, PA, Jeffrey Tomaszewski, Camden, NJ, Edouard Trabulsi, Philadelphia, PA, Eric Singer, New Brunswick, NJ, Bruce Jacobs, Pittsburgh, PA, Jay Raman, Hershey, PA, Thomas Guzzo, Robert Uzzo, Adam Reese, Philadelphia, PA

180

MP43-07 NEGATIVE PROSTATE MRI AS A PREDICTOR OF DISEASE STABILITY IN PATIENTS ON ACTIVE SURVEILLANCE

Jacob Enders*, Michael Rothberg, Zach Kozel, Michael Daneshvar, Luke O’Connor, Alex Wang, Cheyenne Williams, Nitin Yerram, Sandeep Gur-ram, Maria Merino, Baris Turkbey, Bradford Wood, Peter Pinto, Bethesda, MD

MP43-08 ACTIVE SURVEILLANCE FOR PROSTATE CANCER: UPTAKE OVER TIME AND THE IMPACT OF AN ORGANIZED PROTOCOL

Sebastiaan Remmers*, Monique Roobol, ERSPC Rotterdam Study Group, Rotterdam, Netherlands

MP43-09 RISK OF ADVERSE PATHOLOGY AFTER DEFERRED PROSTATECTOMY FOR GRADE GROUP 1 AND 2 PROSTATE CANCER BEING MANAGED BY ACTIVE SURVEILLANCE

Cheyenne Williams*, Philadelphia, PA, Michael Daneshvar, Patrick Gomella, Luke O’Connor, Sandeep Gurram, Peter Choyke, Bradford Wood, Baris Turkbey, Maria Merino, Peter Pinto, Bethes-da, MD

MP43-10 IMPACT OF FAMILY HISTORY AND GERMLINE GENETIC RISK VARIANTS ON LONG-TERM OUTCOMES OF ACTIVE SURVEILLANCE-ELIGIBLE PROSTATE CANCER

Florian Rumpf, Anna Plym, Jane Vaselkiv, Mark Preston, Adam Kibel, Lorelei Mucci, Keyan Sala-ri*, Boston, MA

MP43-11 THE USE AND OUTCOMES OF MEN WITH NCCN FAVORABLE INTERMEDIATE RISK PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE

Roshan Paudel*, Ann Arbor, MI, Raghav Madan, Detroit, MI, Ji Qi, Ann Arbor, MI, Michael Cher, Detroit, MI, Brian Lane, Grand Rapids, MI, Arvin George, Alice Semerjian, Ann Arbor, MI, Kevin Ginsburg, Detroit, MI, for the Michigan Urolog-ical Surgery Improvement Collaborative, Ann Arbor, MI

MP43-12 IMPACT OF NCCN-COMPLIANT MULTIDISCIPLINARY CONFERENCE ON THE UTILIZATION OF ACTIVE SURVEILLANCE FOR PATIENTS WITH LOCALIZED PROSTATE CANCER

Ayat A. Shah*, Holly Houenstein, Yousuf Ramahi, Philippa Doherty, Zhe Jing, Umar Iqbal, Caleb J. Eun, Grace E. Harrington, Mohammad Khan, Thomas Schwaab, Qiang Li, Eric C. Kauffman, James L. Mohler, Michael Kuettel, Khurshid A. Guru, Ahmed A. Hussein, Buffalo, NY

MP43-13 INTERLABORATORY GLEASON GRADING VARIATION AFFECTS TREATMENT: A DUTCH HISTORIC COHORT STUDY IN 30,509 PROSTATE CANCER PATIENTS

Rachel Flach*, Carmen van Dooijeweert, Katja Aben, Britt Suelmann, Peter-Paul Willemse, Paul van Diest, Richard Meijer, Utrecht, Netherlands

MP43-14 EXTERNAL VALIDATION OF A MODEL PREDICTING INCREASE IN GLEASON GRADE FOR MEN ON ACTIVE SURVEILLANCE IN THE GAP3 CONSORTIUM DATABASE

Daan Nieboer*, Ivo de Vos, Rotterdam, Nether-lands, Lui Shiong Lee, Singapore, Singapore, Phillip Stricker, Darlinghurst, Australia, Mark Frydenburg, Melbourne, Australia, Anders Bjartell, Malmö, Sweden, Jose Rubio-Briones, Valencia, Spain, Axel Semjonow, Muenster, Germany, Antti Rannikko, Helsinki, Finland, Mieke van Hemelri-jck, London, United Kingdom, Christian Pavlovich, Baltimore, MD, Peter Carroll, San Fransisco, CA, Monique Roobol, Rotterdam, Netherlands

MP43-15 A 5-YEAR PROSPECTIVE STUDY OF AFRICAN AMERICAN MEN ON PROSTATE CANCER ACTIVE SURVEILLANCE: DOES RACE PREDICT UPGRADING?

Joshua Pincus*, Jacob W. Greenberg, Christo-pher Koller, New Orleans, LA, Jonathan Sil-berstein, Aventura, FL, L. Spencer Krane, New Orleans, LA

MP43-16 RACIAL DISPARITIES IN RATES OF GLEASON GRADE RECLASSIFICATION IN A MULTI-INSTITUTIONAL PROSTATE CANCER ACTIVE SURVEILLANCE COHORT: A PENNSYLVANIA UROLOGY REGIONAL COLLABORATIVE (PURC) ANALYSIS

Rohit Reddy*, David Strauss, Matthew Loecher, Kaynaat Syed, Philadelphia, PA, John Danella, Danville, PA, Serge Ginzburg, Philadelphia, PA, Laurence Belkoff, Bala Cynwyd, PA, Jeffrey Tomaszewski, Camden, NJ, Edouard Trabulsi, Philadelphia, PA, Eric A Singer, New Brunswick, NJ, Bruce L. Jacobs, Pittsburgh, PA, Jay Raman, Hershey, PA, Thomas Guzzo, Thomas Guzzo, Robert Uzzo, Adam C. Reese, Philadelphia, PA

MP43-17 PREDICTING TRUE PATHOLOGIC GLEASON GRADE DURING ACTIVE SURVEILLANCE FOR PROSTATE CANCER: CALIBRATION OF THE JOHNS HOPKINS ACTIVECARE MODEL IN FIVE LARGE ACTIVE SURVEILLANCE COHORTS

Christian Pavlovich*, Baltimore, MD, Daan Niebo-er, Rotterdam, Netherlands, Mufaddal Mamawala, Akihiko Nishimura, Patricia Landis, Katarzyna Macura, Jonathan Epstein, Baltimore, MD, Jozien Helleman, Rotterdam, Netherlands, Bruce Trock, Baltimore, MD, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium, Rotterdam, Netherlands

MP43-18 PROSTATE CANCER MORTALITY RATES IN LOW AND FAVORABLE INTERMEDIATE RISK ACTIVE SURVEILLANCE PATIENTS: A POPULATION-BASED COMPETING RISKS ANALYSIS

Rashid Sayyid*, John Benton, William Reed, Mer-ry Ma, Phillip Woodruff, Martha Terris, Augusta, GA, Christopher Wallis, Toronto, Canada, Zachary Klaassen, Augusta, GA


SU

ND

AY

MP43-19 DROP-OUT RATES FROM ACTIVE SURVEILLANCE FOR DISEASE PROGRESSION REMAIN CONSISTENT AND NOT NEGLIGIBLE OVER TIME. A PLEA FOR LONG-TERM ASSESSMENT BASED ON A LARGE, PROSPECTIVELY COLLECTED ACTIVE SURVEILLANCE COHORT

Luigi Nocera*, Milan, Italy, Riccardo Leni, Milano, Italy, Armando Stabile, Milan, Italy, Giorgio Gandaglia, Elio Mazzone, Milano, Italy, Gabri-ele Sorce, Francesco Pellegrino, Milan, Italy, Francesco Barletta, Simone Scuderi, Milano, Italy, Andrea Gallina, Nicola Fossati, Lugano, Switzerland, Emanuele Zaffuto, Milan, Italy, Marco Moschini, Lucerne, Switzerland, Nazareno Suardi, Genoa, Italy, Shahrokh F. Shariat, Vienna, Austria, Francesco Montorsi, Alberto Briganti, Milano, Italy

MP43-20 LONG TERM HEALTH-RELATED QUALITY OF LIFE (HRQOL) OUTCOMES AFTER SURGERY, RADIOTHERAPY, OR ACTIVE SURVEILLANCE FOR LOCALIZED PROSTATE CANCER

Eyal Kord*, Nathan Jung, Seattle, WA, Jiji Jiang, Bethesda, MD, Natasza Posielski, On Ho, Seattle, WA, Sally Elsamanoudi, Gregory T. Chesnut, Bethesda, MD, Ryan Speir, Tacoma, WA, Sean Stroup, San diego, CA, John Musser, Honolulu, HI, Alexander Ernest, Houston, TX, Timothy Tausch, Bethesda, MD, John Paul Flores, Christo-pher Porter, Seattle, WA


Sunday, May 15, 2022 10:30 am – 2:30 pm

UROLOGICAL SOCIETY FOR AMERICAN VETERANS (USAV)St. Charles Ballroom @ Hilton New Orleans Riverside

Chair: Arvin George

10:30 WELCOME/USAV UPDATE Society President: Robert Grubb Chair: Arvin George

10:40 CONDUCTING RESEARCH AT THE VA-NAVREF Julia Houston

10:55 MODERATED POSTER SESSION

11:40 KEYNOTE TALKS: BALLOON DEBATE

ENUCLEATION John DiBianco

TURP L. Spencer Krane

UROLIFT Amin Herati

REZU–

M™ Arvin George

AQUABLATION Gopal Badlani

12:20 VISIT EXHIBITS - LUNCH BREAK - VIEW POSTERS

12:50 INDUSTRY SUPPORTED TALK BY EXACT SCIENCES

1:10 ADDRESSING NEEDS OF FEMALE VETS AT THE VA Rachel Rubin

1:25 PSMA PET - INDICATIONS AND OUTCOMES Kevin Ginsberg

1:40 INDUSTRY SUPPORTED TALK

2:00 NOVEL LASERS IN ENDOUROLOGY Khurshid Ghani

2:15 POSTERS AWARDS CEREMONY

2:25 CONCLUDING REMARKS Society President: Robert Grubb Chair: Arvin George

Sunday, May 15, 2022 12:00 pm – 6:00 pm

SOCIETY OF UROLOGIC ROBOTIC SURGERY (SURS)Grand Ballroom A @ Hilton New Orleans Riverside

12:00 INVITED VIDEO SESSION Moderator: Ashok Hemal

ROBOTIC SINGLE PORT RADICAL CYSTECTOMY Jeffery Nix

ROBOTIC TRANSVESICAL RADICAL PROSTATECTOMY USING MULTIPORT

Vinayak Wagaskar

ROBOTIC SINGLE PORT PARTIAL NEPHRECTOMY

ROBOTIC VEIL TECHNIQUE FOR LYMPH NODES DISSECTION

Sudhir Rawal

HYDRO DISSECTION Adriana Pedraza

1:00 WELCOME AND SURS UPDATE Ashutosh Tewari

1:05 SESSION 1 Moderators: Ashok Hemal, Ashutosh Tewari

ADVANCING LANDSCAPE OF ROBOTIC SURGERY Prokar Dasgupta

ADVANCING FIELD OF ROBOTIC URO- ONCOLOGIC SURGERY

Inderbir Gill

ESTABLISHING STRUCTURED ORSI ROBOTIC TRAINING PROGRAM

Alex Mottrie

1:45 SESSION 2: DEBATE SESSION Moderators: Prokar Dasgupta, Kirsten Greene, Chandru Sundaram

182

SINGLE PORT ROBOTIC RADICAL PROSTATECTOMY

Debater-Pro: Jihad Kaouk Debater-Con: Jim Porter

SINGLE PORT ROBOTIC PARTIAL NEPHRECTOMY Debater-Pro: Simone Crivellaro Debater-Con: Inderbir Gill

SINGLE PORT ROBOTIC RADICAL CYSTECTOMY Debater-Pro: Mutahar Ahmed Debater-Con: Mihir Desai

MALE WITH UNFAVORABLE INTERMEDIATE-RISK PROSTATE CANCER

Debaters: John Davis, Avi Reddy

3:05 SESSION 3: PROSTATE Moderators: Peter Carroll, Li-Ming Su, Aneesh Shrivastava

ROBOTIC RADICAL PROSTATECTOMY: ADVANC-ES IN NERVE SPARING PROSTATECTOMY

Ashutosh Tewari

ROBOTIC RADICAL PROSTATECTOMY IN HIGH-GRADE HIGH-RISK PROSTATE CANCER

3:30 SESSION 4: KIDNEY & RECONSTRUCTIVE SURGERY

Moderators: Rajesh Ahlawat, Mo Allaf, Francesco Porpiglia, Casey Seideman

ROBOTIC PARTIAL NEPHRECTOMY: ENDOPHYT-IC & HILAR

Craig Rogers

ROBOTIC PARTIAL NEPHRECTOMY: COMPLEX, T1B & BEYOND

Ketan Badani

INDIVIDUALIZED APPROACH TO HIGH-RISK UTUC: WHEN IS SEGMENTAL RESECTION VS. DISTAL URETERECTOMY VS. RADICAL NEPHRO-URETERECTOMY PREFERRED?

Ram Pathak

ROBOTIC RECONSTRUCTIVE UPPER TRACT URETERAL SURGERY

Lee Zhao

ROBOTIC RECONSTRUCTIVE LOWER TRACT URETERAL SURGERY

Raju Thomas

ROBOTIC RENAL TRANSPLANT Alberto Breda

ROBOTIC SURGERY IN CHILDREN Aseem Shukla

4:50 SESSION 5: BLADDER & TESTIS Moderators: Ali Reza Kural, Reza Mehrazin, Raj Pruthi

ROBOTIC RADICAL CYSTECTOMY: IS IT WAY TO GO?

Khurshid Guru

INTRACORPOREAL URINARY DIVERSION Peter Wiklund

ROBOTIC RETROPERITONEAL LYMPHADENEC-TOMY

John Sfakianos

5:30 SURS BUSINESS MEETING

APPROVED FOR AMA PRA CATEGORY 1 CREDIT™

Sunday, May 15, 2022 1:00 pm – 2:15 pm

Moderated Poster Session 44STONE DISEASE: SURGICAL THERAPY (INCLUDING ESWL) III

Room 228 @ Ernest N. Morial Convention CenterModerators: Ojas Shah & Michael Bailey


MP44-01 WHAT IS THE IDEAL FOLLOW UP AFTER KIDNEY STONE TREATMENT? A SYSTEMATIC REVIEW AND FOLLOW-UP ALGORITHM FROM THE EUROPEAN ASSOCIATION OF UROLOGY UROLITHIASIS PANEL

Riccardo Lombardo*, Rome, Italy, Lazaros Tzelves, Athens, Greece, Robert Geraghty, New-castle-upon-Tyne, United Kingdom, Niall F. Davis, Dublin, Ireland, Andreas Neisius, Trier, Germany, Ales Petrík, Prague, Czech Republic, Giovanni Gambaro, Verona, Italy, Christian Türk, Vienna, Austria, Bhaskar Somani, Southampton, United Kingdom, Andreas Skolarikos, Athens, Greece, Kay Thomas, London, United Kingdom


MP44-02 FAVORABLE OUTCOMES OF CONTEMPORARY PERCUTANEOUS NEPHROLITHOTOMY VERSUS RETROGRADE INTRARENAL SURGERY FOR TREATMENT OF RENAL STONES IN ADULT PATIENTS: A COCHRANE REVIEW

Leah Soderberg, Rochester, MN, Maylynn Ding, Hamilton, Canada, Vernon Pais, Lebanon, NH, Mi-chael S Borofsky, Minneapolis, MN, Robin Parker, Halifax, Canada, Philipp Dahm*, Minneapolis, MN

MP44-03 ULTRASOUND-ONLY PERCUTANEOUS NEPHROLITHOTOMY IS SAFE AND EFFECTIVE COMPARED TO FLUOROSCOPY-DIRECTED PCNL

Nizar Hakam*, Gregory Hosier, Xavier Cortez, Fadl Hamouche, Leslie Charondo, Heiko Yang, Carter Chan, Kevin Chang, David Bayne, Marshall Stoller, Thomas Chi, San Francisco, CA


SU

ND

AY

MP44-04 REAL-WORLD PRACTICE STONE-FREE RATES AFTER URETEROSCOPY FROM A SURGICAL COLLABORATIVE: MUCH TO IMPROVE

Hyung Joon Kim*, Stephanie Daignault-Newton, John M. DiBianco, Ann Arbor, MI, S. Mohammad Jafri, Royal Oak, MI, Brian Seifman, Royal Oak, Troy, MI, Eduardo Kleer, Ypsilanti, MI, Casey A. Dauw, Khurshid R. Ghani, for the Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI

MP44-05 TREATMENT OF URETERIC STONES WITH LITHOEVO DEVICE AND VAPOR TUNNEL TOOL

Matteo Maltagliati, Lorenzo Berti, Umberto Besa-na, Carlo Buizza, Busto Arsizio, Italy, Davide Per-ri, Novara, Italy, Salvatore Micali, Modena, Italy, Bernardo Rocco, Maria Chiara Sighinolfi, Milano, Italy, Carmine Sciorio, Lecco, Italy, Antonio Luigi Pastore, Latina, Italy, Dymitry Pushkar, Alexander Govorov, Moscow, Russian Federation, Javier Romero Otero, Madrid, Spain, Giorgio Bozzini*, Como, Italy

MP44-06 MORBIDLY OBESE PATIENTS MAY SAFELY UNDERGO PERCUTANEOUS NEPHROLITHOTOMY AT AN AMBULATORY SURGERY CENTER

Max Drescher*, Baltimore, MD, Daniel Rosen, Hanover, MD, Joel Abbott, Las Vegas, NV, Julio Davalos, Hanover, MD

MP44-07 RELATIONSHIP BETWEEN RENAL PELVIS PRESSURE AND POST-URETEROSCOPY INFECTION IN A LIVE SWINE MODEL

David Hinojosa-Gonzalez, Christina Kottooran, Boston, MA, Jennifer Saunders, Marle Franco, Marlborough, MA, Brian Eisner*, Boston, MA

MP44-08 A NOVEL SCORE TO PREDICT SEPSIS IN PATIENTS UNDERGOING URETERAL STENT PLACEMENT FOR OBSTRUCTING STONE AND PRESUMED URINARY TRACT INFECTION

David E. Hinojosa-Gonzalez*, Jason J. Lee, Christina S Kottooran, Alan J. Yaghoubian, Boston, MA, Nikil R. Uppaluri, Kate A. Hanson, Micheal S. Borofsky, Minneapolis, MN, Brian H. Eisner, Boston, MA

MP44-09 A PROSPECTIVE, RANDOMIZED, SINGLE-BLIND STUDY OF URETERAL STENT BIOMATERIAL ENCRUSTATION AFTER URETEROSCOPIC LITHOTROPISY

Shuzo Hamamoto*, Ryosuke Chaya, Kazumi Taguchi, Kengo Kawase, Tomoki Okada, Tatsuya Hattori, Terukaki Sugino, Rei Unno, Atsushi Okada, Takahiro Yasui, Nagoya, Japan

MP44-10 A COMPARISON AMONG RIRS AND MINIPERC FOR RENAL STONES BETWEEN 1 AND 2 CM USING FIBER DUST: A RCT

Lorenzo Berti, Matteo Maltagliati, Umberto Be-sana, Carlo Buizza, Busto Arsizio, Italy, Andrea Pacchetti, Genova, Italy, Salvatore Micali, Mode-na, Italy, Maria Chiara Sighinolfi, Bernardo Rocco, Milano, Italy, Giorgio Bozzini*, Como, Italy

MP44-11 URETEROSCOPY VS. SHOCKWAVE LITHOTRIPSY FOR LOWER POLE RENAL STONES: TREATMENT VARIATION AND OUTCOMES IN A SURGICAL COLLABORATIVE

John Michael DiBianco*, Stephanie Daig-nault-Newton, Ann Arbor, MI, Eric Stockall, Lansing, MI, Spencer Hiller, Hyung Joon Kim, Ann Arbor, MI, Hector Pimentel, Grand Rapids, MI, Casey A. Dauw, Khurshid R. Ghani, for the Michigan Urological Surgery Improvement Collab-orative, Ann Arbor, MI

MP44-12 VACUUM-ASSISTED MINI PERCUTANEOUS NEPHROLITHOTOMY ALLOWS OUTPATIENT MANAGEMENT OF LARGE KIDNEY STONES, A STUDY FROM RESKU

Fadl Hamouche, Kevin Chang*, Rei Unno, Greg Hosier, Heiko Yang, Justin Ahn, David Bayne, San Francisco, CA, Marshall Stoller, San Francisco, CA, Thomas Chi, San Francisco, CA

MP44-13 STONE CULTURES FOR URETEROSCOPY: ARE THEY NECESSARY AND WHO NEEDS THEM? RESULTS FROM A SINGLE INSTITUTION SERIES

Daniel Wong*, Kenneth Sands, Alana Desai, Saint Louis, MO

MP44-14 MINI-PNL FACILITATES SAME DAY DISCHARGE WITHOUT AFFECTING OUTCOMES COMPARED TO STANDARD SIZED PCNL

Fadl Hamouche*, Kevin Chang, Rei Unno, Greg Hosier, Heiko Yang, Justin Ahn, David Bayne, San Francisco, CA, Marshall Stoller, San Francisco, CA, Thomas Chi, San Francisco, CA

MP44-15 EARLY EXPERIENCE WITH VACUUM ASSISTED URETERAL ACCESS SHEATHS

Daniel Wong*, Alana Desai, Saint Louis, MO

MP44-16 ESTIMATED DOSES OF RADIATION RECEIVED BY THE EYE LENS DURING ENDOUROLOGICAL PROCEDURES: ARE WE BEING CAREFUL ENOUGH? ESUT-YAU ENDOUROLOGY GROUP COLLABORATION

Alejandra Bravo-Balado*, Sofía Fontanet, Barcelona, Spain, Andreas Skolarikos, Athens, Greece, Ali Serdar Gozen, Heilbronn, Germany, Bhaskar Somani, Southampton, United Kingdom, Olivier Traxer, Paris, France, Michele Talso, Luca Villa, Milan, Italy, Athanasios Papatsoris, Athens, Greece, Amelia Pietropaolo, Southampton, United Kingdom, Senol Tonyali, Istanbul, Turkey, Etienne Xavier Keller, Zurich, Switzerland, Thomas Tailly, Ghent, Belgium, Panagiotis Kallidonis, Patras, Greece, Emre Sener, Istanbul, Turkey, Udo Nagele, Hall in Tirol, Austria, Esteban Emiliani, Barcelona, Spain

184

MP44-17 COMPARISON OF OPERATIVE EFFICIENCY AND EFFECTIVENESS BETWEEN A DUAL LUMEN AND SINGLE LUMEN URETEROSCOPE FOR URETEROSCOPIC STONE REMOVAL

Andrew Brevik, Rohit Bhatt*, Kalon Morgan, Sohr-ab Ali, Akhil Peta, Sina Zarandi, Luke Limfueco, Rajiv Karani, Lillian Xie, Raphael Arada, John Sung, Francis Jefferson, Egor Parkhomenko, Daniel Lama, Shoaib Safiullah, Pengbo Jiang, Roshan Patel, Ralph Clayman, Jaime Landman, Orange, CA

MP44-18 PROLONGED ENDOUROLOGICAL TRAINING IS THE KEY TO IMPROVE SURGICAL OUTCOMES OF STONE PATIENTS TREATED WITH FLEXIBLE URETEROSCOPY

Luca Villa*, Pietro Dioni, Margherita Fantin, Mario de Angelis, Christian Corsini, Milan, Italy, Olivier Traxer, Paris, France, Alberto Briganti, Francesco Montorsi, Eugenio Ventimiglia, Andrea Salonia, Milan, Italy

MP44-19 PCNL USING ZEEGO ROBOTIC HYBRID SYSTEM HAS LOWER EFFECTIVE RADIATION DOSE THAN PCNL USING STANDARD FLUOROSCOPY

Mark Sawyer, Xavier Glover*, Eric Ballon-Landa, Denver, CO

MP44-20 COMPARISON OF ULTRA-MINI PERCUTANEOUS NEPHROLITHOTOMY AND RETROGRADE INTRARENAL SURGERY FOR RENAL STONES: A SYSTEMATIC REVIEW AND META-ANALYSIS FROM KSER UPDATE SERIES

Hae Do Jung*, Gunpo, Korea, Republic of, Doo Yong Chung, Incheon, Korea, Republic of, Min Ho Lee, Changwon, Korea, Republic of, Do Kyung Kim, Sin Woo Lee, Sunghyun Paick, Seung Hyun Jeon, Joo Yong Lee, Seoul, Korea, Republic of


Sunday, May 15, 2022 1:00 pm – 2:15 pm

Moderated Poster Session 45PROSTATE CANCER: MARKERS

Room 225 @ Ernest N. Morial Convention CenterModerators: Daniel Lin, Ketan Badani & Jose Luis Alvarez Ossorio


MP45-01 A NEW SERUM BIOMARKER TO PREDICT THE RISK OF PROSTATE CANCER AT BIOPSY: PENTRAXIN-3

Gian Maria Busetto*, Ugo Giovanni Falagario, Gi-useppe Stefano Netti, Oscar Selvaggio, Frances-ca Sanguedolce, Elena Ranieri, Carlo Bettocchi, Giuseppe Carrieri, Luigi Cormio, Foggia, Italy

MP45-02 A PROSPECTIVE STUDY OF THE PROSTATE HEALTH INDEX DENSITY AND MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN DIAGNOSING CLINICALLY SIGNIFICANT PROSTATE CANCER

Gang Song*, Yuanchong Chen, Beijing, China, People’s Republic of

MP45-03 URINARY EXOSOME MICRORNA SIGNATURES AS A NONINVASIVE PROGNOSTIC BIOMARKER FOR PROSTATE CANCER

Hyeok Jae Kwon*, Chang Eil Yoon, Dongho Shin, Sun Shin, Hyong Woo Moon, Hyuk Jin Cho, U-Syn Ha, Sung-Hoo Hong, Ji Youl Lee, Yeun–Jun Chung, Sae Woong Kim, Yong Hyun Park, Seoul, Korea, Republic of

MP45-04 SELECTMDX URINE TEST DIAGNOSE MEN WITH HIGH-GRADE PROSTATE CANCER

Whitney Stanton, Aurora, CO, E David Crawford*, La Jolla, CA, Paul Arangua, Joshua Romero, Francisco G. La Rosa, Adrie van Bokhoven, M. Scott Lucia, Paul Maroni, Aurora, CO, Wendy Po-age, Centennial, CO, Jack Schalken, Nijmegen, Netherlands, Fernando Kim, Denver, CO, Jack Groskopf, Irvine, CA, Priya Werahera, Aurora, CO


MP45-05 MICRORNA 185-5P IS A NOVEL BIOMARKER ASSOCIATED WITH HIGH-RISK PATHOLOGY AT RADICAL PROSTATECTOMY IN PATIENTS WITH LOW-RISK DISEASE AT DIAGNOSIS

Kevin Shee*, Cassandra Belair, John Neuhaus, Janet Cowen, Robert Blelloch, Matthew Cooper-berg, San Francisco, CA

MP45-06 CLINICAL SIGNIFICANCE OF α2,3-SIALYLATED PROSTATE-SPECIFIC ANTIGEN DENSITY AND MRI FOR HIGH-GRADE PROSTATE CANCER IN BIOPSY-NAÏVE MEN WITH ELEVATED PSA LEVEL

Tohru Yoneyama*, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Yuki Tobisawa, Takuma Nari-ta, Hirotake Kodama, Masaki Momota, Hirosaki, Japan, Hiroyuki Ito, Aomori, Japan, Shintaro Narita, Akita, Japan, Fumiyasu Tsushima, Hirosaki, Japan, Koji Mitsuzuka, Sendai, Japan, Takahiro Yoneyama, Yasuhiro Hashimoto, Hirosaki, Japan, Wilhelmina Duivenvoorden, Je-honathan H. Pinthus, Hamilton, Canada, Shingo Kakeda, Hirosaki, Japan, Akihiro Ito, Sendai, Japan, Norihiko Tsuchiya, Yamagata, Japan, To-monori Habuchi, Akita, Japan, Chikara Ohyama, Hirosaki, Japan

MP45-07 ONCOLOGIC OUTCOMES OF TOTAL LENGTH GLEASON PATTERN 4 ON BIOPSY IN MEN WITH GRADE GROUP 2 PROSTATE CANCER

Marlon Perera*, Melissa Assel, Nicole Benfante, Andrew Vickers, Victor Reuter, Sigrid Carlsson, Vincent Laudone, Karim Touijer, James Eastham, Peter Scardino, Samson Fine, Behfar Ehdaie, New York, NY


SU

ND

AY

MP45-08 A COMPARISON OF BIOPSY GENOMIC TEST TO PREDICT ADVERSE DISEASE ON PROSTATECTOMY

Joon Yau Leong, Alex Uhr*, Benjamin Rudnick, Andrea Quinn, Brian Calio, Edouard Trabulsi, Tingting Zhan, Leonard Gomella, Mark Mann, Collaborators of PURC, Philadelphia, PA

MP45-09 DISCRIMINATIVE SIGNIFICANCE OF PROSTATE BIOPSY DECIPHER SCORE TO PREDICT ADVERSE PATHOLOGY AND PATHOLOGICAL DISCORDANCE AT RADICAL PROSTATECTOMY

Ghazal Khajir*, Deepika Kumar, Syed Rahman, Michael Leapman, Angelique Levi, Peter Hum-phrey, Preston Sprenkle, New Haven, CT

MP45-10 DOES PERIOPERATIVE TESTOSTERONE PREDICT POST-PROSTATECTOMY GENOMIC RISK SCORE?

Mohammed Shahait*, Amman, Jordan, Joseph G. Cheaib, Baltimore, MD, Elai Davicioni, Yang Liu, San Francisco, CA, Ibrahim Abu Ghaida, Abu Dhabi, United Arab Emirates, Ryan Dobbs, Chica-go, IL, Priti Lal, Daniel Lee, Philadelphia, PA, PA, David Lee, Irvine, CA

MP45-11 METABOLOMICS OF BLACK-WHITE DIFFERENCES IN RISK OF PROSTATE CANCER BIOCHEMICAL RECURRENCE

Bruce Trock*, Yuezhou Jing, Tracy Jones, Angelo De Marzo, Baltimore, MD

MP45-12 PTEN LOSS AND DIFFUSIVE KI67 PREDICT BIOCHEMICAL RECURRENCE OF LOCALIZED PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: A VALIDATION COHORT STUDY

Che Hsueh Yang*, Yi Sheng Lin, Wei Chun Weng, Chin Heng Lu, Chung Hsiao Chin, Tang Yi Tsao, Chao Yu Hsu, Min Che Tung, Yen Chuan Ou, Taichung, Taiwan

MP45-13 ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY

Vito Cucchiara*, Luigi Nocera, Dejan Lazarevic, Davide Cittaro, Matteo Zoccolillo, Milan, Italy, Giorgio Gandaglia, Elio Mazzone, Armando Stabile, Francesco Barletta, Simone Scuderi, Daniele Robesti, Andrea Necchi, Milano, Italy, Vincenzo Mirone, Napoli, Italy, Pierre I. Karakiewicz, Montreal, Canada, Francesco Montorsi, Milano, Italy, Giovanni Tonon, Milan, Italy, Alberto Briganti, Milano, Italy

MP45-14 THE SPATIAL LANDSCAPE OF CLONAL SOMATIC MUTATIONS IN BENIGN AND MALIGNANT PROSTATE EPITHELIA

Andrew Erickson*, Oxford, United Kingdom, Eme-lie Berglund, Mengxiao He, Maja Marklund, Reza Mirzazadeh, Niklas Schultz, Ludvig Bergenstråhle, Linda Kvastad, Alma Andersson, Joseph Ber-genstråhle, Ludvig Larsson, Solna, Sweden, Alia Shamikh, Elisa Basmaci, Teresita Diaz De Ståhl, Stockholm, Sweden, Timothy Rajakumar, Oxford, United Kingdom, Kim Thrane, Solna, Sweden, An-drew Ji, Paul Khavari, Stanford, CA, Firaz Tarish, Solna, Sweden, Anna Tanoglidi, Uppsala, Swe-den, Jonas Maaskola, Solna, Sweden, Richard Colling, Oxford, United Kingdom, Tuomas Mirtti, Helsinki, Finland, Freddie C Hamdy, Dan Wood-cock, Oxford, United Kingdom, Thomas Helleday, Solna, Sweden, Ian Mills, Oxford, United Arab Emirates, Alastair Lamb, Oxford, United Kingdom, Joakim Lundeberg, Solna, Sweden

MP45-15 PTEN LOSS AND DIFFUSIVE KI67 ARE RELATED TO CASTRATION-RESISTANT PROSTATE CANCER: A VALIDATION COHORT STUDY

Che Hsueh Yang*, Yi Sheng Lin, Wei Chun Weng, Chin Heng Lu, Chung Hsiao Chin, Tang Yi Tsao, Chao Yu Hsu, Min Che Tung, Yen Chuan Ou, Taichung, Taiwan

MP45-16 CRISRP SCREENS REVEAL DETERMINANTS OF PARP INHIBITOR RESPONSE IN PROSTATE CANCER

Takuya Tsujino*, Chenkui Miao, Boston, MA, Har-uhito Azuma, Osaka, Japan, Li Jia, Boston, MA

MP45-17 CORRELATION BETWEEN CTC COUNTS AND RADIOMIC METRICS FROM MULTIPLE OSSEOUS METASTATIC LESIONS IN METASTATIC PROSTATE CANCER

Bino Varghese, Steven Cen, Gareth Morrison, Jonathan Buckley, Dejerianne Ostrow, David Quinn, Timothy Triche, Amir Goldkorn, Vinay Duddalwar*, Los Angeles, CA

MP45-18 IDENTIFICATION OF DNA DAMAGE REPAIR-ASSOCIATED PROGNOSTIC BIOMARKERS FOR PROSTATE CANCER USING TRANSCRIPTOMIC DATA ANALYSIS

Shu-Pin Huang*, Kaohsiung, Taiwan, Pai-Chi Teng, Taipei, Taiwan, Chia-Hsin Liu, Taichung, Taiwan, Ting-Yi Lin, Taipei, Taiwan, Yi-Chun Cho, Yo-Liang Lai, Taichung, Taiwan, Shu-Chi Wang, Hsin-Chih Yeh, Kaohsiung, Taiwan, Chih-Pin Chuu, Miaoli, Taiwan, Deng-Neng Chen, Pingtung, Taiwan, Wei-Chung Cheng, Taichung, Taiwan, Chia-Yang Li, Kaohsiung, Taiwan

MP45-19 COMPARISON OF PREDICTIVE MARKERS OF EFFECTIVENESS OF PARP INHIBITORS VS IMMUNOTHERAPY FOR TREATMENT OF CLINICALLY ADVANCED PROSTATE CANCER (CAPC) BASED ON TMPRSS2:ERG FUSION STATUS

Aleksandar Popovic*, Anastasija Useva, Alex Wang, Michael Basin, Rebecca Sager, Jeffrey Ross, Gennady Bratslavsky, Syracuse, NY

186

MP45-20 VARIABILITY IN TESTOSTERONE MEASUREMENT BETWEEN RADIOIMMUNOASSAY (RIA), CHEMILUMINESCENCE ASSAY(CLIA) AND LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY(MS) AMONG PROSTATE CANCER PATIENTS ON ANDROGEN DEPRIVATION THERAPY (ADT)

Raj Tiwari*, Katherine Lajkosz, MohamedBaker Berjaoui, Yazan Qaoud, Toronto, Canada, Clive Woffendin, Portland, OR, Patrick Caron, Chantal Guillemette, Quebec City, Canada, Neil Fleshner, Toronto, Canada


Sunday, May 15, 2022 1:00 pm – 2:15 pm

Moderated Poster Session 46PENILE & TESTICULAR CANCER I

Room 222 @ Ernest N. Morial Convention CenterModerator: Curtis Pettaway


MP46-01 COLLABORATIVE RESILIENCE PROGRAM TO ENHANCE QUALITY OF LIFE FOR POST-PENECTOMY PATIENTS: DYADIC COPING PERSPECTIVE

George Soko*, Lusaka, Zambia, Mwila Mulubwa, Cape Town, South Africa, Tepwanji Mpetemoya, Lusaka, Zambia

MP46-02 REFINEMENT OF THE SERUM MIR-371A-3P TEST FOR THE DETECTION OF CHEMOTHERAPY-NAIVE MINIMAL RESIDUAL TESTICULAR CANCER

John T. Lafin, Armon Amini, Bendu Konneh, Anna Savelyeva, Dallas, TX, Jin Piao, Michelle Nuno, Monrovia, CA, Cinzia G. Scarpini, Cambridge, United Kingdom, Jeffrey M. Howard, Thomas Gerald, Dallas, TX, Nicholas Coleman, Matthew J. Murray, Cambridge, United Kingdom, A. Lindsay Frazier, Boston, MA, James F. Amatruda, Los Angeles, CA, Aditya Bagrodia*, La Jolla, CA

MP46-03 OUTCOMES OF PENILE CANCER STRATIFIED BY NODAL STAGING: IMPORTANCE OF PELVIC NODAL INVOLVEMENT

Uday Chandankhede*, Amandeep Arora, Gagan Prakash, Mahendra Pal, Manoj Tummala, Anand Mohan, Ganesh Bakshi, Mumbai, India

MP46-04 10-YEAR EXPERIENCE WITH MIDLINE EXTRAPERITONEAL RETROPERITONEAL LYMPH NODE DISSECTION

Muhannad Alsyouf*, Sanam Ladi Seyedian, Arman Ashrafi, Hamed Ahmadi, Madeleine Burg, Alireza Ghoreifi, Antoin Douglawi, Sumeet Bhanvadia, Anne Schuckman, Hooman Djaladat, Siamak Daneshmand, Los Angeles, CA

MP46-05 CHARACTERIZING ONLINE TESTICULAR CANCER DISCUSSIONS WITH QUANTITATIVE THEMATIC ANALYSIS

Krishna Ravivarapu*, Alexander Small, Micah Levy, Chih Peng Chin, Evan Garden, Osama Al-Alao, Joseph Sewell Araya, Michael Palese, New York, NY


MP46-06 TRENDS IN PERIOPERATIVE OUTCOMES FOLLOWING MIDLINE EXTRAPERITONEAL RETROPERITONEAL LYMPH NODE DISSECTION: SINGLE TERTIARY CENTER EXPERIENCE

Hamed Ahmadi, Muhannad Alsyouf*, Madeleine Burg, Arman Ashrafi, Sidney Roberts, Sanam Ladi Seyedian, Alireza Ghoreifi, Antoin Douglawi, Sumeet Bhanvadia, Hooman Djaladat, Anne Schuckman, Siamak Daneshmand, Los Angeles, CA

MP46-07 THE PROGNOSTIC SIGNIFICANCE OF TIM-3 EXPRESSING TUMOR-INFILTRATING LYMPHOCYTES IN TESTICULAR GERM CELL TUMORS

Ki Hong Kim*, Hee Jo Yang, Si Hyun Kim, Doo Sang Kim, Chang Ho Lee, Cheonan, Korea, Republic of, Soon Auck Hong, Byung Hoon Chi, Seoul, Korea, Republic of, Ji-Hye Lee, Youn Soo Jeon, Cheonan, Korea, Republic of

MP46-08 COST AND UTILIZATION OF CONCURRENT VS STAGED TESTICULAR IMPLANT FOR RADICAL ORCHIECTOMY

Arman Walia*, San Diego, CA, Joshua Horns, Niraj Paudel, Salt Lake City, UT, Aditya Bagrodia, San Diego, CA, Jim Hotaling, Salt Lake City, UT, Tung-Chin Hsieh, San Diego, CA

MP46-09 DOES TIME TO DYNAMIC SENTINEL LYMPH NODE BIOPSY AFFECT RECURRENCE-FREE SURVIVAL IN PENILE SQUAMOUS CELL CARCINOMA?

James A. Churchill*, Ashwin Sachdeva, Allaudin Issa, Craig Jones, Noel W. Clarke, Maurice W. Lau, Arie S. Parnham, Vijay K. Sangar, Manches-ter, United Kingdom

MP46-10 ELUCIDATING THERAPEUTIC OPTIONS FOR TREATMENT-NAÏVE AND CISPLATIN-RESISTANT TESTICULAR CANCER

Julie-Ann Cavallo, Daniel Ranti*, Elliot Merritt, Anna Tocheva, John P. Sfakianos, Benjamin Hop-kins, New York, NY


SU

ND

AY

MP46-11 BILATERAL INGUINAL LYMPHNODE DISSECTION VERSUS INGUINAL LYMPHNODE DISSECTION AND DYNAMIC SENTINEL NODE BIOPSY IN CLINICAL N1 SQUAMOUS CELL CARCINOMA OF THE PENIS

Sebastiano Nazzani*, Mario Achille Catanzaro, Alberto Macchi, Tullio Torelli, Silvia Stagni, Antonio Tesone, Alice Lorenzoni, Mauro Maccauro, Rodolfo Lanocita, Tommaso Cascella, Davide Biasoni, Luigi Piva, Roberto Salvioni, Nicola Nicolai, Milan, Italy

MP46-12 DECLINES IN SKELETAL MUSCLE MASS AND QUALITY DURING CYTOTOXIC CHEMOTHERAPY PREDICT INCREASED RISK OF CHEMOTHERAPY-ASSOCIATED ADVERSE EVENTS IN MEN WITH TESTIS CANCER

Anthea Phuong*, Seattle, WA, J. Peter Marquardt, Florian J. Fintelmann, Boston, MA, Ryan O’Mal-ley, Grace Laidlaw, Zachary Eagle, Steven Ngo, Sarah Holt, Delaney Orcutt, George R. Schade, Daniel W. Lin, Michael T. Schweizer, Todd Yezefski, Evan Y. Yu, Bruce Montgomery, Petros Grivas, Sarah Psutka, Seattle, WA

MP46-13 TEX11 SUPPRESS THE MIGRATION AND INVASION IN TESTICULAR GERM CELL TUMOR BY DOWN-REGULATED ITGB2

Wenjun Zhou*, Changsha, China, People’s Republic of

MP46-14 INGUINAL LYMPHADENECTOMY FOR PENILE CANCER USING A FASCIAL SPARING TECHNIQUE - OUTCOMES FROM A SINGLE CENTRE

Nicolo’ Schifano*, Milan, Italy, Castiglione Fabio, Matthew Rewhorn, Paul Hadway, Rees Rowland, Raj Nigam, Hussain M. Alnajjar, Asif Muneer, London, United Kingdom

MP46-15 POST-OPERATIVE MORBIDITY AND COMPLICATIONS OF INGUINAL LYMPHADENECTOMY FOR PENILE CANCER: A SYSTEMATIC REVIEW

Giacomo Rebez*, Carmelo Morreale, Ottavia Runti, Trieste, Italy, Tommaso Cai, Rovereto, Italy, Michele Rizzo, Carlo Trombetta, Giovanni Liguori, Trieste, Italy

MP46-16 INGUINAL LYMPH NODE DISSECTION FOR PENILE CANCER: RESULTS OF A MINIMALLY INVASIVE APPROACH FROM A MULTICENTER DATABASE

Aldo Brassetti*, Alfredo Bove, Umberto Anceschi, Maria Consiglia Ferriero, Salvatore Guaglianone, Riccardo Mastroianni, Leonardo Misuraca, Gabri-ele Tuderti, Rome, Italy, Gabriele Cozzi, Milan, Italy, Pavel Gavrilov, Barcelona, Spain, Julian Andres Chavarriaga, Bogota, Colombia, Gennaro Musi, Ottavio de Cobelli, Milan, Italy, Alberto Breda, Josep Maria Gaya Sopena, Barcelona, Spain, Diego Camacho, Rodolfo Varela, Bogota, Colombia, Giuseppe Simone, Rome, Italy

MP46-17 HEALTH-RELATED QUALITY OF LIFE AND TREATMENT-RELATED SIDE-EFFECTS IN PATIENTS WHO HAVE BEEN IN REMISSION FROM TESTICULAR CANCER FOR 12–24 MONTHS

Walter Cazzaniga*, London, United Kingdom, Adam Pearce, Brisbane, Australia, Chandran Tanabalan, Prabhakar Rajan, Netty Kinsella, Alison Reid, Robert Huddart, David Nicol, London, United Kingdom

MP46-18 HUMAN PAPILLOMAVIRUS MEDIATED PENILE CANCER OVEREXPRESS NOTCH2 AND JAG1

Carlos Rivera-López*, San Juan, Puerto Rico, María Sánchez-Vázquez, San Juan, Puerto Rico, Andrés Hernández-González, San Juan, Puerto Rico, María Marcos-Martínez, Jasmine Figueroa-Díaz, Josue Pérez-Santiago, San Juan, Puerto Rico, Xin Lu, Notre Dame, IN, Jad Chahoud, Tampa, FL, Niki Zacharias, Houston, TX, Antonio Puras-Baez, San Juan, Puerto Rico, Curtis Petta-way, Houston, TX, Magaly Martínez-Ferrer, San Juan, Puerto Rico

MP46-19 COMBINED REPORTING OF SURGICAL QUALITY AND CANCER CONTROL AFTER SURGICAL TREATMENT FOR PENILE TUMORS: THE TETRAFECTA ACHIEVEMENT

Aldo Brassetti*, Alfredo Bove, Umberto An-ceschi, Maria Consiglia Ferriero, Salvatore Guaglianone, Riccardo Mastroianni, Leonardo Misuraca, Gabriele Tuderti, Rome, Italy, Gabri-ele Cozzi, Milan, Italy, Pavel Gavrilov, Barcelo-na, Spain, Julian Andres Chavarriaga, Bogota, Colombia, Gennaro Musi, Ottavio de Cobelli, Milan, Italy, Alberto Breda, Josep Maria Gaya Sopena, Barcelona, Spain, Diego Camacho, Rodolfo Varela, Bogota, Colombia, Giuseppe Simone, Rome, Italy

MP46-20 INFLUENCE OF RESISTANCE TO CISPLATIN AND OSIMERTINIB ON PATTERNS OF METASTATIC BEHAVIOR OF PENILE CANCER

Anita Thomas*, Shirine Huck, Kimberly Slade, Olesya Vakhrusheva, Mainz, Germany, Martin Michaelis, Kent, United Kingdom, Jaroslav Jinatl, Florian Rothweiler, Frankfurt, Germany, Axel Haf-erkamp, Eva Juengel, Mainz, Germany, Jindrich Cinatl, Frankfurt, Germany, Igor Tsaur, Mainz, Germany


188

Sunday, May 15, 2022 1:00 pm – 3:00 pm

Podium Session 45BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY IV

Room 252 @ Ernest N. Morial Convention CenterModerators: Ricardo Gonzalez, Steven Kaplan & Kevin Zorn

ABSTRACTTIME NUMBER TITLE1:00 PD45-01 SHORT-TERM POSTOPERATIVE FUNCTIONAL

OUTCOMES OF REZÜM VS. GREENLIGHT PVP 180W XPS: A PROPENSITY MATCH SCORE STUDY

Iman Sadri*, David-Dan Nguyen, Adel Arezki, Naeem Bhojani, Montreal, Canada, Bilal Chughtai, New York, NY, Dean Elterman, Toronto, Canada, Kevin C. Zorn, Montreal, Canada

1:10 PD45-02 UROLIFT VERSUS REZUM FOR BENIGN PROSTATIC HYPERPLASIA: A REAL-WORLD SINGLE-INSTITUTION ANALYSIS

Chih Peng Chin*, Evan Garden, Krishna Ravi-varapu, Devki Shukla, Olamide Omidele, Micah Levy, Joseph Sewell Araya, New York, NY, Alex-ander Small, Bronx, NY, Steven Kaplan, Robert Valenzuela, Avinash Reddy, Susan Marshall, Jay Motola, Craig Nobert, Mantu Gupta, Michael Palese, New York, NY

1:20 PD45-03 THE MORBIDITY OF PROSTATIC URETHRAL LIFTS IN THE MANAGEMENT OF BLADDER OUTLET OBSTRUCTION FOLLOWING RADIOTHERAPY

Monika Tedeschi*, Lauren Keenan, Gregg Eure, Kurt McCammon, Norfolk, VA

1:30 PD45-04 CHANGE IN PROSTATE VOLUME REDUCTION AND SYMPTOMATIC IMPROVEMENT IN MEN TREATED WITH REZUM CONVECTIVE WATER VAPOUR THERMAL THERAPY

Dean Elterman*, Katherine Lajkosz, Toronto, Canada, Kevin C. Zorn, Montreal, Canada, Bilal Chughtai, New York, NY, Naeem Bhojani, Montreal, Canada

1:40 PD45-05 FUNCTIONAL IMPROVEMENT AND PRESERVATION OF SEXUAL FUNCTION 3 YEARS AFTER TREATMENT WITH THE OPTILUME BPH CATHETER SYSTEM

Steven Kaplan*, New York, NY, Merycarla Pichar-do, Santo Domingo, Dominican Republic, Edwin Rijo, La Romana, Dominican Republic, Ramon Rodriguez Lay, Gustavo Espino, Panama City, Panama, Rafael Estrella, Santiago de los Caballe-ros, Dominican Republic

ABSTRACTTIME NUMBER TITLE1:50 PD45-06 URINARY AND SEXUAL OUTCOMES AFTER

AQUABLATION IN MEN WITH BENIGN PROSTATE HYPERPLASIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

David Chen, Liang Qu, Howard Webb, Michael Harvey, Kirby Qin, Melbourne, Australia, Sari Khaleel, New York City, NY, Ahmed Adam, Jo-hannesburg, South Africa, Damien Bolton, Marlon Perera*, Melbourne, Australia

2:00 PD45-07 PROSPECTIVE COMPARISON OF FUNCTIONAL OUTCOMES AFTER ENDOSCOPIC SURGICAL INTERVENTIONS FOR BENIGN PROSTATIC HYPERPLASIA: THE ROLE OF EJACULATION-SPARING ANATOMIC PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE (ESA-PVP)

Mattia Sibona*, Paolo Destefanis, Federico Vitiel-lo, Eugenia Vercelli, Gabriele Montefusco, Ales-sandro Mara, Andrea Bosio, Alessandro Bisconti, Paolo Gontero, Turin, Italy

2:10 PD45-08 SELECTIVE MEDIAN LOBE LASER ENUCLEATION OF THE PROSTATE: PRESERVING SEXUAL FUNCTION WITHOUT COMPROMISING URINARY OUTCOMES

Benjamin Press*, David Kim, New Haven, CT, Eric Ghiraldi, Philadelphia, PA, Michael Siev, Daniel Kellner, New Haven, CT

2:20 PD45-09 LONG TERM OUTCOME OF A RANDOMIZED CLINICAL TRIAL COMPARING THULIUM VAPORIZATION OF THE PROSTATE VERSUS MONOPOLAR TURP, THE TEST OF TIME

Osama Ezzat*, Ahmed M. Elshal, Mahmoud Lay-mon, Ahmed El-Assmy, Ahmed Shoma, Mansou-ra, Egypt

2:30 PD45-10 OUTCOMES AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE, OPEN SIMPLE PROSTATECTOMY, AND ROBOTIC SIMPLE PROSTATECTOMY: EXPERIENCE FROM A LARGE ACADEMIC MEDICAL CENTER

Matthew Lee*, Meera Ganesh, Joshua Han, Quan Mai, Mark Assmus, Jessica Helon, Chicago, IL, Briana Kaplunov, Philadelphia, PA, Amy Kram-beck, Chicago, IL

Sunday, May 15, 2022 1:00 pm – 3:00 pm

ForumsAUA ROBOTICS THEATER SPONSORED BY INTUITIVE: SINGLE PORT ROBOTIC PROCEDURES

S&T Hall C: Booth 311 @ Ernest N. Morial Convention CenterChair: Ashutosh Tewari

AUA ROBOTICS THEATER: SINGLE PORT ROBOTIC PROCEDURES

Program Leaders: Simone Crivellaro, Jihad Kaouk Panelists: Ronney Abaza, Mihit Desai Porpiglia Francesco


SU

ND

AY

2:40 PD45-11 PERI-OPERATIVE OUTCOMES OF OPEN VERSUS ROBOT-ASSISTED SIMPLE PROSTATECTOMY: RESULTS FROM TWO HIGH-VOLUME CENTRES

Simone Scarcella*, Ancona, Italy, Angelo Mot-taran, Bologna, Italy, Carlo Andrea Bravi, Milan, Italy, Luca Sarchi, Modena, Italy, Pietro Piazza, Bologna, Italy, Marco Paciotti, Milan, Italy, Marco Amato, Stefano Puliatti, Modena, Italy, Paolo Umari, Padova, Italy, Carlo Giuloni, Giulio Milan-ese, Lucio Dell’Atti, Daniele Castellani, Ancona, It-aly, Edward Lambert, Jonathan Vollemaere, Dries Develtere, Ralf Veys, Marijn Goossens, Jolien Van der Jeugt, Ghent, Belgium, Andrea Galosi, Ancona, Italy, Alexandre Mottrie, Aalst, Belgium

2:50 PD45-12 SEXUAL AND FUNCTIONAL OUTCOMES AFTER TRANS-URETHRAL INCISION OF THE PROSTATE: A LONG TERM FOLLOW UP ANALYSIS

Riccardo Lombardo*, Antonio Maria Cicione, Rome, Italy, Antonio Nacchia, Rionero in Vulture, Italy, Carmen Gravina, Beatrice Turchi, Jordi Stira, Simone D’Annunzio, Lorenzo Maria Rivesti, Alessandro Guercio, Giorgio Guarnotta, Antonio Franco, Giacomo Gallo, Elisa Mancini, Olivia Ales-sandra Voglino, Valeria Baldassarri, Sara Riolo, Andrea Tubaro, Cosimo De Nunzio, Rome, Italy


Sunday, May 15, 2022 1:00 pm – 3:00 pm

Podium Session 46PROSTATE CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY II

Room 255 @ Ernest N. Morial Convention CenterModerators: James Brooks, Christopher Evans & Bal Lokeshwar

ABSTRACTTIME NUMBER TITLE1:00 PD46-01 THE EXPRESSION OF ANDROGEN

RECEPTOR SPLICE VARIANT 7 AT RADICAL PROSTATECTOMY PREDICTS THE RISK OF PROGRESSION IN UNTREATED NON-METASTATIC PROSTATE CANCER PATIENTS

Martina Maggi*, Alessandro Sciarra, Stefano Sal-ciccia, Alice Nicolai, Elisabetta Tortorella, Sabrina Giantulli, Fabio Massimo Magliocca, Ida Silvestri, Ludovica Taglieri, Susanna Cattarino, Susanna Scarpa, Rome, Italy

1:10 PD46-02 OPTICAL GENOME MAPPING IDENTIFIES CLINICALLY RELEVANT GENOMIC REARRANGEMENTS IN PROSTATE CANCER BIOPSY SAMPLE

Jong Su Lee, Yeeun Shim, Jieun Seo, Hyun-ho Han*, Young Deuk Choi, Cheol Keun Park, Saeam Shin, Seung-Tae Lee, Jong Rak Choi, Seoul, Korea, Republic of

1:20 PD46-03 METASTASIS PRONE GENES IN PROSTATE CANCER REVEALED BY TARGETED SEQUENCING

Seung-Hwan Jeong*, Jang Hee Han, Hyeo-ng-Dong Yuk, Chang-Wook Jeong, Hyeon-Hoe Kim, Ja-Hyeon Ku, Cheol Kwak, Seoul, Korea, Republic of

1:30 PD46-04 BRCA1/2 AND ATM MUTATED METASTATIC PROSTATE CANCERS MAY PRESENT WITH LOW SERUM PSA

Hyunho Han*, Cheol Keun Park, Nam Hoon Cho, Jong Su Lee, Won Sik Ham, Woong Kyu Han, Young Deuk Choi, Seoul, Korea, Republic of

1:40 PD46-05 NOVEL CYCLIN-DEPENDENT KINASE 12 (CDK12) AND PROTEIN KINASE D1 (PRKD1) INTERACTION IN CASTRATION RESISTANT PROSTATE CANCER CELL LINES

Victor Chalfant*, Carlos Riveros, Sanjeev Shukla, Teruko Osumi, K.C. Balaji, Jacksonville, FL

ABSTRACTTIME NUMBER TITLE1:50 PD46-06 SYMPTOMATIC BENIGN PROSTATIC

HYPERPLASIA WITH IMMUNE-ENRICHED LANDSCAPES SHOW LOWER INCIDENCE OF PROSTATE CANCER DEVELOPMENT

Nimrod Barashi Gozal*, Tiandao Li, Bo Zhang, Charles Nottingham, Gerald Andriole, Kiran Maha-jan, Eric Kim, Saint Louis, MO

2:00 PD46-07 THE ROLE OF B7-H4/AR MEDIATED IMMUNE ESCAPE IN CASTRATION RESISTANCE OF PROSTATE CANCER

Bintao Hu*, Yue Wu, Xian Wei, Huan Feng, Jihong Liu, Tao Wang, Wuhan, China, People’s Republic of

2:10 PD46-08 COMBINED TREATMENT WITH ULTRASOUND AND IMMUNE CHECKPOINT INHIBITORS FOR PROSTATE CANCER

Fuuka Hayashi*, Katsumi Shigemura, Koichi Kitagawa, Noriaki Maeshige, Koki Maeda, Masato Fujisawa, Kobe, Japan

2:20 PD46-09 LIPOPOLYSACCHARIDE FROM DYSBIOTIC GUT MICROBIOTA PROMOTES INFLAMMATORY PROSTATE CANCER GROWTH THROUGH HISTAMINE H1 RECEPTOR SIGNALING

Makoto Matsushita*, Suita, Japan, Kazutoshi Fujita, Osakasayama, Japan, Takuji Hayashi, Hisako Kayama, Daisuke Motooka, Hiroaki Hase, Toshihiko Uemura, Akinaru Yamamoto, Gaku Yamamichi, Eisuke Tomiyama, Yoko Koh, Taigo Kato, Koji Hatano, Atsunari Kawashima, Motohide Uemura, Satoshi Nojima, Ryoichi Ima-mura, Kazutake Tsujikawa, Shota Nakamura, Kiyoshi Takeda, Eiichi Morii, Norio Nonomura, Suita, Japan

190

2:30 PD46-10 SATURATED FATTY ACID PROMOTES PROSTATE CANCER DEVELOPMENT WITH TUMOR INFILTRATING REGULATORY T CELL ALTERATION IN A PTEN-DEFICIENT MOUSE MODEL

Hiromi Sato*, Shintaro Narita, Yoshiko Takahashi, Masanori Ishida, Soki Kasima, Ryohei Yamamoto, Atsushi Koizumi, Taketoshi Nara, Mingguo Huang, Kazuyuki Numakura, Mitsuru Saito, Toshiaki Yoshioka, Tomonori Habuchi, Akita, Japan

2:40 PD46-11 IMMUNE TRANSCRIPTOMIC REPERTOIRE EVALUATION IN PROSTATE CANCER PROGRESSION

Derek Van Booven*, Anastasia Vedenko, Ra-ghuram Reddy, Himanshu Arora, Miami, FL

2:50 PD46-12 PRECLINICAL STUDIES USING CISPLATIN/CARBOPLATIN TO RESTORE THE ENZALUTAMIDE SENSITIVITY VIA DEGRADING THE ANDROGEN RECEPTOR SPLICING VARIANT 7 (ARV7) TO FURTHER SUPPRESS ENZALUTAMIDE RESISTANT PROSTATE CANCER

Fu-Ju Chou, Yixi Hu*, ChangYi Lin, Hao Tian, Deepak Sahasrabudhe, Jean Joseph, Edward M. Messing, Shuyuan Yeh, Chawnshang Chang, Rochester, NY


Sunday, May 15, 2022 1:00 pm – 3:00 pm

Podium Session 47SEXUAL FUNCTION/DYSFUNCTION: EVALUATION II

Room 245 @ Ernest N. Morial Convention CenterModerators: Hossein Sadeghi-Nejad, Rachel Rubin & Nelson Bennett

ABSTRACTTIME NUMBER TITLE1:00 PD47-01 LOW SOCIOECONOMIC STATUS IS A RISK

FACTOR FOR ERECTILE DYSFUNCTION: AN ANALYSIS OF NHANES DATA

Eric Macdonald*, Lake Success, NY, Joseph Kim, Bronx, NY, Darius A. Paduch, Lake Success, NY

1:10 PD47-02 ASSOCIATION OF LOW TESTOSTERONE AND FRAILTY AMONG VETERANS UNDERGOING CANCER SURGERY

Matthew Hudnall*, Neil Mistry, David Bentrem, Justin Dubin, Robert Brannigan, Joshua Halpern, Chicago, IL

1:20 PD47-03 LOW TESTOSTERONE LEVELS AND THE RISK OF ANEMIA IN MIDDLE-AGED MEN: A PROPENSITY SCORE–MATCHED ANALYSIS

Jun Ho Lee*, Dong-Gi Lee, Seoul, Korea, Republic of

1:30 PD47-04 ANALYZING THE IMPACT OF TESTOSTERONE ON BONE DENSITY LOSS

Jose M. Flores*, Nicole Benfante, Elizabeth Schof-ield, John P. Mulhall, New York, NY

1:40 PD47-05 SERUM PREDICTORS OF PITUITARY TUMOR PRESENCE ON MRI

Jose M. Flores*, Nicole Benfante, John P. Mulhall, New York, NY

1:50 PD47-06 DIFFERENCES IN SEXUAL ADVERSE EFFECTS OF PREMATURE EJACULATION MEDICATIONS RECOMMENDED BY THE AMERICAN UROLOGICAL ASSOCIATION IN THE FEDERAL ADVERSE EVENTS REPORTING SYSTEM DATABASE

Michael Tram*, Brian Meyerson, Charles Welliver, Brian Inouye, Albany, NY

ABSTRACTTIME NUMBER TITLE

2:00 PD47-07 RATE OF PRIOR INVASIVE PELVIC PROCEDURES, CO-DIAGNOSES, AND TREATMENT CHOICES IN WOMEN PRESENTING WITH DYSPAREUNIA-A UNITED STATES CLAIMS DATABASE ANALYSIS

Kathryn Dumas*, Baltimore, MD, Corey Able, Galveston, TX, Jaden R. Kohn, Taylor P. Kohn, Marisa Clifton, Baltimore, MD

2:10 PD47-08 ASSOCIATION OF SEXUAL DYSFUNCTION AND DEPRESSION IN WOMEN FOLLOWING TRAUMATIC PELVIC FRACTURE

Helen Gambrah*, Niels Vass Johnsen, MD, MPH, Nashville, TN

2:20 PD47-09 ANALYZING THE IMPACT OF CIRCUMCISION ON PENILE SENSATION

Serkan Deveci*, I·stanbul, Turkey, Jose Torre-made, Patricia Guhring, Marilyn Parker, John P. Mulhall, New York, NY

2:30 PD47-10 THE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK SCORE IS A RELIABLE TOOL TO IDENTIFY PATIENTS WITH ARTERIOGENIC ERECTILE DYSFUNCTION AT DYNAMIC PENILE COLOR DOPPLER DUPLEX ULTRASOUND–FINDINGS FROM A REAL-LIFE CROSS-SECTIONAL STUDY

Edoardo Pozzi*, Massimiliano Raffo, Milan, Italy, Paolo Capogrosso, Varese, Italy, Giuseppe Fallara, Federico Belladelli, Christian Corsini, Daniele Cignoli, Luigi Candela, Nicolò Schifano, Alessia d’Arma, Luca Boeri, Eugenio Ventimiglia, Rayan Matloob, Milan, Italy, Vincenzo Mirone, Naples, Italy, Francesco Montorsi, Andrea Salo-nia, Milan, Italy


SU

ND

AY

2:40 PD47-11 YOUNG MEN WITH REFRACTORY ERECTILE DYSFUNCTION SHOULD UNDERGO A PENILE DUPLEX ULTRASOUND

Aaron Smith*, Bruce Gilbert, New Hyde Park, NY

2:50 PD47-12 PREDICTING MAJOR ISCHEMIC PRIAPISM: A NOVEL DYNAMIC NOMOGRAM BASED ON RECURRENT ISCHEMIC PRIAPISM RISK FACTORS

Laurence Hou*, Hackensack, NJ, Yuezhou Jing, Bruce Trock, Arthur Burnett, Baltimore, MD


Sunday, May 15, 2022 1:00 pm – 3:00 pm

Podium Session 48PEDIATRIC UROLOGY: GENITALIA, UPPER & LOWER URINARY TRACT

Room 244 @ Ernest N. Morial Convention CenterModerators: Briony Varda & Pankaj Dangle

ABSTRACTTIME NUMBER TITLE1:00 PD48-01 SAFETY AND EFFICACY OF FLUOXETINE,

SELECTIVE SEROTONIN REUPTAKE INHIBITOR, FOR THE TREATMENT OF REFRACTORY PRIMARY MONOSYMPTOMATIC NOCTURNAL ENURESIS IN CHILDREN: A RANDOMIZED PLACEBO-CONTROLLED STUDY

Mohamed Hussiny*, Ahmed Abdelhalim, Abdel-wahab Hashem, Mohamed A. Soltan, Mahmoud R.El-Kenawy, Tamer Helmy, Mansoura, Egypt

1:10 PD48-02 IS THE THULIUM FIBER LASER SUPERIOR TO THE LOW-POWER HO:YAG LASER FOR URETEROSCOPY IN CHILDREN?

Christopher Jaeger*, Caleb Nelson, Bartley Cilen-to, Tanya Logvinenko, Michael Kurtz, Boston, MA

1:20 PD48-03 HOW FAR SHOULD WE EXPLORE HYPOSPADIAS? NEXT-GENERATION SEQUENCING APPLIED TO A LARGE COHORT OF HYPOSPADIAC PATIENTS

Nicolas Kalfa*, Anne Bergougnoux, Pascal Philibert, Nadège Servant-Fauconnet, Montpell-ier, France, Alice Faure, Marseille, France, Jean Breaud, Nice, France, Laura Gaspari, Charles Sultan, Françoise Paris, Vuthy Ea, Montpellier, France

1:30 PD48-04 RECURRENT CURVATURE AFTER CORPOROPLASTY WITH TUNICA VAGINALIS FLAP: AN ANALYSIS OF BOYS WHO UNDERWENT VENTRAL PENILE LENGTHENING FOR PROXIMAL HYPOSPADIAS

Kathy Huen*, Amanda Macaraeg, Carol Da-vis-Dao, Sarah Holzman, Timothy Boswell, Zayn Suhale, Kai-Wen Chuang, Heidi Stephany, Elias Wehbi, Antoine Khoury, Orange, CA

1:40 PD48-05 SHORT- AND LONG-TERM OUTCOMES OF SMALL INTESTINAL SUBMUCOSA FOR CORPOREAL BODY GRAFTING IN PATIENTS WITH PROXIMAL HYPOSPADIAS AND SEVERE CHORDEE

Maria Camila Suarez*, Christian Guevara, Daniel Nassau, Andrew Labbie, Andrew Ransford, Alireza Alam, Miguel Castellan, Rafael Gosalbez, Miami, FL


1:50 PD48-06 MEAN TRANSIT TIME: A NOVEL MARKER TO IDENTIFY OBSTRUCTIVE UROPATHY IN THE SETTING HYDRONEPHROSIS USING FUNCTIONAL MAGNETIC RESONANCE UROGRAPHY

Karmon Janssen, Richard Jones, Damien Grattan-Smith, Andrew Kirsch, Jennifer Lovin*, Atlanta, GA

2:00 PD48-07 PEDIATRIC PYELOPLASTY AND PERIOPERATIVE URETHRAL CATHETER: WHAT ARE THE BENEFITS?

Maria Camila Suarez*, Sirpi Nackeeran, Daniel E. Nassau, Alireza Alam, Rafael Gosalbez, Miguel Castellan, Miami, FL

2:10 PD48-08 PREDICTORS OF RESOLUTION OF HYDRONEPHROSIS AFTER PYELOPLASTY IN CHILDREN. WILL IT GO AWAY?

Mohamed Soltan*, Ahmed Abdelhalim, Mohamed Edwan, Ahmed Elkashef, Ahmed Atwa, Mohamed Abou-El Ghar, Tamer Helmy, Ashraf Tarek, Mohamed Dawaba, Ahmed Shokier, Mansoura, Egypt

2:20 PD48-09 IS THERE AN OPTIMAL WAY TO MEASURE RENAL FUNCTION IN PRUNE BELLY SYNDROME?

Shane Batie*, Samuel Gold, Shaheer Ali, Daniel Wong, Niccolo Passoni, Steven Harrison, Nida Karra, Nathalia Amado, Jyothsna Gattineni, Linda Baker, Dallas, TX

2:30 PD48-10 TESTICULAR TRANSCRIPTOME ANALYSIS REVEALS POTENTIAL GENES ASSOCIATED WITH ENDOCRINE SYSTEM IN A MOUSE MODEL OF COMPENSATED TESTICULAR HYPERTROPHY

Daniel E. Nassau*, Alexandra Dullea, Eliyahu Kresch, Vinayak Madhusoodanan, Shathiyah Kulandavelu, Miguel Castellan, Himanshu Arora, Ranjith Ramasamy, Miami, FL

2:40 PD48-11 DECISIONAL CONFLICT IN PARENTS REGARDING NEWBORN CIRCUMCISION

Hannah Botkin*, Denise Juhr, Douglas Storm, Christopher Cooper, Gina Lockwood, Iowa City, IA

192

2:50 PD48-12 NEWBORN CIRCUMCISIONS BY NON-UROLOGIST: CIRCUMCISION COMPLICATIONS REQUIRING SURGICAL REVISION

Abdul Qadar*, Michael Anderson, Oklahoma City, OK, Oren Miller, Tulsa, OK, Bahar Iranpour Brou-jeni, Adam Rensing, Bhalajee Meenakshi Sundar-am, Dominic Frimberger, Oklahoma City, OK


Sunday, May 15, 2022 1:00 pm – 3:00 pm

Video Session 9BLADDER & UROTHELIAL UPPER TRACT ONCOLOGY

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerators: Richard Matulewicz & Matthew Kaag

ABSTRACTTIME NUMBER TITLE1:00 V09-01 THULIUM FIBER LASER EN BLOC

RESECTION FOR BLADDER TUMOUR. TIPS AND TRICKS

Dmitry Enikeev*, Andrey Morozov, Mark Taratkin, Diana Babaevskaya, Roman Sukhanov, Petr Glybochko, Moscow, Russian Federation

1:10 V09-02 THULIUM FIBER LASER FOR BLADDER LEIOMYOMA TREATMENT

Alim Dymov*, Evgeny Shpot, Alexandra Proskura, Roman Sukhanov, Vladimir Lekarev, Temirlan Karakotov, Yuliya Lee, Leonid Rapoport, Moscow, Russian Federation

1:20 V09-03 A NOVEL APPLICATION OF THE HOLMIUM LASER: EN BLOC RESECTION OF INTRAURETERAL UROTHELIAL CARCINOMA

Tavya Benjamin*, New Hyde Park, NY, Zachary Kozel, Bethesda, MD, Ryan Margolin, New York, NY, Daniel Sagalovich, Staten Island, NY

1:30 V09-04 URETERAL STRICTURE PREVENTION THROUGH A MULTI-MODAL INTERVENTION FOR ROBOTIC INTRACORPOREAL ILEAL CONDUIT URINARY DIVERSION

Shu Wang*, Ryan Russell, Michael Phelan, M. Minhaj Siddiqui, Baltimore, MD

1:40 V09-05 NOVEL TECHNIQUE FOR INJECTION OF LIPIODOL AS FIDUCIAL MARKER FOR RADIOTHERAPY TREATMENT IN BLADDER CANCER

Aoife McVey*, Elvira Polo Alonso, Olivia Fraser, Daryl Lim Joon, Gregory Jack, Melbourne, Aus-tralia

1:50 V09-06 PROSTATE-CAPSULE SPARING RADICAL CYSTECTOMY WITH MODIFIED W-POUCH ORTHOTOPIC NEOBLADDER RECONSTRUCTION

Christopher Dall*, Charlotte Goldman, James Mason, Lisa Chuong, Keith Kowalczyk, Lambros Stamatakis, Ross Krasnow, Washington, DC

2:00 V09-07 ROBOTIC PROSTATE-SPARING CYSTECTOMYSharon White*, Denver, CO, Xavier Glover, Janet Kukreja, Aurora, CO

ABSTRACTTIME NUMBER TITLE2:10 V09-08 IMPLEMENTATION OF ROBOTIC RADICAL

CYSTECTOMY WITH INTRACORPOREAL NEOBLADDER RECONSTRUCTION: STEP-BY-STEP TECHNIQUE

Maria Sighinolfi*, Simone Assumma, Elena Morini, Modena, Italy, Alberto Del Nero, Igor Piacentini, Barbara Mangiarotti, Matteo Maggioni, Stefano Picozzi, Milano, Italy, Giorgio Bozzini, Como, Italy, Stefano Puliatti, Salvatore Micali, Modena, Italy, Bernardo Rocco, Milano, Italy

2:20 V09-09 ROBOTIC RADICAL CYSTECTOMY WITH INTRACORPOREAL ILEAL CONDUIT: SURGICAL TECHNIQUE, PERIOPERATIVE, FUNCTIONAL AND ONCOLOGIC OUTCOMES

Leonardo Misuraca*, Gabriele Tuderti, Umberto Anceschi, Riccardo Mastroianni, Aldo Brassetti, Mariaconsiglia Ferriero, Alfredo Maria Bove, Sal-vatore Guaglianone, Michele Gallucci, Giuseppe Simone, Rome, Italy

2:30 V09-10 NEWLY ESTABLISHED APPROACH OF AN ENTIRELY RETROPERITONEAL ROBOTIC NEPHROURETERECTOMY

Peter Sparwasser*, Stefan Epple, Anita Thomas, Robert Dotzauer, Katharina Böhm, Maximilian Peter Brandt, Kamal Gheith, Rene Mager, Martin Kurosch, Hendrik Borgmann, Thomas Höfner, Axel Haferkamp, Igor Tsaur, Mainz, Germany

2:40 V09-11 NOVEL USE OF THE DAVINCI SINGLE PORT ROBOT IN NEPHROURETERECTOMY OF A HORSESHOE KIDNEY

John Sheng*, Chrystal Chang, Newark, NJ, Mi-chael Stifelman, Mutahar Ahmed, Hackensack, NJ

2:50 V09-12 SINGLE PORT MODIFIED PARTIAL NEPHRECTOMY: NOVEL TECHNIQUE FOR SIMULTANEOUS ACCESS TO PERITONEAL AND RETROPERITONEAL PARTIAL NEPHRECTOMY

Mubashir Billah, Fahad Sheckley*, Tanner Corse, Nathan Cheng, Hackensack, NJ, David Ali, Newark, NJ, Michael Stifelman, Gregory Lovallo, Mutahar Ahmed, Hackensack, NJ



SU

ND

AY

Sunday, May 15, 2022 1:00 pm – 3:00 pm

LATE-BREAKING ABSTRACT I – CANCER & BPHRoom 243 @ Ernest N. Morial Convention Center

ABSTRACTTIME NUMBER TITLE1:00 LBA01-01 HARM-TO-BENEFIT OF THREE

DECADES OF PROSTATE CANCER SCREENING IN BLACK MEN

Spyridon Basourakos, Roman Gulati, Randy Vince, Daniel Spratt, Patrick Lewicki, Alexander Hill, Yaw Nyame, Jennifer Cullen, Sarah Markt, Christopher Barbieri, Jim Hu, Jonathan Shoag

1:10 LBA01-02 EFFICACY OF LOW-POWER THULIUM LASER ENUCLEATION OF PROSTATE LARGER THAN 80 GRAMS

Samer Morsy, Islam Kamal, Alaa Meshref, Ahmed Yehia, Mahmoud Abdel-Hakim

1:20 LBA01-03 A PROSPECTIVE STUDY OF SINGLE-PORT VERSUS MULTI-PORT PATIENT REPORTED SURGICAL OUTCOMES

Luca Morgantini, Matthew Del Pino, Arthi Bharad-waj, Erin Egan, Ashwin Ganesh, Ahmad Alzein, Simone Crivellaro

1:30 LBA01-04 ARTIFICIAL INTELLIGENCE PET INTERPRETATION VS HUMAN SPECIALISTS. LATAM STUDY

Danny Mena, Diego Barreiro, Federico Losco, Andres Lopez-Cortes, Juan Pablo Sade

1:40 LBA01-05 SURGICAL TREATMENT OF LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC ENLARGEMENT BY HOLMIUM LASER ENUCLEATION OF THE PROSTATE VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE AND OPEN ADENOMECTOMY

Miguel Beltran, Yoni Pallas , Ivan Povo, Sara Mitjana, Kevin Rechi, Marta Diranzo, Fernando Martinez, Rosa Gras, Emilio Lopez

1:50 LBA01-06 LONG TERM FOLLOW-UP OF AN INTERNATIONAL MULTICENTER PROSPECTIVE STUDY IN APPLICATION OF TEMPORARY IMPLANTABLE NITINOL DEVICE (ITIND) IN MEN WITH LOWER URINARY TRACT SYMPTOMS FOR BPH

Daniele A, Sabrina De Cillis, Cristian Fiori, Gregor Kadner, Claude Schulman, Francesco Porpiglia

ABSTRACTTIME NUMBER TITLE2:00 LBA01-07 OVERALL SAFETY AND INCIDENCES OF

ADVERSE EVENTS BY TIME INTERVAL WITH DAROLUTAMIDE PLUS ANDROGEN-DEPRIVATION THERAPY AND DOCETAXEL IN THE PHASE 3 ARASENS TRIAL

E. David Crawford, Matthew R. Smith, Bertrand Tombal, Karim Fizazi, Maha Hussain, Cora N. Sternberg, Arash Rezazadeh Kalebasty, Ronald Tutrone, Neal D. Shore, Laurence Belkoff, Silke Thiele, Rui Li, Iris Kuss, Heikki Joensuu, Fred Saad

2:10 LBA01-08 INTERIM ANALYSIS OF PADRES (PRIOR AXITINIB AS A DETERMINANT OF OUTCOME OF RENAL SURGERY NCT03438708) CLINICAL TRIAL

Kevin Hakimi, Steven Campbell, Mimi Nguyen, Nityam Rathi, Luke Wang, Brian Rini, Moshe Ornstein, Rana McKay, Ithaar Derweesh

2:20 LBA01-09 INTERIM ANALYSIS NCT04046094: IV VITAMIN C WITH CHEMOTHERAPY FOR CISPLATIN INELIGIBLE BLADDER CANCER PATIENTS (CI-MIBC)

John Taylor, Rahul Parikh, Qi Chen, Benjamin Woolbright, Ping Chen, Elizabeth Wulff-Burch-field, Jeff Holzbeierlein, Jane Ledesma, Roy Jensen, Jeanne Drisko

2:30 LBA01-10 INTERIM RESULTS FROM A PHASE 1B CLINICAL TRIAL EVALUATING TOLERABILITY AND ACTIVITY OF FGFR INHIBITION IN LOCALIZED UPPER TRACT UROTHELIAL CARCINOMA (UTUC)

Surena Matin, Mehrad Adibi, Amishi Shah, Omar Alhalabi, Paul Corn, Charles Guo, Rhenita Amirtharaj, Marisa Lozano, Lianchun Xiao, Sumanta Pal, Matthew Campbell

Sunday, May 15, 2022 1:00 pm – 3:00 pm

ForumsRESEARCH FORUM: EARLY CAREER INVESTIGATORS SHOWCASE


Sunday, May 15, 2022 1:00 pm – 3:00 pm

GERIATRIC UROLOGICAL SOCIETY (GUS)Room 353 @ Ernest N. Morial Convention Center

1:00 WELCOME AND INTRODUCTIONS Society President: Tomas Griebling

1:05 AGING AND BLADDER HEALTH: A CLINICAL CASE-BASED DISCUSSION

Moderator: Alexander Gomelsky Panelists: Ryan Krlin, Elizabeth Rourke, J. Christian Winters

194

1:45 PARKINSON’S DISEASE AND THE IMPACT ON UROLOGIC HEALTH IN OLDER ADULTS

E.Camille Vaughan

2:00 AGING-ASSOCIATED LOWER URINARY TRACT (LUT) DYSFUNCTION INVOLVES ALTERED PU-RINE METABOLISM

Lori Birder

2:15 CANCER SURVIVORSHIP IN OLDER UROLOGIC PATIENTS: ISSUES AFTER PELVIC RADIATION

Bernadette Zwaans

2:30 TESTOSTERONE TREATMENT FOR HYPOGONADISM AND AGING-RELATED PROSTATE GLAND DISEASES: EVIDENCE-BASED NEW APPROACH

Ananias Diokno

2:45 RESEARCH ROUNDTABLE Moderator: Ananias Diokno

CHEMODENERVATION WITH INTRAVESICAL INJECTION IN OLDER ADULTS

Michael Basin

IMPROVEMENT IN OVERACTIVE BLADDER SYMP-TOMS FOLLOWING DIFFERENT PROSTATEC-TOMY PROCEDURES: COMPARISON BETWEEN HOLEP, PVP AND TURP

Mostafa Mostafa

Q&A

APPROVED FOR AMA PRA CATEGORY 1 CREDIT™

Sunday, May 15, 2022 1:00 pm – 3:30 pm

ENGINEERING AND UROLOGY SECTION OF THE ENDOUROLOGY SOCIETY (EUS) POSTER SESSIONGrand Salon @ Hilton New Orleans Riverside

1:00 EUS POSTER SESSION 1 Moderators: Zhamshid Okhunov, Arun Rai

2:30 EUS POSTER SESSION 2 Moderators: Alexa Meyer, TBD

Sunday, May 15, 2022 1:00 pm – 3:30 pm

SOCIETY FOR INFECTION AND INFLAMMATION (SIIU)Rivergate Room @ Ernest N. Morial Convention Center

Chairs: Michel Pontari & Kymora Scotland

1:00 OVERVIEW OF MAPP HIGHLIGHTS

OVERVIEW Quentin Clemens

REVIEW MAJOR NEURO FINDINGS Jason Kutch

FOCUS ON BIOMARKER STUDIES

2:00 DISCUSSION: WHERE THE FIELD OF PELVIC PAIN NEEDS TO GO

Discussants: A. Ackerman, Karl Kreder, J. Curtis Nickel Larissa Rodriguez

2:20 NIH OVERVIEW OF FUTURE PELVIC PAIN STUDIES

Chris Mullins

DISCUSSION

2:45 ABSTRACT PRESENTATIONS

3:15 BUSINESS MEETING

Sunday, May 15, 2022 1:00 pm – 5:00 pm

R. FRANK JONES UROLOGICAL SOCIETY (RFJUS)Jackson Room @ Hilton New Orleans Riverside

1:00 WELCOME Society President: Linda McIntire AUA President: Raju Thomas

1:15 AUA UPDATE ON DIVERSITY AND INCLUSION Efe Ghanney Simons

1:25 MENTORSHIP IN UROLOGY FOR BLACK WOMEN Shenelle Wilson

1:35 KEYNOTE: RECONCILING WORK-LIFE BALANCE WITH PROMOTION AND GENDER PAY EQUITY IN ACADEMIC LEADERSHIP ROLES: WHAT ARE THE UNIQUE CHALLENGES BLACK WOMEN FACE AND HOW TO OVERCOME THEM?

Keynote Speaker: O. Lenaine Westney

1:55 ROUND TABLE DISCUSSION Moderator: Emilie Johnson Panelists: Elodi Dielubanza, Cheryl Lee, O. Lenaine Westney, Tracey Wilson

2:45 JOURNAL CLUB Moderators: Denise Asafu-Adjei, J. Curtis Nickel Kymora Scotland

THE FUTURE IS FEMALE: UROLOGY WORK-FORCE PROJECTION FROM 2020 TO 2060

Ashanda Esdaille

RISING TIDES: CHALLENGES AND OPPORTUNITIES FOR WOMEN IN THE UROLOGIC WORKFORCE

Onika Noel

THE GENDER PAY GAP IN UROLOGY Oluwarotimi Nettey


SU

ND

AY

GENDER AND RACIAL DISPARITIES IN EAR-LY UROLOGY EXPOSURES DURING MEDICAL SCHOOL

Efe Ghanney Simons

3:30 ROUND TABLE DISCUSSION OF JOURNAL ARTICLES

Moderators: Denise Asafu-Adjei, Kymora Scotland Panelists: Kirsten Greene, Kate Kraft, Amanda North, Simone Thavaseelan, Hadley Wood


Sunday, May 15, 2022 1:00 pm – 5:00 pm

SOCIETY FOR THE STUDY OF MALE REPRODUCTION (SSMR)LaNouvelle Orleans Ballroom B @ Ernest N. Morial Convention Center

1:00 INTRODUCTION James Smith

1:10 SESSION 1: STARTING WITH THE PATIENT Moderator: James Smith

A PATIENT’S PERSPECTIVE ON HAVING INFER-TILITY NOW AND WHAT’S NEEDED FOR THE FUTURE

Jacob Anderson-Bialis

Q&A

1:25 SESSION 2: DEBATE-THE IMPACT OF COVID-19 ON MALE REPRODUCTIVE HEALTH AND OUR PRACTICES

Moderator: James Dupree

DEBATE #1: THE SARS-COV-2 VIRUS HAS A NEG-ATIVE IMPACT ON SPERMATOGENESIS, MALE REPRODUCTIVE HEALTH, AND OFFSPRING

Debater-Pro: Ranjith Ramasamy Debater-Con: James Hotaling

DEBATE #2: TELEMEDICINE CAN REPLACE IN-PERSON CLINIC VISITS BECAUSE MALE IN-FERTILITY CARE DOES NOT REQUIRE A PHYSI-CAL EXAM

Debater-Pro: Akanksha Mehta Debater-Con: Sarah Vij

PANEL DISCUSSION AND Q & A

2:45 BREAK

3:00 SESSION 3: KEYNOTE SPEAKER – THE IMPACT OF SYSTEMIC RACISM ON MALE INFERTILITY PATIENTS AND PRACTICES

Moderator: David Shin

KEYNOTE LECTURE Keynote Speaker: Tracy Downs

BUILDING MALE INFERTILITY PRACTICES THAT SUPPORT OUR MULTICULTURAL PATIENTS

Tolulope Bakare

Q&A

4:00 SESSION 4: MALE INFERTILITY CARE IN 2026 AND BEYOND: WHERE DO WE NEED TO GO AND HOW DO WE GET THERE?

Moderator: Christopher Deibert

ADVANCED DIAGNOSTICS: WHAT’S COMING AND WHAT’S NEEDED?

Dolores Lamb

ADVANCED THERAPEUTICS: WHAT’S COMING AND WHAT’S NEEDED?

Kathleen Hwang

SSMR/SMRU WHITE PAPER: PRODUCTIVITY METRICS AND THREATS TO SOCIETY

James Dupree

PANEL DISCUSSION AND Q & A


Sunday, May 15, 2022 1:00 pm – 5:00 pm

UROLOGIC SOCIETY FOR TRANSPLANTATION & RENAL SURGERY (USTRS)Room 355 @ Ernest N. Morial Convention Center

1:00 RECEPTION WITH EXHIBITORS - VIEWING AND JUDGING OF POSTERS (NON-CME)

1:20 PRESIDENT WELCOME - ANNOUNCEMENT OF BARRY INAUGURAL TRAVELING FELLOWSHIP

1:25 ROBOTIC AUTOTRANSPLANTATION: ‘THE NO INCISION TRANSPLANT’

Alberto Breda

1:45 ROBOTIC PROSTATECTOMY/CYSTECTOMY FOLLOWING RENAL TRANSPLANTATION

Obi Ekwenna

2:05 TRUE MIRACLES: TRANSPLANTING KIDNEYS IN THE THIRD WORLD

Kamrul Islam

2:25 POSTER PRESENTATIONS

2:55 BREAK WITH EXHIBITORS–POSTER PRESENTATION AWARDS

3:15 GIVING OUT ‘VOUCHERS’ FOR FUTURE KIDNEY TRANSPLANTATIONS

Jeffrey Veale

3:55 NOVICK RESIDENT PRESENTATIONS

USE OF RIGHT KIDNEYS VERSUS LEFT KIDNEYS IN LIVING-DONOR ROBOT-ASSISTED KIDNEY TRANSPLANTATION: A COMPARATIVE ANALYSIS

Arnau Abella

ROBOTIC SURGERY TO SOLVE URINARY TRACT COMPLICATIONS AFTER KIDNEY TRANSPLANTA-TION

Pol Sanz-Serra

196

RECIPIENTS WITH ABNORMAL URINARY TRACT: EXPERIENCE IN OUR TERTIARY CARE CENTER

Victor Javier Tames Chacon

CAN WE PREDICT DELAYED GRAFT FUNCTION AND GRAFT SURVIVAL RATE USING HYPOTHER-MIC MACHINE PERFUSION PARAMETERS FROM DONORS AFTER CARDIAC DEATH?

Juliano Offerni

4:30 NOVICK WINNER AWARD – BUSINESS MEETING


Sunday, May 15, 2022 1:00 pm – 5:00 pm

ForumsQUALITY IMPROVEMENT SUMMIT


QUALITY IMPROVEMENT SUMMIT: LAYING THE FOUNDATION FOR PRIMARY PALLIATIVE CARE IN UROLOGY

Chairs: Jonathan Bergman, John Gore, Matthew Nielsen

1:00 WELCOME AND INTRODUCTION Chairs: John Gore, Jonathan Bergman, Matthew Nielsen

1:25 GROWING PERIOPERATIVE PALLIATIVE CARE IN THE VETERANS AFFAIRS HEALTH CARE SYSTEM

Scott Shreve, Karleen Giannitrapani

1:55 OPTIMAL STATE OF PALLIATIVE CARE IN UROLO-GY & HOW CAN WE OPERATIONALIZE A PRIMA-RY PALLIATIVE CARE MODEL?

Moderators: Jonathan Bergman, Martha Terris Panelists: Katherine Fero, Scott Gilbert, Jaime Goldberg, Bruce Jacobs, Farnoosh Nik-Ahd

DISCUSSION/Q & A

2:40 BREAK

2:50 WHAT CLINICAL INNOVATIONS AND OTHER IN-TERVENTIONS ARE NEEDED?

Moderators: Joshua Hauser, Karl Lorenz Panelists: icheal Darson, Jaime Goldberg, Kevin Koo, Kelvin Moses, Desiree Sanchez

DISCUSSION/Q & A

3:30 BREAK

3:40 WHAT OUTCOMES SHOULD WE TRACK? Moderators: Pauline Filippou, John Gore, Panelists: Lee Hugar, John Leppert, Karl Lorenz, Charles Scales, Anne Suskind

DISCUSSION/Q & A

4:45 CONCLUSION Jonathan Bergman, John Gore


Sunday, May 15, 2022 2:00 pm – 5:00 pm

ForumsBLADDER CANCER FORUM

LaNouvelle Orleans Ballroom C @ Ernest N. Morial Convention Center

2:00 INTRODUCTION Chairs: Ashish Kamat, Sima Porten

2:05 CASE-BASED DEBATE: IS ACTIVE SURVEIL-LANCE VALID OPTION FOR 57 YEAR OLD PA-TIENT WITH RECURRENT TALG TUMORS, SMALL SIZE, NEGATIVE CYTOLOGY?

Moderator: Mark Soloway Debater-Pro: Wes Kassouf Debater-Con: Juan Palou

2:25 CASE-BASED DEBATE: SHOULD VARIANT HISTOLOGY CHANGE THE MANAGEMENT OF BLADDER CANCER?

Moderator: Peter Black Debater-Pro: Mario Fernandez Debater-Con: Michael O’Donnell

2:45 STATE-OF-THE-ART LECTURE: IBCG MASTER CLASS ON TURBT

Arnulf Stenzl

DISCUSSANT Sarah Psutka

3:00 CASE-BASED DEBATE: DO I NEED TO DO REPEAT TUR FOR ALL HIGH GRADE NMIBC PATIENTS?

Moderator: Neal Shore Debater-Pro: Trinity Bivalacqua Debater-Con: Fred J. Witjes

3:20 STATE-OF-THE-ART LECTURES

BCG UNRESPONSIVE DISEASE Seth Lerner

TIMING OF RADICAL CYSTECTOMY IN BCG UN-RESPONSIVE DISEASE

Patrick Hensley

DISCUSSANT Roger Li

3:35 STATE-OF-THE-ART LECTURE: SYSTEMIC THER-APY FOR MUSCLE INVASIVE BLADDER CANCER (NON METASTATIC)

Matthew Galsky

DISCUSSANT Stephen B. Williams


SU

ND

AY

3:50 CASE-BASED DEBATE: IN PATIENT WITH PURE T2 UC, PDL1-HIGH, GFR 60 DO I NEED NEOADJU-VANT THERAPY?

Moderator: Siamak Daneshmand Debater-Pro: Shilpa Gupta Debater-Con: Arlene Siefker-Radtke

4:10 CASE PRESENTATION: DO WE NEED TO PER-FORM RADICAL CYSTECTOMY FOR PATIENT WHO IS CT0 AFTER NEOADJUVANT CHEMO-THERAPY?

Moderator: Angela Smith Debater-Pro: Gary Steinberg Debater-Con: John Taylor

4:30 CASE PRESENTATION: IS THERE A ROLE OF RADICAL CYSTECTOMY IN CN1-2 DISEASE?

Moderator: Kamal Pohar Debater-Po: Brant Inman Debater-Con: Yair Lotan

4:50 CLOSING REMARKS Chairs: Ashish Kamat, Sima Porten


Sunday, May 15, 2022 2:00 pm – 5:00 pm

BRITISH ASSOCIATION OF UROLOGICAL SURGEONS/BJU INTERNATIONAL/UROLOGICAL SOCIETY OF AUSTRALIA AND NEW ZEALAND/SCANDINAVIAN ASSOCIATION OF UROLOGY (BAUS/BJUI/USANZ/SCAUR)

Jefferson Ballroom @ Hilton New Orleans Riverside

2:00 NEXT GENERATION SCREENING FOR PROSTATE CANCER

Chair: Alastair Lamb

SESSION INTRODUCTION

2:05 A COMBINATION OF BIOMARKERS AND MRI: TARGETED OR STANDARD BIOPSY IN PROSTATE CANCER SCREENING

2:30 PROSTAGRAM MRI: THE FUTURE OF PROSTATE CANCER SCREENING

Hashim Ahmed

2:55 SMARTER SCREENING: LIQUID MARKERS FIRST, IMAGING SECOND

Matthew Cooperberg

3:20 AFTERNOON TEA

3:40 THE STONY WAY TO SUCCESS Chair: Palle Osther

SESSION INTRODUCTION

3:45 NATURAL HISTORY OF SMALL ASYMPTOMATIC KIDNEY AND RESIDUAL STONES (BJUI SPONSORED USANZ SPEAKER)

Nadya York

4:10 TOWARD IMPROVED ENDOSCOPIC EXAMINA-TION OF URINARY STONES: A CONCORDANCE STUDY BETWEEN ENDOSCOPIC DIGITAL PICTURES VS MICROSCOPY (BJUI SPONSORED SPEAKER)

Olivier Traxer

4:35 UTILITY OF BLOOD TESTS IN SCREENING FOR METABOLIC DISORDERS IN KIDNEY STONE DISEASE (BJUI SPONSORED BAUS SPEAKER)

Sarah Howles

4:55 BJUI AMERICAS AWARD


Sunday, May 15, 2022 2:00 pm – 6:00 pm

SOCIEDAD ARGENTINA DE UROLOGÍA (SAU)Room 345 @ Ernest N. Morial Convention Center

Chairs: Miguel Costa & Carlos ScorticatiModerators: Gerardo Perazzo & Antonio Villamil

2:00 APERTURA (OPENING)

2:10 EL CAMINO HACIA LA CIRUGÍA PERCUTÁNEA IDEAL (THE ROAD TO THE IDEAL PERCUTANEOUS SURGERY)

Norberto Bernardo

2:30 ENUCLEACIÓN PROSTÁTICA AMBULATORIA: ¿ES POSIBLE? (AMBULATORY PROSTATIC ENUCLEATION: IS IT POSSIBLE?)

Mariano González

2:50 NOVEDADES EN TERAPIA INTRACAVERNOSA PARA DISFUNCIÓN SEXUAL (NEWS IN INTRA-CAVERNOUS THERAPY FOR SEXUAL DYSFUNCTION)

Adrián Momesso

3:10 MANEJO CONSERVADOR DEL CARCINOMA DEL TRACTO URINARIO SUPERIOR (CONSERVATIVE MANAGEMENT OF UPPER URINARY TRACT CARCINOMA)

Pablo Contreras

3:30 BREAK

198

4:00 SITUACIONES COMPLEJAS EN CIRUGÍA RECONSTRUCTIVA GENITAL (COMPLEX SITUATIONS IN GENITAL RECONSTRUCTIVE SURGERY)

Javier Belinky

4:20 ESTRECHEZ PANURETRAL: UN DESAFÍO PARA EL URÓLOGO-CUÁNDO EMBARCARSE EN CIRUGÍAS COMPLEJAS (PAN-URETHRAL STRICTURES: A CHALLENGE FOR THE UROLOGIST-WHEN TO EMBARK IN COMPLEX SURGERIES)

Leandro Capiel

4:40 MANEJO CONSERVADOR DE LESIONES RENALES PEQUEÑAS (CONSERVATIVE MANAGEMENT OF SMALL RENAL LESIONS)

Gabriel Moncalvo

5:00 ACTUALIZACIÓN EPIDEMIOLÓGICA EN CÁNCER DE PENE (UPDATE ON EPIDEMIOLOGY IN PENILE CANCER)

Carlos Palazzo

5:20 PRTU COMO TRATAMIENTO FOCAL PARA EL CÁNCER DE PRÓSTATA (TURP AS FOCAL TREATMENT FOR PROSTATE CANCER)

Diego Barreiro

5:40 CONCLUSIONES Y CIERRE DEL SIMPOSIO (CONCLUSIONS AND CLOSING OF THE SYMPOSIUM)

Sunday, May 15, 2022 2:25 pm – 5:30 pm

SOCIETÀ ITALIANA DI UROLOGIA (SIU)Commerce Room @ Hilton New Orleans Riverside

2:25 WELCOME AND INTRODUCTION Society Secretary: Giuseppe Carrieri

2:30 SESSION I Moderator: Vincenzo Ficarra

HOW TO “BETTER” DETECT AN INSIDIOUS BLADDER CANCER?

Gianluca Giannarini

PRECISION MEDICINE IN ONCOLOGY: THE CASE FOR PERSONALIZED NEOADJUVANT THERAPY FOR BLADDER CANCER

Roger Li

ADJUVANT CHEMOTHERAPY FOR MUSCLE-IN-VASIVE BLADDER CANCER: WHERE WE ARE? WHERE DO WE GO?

Cora Sternberg

ROBOT-ASSISTED RADICAL CYSTECTOMY: A CRITICAL REAPPRAISAL OF INTRACORPOREAL NEOBLADDER RECONSTRUCTION TECHNIQUES

Riccardo Autorino

3:45 DEBATE

3:55 SESSION II Moderator: Andrea Salonia

ROBOT-ASSISTED RADICAL CYSTECTOMY: A RIGOROUS ANALYSIS OF POSTOPERATIVE COMPLICATIONS

Debater: Peter Wiklund

ROBOT-ASSISTED RADICAL CYSTECTOMY: A CRITICAL REAPPRAISAL OF FUNCTIONAL OUTCOMES

Marco Moschini

ROBOT-ASSISTED RADICAL CYSTECTOMY: LONG-TERM ONCOLOGIC OUTCOMES

Khurshid Guru

4:55 TAKE HOME MESSAGE AND GUIDELINES UPDATE

Sam Chang

5:15 DEBATE

5:25 AWARD: BEST ITALIAN ABSTRACT PRESENTED AT THE 2022 AUA ANNUAL MEETING

Giuseppe Carrieri


SU

ND

AY

Sunday, May 15, 2022 2:45 pm – 4:00 pm

Moderated Poster Session 47KIDNEY CANCER: EPIDEMIOLOGY & EVALUATION/STAGING/SURVEILLANCE III

Room 228 @ Ernest N. Morial Convention CenterModerators: Allan Pantuck, Stephen Savage & John Pattaras


MP47-01 DEVELOPMENT OF INDIVIDUAL LEVEL INFERENCE AVAILABLE EXPLAINABLE ARTIFICIAL INTELLIGENCE MODEL FOR CANCER-SPECIFIC SURVIVAL AFTER NEPHRECTOMY IN RENAL CELL CARCINOMA PATIENTS

Jungyo Suh*, Dongwon Kim, Bumjin Lim, Cheryn Song, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Bumsik Hong, Hanjong Ahn, Choung-Soo Kim, Seoul, Korea, Republic of

MP47-02 MACHINE LEARNING APPROACH TO PREDICT PT3A UPSTAGING OF CLINICALLY LOCALIZED RENAL CELL CARCINOMA AND ONCOLOGICAL OUTCOMES AFTER SURGERY (UROCCR 15 STUDY)

Astrid Boulenger de Hauteclocque*, Loïc Ferrer, Bordeaux, France, Damien Ambrosetti, Nice, France, Solène Ricard, Bordeaux, France, Pierre Bigot, An-gers, France, Karim Bensalah, Rennes, France, Ar-nauld Villers, François Henon, Lille, France, Nicolas Doumerc, Toulouse, France, Arnaud Méjean, Virginie Verkarre, Charles Dariane, Paris, France, Stéphane Larré, Reims, France, Cécile Champy, Alexandre de La Taille, Créteil, France, Franck Bruyère, Tours, France, Morgan Rouprêt, Paris, France, Philippe Paparel, Lyon, France, Stéphane Droupy, Alexis Fontenil, Nîmes, France, Jean-Jacques Patard, Mont de Marsan, France, Romain Boissier, Marseille, France, Mokrane Yacoub, Thierry Colin, Jean-Chris-tophe Bernhard, Bordeaux, France

MP47-03 MAYO CLINIC VALIDATION OF THE AMERICAN UROLOGIC ASSOCIATION RISK GROUPS FOR LOCALIZED RENAL CANCER

Andrew Zganjar*, Abhinav Khanna, Dan Joyce, Paige Nichols, Christine Lohse, John Cheville, Sounak Gupta, Aaron Potretzke, R. Houston Thompson, Bradley Leibovich, Stephen Boorjian, Vidit Sharma, Rochester, MN

MP47-04 VALIDATION OF A 22-GENE EPITHELIAL-MESENCHYMAL TRANSITION (EMT) PROGNOSTIC SIGNATURE IN CLEAR CELL RENAL CELL CARCINOMA

Brittney Cotta*, Srinivas Nallandhighal, Ann Arbor, MI, Judith Stangl-Kremser, Vienna, Austria, Trinh Pham, Ann Arbor, MI, Jeffrey Tosoian, Nashville, TN, Kathryn Marchetti, Joel Berends, Mahir Maruf, Scott Tomlins, Todd Morgan, Ganesh Palapattu, Eman Abdulfatah, Aaron Udager, Simpa Salami, Ann Arbor, MI


MP47-05 STIMULATED RAMAN HISTOLOGY ALLOWS FOR REAL TIME DETERMINATION OF THE ADEQUACY OF RENAL MASS BIOPSY AND IDENTIFY MALIGNANT SUBTYPES OF RENAL CELL CARCINOMA

Miles P. Mannas*, Fang-Ming Deng, Derek Jones, William Huang, Daniel Orringer, Samir S Taneja, New York, NY

MP47-06 ASSESSING RENAL MASS MANAGEMENT OF PATIENTS WITH INCREASED COMORBIDITIES: RESULTS FROM A STATEWIDE REGISTRY

Mohit Butaney*, Amit Patel, Detroit, MI, Ji Qi, Karandeep Singh, Anna Johnson, Ann Arbor, MI, Alison Levy, Detroit, MI, Sabrina Noyes, Grand Rapids, MI, Khurshid Ghani, Ann Arbor, MI, Craig Rogers, Detroit, MI, Brian Lane, Grand Rapids, MI, for the Michigan Urological Surgery Improve-ment Collaborative, Ann Arbor, MI

MP47-07 DEFINING THE IMPACT OF PERCUTANEOUS RENAL BIOPSY ON RISK OF INTERVENTION FOR PATIENTS ON ACTIVE SURVEILLANCE FOR SMALL RENAL MASSES

Song Jiang*, Dan Sjoberg, Sari Khaleel, Nicole Benfante, Paul Russo, Abraham Hakimi, Jonathan Coleman, New York, NY

MP47-08 SURGICAL DELAY AFTER BIOPSY AND RISK OF UPSTAGING FOR CLINICAL T1A RENAL CELL CARCINOMA

Leilei Xia*, Ruchika Talwar, Raju Chelluri, Daniel Lee, Thomas Guzzo, Philadelphia, PA

MP47-09 THE ADDED VALUE OF HISTOLOGICAL SUBTYPE IN THE PREDICTION OF ONCOLOGIC OUTCOMES IN PATIENTS WITH NON-METASTATIC PAPILLARY RENAL CELL CARCINOMA

Giuseppe Rosiello, Gianfranco Baiamonte*, Giuseppe Fallara, Giuseppe Basile, Roberta Lucianò, Maurizio Colecchia, Alberto Martini, Daniele Cignoli, Luigi Nocera, Federico Belladelli, Gianmarco Colandrea, Daniela Canibus, Chiara Re, Giacomo Musso, Francesco Cei, Alberto Briganti, Roberto Bertini, Andrea Necchi, Daniele Raggi, Milan, Italy, Pierre I. Karakiewicz, Montreal, Canada, Francesco Montorsi, Andrea Salonia, Alessandro Larcher, Umberto Capitanio, Milan, Italy

200

MP47-10 DIFFERENCES IN PREDICTIVE ABILITY OF CRP AND DE RITIS RATIO FOR OUTCOMES IN RENAL CELL CARCINOMA

John Perry*, La Jolla, CA, Viraj Master, Atlanta, GA, Hajime Tanaka, Tokyo, Japan, Arman Walia, Ava Saidian, Rekha Narasimhan, Mimi Nguyen, Madison Chakoumakos, Margaret Meagher, Juan Javier-Desloges, La Jolla, CA, Dattatraya Patil, Atlanta, GA, Kazutaka Saito, Yasuhisa Fujii, To-kyo, Japan, Ithaar Derweesh, La Jolla, CA

MP47-11 DIFFERENTIAL ASSOCIATION OF BODY MASS INDEX ON SURVIVAL OUTCOMES IN RENAL CELL CARCINOMA: IMPACT OF TUMOR HISTOLOGY

Arman Walia*, San Diego, CA, Yasuhisa Fujii, To-kyo, Japan, Viraj Master, Atlanta, GA, Ava Saidi-an, Rekha Narasimhan, Mimi Nguyen, John Perry, Margaret Meagher, Madison Chakoumakos, Kevin Hakimi, San Diego, CA, Dattatraya Patil, Atlanta, GA, Yosuke Yasuda, Hajime Tanaka, Tokyo, Japan, Ithaar Derweesh, San Diego, CA

MP47-12 FRAILTY STATUS PREDICTS WORSE POSTOPERATIVE AND LONG-TERM ONCOLOGIC OUTCOMES IN PATIENTS TREATED WITH PARTIAL NEPHRECTOMY FOR SMALL RENAL MASSES

Giuseppe Rosiello*, Giuseppe Fallara, Daniele Cignoli, Giuseppe Basile, Gianmarco Colandrea, Gianfranco Baiamonte, Isaline Rowe, Daniela Canibus, Giacomo Musso, Federico Belladelli, Francesco Cei, Cristina Giancristofaro, Milan, Italy, Pierre I. Karakiewicz, Montreal, Canada, Alberto Briganti, Roberto Bertini, Francesco Montorsi, Andrea Salonia, Alessandro Larcher, Umberto Capitanio, Milan, Italy

MP47-13 MUSCLE MASS CHANGE USING LINEAR MEASUREMENT ANALYSIS AFTER NEPHRECTOMY FOR PT3 RENAL CELL CARCINOMA IS ASSOCIATED WITH MORTALITY

Alexandra Medline*, Eric Midenberg, Dattatraya Patil, Sean Evans, Fatima Kamal, Kenneth Ogan, Atlanta, GA, Sarah Psutka, Seattle, WA, Mehmet Asim Bilen, Viraj Master, Atlanta, GA

MP47-14 THE ROLE OF COMBINED SARCOPENIA AND ALBUMIN IN THE SURGICAL PROGNOSTICATION OF LOCALLY ADVANCED RENAL CELL CARCINOMA WITH VENOUS TUMOR THROMBUS

Eric Midenberg*, Dattatraya Patil, Alexandra Med-line, Atlanta, GA, Michelle Higgins, Baltimore, MD, Milton Williams, Birmingham, AL, Sarah P. Psutka, Seattle, WA, Kenneth Ogan, Mehmet A. Bilen, Viraj A. Master, Atlanta, GA

MP47-15 IMPACT OF DIABETES MELLITUS ON FUNCTIONAL DECLINE AND NON-CANCER MORTALITY IN RENAL CELL CARCINOMA: ANALYSIS OF THE INTERNATIONAL MARKER CONSORTIUM (INMARC)

Ava Saidian*, Arman Walia, Rekha Narashimhan, John Perry, La Jolla, CA, Hajime Tanaka, Tokyo, Japan, Kevin Hakimi, Margaret Meagher, La Jolla, CA, Dattatraya Patil, Atlanta, GA, Yosuke Yasuda, Kazutaka Saito, Yasuhisa Fujii, Tokyo, Japan, Viraj Master, Atlanta, GA, Ithaar Derweesh, La Jolla, CA

MP47-16 DECLINE TO “SEVERE” CKD-S IS A PREDICTIVE MARKER FOR ALL-CAUSE AND NON-CANCER MORTALITY IN RENAL CELL CARCINOMA: ANALYSIS OF THE INTERNATIONAL MARKER CONSORTIUM FOR RENAL CANCER (INMARC)

Mimi Nguyen*, Arman Walia, Rekha Narasimhan, Ava Saidian, John Matthew Perry, La Jolla, CA, Hajime Tanaka, Tokyo, Japan, Kevin Hakimi, Margaret Meagher, La Jolla, CA, Dattatraya Patil, Atlanta, GA, Yosuke Yasuda, Kazutaka Saito, Yasuhisa Fujii, Tokyo, Japan, Viraj Master, Atlan-ta, GA, Ithaar Derweesh, La Jolla, CA

MP47-17 IMPACT OF PATIENT AND LIFESTYLE FACTORS IN PATIENTS WITH STAGE III & IV RENAL CANCER: A DANISH NATIONWIDE STUDY

Freja Ebbestad*, Copenhagen, Denmark, Louise Geertsen, Odense, Denmark, Naomi Nadler, Roskilde, Denmark, Sofie Axelsen, Hjørring, Den-mark, Trine Horsbøll, Odense, Denmark, Susanne Dalton, Copenhagen, Denmark, Jane Chris-tensen, Copenhagen, Denmark, Frede Donskov, Aarhus, Denmark, Lars Lund, Odense, Denmark, Nessn Azawi, Roskilde, Denmark

MP47-18 SUSTAINABLE MULTIDISCIPLINARY TEAM REFERRAL FOR NON-METASTATIC RENAL CELL CARCINOMA: A SURVIVAL-BASED RECOMMENDATION

Giuseppe Basile*, Alberto Martini, Giuseppe Fal-lara, Antony Pellegrino, Alessandro Larcher, Dan-iele Raggi, Milan, Italy, Riccardo Campi, Florence, Italy, Sumanta Pal, Duarte, CA, Philippe Spiess, Tampa, FL, Francesco Montorsi, Milan, Italy, Toni K. Choueiri, Boston, MA, Andrea Necchi, Umberto Capitanio, Milan, Italy

MP47-19 UNDERREPRESENTATION OF HISPANICS AND AMERICAN INDIAN/ALASKA NATIVES IN THE NATIONAL CANCER DATABASE

Juan Javier-DesLoges*, Arman Walia, Margaret Meagher, John Perry, Mimi Nguyen, Rekha Nar-asimhan, Madison Chakoumakos, Ava Saidian, Ithaar Derweesh, San Diego, CA

MP47-20 UNIVERSAL GERMLINE GENETIC TESTING OF PATIENTS WITH NEWLY DIAGNOSED UPPER TRACT UROTHELIAL CARCINOMA: AN INTERIM ANALYSIS

Craig Labbate*, Donika Saporito, Maureen Mork, Eduardo Vilar Sanchez, Eric Jonasch, Mehrad Adibi, Surena Matin, Houston, TX



SU

ND

AY

Sunday, May 15, 2022 2:45 pm – 4:00 pm

Moderated Poster Session 48PROSTATE CANCER: ADVANCED (INCLUDING DRUG THERAPY) III

Room 225 @ Ernest N. Morial Convention CenterModerators: Todd Morgan, Brian Chapin & Chengfei Liu


MP48-01 HOW TO OPTIMIZE PATIENT SELECTION BEFORE SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENT PROSTATE CANCER: A NOVEL RISK STRATIFICATION TOOL

Nicola Fossati*, Lugano, Switzerland, Jeffrey R. Karnes, Rochester, MN, David Pfister, Munich, Germany, Axel Heidenreich, Cologne, Germa-ny, Alexander Kretschmer, Alexander Buchner, Christian Stief, Munich, Germany, Steven Joniau, Hendrik van Poppel, Leuven, Belgium, Daniar Osmonov, Klaus-Peter Juenemann, Kiel, Germa-ny, Shahrokh Shariat, Vienna, Austria, Andreas Hiester, Peter Albers, Düsseldorf, Germany, Derya Tilki, Markus Graefen, Hamburg, Germany, Inderbir S. Gill, Los Angeles, CA, Elio Mazzone, Armando Stabile, Milan, Italy, Alexander Mottrie, Melle, Belgium, Giorgio Gandaglia, Milan, Italy, Andrea Gallina, Lugano, Switzerland, Francesco Montorsi, Alberto Briganti, Milano, Italy

MP48-02 PERSISTENT TESTOSTERONE SUPPRESSION AFTER CESSATION OF ANDROGEN DEPRIVATION THERAPY FOR LOCALIZED PROSTATE CANCER

Jessica Delgado*, Miami, FL, Jesse Ory, Nova Scotia, Canada, Joshua Bitran, Ruben Blachman Braun, Sirpi Nackeeran, Ranjith Ramasamy, Miami, FL

MP48-03 PREVALENCE AND NATURAL HISTORY OF NON-METASTATIC CASTRATE RESISTANT PROSTATE CANCER: A POPULATION-BASED ANALYSIS

Amanda Hird*, Erind Dvorani, Refik Saskin, Send-er Herschorn, Ronald Kodama, Girish Kulkarni, Robert Nam, Toronto, Canada

MP48-04 EVALUATING CARDIOVASCULAR RISK IN MEN STARTING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER

Benjamin Lowentritt*, Towson, MD, Mark Fallick, Robert Dufour, Janis Pruett, Brisbane, CA, Tao Jiang, Boston, MA, Esmond Nwokeji, New York, NY, Mitch Nagao, Brisbane, CA

MP48-05 CHANGES IN PITUITARY–GONADAL HORMONES AFTER ENZALUTAMIDE OR ABIRATERONE PLUS PREDNISONE IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER (HEAT): RESULTS FROM A RANDOMISED CLINICAL TRIAL

Klara Ternov*, Jens Sønksen, Mikkel Fode, Henriette Lindberg, Herlev, Denmark, Caroline Kistorp, copenhagen, Denmark, Rasmus Bisbjerg, Jens Faber, Herlev, Denmark, Ganesh Palapattu, Ann Arbor, MI, Peter Busch Østergren, Herlev, Denmark


MP48-06 ADVERSE EVENTS RELATED TO DAROLUTAMIDE TREATMENT: ANALYSIS OF “REAL LIFE” DATA FROM EUDRAVIGILANCE (EV) AND THE FOOD AND DRUG ADMINISTRATION (FDA) DATABASE ENTRIES

Antonio Cicione*, Rome, Italy, Antonio Nacchia, Rionero in Vulture, Italy, Beatrice Turchi, Carmen Gravina, Giacomo Gallo, Alessandro Guercio, Lorenzo Maria Rovesti, Giorgio Guarnotta, Elisa Mancini, Jordi Stira, Sara Riolo, Antonio Franco, Olivia Alessandra Voglino, Valeria Baldassarri, Simone D’Annunzio, Rome, Italy, Ferdinando Di Giacomo, Giuseppe Disabato, Alfredo Tartarone, Rionero in Vulture, Italy, Cosimo De Nunzio, Andrea Tubaro, Rome, Italy

MP48-07 THE NEUROTOXICITY OF ANDROGEN DEPRIVATION THERAPY: A PHARMACOVIGILANCE STUDY

Logan Briggs*, Stephen Reese, Peter Herzog, Da-vid-Dan Nguyen, Muhieddine Labban, Khalid Alkhat-ib, Quoc-Dien Trinh, Alicia K Morgans, Boston, MA

MP48-08 RESPONSE RATES AND SURVIVAL OUTCOMES OF METASTASIS DIRECTED THERAPIES IN SOLITARY OLIGO-RECURRENT PROSTATE CANCER

Mohamed Ahmed*, Jack Andrews, Vidit Sharma, Cameron Britton, Vidhu Joshi, Bradley Stish, Ryan Phillips, R. Jeffrey Karnes, Eugene Kwon, Rochester, MN

MP48-09 TOXICITY PROFILE OF IMMEDIATE POST-PROSTATECTOMY RADIATION THERAPY: RESULTS FROM A LARGE MULTI-INSTITUTIONAL SERIES

Nicola Fossati*, Lugano, Switzerland, Jeffrey R. Karnes, Stephen A. Boorjian, Alberto Bossi, Roches-ter, MN, Nadia Di Muzio, Cesare Cozzarini, Barbara Noris Chiorda, Giorgio Gandaglia, Milano, Italy, Detlef Bartkowiak, Ulm, Germany, Shahrokh Shariat, Vien-na, Austria, Gregor Goldner, Department of Radiation Oncology, Austria, Charlien Berghen, Steven Joniau, Gert De Meerleer, Leuven, Belgium, Elio Mazzone, Armando Stabile, Milano, Italy, Hendrik van Poppel, Leuven, Belgium, Andrea Gallina, Lugano, Swit-zerland, Francesco Montorsi, Milano, Italy, Thomas Wiegel, Ulm, Germany, Alberto Briganti, Milano, Italy

MP48-10 ANDROGEN DEPRIVATION THERAPY FOR NODE-POSITIVE PROSTATE CANCER AT RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION: CONTEMPORARY PRACTICE PATTERNS AND ASSOCIATED FACTORS

Leilei Xia, Ruchika Talwar, Raju Chelluri*, Daniel Lee, Thomas Guzzo, Philadelphia, PA

202

MP48-11 CARDIOVASCULAR ADVERSE EVENTS-RELATED TO GNRH AGONISTS AND GNRH ANTAGONISTS: ANALYSIS OF REAL-LIFE DATA FROM EUDRA-VIGILANCE DATABASE

Cosimo De Nunzio, Rome, Italy, Antonio Nacchia*, Rionero in Vulture, Italy, Antonio Cicione, Beatrice Turchi, Giacomo Gallo, Carmen Gravina, Alessandro Guercio, Jordi Stira, Lorenzo Maria Rivesti, Antonio Franco, Elisa Mancini, Olivia Alessandra Voglino, Valeria Baldassarri, Giorgio Guarnotta, Rome, Italy, Ferdinando Di Giacomo, Giuseppe Disabato, Rione-ro in Vulture, Italy, Andrea Tubaro, Rome, Italy

MP48-12 OPTIMIZING TIMING AND INDICATIONS FOR 68GA-PSMA PET/CT IN PATIENTS WITH BIOCHEMICAL RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY

Daniele Robesti*, Elio Mazzone, Milano, Italy, Giorgio Gandaglia, Armando Stabile, Milan, Italy, Carlo Andrea Bravi, Andrea Necchi, Daniele Raggi, Laura Marandino, Milano, Italy, Giuseppe Cirulli, Milan, Italy, Francesco Barletta, Simone Scuderi, Riccardo Leni, Milano, Italy, Luigi Nocera, Milan, Italy, Eleonora Balestrazzi, Stefano Fanti, Andrea Farolfi, Lorenzo Bianchi, Riccardo Schiavina, Bologna, Italy, Francesco Montorsi, Alberto Briganti, Milano, Italy

MP48-13 THE KEY ROLE OF CONCOMITANT ANDROGEN-DEPRIVATION THERAPY ON THE EFFICACY OF IMAGING GUIDED TREATMENTS IN MEN WITH BIOCHEMICAL RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY AND POSITIVE 68GA-PSMA PET/CT SCAN

Daniele Robesti*, Milano, Italy, Elio Mazzone, Milan, Italy, Giorgio Gandaglia, Armando Stabile, Giuseppe Rosiello, Alberto Martini, Carlo Andrea Bravi, Milano, Italy, Giuseppe Cirulli, Antony Pellegrino, Riccardo Leni, Milan, Italy, Francesco Barletta, Milano, Italy, Mario De Angelis, Milan, Italy, Simone Scuderi, Milano, Italy, Luigi Nocera, Milan, Italy, Daniele Raggi, Milano, Italy, Vito Cuc-chiara, Milan, Italy, Nazareno Suardi, Genoa, Italy, Andrea Necchi, Milano, Italy, Shahrokh F. Shariat, Vienna, Austria, Francesco Montorsi, Alberto Briganti, Milano, Italy

MP48-14 WHEN NODE-POSITIVE PROSTATE CANCER SHOULD BE CONSIDERED A SYSTEMIC DISEASE? ASSESSING THE PROGNOSTIC ROLE OF PREOPERATIVE 68GA-PSMA PET/CT RESULTS IN PATIENTS WITH LYMPH NODE INVASION AT FINAL PATHOLOGY

Daniele Robesti*, Elio Mazzone, Milano, Italy, Giorgio Gandaglia, Armando Stabile, Milan, Italy, Carlo Andrea Bravi, Andrea Necchi, Daniele Raggi, Laura Marandino, Milano, Italy, Giuseppe Cirulli, Milan, Italy, Francesco Barletta, Simone Scuderi, Riccardo Leni, Milano, Italy, Mario de Angelis, Vito Cucchiara, Milan, Italy, Eleonora Balestrazzi, Stefano Fanti, Andrea Farolfi, Loren-zo Bianchi, Riccardo Schiavina, Bologna, Italy, Francesco Montorsi, Alberto Briganti, Milano, Italy

MP48-15 CORRELATION BETWEEN 18F-DCFPYL PET DETECTED LOCAL RECURRENCE AND RADICAL PROSTATECTOMY HISTOPATHOLOGY: A PILOT STUDY

Sophie Tissot*, Jessica Wynn, Lih-Ming Wong, Michael Ng, Fitzroy, Australia

MP48-16 18F-DCFPYL PSMA PET IMAGING IMPROVES DETECTION OF NODAL METASTASES IN COMPARISON TO CONVENTIONAL IMAGING IN PATIENTS WITH LOCALLY ADVANCED OR OLIGOMETASTATIC PROSTATE CANCER

Ashanda Esdaille*, Edward Lawrence, Chris-tos Kyriakopoulos, Brian Johnson, Alejandro Roldan-Alzate, Wei Huang, David Beebe, Hamid Emamekhoo, Shane Wells, Joshua Lang, Steve Cho, David Jarrard, Madison, WI

MP48-17 ONCOLOGICAL OUTCOMES IN PATIENTS WITH RECURRENT PROSTATE CANCER STAGED WITH PSMA PET/CT: RESULTS FROM 3 EUROPEAN TERTIARY CENTERS

Matteo Droghetti*, Lorenzo Bianchi, Francesco Costa, Eleonora Balestrazzi, Francesco Chessa, Bologna, Italy, Francesco Ceci, milano, Italy, Ric-cardo Mei, Andrea Farolfi, Paolo Castellucci, Pietro Piazza, Bologna, Italy, Stefano Puliatti, Modena, Italy, Alessandro Larcher, Giorgio Gandaglia, Milano, Italy, Alexandre Mottrie, Aalst, Belgium, Alberto Briganti, Milano, Italy, Stefano Fanti, Bologna, Italy, Francesco Montorsi, Milano, Italy, Riccardo Schiavi-na, Eugenio Brunocilla, Bologna, Italy

MP48-18 THE IMPACT OF LOCOREGIONAL TREATMENTS FOR METASTATIC CASTRATION RESISTANT PROSTATE CANCER ON DISEASE PROGRESSION: REAL LIFE EXPERIENCE FROM A MULTICENTER COHORT

Mariaconsiglia Ferriero*, Gabriele Tuderti, Umber-to Anceschi, Alfredo Maria Bove, Aldo Brassetti, Leonardo Misuraca, Salvatore Guaglianone, Riccardo Mastroianni, Cosimo De Nunzio, Silvana Giacinti, Giorgia Tema, Rome, Italy, Luca Cindolo, Vasto, Italy, Andrea Tubaro, Michele Gallucci, Rome, Italy, Luigi Schips, Vasto, Italy, Fabio Cal-abrò, Giuseppe Simone, Rome, Italy

MP48-19 RISK OF METABOLIC AND CARDIOVASCULAR ADVERSE EVENTS WITH ABIRATERONE OR ENZALUTAMIDE AMONG MEN WITH ADVANCED PROSTATE CANCER

Lillian Lai*, Mary Oerline, Megan Caram, Phoebe Tsao, Samuel Kaufman, Brent Hollenbeck, Va-hakn Shahinian, Ann Arbor, MI

MP48-20 PROTECTIVE EFFECTS OF METFORMIN AGAINST BIOCHEMICAL FAILURE FOLLOWING RADICAL PROSTATECTOMY OR RADIATION THERAPY IN LOCALIZED PROSTATE CANCER

Linda My Huynh*, Orange, CA, Emily Keit, Omaha, NE, Erica Huang, Raymond Ceja Carrillo, Thomas Ahlering, Orange, CA, Shawna Boyle, Charles Enke, Michael J. Baine, Omaha, NE



SU

ND

AY

Sunday, May 15, 2022 3:30 pm – 5:30 pm

Podium Session 49SEXUAL FUNCTION/DYSFUNCTION: MEDICAL, HORMONAL & NON-SURGICAL THERAPY II

Room 252 @ Ernest N. Morial Convention CenterModerators: Mohit Khera, Ingrid Perscky & Joseph Alukal

ABSTRACTTIME NUMBER TITLE3:30 PD49-01 SECONDARY POLYCYTHEMIA WHILE ON

TESTOSTERONE THERAPY INCREASES RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND VENOUS THROMBOEMBOLISM IN MEN: INSIGHTS FROM A GLOBAL HEALTH RESEARCH NETWORK

Jesse Ory*, Halifax, Canada, Sirpi Nackeeran, Navin Balaji, Joshua Hare, Ranjith Ramasamy, Miami, FL

3:40 PD49-02 MEDICATIONS MOST COMMONLY ASSOCIATED WITH ERECTILE DYSFUNCTION: EVALUATION OF THE FOOD AND DRUG ADMINISTRATION NATIONAL PHARMACOVIGILANCE DATABASE

Elie Kaplan-Marans*, Mariela Martinez, Arshia Sandozi, Jeffrey Lee, Jacob Khurgin, Ariel Schulman, New York, NY

3:50 PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?

Ruben Blachman-Braun*, Miami, FL, Sankalp Goberdhan, Orlando, FL, Sirpi Nackeeran, Thomas Masterson, Ranjith Ramasamy, Miami, FL

4:00 PD49-04 5 YEARS FOLLOW-UP OUTCOMES OF PELVIC FLOOR REHABILITATION PROTOCOL IN SUBJECTS WITH LIFELONG PREMATURE EJACULATION: THE DEFINITIVE LONG-TERM EVALUATION

Antonio Luigi Pastore*, Andrea Fuschi, Yazan Al Salhi, Alessia Martoccia, Lorenzo Capone, Silvio Scalzo, Paolo Pietro Suraci, Gennaro Velotti, Latina, Italy, Ester Illiano, Terni, Italy, Giorgio Bozzini, Milan, Italy, Serena Maruccia, Monza, Italy, Alessandro Zucchi, Pisa, Italy, Elisabetta Costantini, Terni, Italy, Antonio Carbone, Latina, Italy

4:10 PD49-05 ERECTILE DYSFUNCTION IS AN INDEPENDENT RISK FACTOR FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS

Uday Mann*, Ranveer Brar, Premal Patel, Winnipeg, Canada

4:20 PD49-06 EFFICACY OF RESTOREX PENILE TRACTION THERAPY IN IMPROVING PENILE LENGTH AND ERECTILE FUNCTION POST PROSTATECTOMY

Andrew Zganjar*, Amir Toussi, Matthew Ziegelmann, David Yang, Madeleine Manka, Tobias Kohler, Sevann Helo, Landon Trost, Rochester, MN


4:30 PD49-07 SEXUAL FUNCTION RECOVERY FOLLOWING OPEN AND ROBOTIC RADICAL PROSTATECTOMY: RESULTS OF AN ACADEMIC PENILE REHABILITATION PROGRAM

Ugo Falagario*, Michele Di Nauta, Andrea Checchia, Marco Recchia, Anna Ricapito, Nicola D’Altilia, Pasquale Annese, Gian Maria Busetto, Luigi Cormio, Giuseppe Carrieri, Carlo Bettocchi, Foggia, Italy

4:40 PD49-08 INCREASED RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN MEN RECEIVING TESTOSTERONE REPLACEMENT THERAPY

Uday Mann*, Ranveer Brar, Premal Patel, Winni-peg, Canada

4:50 PD49-09 TESTOSTERONE THERAPY IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER

Jose M Flores*, Carolyn A Salter, Nicole Benfan-te, Lawrence Jenkins, Behfar Ehdaie, Vincent Laudone, James Eastham, John P. Mulhall, New York, NY

5:00 PD49-10 SLEEP DISORDERS AND CIRCADIAN RHYTHM SLEEP DISORDERS ARE ASSOCIATED WITH SIGNIFICANTLY HIGHER RATES OF HYPOGONADISM AND ERECTILE DYSFUNCTION - A U.S. CLAIMS DATABASE ANALYSIS

Pranjal Agrawal*, Sajya Singh, Baltimore, MD, Corey Able, Galveston, TX, Taylor P. Kohn, Amin S Herati, Baltimore, MD

5:10 PD49-11 THREE YEARS AFTER FINISHING PENILE REHABILITATION STUDY PROGRAMS AND 5 YEARS AFTER NERVE-SPARING RADICAL PROSTATECTOMY: WHAT`S UP WITH OUR PATIENTS?

Andreas Bannowsky*, Rendsburg, Germany, Daniar Osmonov, Kiel, Germany, Viktoria Märker, Hamburg, Germany, Stefan Ückert, Hannover, Germany

5:20 PD49-12 AWARENESS OF VTE RISK IN KLINEFELTER SYNDROME AND TESTOSTERONE THERAPY

Frederick Melling*, Sophie Birch, Tet Yap, Paul Carrol, Awatul El-Shirif, Leila Frodsham, Paula Allchrone, Karen Briggs, London, United Kingdom


204

Sunday, May 15, 2022 3:30 pm – 5:30 pm

Podium Session 50STONE DISEASE: EPIDEMIOLOGY & EVALUATION II

Room 255 @ Ernest N. Morial Convention CenterModerators: Charles Scales & Shuba De

ABSTRACTTIME NUMBER TITLE3:30 PD50-01 DURATION OF FOLLOW-UP AND TIMING

OF DISCHARGE IN ADULT PATIENTS WITH UROLITHIASIS AFTER SURGICAL OR MEDICAL INTERVENTION: A SYSTEMATIC REVIEW AND META-ANALYSIS FROM THE EUROPEAN ASSOCIATION OF UROLOGY GUIDELINE PANEL ON UROLITHIASIS

Lazaros Tzelves*, Athens, Greece, Robert Ger-aghty, Newcastle, United Kingdom, Riccardo Lom-bardo, Rome, Italy, Niall D. Davis, Dublin, Ireland, Andreas Neisius, Trier, Germany, Ales Petrík, Prague, Czech Republic, Giovanni Gambaro, Verona, Italy, Christian Türk, Vienna, Austria, Kay Thomas, London, United Kingdom, Bhaskar Somani, Southampton, United Kingdom, Andreas Skolarikos, Athens, Greece

3:40 PD50-02 DO SEQUENTIAL 24-HOUR URINE COLLECTIONS IN AN INDIVIDUAL PATIENT RESULT IN IMPROVED URINARY PARAMETERS?

Akin S. Amasyali*, Jason Groegler, Hyukje Sung, Daniel Jhang, Joshua D. Belle, Mohammad Hajiha, D.Duane Baldwin, Loma Linda, CA

3:50 PD50-03 NO ASSOCIATION BETWEEN STATINS AND INCREASED NEPHROLITHIASIS RISK

Wilson Sui, Christina J. Peterson*, Naren Nim-magadda, Nicholas L Kavoussi, Nicole L Miller, S. Duke Herrell, Ryan S. Hsi, Nashville, TN

ABSTRACTTIME NUMBER TITLE4:00 PD50-04 ELECTRONIC HEALTH RECORD-BASED

RISK STRATIFICATION FOR RECURRENCE OF KIDNEY STONES: A FEASIBILITY IMPLEMENTATION

Ryan Hsi*, Tatsuki Koyama, Allison McCoy, Nashville, TN

4:10 PD50-05 A NOVEL PREDICTION OF URIC ACID COMPONENT IN NEPHROLITHIASIS USING SIMPLE CLINICAL INFORMATION: A MACHINE LEARNING-BASED MODEL

Hao-Wei Chen*, Yu-Chen Chen, Jung-Ting Lee, Chung-Yao Kao, Wen-Jeng Wu, Yung-Shun Juan, Kaohsiung, Taiwan

4:20 PD50-06 EXAMINING RISKS OF COMPOSITION CONVERSION IN RECURRENT STONE FORMERS

Hari Nair*, Tinika Montgomery, Michael Siev, New Haven, CT, Erin Murphy, North Haven, CT, Kath-ryn Simmons, Piruz Motamedinia, Neera Dahl, Dinesh Singh, New Haven, CT

4:30 PD50-07 DEFINING STONE PASSAGE IN A CLINICAL TRIAL: ADJUDICATION IN THE PREVENTION OF URINARY STONES WITH HYDRATION (PUSH) STUDY

Hunter Wessells, Seattle, WA, Henry Lai, St. Louis, MO, John Lieske*, Rochester, MN, Brian Matlaga, Baltimore, MD, Sharon Settles, Hongqiu Yang, Durham, NC, Jonathan Harper, Seattle, WA, Charles Scales Jr, Durham, NC, Alana Desai, St. Louis, MO, Naim Maalouf, Dallas, TX, Peter Reese, Sri Sivalingam, Durham, NC, Gregory Tasian, Philadelphia, PA, Hussein Al-Khalidi, Durham, NC, Ziya Kirkali, Bethesda, MD

4:40 PD50-08 PRACTICE PATTERNS IN THE SURGICAL MANAGEMENT OF UROLITHIASIS: DATA FROM THE AUA QUALITY (AQUA) REGISTRY

Amy Showen*, Justin Ahn, San Francisco, CA, Raymond Fang, Cody Weiss, William Meeks, Lin-thicum, MD, Matthew Cooperberg, David Bayne, Tom Chi, San Francisco, CA

4:50 PD50-09 CLINICAL IMPLICATIONS OF ULTRASOUND SHEAR WAVE ELASTOGRAPHY OF URINARY STONES IN PATIENT CANDIDATE FOR URETEROSCOPY

Enrico De Marzo*, Chiara Lonati, Stefania Zambo-ni, Brescia, Italy, Giuseppe Pezzotti, Desenzano, Italy, Claudio Simeone, Brescia, Italy

5:00 PD50-10 EVALUATING THE ENCRUSTATION FEATURES DUE TO THE SHORT-TERM URETERAL STENT PLACEMENT USING MICRO-COMPUTED TOMOGRAPHY: THE RESULTS FROM A PROSPECTIVE STUDY

Shinji Fukui*, Takashi Yoshida, Kuniko Takemoto, Hidefumi Kinoshita, Hirakata, Japan

5:10 PD50-11 THE PATIENT VOICE: EXPERIENCES WITH URETERAL STENT REMOVAL–A URINARY STONE DISEASE RESEARCH NETWORK (USDRN) STUDY

Carrie Dombeck, Charles Scales Jr*, Kevin McKenna, Teresa Swezey, Durham, NC, Jodi Antonelli, Dallas, TX, Alana Desai, St. Louis, MO, Jonathan Harper, Michele Curatolo, Seattle, WA, Naim Maalouf, Dallas, TX, Peter Reese, Rebecca McCune, Philadelphia, PA, Hussein Al-Khalidi, Durham, NC, Ziya Kirkali, Bethesda, MD, Amy Corneli, Durham, NC

5:20 PD50-12 PRELIMINARY VALIDATION OF THE 6-ITEM SHORT FORM OF THE WISCONSIN STONE QUALITY OF LIFE QUESTIONNAIRE (WISQOL)

Shuang Li*, Christopher Haas, Margaret Knoedler, Stephen Nakada, Kristina Penniston, Madison, WI



SU

ND

AY

Sunday, May 15, 2022 3:30 pm – 5:30 pm

Podium Session 51PENILE & TESTICULAR CANCER II

Room 245 @ Ernest N. Morial Convention CenterModerators: Jeffrey Holzbeierlein & Philippe Spiess

ABSTRACTTIME NUMBER TITLE3:30 PD51-01 CONTEMPORARY SURGICAL OUTCOMES

OF RETROPERITONEAL LYMPH NODE DISSECTION FROM THE SEMS TRIAL

Brian Hu*, Loma Linda, CA, Muhannad Alsyouf, Los Angeles, CA, Clint Cary, Timothy A. Mas-terson, Lawrence Einhorn, Indianapolis, IN, Stephen A. Boorjian, Rochester, MN, Christian K. Kollmannsberger, Vancouver, Canada, Anne K. Schuckman, Los Angeles, CA, Alan So, Peter C. Black, Vancouver, Canada, Aditya Bagro-dia, Dallas, TX, Eila C. Skinner, Palo Alto, CA, Mehrdad Alemozaffar, Atlanta, GA, Timothy C. Brand, Tacoma, WA, Scott E. Eggener, Chicago, IL, Phillip M. Pierorazio, Baltimore, MD, Kelly Lynn Stratton, Oklahoma, OK, Lucia Nappi, Vancouver, Canada, Craig R. Nichols, Seattle, WA, Siamak Daneshmand, Los Angeles, CA

3:40 PD51-02 ONCOLOGIC OUTCOMES OF PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION FOR STAGE II SEMINOMA: INDIANA UNIVERSITY EXPERIENCE

Isamu Tachibana*, Andre Alabd, Sean Kern, Mohammad Mahmoud, Timothy Masterson, Nabil Adra, Richard Foster, Lawrence Einhorn, Clint Cary, Indianapolis, IN

ABSTRACTTIME NUMBER TITLE3:50 PD51-03 MOLECULAR CHARACTERISTICS OF

METASTATIC TERATOMAS AND MATCHED PRIMARY TESTICULAR GERM CELL TUMORS

Anna Savelyeva*, Feng Wang, Lei Guo, John Lafin, Liwei Jia, Kirill Medvedev, Cheryl Lewis, Payal Kapur, Vitaly Margulis, Solomon Woldu, Xiaosong Meng, Nick Grishin, Dallas, TX, James Amatruda, Los Angeles, CA, Lin Xu, Dallas, TX, Aditya Bagrodia, San Diego, CA

4:00 PD51-04 MEDIUM TO LONG TERM HEALTH-RELATED QUALITY OF LIFE AND TREATMENT-RELATED SIDE-EFFECTS IN PATIENTS TREATED WITH A SINGLE DOSE OF ADJUVANT CARBOPLATIN FOR HIGH-RISK SEMINOMA – RESULTS FROM A PILOT STUDY

Walter Cazzaniga*, London, United Kingdom, Adam Pearce, Brisbane, Australia, Chandran Tanabalan, Prabhakar Rajan, Netty Kinsella, Alison Reid, Robert Huddart, David Nicol, London, United Kingdom

4:10 PD51-05 FEASIBILITY OF OMITTING CT PELVIS IN PATIENTS WITH STAGE I GERM CELL TUMOR (GCT) ON ACTIVE SURVEILLANCE: A MULTI-INSTITUTIONAL STUDY

Hamed Ahmadi*, Minneapolis, MN, Tarik Benidir, Cleveland, OH, Ragheed Saoud, New Jersey, NJ, Lynn Anson-Cartwright, Martin O’Malley, Toronto, Canada, Scott E. Eggener, Chicago, IL, Robert J Hamilton, Toronto, Canada, Siamak Daneshmand, Los Angeles, CA

4:20 PD51-06 EVALUATION OF MIR-371A-3P PERFORMANCE IN DETECTING SEMINOMATOUS TESTICULAR CANCER METASTASES

Bendu Konneh*, John T Lafin, Anna Savelyeva, Solomon L. Woldu, Cheryl Lewis, Vitaly Margulis, Dallas, TX, Lindsay Frazier, Boston, MA, Nicholas Coleman, Matthew Murray, Cambridge, United Kingdom, Armon Amini, Dallas, TX, James F. Am-atruda, Boston, MA, Cinzia Scarpini, Cambridge, United Kingdom, Aditya Bagrodia, San Diego, CA

4:30 PD51-07 PREDICTING THE HISTOPATHOLOGY RESULT OF POST-CHEMO RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND)

Axel Gerdtsson, Malmö, Sweden, Anna Thor*, Stockholm, Sweden, Anna Grenabo Bergdahl, Göteborg, Sweden, Helene Negaard, Oslo, Norway, Bjarte Almås, Bergen, Norway, Ingrid Glimelius, Uppsala, Sweden, Åsa Karlsdottir, Ber-gen, Norway, Dag Halvorsen, Trondheim, Norway, Kristine Engen Andreassen, Signe Melsen Larsen, Rolf Wahlqvist, Oslo, Norway, Hege Saagstuen Haugnes, Tromsö, Norway, Torgrim Tandstad, Trondheim, Norway, Göran Holmberg, Göteborg, Sweden, Gabriella Cohn Cedermark, Stockholm, Sweden, Olof Ståhl, Lund, Sweden, Gustav Thorison, Malmö, Sweden, Anders Kjellman, Stockholm, Sweden

4:40 PD51-08 NERVE SPARING RETROPERITONEAL LYMPH NODE DISSECTION IN LOW VOLUME METASTATIC SEMINOMA

Axel Heidenreich*, Pia Paffenholz, Tim Nestler, David Pfister, Cologne, Germany

4:50 PD51-09 SURVIVAL IN N3 PENILE CANCER: DOES PELVIC LYMPHADENOPATHY PREDICT A WORSE PROGNOSIS THAN INGUINAL EXTRA-NODAL EXTENSION?

James A. Churchill*, Ashwin Sachdeva, Allaudin Issa, Craig Jones, Fowz Azhar, Ikenna Aneke, Noel W. Clarke, Maurice W. Lau, Vijay K. Sangar, Arie S. Parnham, Manchester, United Kingdom

5:00 PD51-10 PERINEURAL INVASION AS A PROGNOSTIC INDICATOR FOR EARLY METASTATIC SPREAD IN PENILE CANCER

Titus Murphy*, Luis Ribeiro, Marta Skrodzka, Eleni Anastasiadis, Sylvia Yan, Benjamin Ayres, Nicholas Watkin, London, United Kingdom

206

5:10 PD51-11 CONCOMITANT VS STAGED LYMPHADENECTOMY IN CLINICALLY NODE-POSITIVE PENILE SQUAMOUS CELL CARCINOMA: RECURRENCE PATTERNS AND SURVIVAL OUTCOMES

Heather Huelster*, Tampa, FL, Marco Band-ini, Milan, Italy, Oscar Brouwer, Amsterdam, Netherlands, Maarten Albersen, Eduard Roussel, Leuven, Belgium, Hielke de Vries, Amsterdam, Netherlands, Juan Chipollini, Mounsif Azizi, Tam-pa, FL, Yao Zhu, Ding-Wei Ye, Shanghai, China, People’s Republic of, Antonio Ornellas, Rio de Ja-neiro, Brazil, Mario Catanzaro, Laura Marandino, Milan, Italy, Oliver Hakenberg, Rostock, Germany, Axel Heidenreich, Friederike Haidl, Köln, Germa-ny, Nick Watkin, Michael Ager, London, United Kingdom, Mohamed Ahmed, Jeffrey Karnes, Rochester, MN, Alberto Briganti, Roberto Salvioni, Francesco Montorsi, Andrea Necchi, Milan, Italy, Philippe Spiess, Tampa, FL

5:20 PD51-12 PATTERNS OF RECURRENCE IN PENILE CANCER: IMPLICATIONS FOR SURVEILLANCE STRATEGIES

Amandeep Arora*, Gagan Prakash, Mahendra Pal, Uday Chandankhede, Manoj Tummala, Anand Mohan, Ganesh Bakshi, Mumbai, India


Sunday, May 15, 2022 3:30 pm – 5:30 pm

Video Session 10ADRENAL & RENAL ONCOLOGY I

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerators: Robert Figenshau, Kristen Scarpato & Michael Staehler

ABSTRACTTIME NUMBER TITLE3:30 V10-01 ROBOTIC PARTIAL NEPHRECTOMY IN

TRANSPLANTED KIDNEY: LANDMARKS AND STEPS

Aaron Kaviani*, Mahmoud Abou Zeinab, Mark Noble, Alvin Wee, Jihad Kaouk, Mohamed Eltemamy, Cleveland, OH

3:40 V10-02 ROBOTIC PARTIAL NEPHRECTOMY WITH REVERSIBLE SELECTIVE ARTERY ENDOLUMINAL BALLOON OCCLUSION ON A KIDNEY GRAFT

Patrick-Julien Treacy*, Nice, France, Severine Lagarde, Al Emadi Ibrahim, Thomas Prudhomme, Marine Lesourd, Toulouse, France, Rayan Atme, Matthieu Durand, Imad Bentellis, Nice, France, Michel Soulié, Nicolas Doumerc, Toulouse, France

3:50 V10-03 3D VIRTUAL MODELS APPLICATION FOR AN ANATOMIC-FUNCTIONAL APPROACH TO HIGHLY COMPLEX RENAL TUMORS WITH IMPERATIVE INDICATIONS TO NEPHRON SPARING SURGERY

Daniele Amparore*, Angela Pecoraro, Federico Pi-ramide, Paolo Verri, Enrico Checcucci, Sabrina De Cillis, Alberto Piana, Matteo Manfredi, Cristian Fiori, Francesco Porpiglia, Orbassano (Turin), Italy

4:00 V10-04 MINIMALLY-INVASIVE PARTIAL NEPHRECTOMY EMPLOYING 4K VISUALIZATION SYSTEM WITH OPAL 1 NEAR-INFRARED AND INDOCYANINE GREEN TECHNOLOGY

Pietro Diana*, Andrea Gallioli, Alberto Piana, Angelo Territo, Julia Aumatell, Alejandra Bra-vo, Josep Maria Gaya, Jordi Huguet, Antonio Rosales, Francesco Sanguedolce, Pavel Gavrilov, Joan Palou, Alberto Breda, Barcelona, Spain

ABSTRACTTIME NUMBER TITLE4:10 V10-05 UTILIZATION OF A 3D MODEL FOR

REHEARSAL TUMOR RESECTION PRIOR TO ROBOT ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY

Pratik Kanabur*, Sagar Patel, Richard E. Link, Wesley A. Mayer, Houston, TX

4:20 V10-06 ROBOTIZED 3D LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR RIGHT RENAL MIDPOLE MASS LESION

Krishna Mohan Ramaswami*, Pankaj Bhirud, Harigovind Podiyedath, Calicut, India

4:30 V10-07 NEAR-INFRARED FLUORESCENCE IMAGING TECHNOLOGY APPLICATIONS IN UROLOGIC SURGERY

Riccardo Mastroianni*, Gabriele Tuderti, Umberto Anceschi, Alfredo Maria Bove, Aldo Brassetti, Mariaconsiglia Ferriero, Leonardo Misuraca, Giuseppe Simone, Rome, Italy

4:40 V10-08 ROBOT-ASSISTED PARTIAL NEPHRECTOMY OF A RIGHT PELVIC KIDNEY

Nicholas Elliott*, Gaurav Pahouja, Samantha Jakuboski, Marcus Quek, Maywood, IL

4:50 V10-09 SUTURELESS PURELY OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY: TECHNIQUE AND PERIOPERATIVE OUTCOMES

Leonardo Misuraca*, Riccardo Mastroianni, Gabriele Tuderti, Umberto Anceschi, Alfredo Maria Bove, Aldo Brassetti, Mariaconsiglia Ferriero, Sal-vatore Guaglianone, Michele Gallucci, Giuseppe Simone, Rome, Italy


SU

ND

AY

5:00 V10-10 ROBOTIC PARTIAL NEPHRECTOMY FOR COMPLEX RENAL TUMORS; OUR EXPERIENCE AND TIPS AND TRICKS

Burak Ucpinar*, Shirin Razdan, New York, NY, Kennedy Okhawere, Indu Saini, New York City, NY, Tara Tomy, New York, NY, Ketan K. Badani, New York City, NY

5:10 V10-11 PARTIAL NEPHRECTOMY IN COMPLEX KIDNEY MASSES-TWO APPROACHES WITH THE DAVINCI SINGLE PORT ROBOT

John Sheng*, Chrystal Chang, Newark, NJ, Michael Stifelman, Mutahar Ahmed, Hackensack, NJ

5:20 V10-12 COMPLEX PARTIAL NEPHRECTOMY IN SOLITARY KIDNEY

Nimrod Barashi Gozal*, Brijesh Patel, Mark Biebel, Joseph Ippolito, Robert Figenshau, Saint Louis, MO


Sunday, May 15, 2022 3:30 pm – 5:30 pm

LATE-BREAKING ABSTRACT II – BENIGN DISEASERoom 243 @ Ernest N. Morial Convention Center

ABSTRACTTIME NUMBER TITLE3:30 LBA02-01 EFFECT OF CANNABIDIOL OIL ON POST-

URETEROSCOPY PAIN FOR URINARY CALCULI: A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED TRIAL

Gopal Narang, Olufunmilola Adeleye, Kevin Wymer, Mitchell Humphreys, Karen Stern

3:40 LBA02-02 DEVELOPMENT OF A MULTIPHASIC BLADDER PATCH COMPOSED OF COLLAGEN, AMNIOTIC MEMBRANE, AND PATIENT-DERIVED EPITHELIAL CELLS

Ilaha Isali, Phillip McClellan, Thomas Wong, Ozan Akkus, Rachel Pope, Shubham Gupta, Adonis Hijaz

3:50 LBA02-03 MARKED REDUCTION OF URINARY EXCRETION OF OSTEOPONTIN IN CHILDREN WITH UROLITHIASIS AND HYPOCITRATURIA

Larisa Kovacevic, Yegappan Lakshmanan

4:00 LBA02-04 EFFECT OF EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY COMBINED WITH EXTRACORPOREAL PHYSICAL VIBRATION LITHOTRIPSY IN THE TREATMENT OF PATIENTS WITH URETERAL CALCULI

Han Yang, Xueyu Li, Ke Wang

4:10 LBA02-05 OASIS PIVOTAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF THE RENOVA ISTIM SYSTEM™ FOR THE TREATMENT OF WOMEN WITH OAB

Suzette Sutherland, Osvaldo Padron, Kevin Benson, Rebecca McCrery, Kevin Cline, Philip Toozs-Hobson, Alessandro Digesu, John Hee-sakkers

4:20 LBA02-06 AN OPEN SOURCE, NON-INVASIVE, AND INEXPENSIVE ASSEMBLY FOR AUTOMATIC HEMATURIA MONITORING IN CONTINUOUS BLADDER IRRIGATION.

Rohit Malyala, Alireza Habibi, Drew Phillips, Ryan Yan, Christopher Nguan

ABSTRACTTIME NUMBER TITLE4:30 LBA02-07 DELINEATING THE FAILURE MECHANISM

FOR PHOTONIC LITHOTRIPSYIan Houlihan, Prajakatta Mulay, Smitha De, Vijay Krishna

4:40 LBA02-08 RISK FACTORS FOR INCREASED STENT-ASSOCIATED SYMPTOMS FOLLOWING URETEROSCOPY FOR URINARY STONES: RESULTS FROM THE URINARY STONE DISEASE RESEARCH NETWORK (USDRN) STENTS STUDY

Jonathan Harper, Hongqiu Yang, Naim Maalouf, Jodi Antonelli, Alana Desai, Henry Lai, Peter Reese, Gregory Tasian, Hunter Wessells, Hussein Al-Khalidi, Ziya Kirkali, Charles Scales

4:50 LBA02-09 INTRACELLULAR SARS-COV-2 FOUND IN THE SPERMATOZOA OF CONVALESCENT MEN WITH NEGATIVE PCR SEMEN SAMPLES REVEALED BY ELECTRON MICROSCOPY

Jorge Hallak, Elia Tamaso Espin Garcia Caldini, Maria Cássia Jacintho Mendes Corrêa, Marisa Dolhnikoff, Paulo Hilario Nascimento Saldiva, Es-per Georges Kallas, Amaro Nunes Duarte Neto, Raul Segundo Sanchez Gutierrez, Joel R Drevet, Thiago Afonso Carvalho Celestino Teixeira, Felipe Saraiva Bernardes, Heloisa Faquineti

5:00 LBA02-10 ASSESSING THE RISKS OF A POSITIVE URINE CULTURE IN UNCOMPLICATED RENAL COLIC PATIENTS

Nikhile Mookerji, Matthew Mancuso, Vardhil Gan-dhi, Efrem Violato, Stacey Broomfield, Tim Wollin, Trevor Schuler, Shubha De

5:10 LBA02-11 NOVEL ON-DEMAND TREATMENT FOR LIFELONG PREMATURE EJACULATION USING TRANSCUTANEOUS PERINEAL MINI-PATCH STIMULATOR

Ariki Shechter, Nicola Mondaini, Ege Can Serefo-glu, Tal Gollan, Boaz Appel, Ilan Gruenwald

5:20 LBA02-12 RBFOX2 COPY NUMBER VARIATION VITIATES URETHRAL CLOSURE CAUSING HYPOSPADIAS

Victor Ruthig, Fredi Ruiz Rojano, Jeffrey White, Marisol O’Neill, Dolores Lamb

208

Sunday, May 15, 2022 4:30 pm – 5:45 pm

Moderated Poster Session 49URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: BASIC RESEARCH & PATHOPHYSIOLOGY

Room 228 @ Ernest N. Morial Convention CenterModerators: Toby Chai & Marcio Averbeck


MP49-01 HUNNER’S LESIONS CORRELATE WITH A DECREASE AND REDISTRIBUTION OF MUCOSAL COLLAGEN CONTENT IN PATIENTS WITH INTERSTITIAL CYSTITIS

Raymond Xu*, Harrison Martin, Dylan T. Wolff, Wencheng Li, Robert J. Evans, Gopal Badlani, Catherine A. Matthews, Stephen J. Walker, Winston-Salem, NC

MP49-02 MODULATION OF SENSORY GLIA GQ-GPCR SIGNALING IN VIVO AFFECTS SPONTANEOUS VOIDING AND BLADDER FUNCTION IN AN ANIMAL MODEL OF CHRONIC PELVIC PAIN

Alison Xiaoqiao Xie*, Randall Meacham, Anna Malykhina, Aurora, CO

MP49-03 PANNEXIN 1 CHANNELS PLAY AN IMPORTANT ROLE IN MECHANISMS OF DIABETIC BLADDER DYSFUNCTION

Nicole Roselli*, Yi Wang, Marcia Urban-Maldona-do, Melissa Laudano, Sylvia Suadicani, Bronx, NY

MP49-04 MATRIX METALLOPROTEINASE-9 CONTROLS SECRETION OF NERVE GROWTH FACTOR FROM BLADDER CELLS IN VITRO

Aya Hajj, Aalya Hamouda, Stephanie Sir-makesyan, Philippe Cammisotto, Lysanne Cam-peau*, Montreal, Canada

MP49-05 INTRAVESICAL NERVE GROWTH FACTOR-TARGETING THERAPY USING LIPOSOME-CONJUGATED ANTISENSE IN RATS WITH STRESS-INDUCED BLADDER HYPERSENSITIVITY

Tetsuichi Saito*, Matsumoto, Japan, Pradeep Tya-gi, Taro Igarashi, Pittsburgh, PA, Tomonori Minaga-wa, Teruyuki Ogawa, Osamu Ishizuka, Matsumoto, Japan, Naoki Yoshimura, Pittsburgh, PA

MP49-06 SIGNIFICANT DIFFERENCES IN UROTHELIAL GENE EXPRESSION AMONG WOMEN WITH UUI

Gabrielle McNary*, Joseph Prinz, Carole Grenier, Cindy Amundsen, Susan Murphy, Nazema Sid-diqui, Durham, NC

MP49-07 AUTONOMIC SYMPTOM SCORE IS GREATER IN INTERSTITIAL CYSTITIS PATIENTS EXHIBITING A NON-BLADDER-CENTRIC PHENOTYPE

Dylan T. Wolff*, Peyton Lee, Robert J. Evans, Gopal Badlani, Catherine A. Matthews, Stephen J. Walker, Winston-Salem, NC

MP49-08 PRE-CLINICAL APPLICATIONS OF HIGH-DEFINITION MANOMETRY (HDM) SYSTEM TO INVESTIGATE PELVIC FLOOR MUSCLE CONTRIBUTION TO URETHRAL CLOSURE PRESSURE IN A RABBIT MODEL

Samuel Sorkhi*, Valmik Bhargava, Youngjin Seo, Kyoko Sakamoto, Mahadevan Rajasekaran, San Diego, CA


MP49-09 OXIDATIVE STRESS DRIVES NOCTURNAL POLYURIA VIA INTRARENAL SPAK-NCC PATHWAY: A THERAPEUTIC POTENTIAL OF A NOVEL ANTIOXIDANT, SILICON COMPONENT AGENTS

Yosuke Sekii*, Hiroshi Kiuchi, Takahiro Imana-ka, Sohei Kuribayashi, Koichi Okada, Kentaro Takezawa, Shinichiro Fukuhara, Norio Nonomura, Suita, Japan

MP49-10 EFFECTS OF CONSTANT ILLUMINATION ON MOUSE VOIDING BEHAVIOR

Whitney Clearwater*, Yi Wang, Marcia Urban-Mal-donado, Sylvia Suadicani, Bronx, NY

MP49-11 FIDGETIN-LIKE 2 (FL2) DEPLETION AT THE SITE AND TIME OF CAVERNOUS NERVE INJURY IMPROVES BLADDER FUNCTIONAL OUTCOMES

Yi Wang, Moses Tar, Marcia Urban-Maldonado, Lisa Baker, David Sharp, Sylvia Suadicani, Kelvin Davies*, Bronx, NY

MP49-12 A NOVEL BLADDER FIBROSIS PATHWAY THROUGH PDGFRα+ CELLS ASSOCIATED WITH ESTROGEN DEFICIENCY AND REPLACEMENT

Ken Lee*, Masatoshi Eto, Fukuoka, Japan, Ken-ton Sanders, Sang don Koh, Reno, NV

MP49-13 BLADDER-CENTRIC INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME PATIENTS EXHIBIT A VARIABLE BLADDER MUCOSAL FIBROSIS-RELATED GENE EXPRESSION PROFILE BASED ON HUNNER’S LESION STATUS

Dylan T. Wolff*, Raymond Xu, Sarah Wachtman, Robert J. Evans, Gopal Badlani, Catherine A. Matthews, Stephen J. Walker, Winston-Salem, NC

MP49-14 NEW TECHNIQUE FOR VIDEO URODYNAMICS IN MICE ALLOWS NEW INSIGHTS INTO THE ROLE OF ION CHANNEL TRPV4 IN THE MURINE LOWER URINARY TRACT

Helene De Bruyn*, Noémie Luyts, Thomas Voets, Wouter Everaerts, Leuven, Belgium

MP49-15 OVERACTIVE BLADDER MEDICATION; HOW LONG SHOULD IT BE CONTINUED? - MIRABEGRON INTERFERES WITH CENTRAL SENSITIZATION IN A MOUSE MODEL OF OVERACTIVE BLADDER

Joonbeom Kwon*, Eun-Ju Lee, Hye-Ri Park, Hyun-Jung Cho, Ji-Ae Jang, Daegu, Korea, Re-public of, Donghwi Park, Ulsan, Korea, Republic of, Naoki Yoshimura, Pittsburgh, PA


SU

ND

AY

MP49-16 IMPAIRED UROTHELIAL BARRIER FUNCTION INDUCED LOWER URINARY TRACT DYSFUNCTION BY PROTEASE-ACTIVATED RECEPTER 2 ACTIVATION

Hidenori Akaihata*, Yusuke Hakozaki, Hiroki Nat-suya, Tomoyuki Kumekawa, Shunsuke Yoshioka, Hitomi Imai, Akifumi Onagi, Kanako Matsuoka, Tomoyuki Koguchi, Junya Hata, Yuichi Sato, Masao Kataoka, Yoshiyuki Kojima, Fukushima, Japan

MP49-17 PUDENDAL NERVE MAPPING AND THE USE OF URODYNAMICS TO EXAMINE THE EFFECTS OF PUDENDAL NEUROMODULATION

Priyanka Gupta*, Po-Ju Chen, Amador Lagunas, Luis C. Ruiz, Anagha Kotkar, Gaurang Shah, Scott F. Lempka, Tim M. Bruns, Ann Arbor, MI

MP49-18 NITRIC OXIDE CONTROLS NGF SECRETION IN BLADDER CELLS IN VITRO THROUGH MATRIX METALLOPROTEINASES

Stephanie Sirmakesyan, Aya Hajj, Aalya Ham-ouda, Philippe Cammisotto, Lysanne Campeau*, Montreal, Canada

MP49-19 TIME COURSE CHANGES IN VOIDING INTERVAL IN RATS WITH FOCAL CEREBRAL INFARCTION INDUCED BY PHOTOCHEMICALLY-INDUCED THROMBOSIS

Yuya Ota*, Yasue Kubota, Yuji Hotta, Mami Mat-sumoto, Nayuka Matsuyama, Taiki Kato, Takashi Hamakawa, Tomoya Kataoka, Kazunori Kimura, Kazunobu Sawamoto, Takahiro Yasui, Nagoya, Japan

MP49-20 UROTYPES IN YOUNG WOMEN WITH PELVIC PAIN: A PILOT ANALYSIS OF CLINICAL URINARY MICROBIOME CLASSIFICATION

James M. Weinberger*, L. Marcella Henao, Crystal Cisneros, James E. Ackerman, A. Lenore Ackerman, Los Angeles, CA


Sunday, May 15, 2022 4:30 pm – 5:45 pm

Moderated Poster Session 50KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY III

Room 225 @ Ernest N. Morial Convention CenterModerators: R. Houston Thompson, David Duchene & Jeffrey Cadeddu


MP50-01 PROGNOSTIC IMPACT OF PATHOLOGICAL RENAL PARENCHYMAL INFILTRATION IN NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA

Hajime Tanaka*, Yuki Fukawa, Kouhei Yamamoto, Shohei Fukuda, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Tokyo, Japan, Steven C. Campbell, Cleveland, OH, Yasuhisa Fujii, Tokyo, Japan

MP50-02 HOW IMPORTANT ARE MORPHOLOGIC SUBTYPES ON THE PROGNOSIS OF SURGICALLY TREATED NON-METASTATIC PAPILLARY RENAL CELL CARCINOMA? AN ANALYSIS FROM A CONTEMPORARY MULTI-INSTITUTIONAL DATABASE

Selcuk Erdem*, Istanbul, Turkey, Umberto Cap-itanio, Milan, Italy, Riccardo Campi, Florence, Italy, Daniele Amparore, Turin, Italy, Maria Carme Mir, Valencia, Spain, Eduard Roussel, Leuven, Belgium, Nicola Pavan, Trieste, Italy, Onder Kara, Kocaeli, Turkey, Tobias Klatte, Berlin, Germany, Enes Degirmenci, Resat Aydin, Istanbul, Turkey, Andrea Minervini, Sergio Serni, Alessandro Berni, Florence, Italy, Giacomo Rebez, Trieste, Italy, Faruk Ozcan, Istanbul, Turkey


MP50-03 SYSTEMATIC DEFINITION OF TREATMENT MODALITY AND CLINICAL OUTCOMES REPORTING SYSTEM IN CASE OF SURGICAL TREATMENT FOR VON HIPPEL-LINDAU RENAL CELL CARCINOMA

Alessandro Larcher, Federico Belladelli*, Andrea Ieva, Isaline Rowe, Giuseppe Fallara, Daniele Cignoli, Gianmarco Colandrea, Miriam Santan-gelo, Roberta Lucianò, Claudio Doglioni, Stefano Clerici, Laura Castellino, Anna Damascelli, Giorgia Guazzarotti, Francesco De Cobelli, Andrea Necchi, Daniele Raggi, Roberto Bertini, Francesco Montor-si, Umberto Capitanio, Andrea Salonia, Milan, Italy

MP50-04 MULTIMODAL IMAGE-GUIDED ABLATION ON MANAGEMENT OF RENAL CANCER IN VON-HIPPEL-LINDAU (VHL) SYNDROME PATIENTS FROM 2004 TO 2021 AT A SPECIALIST CENTRE: A LONGITUDINAL OBSERVATIONAL STUDY

Vinson Wai-Shun Chan*, James Lenton, Jonathan Smith, Satinder Jagdev, Christy Ralph, Naveen Vasudev, Selina Bhattarai, Andrew Lewington, Mi-chael Kimuli, Jon Cartledge, Tze Min Wah, Leeds, United Kingdom

MP50-05 ORDER OF THROMBECTOMY FOR MANAGEMENT OF RENAL CELL CARCINOMA WITH INFERIOR VENA CAVA THROMBUS

Yudai Ishiyama*, Tsunenori Kondo, Arakawa, Japan, Kazuhiko Yoshida, Junpei Iizuka, Kazunari Tanabe, Toshio Takagi, Tokyo, Japan

210

MP50-06 RADICAL NEPHRECTOMY AND CAVAL THROMBECTOMY WITH HEART BEATING TECHNIQUE FOR RENAL CELL CANCER WITH TUMOR THROMBUS EXTENSION INTO INFERIOR VENA CAVA AND RIGHT ATRIUM: A LESS INVASIVE MULTIDISCIPLINARY APPROACH

Sonia Guzzo, Sebastiano Nazzani*, Chiara Vaccaro, Roberto Di Benedetto, Claudia Signorini, Damiano Vizziello, Andrea Conti, Elisabetta Fin-kelberg, Giacomo Bortolussi, Pietro Acquati, Carlo De Vincentiis, Luca Carmignani, Milan, Italy

MP50-07 IMPLICATIONS OF POSITIVE SURGICAL MARGINS FOLLOWING ROBOTIC PARTIAL NEPHRECTOMY

Sij Hemal*, Mahmoud Abou Zeinab, Alp Tuna Beksac, Jayram Krishnan, Cleveland, OH, Amr Fergany, Sebastian, FL, Robert Stein, Georg-es-Pascal Haber, Jihad Kaouk, Cleveland, OH

MP50-08 THE PROGNOSTIC SIGNIFICANCE OF LYMPH NODE DISSECTION IN PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA WHO UNDERWENT CURATIVE NEPHRECTOMY: A RETROSPECTIVE, LONG-TERM FOLLOW-UP, MULTICENTER STUDY CARCINOMA (NMRCC) WHO UNDERWENT CURATIVE NEPHRECTOMY

Sung Han Kim*, Jinsoo Chung, Hyung Ho Lee, Boram Park, Goyangsi, Korea, Republic of, Seok Soo Byun, Seongnamsi, Korea, Republic of, Chang Wook Chung, Sung Hoo Hong, Seoul, Korea, Republic of, Eu Chang Hwang, Hwasun, Korea, Republic of, Cheol Kwack, Seoul, Korea, Republic of

MP50-09 IMAGING INTENSITY AFTER SURGERY FOR CLEAR CELL RENAL CELL CARCINOMA

Alberto Martini*, Federico Belladelli, Daniele Cignoli, Giuseppe Rosiello, Giuseppe Fallara, Giuseppe Basile, Luigi Nocera, Gianmarco Colandrea, Daniela Canibus, Chiara Re, Giacomo Musso, Francesco Cei, Francesco De Cobel-li, Giorgio Brembilla, Alberto Briganti, Roberto Bertini, Daniele Raggi, Andrea Necchi, Francesco Montorsi, Andrea Salonia, Alessandro Larcher, Umberto Capitanio, Milan, Italy

MP50-10 RISKS AND BENEFITS OF PARTIAL NEPHRECTOMY WITH LIMITED OR WITHOUT ISCHEMIA TIME

Alessandro Larcher, Daniele Cignoli*, Giuseppe Fallara, Giuseppe Rosiello, Giuseppe Basile, Gianmarco Colandrea, Gianfranco Baiamon-te, Francesco Cei, Giacomo Musso, Daniela Canibus, Roberto Bertini, Milan, Italy, Pierre I. Karakiewicz, Montreal, Canada, Alexandre Mottrie, Aalst, Belgium, Federico Dehò, Varese, Italy, Andrea Gallina, Francesco Montorsi, Andrea Salonia, Umberto Capitanio, Milan, Italy

MP50-11 HEAD TO HEAD COMPARISON BETWEEN OFF-CLAMP VS ON-CLAMP RAPN IN HIGH-RISK RENAL SCORE KIDNEY TUMORS

Rocco Simone Flammia*, Umberto Anceschi, Antonio Tufano, Gabriele Tuderti, Rome, Italy, Alexander Kutikov, Robert G. Uzzo, Philadelphia, Philippines, Francesco Porpiglia, Cristian Fiori, Turin, Italy, Andrea Minervini, Florence, Italy, Umberto Capitanio, Milan, Italy, Riccardo Autori-no, Richmond, VA, Michele Gallucci, Costantino Leonardo, Giuseppe Simone, Rome, Italy

MP50-12 BODY MASS INDEX, OBESITY AND ACUTE KIDNEY INJURY AFTER ROBOT-ASSISTED PARTIAL NEPHRECTOMY: RESULTS FROM A HIGH-VOLUME ROBOTIC CENTER

Marco Paciotti*, Carlo Andrea Bravi, Milan, Italy, Luca Sarchi, Modena, Italy, Angelo Mottaran, Pi-etro Piazza, Bologna, Italy, Alberto Martini, Milan, Italy, Fernando Gonzalez Meza, Marco Corsetti, Ghent, Belgium, Sophie Knipper, Hamburg, Ger-many, Marco Amato, Modena, Italy, Rui Farinha, Ghent, Belgium, Stefano Puliatti, Modena, Italy, Simone Scarcella, Celine Sinatti, Ghent, Belgium, Geert De Naeyer, Ruben De Groote, Alexandre Mottrie, Aalst, Belgium

MP50-13 FEASIBILITY AND OPTIMAL SETTING OF ROBOT-ASSISTED PARTIAL NEPHRECTOMY USING A NOVEL MULTI-ARM, MODULAR ROBOTIC PLATFORM

Carlo Andrea Bravi*, Milan, Italy, Luca Sarchi, Modena, Italy, Angelo Mottaran, Pietro Piaz-za, Bologna, Italy, Fernando Gonzalez Meza, Marco Corsetti, Ghent, Belgium, Sophie Knipper, Hamburg, Germany, Marco Paciotti, Milan, Italy, Marco Amato, Modena, Italy, Rui Farinha, Ghent, Belgium, Stefano Puliatti, Modena, Italy, Simone Scarcella, Ghent, Belgium, Geert De Naeyer, Ru-ben De Groote, Alexandre Mottrie, Aalst, Belgium

MP50-14 SINGLE PORT VS MULTI PORT ROBOTIC RENAL SURGERY: ANALYSIS OF PERIOPERATIVE OUTCOMES FOR EXCISION OF HIGH AND LOW COMPLEXITY RENAL MASSES

Grant Henning*, Joel Vetter, Nicholas Pickersgill, Arjun Sivaraman, R. Sherburne Figenshau, Eric Kim, St. Louis, MO

MP50-15 DEVELOPMENT AND VALIDATION OF AN OBJECTIVE SCORING TOOL FOR ROBOT ASSISTED PARTIAL NEPHRECTOMY: SCORING FOR PARTIAL NEPHRECTOMY (SPAN)

Umar Iqbal, Philippa Doherty, Ahmed S. Elsayed, Zhe Jing, Buffalo, NY, Craig Rogers, Detroit, MI, Ronald Boris, Indianapolis, IN, James Porter, Seattle, WA, Mohammad Allaf, Baltimore, MD, Ketan K. Badani, New York, NY, Michael Stifel-man, Hackensack, NJ, Jihad Kaouk, Cleveland, OH, Tomoaki Terakawa, Nobuyuki Hinata, Kobe, Japan, Ahmed A. Aboumohamed, Bronx, NY, Eric C. Kauffman, Qiang Li, Buffalo, NY, Ronney Abaza, Columbus, OH, Khurshid A. Guru, Ahmed A. Hussein, Buffalo, NY, Daniel Eun, Philadelphia, PA, Ayat Shah*, Buffalo, NY


SU

ND

AY

MP50-16 ASSESSING THE ROLE OF OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY IN THE SETTING OF LOW COMPLEXITY RENAL TUMORS: PROPENSITY SCORE-MATCHED ANALYSIS OF A MULTICENTER DATABASE

Gabriele Tuderti*, Riccardo Mastroianni, Umberto Anceschi, Alfredo Maria Bove, Aldo Brassetti, Mariaconsiglia Ferriero, Leonardo Misuraca, Salvatore Guaglianone, Rome, Italy, Riccardo Autorino, Richmond, VA, Ava Saidian, Ithaar Derweesh, John Perry, San Diego, La Jolla, CA, Andrea Mari, Andrea Minervini, Florence, Italy, Manuela Costantini, Michele Gallucci, Giuseppe Simone, Roma, Italy

MP50-17 PROSPECTIVE COMPARATIVE STUDY TO EVALUATE THE CLINICAL UTILITY OF IRIS 3-D ANATOMICAL MODELING SOFTWARE FOR PREOPERATIVE SURGICAL PLANNING AND INTRA-OPERATIVE NAVIGATION FOR ROBOT ASSISTED PARTIAL NEPHRECTOMY (RAPN): A PRELIMINARY ANALYSIS

Ahmed Ghazi*, Rochester, NY, Tanner Corse, Hackensack, NJ, Thomas Osinski, Thomas Frye, William Tabayoyong, Rochester, NY, Linda Dayan, Ravi Munver, Hackensack, NJ, Hani Rashid, Jean Joseph, Rochester, NY, Michael Stifelman, Hackensack, NJ

MP50-18 EFFICACY AND FEASIBILITY OF ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR OCTOGENARIANS: COMPARISON WITH YOUNGER COUNTERPARTS

Yudai Ishiyama*, Tsunenori Kondo, Arakawa, Japan, Kazuhiko Yoshida, Junpei Iizuka, Kazunari Tanabe, Toshio Takagi, Tokyo, Japan

MP50-19 PREDICTORS OF EMERGENCY NEPHRECTOMY FOR RENAL CELL CARCINOMA

Emily Ellmann*, Oussama Darwish, Ali Houjaij, Zafar Dalimov, Buffalo, NY, Mohamad Shahait, Amman, Jordan, Nader Nader, Buffalo, NY

MP50-20 SURGICAL MANAGEMENT AND OUTCOMES OF NATIVE UPPER URINARY TRACT UROTHELIAL CARCINOMA AFTER KIDNEY TRANSPLANTATION

Shi-Jie Tsai*, Eric Yi-Hsiu Huang, Tzu-Hao Huang, Tzu-Chun Wei, Chih-Chieh Lin, Tzu-Ping Lin, Hsiao-Jen Chung, William J.S. Huang, Yen-Hwa Chang, Taipei, Taiwan


Sunday, May 15, 2022 4:30 pm – 5:45 pm

Moderated Poster Session 51PROSTATE CANCER: STAGING

Room 222 @ Ernest N. Morial Convention CenterModerator: Chad Ritch


MP51-01 HOW MANY LYMPH NODES COULD WE SAVE IN PROSTATE CANCER STAGING LYMPHADENECTOMY?

Javier Pérez Ardavín*, Manuel Martínez-Sarmien-to, Juan José Monserrat-Monfort, Jose Vicente Sanchez-Gonzalez, Victor Vera-Pinto, Valencia, Spain, Pilar Bello-Arqués, València, Spain, Fran-cisco Boronat-Tormo, César David Vera Donoso, Valencia, Spain

MP51-02 PROSPECTIVE STUDY TO EVALUATE THE PROGNOSTIC VALUE OF NODAL DISEASE IN PROSTATE CANCER?

Javier Pérez Ardavín*, Manuel Martínez-Sarmien-to, Juan José Monserrat-Monfort, Jose Vicente Sanchez-Gonzalez, Victor Vera-Pinto, Valencia, Spain, Pilar Bello-Arqués, València, Spain, Fran-cisco Boronat-Tormo, César David Vera Donoso, Valencia, Spain


MP51-03 DEVELOPMENT OF A NOVEL NOMOGRAM TO IDENTIFY CANDIDATES FOR EXTENDED PELVIC LYMPH-NODE DISSECTION IN PROSTATE CANCER USING MRI AND PSMA PET

Dennie Meijer*, André Vis, Amsterdam, Neth-erlands, Matthew Roberts, Amila Siriwardana, Andrew Morton, John Yaxley, Hemamali Sa-maratunga, Brisbane, Australia, Louise Emmett, Darlinghurst, Australia, Peter van de Ven, Martijn Heijmans, Henk Van der Poel, Maarten Donswijk, Thierry Boellaard, Ivo Schoots, Daniela Oprea-La-ger, Amsterdam, Netherlands, Geoffrey Coughlin, Brisbane, Australia, Pim van Leeuwen, Amster-dam, Netherlands

MP51-04 P-SCORE IN PREOPERATIVE BIOPSIES ACCURATELY PREDICTS P-SCORE IN FINAL PATHOLOGY AT RADICAL PROSTATECTOMY

Pontus Röbeck*, Uppsala, Sweden, Li-Di Xu, Dil-ruba Ahmed, Stockholm, Sweden, Anca Dragomir, Pär Dahlman, Sam Ladjevardi, Michael Häggman, Uppsala, Sweden

212

MP51-05 IMPACT OF CLINICAL STAGING BASED ON DRE VS IMAGING (TRUS/MRI) IN A LOCALIZED PROSTATE CANCER RISK ASSESSMENT NOMOGRAM

Kevin Chang*, Scott Greenberg, Janet Cowan, Katsuto Shinohara, Hao Nguyen, Matthew Coop-erberg, Peter Carroll, San Francisco, CA

MP51-06 PIRADS SCORE COMBINED WITH POSITIVE CORE NUMBER ON MRI-ULTRASOUND FUSION TARGETED PROSTATE BIOPSY CAN PREDICT THE ABSENCE OF PATHOLOGICAL EXTRAPROSTATIC EXTENSION

Masaki Kobayashi*, Yoh Matsuoka, Sho Uehara, Hiroshi Tanaka, Yuki Nakamura, Yusuke Uchida, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii, Tokyo, Japan

MP51-07 THE PROGNOSTIC VALUE OF THE NUMBER OF POSITIVE TARGETED CORES IN MEN WITH POSITIVE MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING OF THE PROSTATE. RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES

Armando Stabile*, Elio Mazzone, Giorgio Gandaglia, Milan, Italy, Guillaume Ploussard, Raz-van-George Rahota, Toulouse, France, Massimo Valerio, Lausanne, Switzerland, Riccardo Campi, Andrea Mari, Florence, Italy, Agostino Mattei, Lucerne, Switzerland, Giancarlo Marra, Turin, Italy, Jean Baptiste Beauval, Mathieu Roumiguiè, Toulouse, France, Luca Afferi, Lucerne, Italy, Marco Moschini, Lucerne, Switzerland, Paolo Gontero, Turin, Italy, Roderick van den Bergh, Utrecht, Netherlands, Junlong Zhuang, Hongqian Tuo, Jiangsu, China, People’s Republic of, Nicola Fossati, Lugano, Switzerland, Francesco Montor-si, Alberto Briganti, Milan, Italy

MP51-08 DOES A POSITIVE MULTI-PARAMETRIC MRI ALWAYS WARRANT PROSTATE BIOPSY? THE IMPORTANCE OF INTEGRATING CLINICAL AND IMAGING DATA BASED ON A LARGE, MULTI-INSTITUTIONAL SERIES

Armando Stabile*, Giorgio Gandaglia, Elio Mazzone, Francesco Barletta, Simone Scu-deri, Daniele Robesti, Giuseppe Cirulli, Donato Cannoletta, Francesco Pellegrino, Luigi Nocera, Gabriele Sorce, Mario De Angelis, Carlo Andrea Bravi, Milan, Italy, Alberto Martini, Milano, Italy, Thomas Seisen, Morgan Roupret, Paris, France - Metropolitan, Jeffrey R. Karnes, Rochester, MN, Nicola Fossati, Lugano, Switzerland, Francesco De Cobelli, Antonio Esposito, Giorgio Brembilla, Francesco Montorsi, Alberto Briganti, Milan, Italy

MP51-09 THE UTILITY OF NOVEL QUANTIFICATION USING IMAGING SOFTWARE FOR ANALYZING WHOLE-BODY MAGNETIC RESONANCE IMAGING OF PATIENTS WITH METASTATIC PROSTATE CANCER

Yuki Kohada*, Nozomi Satani, Yasuhiro Kaiho, Sendai, Japan, Hiromichi Iwamura, Hirosaki, Japan, Takashi Kukimoto, Masaaki Oikawa, Jun Ito, Tomonori Matsuura, Sendai, Japan, Nobuyuki Hinata, Hiroshima, Japan, Kaneki Koyama, Mako-to Sato, Sendai, Japan

MP51-10 ONCOLOGIC OUTCOMES AFTER RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER: CLASSIFICATION ACCORDING TO PROSTATE MAGNETIC RESONANCE IMAGING FINDINGS

Jin Hyuck Kim, Gyoohwan Jung*, Hwanik Kim, Jung Kwon Kim, Hakmin Lee, Jong Jin Oh, Sangchul Lee, Seong Jin Jeong, Seok-Soo Byun, Sung Kyu Hong, Seongnam, Korea, Republic of

MP51-11 HAS THE INTRODUCTION OF MPMRI IN THE DIAGNOSTIC PATHWAY OF PROSTATE CANCER LED TO IMPROVED ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY? RESULT FROM A LARGE SINGLE-INSTITUTIONAL SERIES

Armando Stabile*, Elio Mazzone, Gabriele Sorce, Francesco Barletta, Luigi Nocera, Vito Cucchiara, Milan, Italy, Emanuele Zaffuto, Federico Dehò, Varese, Italy, Donato Cannoletta, Mario De Angelis, Simone Scuderi, Giorgio Gandaglia, Milan, Italy, Giuseppe Rosiello, Antony Pellegrino, Milano, Italy, Nicola Fossati, Lugano, Switzerland, Nazareno Suardi, Genoa, Italy, Francesco De Cobelli, Antonio Esposito, Giorgio Brembilla, Milan, Italy, Shahrokh Shariat, Vienna, Austria, Francesco Montorsi, Alberto Briganti, Milan, Italy

MP51-12 THE ADDED VALUE OF MICROUS FOR THE PREOPERATIVE STAGING OF PROSTATE CANCER: AN UPDATE OF A SINGLE-INSTITUTIONAL PROSPECTIVE SERIES

Vittorio Fasulo*, Edoardo Beatrici, Luca Disconzi, Pier Paolo Avolio, Nicola Frego, Pietro Diana, Marco Paciotti, Davide Maffei, Alessandro Uleri, Cesare Saitta, Paola Arena, Giuseppe Chiarelli, Andrea Gobbo, Milan, Italy, Alberto Saita, Rodolfo Hurle, Massimo Lazzeri, Milano, Italy, Giorgio Guazzoni, Milan, Italy, Paolo Casale, Milano, Italy, Nicolò Maria Buffi, Giovanni Lughezzani, Milan, Italy

MP51-13 FLUORINE-18 (18F) PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITRON EMISSION TOMOGRAPHY (PET) AND THE DIAGNOSIS AND STAGING OF PRIMARY PROSTATE CANCER (PCA)

Matthew Byrne*, Nithesh Ranasinha, Claudia Mercader, Mutie Raslan, Francesca Lewis, Stefanos Gorgoraptis, Ganesh Sathanapally, Ana Catarina Lopes Vieira, Golebka Jedrzej, Bryony Peiris, Mark Tuthill, Andrew Protheroe, Philip Camilleri, Phil Turner, Gerard Andrade, Saiful Miah, Tom Leslie, Richard Bryant, Freddie Hamdy, Ruth MacPherson, Fergus Gleeson, Alastair D. Lamb, Oxford, United Kingdom


SU

ND

AY

MP51-14 IMPACT OF 68GA-PSMA PET/CT AND METASTASIS-DIRECTED THERAPY ON CLINICAL RECURRENCE IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY. RESULTS FROM A SINGLE CENTER SERIES

Elio Mazzone*, Daniele Robesti, Giorgio Gandaglia, Armando Stabile, Simone Scuderi, Alberto Martini, Carlo Andrea Bravi, Milano, Italy, Gabriele Sorce, Francesco Pellegrino, Luigi Nocera, Milan, Italy, Giuseppe Rosiello, Lucia D’Ambrosio, Milano, Italy, Giuseppe Cirulli, Milan, Italy, Laura Marandino, Daniele Raggi, Andrea Necchi, Milano, Italy, Vincenzo Mirone, Napoli, Italy, Francesco Montorsi, Alberto Briganti, Milano, Italy

MP51-15 THE ROLE OF 68GA-PSMA- AND 68GA-DOTA-RM2 PET/MRI IN THE PRIMARY STAGING OF HIGH-RISK PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY. PRELIMINARY RESULTS OF A PROSPECTIVE, SINGLE CENTER STUDY

Vito Cucchiara, Paola Mapelli*, Samuele Ghezzo, Ana Maria Samanes Gajate, Enrico Camisassa, Sabrina Comana, Erik Preza, Giorgio Brembilla, Naghia Ahmed, Carolina Bezzi, Luca Presot-to, Valentino Bettinardi, Annarita Savi, Patrizia Magnani, Raffaele Menichini, Angela Coliva, Ilaria Neri, Ettore Di Gaeta, Luigi Gianolli, Giorgio Gandaglia, Francesco Montorsi, Alberto Briganti, Francesco De Cobelli, Paola Scifo, Maria Picchio, Milan, Italy

MP51-16 THE RISK OF RECURRENCE IN CN1 PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY VARIES ACCORDING TO THE TYPE PREOPERATIVE STAGING. A COMPARISON BETWEEN 68GA-PSMA-PET VERSUS CONVENTIONAL IMAGING IN A LARGE, MULTI-INSTITUTIONAL STUDY

Gabriele Sorce*, Milan, Italy, Giuseppe Rosiel-lo, Milano, Italy, Giorgio Gandaglia, Milan, Italy, Simone Scuderi, Milano, Italy, Lorenzo Bianchi, Riccardo Schiavina, Bologna, Italy, Bram Vansev-enant, Gaëtan Devos, Leuven, Belgium, Armando Stabile, Riccardo Leni, Daniele Robesti, Elio Mazzone, Antony Pellegrino, Milano, Italy, Nicola Fossati, Lugano, Switzerland, Lucia D’Ambrosio, Milano, Italy, Andrea Gallina, Lugano, Switzer-land, Marta Picozzi, Milan, Italy, Manuela Tutolo, Alberto Martini, Milano, Italy, Steven Joniau, Leu-ven, Belgium, Jeffrey R. Karnes, Rochester, MN, Francesco Montorsi, Alberto Briganti, Milano, Italy

MP51-17 DEMOGRAPHICS AND SOCIOECONOMIC DESCRIPTION OF PATIENTS WITH PROSTATE CANCER IN WHOM A PROSTATE-SPECIFIC MEMBRANE ANTIGEN PET WAS PERFORMED: A SINGLE-INSTITUTION, RETROSPECTIVE ANALYSIS IN NYC

Juana Martinez*, Kritika Subramanian, Mu-hammad Niaz, Ted Getz, Amie Patel, Joseph Osborne, Scott Tagawa, NY, NY

MP51-18 TRENDS OF PRIMARY STAGING FOR NEWLY DIAGNOSED PROSTATE CANCER – ASSESSING THE UPTAKE OF PROSTATE SPECIFIC MEMBRANE ANTIGEN POSITRON EMISSION TOMOGRAPHY: A POPULATION BASED ANALYSIS

Marlon Perera*, Nathan Papa, Declan Murphy, Nathan Lawrentschuk, Melanie Evans, Jeremy Millar, Damien Bolton, Melbourne, Australia

MP51-19 PATHOLOGIC GLEASON GRADE GROUP 1 IN BLACK MEN IMPLICATIONS FOR RENAMING IT “NOT CANCER” IN HIGH-RISK POPULATIONS

Courtney Berg*, Newark, NJ, Matthew DeMasi, Bronx, NY, Amjad Alwaal, Robert Weiss, Evan Kovac, Newark, NJ

MP51-20 THE ASSOCIATION OF TYPE AND NUMBER OF D’AMICO HIGH-RISK CRITERIA WITH RATES OF PATHOLOGICALLY NON ORGAN CONFINED PROSTATE CANCER

Francesco Chierigo*, Genova, Italy, Rocco Simone Flammia, Rome, Italy, Gabriele Sorce, Milan, Italy, Benedikt Hoeh, Frankfurt, Germany, Lukas Hohenhorst, Hamburg, Germany, Zhe Tian, Fred Saad, Montreal, Canada, Markus Graefen, Hamburg, Germany, Michele Gallucci, Rome, Italy, Alberto Briganti, Francesco Montorsi, Milan, Italy, Felix K.H. Chun, Frankfurt, Germany, Shahrokh F. Shariat, Vienna, Austria, Guglielmo Mantica, Maro Borghesi, Nazareno Suardi, Carlo Terrone, Genova, Italy, Pierre I Karakiewicz, Montreal, Canada




MO

ND

AY

Monday, May 16, 2022 Plenary: Prime Time Monday Morning Session 7:30 am – 11:30 am


7:30 PANEL DISCUSSION: RENAL TRAUMA MANAGEMENT Moderator: Judith Hagedorn Panelists: Steven Hudak, Benjamin Breyer, Rachel Moses

7:50 PANEL DISCUSSION: BULBAR URETHRAL STRICTURES 101: A REVIEW OF THE GUIDELINES AND BASIC MANAGEMENT OPTIONS FOR BULBAR

Moderator: Dmitriy Nikolavsky Panelists: Amanda Chung, Matthias Hofer, Lindsay Hampson, Cooper Benson

8:15 SURGICAL TECHNIQUES: ARTIFICIAL URINARY SPHINCTER PLACEMENT Moderator: Brian Flynn Panelists: Keith Rourke, Sean Elliott

9:05 LAPAROSCOPIC ROBOTIC SURGICAL SYSTEMS – EMERGING SYSTEMS IN UROLOGY USE Moderator: Duke Herrell Panelists: Prokar Dasgupta, Kevin de Laet, Ryoichi Joe Shiroki, Liqun Zhou, Koon Ho Rha, Alexandre Mottrie,

Simone Crivellaro, Ashok Hemal

10:10 PANEL DISCUSSION: INTRA-OPERATIVE NAVIGATION TOOLS FOR ROBOT-ASSISTED SURGERY Moderator: Chandru Sundaram Panelists: Ahmed Ghazi

10:35 PANEL DISCUSSION: USES OF APPS IN UROLOGY: CLINIC VISITS, INPATIENT, OFFICE-BASED PROCEDURES, INDEPENDENT PRACTICE

Moderator: Kyle Richards Panelists: Stacy Loeb, Matthew Resnick

11:05 STATE-OF-THE-ART LECTURE: DIGITAL HEALTH INNOVATION IN UROLOGY: USE OF HEALTH-INFORMATION TECHNOLOGY TO REDUCE MORBIDITY, READMISSIONS, AND IMPROVE PATIENT CARE

Presenter: Raj Pruthi

Monday, May 16, 2022 Plenary: Prime Time Monday Afternoon Session 1:00 pm – 4:00 pm


1:00 PANEL DISCUSSION: NOVEL METHODS TO BOOST KIDNEY TRANSPLANTATION GLOBALLY Moderator: Alp Sener Panelists: Jeffrey Veale

1:20 PANEL DISCUSSION: MALE INFERTILITY AS A MARKER FOR OVERALL MALE HEALTH Panelists: Michael Eisenberg, Andrea Salonia

1:45 POINT-COUNTERPOINT DEBATE: TELEMEDICINE IN REPRODUCTIVE UROLOGY Moderator: Jay Sandlow Debaters: James Smith, James Dupree

2:15 CROSSFIRE: CONTROVERSIES IN UROLOGY DEBATE: DOES EXERCISE, DIET MODIFICATION OR ANTIOXIDANTS HELP IMPROVE MALE FERTILITY?

Moderator: Cigdem Tanrikut Debaters-Con: Robert Coward, Akanksha Mehta Debaters-Pro: David Shin, Ryan Smith

2:45 SECOND OPINION CASES: ALTERNATIVES TO TESTOSTERONE SUPPLEMENTATION THERAPY

3:05 FERTILITY SAFETY EVALUATIONS POST COVID-19 VACCINATION Presenter: Jordan Dimitrakoff

Monday, May 16, 2022 6:55 am – 7:55 am

RESEARCH ON CALCULUS KINETICS SOCIETY (ROCK) NON-CME INDUSTRY SPONSORED BREAKFAST PROGRAMRoom 265 @ Ernest N. Morial Convention Center

218

Monday, May 16, 2022 7:55 am – 12:00 pm

RESEARCH ON CALCULUS KINETICS SOCIETY (ROCK)Room 262 @ Ernest N. Morial Convention Center

7:55 INTRODUCTION Society President: Vernon Pais

8:00 SESSION I: EPIDEMIOLOGY; PEDIATRIC AND PREGNANT STONE DISEASE

Moderator: Necole Streeper

DISPARITIES IN STONE EPIDEMIOLOGY AND STONE CARE

Karen Stern

CONSIDERATIONS FOR SURGICAL MANAGE-MENT OF STONES IN CHILDREN

Gregory Tasian

WHAT “NOT TO MISS” IN EVALUATION OF PEDI-ATRIC STONE FORMERS

Michelle Baum

STRATEGIES FOR DIAGNOSIS AND MANAGE-MENT OF SUSPECTED RENAL COLIC DURING PREGNANCY

Amy Krambeck

GROUP DISCUSSION

9:00 SESSION II: PERIOPERATIVE Moderator: Michael Lipkin

PERIOPERATIVE ANALGESIA STRATEGIES FOR STONE SURGERY

Kevan Sternberg

ASSESSING AND OPTIMIZING STENT-RELATED QUALITY OF LIFE

Sero Andonian

SAFETY FOR THE UROLOGIST DURING ENDOUROLOGIC SURGERY

Michelle Semins

REDUCING PERIOPERATIVE INFECTIOUS COMPLICATIONS

Moderator: Nicole Miller

GROUP DISCUSSION

10:00 BREAK

10:30 SESSION 3: SURGICAL MANAGEMENT Kelly Healy

SELECTING A LASER: HOLMIUM VS THULLIUM Bodo Knudsen

OPTIMIZING MINIPCNL Seth Bechis

UPDATES ON BURST WAVE LITHOTRIPSY Jonathan Harper

GROUP DISCUSSION

11:15 SESSION 4: MEDICAL MANAGEMENT Moderator: Sara Best

URINARY AMMONIUM: AN UNSUNG DIAGNOSTIC HERO

Ryan Hsi

EXPLORING OPTIONS FOR URINARY ALKALINI-ZATION

Justin Friedlander

BREAKTHROUGHS IN MANAGEMENT OF HYPER-OXALURIA

Kyle Wood

GROUP DISCUSSION

11:55 CLOSING REMARKS Society President:Vernon Pais


Monday, May 16, 2022 12:00 pm – 12:30 pm

AUA ANNUAL BUSINESS MEETINGRivergate Room @ Ernest N. Morial Convention Center

Monday, May 16, 2022 12:00 pm – 1:00 pm

RESEARCH ON CALCULUS KINETICS SOCIETY (ROCK) NON-CME INDUSTRY SPONSORED LUNCH PROGRAMRoom 265 @ Ernest N. Morial Convention Center


MO

ND

AY

Monday, May 16, 2022 7:00 am – 8:15 am

Moderated Poster Session 52URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: MALE INCONTINENCE: THERAPY

Room 228 @ Ernest N. Morial Convention CenterModerators: Jaspreet Sandhu & Craig Comiter


MP52-01 ANALYZING OUTCOMES OF THE ADJUSTABLE TRANSOBTURATOR MALE SYSTEM (ATOMS) FOR POST-PROSTATECTOMY INCONTINENCE: RESULTS OF A SINGLE-CENTER STUDY

Samuel Farag*, Joanie Pelletier, Salima Ismail, Le Mai Tu, Sherbrooke, Canada

MP52-02 ADJUSTABLE ARTIFICIAL URINARY SPHINCTER (VICTO): EXPERIENCE AFTER 110 CASES OF MALE STRESS URINARY INCONTINENCE

Ghazal Ameli*, Peter Weibl, Michael Rutkowski, Wilhelm Huebner, Korneuburg, Austria

MP52-03 PRECLINICAL EVALUATION OF A NOVEL ARTIFICIAL URINARY SPHINCTER IN A WETHER MODEL

Aurelien Beaugerie, Florence Poinard, Juliette Cotte, Anne Denormandie, Paris, France, Chris-tine Reus, Stockholm, Sweden, Pierre Mozer, Emmanuel Chartier-Kastler*, Paris, France

MP52-04 COMPARATIVE URODYNAMIC STUDY IN CADAVER OF URETHRAL PRESSURE PROFILOMETRY BETWEEN THE UROMEMS ARTIFICIAL URINARY SPHINCTER AND THE AMS80TM

Aurelien Beaugerie, Florence Poinard, Anne Denormandie, Juliette Cotte, Paris, France, Christine Reus, Stockholm, Sweden, Pierre Moz-er, Emmanuel Chartier-Kastler*, Paris, France

MP52-05 PRE-EXISTING DETRUSOR OVERACTIVITY LEADS TO EARLIER ARTIFICIAL URINARY SPHINCTER FAILURE AND NEED FOR REVISION

Kevin Krughoff*, Andrew C. Peterson, Durham, NC

MP52-06 LONGITUDINAL CHANGES IN LOWER URINARY TRACT SYMPTOMS AFTER ARTIFICIAL URETHRAL SPHINCTER IMPLANTATION IN PATIENTS UNDERGOING PRIOR RADIOTHERAPY

Minato Yokoyama*, Madoka Kataoka, Yusuke Uchida, Yuki Nakamura, Shohei Fukuda, Sho Uehara, Hajime Tanaka, Soichiro Yoshida, Yoh Matsuoka, Yasuhisa Fujii, Tokyo, Japan

MP52-07 IMPACT OF FRAILTY ON ADVERSE COMPLICATIONS FOLLOWING ARTIFICIAL URINARY SPHINCTER IMPLANTATION

Rohan Bhalla*, Jackson Cabo, Tanya Marvi, Abimbola Ayangbesan, George Koch, Stephen Hill, Douglas Milam, Melissa Kaufman, Niels Johnsen, Nashville, TN


MP52-08 ARTIFICIAL URINARY SPHINCTER CUFF DOWNSIZING IMPROVES CONTINENCE AND PATIENT SATISFACTION IN CASES OF SUB-CUFF ATROPHY

Kevin Krughoff*, Brent D Nosé, Andrew C. Peterson, Durham, NC

MP52-09 SAFETY OF TRANSURETHRAL ENDOSCOPIC TREATMENT IN MEN WITH AN ARTIFICIAL URINARY SPHINCTER: A 15 YEAR ANALYSIS

Corey Weinstein*, Brooklyn, NY, Jaspreet Sandhu, New York, NY

MP52-10 EARLY ARTIFICIAL URINARY SPHINCTER PLACEMENT AND DEVICE SURVIVAL AFTER BLADDER NECK CONTRACTURE TREATMENT: WHAT IS THE EVIDENCE?

Samantha Nealon*, Raj Bhanvadia, Shervin Bhadkhshan, Sarah Sanders, Steve Hudak, Allen Morey, Dallas, TX

MP52-11 BLADDER NECK CONTRACTURES STABILIZE AFTER ARTIFICIAL URINARY SPHINCTER PLACEMENT

Kevin Krughoff*, Hayley Premo, Andrew C. Peterson, Durham, NC

MP52-12 RISK FACTORS ASSOCIATED WITH VENOUS THROMBOEMBOLISM AFTER ARTIFICIAL URINARY SPHINCTER SURGERY? AN ASSESSMENT OF 4,870 PATIENTS

Kevin Hebert*, Niraj Paudel, Rupam Das, Rano Matta, Joshua Calvert, Benjamin McCormick, Josh-ua Horns, Salt Lake City, UT, James Hotaling, Salt Lake City, UT, Jeremy Myers, Salt Lake City, UT

MP52-13 PRESENTING SIGNS AND SYMPTOMS OF ARTIFICIAL URINARY SPHINCTER CUFF EROSION

Linley Diao*, Samantha Nealon, Shervin Badkhshan, Avery Wolfe, Gianpaolo Carpinito, Benjamin Dropkin, Sarah Sanders, Steven Hudak, Allen Morey, Dallas, TX

MP52-14 ESTIMATED GLOMERULAR FILTRATION RATE PREDICTS ADVERSE OUTCOMES AMONG MEN UNDERGOING ARTIFICIAL URINARY SPHINCTER SURGERY

Carlos Riveros*, Victor Chalfant, Ahmed Elshafei, KC Balaji, Jacksonville, FL

220

MP52-15 ABDOMINAL SUBCUTANEOUS FAT THICKENING IS THE USEFUL MARKER TO PREDICT LOWER URINARY TRACT DYSFUNCTION AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY

Shunta Makabe*, Yusuke Kirihana, Tomoyuki Kumekawa, Hiroki Natsuya, Yusuke Hakozaki, Shunsuke Yoshioka, Yu Endo, Akihisa Hasegawa, Yuki Harigane, Kei Yaginuma, Hitomi Imai, Akifumi Onagi, Kanako Matsuoka, Tomoyuki Koguchi, Jun-ya Hata, Yuichi Sato, Hidenori Akaihata, Masao Kataoka, Yoshiyuki Kojima, Fukushima, Japan

MP52-16 ELUCIDATION OF URINARY INCONTINENCE MECHANISM AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY FOCUSING ON THE SLING MECHANISM BY THE LEVATOR ANI MUSCLE

Masao Kataoka*, Tomoyuki Koguchi, Junya Sato, Yuichi Sato, Hidenori Akaihata, Yoshiyuki Kojima, Fukushima, Japan

MP52-17 RACIAL AND REGIONAL DISPARITIES AND SURGICAL INTERVENTION FOR URINARY INCONTINENCE AFTER PROSTATE CANCER THERAPY: A SEER-MEDICARE STUDY

Nishant Garg*, Alexandra Muise, Michael Pan, Michael Witthaus, Brent Rose, Jill Buckley, San Diego, CA

MP52-18 QUALITY OF INFORMATION FOR POST-PROSTATECTOMY INCONTINENCE TREATMENTS ON YOUTUBE

Daniel Bockelman*, Aaron Huang, Lakshay Khosla, So Yeon Pak, Jacob Bamberger, Corey Weinstein, Abdo Kabarriti, Brooklyn, NY

MP52-19 COMPARISON OF IN-PERSON FPMRS-DIRECTED PELVIC FLOOR THERAPY PROGRAM VERSUS UNSUPERVISED PELVIC FLOOR EXERCISES FOLLOWING PROSTATECTOMY

Jacques Farhi*, Anthony DeNovio, David Barquin, David Rapp, Charlottesville, VA


Monday, May 16, 2022 7:00 am – 8:15 am

Moderated Poster Session 53PROSTATE CANCER: DETECTION & SCREENING V

Room 225 @ Ernest N. Morial Convention CenterModerators: Andre Abreu, James McKiernan & Ryan Berglund


MP53-01 DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN MPMRI VISIBLE LESIONS: SIZE MATTERS. RESULTS FROM A LARGE, TWO-INSTITUTIONAL SERIES

Armando Stabile*, Giorgio Gandaglia, Elio Mazzone, Francesco Barletta, Daniele Robesti, Giuseppe Cirulli, Donato Cannoletta, Francesco Pellegrino, Luigi Nocera, Gabriele Sorce, Mario De Angelis, Carlo Andrea Bravi, Milan, Italy, Alberto Martini, Milano, Italy, Thomas Seisen, Morgan Roupret, Paris, France - Metropolitan, Jeffrey R. Karnes, Rochester, MN, Vito Cucchiara, Milan, Italy, Nicola Fossati, Lugano, Switzerland, Francesco De Cobelli, Antonio Esposito, Giorgio Brembilla, Franc-esco Montorsi, Alberto Briganti, Milan, Italy

MP53-02 COMPARISON OF HIGHEST-GRADE TUMOR PERCENTAGE IN CORE SAMPLES FROM MRI-TARGETED BIOPSY AND SYSTEMATIC BIOPSY FOR PROSTATE CANCER DIAGNOSIS

Shu Wang*, Ryan Russell, Ashley Park, Alexa Van Besien, Adrianna Lee, Linhan Xu, Ankur Choksi, M. Adil Afzal, Amelia Wnorowski, Michael Naslund, M. Minhaj Siddiqui, Baltimore, MD

MP53-03 EFFECT OF TARGETED CORES ON RISK STRATIFICATION IN THE ERA OF IMAGE-GUIDED PROSTATE BIOPSY

Samuel Washington*, Janet Cowan, San Francis-co, CA, Peter Lonergan, Dublin, Ireland, Alexan-der Bell, Robert Parker, Katsuto Shinohara, Hao Nguyen, Peter Carroll, Matthew Cooperberg, San Francisco, CA


MP53-04 RATES OF UPGRADING AND UPSTAGING IN PROSTATE CANCER PATIENTS WITH SINGLE GGG1 POSITIVE BIOPSY CORE

Benedikt Hoeh*, Frankfurt am Main, Germany, Rocco Flammia, Rome, Italy, Mike Wenzel, Frank-furt am Main, Germany, Sorce Gabriele, Milan, Italy, Francesco Chierigo, Genova, Italy, Zhe Tian, Fred Saad, Montreal, Canada, Markus Graefen, Hamburg, Germany, Michele Gallucci, Rome, Italy, Alberto Briganti, Milan, Italy, Carlo Terrone, Genova, Italy, Shahrokh Shariat, Vienna, Austria, Derya Tilki, Luis Kluth, Hamburg, Germany, Philipp Mandel, Felix Chun, Frankfurt am Main, Germany, Pierre Karakiewicz, Montreal, Canada

MP53-05 CLINICALLY SIGNIFICANT PROSTATE CANCER DETECTION RATE OF PROSTATE IMAGING REPORTING AND DATA SYSTEM SCORE 4 IN THE PERIPHERAL ZONE

Gang Song*, Zhoujie Sun, Beijing, China, Peo-ple’s Republic of

MP53-06 MRI AND MRI-TARGETED BIOPSY CAN DETECT CRIBRIFORM CANCER OF THE PROSTATE

Sho Uehara*, Yoh Matsuoka, Kurara Yamamoto, Yuki Nakamura, Yusuke Uchida, Shohei Fuku-da, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Kenichi Ohashi, Yasuhisa Fujii, Tokyo, Japan


MO

ND

AY

MP53-07 HISTOLOGICAL VARIANTS OF PROSTATE CANCER ARE UNDER-REPORTED IN PROSTATE BIOPSIES ASSESSED OUTSIDE TERTIARY REFERRAL CENTERS. A PLEA FOR BIOPSY REVIEW FOR OPTIMAL PATIENT MANAGEMENT

Simone Scuderi*, Francesco Pellegrino, Roberta Lucianò, Nazario Tenace, Milan, Italy, Francesca Paparesta, Laura Pepi, Ancona, Italy, Leonar-do Quarta, Lorenzo Toneatto, Elio Mazzone, Francesco Barletta, De Angelis Mario, Daniele Robesti, Donato Cannoletta, Antony Pellegrino, Vito Cucchiara, Riccardo Leni, Giorgio Gandaglia, Armando Stabile, Milan, Italy, Alessia Cimada-more, Rodolfo Montironi, Ancona, Italy, Francesco Montorsi, Alberto Briganti, Milan, Italy

MP53-08 EFFECT OF NEARNESS TO CANCER CENTRE ON PROSTATE CANCER OUTCOMES AND PATIENT’S CHOICE FOR THE TYPE OF INTERVENTION

Waleed Shabana*, Vahid Mehrnoush, Neda Ghaffari-Marandi, Kristi Dolcetti, Hazem Elmansy, Kevin Ramchandar, Edwin Long, Ahmed Zakaria, Ahmed Kotb, Walid Shahrour, Thunder Bay, Canada

MP53-09 MACHINE LEARNING MODELS TO PERFORM ACTIVE SURVEILLANCE ON PROSTATE CANCER

Derek Van Booven*, Miami, FL, Victor Sandoval, Guadalajara, Mexico, Farhan Ismael, Ahmed Norman, Karachi, Pakistan, Oleksandr Kryvenko, Sanoj Punnen, Himanshu Arora, Miami, FL

MP53-10 THE ROLE OF SELECTMDX IN MEN UNDERGOING PRIMARY PROSTATE BIOPSY: A PROSPECTIVE MULTI-INSTITUTIONAL STUDY

Martina Maggi*, Francesco Del Giudice, Rome, It-aly, Ugo G Falagario, Foggia, Italy, Andrea Cocci, Florence, Italy, Giorgio I. Russo, Marina Di Mauro, Catania, Italy, Giuseppe Salvatore Sepe, Mon-dragone, Italy, Fabio Galasso, Eboli, Italy, Rosario Leonardi, Gravina di Catania, Italy, Gabriele Iaco-na, Acireale, Italy, Peter R. Carroll, Matthew R. Cooperberg, San Francisco, CA, Angelo Porreca, Padua, Italy, Matteo Ferro, Milan, Italy, Giuseppe Lucarelli, Bari, Italy, Daniela Terracciano, Naples, Italy, Luigi Cormio, Giuseppe Carrieri, Foggia, Italy, Ettore De Berardinis, Alessandro Sciarra, Rome, Italy, Gian Maria Busetto, Foggia, Italy

MP53-11 FOUR KALLIKREIN PANEL TESTING AMONG MEDICARE BENEFICIARIES UNDERGOING PROSTATE CANCER SCREENING

Michael Leapman*, Jessica Long, Rong Wang, Preston Sprenkle, Xiaomei Ma, Cary Gross, New Haven, CT

MP53-12 HOW DO PSA-BASED MARKERS PREDICT CLINICALLY SIGNIFICANT PROSTATE CANCER (CSPCA) ON PROSTATE BIOPSY INDEPENDENT OF PROSTATE SIZE

Max Kuster*, Michelle Ou, Jacob Gaines, Eric Macdonald, Simon Hall, Lake Success, NY

MP53-13 TRANSITION OF PROSTATE CANCER PRIMARY DIAGNOSTICS: TAKEOVER OF MRI-GUIDED TARGETED- VERSUS SYSTEMATIC BIOPSY

Mykyta Kachanov*, Hamburg, Germany, Sami-Ramzi Leyh-Bannurah, Gronau, Germany, Christoph Würnschimmel, Dirk Beyersdorff, Fa-bian Falkenbach, Tobias Maurer, Hendrik Isbarn, Thomas Steuber, Markus Graefen, Lars Budäus, Hamburg, Germany

MP53-14 FEASIBILITY OF TRANSPERINEAL PROSTATE BIOPSIES UNDER LOCAL ANESTHESIA: A COMPARATIVE STUDY WITH THE TRANSRECTAL APPROACH

Camille Berquin*, Dries Develtere, Hannah Van Puyvelde, Elisabeth Pauwels, Ruben De Groote, Frederiek D’Hondt, Peter Schatteman, Alex Mot-trie, Geert De Naeyer, Aalst, Belgium

MP53-15 MRI-DIRECTED BIOPSY FOR PRIMARY DETECTION OF PROSTATE CANCER: MRI IN-BORE VS MRI-TRANSRECTAL ULTRASOUND FUSION-TARGETED TECHNIQUES

Francesco Del Giudice*, Maurizio Del Monte, Ste-fano Cipollari, Martina Pecoraro, Marco Bicchetti, Emanuele Messina, Ailin Dehghanpour, Alessan-dro Sciarra, Ettore De Berardinis, Rome, Italy, Benjamin I. Chung, Stanford, CA, Carlo Catalano, Valeria Panebianco, Rome, Italy

MP53-16 THE TRENDS OF COMPLICATION RATES AND THE ROLE OF AZTREONAM AS A PROPHYLACTIC ANTIBIOTIC AFTER PROSTATE BIOPSY

Sung Jin Kim*, Han Kyu Chae, Wook Nam, Kim Han Gwun, Park Jong Yeon, Gangneung-si, Korea, Republic of

MP53-17 CULTURE-DIRECTED ANTIMICROBIAL PROPHYLAXIS IN TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSIES: CONTEMPORARY 7-YEAR EXPERIENCE

Steven A Sidelsky*, Chicago, IL, Pooja Talaty, Pranvera Sulejmani, Mira Suseno, Sandra Naege-le, Kristian Novakovic, Brian T Helfand, Alexander P Glaser, Evanston, IL

MP53-18 CONTINUED PSA SCREENING IN MEN AGED 60 YEARS AND OLDER WITH VERY LOW SERUM PROSTATE SPECIFIC ANTIGEN IN A LARGE, INTEGRATED HEALTHCARE SYSTEM

James Kearns*, Erin Donahue, Rupali Bose, Jason Zhu, Claud Grigg, Earle Burgess, Kris Gas-ton, Stephen Riggs, Justin Matulay, Peter Clark, Charlotte, NC

MP53-19 PROSTATE SPECIFIC ANTIGEN SCREENING UTILIZATION IN MEN WITH A FAMILY HISTORY OF PROSTATE CANCER AND EXTENDED LIFE EXPECTANCY

Taylor Malchow*, Dayton, OH, Deepansh Dalela, Sami Majdalany, Austin Piontkowski, Nicholas Corsi, Ivan Rakic, Marcus Jamil, Detroit, MI, Akshay Sood, Houston, TX, Sohrab Arora, Craig Rogers, Detroit, MI, Mara Schonberg, Boston, MA, Firas Abdollah, Detroit, MI

222

MP53-20 ADDED VALUE OF MPMRI IN THE STRATIFICATION OF PATIENTS WITH HIGH-RISK PATIENTS PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: IMPLICATIONS FOR TAILORED MULTI-MODAL STRATEGIES

Giuseppe Cirulli*, Milan, Italy, Elio Mazzone, Milano, Italy, Giorgio Gandaglia, Milan, Italy, Razvan-George Rahota, Toulouse, France, Giancarlo Marra, Turin, Italy, Massimo Valerio, Lausanne, Switzerland, Riccardo Campi, Andrea Mari, Florence, Italy, Agostino Mattei, Marco Moschini, Lucerne, Switzerland, Jean Baptiste Beauval, Mathieu Roumiguiè, Toulouse, France, Luca Afferi, Lucerne, Italy, Paolo Gontero, Turin, Italy, Armando Stabile, Milan, Italy, Nicola Fossati, Lugano, Switzerland, Vito Cucchiara, Giuseppe Rosiello, Francesco Montorsi, Alberto Briganti, Milan, Italy


Monday, May 16, 2022 7:00 am – 9:00 am

Podium Session 52SEXUAL FUNCTION/DYSFUNCTION: SURGICAL THERAPY II

Room 252 @ Ernest N. Morial Convention CenterModerator: Joshua Halpern

ABSTRACTTIME NUMBER TITLE7:00 PD52-01 COMPLICATIONS OF THE PENUMA PENILE

IMPLANT FOR GENITAL ENHANCEMENTDavid Barham*, Orange, CA, John Barnard, Mor-gantown, WV, Joel Gelman, Orange, CA

7:10 PD52-02 EXTENDED CORPORAL DILATION (ECD) OF MEN WITH PEYRONIE’S DISEASE (PD) AT THE TIME OF INFLATABLE PENILE IMPLANT SURGERY (IPP)

Hisanori Taniguchi*, Jose Flores, Carolyn Salter, Helen Bernie, John Mulhall, New York, NY

7:20 PD52-03 EVALUATION OF PROTECTION AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA IN A NOVEL IN VITRO BIOFILM MODEL OF PENILE PROSTHESIS

Manish Narasimman*, Gregory Plano, Miami, FL, Jesse Ory, Halifax, Canada, Sara Schesser Bartra, Ranjith Ramasamy, Miami, FL

7:30 PD52-04 OUTCOMES OF PENILE PROSTHESIS IMPLANTATION IN TRANSGENDER NEOPHALLUS: A SINGLE CENTER EXPERIENCE

Jesse Persily*, New York, NY, Begoña Etchev-erry, Barcelona, Spain, Kirtishri Mishra, Gaines Blasdel, Rachel Bluebond-Langner, Lee Zhao, New York, NY

7:40 PD52-05 UNINFECTED INFLATABLE PENILE PROSTHESES UNIFORMLY DEMONSTRATE RICH DYNAMIC BACTERIAL BIOFILMS WITH COMPLEX UNDERLYING MICROBE-METABOLITE INTERACTION NETWORKS

Glenn T. Werneburg, Daniel Hettel*, Bradley Gill, Ava Adler, Hadley Wood, Petar Bajic, Kenneth Angermeier, Scott Lundy, Daniel Shoskes, Aaron Miller, Cleveland, OH

ABSTRACTTIME NUMBER TITLE7:50 PD52-06 PENILE IMPLANT BACTERIAL BIOFILM

PROFILES VARY BY SURGICAL INDICATION: AN OPPORTUNITY TO MODIFY PERI-OPERATIVE CARE?

Paul H. Chung, Joon Yau Leong*, Philadelphia, PA, Caleb D. Phillips, Lubbock, TX, Gerard D. Henry, Bossier City, LA

8:00 PD52-07 OUTCOMES AND SATISFACTION AFTER PENILE SILICONE IMPLANT SURGERY

Morgan Salkowski*, Kevin Alter, Laurence Levine, Chicago, IL

8:10 PD52-08 SINGLE CENTER EXPERIENCE WITH ZSI FTM PENILE IMPLANTS FOR PHALLOPLASTY

Garry Pigot*, Joost van Leeuwen, Freek de Rooij, Brechje Ronkes, Wouter van der Sluis, Mark Bram Bouman, Amsterdam, Netherlands

8:20 PD52-09 LOW CONCENTRATION CHLORHEXIDINE GLUCONATE (CHG) IN STERILE WATER SOLUTION ADHERENCE DIP TIME, EFFECT ON THE HYDROPHILIC INFLATABLE PENILE PROSTHESIS (HIPP) COATING, AND PATIENT TOLERANCE

Ryan Griggs*, Bossier City, LA, Edward Karpman, Mountainview, CA, Wei Zhang, Eden Prairie, MN, Gerard Henry, Bossier City, LA

8:30 PD52-10 COMPLETE VESTIBULECTOMY IN WOMEN WITH PERSISTENT ENTRANCE DYSPAREUNIA FOLLOWING PARTIAL POSTERIOR VESTIBULECTOMY

Alyssa Yee*, Maria Uloko, Sue Goldstein, Irwin Goldstein, San Diego, CA


MO

ND

AY

8:40 PD52-11 COMPARISON OF SURGICAL OUTCOMES AFTER INSERTION OF PENILE IMPLANTS IN PHALLOPLASTY WITH AND WITHOUT URETHRAL LENGTHENING

Sterre Mokke, Freek de Rooij, Joost van Leeuw-en, Brechje Ronkes, Pip Roijer, Wouter van der Sluis, Mark Bram Bouman, Garry Pigot*, Amster-dam, Netherlands

8:50 PD52-12 ASSESSMENT OF WORK-RELATED MUSCULOSKELETAL PAIN IN UROLOGIC MICROSURGEONS

Douglas Schneider*, Charles Loeb, Orange, CA, R. Matthew Coward, Chapel Hill, NC, Lawrence Jenkins, Tucson, AZ, Faysal Yafi, Orange, CA


Monday, May 16, 2022 7:00 am – 9:00 am

Podium Session 53BLADDER CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY III

Room 255 @ Ernest N. Morial Convention CenterModerators: Debasish Sundi, Joshua Meeks & Vinata Lokeshwar

ABSTRACTTIME NUMBER TITLE7:00 PD53-01 MOLECULAR SUBTYPING OF N-METHYL-

N-NITROSOUREA (MNU) RAT MODEL OF UROTHELIAL CARCINOMA REVEALS BOTH LUMINAL AND BASAL SIGNATURES

Kara Lombardo*, Takahiro Yoshida, Kate Fitzger-ald, Kate Johnson, David McConkey, Alok Singh, Ridwan Alam, Max Kates, Alex Baras, Baltimore, MD, Trinity Bivalacqua, Philadelphia, PA

7:10 PD53-02 CYTOTOXICITY CAUSED BY CISPLATIN, VENETOCLAX, AND S63845 TO UROTHELIAL CARCINOMA CELLS EXPANDED IN 3D ORGANOIDS DIFFERS CLEARLY FROM CYTOTOXICITY TO AUTOLOGOUS 2D ADHERENT CELLS

Yi Wei, Bastian Amend, Wilhelm K. Aicher*, Arnulf Stenzl, Niklas Harland, Tuebingen, Germany

7:20 PD53-03 SCHISTOSOMA HAEMATOBIUM MAY PROMOTE BLADDER CARCINOGENESIS THROUGH DNA BINDING OF ITS HOMOLOG OF THE INTERLEUKIN-4-INDUCING PRINCIPLE FROM SCHISTOSOMA MANSONI EGGS

Derick Osakunor*, Washington, DC, Trevor Sig-gers, Boston, MA, Olivia Lamanna, Kenji Ishida, Washington, DC, Heather Hook, Boston, MA, Michael Hsieh, Washington, DC

7:30 PD53-04 BIODEGRADABLE DEVICE FOR CONTROLLED RELEASE OF CISPLATIN AS LOCAL CHEMOTHERAPY FOR BLADDER CANCER

Gilad Amiel*, Alexandra Bukchin-Tihomirov, Ahmed Kabha, Azik Hoffman, Eyal Zussman, Haifa, Israel

7:40 PD53-05 BLADDER CANCER TUMOROIDS AND NORMAL UROTHELIAL ORGANOIDS AS NEAR-PATIENT MODELS TO STUDY BLADDER CANCER TUMORIGENESIS AND PREDICT TREATMENT RESPONSE

Maryam Akbarzadeh, Mathijs Scholtes*, Ameneh Bazrafshan, Tokameh Mahmoudi, Tahlita Zuiver-loon, Rotterdam, Netherlands

ABSTRACTTIME NUMBER TITLE7:50 PD53-06 CHANGES IN MOUSE STOOL

MICROBIOME WITH EXPOSURE TO BLADDER CARCINOGEN N-BUTYL-N- (4-HYDROXYBUYTL) NITROSAMINE (BBN): LONGITUDINAL ANALYSIS

Rashida Ginwala, Laura Bukavina*, Alexander Kutikov, Philadelphia, PA, Ilaha Isali, Cleveland, OH, Mohit Sindhani, Delhi, India, Megan Prunty, Cleveland, OH, Philip Abbosh, Philadelphia, PA

8:00 PD53-07 DETECTION OF EARLY-STAGE BLADDER CANCER USING PLASMA EXTRACELLULAR VESICLE PROTEIN BIOMARKERS

Juan Hinestrosa*, Jean Lewis, Gregor Schroder, Heath Balcer, Rajaram Krishnan, San Diego, CA

8:10 PD53-08 E-CIGARETTE EXPOSURE IN MICE PROMOTES CHANGES IN DNA METHYLATION OF THE BLADDER UROTHELIUM

Ibardo Zambrano*, Ujjawal Manocha, Weida Gong, Yi-Hsuan Tsai, Manhua Zhu, Melissa Her-man, Marc Bjurlin, William Kim, Chapel Hill, NC

8:20 PD53-09 ANTIBODY DRUG CONJUGATES AND VARIANT HISTOLOGY MUSCLE-INVASIVE BLADDER CANCER: ARE THE TARGETS PRESENT IN PRIMARY AND/OR METASTATIC TUMORS?

Fady Ghali*, Martine Roudier, Funda Vakar-Lopez, Jose Garcia, Yan Wang, Gavin Ha, Petros Grivas, John Lee, Evan Yu, Bruce Montgomery, Andrew Hsieh, Jonathan Wright, Hung-Ming Lam, Seattle, WA

8:30 PD53-10 IDENTIFYING BLADDER UROTHELIAL CARCINOMAS USING FLUORESCENT SIGNAL INTENSITY OF PH LOW INSERTING PEPTIDES

Borivoj Golijanin*, Providence, RI, Michael Du-Pont, Kingston, RI, Ali Amin, Providence, RI, Anna Moshnikova, Kingston, RI, Ohad Kott, Providence, RI, Yana Reshetnyak, Oleg Andreev, Kingston, RI, Dragan Golijanin, Providence, RI

224

8:40 PD53-11 DIVERGENT THERAPEUTIC OUTCOMES OF STING AGONIST ADU-S100 IN INTRATUMORAL AND INTRAVESICAL TREATMENT REGIMENS IN SYNGENEIC MURINE MB49 AND IN THE N-METHYL-N-NITROSOUREA (MNU) RAT MODEL OF UROTHELIAL CARCINOMA

Alok Kumar Singh*, Kara Lombardo, Monali Praharaj, James Liu, Russel Becker, Kelly Harris, Max Kates, David McConkey, Andres Matoso, William R Bishai, Baltimore, MD, Trinity Jude Bivalacqua, Philadelphia, PA

8:50 PD53-12 IMPACT OF TUMOUR-INFILTRATING LYMPHOCYTES (TIL) IN SQUAMOUS CELL CARCINOMA OF THE BLADDER

Severin Rodler*, Stephan Ledderose, Frederick Klauschen, Alexander Buchner, Boris Schlen-ker, Christian Stief, Lennert Eismann, Munich, Germany


Monday, May 16, 2022 7:00 am – 9:00 am

Podium Session 54PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY III

Room 245 @ Ernest N. Morial Convention CenterModerators: Ali Kural & Panagiotis Mourmouris

ABSTRACTTIME NUMBER TITLE7:00 PD54-01 REDEFINING OPIOID USE AFTER

PROSTATECTOMY: RESULTS FROM THE IMPLEMENTATION OF A STATEWIDE OPIOID-FREE PAIN OPTIMIZATION PATHWAY

Udit Singhal*, Ji Qi, Ann Arbor, MI, Kevin Gins-berg, Detroit, MI, Alice Semerjian, Ann Arbor, MI, Thomas Maatman, Grand Rapids, MI, John Dibianco, Todd M. Morgan, Jeffrey S. Montgom-ery, Mary Nowlin, Anna Johnson, Stephanie Fer-rante, James E. Montie, Ann Arbor, MI, William Johnston, Novi, MI, Mohammad Jafri, Bradley Rosenberg, Royal Oak, MI, Richard Sarle, Lansing, MI, Arvin K. George, for the Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI

7:10 PD54-02 REVISITING CURRENT NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) HIGH RISK PROSTATE CANCER STRATIFICATION: A NATIONAL CANCER DATABASE ANALYSIS

Harshit Garg*, Furkan Dursun, Ahmed Elshabrawy, Hanzhang Wang, Michael Liss, Dhar-am Kaushik, Ahmed Mansour, San Antonio, TX

7:20 PD54-03 ARTIFICIAL INTELLIGENCE IN ROBOTIC-ASSISTED LAPAROSCOPIC PROSTATECTOMY: DEVELOPING PREDICTIVE MODELS FOR POSITIVE SURGICAL MARGINS

Stephen Schmit*, Rebecca Ortiz, Philip Caffery, Christopher Tucci, Carsten Eickhoff, Elias Hyams, Gyan Pareek, Providence, RI

ABSTRACTTIME NUMBER TITLE7:30 PD54-04 CHALLENGING THE DOGMA: SHOULD

UNILATERAL PELVIC LYMPH NODE DISSECTION BE ENVISIONED IN THE MULTIPARAMETRIC PROSTATE MRI ERA?

Alberto Martini*, Milan, Italy, Lieke Wever, Utrecht, Netherlands, Arnas Rakauskas, Lausanne, Swazi-land, Christian Daniel Fankhauser, Josias Bastian Grogg, Zurich, Swaziland, Enrico Checcucci, Dan-iele Amparore, Turin, Italy, Guillaume Ploussard, Toulouse, France, Claudia Kesch, Essen, Germa-ny, Fabio Zattoni, Udine, Italy, Alessandro Marquis, Giancarlo Marra, Turin, Italy, Maria Apfelbeck, Mu-nich, Germany, Ugo Giovanni Falagario, Foggia, Italy, Otto Ettala, Turku, Finland, Mario de Angelis, Donato Cannoletta, Alberto Briganti, Francesco Montorsi, Milan, Italy, Ivan Jambor, Turku, Finland, Alexander Kretschmer, Munich, Germany, Veeru Kasivisvanathan, London, United Kingdom, Jan Philipp Radtke, Essen, Germany, Hubert John, Winterthur, Switzerland, Peter K Chiu, Honk Kong, China, People’s Republic of, Francesco Porpiglia, Turin, Italy, Thomas Hermanns, Zurich, Swaziland, Roderick CN Van den Bergh, Utrecht, Nether-lands, Giorgio Gandaglia, Milan, Italy, Massimo Valerio, Lausanne, Swaziland

7:40 PD54-05 HALSTEADIAN VIEW OF PROSTATE CANCER: DOES REMOVING MORE NODES AT RADICAL PROSTATECTOMY AFFECT BIOCHEMICAL RECURRENCE?

Lior Taich*, Los Angeles, CA, Lin Gu, Durham, NC, Christopher L. Amling, Portland, OR, William J. Aronson, Los Angeles, CA, Matthew R. Coop-erberg, San Francisco, CA, Lourdes G. Rivera, San Juan, Puerto Rico, Christopher J. Kane, San Diego, CA, Zachary Klassen, Martha K. Terris, au-gusta, GA, Stephen Freedland, Los Angeles, CA


MO

ND

AY

7:50 PD54-06 ACTIVE OBSERVATION OF BIOCHEMICAL RECURRENCE WITHOUT TREATMENT FOLLOWING RADICAL PROSTATECTOMY: LONG TERM ANALYSIS OF OUTCOMES

Erica Huang, Linda My Huynh, Adam Gordon, Ryan Chandhoke, Orange, CA, Blanca Morales, San Francisco, CA, Douglas Skarecky, Joshua Tran, Thomas Ahlering*, Orange, CA

8:00 PD54-07 COMPARATIVE EFFECTIVENESS ANALYSES OF SALVAGE PROSTATECTOMY AND SALVAGE RADIOTHERAPY OUTCOMES FOLLOWING FOCAL OR WHOLE-GLAND ABLATIVE THERAPY (HIGH INTENSITY FOCUSED ULTRASOUND (HIFU), CRYOTHERAPY OR ELECTROPORATION) FOR LOCALISED PROSTATE CANCER

Alexander Ng*, Arjun Nathan, Anita Mitra, Prasan-na Sooriakumaran, Reena Davda, Sonam Patel, London, United Kingdom, Monty Fricker, New-castle, United Kingdom, John Kelly, Greg Shaw, Prabhakar Rajan, Ashwin Sridhar, Senthil Nathan, Heather Payne, London, United Kingdom

8:10 PD54-08 SINGLE-PORT EXTRAPERITONEAL VS TRANSPERITONEAL ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: A MULTI-INSTITUTIONAL MATCHED-PAIR COMPARISON OF OUTCOMES

Mahmoud Abou Zeinab*, Ethan Ferguson, Aaron Kaviani, Alp T. Beksac, Cleveland, OH, Marcio Moschovas, Celebration, FL, Luca Morgantini, Chicago, IL, Sij Hemal, Cleveland, OH, Susan Ta-lamini, Chicago, IL, Jean Joseph, Rochester, NY, Moses Kim, Laguna Hills, CA, Simone Crivellaro, Chicago, IL, Vipul Patel, Celebration, FL, Jeffrey Nix, Birmingham, AL, Jihad Kaouk, Cleveland, OH

8:20 PD54-09 COMPARISON OF ROBOTIC-ASSISTED LAPAROSCOPIC PROSTATECTOMY: SP VERSUS XI, A SINGLE INSTITUTION EXPERIENCE

Samit Sunny Roy*, Chattanooga, TN, Aditya Sathe, Memphis, TN, Matthew Watson, Bejamin Waldorf, Amar Singh, Chattanooga, TN

8:30 PD54-10 DIFFERENCES OF QUALITY OF LIFE BETWEEN GERMAN AND DUTCH PROSTATE CANCER PATIENTS, WHO ARE TREATED WITH ROBOT-ASSISTED RADICAL PROSTATECTOMY: IMPLICATIONS FOR INTERNATIONAL MULTICENTER RANDOMIZED CONTROLLED TRIALS

Christian Wagner, Jorn Witt, Gronau, Germany, Merkourios Kolvatzis, Thessaloniki, Greece, Nikolaos Liakos, Theodoros Karagiotis, Miko-laj Mendrek, Lukas Esch, Thomas Jankowski, Andreas Schuette, Sami-Ramzi Leyh-Bannurah*, Gronau, Germany

8:40 PD54-11 RESULTS OF THE PHASE 1 SAFETY AND EFFICACY PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETING FLUOROPHORE FOR IMAGE GUIDED SURGERY IN PATIENTS UNDERGOING ROBOTIC PROSTATECTOMY

Hao Nguyen*, San Francisco, CA, Alexander Antaris, Nynke Van den Berg, Sunnyvale, CA, Lingru Xue, Scott Greenberg, San Francisco, CA, Anna Muchnik, Alwin Klaassen, Sunnyvale, CA, Jeff Simko, Pamela Munster, San Francisco, CA, Sanjeev Dutta, Jonathan Sorger, Sunnyvale, CA, Peter Carroll, San Francisco, CA

8:50 PD54-12 68 GA-PSMA PET/CT FOR PREOPERATIVE LYMPH NOSDE STAGING OF HIGH RISK PROSTATE CANCER

Maximilian Schmautz*, David Pfister, Florian Hart-mann, Axel Heidenreich, Cologne, Germany


Monday, May 16, 2022 7:00 am – 9:00 am

Video Session 11PROSTATE, PENILE, TESTIS & MISC. ONCOLOGY II

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerators: Costas Lallas, Anant Kumar & Ed Schaeffer

ABSTRACTTIME NUMBER TITLE7:00 V11-01 OBTURATOR NERVE INJURY DURING

ROBOTIC PELVIC SURGERY: HOW TO APPROACH IT?

Laura C. Perez, Aref S. Sayegh*, Anibal La Riva, Luis G. Medina, Brittany Adamic, Ryan Powers, Inderbir S. Gill, Rene Sotelo, Los Angeles, CA


226

7:10 V11-02 99M-TECHNETIUM-PSMA RADIO-GUIDED SURGERY TO DETECT NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION: A PHASE 2 PROSPECTIVE, SINGLE-INSTITUTION STUDY

Giorgio Gandaglia*, Elio Mazzone, Antony Pellegrino, Milano, Italy, Nicola Fossati, Lugano, Switzerland, Armando Stabile, Francesco Barletta, Simone Scuderi, Riccardo Leni, Daniele Robesti, Lucia D’Ambrosio, Luca Maria Vitale, Ana Maria Samanes Gajate, Maria Picchio, Luigi Gianolli, Francesco Montorsi, Alberto Briganti, Milano, Italy

7:20 V11-03 REMOTE TRAINING FOR SURGICAL PROCEDURES USING AUGMENTED REALITY: INSERTION OF A HYDROGEL RECTAL SPACER

Michael Wilson*, Steven Griffith, Laura Kim, Jonathan Stone, Rochester, NY, Nelson Stone, Vail, CO

7:30 V11-04 FOCAL CRYOTHERAPY FOR PROSTATE CANCER USING MRI-ULTRASOUND FUSION ORGAN-BASED TRACKING AND NAIL-GRID GUIDANCE

Peter Ka-Fung CHIU*, Jeremy Yuen-Chun Teoh, Chi Fai Ng, Chi Hang Yee, Hong Kong, Hong Kong

7:40 V11-05 DEVICE-FREE, TWO-SITE ENTRY TRANSPERINEAL ULTRASOUND-GUIDED PROSTATE BIOPSY UTILIZING 14-GAUGE ANGIOCATHETERS

Nicklaus Houston*, Johnathan Drevik, Serge Gin-zburg, Alexander Kutikov, Philadelphia, PA

7:50 V11-06 DYNAMIC SENTINEL LYMPH NODE BIOPSY FOR PENILE CANCER: ACCURACY IS IN THE TECHNIQUE

Jonathan O’Brien*, Jiasian Teh, Kenneth Chen, Brian Kelly, Melbourne, Australia, Justin Chee, East Melbourne, Australia, Nathan Lawrentschuk, Melbourne, Australia

8:00 V11-07 A VIDEO DEMONSTRATION AND CASE SERIES OF A MODIFIED SPLIT THICKNESS SKIN GRAFT TECHNIQUE USING ARTISS SEALANT® PERFORMED WITH PENILE CANCER PROCEDURES

James A Churchill*, Christian Fankhauser, Maurice W Lau, Vijay K Sangar, Arie S Parnham, Manchester, United Kingdom

8:10 V11-08 SINGLE-PORT ROBOTIC ANTEGRADE BILATERAL INGUINAL LYMPH NODE DISSECTION

Nathan Cheng*, Hackensack, NJ, Christopher Wright, Nutley, NJ, Nizar Bou Diab, Hackensack, NJ, Mubashir Billah, Mutahar Ahmed, Nutley, NJ

8:20 V11-09 ROBOT-ASSISTED VIDEO-ENDOSCOPIC RADICAL INGUINAL LYMPHADENECTOMY FOR PENILE CANCER: SURGICAL ANATOMY AND TECHNIQUE

Aldo Brassetti*, Alfredo Bove, Umberto Anceschi, Maria Consiglia Ferriero, Salvatore Guaglianone, Riccardo Mastroianni, Leonardo Misuraca, Gabri-ele Tuderti, Giuseppe Simone, Rome, Italy

8:30 V11-10 BILATERAL ROBOTIC-ASSISTED INGUINAL LYMPHADENECTOMY USING THE SYNCHROSEAL DEVICE: DESCRIPTION OF THE TECHNIQUE

Safiya-Hana Belbina*, Scott Spivey Provencio, Pegah Taheri, Eric Giesler, Aaron A. Laviana, Austin, TX

8:40 V11-11 ROBOTIC-ASSISTED INGUINAL LYMPHADENECTOMY FOR PENILE CANCER: STEP-BY-STEP TECHNIQUE

Alberto Piana*, Josep Maria Gaya, Pietro Diana, Andrea Gallioli, Antonio Rosales, Pavel Gavrilov, Angelo Territo, Joan Palou, Alberto Breda, Barce-lona, Spain

8:50 V11-12 ROBOT ASSISTED VIDEO ENDOSCOPIC INGUINAL LYMPH NODE DISSECTION (VEIL) IN POST CHEMOTHERAPY PENILE CANCERS

Kinju Adhikari*, Bangalore, India, Indraneel Banarjee, Calcutta, India, Raghunath SK, Tejus Chiranjeevi, Bangalore, India


Monday, May 16, 2022 7:30 am – 12:10 pm

SOCIETY OF BENIGN PROSTATE DISEASEJefferson Ballroom @ Hilton New Orleans Riverside

7:30 INTERVIEWS W/ BPH EXPERTS: LESSONS FROM THE PAST IN BPH MANAGEMENT – WHAT HAVE WE LEARNED?

Moderators: Naeem Bhojani, Peter Gilling, Kevin Zorn

DIAGNOSTICS Steven Kaplan

MEDICATION Claus Roehrborn

MISTS Kevin McVary

PANEL WITH CASE DISCUSSION Panelists: Steven Kaplan, Kevin McVary,

Claus Roehrborn

8:30 BPH WARS AND HOW I DO IT

MIDDLE LOBE: TO REMOVE ACUTELY OR NOT? Dean Elterman, Amy Krambeck


MO

ND

AY

ANTICOAGULANT STRATEGY HOW I DO IT: TRANSURETHRAL RESECTION OF THE PROS-TATE (TURP) VS. ENUCLEATION

James Forde, Brian Helfand

MASSIVE PROSTATES: MY MANAGEMENT Enrique Rijo, Alexis Te

9:15 BREAK

9:45 NON-CME INDUSTRY SPONSORED TALKS

10:45 BREAK

11:15 BPH GUIDELINES: CONFLICT AND CONTRAST IN THE AUA, EAU, NICE BPH GUIDELINES

Neil Barber

11:30 NEW TREATMENTS AND BPH RESEARCH IN PRACTICE

HOW TO COUNCIL PATIENTS FOR NOVEL BPH TREATMENTS: THIS IS MY FIRST ONE!

Lori Lerner

HOW TO ADOPT NEW BPH TECHNOLOGIES INTO YOUR PRACTICE

Jaspreet Sandhu

11:40 RAPID FIRE

BPH PROCEDURES: THE OR VS. THE OFFICE Brian Mazzarella

DISPARITIES IN BPH CARE Charles Welliver

DIET AND SUPPLEMENTS IN BPH Gopal Badlani

MICROBIOME AND BPH Bilal Chughtai

IS MEDICAL THERAPY SAFE FOR LONG TERM MANAGEMENT OF BPH?

LESSONS I LEARNED FROM FAILED BPH THERA-PIES: ILC, TUNA, ETC.

David Albala


Monday, May 16, 2022 8:00 am – 11:00 am

UROLOGICAL ASSOCIATION OF CENTRAL AMERICA & THE CARIBBEAN (AUCA)St. Charles Ballroom @ Hilton New Orleans Riverside

Monday, May 16, 2022 8:45 am – 10:00 am

Moderated Poster Session 54BLADDER CANCER: NON-INVASIVE II

Room 228 @ Ernest N. Morial Convention CenterModerators: Kamal Pohar, Tracy Downs & Christopher Anderson


MP54-01 DISCORDANCE BETWEEN CLINICAL AND PATHOLOGIC CARCINOMA IN SITU FOR TURBT AND RADICAL CYSTECTOMY IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER: IMPLICATIONS FOR BCG UNRESPONSIVE CLINICAL TRIAL DESIGN AND INTERPRETATION

Manuel R. de Jesus Escano*, Carissa Chu, Song Jiang, Wesley Yip, New York, NY, Nima Almassi, Cleveland, OH, Peter Reisz, Andrew Lenis, Nicole Benfante, Eugene Cha, Timothy F Donahue, Gui-do Dalbagni, Alvin Goh, Bernard Bochner, Eugene Pietzak, New York, NY

MP54-02 TWO-YEAR EFFICACY FOLLOW-UP OF A PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUÉRIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN RECURRENT OR PERSISTENT HIGH-GRADE NON-MUSCLE-INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUÉRIN TREATMENT

Shaheen Alanee, Detroit, MI, Jazzmyne Montgom-ery*, Springfield, IL, Sherjeel Sana, Milwaukee, WI, Ahmed El-Zawahry, Toledo, OH, James Peabody, Tiffany Pearce, Nicole Adams, Mustafa Deebajah, De-troit, MI, Danuta Dynda, Kara Babaian, Jane Crabtree, Kristin Delfino, Springfield, IL, Kevin McVary, May-wood, IL, Kathy Robinson, Krishna Rao, Springfield, IL


MP54-03 CORE1: PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)

Roger Li*, Tampa, FL, Gary Steinberg, New York, NY, Donald Lamm, Phoenix, AZ, Ed M. Uchio, Orange, CA, Paras Shah, Rochester, MN, Ashish M. Kamat, Houston, TX, Nataliya Hnat, Irvine, CA, Michael J. Chisamore, Kenilworth, NJ, Paola Grandi, James Burke, Irvine, CA

MP54-04 A PHASE II STUDY OF CHECK POINT INHIBITOR, DURVALUMAB (MEDI4736) FOR BACILLUS CALMETTE-GUERIN UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER

Roger Li*, Kyle Rose, Michael Poch, Philippe Spiess, Scott Gilbert, Wade Sexton, Jingsong Zhang, Tampa, FL

228

MP54-05 EVALUATING INTRAVESICAL NADOFARAGENE FIRADENOVEC AND IMMUNE CHECKPOINT BLOCKADE COMBINATION THERAPY IN BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: EVIDENCE FROM A PHASE 3 TRIAL

Anirban P Mitra*, Sharada Mokkapati, Tanner S Miest, Houston, TX, Vikram M Narayan, Atlanta, GA, Richard Philipson, Stockholm, Sweden, Sep-po Yla-Herttuala, David Sawutz, Nigel R Parker, Kuopio, Finland, David J McConkey, Baltimore, MD, Colin P N Dinney, Houston, TX

MP54-06 LONGITUDINAL HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN ADULTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER RECEIVING A CHEMOABLATIVE GEL AS A PRIMARY TREATMENT (OPTIMA II: PHASE 2B, SINGLE ARM, OPEN-LABEL TRIAL)

Angela Smith*, Ramsankar Basak, Dana Mueller, Chapel Hill, NC, Robert Lipman, Bethesda, MD, Randall Teal, Alison Hilton, Kara Giannone, Myra Waheed, Angela Stover, Chapel Hill, NC

MP54-07 A URINE-BASED MOLECULAR ASSAY REFINES THE RISK STRATIFICATION OF THE RECENT AMERICAN UROLOGICAL ASSOCIATION GUIDELINE ON HEMATURIA

Joep de Jong*, Olga Pijpers, Kim van Kessel, Joost Boormans, Rotterdam, Netherlands, Wim van Criekinge, Ghent, Belgium, Ellen Zwarthoff, Rotterdam, Netherlands, Yair Lotan, Dallas, TX

MP54-08 URINARY COMPREHENSIVE GENOMIC PROFILING PREDICTS CLINICAL RECURRENCE IN PATIENTS UNDERGOING SURVEILLANCE FOR UROTHELIAL CARCINOMA

Jason Lee, Boston, MA, Vincent Bicocca, Vincent Caruso, Brian Mazzarella, Kevin Phillips, Trevor Levin, San Francisco, CA, Adam Feldman, Keyan Salari*, Boston, MA

MP54-09 URINE COMPREHENSIVE GENOMIC PROFILING PREDICTS RECURRENCE IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH INTRAVESICAL THERAPY

Goran Rac*, Shalin Desai, Hiten D. Patel, Chirag Doshi, Ryan Dornbier, Maywood, IL, Vincent Ca-ruso, Peter Lentz, Brian C. Mazzarella, Kevin G. Phillips, Trevor Levin, South San Francisco, CA, Alan J. Wolfe, Gopal N. Gupta, Maywood, IL

MP54-10 UTILITY OF A URINE-BASED DNA METHYLATION TEST FOR SURVEILLANCE IN NON-MUSCLE INVASIVE BLADDER CANCER: A PILOT STUDY

Seyedeh Sanam Ladi Seyedian*, Alireza Ghoreifi, Sidney Roberts, Farshad Sheybaee Moghad-am, Hamed Ahmadi, Los Angeles, CA, Saum Ghodoussipour, New Brunswick, CA, Muhannad Alsyouf, Los Angeles, CA, Paolo Piatti, Benja-min Jara, Lucy Sanossian, Irvine, CA, Sumeet Bhanvadia, Anne Schuckman, Hooman Djaladat, Gangning Liang, Siamak Daneshmand, Los Angeles, CA

MP54-11 THE ROLE OF A DNA METHYLATION TEST IN THE SURVEILLANCE OF BLADDER CANCER: A SINGLE-CENTER BLINDED PROSPECTIVE STUDY

Marialaura Righetto*, Daniele Modonutti, Monica Montopoli, Francesco Pagano, Fabrizio Dal Moro, Mariangela Mancini, Padova, Italy

MP54-12 T1 BLADDER CANCER: COMPARISON OF THE PROGNOSTIC IMPACT OF TWO SUBSTAGING SYSTEMS ON DISEASE RECURRENCE AND PROGRESSION AND SUGGESTION OF A NOVEL NOMOGRAM

Andrea Fuschi*, Yazan Al Salhi, Alessia Martoc-cia, Lorenzo Capone, Silvio Scalzo, Paolo Pietro Suraci, Antonio Carbone, Antonio Luigi Pastore, Latina, Italy, Rossana Telesca, Rome, Italy, Gaia Colalillo, Roberto Miano, Enrico Finazzi Agro’, Anastasios Asimakopoulos, Rome, Italy

MP54-13 THE UPDATE FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT FOR LOW-GRADE BLADDER TUMORS: LONG-TERM ONCOLOGICAL OUTCOMES OF PATIENTS UNDER ACTIVE SURVEILLANCE

Edoardo Beatrici*, Roberto Contieri, Nicola Frego, Vittorio Fasulo, Pietro Diana, Marco Paciotti, Davide Maffei, Pier Paol Avolio, Alessandro Uleri, Cesare Saitta, Paola Arena, Giuseppe Chiarelli, Andrea Gobbo, Nicolò Maria Buffi, Milan, Italy, Massimo Lazzeri, Paolo Casale, Alberto Saita, Milano, Italy, Giorgio Guazzoni, Giovanni Lughez-zani, Milan, Italy, Rodolfo Hurle, Milano, Italy

MP54-14 SEQUENTIAL INTRAVESICAL GEMCITABINE/DOCETAXEL PROVIDES A DURABLE REMISSION IN RECURRENT HIGH RISK NMIBC FOLLOWING BCG THERAPY

Kendrick Yim*, Kevin Melnick, Boston, MA, Sarah L Mott, Iowa City, IA, Vani Gupta, Timothy N Clinton, Filipe LF Carvalho, Matthew Mossanen, Graeme S Steele, Kent Mouw, Boston, MA, Michael A O’Don-nell, Iowa City, IA, Mark A Preston, Boston, MA

MP54-15 A MULTICENTER STUDY OF 2-YEAR OUTCOMES FOLLOWING HYPERTHERMIA THERAPY WITH MITOMYCIN C IN TREATING BCG UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: RECIRCULANT HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY

Andrew Stemberger*, Wei Phin Tan, Camden, NJ, Ana Plata Bello, Juan Carlos Garcia Alvarez, Canary Islands, Spain, Félix Guerrero-Ramos, Daniel A. González-Padilla, Madrid, Spain, Cajetan Nzeh, Gladbeck, Germany, Jose Manuel de la Morena, Ignacio Gonzalez Valcarcel de Torres, Madrid, Spain, Kees Hendricksen, Amsterdam, Netherlands, Fran-cisco Javier Díaz-Goizueta, J. Fernandez Del Alamo, Madrid, Spain, Francesco Chiancone, Paolo Fedelini, Naples, Italy, Massimiliano Poggio, Francesco Porpiglia, Turin, Italy, Victoria C. Gonzalo Rodríguez, Javier Montero Torres, Burgos, Spain, Daniel Wilby, Richard Robinson, Portsmouth, United Kingdom, Alejandro Sousa-Escandón, Juan León-Mata, Lugo, Spain, Jose L Pontones Moreno, Francisco Delgado Molina, Valencia, Spain, Miguel A. Adriazola Semino, Palencia, Spain, Jesús Calleja-Escudero, Valladolid, Spain, Joan Palou Redorta, Barcelona, Spain, Wei Shen Tan, London, United Kingdom


MO

ND

AY

MP54-16 IMMEDIATE RADICAL CYSTECTOMY VS. BCG IMMUNOTHERAPY FOR T1 HIGH GRADE NON-MUSCLE-INVASIVE BLADDER CANCER: AN INTERNATIONAL MULTICENTRE COLLABORATION

Chiara Lonati*, Brescia, Italy, Luca Afferi, Lucerne, Switzerland, Andrea Mari, Andrea Minervini, Flor-ence, Italy, Wojciech Krajewski, Wroclaw, Poland, Marco Borghesi, Genova, Italy, Gerald B. Schulz, Munich, Germany, Michael Rink, Hamburg, Germany, Francesco Montorsi, Alberto Briganti, Alberto Martini, Milan, Italy, Stefania Zamboni, Claudio Simeone, Brescia, Italy, Francesco Soria, Turin, Italy, Jeremy Y.C. Teoh, Hong Kong, China, People’s Republic of, Mathieu Roumiguié, Toulouse, France, Morgan Roupret, Paris, France, M. Carmen Mir, Valencia, Spain, Alessandro An-tonelli, Verona, Italy, Kees Hendricksen, Amster-dam, Netherlands, Roberto Carando, Christian D. Fankhauser, Philipp Baumeister, Agostino Mattei, Lucerne, Switzerland, Shahrokh F. Shariat, Vien-na, Austria, Marco Moschini, Milan, Italy

MP54-17 TIMING OF RADICAL CYSTECTOMY FOR BCG FAILURE

Patrick Hensley*, Niyati Lobo, Kelly Bree, Akshay Sood, Neema Navai, Colin Dinney, Ashish Kamat, Houston, TX

MP54-18 NOVEL THERAPEUTIC TARGETS AND POTENTIAL DRUGS FOR BCG INCURABLE NON-MUSCLE-INVASIVE BLADDER CANCER

Zhou Peng*, Hu Henglong, Wang Shaogang, Wuhan, China, People’s Republic of

MP54-19 PROTEIN DISULFIDE ISOMERASE AS A PREDICTIVE BIOMARKER FOR NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE

Kit L. Yuen*, Chia-Hao Wu, Christopher R. Sil-vers, Alexis Steinmetz, Hiroshi Miyamoto, Edward M. Messing, Yi-Fen Lee, Rochester, NY

MP54-20 ROLE OF ORAL PENTOSAN POLYSULFATE IN BACILLUS CALMETTE-GUERIN THERAPY IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER

Yu Seong Hyeon, Chung Ho Seok*, Hwang Eu Chang, Kim Sun-Ouck, Oh Kyung Jin, Jung Seung Il, Kang Taek Won, Kwon Dongdeuk, Park Kwangsung, Gwangju, Korea, Republic of


Monday, May 16, 2022 8:45 am – 10:00 am

Moderated Poster Session 55PROSTATE CANCER: LOCALIZED: ABLATIVE THERAPY

Room 225 @ Ernest N. Morial Convention CenterModerators: Aaron Katz & Franz Schmidlin


MP55-01 CANCER CONTROL OUTCOMES FOLLOWING FOCAL THERAPY USING HIFU IN 1,379 MEN WITH NON-METASTATIC PROSTATE CANCER: A MULTI-INSTITUTE 15-YEAR EXPERIENCE

Deepika Reddy*, London, United Kingdom, Max Peters, Utrecht, Netherlands, Taimur Shah, London, United Kingdom, Marieke van Son, Utrecht, Netherlands, Mariana Tanaka Bertoncelli, London, United Kingdom, Philipp Huber, Luzern, Switzerland, Derek Lomas, Rochester, MN, Arnas Rakauskas, Lausanne, Switzerland, Saiful Miah, Amersham, United Kingdom, David Eldred-Evans, Stephanie Guillaumier, Feargus Hosking-Jer-vis, Ryan Engle, London, United Kingdom, Tim Dudderidge, Southampton, United Kingdom, Richard Hindley, Amr Emara, Basingstoke, United Kingdom, Raj Nigam, Guildford, United King-dom, Neil McCartan, London, United Kingdom, Massimo Valerio, Lausanne, Switzerland, Naveed Afzal, Dorchester, United Kingdom, Henry Lewi, Chelmsford, United Kingdom, Clement Orczyk, Chris Ogden, London, United Kingdom, Iqbal Shergill, Wrexham, United Kingdom, Raj Persad, Bristol, United Kingdom, Jaspal Virdi, Harlow, United Kingdom, Caroline Moore, Manit Arya, Mathias Winkler, Mark Emberton, Hashim Ahmed, London, United Kingdom


MP55-02 REPEAT FOCAL THERAPY OF PROSTATE CANCER

Nima Nassiri*, Caroline Wallner, David Kupper-man, Shannon Richardson, Samantha Gonzalez, Lorna Herbert, Leonard Marks, Los Angeles, CA

MP55-03 USING MAGNETIC RESONANCE IMAGING TO DEFINE FOCAL THERAPY TEMPLATES IN PATIENTS WITH INTERMEDIATE-RISK PROSTATE CANCER

Alberto Pieretti*, Hyunseon Kang, Haesun Choi, Miao Zhang, Brian Chapin, John Ward, Patricia Troncoso, Justin Gregg, Houston, TX

MP55-04 THE PREDICTIVE VALUE OF TISSUE CHANGE DURING ULTRASOUND GUIDED HIGH INTENSITY FOCUSED ULTRASOUND (USGHIFU) FOCAL THERAPY ON TREATMENT SUCCESS

Yash Khandwala*, Shravan Morisetty, Sulaiman Vesal, Richard E. Fan, Ahmed El Kaffas, Pejman Ghanouni, Mirabela Rusu, Geoffrey A. Sonn, Palo Alto, CA

MP55-05 5-YEAR ONCOLOGIC OUTCOMES AT A SINGLE-INSTITUTION FOLLOWING FOCAL CRYOTHERAPY FOR PROSTATE CANCER MANAGEMENT

Ashley Monaco*, Glen Head, NY, Jessica Sommer, Garden City, NY, Meredith Akerman, Mineola, NY, Anthony Corcoran, Aaron Katz, Garden City, NY

230

MP55-06 FOCAL ABLATIVE SALVAGE THERAPY FOR RADIO-RECURRENT PROSTATE CANCER: 6 YEAR ONCOLOGICAL AND SAFETY OUTCOMES

Deepika Reddy*, London, United Kingdom, Max Peters, Utrecht, Netherlands, Taimur Shah, London, United Kingdom, Marieke van Son, Utrecht, Netherlands, Mariana Tanaka Bertoncelli, London, United Kingdom, Philipp Huber, Luzern, Switzerland, Derek Lomas, Rochester, MN, Arnas Rakauskas, Lausanne, Switzerland, Saiful Miah, Amersham, United Kingdom, David Eldred-Evans, Stephanie Guillaumier, Feargus Hosking-Jervis, Ryan Engle, London, United Kingdom, Tim Dud-deridge, Southampton, United Kingdom, Richard Hindley, Amr Emara, Basingstoke, United Kingdom, Raj Nigam, Guildford, United Kingdom, Neil McCa-rtan, London, United Kingdom, Massimo Valerio, Lausanne, Switzerland, Naveed Afzal, Dorchester, United Kingdom, Henry Lewi, Chelmsford, United Kingdom, Clement Orczyk, Chris Ogden, London, United Kingdom, Iqbal Shergill, Wrexham, United Kingdom, Raj Persad, Bristol, United Kingdom, Jaspal Virdi, Harlow, United Kingdom, Stuart McCracken, london, United Kingdom, Damian Greene, Washington, United Kingdom, Caroline Moore, Manit Arya, Mathias Winkler, Mark Ember-ton, Hashim Ahmed, London, United Kingdom

MP55-07 PARTIAL ABLATION AND TOTAL ABLATION WITH HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) COMPARED TO RADICAL PROSTATECTOMY (RP): A PROPENSITY SCORE-MATCHED STUDY

Changhee Ye*, Gyoohwan Jung, Hwanik Kim, Jung Kwon Kim, Jong Jin Oh, Sangchul Lee, Seong Jin Jeong, Sung Kyu Hong, Seok-Soo Byun, Hakmin Lee, Seongnam, Korea, Republic of

MP55-08 HIGH INTENSITY FOCUSED ULTRASOUND AND CRYOABLATION FOCAL THERAPY FOR INTERMEDIATE RISK PROSTATE CANCER: ONCOLOGIC AND FUNCTIONAL OUTCOMES

Masatomo Kaneko*, Alireza Ghoreifi, Los An-geles, CA, Samuel Peretsman, Charlotte, NC, Dordaneh Sugano, Giovanni Cacciamani, Amir Lebastchi, Suzanne Palmer, Manju Aron, Los Angeles, CA, Osamu Ukimura, Kyoto, Japan, Inderbir Gill, Andre Abreu, Los Angeles, CA

MP55-09 EARLY PERCENT PROSTATE-SPECIFIC ANTIGEN REDUCTION POST CRYOTHERAPY CAN PREDICT BIOCHEMICAL RECURRENCE IN MEN WITH PROSTATE CANCER

Jessica Sommer*, Garden City, NY, Ashley Mona-co, Glen Head, NY, Meredith Akerman, Mineola, NY, Aaron Katz, Garden City, NY

MP55-10 A PROSPECTIVE LONGITUDINAL STUDY OF ERECTILE FUNCTION FOLLOWING PARTIAL GLAND CRYOABLATION FOR INTERMEDIATE RISK PROSTATE CANCER

Sameer Thakker*, James Wysock, Rozalba Gogaj, Herbert Lepor, New York, NY

MP55-11 PROSTATE CANCER FOCAL THERAPY – LOCATIONS OF POST-ABLATION DISEASE

Hemant Chaparala*, Anis Davoudi, Gainesville, FL, Alan M. Priester, Adam Kinnaird, David Kuppermann, Ely R. Felker, Anthony E. Sisk, Elizabeth Tran, Merdie K. Delfin, Leonard S. Marks, Los Angeles, CA, Wayne G. Brisbane, Gainesville, FL

MP55-12 MRI/US FUSION GUIDED CRYOTHERAPY UNDER LOCAL ANESTHESIA: ONCOLOGICAL OUTCOMES

Fernando Bianco*, Luna Eusebio, Alberto Lopez, Edward Gheiler, Kaufman Ariel, Miami, FL, Far-shad Shafizadeh, New York, NY, Michael Zachar-eas, Beverly, MA, Gloria Egui-Benatuil, Dailianys Barrios, Miami, FL, Juan Martinez-Salamanca, Madrid, Spain

MP55-13 MULTIFOCALITY OF PROSTATE CANCER AND CANDIDACY FOR FOCAL THERAPY BASED ON MAGNETIC RESONANCE IMAGING

Hiten Patel, Yudai Okabe, Goran Rac*, Gopal N. Gupta, Maywood, IL

MP55-14 SALVAGE ROBOTIC RADICAL PROSTATECTOMY AFTER FOCAL THERAPY VERSUS RADIATION: A 10-YEAR EXPERIENCE

Alireza Ghoreifi*, Masatomo Kaneko, Hooman Djaladat, Andrew Hung, Rene Sotelo, Andre Berg-er, Mihir Desai, Inderbir Gill, Monish Aron, Andre Luis Abreu, Los Angeles, CA

MP55-15 CAN MRI LOCALIZE THE PROXIMITY OF PROSTATE CANCER TO THE URETHRA IN MEN WHO ARE CANDIDATES FOR FOCAL GLAND ABLATION?

Neal Patel*, Alexa Hughes, Los Angeles, CA, Wayne Brisbane, Gainsville, FL, Ali Rastegarpour, Sohrab Afshari, Lorna Kwan, Anissa V Nguyen, Anthony Sisk, Steven Raman, Robert Reiter, Los Angeles, CA

MP55-16 FOCAL CRYOTHERAPY AND STEREOTACTIC BODY RADIOTHERAPY HAVE SIMILAR ONCOLOGIC AND FUNCTIONAL OUTCOMES IN TREATMENT OF LOW-TO-INTERMEDIATE UNILOBE PROSTATE CANCER

Ashley Monaco*, Glen Head, NY, Jessica Som-mer, Garden City, NY, Chinyere Okpara, Jonathan Haas, Mineola, NY, Anthony Corcoran, Aaron Katz, Garden City, NY

MP55-17 SALVAGE LOCAL TREATMENT FOR RECURRENT PROSTATE CANCER AFTER FOCAL THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS

Oliver Claros*, Sao Paulo, Brazil, Rafael Tourinho, Salvador, Brazil, Saulo Teles, Lucas Takemura, Pedro Costa, Sao Paulo, Brazil, Rafael Sanchez-Salas, Paris, France, Bruno Nahar, Abhishek Bhat, Miami, FL, Ruben Olivares, Santiago, Chile, Gustavo Lemos, Arie Carneiro, Sao Paulo, Brazil


MO

ND

AY

MP55-18 A NATIONAL COHORT STUDY OF CANCER OUTCOMES FOLLOWING HIGH-INTENSITY FOCUSED ULTRASOUND TREATMENT OF CLINICALLY LOCALISED PROSTATE CANCER

Matthew Parry*, Arunan Sujenthiran, Julie Nossit-er, Melanie Morris, Brendan Berry, Ajay Aggarwal, Heather Payne, Jan van der Meulen, London, United Kingdom, Noel Clarke, Manchester, United Kingdom

MP55-19 MRI ALONE IS NOT AN APPROPRIATE SURVEILLANCE MECHANISM FOR PATIENTS AFTER FOCAL CRYOABLATION FOR LOCALIZED PROSTATE CANCER

Avi Baskin*, Leslie Charondo, Ashwin Balakr-ishnan, Janet Cowan, Matthew Cooperberg, Peter Carroll, Hao Nguyen, Katsuto Shinohara, San Francisco, CA

MP55-20 OUTCOMES OF PRIMARY CRYOTHERAPY FOR LOCALIZED PROSTATE CANCER: 14-YEARS SINGLE INSTITUTION EXPERIENCE

Andrew Wang*, Greg Mansour, Robert Given, Virginia Beach, VA


Monday, May 16, 2022 9:30 am – 11:30 am

Podium Session 55STONE DISEASE: SURGICAL THERAPY (INCLUDING ESWL) IV

Room 252 @ Ernest N. Morial Convention CenterModerators: Naeem Bhojani, Kenneth Pace & Husain Alenezi

ABSTRACTTIME NUMBER TITLE9:30 PD55-01 TAMSULOSIN AS MEDICAL EXPULSIVE

THERAPY AFTER SHOCK WAVE LITHOTRIPSY FOR RENAL STONES, A RANDOMIZED CONTROLLED TRIAL (NCT05032287)

Abdelwahab Hashem*, Mahmoud Laymon, Mostafa Elgamal, Doaa Elsayed Sharaf, Ahmed E. Elzalouey, A. M. Elmeniar, Ahmed El-Assmy, Yasser Osman, Khaled Z. Sheir, Mansoura, Egypt

9:40 PD55-02 PREDICTION OF CHEMICAL COMPOSITION OF URINARY STONE THROUGH DEEP LEARNING

Ui Seok Kim*, Hyo Sang Kwon, Wonjong Yang, Wonchul Lee, Changil Choi, Jong Keun Kim, Seong Ho Lee, Jun Hyun Han, Hwaseong, Korea, Republic of

9:50 PD55-03 PATIENT-REPORTED OUTCOMES FOLLOWING HOME URETERAL STENT REMOVAL AFTER URETEROSCOPY

John Graves*, John Bell, Lexington, KY, Amul Bhalodi, Corbin, KY, Will Cranford, Adam Dugan, Jason Bylund, Lexington, KY

10:00 PD55-04 PREDICTING THE NEED FOR INTERVENTION IN RENAL COLIC DUE TO A URETERAL STONE <5 MM: A MACHINE LEARNING MODEL

Rennen Haramaty*, Nir Kleinmann, Miki Haifler, Dorit E Zilberman, Ramat Gan, Israel

ABSTRACTTIME NUMBER TITLE10:10 PD55-05 WORLDWIDE SURVEY ON THE CURRENT

PRACTICE OF ASYMPTOMATIC URINARY STONE MANAGEMENT: A SURVEY FROM EAU, YOUNG ACADEMIC UROLOGISTS (YAU), ENDOUROLOGY AND UROLITHIASIS WORKING PARTY

Tarik Emre Sener, Istanbul, Turkey, Thomas Tailly*, Ghent, Belgium, Amelia Pietropaolo, Southampton, United Kingdom, Etienne Xavier Keller, Zurich, Swit-zerland, Yiloren Tanidir, Istanbul, Turkey, Juan Gomez Rivas, Madrid, Spain, Zeeshan Hameed, Manipal, India, Vincent De Coninck, Brasschaat, Belgium, Tzevat Tefik, Kemal Sarica, Istanbul, Turkey, Ali Serdar Gozen, Heilbronn, Germany, Andreas Skolar-ikos, Athens, Greece, Olivier Traxer, Paris, France, Bhaskar Somani, Southampton, United Kingdom

10:20 PD55-06 DOES DRAINAGE METHOD AFTER FLEXIBLE URETEROSCOPY FOR RENAL STONES AFFECT THE TREATMENT OUTCOMES OR QUALITY OF LIFE?

Amr Elsawy*, Nasr El-Tabey, Mohamed Zahran, Ahmed Shoma, Mansoura, Egypt

10:30 PD55-07 OUTCOMES AND PROCEDURAL COSTS FOLLOWING MINI-PERCUTANEOUS NEPHROLITHOTOMY OR FLEXIBLE URETEROSCOPIC LITHOTRIPSY FOR KIDNEY STONES BETWEEN 1-2CM: DATA FROM A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL

Rahul Dutta*, Prabhakar Mithal, Ilan Klein, Manish Patel, Jorge Gutierrez-Aceves, Winston Salem, NC

10:40 PD55-08 OPTIMIZATION OF PERCUTANEOUS NEPHROLITHOTOMY FOR A FREE-STANDING AMBULATORY SURºGERY CENTER: OUTCOMES FROM 1200 CASES

Daniel Rosen*, Meagan Dunne, Hanover, MD, Max Drescher, Baltimore, MD, Brian Panish, Liam Hatch, Washington, DC, Joel Abbott, Las Vegas, NV, Julio Davalos, Hanover, MD

232

10:50 PD55-09 A NEWLY DESIGNED NOMOGRAM TO PREDICT INFECTIOUS AND HEMORRHAGIC COMPLICATIONS AFTER PERCUTANEOUS NEPHROLITHOTOMY

Guohua Zeng, Giorgio Mazzon*, Guangzhou, China, People’s Republic of, Caterina Gregorio, Trieste, Italy, Jiehui Zhong, Chao Cai, Guangzhou, China, People’s Republic of, Nicola Pavan, Trieste, Italy, Wen Zhong, Guangzhou, China, People’s Republic of

11:00 PD55-10 MOSES 2.0 LASER IMPACT ON INTRAOPERATIVE PARAMETERS

Samuel Antoine, Aurora, CO, Kerri Thurmon, Den-ver, CO, Michael Atwell, Xavier Glover*, Miguel Rodriguez-Homs, Fernando Kim, Aurora, CO, Rodrigo Donalisio da Silva, Denver, CO

11:10 PD55-11 ERECTOR SPINAE PLANE BLOCKS FOR ANALGESIA AFTER PERCUTANEOUS NEPHROLITHOTOMY: A PATHWAY TO REDUCE OPIATES

Waseem Abdou*, Jacob Roberts, John Ryan, Saisantosh Attaluri, Roger Sur, John Finneran IV, Seth Bechis, San Diego, CA

11:20 PD55-12 ULTRA-LOW DOSE INTRAOPERATIVE CT CONFIRMS STONE-FREE STATUS DURING PCNL USING ROBOTIC FLUOROSCOPY PLATFORM: A PROSPECTIVE QUALITY IMPROVEMENT STUDY

Xavier Glover*, Eric Ballon-Landa, Mark Sawyer, Denver, CO


Monday, May 16, 2022 9:30 am – 11:30 am

Podium Session 56KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY IV

Room 255 @ Ernest N. Morial Convention CenterModerators: William C. Huang, Chandru Sundaram & Robert Abouassaly

ABSTRACTTIME NUMBER TITLE9:30 PD56-01 IMPROVED PREDICTION OF RENAL

FUNCTION AFTER RADICAL NEPHRECTOMYNityam Rathi*, Yosuke Yasuda, Diego Aguilar Palacios, Cleveland, OH, Yunlin Ye, Guangzhou, China, People’s Republic of, Jianbo Li, Chris-topher Weight, Mohammed Eltemamy, Robert Abouassaly, Steven Campbell, Cleveland, OH

9:40 PD56-02 THE DETRIMENTAL EFFECT OF FRAILTY STATUS ON RENAL FUNCTION RECOVERY AFTER PARTIAL NEPHRECTOMY – LONG-TERM RESULTS FROM A PROSPECTIVE SURGICAL COHORT

Giuseppe Rosiello*, Giuseppe Fallara, Giuseppe Basile, Alberto Martini, Daniele Cignoli, Luigi Nocera, Federico Belladelli, Gianmarco Colandrea, Daniela Canibus, Chiara Re, Giacomo Musso, Francesco Cei, Cristina Giancristofaro, Alberto Briganti, Roberto Bertini, Andrea Necchi, Daniele Raggi, Milan, Italy, Pierre I. Karakiewicz, Montreal, Canada, Francesco Montorsi, Andrea Salonia, Ales-sandro Larcher, Umberto Capitanio, Milan, Italy

9:50 PD56-03 CONTEMPORARY PERIOPERATIVE COMPLICATIONS OF SURGERY FOR RENAL CELL CARCINOMA WITH INFERIOR VENA CAVA THROMBECTOMY

Daniel D. Joyce*, Andrew Zganjar, Vidit Shar-ma, Christine M. Lohse, R. Houston Thompson, Stephen A. Boorjian, John C. Cheville, Brian A. Costello, Bradley C. Leibovich, Rochester, MN

10:00 PD56-04 ASSESSMENT OF CHANGES IN ARTERIAL BLOOD PRESSURE AFTER NEPHRECTOMY FOR KIDNEY CANCER VAPANCR (UROCCR 26)_PROSPECTIVE STUDY

Pierre Bigot*, Angers, France, Jean-Christophe Bernhard, Bordeaux, France, Nicolas Doumerc, François-Xavier Nouhaud, Toulouse, France, Idir Ouzaid, Paris, France, Patrick Saulnier, Angers, France, Arnaud Mejean, Morgan Rouprêt, Paris, France, Karim Bensalah, Rennes, France

ABSTRACTTIME NUMBER TITLE10:10 PD56-05 SHORT AND INTERMEDIATE TERM

INFERIOR VENA CAVA PATENCY OUTCOMES IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY AND VENOUS TUMOR THROMBECTOMY FOR RENAL CELL CARCINOMA

Harshit Garg*, Furkan Dursun, Robert Cooper, Hanzang Wang, Michael Liss, Ahmed Mansour, Ahmed Mansour, Robert Svatek, Ronald Rodri-guez, Dharam Kaushik, Deepak Pruthi, San Antonio, TX

10:20 PD56-06 SURGERY FOR RENAL MASSES IN HORSESHOE KIDNEYS

Yosuke Yasuda*, JJ Zhang, Nityam Rathi, Gustavo Roversi, Ao Zhang, Diego Palacios, Jihad Kaouk, Georges-Pascal Haber, Venkatesh Krishnamurthi, Robert Abouassaly, Christopher Weight, Steven Campbell, Cleveland, OH

10:30 PD56-07 RENAL CELL CARCINOMA WITH IVC INVASION: THE EVOLUTION OF CURRENT CONCEPTS AND A NOVEL APPROACH FOR HIGH LEVEL IVC TUMOR THROMBUS

John Libertino*, Concord, MA

10:40 PD56-08 EN BLOC RESECTION OF RIGHT RENAL CELL CARCINOMA AND INFERIOR VENA CAVA WITH TUMOR THROMBUS: IS IT SAFE TO DIVIDE THE LEFT RENAL VEIN?

Laura Horodyski*, Miami, FL, Javier Gonzalez, Madrid, Spain, Marina Tabbara, Jeffrey Gaynor, Miami, FL, Maria Rodriguez-Cabero, Felipe Herranz-Amo, Carlos Hernández, Madrid, Spain, Rushi Shah, Gaetano Ciancio, Miami, FL

10:50 PD56-09 IMPACT OF MIXED REALITY APPLICATION ON THE LEARNING CURVE OF LAPAROSCOPIC NEPHRECTOMY

Roman Pogosyan*, Igor’ Semenyakin, Amir Gabdullin, Moscow, Russian Federation


MO

ND

AY

11:00 PD56-10 THE IMPORTANT ROLE OF TUMOR VOLUME ON THE SURGICAL APPROACH CHOICE, SURGICAL COMPLEXITY, AND POSTOPERATIVE COMPLICATIONS IN RENAL CELL CARCINOMA WITH VENOUS TUMOR THROMBUS FROM A LARGE CHINESE CENTER EXPERIENCE

Qais Baheen*, Zhuo Liu, Peking, China, People’s Republic of

11:10 PD56-11 COMPARISON OF INTERMEDIATE OUTCOMES OF SINGLE PORT AND MULTIPORT ROBOTIC ASSISTED PARTIAL NEPHRECTOMY

Janmejay Hingu, Hackensack, NJ, Tanner Corse, Jay Zaifman*, Nutley, NJ, Ruth Sanchez De La Rosa, Bilal Ahmed Khan, Kevin Alter, Fahad Sheckley, Suzannah Sorin, Gregory Lovallo, Hackensack, NJ, Ravi Munver, Mutahar Ahmed, Michael Stifelman, Nutley, NJ

11:20 PD56-12 SURGICAL OUTCOMES FOR OLDER PATIENTS WITH RENAL CELL CARCINOMA AND INFERIOR VENA CAVA THROMBUS

Yudai Ishiyama*, Tsunenori Kondo, Hidekazu Tachibana, Hiroki Ishihara, Arakawa, Japan, Ka-zuhiko Yoshida, Junpei Iizuka, Kazunari Tanabe, Toshio Takagi, Tokyo, Japan


Monday, May 16, 2022 9:30 am – 11:30 am

Podium Session 57PROSTATE CANCER: DETECTION & SCREENING VI

TBD @ Ernest N. Morial Convention CenterModerator: Janet Kukreja

ABSTRACTTIME NUMBER TITLE9:30 PD57-01 MULTI-INSTITUTIONAL ANALYSIS OF CLINICAL

AND IMAGING RISK FACTORS FOR DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN MEN WITH PI-RADS 3 LESIONS

Andrew Fang*, Luke Shumaker, Kimberly Martin, Birmingham, AL, Okechukwu Onah, Jamaal Jackson, Chicago, IL, Ghazal Khajir, New Haven, CT, Richard Fan, Stanford, CA, Nachiketh Soo-dana-Prakash, Miami, FL, Hiten Patel, Srinivas Vourganti, Chicago, IL, Christopher Filson, Atlanta, GA, Preston Sprenkle, New Haven, CT, Geoffrey Sonn, Stanford, CA, Sanoj Punnen, Miami, FL, Gopal Gupta, Chicago, IL, Soroush Rais-Bahrami, Birmingham, AL

9:40 PD57-02 ASSESSMENT OF CLINICAL UTILITY OF PSA DENSITY IN RISK STRATIFICATION OF PI-RADS V2.1 CATEGORIES ON PROSTATE MRI

Gianluca Giannarini*, Rossano Girometti, Udine, Italy, Valeria Panebianco, Rome, Italy, Silvio Maresca, Lorenzo Cereser, Maria De Martino, Stefano Pizzolitto, Udine, Italy, Vincenzo Ficarra, Messina, Italy, Chiara Zuiani, Claudio Valotto, Udine, Italy

9:50 PD57-03 PREDICTORS OF CONTRALATERAL DISEASE IN MEN WITH UNILATERAL LESIONS ON MULTIPARAMETRIC MRI

Vyom Sawhney*, Richard Huang, William C. Huang, Herbert Lepor, Samir S. Taneja, James Wysock, New York, NY

ABSTRACTTIME NUMBER TITLE10:00 PD57-04 MRI-BASED PI-RADS SCORE PREDICTS ISUP

UPGRADING AND ADVERSE PATHOLOGY AT RADICAL PROSTATECTOMY IN MEN WITH BIOPSY ISUP 1 PROSTATE CANCER

Snir Dekalo, Tel Aviv, Israel, Jeremy Cepek*, London, Canada, Mario Sofer, Sophie Barnes, Ofer Yossepowitch, Roy Mano, Tel Aviv, Israel

10:10 PD57-05 A RACE-STRATIFIED ANALYSIS OF THE ACCURACY OF PROSTATE MRI IN BIOPSY NAIVE MEN

Julio Meza*, Rilwan Babajide, Ragheed Saoud, Josephine Abelleria, Irene Helenowski, Adam Murphy, Jeanne Horowitz, David Casalino, Chicago, IL

10:20 PD57-06 FACTORS PREDICTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN PIRADS 3 LESIONS

Jasmine Lin*, Mohammad Rashid Siddiqui, Eric Li, Jonathan Aguiar, Brandon Ansbro, Moataz Soliman, Jordan Rich, Johan Alfaro, Mary Kate Keeter, Edward Schaeffer, Ashley Ross, Chicago, IL

10:30 PD57-07 FACTORS PREDICTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN PIRADS 4 LESIONS

Mohammad Siddiqui*, Jasmine Lin, Jonathan Aguiar, Brandon Ansbro, Moataz Soliman, Jordan Rich, Johan Alfaro, Mary-Kate Keeter, Quan Mai, Edward Schaeffer, Ashley Ross, Chicago, IL

234

10:40 PD57-08 DEVELOPMENT OF A NOVEL RISK STRATIFICATION NOMOGRAM FOR PIRADS 4 AND 5 PROSTATE CANCER ON MRI-FUSION BIOPSY

Holly Houenstein, Ayat A. Shah*, Yousuf Ramahi, Philippa Doherty, Kristopher Attwood, Zhe Jing, James Mohler, Khurshid A. Guru, Eric C. Kauffman, Ahmed A. Hussein, Buffalo, NY

10:50 PD57-09 THE IMPORTANCE OF MRI-TARGETED BIOPSY FOR TUMORS IN ANTERIOR FIBROMUSCULAR STROMA

Hayato Yamamoto*, Teppei Okamoto, Toru Yoneyama, Chikara Ohyama, Hirosaki, Japan

11:00 PD57-10 OPTIMIZING THE PROSTATE BIOPSY TEMPLATE: ADDITIONAL VALUE OF CONTRALATERAL AND IPSILATERAL SYSTEMATIC BIOPSIES IN PATIENTS WITH AN UNILATERAL LESION ON MAGNETIC RESONANCE IMAGING

Auke Jager*, Luigi van Riel, Arnoud Postema, Theo de Reijke, Tim van der Sluis, Jorg Oddens, Amsterdam, Netherlands

11:10 PD57-11 IMPACT OF CONTACT SURFACE AREA AND PI-RADS CATEGORY ON THE CAPSULAR INVASION OF LOCALIZED CANCER WITH SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS ≤20 NG/ML AND TUMOR-CAPSULE CONTACT

Takahiro Ogawa*, Sunao Shoji, Isehara, Japan, Kazuma Takeda, Hiratsuka, Japan, Takahi-to Uchida, Soichiro Yuzuriha, Izumi Hanada, Satoshi Kuroda, Isehara, Japan, Kentaro Nagao, Okayama, Japan, Taro Higure, Chichibu, Japan, Masayoshi Kawakami, Mayura Nakano, Masahiro Nitta, Yoshiaki Kawamura, Masanori Hasegawa, Akira Miyajima, Isehara, Japan

11:20 PD57-12 DUAL-TRACER PET/CT-TARGETED, MPMRI-TARGETED, SYSTEMATIC BIOPSY, AND COMBINED BIOPSY FOR THE DIAGNOSIS OF PROSTATE CANCER

Dongxu Qiu, Jian Li, Jinwei Zhang, Minfeng Chen, Xiaomei Gao, Yongxiang Tang, Ye Zhang, Xiaoping Yi, Hongling Yin, Yu Gan, Guilin Wang, Xiongbing Zu, Shuo Hu, Yi Cai*, Changsha, China, People’s Republic of


Monday, May 16, 2022 9:30 am – 11:30 am

Video Session 12SEXUAL DYSFUNCTION/INFERTILITY/ANDROLOGY

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerators: Gerard Henry, Stanton Honig & Jason Kovac

ABSTRACTTIME NUMBER TITLE9:30 V12-01 NEW BIPOLAR RADIOFREQUENCY SEALING

TOOL FOR TRANSDERMAL VASECTOMY IN THE RABBIT MODEL: A PARADIGM SHIFT IN VASECTOMY TECHNIQUE?

Gerard Henry, Ryan Griggs*, Bossier City, LA, Michel Labrecque, Charlesbourg, Canada, Joel Marmar, Bala Cynwyd, PA, Tariq Hakky, Atlanta, GA

9:40 V12-02 BILATERAL HERNIA MESH OBSTRUCTION: SUBINGUINAL VASOVASOSTOMIES WITH LAPAROSCOPIC ASSISTANCE

Kevin Campbell*, Gainesville, FL, Jorge Rivera Mirabal, Richard Link, Larry Lipshultz, Houston, TX

9:50 V12-03 TRANSURETHRAL LASER INCISION OF EJACULATORY DUCT OBSTRUCTION: AN UNDERUSED TERMINOLOGY REAWAKEN BY ENDOUROLOGY

Mohamed Omar*, Shbeen El Kom, Egypt

10:00 V12-04 TRANSURETHRAL RESECTION OF THE EJACULATORY DUCTS

Wael Almajed*, New Orelans, LA, Christopher Koller, New Orelans, LA, Wayne Hellstrom, New Orelans, LA, Omer Raheem, Chicago, IL

ABSTRACTTIME NUMBER TITLE10:10 V12-05 WHAT TREATMENT OPTIONS ARE THERE

FOR PEYRONIE’S DISEASE?Consuelo Conde Redondo*, Alejandro García Viña, María Núñez, Ana Ruano Mayo, Álvaro Zamora Horcajada, Fernando Natal Rodriguez, Luis Cuellar Martín, Valladolid, Spain

10:20 V12-06 PENILE PLAQUE INCISION AND GRAFTING: OUR EXPERIENCE AND HOW WE DO IT

Preston Kerr*, Jane Kurtzman, Steven Brandes, New York City, NY

10:30 V12-07 SURGICAL TECHNIQUE FOR CONCURRENT PENILE PLICATION AND EXCISION WITH GRAFTING FOR SEVERE PEYRONIE’S DISEASE

Jacob Tannenbaum, Bryan Herzog, New Orleans, LA, Omer Raheem*, Chicago, IL

10:40 V12-08 SST AND THE FROZEN PUMPEngy Habashy*, Tobias Kohler, Rochester, MN

10:50 V12-09 CORPORAL DILATION TECHNIQUES DURING A DIFFICULT PENILE IMPLANT

Tejash Shah, Egor Parkhomenko*, Ricardo Mu-narriz, Boston, MA

11:00 V12-10 IPP CYLINDER EXTRUSIONEngy Habashy*, Tobias Kohler, Rochester, MN


MO

ND

AY

11:10 V12-11 COMPLEX TREATMENT FOR COMPLEX PATHOLOGY: INFLATABLE PENILE IMPLANT AND PENILE CORPOROPLASTY WITH COLLAGEN FLEECE GRAFT PLUS MALE URETHRAL SLING

Pedro Simoes de Oliveira*, Afonso Castro, Miguel Miranda, Anatoliy Sandul, Francisco Martins, José Palma Reis, Lisboa, Portugal

11:20 V12-12 PENOSCROTAL DECOMPRESSION OF REFRACTORY ISCHEMIC PRIAPISM: SURGICAL TECHNIQUE

Nicholas Ottaiano, Ganesh Sanekommu, Chris-topher Koller, Wayne Hellstrom, New Orleans, LA, Allen Morey, Dallas, TX, Omer Raheem*, Chicago, IL


Monday, May 16, 2022 10:30 am – 11:45 am

Moderated Poster Session 56BLADDER CANCER: INVASIVE V

Room 228 @ Ernest N. Morial Convention CenterModerators: Brant Inman & Matthew Tollefson


MP56-01 RENAL FUNCTIONAL CHANGES AFTER CYSTECTOMY: WHO IMPROVES AND WHO DOES NOT?

Benjamin Croll*, Dattatraya Patil, Khushali Vashi, Atlanta, GA, Mehrdad Alemozaffar, Anaheim, CA, Viraj Master, Christopher Filson, Kenneth Ogan, Vikram Narayan, Shreyas Joshi, Atlanta, GA

MP56-02 NEOADJUVANT PEMBROLIZUMAB MAY RESULT IN LONG-TERM OUTCOME IMPROVEMENT IN BIOMARKER-UNSELECTED PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER (MIBC): UPDATED RESULTS FROM PURE-01

Luigi Nocera*, Marco Moschini, Daniele Raggi, Milan, Italy, Laura Marandino, Bellinzona, Swit-zerland, Maurizio Colecchia, Roberta Lucianò, Milan, Italy, Ewan Gibb, Vancouver, Canada, Jeffrey Ross, Syracuse, NY, Antonella Messina, Giuseppina Calareso, Milan, Italy, Andrea Gallina, Lugano, Switzerland, Federico Dehò, Varese, Italy, Alberto Briganti, Francesco Montorsi, Andrea Necchi, Milan, Italy

MP56-03 CLINICAL OUTCOMES AND SURGICAL MANAGEMENT OF URACHAL CARCINOMA: AN ANALYSIS OF THE NATIONAL CANCER DATABASE

Furkan Dursun, San Antonio, TX, Kelvin Lim*, Evan Wenker, Jiaqiong Xu, Houston, TX, Robert Svatek, Ahmed Mansor, San Antonio, TX, Zachary Klaassen, Augusta, GA, Taliah Muhammed, Ziad El-Zaatari, Steven Shen, Eleni Efstathiou, Hou-ston, TX, Guru Sonpavade, Boston, MA, Christo-pher Wallis, Toronto, Canada, Raj Satkunasivam, Houston, TX

ABSTRACTTIME NUMBER TITLE MP56-04 THE ROLE OF FDG PET IN THE STAGING OF

BLADDER CANCER PATIENTS CANDIDATE FOR RADICAL CYSTECTOMY

Luigi Nocera*, Giuseppe Basile, Riccardo Leni, Mario De Angelis, Alberto Martini, Simone Scuderi, Giorgio Gandaglia, Milan, Italy, Alex Mottrie, Aalst, Belgium, Andrea Gallina, Lugano, Switzerland, Daniele Raggi, Laura Marandino, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Marco Moschini, Milan, Italy

MP56-05 IMPACT OF COMPREHENSIVE MEASUREMENT OF SURGICAL OUTCOMES ON SUBJECTIVE ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE IN PATIENTS RECEIVING RADICAL CYSTECTOMY WITH ORTHOTOPIC PADUA ILEAL BLADDER: SINGLE CENTER RANDOMIZED CONTROLLED TRIAL

Riccardo Mastroianni*, Gabriele Tuderti, Um-berto Anceschi, Alfredo Maria Bove, Leonardo Misuraca, Aldo Brassetti, Mariaconsiglia Ferri-ero, Salvatore Guaglianone, Michele Gallucci, Giuseppe Simone, Rome, Italy

MP56-06 ASSOCIATIONS BETWEEN SKELETAL MUSCLE GAUGE AND SURVIVAL FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER: A NOVEL ASSESSMENT OF MUSCLE MASS AND QUALITY

Meghana Noonavath*, Kevin Mun, Seattle, WA, J. Peter Marquardt, Florian J. Fintelmann, Boston, MA, Ryan O’Malley, Sarah K. Holt, Erin Dwyer, Reno Maldonado, Seattle, WA, Leoni-das Diamantopoulos, Pittsburgh, PA, Dimitrios Makrakis, Grace Laidlaw, George R. Schade, Dan W. Lin, Jonathan L. Wright, John L. Gore, Yaw Nyame, Petros Grivas, Evan Yu, Bruce Montgom-ery, Andrew C. Hsieh, Todd A. Yezefski, Michael Schweizer, Heather H. Cheng, Sarah P. Psutka, Seattle, WA

236

MP56-07 PREDICTORS OF RESPONSE FOLLOWING NEOADJUVANT CISPLATIN BASED CHEMOTHERAPY FOR MUSCLE INVASIVE UROTHELIAL BLADDER CANCER USING MOLECULAR PROFILE

Ahmed Elkarta*, Ahmed Elhefnawy, Hassan Abol-Enein, Ahmed Shokeir, Mansoura, Egypt

MP56-08 CLINICOPATHOLOGIC AND SURVIVAL AFTER CYSTECTOMY OUTCOMES IN SQUAMOUS CELL CARCINOMA OF THE BLADDER

Pranjal Agrawal*, Mary Rostom, Ridwan Alam, Michael Biles, Noah M. Hahn, Andres Matoso, Armine Smith, Baltimore, MD, Trinity J. Bivalac-qua, Philadelphia, PA, Max Kates, Jean Hoff-man-Censits, Sunil H. Patel, Baltimore, MD

MP56-09 RADIOMICS-BASED DEEP-LEARNING IMPROVES CT-STAGING OF LYMPH NODE STATUS FOR BLADDER CANCER PATIENTS

Eva Gresser, Piotr Woznicki, Katharina Messmer, Wolfgang Kunz, Alexander Buchner, Christian Stief, Jens Ricke, Munich, Germany, Dominik Nörenberg, Mannheim, Germany, Gerald Schulz*, Munich, Germany

MP56-10 CHARACTERIZATION AND FUNCTIONAL ANALYSIS OF MICROBIOME IN BLADDER CANCER

Laura Bukavina*, Philadelphia, PA, Adam Cala-way, Ilaha Isali, Megan Prunty, Cleveland, OH, Mohit Sindhani, Delhi, India, Mahmoud Ghan-noum, Mauricio Retuerto, Gregory MacLennan, Sarah Markt, Lee Ponsky, Cleveland, OH, Philip Abbosh, Philadelphia, PA

MP56-11 THE ASSOCIATION BETWEEN EARLY POST-RADICAL CYSTECTOMY ACUTE KIDNEY INJURY AND PERIOPERATIVE OUTCOME IN ENHANCED RECOVERY ERA

Sina Sobhani*, Hamed Ahmadi, Wenhao Yu, Alireza Ghoreifi, Giovanni Cacciamani, Gus Miranda, Jie Cai, Sumeet Bhanvadia, Anne Schuckman, Monish Aron, Inderbir Gill, Siamak Daneshmand, Mihir Desai, Hooman Djaladat, Los Angeles, CA

MP56-12 UPPER TRACT RECURRENCE RISK BASED ON DRAINAGE METHOD FOR URETERAL OBSTRUCTION PRIOR TO RADICAL CYSTECTOMY

Wesley Yip*, Daniel Sjoberg, Nathan Wong, Manuel de Jesus Escano, Song Jiang, Carissa Chu, Nicole Benfante, Sherri Donat, Harry Herr, Guido Dalbagni, Bernard Bochner, Eugene Cha, New York, NY

MP56-13 ROLE OF RADICAL CYSTECTOMY AND LYMPH NODE DISSECTION IN PATIENTS WITH NON-METASTATIC CLINICALLY ADVANCED LYMPH NODAL (CN2/N3) BLADDER CANCER: AN ANALYSIS FROM NATIONAL CANCER DATABASE

Harshit Garg*, Furkan Dursun, Ahmed Elshabrawy, Hanzhang Wang, Michael Liss, Dhar-am Kaushik, Robert Svatek, Ahmed Mansour, San Antonio, TX

MP56-14 UTILIZING THE MODIFIED FRAILTY INDEX TO PREDICT OUTCOMES AFTER RADICAL CYSTECTOMY

Hannah Jarvis*, Andrew Harris, Lexington, KY

MP56-15 PERIOPERATIVE OUTCOMES OF PATIENTS UNDERGOING CONCURRENT NEPHROURETERECTOMY AND CYSTECTOMY FOR UROTHELIAL CANCER: AN NSQIP DATABASE ANALYSIS

Pratik Kanabur*, Sagar Patel, Guilherme Godoy, Houston, TX

MP56-16 SURGICAL MANAGEMENT OF CLINICALLY LOCALIZED URACHAL CARCINOMA: EVALUATING THE ROLE OF LYMPHADENECTOMY AS STANDARD OF CARE

Kyle Rose*, Erica Roberts, Heather Huelster, Andrew Chang, Logan Zemp, Alice Yu, Michael Poch, Roger Li, Phillippe Spiess, Scott Gilbert, Wade Sexton, Tampa, FL

MP56-17 RADICAL CYSTECTOMY VIDEO CONSENSUS: A SIMPLE AND EFFECTIVE WAY TO IMPROVE AWARENESS OF PATIENTS UNDERGOING RADICAL CYSTECTOMY

Francesco Esperto, Francesco Prata*, Francesco Tedesco, Alberto Ragusa, Noemi Deanesi, Anto-nio Testa, Angelo Civitella, Piergiorgio Tuzzolo, Luca Romei, Vito Giuseppe Crimi, Loris Cac-ciatore, Gerardo Paolo Flammia, Antonio Alcini, Annamaria Salerno, Rome, Italy, Salvatore Mario Prata, Sora, Italy, Roberto Mario Scarpa, Rocco Papalia, Rome, Italy

MP56-18 PREVALENCE AND PREDICTORS OF PSYCHOLOGICAL DISTRESS AMONG PATIENTS TREATED FOR BLADDER CANCER

Nihal Mohamed*, Tung Ming Leung, New York, NY

MP56-19 TRIMODAL THERAPY VERSUS RADICAL CYSTECTOMY FOR T2 BLADDER CANCER: REAL-WORLD EVIDENCE FROM ONTARIO

Marian Severin Wettstein*, Alejandro Berlin, Song Pham, Srikala Sridhar, Peter Chung, Shabbir Al-ibhai, Syed R. Qadri, Kathy Li, Ning Liu, Toronto, Canada, Thomas Hermanns, Zurich, Switzerland, Girish S. Kulkarni, Toronto, Canada

MP56-20 SURROGATE ENDPOINTS AS PREDICTORS OF SURVIVAL IN METASTATIC UROTHELIAL CANCER TRIALS

Fady Ghali*, Seattle, WA, Devin Patel, Denver, CO, Teresa Jewell, John Gore, Jonathan Wright, Seattle, WA



MO

ND

AY

Monday, May 16, 2022 10:30 am – 11:45 am

Moderated Poster Session 57PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY IV

Room 225 @ Ernest N. Morial Convention CenterModerators: Simon Kim, Raj Pruthi & Christopher Warlick


MP57-01 POSTOPERATIVE RECURRENCE CAN BE PREDICTED BY BOTH LENGTH AND GLEASON PATTERN AT POSITIVE SURGICAL MARGIN AFTER RADICAL PROSTATECTOMY

Masashi Kato*, Nagoya, Japan, Toyonori Tsuzuki, Nagakute, Japan

MP57-02 MRI VERSUS NON-MRI DIAGNOSTIC PATHWAYS BEFORE RADICAL PROSTATECTOMY: IMPACT ON NERVE-SPARING, POSITIVE SURGICAL MARGINS, AND BIOCHEMICAL RECURRENCE

Hiten D. Patel, Goran Rac*, Yudai Okabe, Gaurav Pahouja, Shalin Desai, Steven M. Shea, Alex Gorbonos, Marcus L. Quek, Robert C. Flanigan, Ari Goldberg, Gopal N. Gupta, Maywood, IL

MP57-03 IS ADVERSE PATHOLOGY AT THE TIME OF RADICAL PROSTATECTOMY A USEFUL PREDICTOR OF LONG-TERM OUTCOMES IN ACTIVE SURVEILLANCE CANDIDATES? RESULTS FROM THE SEARCH COHORT

Paige Kuhlmann*, Los Angeles, CA, Lauren How-ard, Durham, NC, Zachary Klaassen, Augusta, GA, Christopher Amling, Portland, OR, William Aronson, Los Angeles, CA, Matthew Cooperberg, San Francisco, CA, Christopher Kane, San Diego, CA, Martha Terris, Augusta, GA, Stephen Freed-land, Los Angeles, CA

MP57-04 ASSOCIATION BETWEEN FAMILY HISTORY AND ONCOLOGIC OUTCOMES AFTER RADICAL PROSTATECTOMY FOR CLINICALLY NONMETASTATIC PROSTATE CANCER

Paweł Rajwa*, Fahad Quhal, Stephan Korn, Takafumi Yanagisawa, Tatsushi Kawada, Reza Sari Motlagh, Hadi Mostafaei, Ekaterina Laukhti-na, Abdulmajeed Aydh, Frederik König, Maximil-ian Pallauf, Benjamin Pradere, Vienna, Austria, Peter Nyirády, Budapest, Hungary, Mohammad Abufaraj, Amman, Jordan, Alberto Briganti, Milan, Italy, Pierre Karakiewicz, Montreal, Canada, Ding-wei Ye, Shanghai, China, People’s Republic of, Martin Haydter, Vienna, Austria, Piotr Chlosta, Krakow, Poland, Petr Glybochko, Dmitry Enikeev, Moscow, Russian Federation, Shahrokh Shariat, Vienna, Austria

MP57-05 ONE NOVEL NOMOGRAM TO PREDICT BIOCHEMICAL RECURRENCE MORE ACCURATE IN RADICAL PROSTATECTOMY

Jian Lu*, Ji De He, Ye Yan, Xue Hua Zhu, Ze Nan Liu, Hai Zhui Xia, Hai Bi, Bin Yang, Run Zhuo Ma, Wei He, Zhi Ying Zhang, Yu Ting Zhang, Lu Lin Ma, Xiao Fei Hou, Beijing, China, People’s Republic of


MP57-06 EXTERNAL VALIDATION AND COMPARISON OF TWO NOMOGRAMS PREDICTING THE PROBABILITY OF LYMPH NODE INVASION IN PATIENTS SUBJECTED TO ROBOTIC RADICAL PROSTATECTOMY AND CONCOMITANT LYMPH NODE DISSECTION

Nicola Frego*, Paciotti Marco, Davide Maffei, Pier Paolo Avolio, Roberto Contieri, Alessandro Uleri, Massimo Lazzeri, Alberto Saita, Paolo Casale, Nicolò Maria Buffi, Giovanni Lughezzani, Milan, Italy

MP57-07 IMPACT OF THE MINIMALLY INVASIVE APPROACH ON MORBIDITY OF SALVAGE RADICAL PROSTATECTOMY

Marlon Perera*, Antoni Vilaseca, Amy Tin, Daniel Nguyen, Renato Carradi, Adam Touijer, Nicole Benfante, Daniel Sjoberg, Vincent Laudone, Peter Scardino, James Eastham, Karim Touijer, New York, NY

MP57-08 SELECTIVE RADICAL PROSTATECTOMY IN GRADE GROUP 1 PROSTATE CANCER

Masood Moghul*, Claire Mcnally, Kaljit Kaur, Netty Kinsella, Derfel Dafydd, Aslam Sohaib, Steve Hazell, Declan Cahill, London, United Kingdom

MP57-09 COMPARISON OF PERIOPERATIVE AND SHORT-TERM FUNCTIONAL OUTCOMES BETWEEN SINGLE-PORT TRANSVESICAL AND MULTI-PORT TRANSPERITONEAL ROBOTIC RADICAL PROSTATECTOMY

Alp Tuna Beksac*, Mahmoud Abou Zeinab, Aaron Kaviani, Ethan Ferguson, Jihad Kaouk, Cleveland, OH

MP57-10 SINGLE-PORT EXTRAPERITONEAL ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: A MULTI-INSTITUTIONAL COHORT STUDY

Mahmoud Abou Zeinab*, Ethan Ferguson, Aaron Kaviani, Alp T. Beksac, Cleveland, OH, Luca Morgantini, Susan Talamini, Chicago, IL, Jean Joseph, Rochester, NY, Moses Kim, Laguna Hills, CA, Simone Crivellaro, Chicago, IL, Jeffrey Nix, Birmingham, AL, Jihad Kaouk, Cleveland, OH

MP57-11 INTRAOPERATIVE WORKLOAD DURING ROBOTIC RADICAL PROSTATECTOMY: COMPARISON BETWEEN MULTI-PORT DA VINCI XI AND SINGLE-PORT DA VINCI SP ROBOTS

Mazeed Aro-Lambo*, Susan Hallbeck, Katherine Law, Hamid Norasi, Matthew Tollefson, Rochester, MN

238

MP57-12 PATIENT REPORTED SEXUAL AND URINARY FUNCTIONAL OUTCOMES IN MEN WITH INTERMEDIATE RISK PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY: ANALYSIS OF THE MUSIC REGISTRY

Roshan Paudel*, Ann Arbor, MI, John Cochrane, Detroit, MI, Ji Qi, Ann Arbor, MI, Michael Cher, Detroit, MI, Richard Sarle, Lansing, MI, James Pe-abody, Detroit, MI, S. Mohammad Jafri, Royal Oak, MI, Brian Lane, Grand Rapids, MI, Alice Semerjian, Arvin George, Ann Arbor, MI, Kevin Ginsburg, Detroit, MI, for the Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI

MP57-13 SPIDER SILK NERVE RECONSTRUCTION IN ROBOTIC RADICAL PROSTATECTOMY: A FIRST IN MEN ANALYSIS

Nina N. Harke*, Sarah Strauss, Inga Peters, Olga Katzendorn, Markus A. Kuczyk, Peter M. Vogt, Hannover, Germany

MP57-14 MACHINE LEARNING PREDICTION OF CONTINENCE RECOVERY OF ROBOTIC-ASSISTED RADICAL PROSTATECTOMY

Adel Arezki*, Iman Sadri, David-Dan Nguyen, Montreal, Canada, Ahmed S. Zakaria, Thunder Bay, Canada, Assaad Elhakim, Malek Meskawi, Pierre Karakiewicz, Kevin C. Zorn, Montreal, Canada

MP57-15 PELVIC LYMPH NODE METASTASIS PREDICTION WITH INDOCYANINE GREEN FLUORESCENCE LYMPHANGIOGRAPHY IN ROBOTIC ASSISTED RADICAL PROSTATECTOMY

YuFeng Chuang*, Chin-Heng Lu, Yi-Shang Lin, Li-Hua Huang, Wei-Chun Weng, Chao-Yu Hsu, Min-Che Tung, Yen-Chuan Ou, Taichuang, Taiwan

MP57-16 IMPACT OF EXTENT OF LYMPHADENECTOMY ON ALL CAUSE MORTALITY IN PATIENTS WITH INTERMEDIATE AND HIGH-RISK PROSTATE CANCER MANAGED WITH RADICAL PROSTATECTOMY

Furkan Dursun*, Ahmed Elshabrawy, Hanzhang Wang, Michael A. Liss, Ronald Rodriguez, Dharam Kaushik, Ahmed M. Mansour, San Antonio, TX

MP57-17 THE COLLAR TECHNIQUE FOR APICAL DISSECTION DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: UPDATED SERIES AFTER FIVE YEARS FROM ITS INTRODUCTION

Angelo Mottaran*, Bologna, Italy, Carlo Andrea Bravi, Milan, Italy, Luca Sarchi, Modena, Italy, Pietro Piazza, Bologna, Italy, Fernando Gonzalez Meza, Marco Corsetti, Ghent, Belgium, Sophie Knipper, Hamburg, Germany, Marco Paciotti, Milan, Italy, Marco Amato, Modena, Italy, Rui Farinha, Ghent, Belgium, Stefano Puliatti, Mode-na, Italy, Simone Scarcella, Celine Sinatti, Ghent, Belgium, Geert De Naeyer, Ruben De Groote, Alexandre Mottrie, Aalst, Belgium

MP57-18 RATE OF BLADDER NECK CONTRACTURE AFTER OPEN AND MINIMALLY INVASIVE RADICAL PROSTATECTOMY OVER 18 YEARS AT THE VETERANS HEALTH ADMINISTRATION

Mitch Hayes*, Michael Conlin, Portland, OR, Helen Hougen, Portland, FL, Ryan Kopp, Portland, OR

MP57-19 VALIDATION OF PROSTATE SPECIFIC ANTIGEN DOUBLING TIME KINETICS FOLLOWING RADICAL PROSTATECTOMY TO GUIDE ACTIVE OBSERVATION AND INTERVENTION

Erica Huang*, Linda My Huynh, Adam Gordon, Ryan Chandhoke, Orange, CA, Blanca Morales, San Francisco, CA, Douglas Skarecky, Joshua Tran, Thomas Ahlering, Orange, CA

MP57-20 SHORTER STANDARD HOSPITAL ADMISSION FOLLOWING RADICAL PROSTATECTOMY IS ASSOCIATED WITH LOWER RISK OF POSTOPERATIVE COMPLICATIONS

Brittany Berk*, Boston, MA, Tzu-Hao Huang, Taipei, Taiwan, Maheetha Bharadwaj, Adam Kibel, Quoc-Dien Trinh, Boston, MA, Benjamin Chung, Stanford, CA, Steven Chang, Boston, MA



MO

ND

AY

Monday, May 16, 2022 1:00 pm – 2:15 pm

Moderated Poster Session 58PROSTATE CANCER: DETECTION & SCREENING VII

Room 228 @ Ernest N. Morial Convention CenterModerators: Kevin Loughlin, Douglas Scherr & Peter Pinto


MP58-01 IS MRI AND FUSION BIOPSIES NECESSARY IN PATIENTS WITH PSA LEVELS >10 NG/ML?

Lorenzo Maria Rovesti*, Riccardo Lombardo, Rome, Italy, Antonio Nacchia, Rionero in Vulture, Italy, Sara Riolo, Antonio Cicione, Beatrice Turchi, Giacomo Gallo, Carmen Gravina, Alessandro Guercio, Jordi Stira, Antonio Franco, Rome, Italy, Ferdinando Di Giacomo, Giuseppe Disabato, Rionero in Vulture, Italy, Giorgio Guarnotta, Elisa Mancini, Olivia Alessandra Voglino, Valeria Bal-dassarri, Simone D’Annunzio, Cosimo De Nunzio, Andrea Tubaro, Rome, Italy

MP58-02 PSA-DENSITY DETERMINES THE NEED FOR SYSTEMATIC BIOPSY IN MEN WITH PI-RADS 4/5 MRI

Zachary Feuer*, Richard Huang, Fang-Ming Deng, James Wysock, William Huang, Samir Taneja, New York, NY

MP58-03 PROSTATE CANCER SCREENING - A NOVEL RISK PREDICTION TOOL WITH STANDARD BIOPSIES VS. PSA WITH MRI-TARGETED BIOPSIES

Lars Björnebo*, Andrea Discacciati, Martin Eklund, Henrik Grönberg, Anna Lantz, Tobias Nordström, Solna, Sweden

MP58-04 PSA DENSITY DIRECTLY CORRELATES WITH PI-RADS LESION SCORE ON PROSTATE MRI

Clay Martin*, Jacob Gaines, Eric Macdonald, Max Kuster, Simon Hall, New Hyde Park, NY

MP58-05 URINARY SMART TEST FOR EARLY DETECTION OF PROSTATE CANCER

Sergio Occhipinti, Turin, Italy, Daniele Amparore, Stefano Granato, Enrico Checcucci, Federico Piramide, Sabrina De Cillis, Alberto Piana, Ga-briele Volpi, Paolo Verri, Michele Sica, Stefano Piscitello, Beatrice Carbonaro, Mariano Burgio, Juliette Meziere, Edoardo Cisero, Edoardo Dibilio, Giovanni Busacca, Matteo Manfredi, Cristian Fiori, Francesco Porpiglia*, Orbassano (Turin), Italy

MP58-06 DIAGNOSTIC PERFORMANCE OF MIXED TARGETED PROSTATE BIOPSY APPROACHES USING MICRO-ULTRASOUND AND MRI-FUSION BIOPSIES

Davide Maffei*, Cesare Saitta, Pier Paolo Avolio, Marco Paciotti, Vittorio Fasulo, Nicola Frego, Piet-ro Diana, Pieve Emanuele, Italy, Lazzeri Massimo, Rodolfo Hurle, Alberto Rosario Saita, Rozzano, It-aly, Giorgio Ferruccio Guazzoni, Pieve Emanuele, Italy, Paolo Casale, Rozzano, Italy, Nicolò Maria Buffi, Giovanni Lughezzani, Pieve Emanuele, Italy


MP58-07 CLINICALLY SIGNIFICANT PROSTATE CANCER DETECTION RATE BY PI-RADS SCORE AND PSA-DENSITY: A DESCRIPTIVE ANALYSIS

Zachary Feuer*, Richard Huang, Fang-Ming Deng, James Wysock, William Huang, Samir Taneja, New York, NY

MP58-08 TRANSPERINEAL VS TRANSRECTAL MRI/TRUS FUSION PROSTATE BIOPSY: A MATCHED-PAIR COMPARISON

Masatomo Kaneko*, Luis Medina, Amir Lebastchi, Giovanni Cacciamani, Alireza Ghoreifi, Marina Lenon, Reid Senesac, Manju Aron, Vinay Duddal-war, Suzanne Palmer, Inderbir Gill, Andre Abreu, Los Angeles, CA

MP58-09 DIAGNOSTIC PERFORMANCE OF FUSION (US/MRI GUIDED) PROSTATE BIOPSY: PROPENSITY SCORE MATCHED COMPARISON OF ELASTIC VERSUS RIGID FUSION SYSTEM

Mariaconsiglia Ferriero*, Rome, Italy, Cristian Fiori, Orbassano, Turin, Italy, Gabriele Tuderti, Umberto Anceschi, Alfredo Maria Bove, Aldo Brassetti, Leonardo Misuraca, Salvatore Guag-lianone, Riccardo Mastroianni, Michele Gallucci, Rome, Italy, Sabrina Decillis, Enrico Checcucci, Francesco Porpiglia, Orbassano, Turin, Italy, Giuseppe Simone, Rome, Italy

MP58-10 A NOVEL APPROACH FOR 3D RECONSTRUCTION OF THE PROSTATE GLAND THAT ALLOWS TUMOUR LOCATION, VOLUME ESTIMATION, AND GLEASON CHARACTERIZATION

Pedro Oliveira*, Manchester, United Kingdom, Avaneesh Meena, Saikiran Bonthu, Nitin Singhal, Mumbai, India, Ashwin Sachdeva, Yatin Jain, Vijay Ramani, Manchester, United Kingdom

MP58-11 COMPARISON OF PROSTATE CANCER DETECTION RATES BETWEEN TRANS-RECTAL MRI/US FUSION AND TRANS-PERINEAL COGNITIVE TARGETED PROSTATE BIOPSY APPROACHES

Johnathan Drevik*, Zafardjan Dalimov, Allen Rojhani, Phillip Abbosh, Steven Sterious, Joshua Cohn, Jay Simhan, Justin Friedlander, Eric Ghiral-di, Robert Uzzo, Serge Ginzburg, Philadelphia, PA

MP58-12 ADDITIONAL SYSTEMATIC TO MRI-TARGETED BIOPSY IN PROSTATE CANCER DIAGNOSIS: A DOUBLE-EDGED SWORD

Rodrigo Suarez-Ibarrola*, Cordula A. Jilg, Markus Grabbert, Christian Gratzke, August Sigle, Frei-burg, Germany

240

MP58-13 ATM MUTATIONS ARE ASSOCIATED WITH HIGH-RISK ARCHITECTURAL FEATURES IN MEN WITH FAMILIAL PROSTATE CANCER

Romy Mondschein*, Bolton Damien, David Clou-ston, Declan Murphy, Prudence Scott, Renea Taylor, James Dowty, Heather Thorne, Melbourne, Australia

MP58-14 DISCORDANCE BETWEEN PROSTATE IMAGING REPORTING & DATA SYSTEM SCORE AND TARGETED PROSTATE BIOPSY: AN OPPORTUNITY FOR QUALITY IMPROVEMENT

Rohith Arcot*, Srinath Kotamarti, Madison Krischak, Zoe Michael, Isaac Alderete, Thomas Polascik, Rajan Gupta, Durham, NC

MP58-15 ASSESSING THE ROLE OF HIGH-RESOLUTION MICRO-ULTRASOUND AMONG PATIENTS WITH A NEGATIVE MULTIPARAMETRIC MRI AND A PERSISTENT SUSPICION OF PROSTATE CANCER

Pier Paolo Avolio*, Milan, Italy, Vittorio Fasulo, Ce-sare Saitta, Pietro Diana, Alessandro Uleri, Andrea Gobbo, Paola Arena, Edoardo Beatrici, Giuseppe Chiarelli, Contieri Roberto, Nicola Frego, Davide Ma-ffei, Alberto Saita, Paolo Casale, Giorgio Ferruccio Guazzoni, Massimo Lazzeri, Rodolfo Hurle, Giovan-ni Lughezzani, Nicolò Maria Buffi, Milano, Italy

MP58-16 DOES VETERAN STATUS MITIGATE RACIAL DISPARITIES IN PROSTATE CANCER SCREENING? ANALYSIS OF PROSTATE-SPECIFIC ANTIGEN SCREENING PATTERNS IN THE 2018 BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM DATA

Khalid Alkhatib*, Muhieddine Labban, Logan Briggs, David-Dan Nguyen, Peter Herzog, Alexan-der P. Cole, Boston, MA, Austin Haag, Waco, TX, Quoc-Dien Trinh, Boston, MA

MP58-17 BLACK-TAILORED PROSTATE BIOPSY RISK CALCULATOR OUTPERFORMS PROSTATE CANCER PREVENTION TRIAL 2.0

Neil Mistry*, Norma Marshall, Adam Murphy, Chicago, IL

MP58-18 REAL WORLD APPLICATION AND EXPERIENCE OF A PROSTATE SPECIFIC ANTIGEN (PSA) MACHINE LEARNING MODEL IN A SCREENING POPULATION

Marlon Perera*, Lewis Smith, Peter Swindle, Brisbane, Australia, Anthony Costello, Melbourne, Australia, Elliot Smith, Brisbane, Australia

MP58-19 COMPARISON OF URONAV TRUS AND COGNITIVE FUSION TP BIOPSY IN DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER

Amanda Sherman*, Daneil Kuftinec, Burlington, MA, Lori Lyn Price, Boston, MA, Alireza Moinza-deh, William Faust, Burlington, MA

MP58-20 USE OF LOW-VALUE PROSTATE-SPECIFIC ANTIGEN SCREENING AMONG YOUNG MEN WITH PRIVATE INSURANCE

Jeffrey Vehawn*, Suzanne Lange, Mouneeb Choudry, Jacob Ambrose, Benjamin Haaland, Jonathan Chipman, Heidi A. Hanson, Brock O’Neil, Salt Lake City, UT


Monday, May 16, 2022 1:00 pm – 2:15 pm

Moderated Poster Session 59BLADDER CANCER: NON-INVASIVE III

Room 225 @ Ernest N. Morial Convention CenterModerators: Boris Gershman & Sumeet Bhanvadia


MP59-01 URINE MICRORNAS AS LIQUID BIOPSY ASSAY FOR PREDICTING RESPONSE TO INTRAVESICAL BCG THERAPY

Anirban P Mitra*, Sharada Mokkapati, H Barton Grossman, Ashish M Kamat, Houston, TX, David J McConkey, Baltimore, MD, Colin P N Dinney, Houston, TX


MP59-02 APPLICATION OF A MULTIPLEX URINALYSIS TEST FOR THE PREDICTION OF INTRAVESICAL BCG TREATMENT RESPONSE: A PILOT STUDY

Kaoru Murakami, Los Angeles, CA, Ashish M. Kamat, Houston, TX, Yunfeng Dai, Gainesville, FL, Ian Pagano, Honolulu, HI, Runpu Chen, Yijun Sun, Buffalo, NY, Amit Gupta, Nari Kim, Los Angeles, CA, Steve Goodison, Jacksonville, FL, Charles J. Rosser, Hideki Furuya*, Los Angeles, CA


MO

ND

AY

MP59-03 A URINE-BASED MUTATION-METHYLATION ASSAY FOR THE SURVEILLANCE OF HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS

Joep de Jong*, Florus de Jong, Angelique Ziel-van der Made, Ties Hagdorn, Egbert Boevé, Rotterdam, Netherlands, Hossain Roshani, The Hague, Netherlands, Eric Oomens, Breda, Neth-erlands, Rob Pelger, Ewout Steyerberg, Leiden, Netherlands, Joost Boormans, Chris Bangma, Tahlita Zuiverloon, Ellen Zwarthoff, Rotterdam, Netherlands

MP59-04 BLADDER CANCER RECURRENCE MONITORING BY URINARY EXTRACELLULAR VESICLE RNA BIOMARKERS

Toru Harabayashi*, Takahiro Osawa, Hiroshi Harada, Keita Minami, Norikata Takada, Akira Kashiwagi, Haruka Miyata, Kazushi Hirakawa, Yasuyuki Sato, Ryuji Matsumoto, Hiroshi Kikuchi, Takashige Abe, Sachiyo Murai, Nobuo Shinohara, Sapporo, Japan, Taku Murakami, Irvine, CA

MP59-05 FREQUENCY OF FIBROBLAST GROWTH FACTOR RECEPTOR ALTERATIONS AND ASSOCIATION WITH BACILLUS CALMETTE-GUERIN OUTCOMES IN A REAL-WORLD GENOMIC ANALYSIS OF HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER (GARNER) STUDY

Tahlita C.M Zuiverloon, Florus C. de Jong*, Rotterdam, Netherlands, Jenna Cody Carcione, Ramesh Sundaram, Titusville, NJ, Yoichiro Shiba-ta, Durham, NC, Spyros Triantos, Ademi Santia-go-Walker, Mahadi Baig, Titusville, NJ

MP59-06 PD-L1 EXPRESSION AND BCG RESPONSE IN NON-MUSCLE INVASIVE BLADDER CANCER

Solomon Woldu*, Thomas Gerald, Vitaly Margulis, Dallas, TX, Daniel Halstuch, Yaara Ber, Karin Lifshitz, David Margel, Petah Tikva, Israel, Yair Lotan, Liwei Jia, Dallas, TX

MP59-07 DOES THE URINARY MICROBIOME PROFILE CHANGE AFTER TREATMENT OF BLADDER CANCER?

Holly Houenstein, Yousuf Ramahi*, Ayat A. Shah, Philippa Doherty, Zhe Jing, Eduardo Cortes Gomez, Prashant K. Singh, Song Liu, Gary Smith, Li Tang, Khurshid A. Guru, Ahmed A. Hussein, Buffalo, NY

MP59-08 DISPARITIES IN THE PREVALENCE AND MANAGEMENT OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER

Angela Estevez*, Sumedh Kaul, Aaron Fleishman, Ruslan Korets, Peter Chang, Andrew Wagner, Joaquim Bellmunt, Aria Olumi, Heidi Rayala, Boris Gershman, Boston, MA

MP59-09 CHARACTERIZING MOLECULAR SUBTYPES OF HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER IN AFRICAN AMERICAN PATIENTS

Sungyong You, Minhyung Kim, Los Angeles, CA, Stephen G. Widen, Alexander Yu, Eduardo J. Eyzaguirre, Galveston, TX, Lars Dyrskjøt, Aarhus N, Denmark, David McConkey, Woonyoung Choi, Baltimore, MD, Dan Theodorescu, Keith S. Chan, Los Angeles, CA, Yong Shan, Douglas S. Tyler, Galveston, TX, Amanda M. De Hoedt, Durham, NC, Stephen J. Freedland, Los Angeles, CA, Stephen B. Williams*, Galveston, TX

MP59-10 EVALUATING EX VIVO INNATE IMMUNE TRAINING AS A PREDICTIVE MEASURE OF RESPONSIVENESS TO BCG IMMUNOTHERAPY IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER

Song Jiang*, Gil Redelman-Sidi, Eugene J. Pietzak, Bernard H. Bochner, Michael Glickman, New York, NY

MP59-11 EN BLOC RESECTION FOR BLADDER TUMORS: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSES OF ITS DIFFERENTIAL EFFECT ON ITS SAFETY, HISTOPATHOLOGY AND, RECURRENCE

Takafumi Yanagisawa*, Vienna, Austria, Keiichiro Mori, Tokyo, Japan, Reza Sari Motlagh, Tatsushi Kawada, Hadi Mostafaei, Fahad Quhal, Ekaterina Laukhtina, Pawel Rajwa, Frederik König, Maximil-ian Pallauf, Benjamin Pradere, David D’Andrea, Eva Compérat, Vienna, Austria, Jun Miki, Takahiro Kimura, Shin Egawa, Tokyo, Japan, Shahrokh F. Shariat, Vienna, Austria

MP59-12 DEPTH OF ENDOSCOPIC PERFORATION (DEEP SCALE): A NEW CLASSIFICATION TO PREDICT EARLY POST-OPERATIVE OUTCOMES IN THE ENDOSCOPIC TREATMENT OF BLADDER CANCER

Alberto Piana*, Andrea Gallioli, Pietro Diana, Angelo Territo, Matteo Fontana, Rodriguez Faba Óscar, Josep Maria Gaya, Ruben Parada, Asier Mercadé, Jorge Robalino, Joan Palou, Alberto Breda, Barcelona, Spain

MP59-13 BLADDER TUMOR ACCURATE RADIOFREQUENCY RESECTION: 38 CASES REPORTS

SHENGKUN SUN*, Guangfu Chen, Weijun Fu, Xu Zhang, Beijing, China, People’s Republic of

MP59-14 CROSS-SECTIONAL STUDY ASSESSING UTILIZATION PATTERNS OF COMBINATION INTRAVESICAL GEMCITABINE AND DOCETAXEL IN THE MANAGEMENT OF BLADDER CANCER

Andrew Gabrielson*, Sunil Patel, Noah Hahn, Baltimore, MD, Angela Smith, Chapel Hill, NC, Eugene Pietzak, New York, NY, Peter Black, Van-couver, Canada, Trinity Bivalacqua, Philadelphia, PA, Max Kates, Baltimore, MD

242

MP59-15 INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF MP17-11MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER: UPDATES FROM A PHASE 2 TRIAL

Sunil Patel*, Connie Collins, Nirmish Singla, Andrew Gabrielson, Baltimore, MD, Trinity J Bivalacqua, Philadelphia, PA, Noah Hahn, Max Kates, Baltimore, MD

MP59-16 SEQUENTIAL INTRAVESICAL VALRUBICIN AND DOCETAXEL FOR THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER

Ian M. McElree*, Vignesh T. Packiam, Ryan L. Steinberg, Sarah L. Mott, Paul T. Gellhaus, Kenneth G. Nepple, Michael A. O’Donnell, Iowa City, IA

MP59-17 DEVELOPMENT AND INTERNAL VALIDATION OF A PREDICTIVE MODEL FOR RECURRENCE-FREE SURVIVAL IN PTA LOW-GRADE BLADDER CANCER

Jorge Daza*, Buffalo, NY, Ralph Grauer, Sophie Chen, Etienne Lavallèe, Shirin Razdan, New York, NY, Linda Dey, Gunnar Steineck, Stockholm, Sweden, Qiang Li, Aly Ahmed, Buffalo, NY, Reza Mehrazin, Nikhil Waingankar, New York, NY, Khurshid Guru, Buffalo, NY, Peter Wiklund, John Sfakianos, New York, NY

MP59-18 INCIDENCE AND OUTCOMES OF NODAL METASTASIS IN CLINICALLY NON-MUSCLE INVASIVE BLADDER CANCER

Muhannad Alsyouf*, Sanam Ladi Seyedian, Alireza Ghoreifi, Antoin Douglawi, Jie Cai, Gus Miranda, Sumeet Bhanvadia, Anne Schuckman, Hooman Djaladat, Siamak Daneshmand, Los Angeles, CA

MP59-19 UPDATE OF TRUCE-02: AN OPEN LABEL, SINGLE-ARM, PHASE 2 STUDY OF TILELIZUMAB COMBINED WITH NAB-PACLITAXEL FOR HIGH-RISK NON-MUSCLE-INVASIVE UROTHELIAL BLADDER CARCINOMA (HR-NMIBC) WHICH IS NOT COMPLETELY RESECTABLE

Hailong Hu, Yuanjie Niu*, Haitao Wang, Chong Shen, La Da, Gangjian Zhao, Lili Wang, Zhouliang Wu, Zhe Zhang, Zhi Li, Zhan Jiang, Xuejian Zhan, Shaobo Yang, Tianjin, China, People’s Republic of

MP59-20 [18F]-FDG PET/CT FOR BLADDER CANCER STAGING AND DECISION-MAKING IN PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (HR-NMIBC)

Rodolfo Hurle, Paolo Casale, Alberto Saita, Roz-zano, Italy, NicolòMaria Buffi, Giovanni Lughezza-ni, Roberto Contieri, Vittorio Fasulo, Nicola Frego, Pieve Emanuele, Italy, Alessio Benetti, Rozzano, Italy, Arturo Chiti, Pieve Emanuele, Italy, Marcello Rodari, Rozzano, Italy, Martini Sollini, Cristiano Pini, Fabrizia Gelardi, Giorgio Guazzoni, Pieve Emanuele, Italy, Massimo Lazzeri*, Rozzano, Italy


Monday, May 16, 2022 1:00 pm – 3:00 pm

Podium Session 58BLADDER CANCER: UPPER TRACT TRANSITIONAL CELL CARCINOMA II

Room 252 @ Ernest N. Morial Convention CenterModerators: Seth Lerner & Firas Petros

ABSTRACTTIME NUMBER TITLE1:00 PD58-01 PREVALENCE AND SPECTRUM OF

GERMLINE MUTATIONS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA

Hong Truong*, Rania Sheikh, Yelena Kemel, Ma-nuel Jesus Escano, Andrew Lenis, Peter Reisz, Alvin Goh, Eugene Cha, Bernard Bochner, Maria Carlo, Hikmat Al-Ahmadie, Jonathan Coleman, New York, NY

1:10 PD58-02 NOVEL USE OF CTDNA TO IDENTIFY LOCALLY ADVANCED AND METASTATIC UPPER TRACT UROTHELIAL CARCINOMA

Heather Huelster*, Elizabeth Green, Alex Soupir, Kyle Rose, Esther Katende, Shreyas Naidu, Scott Gilbert, Brandon Manley, Michael Poch, Wade Sexton, Alice Yu, Youngchul Kim, Tampa, FL, Pan Du, Shidong Jia, Il-Jin Kim, Lu Tan, Hayward, CA, Liang Wang, Roger Li, Tampa, FL

ABSTRACTTIME NUMBER TITLE1:20 PD58-03 DETECTION OF INDIVIDUALIZED

MUTATION USING PLASMA AND URINARY CIRCULATING TUMOR DNA IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA

Daichi Tamura*, Masakazu Abe, Renpei Kato, Yoichiro Kato, Shigekatsu Maekawa, Mitsugu Kanehira, Ryo Takata, Yahaba, Japan, Yutaka Suzuki, Kashiwa, Japan, Hidewaki Nakagawa, Yokohama, Japan, Satoshi Nishizuka, Wataru Obara, Yahaba, Japan

1:30 PD58-04 A COMPREHENSIVE LIQUID BIOPSY TO DETECT PRIMARY UPPER TRACT UROTHELIAL CARCINOMA: A PILOT STUDY

Alireza Ghoreifi*, Stephanie Shishido, Jeremy Mason, George Courcoubetis, Manju Aron, Inderbir Gill, Monish Aron, Mihir Desai, Siamak Daneshmand, Peter Kuhn, Hooman Djaladat, Los Angeles, CA


MO

ND

AY

1:40 PD58-05 FINAL RESULTS OF A PHASE I TRIAL OF WST11 (TOOKAD SOLUBLE) VASCULAR-TARGETED PHOTODYNAMIC THERAPY FOR UPPER TRACT UROTHELIAL CARCINOMA

Wesley Yip*, Daniel Sjoberg, Lucas Nogueira, Andrew Tracey, Ricardo Alvim, Peter Reisz, Quinlan Demac, Nicole Benfante, Karan Nagar, Jasmine Thomas, Jie Chen, Kwanghee Kim, Oscar Lin, David Solit, New York, NY, Avigdor Scherz, Rehovot, Israel, Jonathan Coleman, New York, NY

1:50 PD58-06 ANTEGRADE ADMINISTRATION OF REVERSE THERMAL MITOMYCIN GEL FOR PRIMARY CHEMOABLATION OF UPPER TRACT UROTHELIAL CARCINOMA VIA PERCUTANEOUS NEPHROSTOMY TUBE: A MULTI-INSTITUTIONAL REAL-WORLD EXPERIENCE

Kyle Rose*, Tampa, FL, Gopal Narang, Scotts-dale, AZ, Geoffrey Rosen, Columbia, MO, Craig Labbate, Houston, TX, Justin Campagna, Scottsdale, AZ, Alice Yu, Brandon Manley, Phillipe Spiess, Roger Li, Tampa, FL, Mehrad Adibi, Houston, TX, Katie Murray, Columbia, MO, Wade Sexton, Tampa, FL, Mitchell Humphreys, Scottsdale, AZ

2:00 PD58-07 IMPACT OF NODE COUNT ON SURVIVAL OUTCOMES OF LYMPH NODE DISSECTION IN NON-METASTATIC UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY

Kevin Hakimi*, La Jolla, CA, Umberto Carbonara, Richmond, VA, Hooman Djaladat, Los Angeles, CA, Reza Mehrazin, New York, NY, Daniel Eun, Adam Reese, Philadelphia, PA, Mark Gonzalgo, Miami, FL, Vitaly Margulis, Houston, TX, Robert Uzzo, Phil-adelphia, PA, James Porter, Seattle, WA, Chandru Sundaram, Indianapolis, IN, Firas Abdollah, Detroit, MI, Alexandre Mottrie, Aalast, Belgium, Riccardo Tellini, Florence, Italy, Matteo Ferro, Milan, Italy, Margaret Meagher, Ava Saidian, Arman Walia, La Jolla, CA, Alessandro Veccia, Richmond, VA, Al-ireza Ghoreifi, Giovanni Cacciamani, Los Angeles, CA, Amit Bhattu, Miami, FL, Xiaosong Meng, Hou-ston, TX, Jason Farrow, Indianapolis, IN, Marcus Jamil, Detroit, MI, Andrea Minervini, Florence, Italy, Koon Rha, Seoul, Korea, Republic of, Zhenjie Wu, Shanghai, China, People’s Republic of, Giuseppe Simone, Rome, Italy, Riccardo Autorino, Richmond, VA, Ithaar Derweesh, La Jolla, CA

2:10 PD58-08 SURVIVAL OUTCOMES IN SOLITARY KIDNEY PATIENTS DIAGNOSED WITH UPPER TRACT UROTHELIAL CARCINOMA

Ridwan Alam*, Joseph Cheaib, Michael Biles, Baltimore, MD, Jared Winoker, New York City, NY, Nirmish Singla, Baltimore, MD, Trinity Bivalacqua, Phillip Pierorazio, Philadelphia, PA, Max Kates, Sunil Patel, Baltimore, MD

2:20 PD58-09 IS SEGMENTAL URETERECTOMY ASSOCIATED WITH INFERIOR SURVIVAL FOR LOCALIZED UPPER TRACT UROTHELIAL CARCINOMA OF THE URETER COMPARED TO RADICAL NEPHROURETERECTOMY

Marco Paciotti*, Rozzano, Italy, Khalid Alkhat-ib, David-Dan Nguyen, Kendrick Yim, Stuart R. Lipsitz, Matthew Mossanen, Adam S. Kibel, Quoc-Dien Trinh, Boston, MA, Nicoló Buffi, Gio-vanni Lughezzani, Rozzano, Italy, Alexander P. Cole, Boston, MA

2:30 PD58-10 IMPLEMENTING THE FOLLOW-UP SCHEDULE AFTER RADICAL NEPHROURETRECTOMY FOR LOW RISK UPPER TRACT UROTHELIAL CARCINOMA

Alberto Martini*, Riccardo Leni, Giuseppe Basile, Simone Scuderi, Mario De Angelis, Luigi Nocera, Giuseppe Rosiello, Milan, Italy, Chiara Lonati, Luca Afferi, Lucerne, Switzerland, Giorgio Gandaglia, Milan, Italy, Andrea Gallina, Lugano, Switzerland, Pierre Karakiewicz, Montreal, Canada, Shahrokh Shariat, Vienna, Austria, Francesco Montorsi, Alber-to Briganti, Marco Moschini, Milan, Italy

2:40 PD58-11 IMPACT OF PRE-OPERATIVE KIDNEY FUNCTION ON SURVIVAL OUTCOMES IN UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY

Kevin Hakimi*, La Jolla, CA, Umberto Carbonara, Richmond, VA, Hooman Djaladat, Los Angeles, CA, Reza Mehrazin, New York, NY, Daniel Eun, Adam Reese, Philadelphia, PA, Mark Gonzalgo, Miami, FL, Vitaly Margulis, Houston, TX, Robert Uzzo, Philadelphia, PA, James Porter, Seattle, WA, Chandru Sundaram, Indianapolis, IN, Firas Abdollah, Detroit, MI, Alexandre Mottrie, Aalast, Belgium, Riccardo Tellini, Florence, Italy, Matteo Ferro, Milan, Italy, Margaret Meagher, Ava Saidian, Arman Walia, La Jolla, CA, Alessandro Veccia, Richmond, VA, Alireza Ghoreifi, Giovan-ni Cacciamani, Los Angeles, CA, Amit Bhattu, Miami, FL, Xiaosong Meng, Houston, TX, Jason Farrow, Indianapolis, IN, Marcus Jamil, Detroit, MI, Andrea Minervini, Florence, Italy, Koon Rha, Seoul, Korea, Republic of, Zhenjie Wu, Shanghai, China, People’s Republic of, Giuseppe Simone, Rome, Italy, Riccardo Autorino, Richmond, VA, Ithaar Derweesh, La Jolla, CA

2:50 PD58-12 CROSS-REACTIVITY BETWEEN THE FIRST-LINE CHEMOTHERAPY AND SUBSEQUENT IMMUNOTHERAPY IN PATIENTS WITH UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA

Tomoko Hamaya*, Shingo Hatakeyama, Kai Oza-ki, Kazutaka Okita, Yasuhiro Hashimoto, Chikara Ohyama, Hirosaki, Japan


244

Monday, May 16, 2022 1:00 pm – 3:00 pm

Podium Session 59KIDNEY CANCER: ADVANCED (INCLUDING DRUG THERAPY) II

Room 255 @ Ernest N. Morial Convention CenterModerator: Stephen Boorjian

ABSTRACTTIME NUMBER TITLE1:00 PD59-01 BAP1 LOSS IS ASSOCIATED WITH

METASTASIS IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA

Sari Khaleel*, Anne Reiner, Cameron Brennan, Ibrahim Hussain, Samuel Berman, Ari Hakimi, Nelson Moss, New York, NY

1:10 PD59-02 PROSTATE SPECIFIC MEMBRANE ANTIGEN EXPRESSION IS ASSOCIATED WITH ANGIOGENESIS AND TYROSINE KINASE INHIBITOR RESPONSE IN CLEAR CELL RENAL CELL CARCINOMA

Sari Khaleel*, Marlon Perera, Fengshen Kuo, Phil-ip Rappold, Robert Motzer, Paul Russo, Jonathan Coleman, Martin Voss, Eduard Reznik, Ari Hakimi, New York, NY

1:20 PD59-03 ADJUVANT THERAPY AFTER SURGICAL RESECTION OF NONMETASTATIC RENAL-CELL CARCINOMA: ONE SIZE DOES NOT FIT ALL

Zine-Eddine Khene*, Rennes, France, Axel Bex, London, United Kingdom, Karim Bensalah, Rennes, France

1:30 PD59-04 APPLICATION OF THE KEYNOTE-564 TRIAL RESULTS TO REAL LIFE POPULATION: WHICH PATIENTS WITH ADVANCED KIDNEY CANCER SHOULD RECEIVE ADJUVANT PEMBROLIZUMAB

Giuseppe Fallara*, Giuseppe Rosiello, Daniele Raggi, Laura Marandino, Greta Malena, Giuseppe Basile, Gianmarco Colandrea, Daniele Cignoli, Federico Belladelli, Giacomo Musso, Francesco Cei, Roberto Bertini, Alberto Briganti, Andrea Salonia, Francesco Montorsi, Alessandro Larcher, Andrea Necchi, Umberto Capitanio, Milan, Italy

1:40 PD59-05 COST EFFECTIVENESS OF ADJUVANT PEMBROLIZUMAB AFTER NEPHRECTOMY FOR RCC: INSIGHTS FOR PATIENT SELECTION FROM A MARKOV MODEL

Vidit Sharma*, Kevin M Wymer, Daniel D Joyce, James Moriarty, Bijan J Borah, R. Houston Thompson, Brian A Costello, Bradley C Leibovich, Stephen A Boorjian, Rochester, MN

ABSTRACTTIME NUMBER TITLE1:50 PD59-06 PEMBROLIZUMAB OUTPERFORMS

TYROSINE KINASE INHIBITORS IN THE ADJUVANT THERAPY OF PATIENTS WITH HIGH-RISK RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Ekaterina Laukhtina*, Fahad Quhal, Keiichiro Mori, Reza Sari Motlagh, Satoshi Katayama, Pawel Rajwa, Takafumi Yanagisawa, Nico C. Grossmann, Hadi Mostafaei, Frederik König, Abdulmajeed Aydh, Benjamin Pradere, Vienna, Austria, Jeremy Yuen-Chun Teoh, Hong Kon, China, People’s Republic of, Dmitry Enikeev, Moscow, Russian Federation, Pierre I. Karakie-wicz, Montreal, Canada, Manuela Schmidinger, Shahrokh F. Shariat, Vienna, Austria

2:00 PD59-07 NEGLECTED LYMPH NODAL METASTASES IN PATIENTS WITH RENAL CANCER: WHEN TO EXTEND THE ANATOMICAL TEMPLATE OF LYMPH NODE DISSECTION DURING NEPHRECTOMY

Giuseppe Rosiello*, Giuseppe Fallara, Giuseppe Basile, Daniele Cignoli, Alberto Martini, Francesco De Cobelli, Giorgio Brembilla, Luigi Nocera, Fed-erico Belladelli, Gianmarco Colandrea, Daniela Canibus, Chiara Re, Giacomo Musso, Francesco Cei, Rayan Matloob, Alberto Briganti, Roberto Bertini, Andrea Necchi, Daniele Raggi, Milan, Italy, Pierre I. Karakiewicz, Montreal, Canada, Frances-co Montorsi, Andrea Salonia, Alessandro Larcher, Umberto Capitanio, Milan, Italy

2:10 PD59-08 INTERNATIONAL MULTI-INSTITUTIONAL CHARACTERIZATION OF THE PERIOPERATIVE MORBIDITY OF METASTASECTOMY FOR RENAL CELL CARCINOMA

Timothy Lyon*, Jacksonville, FL, Eduard Rous-sel, Leuven, Belgium, Vidit Sharma, Rochester, MN, Gianpiero Carames, Jacksonville, FL, Christine Lohse, Stephen Boorjian, Houston Thompson, Rochester, MN, Steven Joniau, Maarten Albersen, Leuven, Belgium, Bradley Leibovich, Rochester, MN

2:20 PD59-09 OUTCOMES OF CYTOREDUCTIVE NEPHRECTOMY FOLLOWED BY ACTIVE SURVEILLANCE IN METASTATIC RENAL CELL CARCINOMA

Sari Khaleel*, New York, NY, Andrew Silagy, Melbourne, Australia, Cihan Duzgol, Ritesh Kote-cha, Philip Rappold, Robert Motzer, Paul Russo, Jonathan Coleman, Martin Voss, Ari Hakimi, New York, NY


MO

ND

AY

2:30 PD59-10 IMPROVING DECISION-MAKING FOR CYTOREDUCTIVE NEPHRECTOMY BY EVALUATING PRE-SURGICAL RADIOGRAPHIC TUMOR CHARACTERISTICS

Daniel Shapiro*, Madison, WI, Jose Karam, Alberto Pieretti, Mary Westerman, Houston, TX, Philippe Spiess, Tampa, FL, Viraj Master, Atlanta, GA, Jay Raman, Hershey, PA, Wade Sexton, Tampa, FL, Glenn Allen, Madison, WI, Surena Matin, Christopher Wood, Houston, TX, E. Jason Abel, Madison, WI

2:40 PD59-11 ASSOCIATION BETWEEN IMMUNE-RELATED ADVERSE EVENTS AND CLINICAL OUTCOMES IN ADVANCED GENITOURINARY CANCERS TREATED WITH IMMUNOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS

Junru Chen*, Yaowen Zhang, Yuchao Ni, Guangxi Sun, Hao Zeng, Chengdu, China, People’s Re-public of

2:50 PD59-12 MICROWAVE ABLATION COMBINED WITH ANTI-PD-1/CTLA-4 THERAPY INDUCES ANTI-TUMOR IMMUNE RESPONSE TO RENAL CELL CARCINOMA IN A MURINE MODEL

Run-Qi Guo*, Jin-Zhao Peng, Xiao-Guang LI, Beijing, China, People’s Republic of


Monday, May 16, 2022 1:00 pm – 3:00 pm

Podium Session 60PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY V

Room 245 @ Ernest N. Morial Convention CenterModerators: Leticia Ruiz & Reza Ghavamian

ABSTRACTTIME NUMBER TITLE1:00 PD60-01 THE IMPACT OF BASELINE HEALTH-

RELATED QUALITY OF LIFE ON BIOCHEMICAL RECURRENCE FREE SURVIVAL IN HIGH-RISK PROSTATE CANCER PATIENTS FOLLOWING RADICAL PROSTATECTOMY

Thilo Westhofen*, Alexander Buchner, Boris Schlenker, Armin Becker, Christian G. Stief, Alex-ander Kretschmer, Munich, Germany

1:10 PD60-02 CAN PELVIC LYMPH NODE DISSECTION BE OMITTED AT THE TIME OF RADICAL PROSTATECTOMY IN PATIENTS WITH A NEGATIVE PREOPERATIVE 68GA-PSMA PET/CT? THE IMPORTANCE OF PATIENT RISK STRATIFICATION ACCORDING TO INDIVIDUAL RISK OF LYMPH NODE METASTASES

Elio Mazzone*, Milan, Italy, Daniele Robesti, Giorgio Gandaglia, Armando Stabile, Carlo Andrea Bravi, Andrea Necchi, Daniele Raggi, Laura Marandino, Milano, Italy, Giuseppe Cirulli, Milan, Italy, Eleonora Balestrazzi, Stefano Fanti, Bologna, Italy, Vito Cuc-chiara, Milan, Italy, Andrea Farolfi, Lorenzo Bianchi, Riccardo Schiavina, Bologna, Italy, Francesco Montorsi, Alberto Briganti, Milano, Italy

ABSTRACTTIME NUMBER TITLE1:20 PD60-03 THE IMPACT OF HISTOLOGICAL VARIANTS

ON THE PERFORMANCE CHARACTERISTICS OF 68GA-PSMA PET/CT IN THE PRIMARY AND RECURRENT SETTING

Simone Scuderi*, Elio Mazzone, Milano, Italy, Giorgio Gandaglia, Milan, Italy, Roberta Lucianò, Nazario Pio Tenace, Milano, Italy, Alessia Cimad-amore, Ancona, Italy, Andrea Necchi, Daniele Raggi, Laura Marandino, Riccardo Leni, Daniele Robesti, Lorenzo Toneatto, Donato Cannoletta, Leonardo Quarta, Milano, Italy, Mario De Angelis, Francesco Pellegrino, Gabriele Sorce, Milan, Italy, Francesco Barletta, Milano, Italy, Luigi Nocera, Milan, Italy, Giuseppe Rosiello, Milano, Italy, Armando Stabile, Milan, Italy, Francesco Montorsi, Alberto Briganti, Milano, Italy

1:30 PD60-04 SURVIVAL AFTER RADICAL PROSTATECTOMY VS. RADIATION THERAPY IN CLINICAL NODE-POSITIVE PROSTATE CANCER

Francesco Chierigo*, Genova, Italy, Christoph Würnschimmel, Hamburg, Germany, Rocco Simone Flammia, Rome, Italy, Benedikt Horle-mann, Montreal, Canada, Gabriele Sorce, Milan, Italy, Benedikt Hoeh, Frankfurt, Germany, Zhe Tian, Fred Saad, Montreal, Canada, Markus Graefen, Hamburg, Germany, Michele Gallucci, Rome, Italy, Alberto Briganti, Francesco Montorsi, Milan, Italy, Felix K.H. Chun, Frankfurt, Germany, Shahrokh F. Shariat, Vienna, Austria, Guglielmo Mantica, Maro Borghesi, Nazareno Suardi, Carlo Terrone, Genova, Italy, Pierre I Karakiewicz, Montreal, Canada

246

1:40 PD60-05 A 20 YEAR FOLLOW-UP STUDY OF ONCOLOGIC OUTCOMES, QUALITY OF LIFE AND COMPLICATIONS IN PATIENTS UNDERGOING ROBOTIC RADICAL PROSTATECTOMY

Alexander Bandin*, Ilene Staff, Joseph Tortora, Kevin Pinto, Tara McLaughlin, Rosa Negron, Lau-ra OlivoValintin, Hartford, CT, Caner Dinlenc, New York, NY, Joseph Wagner, Hartford, CT

1:50 PD60-06 PATIENT REPORTED OUTCOMES OF URINARY INCONTINENCE RATES USING VIABLE CRYOPRESERVED UMBILICAL TISSUE OVER NEUROVASCULAR BUNDLES DURING ROBOTIC ASSISTED RADICAL PROSTATECTOMY

Mit Shah*, Alexander Geisenhoff, Samantha Kraemer, Royal Oak, MI, Ji Qi, Ann Arbor, MI, Chirag Dave, Fiona Sun, Sugandh Shetty, Brian Seifman, Jason Hafron, Royal Oak, MI

2:00 PD60-07 OBJECTIVE RISK SCORE RELIABLY PREDICTS MAJOR MORBIDITY AND MORTALITY AFTER RADICAL PROSTATECTOMY

Kristen Maatman*, Christopher Ledbetter, A. Lynn Patterson, Robert Wake, Memphis, TN

2:10 PD60-08 OUTCOMES OF SALVAGE ROBOTIC-ASSISTED RADICAL PROSTATECTOMY COMPARING PATIENTS WITH PRIMARY FOCAL THERAPY VERSUS WHOLE GLAND ABLATION: A MULTICENTRIC COLLABORATIVE DATA

Seetharam Bhat Kulthe Ramesh*, Celebration, FL, Arjun Nathan, London, United Kingdom, Marcio Moschovas, Celebration, India, Senthil Nathan, London, United Kingdom, Vipul Patel, Celebration, India

2:20 PD60-09 LAPAROSCOPIC VERSUS ROBOT-ASSISTED RADICAL PROSTATECTOMY: TEN-YEAR OUTCOME OF A PROSPECTIVE RANDOMISED TRIAL

Enrico Checcucci, Orbassano (Turin), Italy, Euge-nio Alladio, Turin, Italy, Sabrina De Cillis, Stefano Granato, Daniele Amparore, Alberto Piana, Federico Piramide, Gabriele Volpi, Michele Sica, Paolo Verri, Beatrice Carbonaro, Juliette Meziere, Davide Zamengo, Marcello Della Corte, Edoardo Dibilio, Angela Pecoraro, Giovanni Cattaneo, Orbassano (Turin), Italy, Michele Di Dio, Cosen-za, Italy, Matteo Manfredi, Francesco Porpiglia*, Orbassano (Turin), Italy

2:30 PD60-10 A MORE EXTENDED PELVIC LYMPH NODE DISSECTION DECREASES RECURRENCE RATES IN SELECTED PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY

Giorgio Gandaglia*, Giuseppe Rosiello, Milano, Italy, Francesco Pellegrino, Milan, Italy, Antony Pel-legrino, Marco Bandini, Andrea Salonia, Manuela Tutolo, Mario De angelis, Milano, Italy, Gabriele Sorce, Elio Mazzone, Armando Stabile, Vito Cucchiara, Emanuele Zaffuto, Milan, Italy, Pierre I. Karakiewicz, Montreal, Canada, Shahrokh F. Shar-iat, Vienna, Austria, Vincenzo Mirone, Napoli, Italy, Francesco Montorsi, Alberto Briganti, Milano, Italy

2:40 PD60-11 IMPACT OF THE TIME ELAPSED BETWEEN PROSTATE BIOPSY AND SURGERY ON THE ACCURACY OF THE BRIGANTI NOMOGRAM PREDICTING LYMPH NODE INVASION IN MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER

Giorgio Gandaglia*, Elio Mazzone, Emanuele Zaf-futo, Gabriele Sorce, Francesco Pellegrino, Luigi Nocera, Armando Stabile, Umberto Capitanio, Alessandro Larcher, Milan, Italy, Andrea Salonia, Milano, Italy, Federico Dehò, Varese, Italy, Pierre I. Karakiewicz, Montreal, Canada, Shahrokh F. Shariat, Vienna, Austria, Francesco Montorsi, Alberto Briganti, Milano, Italy

2:50 PD60-12 THE IMPACT OF FRAILTY STATUS ON SURGICAL OUTCOMES AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY - A PROSPECTIVE ASSESSMENT USING A STANDARDIZED COLLECTION SYSTEM FOR PERIOPERATIVE OUTCOMES

Giuseppe Rosiello*, Simone Scuderi, Giorgio Gandaglia, Elio Mazzone, Armando Stabile, Francesco Barletta, Antony Pellegrino, Lorenzo Toneatto, Donato Cannoletta, Leonardo Quarta, Gianmarco Colandrea, Riccardo Leni, Dan-iele Robesti, Milano, Italy, Umberto Capitanio, Alessandro Larcher, Milan, Italy, Andrea Salonia, Milano, Italy, Federico Dehò, Varese, Italy, Pierre I. Karakiewicz, Montreal, Canada, Francesco Montorsi, Alberto Briganti, Milano, Italy



MO

ND

AY

Monday, May 16, 2022 1:00 pm – 3:00 pm

Video Session 13ADRENAL & RENAL ONCOLOGY II

Video Abstracts Theater @ Ernest N. Morial Convention CenterModerators: Eric Kim, David Canes & Allen Chiu

ABSTRACTTIME NUMBER TITLE1:00 V13-01 SUPERIOR MESENTERIC ARTERY

INJURY DURING ROBOTIC LEFT RADICAL NEPHRECTOMY: PREVENTION AND MANAGEMENT

Aref S. Sayegh*, Anibal La Riva, Laura C. Perez, Luis G. Medina, Edward Forsyth, Ryan Powers, Los Angeles, CA, Ben Challacombe, London, United Kingdom, Michael Stifelman, Hackensack, NJ, Inderbir S. Gill, Rene Sotelo, Los Angeles, CA

1:10 V13-02 INTRAOPERATIVE RECOGNITION & MANAGEMENT OF AN LATROGENIC CLIPPING OF THE SUPERIOR MESENTERIC ARTERY DURING ROBOTIC LEFT CYTOREDUCTIVE NEPHRECTOMY

Brijesh Patel*, Daniel Roadman, Chicago, IL, Mark Biebel, St. Louis, MO, Alexander Chow, Chicago, IL, Robert Figenshau, St. Loius, MO

1:20 V13-03 EIGHT-YEAR EXPERIENCE OF ROBOTIC IVC THROMBECTTOMY:SURGICAL TECHNIQUE, PERIOPERATIVE AND ONCOLOGIC OUTCOMES

Leonardo Misuraca*, Umberto Anceschi, Gabriele Tuderti, Riccardo Mastroianni, Mariaconsiglia Ferriero, Aldo Brassetti, Alfredo Maria Bove, Salvatore Guaglianone, Rome, Italy, Mihir Desai, Inderbir Singh Gill, Los Angeles, CA, Michele Gallucci, Giuseppe Simone, Rome, Italy

1:30 V13-04 COMPLETE MINIMALLY-INVASIVE SURGERY IS FEASIBLE FOR RENAL CANCER WITH LEVEL IV INTRACARDIAC TUMOUR THROMBUS

Paolo Dell’Oglio*, Mattia Longoni, Milan, Italy, Stefano Tappero, Genova, Italy, Silvia Secco, Milan, Italy, Erika Palagonia, Ancona, Italy, Alberto Olivero, Francesca Mulazzani, Ombretta Amici, Andrea Brunetti, Aldo Massimo Bocciardi, Antonio Galfano, Milan, Italy

1:40 V13-05 A NOVEL SUPINE APPROACH TO ROBOTIC RADICAL NEPHRECTOMY AND LEVEL III INFERIOR VENA CAVA THROMBECTOMY

Christopher Dall*, James Mason, Charlotte Gold-man, Sholklapper Tamir, Jason Hawksworth, Keith Kowalczyk, Washington, DC

1:50 V13-06 OPEN RIGHT PARTIAL NEPHRECTOMY WITH INFERIOR VENA CAVA THROMBECTOMY FOR RENAL CELL CARCINOMA

Ryan Nasseri*, Devin Patel, Daniel Holst, Marga-ret Meagher, Ithaar Derweesh, San Diego, CA

ABSTRACTTIME NUMBER TITLE2:00 V13-07 INFERIOR VENA CAVA MANAGEMENT

DURING LEFT-SIDED LEVEL III TUMOR THROMBECºTOMY

Shawn Dason*, Columbus, OH

2:10 V13-08 ROBOT-ASSISTED LAPAROSCOPIC NEPHROURETERECTOMY IN A HORSESHOE KIDNEY IS FACILITATED WITH INDOCYANINE GREEN AND NEAR-INFRARED FLOURESCENCE IMAGING

Fahad Sheckley*, Nermarie Velazquez, Bethany Desroches, Ravi Munver, Hackensack, NJ

2:20 V13-09 TRICUSPID INSUFFICIENCY CAUSED BY RENAL ANGIOMYOLIPOMA WITH EXTENSION TO THE INFERIOR VENA CAVA AND RIGHT ATRIUM. A MULTIDISCIPLINARY APPROACH

Ruben Santiago*, Omar Vieyra, Rodrigo Perez, Victor Osornio, Gerardo Garza, Roberto Lopez, Mario Ortega, Estado de México, Mexico

2:30 V13-10 LINEAR STAPLING DEVICE IN LAPAROSCOPIC PARTIAL ADRENALECTOMY FOR PHEOCHROMOCYTOMA IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B

Patricio Garcia Marchiñena*, Andrés Germán Alfi-eri, Facundo Barbagallo, Ricardo Hosman Basto, Alberto Jurado, Buenos Aires, Argentina

2:40 V13-11 SINGLE PORT ROBOT-ASSISTED LAPAROSCOPIC ADRENALECTOMY VIA MINI PFANNENSTIEL INCISION

Justin James*, New York, NY, Arun Rai, Jacob Gaines, Eric Macdonald, Manish Vira, New Hyde Park, NY

2:50 V13-12 SINGLE PORT DA VINCI ROBOTIC RADICAL ADRENALECTOMY VIA MCBURNEY INCISION

Jason Elyaguov*, Valhalla, NY, Mubashir Billah, Michael Stifelman, Mutahar Ahmed, Nutley, NJ


WE ARE COUNTING ON YOU

Visit the Census Booth in to take the Census or skip the line and scan the QR code to get started.

• Approved indications

• Resources for health care professionals

• The Merck Access Program

• KEY+YOU Patient Support Program

Visit the Merck Booth and Learn More AboutKEYTRUDA

Copyright © 2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.All rights reserved. US-KEY-04438 12/21 keytrudahcp.com

PROGRAM - American Urological Association

Documents

Transcript of PROGRAM - American Urological Association